<SEC-DOCUMENT>0001376339-21-000093.txt : 20210803
<SEC-HEADER>0001376339-21-000093.hdr.sgml : 20210803
<ACCEPTANCE-DATETIME>20210803171419
ACCESSION NUMBER:		0001376339-21-000093
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		80
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20210803
DATE AS OF CHANGE:		20210803

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MIMEDX GROUP, INC.
		CENTRAL INDEX KEY:			0001376339
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				262792552
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35887
		FILM NUMBER:		211140982

	BUSINESS ADDRESS:	
		STREET 1:		1775 W OAK COMMONS COURT, NE
		CITY:			MARIETTA
		STATE:			GA
		ZIP:			30062
		BUSINESS PHONE:		(770) 651-9100

	MAIL ADDRESS:	
		STREET 1:		1775 W OAK COMMONS COURT, NE
		CITY:			MARIETTA
		STATE:			GA
		ZIP:			30062

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Alynx, Co.
		DATE OF NAME CHANGE:	20060922
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>mdxg-20210630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:2348d07d-1fe7-4f85-b08a-d7c74be22bf0,g:fbe44d2f-ecde-4c93-87d4-07ca0cdbb039,d:586f4d48e4324b41820aaf3f28c0b969--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:mdxg="http://mimedx.com/20210630" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mdxg-20210630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80L2ZyYWc6ODlhZWYxZWExOTIzNDMxZjgwMDVjZmJhZTEyMjc4NWMvdGFibGU6YTkwNDc5MTVjNjczNDEyMThiMTE4ZjY4NzEzY2NlODEvdGFibGVyYW5nZTphOTA0NzkxNWM2NzM0MTIxOGIxMThmNjg3MTNjY2U4MV8zLTEtMS0xLTA_f8e0ff81-ea4e-4a40-a604-9d1cacd68df7">0001376339</ix:nonNumeric><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80L2ZyYWc6ODlhZWYxZWExOTIzNDMxZjgwMDVjZmJhZTEyMjc4NWMvdGFibGU6YTkwNDc5MTVjNjczNDEyMThiMTE4ZjY4NzEzY2NlODEvdGFibGVyYW5nZTphOTA0NzkxNWM2NzM0MTIxOGIxMThmNjg3MTNjY2U4MV80LTEtMS0xLTA_c6bcdbbb-45ea-40ae-8b6d-1105c270267b">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80L2ZyYWc6ODlhZWYxZWExOTIzNDMxZjgwMDVjZmJhZTEyMjc4NWMvdGFibGU6YTkwNDc5MTVjNjczNDEyMThiMTE4ZjY4NzEzY2NlODEvdGFibGVyYW5nZTphOTA0NzkxNWM2NzM0MTIxOGIxMThmNjg3MTNjY2U4MV83LTEtMS0xLTA_eb8a52ec-d8ae-4c27-acae-d384f39afb19">2021</ix:nonNumeric><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80L2ZyYWc6ODlhZWYxZWExOTIzNDMxZjgwMDVjZmJhZTEyMjc4NWMvdGFibGU6YTkwNDc5MTVjNjczNDEyMThiMTE4ZjY4NzEzY2NlODEvdGFibGVyYW5nZTphOTA0NzkxNWM2NzM0MTIxOGIxMThmNjg3MTNjY2U4MV84LTEtMS0xLTA_a93cc69b-5659-4ec3-8d7e-ea6680009215">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80L2ZyYWc6ODlhZWYxZWExOTIzNDMxZjgwMDVjZmJhZTEyMjc4NWMvdGFibGU6YTkwNDc5MTVjNjczNDEyMThiMTE4ZjY4NzEzY2NlODEvdGFibGVyYW5nZTphOTA0NzkxNWM2NzM0MTIxOGIxMThmNjg3MTNjY2U4MV8xMC0xLTEtMS0w_dc530f74-06d8-490e-9877-4f62195c18d9">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mdxg-20210630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ia1567ea2920241da83b0cf184d8203c1_I20210715"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-07-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ef27cfe3bed49c7847029a654380438_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i820448fd1936408287034ea0448702c2_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i863500d35994474dbb64036911295267_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94e12588009a4ccfb7ad506dde230474_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaaed7e418d64295a2fdef9e72420feb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d42da3fca664e9196260b0048b8c7a3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i248ea4052a6f4c4a9e79289b81e5d3c5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb5f8c6fa26a4473999a549b0860daa7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57d5766bcb174f22a384db94fb1662dc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f6cf3288aaf451eb539d95c21c0d3f7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i625a8149caf145fb9f6ec49640947103_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ded271c9e984021b5cc96dfb866079c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40f91b34ec1c4894992f703f06575098_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9609d1f974a4ffab0a6a9d68d904674_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia753205aa5374672ad737a15eeaecfcb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3712fe3086a74c9281904d0dc624c0c7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6653e360f5f4cbd89a180be4fef12f6_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib89406b6d1ed4e27bb530f0566c3e7f4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3d2f62cbcc2471997607a0f531eddcf_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3340cbdc0854f9c82647d193a0bb6c7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5176913ab4841a18870be0accaff0da_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8489118c314c410d9e4ecd5e688a6296_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c6adf93efd64417b653d94ea5764037_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecbaa13b22fc4a349dac5a5be52a1ece_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib743ddf65e0546dc8061175cd5b6f187_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bfff166fb7a47dbade947a596cfe795_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa78efde51724943b11905098dacfc15_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9986cdbe1a3a4875971e5c4896a4f876_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d1e691baee849e4b5421dd9318cfdaa_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dbf6fb74aec470fbddc41840209cdca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6959021b92d74cf7bd68800c7edb8e59_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9814d3643edd40fe8a5543aa058929ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ea175868cc44c02963e1fa0d02e98cc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieac267072afd40b5973cebef23f08bc7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c45415d8d674cdcb88b2754e8ca0f7a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2c14fb9c8534a52af40933de71d470e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61f3769f86034f0caba9e0a5c93826f0_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65c1178147214476b81d7b7b0c807490_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b69bb9ce62747dba42e6f35f7d6bea8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i893ba49ad5c3430a8b5ce9861abc1c91_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7835fe481e7a474d88cb9bc9fc4b4e9d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f7fefe2fb0e4c148fd6ecd8635f790a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2560068f9115460db66d530c87ec76d1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e24f6442afe457aa2166e8538c1e212_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a967865ec2b404e982f0925ee8083a6_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67915ef0633745a1bee624f657dfd70d_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32d60e88dd1c4b5dad71c5e90be4b433_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:Section351Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f69b69d3f9a4ac2b110d37dcc110405_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:Section351Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90e644d3bd014f92ba1bb40b0b78d305_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:Section351Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c9b39d7c36e4c6f960af71b46e8ca65_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:Section351Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib148d38e25b94492bf90c7d639339309_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4419ab9cc84f446692df129d313037a1_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66be1c10c07c47af8bcae86ad35148ae_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cbcb788b0524138bc71b680f77362cc_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54f3fa70af5b41b893e305ac0470f535_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaca0961cc5c74e099acc7bc6fe95a9ef_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reportingunit"><xbrli:measure>mdxg:reportingUnit</xbrli:measure></xbrli:unit><xbrli:context id="iab79a42abcfc49bf821585364d7300c9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9da3db9cb0b24a25ada54ecbe079f087_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28d0157a57fe4b55ac3580147766d8d8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie18163f5013a4be0b9bd02bf40e60571_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i326a81676c33465b89855dd27ba292da_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39f649d4d661481e8d6a6d250cdba5f7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cccbdf946f0459cb7d8cd1a05b4cd5c_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ffcb532f3f045a79f3f2a726bce2285_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45a35085d43841c29afd03db8ea30feb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0cec0ff165d410fb950f0fe592b80e5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7887f65880b416a9a1b7b135b38514d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a82046d4b9b4effaec4f006f2703487_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i804fe80afd1c4483a92cd48a806655ec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fa1ee6b8d8d4beeabdc8444cf7a0a97_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec2d038f80894231a4c3c16bcb971517_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76c421a22e8847a89a5ee26247adacac_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mdxg:AssetRetirementCostMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87db49da4123419b8897eb063c0b4c9c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mdxg:AssetRetirementCostMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5140cbcb67b477eae5103576b9d79ec_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mdxg:FinanceLeaseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i455d7d410196418eba05ebd95eca8809_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mdxg:FinanceLeaseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5af507b3d6eb4a15b70f0d9de1dfba91_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if023d360bddb4609ba7c01984189031c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2bff240b04449a29fba2137bf43f2a5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id528f8cf639346baa0d5733e68b0a62f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d57cdcc92e54b889ac2aebd6d6a1bd5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdxg:CustomerAndSupplierRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb2b2d4264234ed0a37f95b5dd66ce05_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdxg:CustomerAndSupplierRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb88a22bf81946bb95ccd3c5b11de65f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i730a400496914c0995bd54501e4e7e6f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id51bf5d57c5e4be793cdd487a6614d13_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cf6e76c76f74939bf341b622ea02bbc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee3d4e93e5e14202a11a01a6f5173801_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mdxg:PatentsinProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i900de095b8b74867bd9ff846daf9e193_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mdxg:PatentsinProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d8cb358a527440ca633e34b0e64c145_I20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36fba5a1c02d4b94be2074d914f99d5f_I20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:FinancingTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i988d17ea85c647989e6243f2f3379dbe_D20200702-20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-02</xbrli:startDate><xbrli:endDate>2020-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a655ae7f78948dc884c2536cdf9fd11_D20200702-20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-02</xbrli:startDate><xbrli:endDate>2020-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafe464ecd0c245028772137cfcf6b7a0_D20200702-20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-02</xbrli:startDate><xbrli:endDate>2020-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i973342a619924d6ab0a08e0c4e94b963_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida1580ac0a56414d8129f9f379f10f0b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f29d38c99bd445aa0e38a3711d8885e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9bfddcbaf8f4b90bb405439470f7519_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cfe91ee3d3e4b3d9edcd8c90d48aad2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2aaba77a0a5f47b5a0450a1a8b2b3ea4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37aa6fed4311472bb500b5fe0dc149d2_D20210701-20250702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2025-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie28e9a5ef3004dc196ad8be7ab8d8836_D20200702-20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-02</xbrli:startDate><xbrli:endDate>2020-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2750d4e108d4450589ec176ea4bc1a68_D20200703-20210702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-03</xbrli:startDate><xbrli:endDate>2021-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cc550f11ce34dab8a1ee5533fd2f5d8_D20210703-20220702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-03</xbrli:startDate><xbrli:endDate>2022-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c88e9fdfe1944b3a4fb9430459677f4_D20220703-20230702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-03</xbrli:startDate><xbrli:endDate>2023-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb2ea45a6256434aa77aa52d97c892eb_D20230703-20250702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-03</xbrli:startDate><xbrli:endDate>2025-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfaa87d5ef5044f39cfb5c90c4cea4d3_I20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f958b3caaef429182bf8441abc2cad2_I20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a0a54ed1a52415a881e9947529ad09f_I20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4f4a7fffef64fbfb835915c94681b34_D20200702-20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-02</xbrli:startDate><xbrli:endDate>2020-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if47b0734d0cf4bd2a2b9d44595fbacaf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24e573531fad49c7b4a1c7704442ac21_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5df4f4bf6ea45a98669bcf3e1a28aef_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0796339395b546c6950867927cd6139b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i942e6e118deb4bf993725d0b8307938d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5ea19804b864811aa3bd0894d4736be_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1e47a6e2d7b4dc0872d79087da38fa4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i127934462af147b1b7b36883a1681b77_I20190610"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i202be97ddd3241418491fe12bce8c12f_D20190610-20190610"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-10</xbrli:startDate><xbrli:endDate>2019-06-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea093603b31a44c6b009a07438c52b17_I20200422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:AmendedTermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42392901e13144e0b50ffcaa3b266c87_D20200422-20200422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:AmendedTermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-22</xbrli:startDate><xbrli:endDate>2020-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8de3a02e7144468ba0178c4374d8f4a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6299c3dc628d43df867e4bad14106f97_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:TermLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i065ebf02aa6941e1bdf67379b756096e_D20200424-20200424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-24</xbrli:startDate><xbrli:endDate>2020-04-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5d9cce6f74d4093affc241694089467_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bce3a37af914ed9bc5f8c6c3bc59d45_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4f8987ea15d4408a2035650b2c87f80_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ed571a8257d42d0a215125b4da04164_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e66c91f80be4fd983fd0e3efb808448_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8010a62ee3794b6c895396a9baf80f0b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7c826330d9d41ec9b4befdcda0afa9b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d26eec9d61c46dc81a087e6461dcb69_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida46e7ad09274073ab420623ea4c37dd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47d7bba684bf44828fe6f1b9f07feeff_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a894936a837468783a21f9dfa898b71_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fd65f6db4c84b2584ef68fc69fd6b76_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bc25263e6e64af3b15df41c8754ccca_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c4217efe8eb4763aa03a1421b865da2_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if97f9edcdca840aa946e43c3245c6e72_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie877a21137404e27bf43f4596c236a0b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i559662d3c9bb44b2ac2b0a2d023a981b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e6cb875ef234a24a387547a3a122428_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89c45fca675442c183fc2fb72b865f09_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21cedcbc67b9433fb42883dc4ec104eb_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-02</xbrli:startDate><xbrli:endDate>2020-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a8becc5cd6748029d491e754d21f558_I20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i921b8b2918b843b0957acbb1acd7cb40_D20200702-20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">mdxg:DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-02</xbrli:startDate><xbrli:endDate>2020-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib585d269397a4280a16c10b8e637430b_D20200702-20200702"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DividendsAxis">mdxg:PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-02</xbrli:startDate><xbrli:endDate>2020-07-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>mdxg:day</xbrli:measure></xbrli:unit><xbrli:unit id="director"><xbrli:measure>mdxg:director</xbrli:measure></xbrli:unit><xbrli:context id="i6be9faea4b8c45d299d9f176ac10cfcd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cb990ced5454e60b46fb9974649db9f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16cc01f782b84ac9b6f4b691a457573d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i737e0eaa5bad434fa72a35230884fc03_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaddd4342ea2443bb9b81a46e5ee973a5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4546c782bd4c4b0d9660d32d5de807aa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ff6f3016254469984a003f5d14d5292_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia78110d12796433b9330985e2b4ef783_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31a08061cd074967ac410fd896f93157_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00bd0e49ae8e4e4293bd95e2e845969d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94b5714cc2e94fc681505d6f23aecd98_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8dea383f42948e8b56cf4145aeb42f1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie805768234ab4942a5d4fb8ca1a8f3d8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia78947d6c8ca4e8ba3edb9ac39391648_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia54e27be716048c4b4d253e772d6aca1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mdxg:CARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41bb6f1393b14bd2b5dfaa6483ec1fd7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mdxg:CARESActMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65bb668e9dae4047a84b02a215986f46_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mdxg:LegalProceedingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="securityclassaction"><xbrli:measure>mdxg:securityClassAction</xbrli:measure></xbrli:unit><xbrli:context id="i3cb4c6f5e91944bc98bf3dad39781578_D20190116-20190116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-16</xbrli:startDate><xbrli:endDate>2019-01-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="healthcareprovider"><xbrli:measure>mdxg:healthcareProvider</xbrli:measure></xbrli:unit><xbrli:context id="ib237d9ecb84f4d6ab8dfb6cb01b37609_D20200603-20200603"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-03</xbrli:startDate><xbrli:endDate>2020-06-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6a7a1b394c249888a94eef3b4a3a19f_D20210415-20210415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-15</xbrli:startDate><xbrli:endDate>2021-04-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="product"><xbrli:measure>mdxg:product</xbrli:measure></xbrli:unit><xbrli:context id="ic4efd76f6ada46ba8946b7513a22f04a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareTissueAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if46c195635a441178204ec28dde34b01_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareTissueAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89a37b3906b04310b236e33525aaa95c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareTissueAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f2bacc597854374bcc516e82f0c5eed_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareTissueAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbf94484fb9640fc95e9891697e411dd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie638d9289b64407d97b93fe9e2db87ff_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i609c12eea03c4236afb3906bceaa436a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idad418953507466e82cdd357b1a16e0b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf8f1fdd25a54565b673685695a81bfa_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dac69150d044c06bb537de5bc9ec0e2_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab79f8b8ff3646738e954901d9a7200a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4687e4322dec454fa997eabfa8d90145_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="distributionchannel"><xbrli:measure>mdxg:distributionChannel</xbrli:measure></xbrli:unit><xbrli:context id="i03a9f6a871fa4fed9fca89e62057ca76_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45054bede241426187915c74a28a6005_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i279daae437cf44a19a94bd273c1d1703_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bf9f8f4f2bb4f39ba8d91db9fb20a2a_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf429a45cf5f420a848a9ed4775b39e4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b2c8606605244ffa5589d29bede8a28_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00c73051b417433f810f88637d373bcf_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c204e277321442bbfb6659be2a31d13_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i586f4d48e4324b41820aaf3f28c0b969_1"></div><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8xNzkz_0341999e-cab6-4cb4-b421-92340f16e3d0">10-Q</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:25.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:481.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6NWQwN2EzMGVlOTY0NDk3ZmEyNWU4NDkzNjBmOTZlNWEvdGFibGVyYW5nZTo1ZDA3YTMwZWU5NjQ0OTdmYTI1ZTg0OTM2MGY5NmU1YV8wLTAtMS0xLTA_c63bcde8-c004-43d2-ae6e-bf8f51ef14a5">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quarterly Period Ended</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8zODQ4MjkwNjk5MDI5_6860b3e7-86ea-44e3-9304-0997fc040a38">June&#160;30, 2021</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:25.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:483.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6NGFlZTI2YWVjYzVkNGJmNzhhOGQwYjI3ZjFmMDQxYTEvdGFibGVyYW5nZTo0YWVlMjZhZWNjNWQ0YmY3OGE4ZDBiMjdmMWYwNDFhMV8wLTAtMS0xLTA_3ff48d0f-636f-4513-9bbc-aef6ff2d1917">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from _____________________to______________________</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8xNzk0_fc11d4fe-dc16-4a25-8d5c-13d5b4835254">001-35887</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8xNzk4_22285eaf-2bce-4c0c-9e67-ab2f893bb6ba">MIMEDX GROUP, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6YWYxYzQ2MzAzNTdiNDEyNThlMzkwYmUzN2VjMzkyNGUvdGFibGVyYW5nZTphZjFjNDYzMDM1N2I0MTI1OGUzOTBiZTM3ZWMzOTI0ZV8wLTAtMS0xLTA_394c531d-a130-4f3b-a50e-4c0f766a1f51">Florida</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6YWYxYzQ2MzAzNTdiNDEyNThlMzkwYmUzN2VjMzkyNGUvdGFibGVyYW5nZTphZjFjNDYzMDM1N2I0MTI1OGUzOTBiZTM3ZWMzOTI0ZV8wLTItMS0xLTA_7accae96-1a0a-4767-91d6-5b0f628b2fdb">26-2792552</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6MzVkNWUyNzlmOTBlNGVkZTkwMjA0NDI5NWNkMGFjZWUvdGFibGVyYW5nZTozNWQ1ZTI3OWY5MGU0ZWRlOTAyMDQ0Mjk1Y2QwYWNlZV8wLTAtMS0xLTAvdGV4dHJlZ2lvbjoyZjVhNzZlMTllYjA0NTQyYTdhNmI4ZmZlY2I1MDViNV80_283dd2d2-b99c-422d-8515-65eccef50323">1775 West Oak Commons Ct NE</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6MzVkNWUyNzlmOTBlNGVkZTkwMjA0NDI5NWNkMGFjZWUvdGFibGVyYW5nZTozNWQ1ZTI3OWY5MGU0ZWRlOTAyMDQ0Mjk1Y2QwYWNlZV8wLTAtMS0xLTAvdGV4dHJlZ2lvbjoyZjVhNzZlMTllYjA0NTQyYTdhNmI4ZmZlY2I1MDViNV83_fe6844eb-3769-46e0-afa2-277ae898b034">Marietta</ix:nonNumeric>, <ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6MzVkNWUyNzlmOTBlNGVkZTkwMjA0NDI5NWNkMGFjZWUvdGFibGVyYW5nZTozNWQ1ZTI3OWY5MGU0ZWRlOTAyMDQ0Mjk1Y2QwYWNlZV8wLTAtMS0xLTAvdGV4dHJlZ2lvbjoyZjVhNzZlMTllYjA0NTQyYTdhNmI4ZmZlY2I1MDViNV8xMQ_084d5359-aa2a-451e-9580-c1a48d11be2c">GA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6MzVkNWUyNzlmOTBlNGVkZTkwMjA0NDI5NWNkMGFjZWUvdGFibGVyYW5nZTozNWQ1ZTI3OWY5MGU0ZWRlOTAyMDQ0Mjk1Y2QwYWNlZV8wLTItMS0xLTA_ed68c031-28d6-468b-a0d3-e002e9fed08d">30062</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8xNzk1_baa24748-daab-48c5-8589-bde8c5fbc786">770</ix:nonNumeric>) <ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8xNzk2_5e513754-60ce-4ec8-8acd-8f40002fc1c4">651-9100</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;<br/>Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;<br/>Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6OTMzNTUzYWY1ODIwNDhjOGJmMTYzZTAwNDA3ODUxNjQvdGFibGVyYW5nZTo5MzM1NTNhZjU4MjA0OGM4YmYxNjNlMDA0MDc4NTE2NF8xLTAtMS0xLTA_3ad7115a-645e-492f-a158-fcb7a6cc97eb">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6OTMzNTUzYWY1ODIwNDhjOGJmMTYzZTAwNDA3ODUxNjQvdGFibGVyYW5nZTo5MzM1NTNhZjU4MjA0OGM4YmYxNjNlMDA0MDc4NTE2NF8xLTEtMS0xLTA_827bdd6e-b1d1-4051-ac58-b9e0421df3bf">MDXG</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6OTMzNTUzYWY1ODIwNDhjOGJmMTYzZTAwNDA3ODUxNjQvdGFibGVyYW5nZTo5MzM1NTNhZjU4MjA0OGM4YmYxNjNlMDA0MDc4NTE2NF8xLTItMS0xLTA_c997e442-76b2-4394-8ca6-fdea69228331">The Nasdaq Stock Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8xNzk5_afa14667-1d70-4910-a184-589eb246ae30">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> x </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8xODAw_5b8b1ab0-844d-4217-a56f-acbd808de683">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> x </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6ZWFjYWUzM2YwNGNiNGIxNTg2YzcxOWQwOWQ4NGUyNjcvdGFibGVyYW5nZTplYWNhZTMzZjA0Y2I0YjE1ODZjNzE5ZDA5ZDg0ZTI2N18wLTAtMS0xLTM0NjQvdGV4dHJlZ2lvbjo0MDUzYmQzYTRhMTM0OGE5YmM4NjU3MjRmZjZmMjBkMV8zODQ4MjkwNjk3Mjcz_36ec1726-98d2-43e0-a8bd-b5455e014225">Large accelerated filer</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated Filer  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Do not check if a smaller reporting company)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company <ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" format="ixt:booleanfalse" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6ZWFjYWUzM2YwNGNiNGIxNTg2YzcxOWQwOWQ4NGUyNjcvdGFibGVyYW5nZTplYWNhZTMzZjA0Y2I0YjE1ODZjNzE5ZDA5ZDg0ZTI2N18wLTMtMS0xLTAvdGV4dHJlZ2lvbjphMTM0ODk0NGQ2Yzg0NWM0YmNjMDY3MTgyYzQ2ZDQ5Zl8zMA_c9b19649-d952-4f90-9c25-52d9ebd94171">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company <ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6ZWFjYWUzM2YwNGNiNGIxNTg2YzcxOWQwOWQ4NGUyNjcvdGFibGVyYW5nZTplYWNhZTMzZjA0Y2I0YjE1ODZjNzE5ZDA5ZDg0ZTI2N18wLTQtMS0xLTAvdGV4dHJlZ2lvbjpiMjQxZWQ2M2FiMzc0OWU2YjY1MjczNjVhNzJmN2RiNV8yOA_944a1d09-4d61-474d-8311-fcdee00fb3fd">&#9744;</ix:nonNumeric></span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168;</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes <ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8xODAx_4444b2bc-a4d7-493a-8013-bf66f05c0d28">&#9744;</ix:nonNumeric> No&#160;x</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="shares" contextRef="ia1567ea2920241da83b0cf184d8203c1_I20210715" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF84MjQ2MzM3MjEwMTM5_0f3a2cfc-a692-4c01-8500-333ebee3f320">111,946,829</ix:nonFraction> shares of the registrant&#8217;s common stock, par value $0.001 per share, outstanding as of July 15, 2021. </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div></div><div id="i586f4d48e4324b41820aaf3f28c0b969_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.251%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Part I&#160;&#160;&#160;&#160;&#160;FINANCIAL INFORMATION</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Statements (Unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Balance Sheets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i586f4d48e4324b41820aaf3f28c0b969_19">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i586f4d48e4324b41820aaf3f28c0b969_22">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i586f4d48e4324b41820aaf3f28c0b969_25">8</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Cash Flows</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i586f4d48e4324b41820aaf3f28c0b969_28">10</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes to the Condensed Consolidated Financial Statements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i586f4d48e4324b41820aaf3f28c0b969_31">11</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i586f4d48e4324b41820aaf3f28c0b969_85">29</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantitative and Qualitative Disclosures About Market Risk</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i586f4d48e4324b41820aaf3f28c0b969_127">39</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Controls and Procedures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i586f4d48e4324b41820aaf3f28c0b969_130">39</a></span></div></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Part II&#160;&#160;&#160;OTHER INFORMATION</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal Proceedings</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i586f4d48e4324b41820aaf3f28c0b969_136">41</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk Factors</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i586f4d48e4324b41820aaf3f28c0b969_139">41</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unregistered Sales of Equity Securities and Use of Proceeds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i586f4d48e4324b41820aaf3f28c0b969_142">45</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defaults&#160;upon Senior Securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i586f4d48e4324b41820aaf3f28c0b969_145">45</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mine Safety Disclosures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i586f4d48e4324b41820aaf3f28c0b969_148">45</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Information</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i586f4d48e4324b41820aaf3f28c0b969_151">45</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibits</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i586f4d48e4324b41820aaf3f28c0b969_154">45</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signatures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i586f4d48e4324b41820aaf3f28c0b969_157">46</a></span></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i586f4d48e4324b41820aaf3f28c0b969_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used herein, the terms &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MiMedx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">we</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">us</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; refer to MiMedx Group, Inc., a Florida corporation, and its consolidated subsidiaries as a combined entity, except where it is clear that the terms mean only MiMedx Group, Inc.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Important Cautionary Statement Regarding Forward-Looking Statements </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q (this &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quarterly Report</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) contains forward-looking statements. All statements relating to events or results that may occur in the future are forward-looking statements, including, without limitation, statements regarding the following: </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of the end of the period of enforcement discretion announced by the United States Food and Drug Administration (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), including our inability to market our micronized products and certain other products after May 31, 2021;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the timing, size, and prospects for our current and planned clinical trials; the clinical trial process is lengthy and expensive with uncertain outcomes, and often requires the enrollment of large numbers of patients, and suitable patients may be difficult to identify and recruit, and delays or failures in our clinical trials could prevent us from commercializing any modified or new products and will adversely affect our business, operating results and prospects;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our strategic focus, as illustrated by our current business priorities and our ability to implement these priorities;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the sufficiency of our liquidity and existing capital resources to implement our current business priorities;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our ability to fund our ongoing and future operating costs;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the advantages of our products and development of new products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">our expectations regarding the size of the potential market and any growth in such market;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">our expectations regarding ongoing regulatory obligations and oversight and the changing nature thereof impacting our products, research and clinical programs, and business, including those relating to patient privacy;</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our ability to manufacture certain of our products in compliance with current Good Manufacturing Practices (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CGMP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in sufficient quantities to meet current and potential demand;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding costs relating to our compliance with regulatory standards, including those arising from our clinical trials, pursuit of Biologics License Applications (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BLAs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and CGMP compliance;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the likelihood, timing, and scope of possible regulatory approval and commercial launch of our late-stage product candidates and new indications for our products;</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding government and other third-party coverage and reimbursement for our products;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding future revenue growth;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our belief in the sufficiency of our intellectual property rights in our technology;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our ability to procure sufficient supplies of human tissue to manufacture and process our products;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the outcome of pending litigation and investigations;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our ability to remain in compliance with Securities and Exchange Commission (the "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SEC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">") reporting obligations and Nasdaq listing requirements;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the ongoing and future effects arising from the investigation conducted by the Audit Committee (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of the Company&#8217;s Board of Directors (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) into prior-period matters relating to allegations regarding certain sales and distribution practices at the Company and certain other matters (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the restatement of our consolidated financial statements previously filed in our Annual Report on Form 10-K for the year ended December 31, 2016, as well as selected unaudited condensed consolidated financial data as of and for the years ended December 31, 2015 (Restated) and 2014 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Restated), which reflected adjustments to our previously filed consolidated financial statements as of and for the years ended December 31, 2015 and 2014 (collectively, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restatement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and related litigation;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">our expectations regarding the ongoing and future effects of the Covid-19 Pandemic (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Covid-19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) on our business, employees, suppliers and other third parties with whom we do business, and our responses intended to mitigate such effects;</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">demographic and market trends;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our plans to remediate the identified material weaknesses in our internal control environment and to strengthen our internal control environment; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding research and development costs, including those arising from filing additional investigative new drug applications and pursuing new BLAs; and </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to compete effectively.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements generally can be identified by words such as &#8220;expect,&#8221; &#8220;will,&#8221; &#8220;change,&#8221; &#8220;intend,&#8221; &#8220;seek,&#8221; &#8220;target,&#8221; &#8220;future,&#8221; &#8220;plan,&#8221; &#8220;continue,&#8221; &#8220;potential,&#8221; &#8220;possible,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;may,&#8221; &#8220;anticipate,&#8221; &#8220;to be&#8221; and similar expressions. These statements are based on numerous assumptions and involve known and unknown risks, uncertainties and other factors that could significantly affect the Company&#8217;s operations and may cause the Company&#8217;s actual actions, results, financial condition, performance or achievements to differ materially from any future actions, results, financial condition, performance or achievements expressed or implied by any such forward-looking statements. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors that may cause such a difference include, without limitation, those discussed under the heading &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in this Quarterly Report and in our previously-filed Annual Report on Form 10-K for the year ended December 31, 2020 (our &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Form 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), filed with the Securities and Exchange Commission (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SEC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) on March 8, 2021. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless required by law, the Company does not intend, and undertakes no obligation, to update or publicly release any revision to any forward-looking statements, whether as a result of the receipt of new information, the occurrence of subsequent events, a change in circumstances or otherwise. Each forward-looking statement contained in this Quarterly Report is specifically qualified in its entirety by the aforementioned factors. Readers are advised to carefully read this Quarterly Report in conjunction with the important disclaimers set forth above prior to reaching any conclusions or making any investment decisions and not to place undue reliance on forward-looking statements, which apply only as of the date of the filing of this Quarterly Report with the SEC.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Estimates and Projections</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This discussion includes certain estimates, projections and other statistical data. These estimates and projections reflect management&#8217;s best estimates based upon currently available information and certain assumptions we believe to be reasonable. These estimates are inherently uncertain, subject to risks and uncertainties, many of which are not within our control, have not been reviewed by our independent auditors and may be revised as a result of management&#8217;s further review. In addition, these estimates and projections are not a comprehensive statement of our financial results, and our actual results may differ materially from these estimates and projections due to developments that may arise between now and the time the results are final. There can be no assurance that the estimates will be realized, and our results may vary significantly from the estimates, including as a result of unexpected issues in our business and operations. Accordingly, you should not place undue reliance on such information. Projections, assumptions and estimates of our future performance and the future performance of the markets in which we operate are necessarily subject to a high degree of uncertainty and risk. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i586f4d48e4324b41820aaf3f28c0b969_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_16"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_19"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MIMEDX GROUP, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:70.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMy0xLTEtMS0w_06dfd352-f0c9-4484-999c-157b38a4b20a">85,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMy0zLTEtMS0w_ca146b3b-9610-4fe2-93b8-44870040c93d">95,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNC0xLTEtMS0w_e0fd737b-39cc-45d8-8d31-6debfa6441e0">37,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNC0zLTEtMS0w_cbf4de75-8aaf-44ec-98f6-b4f94174bce1">35,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNS0xLTEtMS0w_03ea0220-a35e-439c-bfff-c9ce6e2005e0">10,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNS0zLTEtMS0w_f9386052-5d65-4e5a-9b7f-2152ec7c4c94">10,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNi0xLTEtMS0w_f1d59884-4e0a-4324-bee7-f578a036c270">3,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNi0zLTEtMS0w_8db41e26-2eee-4440-ad63-6e5c789dfbca">5,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNy0xLTEtMS0w_2029d0b1-96ab-49f1-976f-689cafed1e2f">10,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNy0zLTEtMS0w_140c7719-3ace-4534-bee1-daa329e60128">10,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfOC0xLTEtMS0w_337c6191-547d-42e2-b386-fd8ae15ce2d5">1,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfOC0zLTEtMS0w_2094961f-7879-467f-bd91-b88091d4e1f5">3,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfOS0xLTEtMS0w_275588ca-db9d-4a4f-aa23-d9d8bfeb8e66">147,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfOS0zLTEtMS0w_846320cb-d856-4e3c-9a6e-a3503faab6b1">160,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTEtMS0xLTEtMA_f2dff5bd-434e-46aa-9305-fd2bf906977d">10,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTEtMy0xLTEtMA_c3cec02f-1c72-404f-807e-9e85cb6fb90f">11,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="mdxg:OperatingLeaseAndFinancingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTItMS0xLTEtMA_4133e93a-fa9f-4c59-bda1-ce95780ba4aa">3,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mdxg:OperatingLeaseAndFinancingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTItMy0xLTEtMA_93734104-0556-4750-be53-fe5890e4bf75">3,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTMtMS0xLTEtMA_af9a3709-0294-4bf2-8045-694020d02d5d">19,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTMtMy0xLTEtMA_43673bd9-2dab-4ee1-a84a-30a496f9e418">19,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTQtMS0xLTEtMA_95b1fbc3-e83c-49ea-8f37-3c44d753b0d7">5,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTQtMy0xLTEtMA_2c0593e4-5c65-407f-8faf-35760d746673">6,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTYtMS0xLTEtMA_07ef5909-38bb-4ccb-a34a-361328057ffc">313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTYtMy0xLTEtMA_adf25e49-e728-4f5c-ba4c-de8431dff7f9">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTctMS0xLTEtMA_103bc85a-d459-4fb1-9830-472e8b894425">187,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTctMy0xLTEtMA_45f719df-c17c-44ca-bbba-3dc942e8b5d6">202,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS&#8217; DEFICIT</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjAtMS0xLTEtMA_ae69098b-0c50-4655-b037-827724265abe">10,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjAtMy0xLTEtMA_6bdbeba4-6e4a-41cf-8166-aa84533b5eee">8,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjEtMS0xLTEtMA_1c9f6aae-f76a-4e20-98b3-cc91170115d7">21,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjEtMy0xLTEtMA_2896c875-46a1-44bc-9dfb-b755ab4e1939">18,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjItMS0xLTEtMA_796f7484-21d1-4341-9612-b8268c49bebc">17,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjItMy0xLTEtMA_91a872b9-90a1-4e4e-8664-3d87589d4676">30,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjctMS0xLTEtMA_90aa13ba-35cf-48f2-830f-ac817e49f60a">1,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjctMy0xLTEtMA_0a9c3668-abf6-4749-9d0b-fb51b72b8035">1,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjgtMS0xLTEtMA_7ca1a368-86eb-4740-84b3-741723139da3">50,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjgtMy0xLTEtMA_c6eab480-1d3b-403b-9a99-70665387894c">59,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term debt, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjktMS0xLTEtMA_68fc75cd-a8c6-4432-999d-62e84ed8a573">47,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjktMy0xLTEtMA_85f9a73a-21e7-49fe-a35c-5654d12846e5">47,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzAtMS0xLTEtMA_24f30cce-9df5-4a4b-b1de-219c04dfba4a">3,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzAtMy0xLTEtMA_6d5cedd7-2088-4630-9caa-b8906adb0017">3,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzEtMS0xLTEtMA_d8cc5354-da40-489c-bc99-0d344be29e1d">101,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzEtMy0xLTEtMA_7d2196c7-3559-4285-abf4-9c8e08b2d081">110,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 12)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzItMS0xLTEtMA_0d7fcad6-ddbb-4d33-9a23-4562ffd87d31"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzItMy0xLTEtMA_5d8b0036-0697-4b95-accd-08a595c7da79"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock Series B; $<ix:nonFraction unitRef="usdPerShare" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NDhhM2ZjYjNkYzRhZjQ4MzZiMzA1ZmNkYTJiZmE3XzQy_9a01a77f-9775-4c62-899a-3f45ed531807"><ix:nonFraction unitRef="usdPerShare" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NDhhM2ZjYjNkYzRhZjQ4MzZiMzA1ZmNkYTJiZmE3XzQy_b2055115-db41-4b2e-b1df-d491af7ae2c6">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NDhhM2ZjYjNkYzRhZjQ4MzZiMzA1ZmNkYTJiZmE3XzU2_4b6815a9-0fd0-4312-b5d0-477f2500337b"><ix:nonFraction unitRef="shares" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NDhhM2ZjYjNkYzRhZjQ4MzZiMzA1ZmNkYTJiZmE3XzU2_64bbddda-86ec-4297-b919-63f6816a0efd"><ix:nonFraction unitRef="shares" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NDhhM2ZjYjNkYzRhZjQ4MzZiMzA1ZmNkYTJiZmE3XzU2_bafa57be-45a2-4658-864e-c6ec0b7cdda5"><ix:nonFraction unitRef="shares" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NDhhM2ZjYjNkYzRhZjQ4MzZiMzA1ZmNkYTJiZmE3XzU2_c28eb13b-4c3a-4159-a891-0993af076811"><ix:nonFraction unitRef="shares" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NDhhM2ZjYjNkYzRhZjQ4MzZiMzA1ZmNkYTJiZmE3XzU2_d1b6ffb2-20b5-4b99-b6e5-05d19d4ee17a"><ix:nonFraction unitRef="shares" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NDhhM2ZjYjNkYzRhZjQ4MzZiMzA1ZmNkYTJiZmE3XzU2_eff992c5-8f4d-4c43-bc60-675023b11008">100,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares authorized, issued and outstanding at June&#160;30, 2021 and December&#160;31, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMS0xLTEtMA_92941733-f757-4cc3-9635-203d6073ac74">92,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMy0xLTEtMA_e8642eab-47a6-4ca2-9004-eee19f056eaf">91,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders' deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock Series A; $<ix:nonFraction unitRef="usdPerShare" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNGEyNjU4YzBjZjRiZWY4MTY3NDdmNmQ3YmE4YTE1XzMw_1a6499d8-e8a4-41eb-a108-aee5ee21e301"><ix:nonFraction unitRef="usdPerShare" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNGEyNjU4YzBjZjRiZWY4MTY3NDdmNmQ3YmE4YTE1XzMw_98047f93-6b8d-4f75-b6ef-105a1693344c">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNGEyNjU4YzBjZjRiZWY4MTY3NDdmNmQ3YmE4YTE1XzQ0_4587dc86-a7b7-4d58-b640-bcb64e94377b"><ix:nonFraction unitRef="shares" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNGEyNjU4YzBjZjRiZWY4MTY3NDdmNmQ3YmE4YTE1XzQ0_67d93f59-b58f-439b-bd7e-ba42ba9e1a9f">5,000,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNGEyNjU4YzBjZjRiZWY4MTY3NDdmNmQ3YmE4YTE1XzY2_092bfcc2-038d-47f4-8f0e-9fc578154e72"><ix:nonFraction unitRef="shares" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNGEyNjU4YzBjZjRiZWY4MTY3NDdmNmQ3YmE4YTE1XzY2_260ff8a5-2bd0-4060-b0d4-3e01d403107f"><ix:nonFraction unitRef="shares" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNGEyNjU4YzBjZjRiZWY4MTY3NDdmNmQ3YmE4YTE1XzY2_55e90c2f-d653-4ee0-a15b-63bdda5e9d9a"><ix:nonFraction unitRef="shares" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNGEyNjU4YzBjZjRiZWY4MTY3NDdmNmQ3YmE4YTE1XzY2_e8b06079-4ffa-49e3-a0aa-e43854a0c9d1">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at June&#160;30, 2021 and December&#160;31, 2020</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMS0xLTEtMA_c49d0074-24c3-4fc9-b043-ea6bbe14c93f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMy0xLTEtMA_7e621a03-f7f8-4ae0-ba9e-f359c9142f9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock; $<ix:nonFraction unitRef="usdPerShare" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzE4_9c2299e8-78a3-414b-b43a-2bf24b8af087"><ix:nonFraction unitRef="usdPerShare" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzE4_bb526472-9b8d-44b8-8893-690797324ee2">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzMy_43b29d4a-c000-43fa-83d6-f7b2a3a24ca8">187,500,000</ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzU0_1715b260-71d2-4e7f-b3d5-e6c02b3b13b3"><ix:nonFraction unitRef="shares" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzU0_b389c198-4e30-4f9e-a69d-2d500bb7492d">112,703,926</ix:nonFraction></ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzY4_864964a0-9723-4d6e-b6c0-c614e1444e94">111,881,938</ix:nonFraction> outstanding at June&#160;30, 2021 and <ix:nonFraction unitRef="shares" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzkz_1715b260-71d2-4e7f-b3d5-e6c02b3b13b3"><ix:nonFraction unitRef="shares" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzkz_b389c198-4e30-4f9e-a69d-2d500bb7492d">112,703,926</ix:nonFraction></ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzEwNw_fe4f5f14-2ce6-4f1b-83a1-759dbea06fc5">110,930,243</ix:nonFraction> outstanding at December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMS0xLTEtMA_d63d1cf3-2287-4d7a-b1f4-d7fe2d8debbb">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMy0xLTEtMA_caaf693e-4727-4be5-9a9d-9ace5f162e8a">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzctMS0xLTEtMA_ba63e36d-2657-42cd-8ce0-98ae6c2902ff">158,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzctMy0xLTEtMA_486d7554-910d-46fe-a613-66d3d4f275f0">158,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock at cost; <ix:nonFraction unitRef="shares" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NmZjZTg5OTBjMjRmZjdhNzQ2MDg5YmIzZTdhOTNmXzI4_c035eee0-5a7d-46a1-a523-6eb487f6727c">821,988</ix:nonFraction> shares at June&#160;30, 2021 and <ix:nonFraction unitRef="shares" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NmZjZTg5OTBjMjRmZjdhNzQ2MDg5YmIzZTdhOTNmXzQ4_3c1b67f5-4a42-42f1-bd8d-6b08f2b243ff">1,773,683</ix:nonFraction> shares at December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzgtMS0xLTEtMA_30365bd1-5f82-4ece-9fb6-cbaa5e8e5147">4,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzgtMy0xLTEtMA_fd0da5b6-2af5-4886-b75a-19fcf4bf4ce9">7,449</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzktMS0xLTEtMA_62fcb764-d204-49fa-a5f2-1450a6f1a2dc">161,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzktMy0xLTEtMA_c2380b26-f5b7-45b1-acc0-61891fc708a0">151,424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' deficit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNDAtMS0xLTEtMA_2f34fd08-f66c-48af-9d9f-9bee084bfe00">7,137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNDAtMy0xLTEtMA_67858fbd-b405-4529-bb68-dc47de798ebf">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, convertible preferred stock, and stockholders&#8217; deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNDEtMS0xLTEtMA_52d754b9-3613-4153-a0bc-fb5af1287e90">187,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNDEtMy0xLTEtMA_dff4ea2c-e1b5-4967-857c-f631fb7e4cbd">202,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i586f4d48e4324b41820aaf3f28c0b969_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MIMEDX GROUP, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share and per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:45.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMy0xLTEtMS0w_0a28639e-f68d-4b0a-9c4e-ba582f880a87">68,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMy0zLTEtMS0w_644402db-716b-43bb-bd0b-50bcf88dde2e"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMy0zLTEtMS0w_ed84a725-0c55-49d4-bdda-0713b11f5294">53,647</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMy01LTEtMS0w_f42413ab-3f2d-4462-8d71-13d789ff15e7">128,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMy03LTEtMS0w_0daecd0c-7c26-4332-b148-8aea72146eb1">115,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNC0xLTEtMS0w_14954cc5-cc18-4cc0-8a71-740d628492bf">12,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNC0zLTEtMS0w_1f6d74c3-954d-4d45-a655-bef145693154"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNC0zLTEtMS0w_a57dc3d6-a8f3-4e86-b3ba-289b663d6537">8,198</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNC01LTEtMS0w_5af623b8-df7c-4453-84a1-17be3d299f9d">22,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNC03LTEtMS0w_b17f6201-650c-4357-b991-0935385633ef">18,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNS0xLTEtMS0w_bfab3700-f51e-423b-aa12-4da223397e76">55,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNS0zLTEtMS0w_cc05611c-92e4-4879-ae94-f8166672297a">45,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNS01LTEtMS0w_e196a72c-5a8a-4fca-920e-fc593ab9dde6">105,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNS03LTEtMS0w_d4f9fe06-b936-4d5b-8571-0dad90613763">97,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOC0xLTEtMS0w_c9c3c27d-fd75-4831-81fc-b7caf4399ed6">53,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOC0zLTEtMS0w_90c66060-9791-4892-9e77-afdf3b9bf1b1"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOC0zLTEtMS0w_b15ffd2f-ef2a-44ae-9249-acdd05bae856">37,329</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOC01LTEtMS0w_567f9498-c763-4fb3-9939-69617d552a26">99,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOC03LTEtMS0w_c24c3c42-b493-4feb-a165-bc0d55eb3794">84,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investigation, restatement and related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="mdxg:InvestigationRestatementandRelated" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOS0xLTEtMS0w_f39a52e9-61b5-45e1-88df-f6a963f5486a">2,062</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="mdxg:InvestigationRestatementandRelated" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOS0zLTEtMS0w_22ee44c5-99b3-431a-8405-0c9211d7dbf5"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="mdxg:InvestigationRestatementandRelated" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOS0zLTEtMS0w_c5ebc1cf-77a2-4796-ad99-a61934e31e5b">11,446</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="mdxg:InvestigationRestatementandRelated" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOS01LTEtMS0w_0590bd9c-3be2-47b2-baa1-5f36a6cbebcd">5,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="mdxg:InvestigationRestatementandRelated" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOS03LTEtMS0w_5ce4796f-f712-430a-9024-fc84143cdfd3">27,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTAtMS0xLTEtMA_2701b9fd-47a1-4fcb-9e6e-b3c67e31dbdc">4,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTAtMy0xLTEtMA_0157be7d-56d2-4887-bc22-3af6d17fa044"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTAtMy0xLTEtMA_23aec459-f16f-4f70-a371-2ce3e6c8e533">2,259</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTAtNS0xLTEtMA_68cf3e43-a3e1-4c2c-851c-43511c40da19">8,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTAtNy0xLTEtMA_aad949ac-f547-4572-86d2-4f547e6aace0">4,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTEtMS0xLTEtMA_9837a77c-853f-4c68-8b4a-39d7bcf2807e">215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTEtMy0xLTEtMA_45cec807-3333-4a4a-b636-37362d523ad7"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTEtMy0xLTEtMA_f0eccecb-d312-45c6-bcbc-4fca1e52709f">271</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTEtNS0xLTEtMA_e47c3bd9-ba85-4a4a-8eab-4f2a3df06640">454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTEtNy0xLTEtMA_ddbb4f15-1ba1-43ce-98d5-f799b65ce609">542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTMtMS0xLTEtMA_5c4396ff-db70-45cf-a94f-926e519480a0">410</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTMtMy0xLTEtMA_677afc05-21e0-4a17-80bb-379d2101eeca">5,856</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTMtNS0xLTEtMA_962e3c27-05be-4b78-a005-c9aa80375f24">7,262</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTMtNy0xLTEtMA_bac9d132-509e-4eab-b792-e93eb2849066">19,600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTctMS0xLTEtMA_a90d6011-dc8c-4d9f-82d7-feca8f97c0c9">1,371</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTctMy0xLTEtMA_11c64273-f643-4586-96cd-a9ace6f2692c"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTctMy0xLTEtMA_b12535c6-1c81-4287-ba70-9ad15d3aa674">2,574</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTctNS0xLTEtMA_79802d19-158a-4af1-8f81-04adf57894ff">2,844</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTctNy0xLTEtMA_8bea0642-3797-4729-8bdf-ea9a044a07a0">4,961</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTgtMS0xLTEtMA_46be04cf-8eaf-4a9a-9888-23f95aa4f5b7">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTgtMy0xLTEtMA_5a539606-85a1-476f-b7c0-0a203a7f20b3"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTgtMy0xLTEtMA_6b083207-c7ea-4206-aac2-400ee281a255">9</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTgtNS0xLTEtMA_513a7f6c-9198-4f87-a5f8-f358201b7b4d">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTgtNy0xLTEtMA_eee2b0da-806d-48db-948c-84f600e53e77">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income tax provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTktMS0xLTEtMA_dd886a49-f8c7-4a01-aaeb-0aede56449dd">1,784</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTktMy0xLTEtMA_b09d7bd9-5108-499a-9dce-b0d91119046c">8,439</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTktNS0xLTEtMA_ca1e9bc8-5b6c-449a-ab2b-3cff6855b017">10,108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTktNy0xLTEtMA_d9c99111-f499-45dd-b67c-94c3c4c70317">24,564</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjAtMS0xLTEtMA_f203c5eb-e530-48d6-b7b4-dc37da589bc2">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjAtMy0xLTEtMA_05d0e05f-892c-4a3c-a43c-18a89398035b"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjAtMy0xLTEtMA_0cf661af-b723-4122-83f8-5e2f00d84eb4">27</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjAtNS0xLTEtMA_76f48639-f0c6-4683-8770-16e977265aa6">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjAtNy0xLTEtMA_c8cabf98-c56c-4918-9edd-be1b315eaa5c">11,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjEtMS0xLTEtMA_3015aa33-03c8-4e86-a767-9573750c2e34">1,779</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjEtMy0xLTEtMA_a45056cc-2bb4-4cc2-894c-f9aa5bb1065c">8,466</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjEtNS0xLTEtMA_9ded7a20-518c-4710-8cee-08ecc0dddfd2">10,161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjEtNy0xLTEtMA_6c5e3672-ee8f-44cd-abb1-93512d7edae1">13,287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss available to common stockholders (Note 8)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjMtMS0xLTEtMA_bb374a97-310d-4583-941c-9f83bc2db120">3,276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjMtMy0xLTEtMA_4547fee4-c0b4-44d3-a533-11b0a81faa9c"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjMtMy0xLTEtMA_e8f00e35-0717-4ffd-81e3-85d89639053e">8,466</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjMtNS0xLTEtMA_d0e520ae-0fef-4854-bd43-2944c39defd8">13,126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjMtNy0xLTEtMA_5c665667-7ee8-423a-8f97-63a4e93558e8">13,287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share - basic </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjUtMS0xLTEtMA_1e57976a-ef46-4b65-96b8-b5b7e0562278">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjUtMy0xLTEtMA_f8dc2ad9-f5ff-4cd3-8d77-afe2faf7171e">0.08</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjUtNS0xLTEtMA_2407323b-e351-462c-b2fc-9387aed5d8b8">0.12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjUtNy0xLTEtMA_c8207d3a-7224-44b9-a179-6b6a2cca6fd1">0.12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share - diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjYtMS0xLTEtMA_ef409bc1-6ef7-4149-891a-2b68b37d47d5">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjYtMy0xLTEtMA_931f4728-3463-4403-98c0-987e95cd8ccb">0.08</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjYtNS0xLTEtMA_68db7d49-46f2-4557-954c-3e459fe7b459">0.12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjYtNy0xLTEtMA_316d7c76-3467-4813-afa2-d2af512706ab">0.12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtMS0xLTEtMA_f5bddecb-6180-49ff-933c-8243b2dc142e"><ix:nonFraction unitRef="shares" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtMS0xLTEtMA_f5d937dc-14be-442a-b8e5-3e6a6198a841"><ix:nonFraction unitRef="shares" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtMS0xLTEtMA_fbd3bfce-59f9-48dc-a53c-9125d0d868dc">110,276,636</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtMy0xLTEtMA_92be8069-f672-4e66-9d39-ad763174062f"><ix:nonFraction unitRef="shares" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtMy0xLTEtMA_bdf4c466-4d49-47d3-a19c-e4e697bcdccd"><ix:nonFraction unitRef="shares" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtMy0xLTEtMA_e64fc3c8-39f3-4eb3-a698-006835fccebd">108,119,461</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtNS0xLTEtMA_2feaace4-e7f0-4d44-9c05-edc84b830e0a"><ix:nonFraction unitRef="shares" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtNS0xLTEtMA_67d93b88-69c1-46ae-909b-55f8467630f5"><ix:nonFraction unitRef="shares" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtNS0xLTEtMA_6cb305a7-3ddc-4fa4-b92f-3ef94b359694">109,841,428</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtNy0xLTEtMA_4b150d1b-43d9-4e6e-be3b-614efc84e099"><ix:nonFraction unitRef="shares" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtNy0xLTEtMA_a8e4888c-ef3c-4225-a2e2-e3232b652f41"><ix:nonFraction unitRef="shares" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtNy0xLTEtMA_eeed6b3f-e9d5-45a1-905b-41dc7ab36bde">108,081,625</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktMS0xLTEtMA_f5bddecb-6180-49ff-933c-8243b2dc142e"><ix:nonFraction unitRef="shares" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktMS0xLTEtMA_f5d937dc-14be-442a-b8e5-3e6a6198a841"><ix:nonFraction unitRef="shares" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktMS0xLTEtMA_fbd3bfce-59f9-48dc-a53c-9125d0d868dc">110,276,636</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktMy0xLTEtMA_92be8069-f672-4e66-9d39-ad763174062f"><ix:nonFraction unitRef="shares" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktMy0xLTEtMA_bdf4c466-4d49-47d3-a19c-e4e697bcdccd"><ix:nonFraction unitRef="shares" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktMy0xLTEtMA_e64fc3c8-39f3-4eb3-a698-006835fccebd">108,119,461</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktNS0xLTEtMA_2feaace4-e7f0-4d44-9c05-edc84b830e0a"><ix:nonFraction unitRef="shares" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktNS0xLTEtMA_67d93b88-69c1-46ae-909b-55f8467630f5"><ix:nonFraction unitRef="shares" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktNS0xLTEtMA_6cb305a7-3ddc-4fa4-b92f-3ef94b359694">109,841,428</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktNy0xLTEtMA_4b150d1b-43d9-4e6e-be3b-614efc84e099"><ix:nonFraction unitRef="shares" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktNy0xLTEtMA_a8e4888c-ef3c-4225-a2e2-e3232b652f41"><ix:nonFraction unitRef="shares" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktNy0xLTEtMA_eeed6b3f-e9d5-45a1-905b-41dc7ab36bde">108,081,625</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_25"></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MIMEDX GROUP, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; DEFICIT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.554%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Issued</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Paid - in</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated </span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Deficit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i863500d35994474dbb64036911295267_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMi0xLTEtMS0w_553e8600-b627-437f-8864-d253b5633bf2">112,703,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i863500d35994474dbb64036911295267_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMi0yLTEtMS0w_02f860d4-0698-45a7-b62d-61247334e4cf">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e12588009a4ccfb7ad506dde230474_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMi0zLTEtMS0w_267fa732-0dc2-41a1-b45d-7521fb23498e">156,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idaaed7e418d64295a2fdef9e72420feb_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMi00LTEtMS0w_6ac7f16c-5ec7-4eb9-83c0-aedff83ce4bb">1,083,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaaed7e418d64295a2fdef9e72420feb_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMi01LTEtMS0w_36a2c977-4b92-4d2f-9779-a8e36994022b">5,091</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d42da3fca664e9196260b0048b8c7a3_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMi02LTEtMS0w_1132a0fa-d45c-446b-b097-5df70f3dff8d">159,806</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i248ea4052a6f4c4a9e79289b81e5d3c5_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMi03LTEtMS0w_488794fc-57ec-4cdd-b025-a7b105842254">8,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Correction of out-of-period error (Note 1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb5f8c6fa26a4473999a549b0860daa7_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMy0zLTEtMS02Mjg5_56fc6203-32c6-4ce4-87d0-2e2e1c8bc326">928</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i57d5766bcb174f22a384db94fb1662dc_D20210401-20210630" decimals="INF" sign="-" format="ixt:numdotdecimal" name="mdxg:TreasuryStockSharesAdjustment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMy00LTEtMS02Mjg5_a87e072d-3d91-41be-91d2-15a327630a0e">239,502</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57d5766bcb174f22a384db94fb1662dc_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMy01LTEtMS02Mjg5_790106a4-943d-4378-9fa9-c375fe545f6b">928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f6cf3288aaf451eb539d95c21c0d3f7_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMy03LTEtMS02NDAx_aaace679-dece-4444-8e4a-a4ff85911be6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i625a8149caf145fb9f6ec49640947103_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMy0zLTEtMS0w_893b4a4a-a7a9-4a52-abce-ff637240c4c5">464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMy03LTEtMS0w_c69f6257-aa92-4a12-b03d-d00f6833e585">464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation&#160;expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i625a8149caf145fb9f6ec49640947103_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfNC0zLTEtMS0w_882a6608-288a-4345-add5-c93702214bf5">4,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfNC03LTEtMS0w_f7f7b2c7-3431-49eb-8bab-bfdb05c34a20">4,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i625a8149caf145fb9f6ec49640947103_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfNi0zLTEtMS0w_9dddec9b-5ef9-4a2b-978e-02912c7a808a">668</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfNi00LTEtMS0w_fd44f37e-ebfa-4cb0-9643-f2e44837f57f">141,516</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfNi01LTEtMS0w_7f2522c8-0f35-4aa3-85e0-0ac240250b63">1,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfNi03LTEtMS0w_abd2a9ec-37b3-43f6-88b5-6bfd87773224">444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i625a8149caf145fb9f6ec49640947103_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfOC0zLTEtMS0w_0261712d-1e20-4a1f-9a40-5ee4d93b8a97">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfOC00LTEtMS0w_8d4b38b1-7bf8-4d01-a025-0d58d399e88b">19,774</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfOC01LTEtMS0w_dfb38339-5bf0-4396-8e11-185da38dbd99">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfOC03LTEtMS0w_993a8918-337c-4692-b907-24aa1fa05536">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock canceled/forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i625a8149caf145fb9f6ec49640947103_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfOS0zLTEtMS0w_b371b183-01dc-4046-98b4-fc771b1fe2d0">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfOS00LTEtMS0w_c7ec9cbf-d158-4fee-83a3-3ac18b13caec">12,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfOS01LTEtMS0w_fa6a73fd-b11c-4f53-9863-44d5e960ed3d">103</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfOS03LTEtMS0w_21f86661-9b0b-4ea1-aee4-3dba9eccf0cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased for tax withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTItNC0xLTEtMA_60df0f5e-2360-4657-a059-352722a64bdd">127,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTItNS0xLTEtMA_742bc20f-b879-4ed9-a55a-9b6596a263f3">1,347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTItNy0xLTEtMA_5024012e-460c-4ee8-8622-7fefc79e83c4">1,347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ded271c9e984021b5cc96dfb866079c_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTMtNi0xLTEtMA_cc76c49a-e832-488c-b96b-6833657c2be8">1,779</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTMtNy0xLTEtMA_0cdc7e6c-f75f-437d-988b-cd1321e5fe69">1,779</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40f91b34ec1c4894992f703f06575098_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTQtMS0xLTEtMA_c0b88894-fc18-40b3-8b4d-945af5617e5d">112,703,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40f91b34ec1c4894992f703f06575098_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTQtMi0xLTEtMA_2e8e5f25-a908-4863-96cb-9cd989fccf24">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9609d1f974a4ffab0a6a9d68d904674_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTQtMy0xLTEtMA_e49b24b3-5b76-4dcc-9541-fb94fe24ce61">158,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia753205aa5374672ad737a15eeaecfcb_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTQtNC0xLTEtMA_10e9b95c-6b44-4bad-8d1f-807e2a8b2ef9">821,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia753205aa5374672ad737a15eeaecfcb_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTQtNS0xLTEtMA_7ce6edc7-650e-4ab7-bb64-bfae0d942edd">4,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3712fe3086a74c9281904d0dc624c0c7_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTQtNi0xLTEtMA_58cb4c6c-c720-4e47-832f-4cc732c99c09">161,585</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTQtNy0xLTEtMA_41d7747b-dd88-4415-800d-2405d1740121">7,137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.554%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Issued</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Paid - in</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated </span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Deficit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib6653e360f5f4cbd89a180be4fef12f6_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMi0xLTEtMS0w_3fba35b2-d7bc-4b23-a58f-b5bf8fb5c0d6">112,703,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6653e360f5f4cbd89a180be4fef12f6_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMi0yLTEtMS0w_e7a8c758-b12a-4058-9e65-40394dbce5f8">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib89406b6d1ed4e27bb530f0566c3e7f4_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMi0zLTEtMS0w_3d530dce-c870-43eb-a297-d6221d760195">149,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if3d2f62cbcc2471997607a0f531eddcf_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMi00LTEtMS0w_ea48ae55-2abe-4fde-8dce-75b0f2794698">2,163,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3d2f62cbcc2471997607a0f531eddcf_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMi01LTEtMS0w_58952fd7-72c0-441c-8c21-f11572413436">12,578</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3340cbdc0854f9c82647d193a0bb6c7_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMi02LTEtMS0w_a481e439-9a37-4f05-a7ad-1996dc6c68e4">106,961</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5176913ab4841a18870be0accaff0da_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMi03LTEtMS0w_26196305-eb9b-48e6-9c9b-91e6b2d8817d">30,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8489118c314c410d9e4ecd5e688a6296_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMy0zLTEtMS0w_abcccfd3-204e-4c87-a3b0-32a7b39be9d4">1,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMy03LTEtMS0w_988a1fde-2402-443d-968c-771e99d2d5c6">1,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8489118c314c410d9e4ecd5e688a6296_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfNC0zLTEtMS0w_c0686b15-203d-4190-accf-c26d48c67e7e">444</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7c6adf93efd64417b653d94ea5764037_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfNC00LTEtMS0w_f03f0ee7-33da-44a6-8dc3-d7ef235a6c9c">50,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c6adf93efd64417b653d94ea5764037_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfNC01LTEtMS0w_2602886d-f158-4d8d-aad1-7f5567b62738">444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfNC03LTEtMS0w_affcb8fe-d91e-4c51-b528-a45107255497">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock shares canceled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8489118c314c410d9e4ecd5e688a6296_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfNi0zLTEtMS0w_efd52344-a124-4cd5-83c8-967d3cd4e9c7">378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c6adf93efd64417b653d94ea5764037_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfNi00LTEtMS0w_1c7bb4af-b2f8-4a09-8473-ad3aba6c84f7">42,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c6adf93efd64417b653d94ea5764037_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfNi01LTEtMS0w_a3896925-0dc2-4898-82d9-5240f3f3c1af">378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfNi03LTEtMS0w_700354f0-9961-4fdb-9175-30b064beb16d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased for tax withholding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8489118c314c410d9e4ecd5e688a6296_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfOS0zLTEtMS0w_a3537083-c0db-44d1-971a-5d2913fcafd9">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c6adf93efd64417b653d94ea5764037_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfOS00LTEtMS0w_fd809c7f-e4c6-40f6-bb73-afa1e88f29a3">256,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c6adf93efd64417b653d94ea5764037_D20200401-20200630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfOS01LTEtMS0w_b29f2eab-c3f6-4d34-ba9b-af5d02108699">939</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfOS03LTEtMS0w_c8046ee9-024f-4647-8fa0-829729bd9d6a">879</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecbaa13b22fc4a349dac5a5be52a1ece_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTAtNi0xLTEtMA_0a0dac74-a256-4575-ad76-f89ed1493d32">8,466</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTAtNy0xLTEtMA_cbd11c98-ef63-43b4-85a2-5c80928ad580">8,466</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib743ddf65e0546dc8061175cd5b6f187_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTEtMS0xLTEtMA_5c1706fc-93b3-4e9d-9d89-0a94e6c00e71">112,703,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib743ddf65e0546dc8061175cd5b6f187_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTEtMi0xLTEtMA_660ca123-080b-4180-9934-80823c2467a7">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bfff166fb7a47dbade947a596cfe795_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTEtMy0xLTEtMA_1755f305-2891-4d6d-a1cd-ba2f0f461b69">151,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa78efde51724943b11905098dacfc15_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTEtNC0xLTEtMA_23652316-d4b3-4faf-a404-4ec4b8b5fd6c">2,412,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa78efde51724943b11905098dacfc15_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTEtNS0xLTEtMA_c0e925d1-ca53-47d5-810a-d053d3dab502">13,451</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9986cdbe1a3a4875971e5c4896a4f876_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTEtNi0xLTEtMA_4a690d68-4abc-47c5-921f-d04e32605223">115,427</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1e691baee849e4b5421dd9318cfdaa_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTEtNy0xLTEtMA_7b2bad9b-38cc-4fba-9366-230ccf15a6e2">22,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.554%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Issued</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Paid - in</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated </span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Deficit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9dbf6fb74aec470fbddc41840209cdca_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMi0xLTEtMS0yMDM0_05af9e44-7bb7-4daf-b269-282ea72815c5">112,703,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dbf6fb74aec470fbddc41840209cdca_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMi0yLTEtMS0yMDM0_7a891ea2-5564-45c7-ac50-646366ef991b">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6959021b92d74cf7bd68800c7edb8e59_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMi0zLTEtMS0yMDM0_1d2328c5-69bf-4ed2-a601-4bbf16e3f16d">158,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9814d3643edd40fe8a5543aa058929ab_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMi00LTEtMS0yMDM0_cadc4146-54b0-428a-8410-a98eaeaebdc4">1,773,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9814d3643edd40fe8a5543aa058929ab_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMi01LTEtMS0yMDM0_e2c75666-4d54-40ea-96b2-5268b8c21cbf">7,449</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ea175868cc44c02963e1fa0d02e98cc_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMi02LTEtMS0yMDM0_b729d053-0903-4c05-a3f5-4c69b2104e37">151,424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMi03LTEtMS0yMDM0_2e2cfff8-f850-42a1-ad93-4c900acf6626">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Correction of out-of-period error (Note 1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieac267072afd40b5973cebef23f08bc7_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMy0zLTEtMS02MzAy_15964957-a801-4217-95db-7a212be7e314">2,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4c45415d8d674cdcb88b2754e8ca0f7a_D20210101-20210630" decimals="INF" sign="-" format="ixt:numdotdecimal" name="mdxg:TreasuryStockSharesAdjustment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMy00LTEtMS02MzAy_d604c8b2-39b8-46f0-9465-3c644b02c0e3">239,502</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c45415d8d674cdcb88b2754e8ca0f7a_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMy01LTEtMS02MzAy_953a6564-4c9e-4baf-8acd-2d6ef622fc7f">2,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c14fb9c8534a52af40933de71d470e_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMy03LTEtMS02MzAy_70c91d0a-3281-4c9d-821d-ea759716abd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f3769f86034f0caba9e0a5c93826f0_D20210101-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMy0zLTEtMS0yMDM5_a6a32fb7-7eb0-4bd0-8dce-00b5de0071cd">926</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMy03LTEtMS0yMDM5_544d5719-b348-4ed6-aa31-b328f11f8627">926</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation&#160;expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f3769f86034f0caba9e0a5c93826f0_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNC0zLTEtMS0yMDQ5_a2d726e6-3474-4352-8ded-b25707f56b4b">7,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNC03LTEtMS0yMDQ5_ff28bea5-7582-4c48-b488-68cf9d769d07">7,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f3769f86034f0caba9e0a5c93826f0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNS0zLTEtMS0yMDQ5_c0067907-a79a-4277-8112-947a8a20f503">934</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i65c1178147214476b81d7b7b0c807490_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNS00LTEtMS0yMDQ5_73470896-4a2c-44b5-9bad-db8db9eca7da">452,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65c1178147214476b81d7b7b0c807490_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNS01LTEtMS0yMDQ5_127ac5dc-eee6-4808-b2c3-89ceb7c2313f">2,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNS03LTEtMS0yMDQ5_e9b78d2a-5417-4d23-a099-a6b96d92653a">1,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f3769f86034f0caba9e0a5c93826f0_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNi0zLTEtMS0yMDQ5_3d3767f2-1d82-4489-8ec4-f6ac5ddd9ac3">3,576</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i65c1178147214476b81d7b7b0c807490_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNi00LTEtMS0yMDQ5_7d57f362-b30a-45e6-9c32-16adb9da7e80">761,775</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65c1178147214476b81d7b7b0c807490_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNi01LTEtMS0yMDQ5_13063502-7c73-4fd3-835e-e79733a50a91">3,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="0" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNi03LTEtMS0yMDQ5_676a3529-54b9-44b3-bca7-3eb18d13bfcf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock canceled/forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f3769f86034f0caba9e0a5c93826f0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNy0zLTEtMS0yMDQ5_89ea58f1-efe0-4a35-95a0-489efd8dfe93">251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65c1178147214476b81d7b7b0c807490_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNy00LTEtMS0yMDQ5_d58d0911-4d36-4e4e-a0bb-875d616e5189">48,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65c1178147214476b81d7b7b0c807490_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNy01LTEtMS0yMDQ5_96cf3100-e14a-40db-9265-061acccb50ce">251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNy03LTEtMS0yMDQ5_b8295d50-2a00-4036-ba5d-42e9f3425575">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased for tax withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65c1178147214476b81d7b7b0c807490_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfOS00LTEtMS0yMDUy_7f112f71-a609-411a-b573-4ccd3a5b1141">453,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65c1178147214476b81d7b7b0c807490_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfOS01LTEtMS0yMDUy_17342e81-9ed3-42ee-885b-d56fb9df0e09">4,563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfOS03LTEtMS0yMDUy_45b93081-6829-4fae-bc5b-609c4186a93b">4,563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b69bb9ce62747dba42e6f35f7d6bea8_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtNi0xLTEtMjA1Mg_c9e069d2-26e8-4eaf-99ee-b89d5a6a31b7">10,161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtNy0xLTEtMjA1Mg_8320e32b-27c6-40c7-9fef-fb1f05b96e54">10,161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40f91b34ec1c4894992f703f06575098_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtMS0xLTEtMjgxMA_fff573a0-13d8-47b0-91fc-fbcc31909e58">112,703,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40f91b34ec1c4894992f703f06575098_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtMi0xLTEtMjgxMA_b93cd66f-2b7a-4ca2-9fcc-907ac7f36e3d">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9609d1f974a4ffab0a6a9d68d904674_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtMy0xLTEtMjgxMA_6faa7a94-e6d3-45a6-8d3e-45d982b16567">158,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia753205aa5374672ad737a15eeaecfcb_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtNC0xLTEtMjgxMA_a7d8db6a-15f5-4956-bf23-8d5e38ac1448">821,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia753205aa5374672ad737a15eeaecfcb_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtNS0xLTEtMjgxMA_302dc773-6bef-4183-9be8-df9b04802e4c">4,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3712fe3086a74c9281904d0dc624c0c7_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtNi0xLTEtMjgxMA_21b76f74-772a-4b20-a6dc-78df77f753f2">161,585</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtNy0xLTEtMjgxMA_ba524851-7b17-429e-8f34-91b59cbf88fd">7,137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.554%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Issued</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Paid - in</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated </span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Deficit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i893ba49ad5c3430a8b5ce9861abc1c91_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMi0xLTEtMS0yMDgw_9dcd576c-2c94-4e0e-b8e0-1a98cec17ab9">112,703,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893ba49ad5c3430a8b5ce9861abc1c91_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMi0yLTEtMS0yMDgw_eadf0637-1e7a-4679-88bc-d19539c197bf">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7835fe481e7a474d88cb9bc9fc4b4e9d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMi0zLTEtMS0yMDgw_f94d4600-0edf-4d44-a7b8-792473500c47">147,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f7fefe2fb0e4c148fd6ecd8635f790a_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMi00LTEtMS0yMDgw_ebf65904-f7a7-47af-9507-3553a737be02">1,885,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f7fefe2fb0e4c148fd6ecd8635f790a_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMi01LTEtMS0yMDgw_d4848430-fbd6-49c3-8422-9d5b803cf90b">10,806</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2560068f9115460db66d530c87ec76d1_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMi02LTEtMS0yMDgw_aba098b9-c92d-483b-b068-6ee55372d707">102,140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e24f6442afe457aa2166e8538c1e212_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMi03LTEtMS0yMDgw_268b3f42-90ad-4a71-8e4d-b15950a79a0a">34,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation&#160;expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a967865ec2b404e982f0925ee8083a6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNC0zLTEtMS0yMDg2_35d82759-1b5e-4bc1-8a49-6b293743b670">3,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNC03LTEtMS0yMDg2_0e9f13ca-809c-4e4c-a259-d8c249f9c210">3,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a967865ec2b404e982f0925ee8083a6_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNS0zLTEtMS0yMDg2_c56fac85-9021-4518-8c68-b2336b7d8cc6">1,658</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNS00LTEtMS0yMDg2_7bab8f98-4fda-485a-baca-764bedb76e4d">220,300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNS01LTEtMS0yMDg2_8c13597e-678b-416f-abaa-3bee18496bf2">1,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNS03LTEtMS0yMDg2_7569c969-07bf-4cd6-919c-3cec43c720d8">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a967865ec2b404e982f0925ee8083a6_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNi0zLTEtMS0yMDg2_b69a46ab-3de6-42e8-b216-addb5be3308a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630" decimals="INF" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNi00LTEtMS0yMDg2_a4729e4d-1d44-4af2-aa81-c2871ca35c9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNi01LTEtMS0yMDg2_4e8caab9-16f7-47d0-9a2e-8b571b0a63df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="0" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNi03LTEtMS0yMDg2_b514bb78-87e1-43e2-bc15-dcbfa0ac8a50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock canceled/forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a967865ec2b404e982f0925ee8083a6_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNy0zLTEtMS0yMDg2_ba7be457-dbfe-462f-81af-67a69396a223">2,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNy00LTEtMS0yMDg2_9282c55f-eb9e-4cd4-b948-b1fe5fcdfc5e">285,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNy01LTEtMS0yMDg2_c4c42e05-2af3-499b-943e-c365db00883a">2,124</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNy03LTEtMS0yMDg2_22ded607-f07d-4e60-aec9-a97651f23aff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased for tax withholding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a967865ec2b404e982f0925ee8083a6_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfOC0zLTEtMS0yMDg5_7ffa4b65-57e5-4e8e-be19-498d9c11c8bd">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfOC00LTEtMS0yMDg5_7bc460aa-4b21-4a95-9596-900c632b35af">461,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfOC01LTEtMS0yMDg5_92a89ccd-e20c-4bb2-b235-3b9c4d809495">2,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfOC03LTEtMS0yMDg5_104fb29a-79e2-4dfd-8ba2-2ac50e3aa907">2,330</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67915ef0633745a1bee624f657dfd70d_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfOS02LTEtMS0yMDg5_957b0a80-9943-4320-b56e-76074d74bd4a">13,287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfOS03LTEtMS0yMDg5_da793cb1-f872-4c4e-850d-833202c6d4ed">13,287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib743ddf65e0546dc8061175cd5b6f187_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMTAtMS0xLTEtMjgwNA_c3144939-012c-4af2-8d65-8cca31aed4a5">112,703,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib743ddf65e0546dc8061175cd5b6f187_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMTAtMi0xLTEtMjgwNA_7f9c3b24-4621-4fc0-9e64-a008a5e3f3f1">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bfff166fb7a47dbade947a596cfe795_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMTAtMy0xLTEtMjgwNA_aa9e5f7c-dc7f-4ec9-a01d-d15e5c8981b2">151,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa78efde51724943b11905098dacfc15_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMTAtNC0xLTEtMjgwNA_adf2dc08-5e80-43a4-9449-194a58ff0a08">2,412,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa78efde51724943b11905098dacfc15_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMTAtNS0xLTEtMjgwNA_15073882-7d15-45c1-89df-a7db62b91008">13,451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9986cdbe1a3a4875971e5c4896a4f876_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMTAtNi0xLTEtMjgwNA_d6eebadd-906f-4610-8727-a5d3e18d4191">115,427</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1e691baee849e4b5421dd9318cfdaa_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMTAtNy0xLTEtMjgwNA_4a1b019d-8a2a-4f72-8559-9c53b91db072">22,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements</span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i586f4d48e4324b41820aaf3f28c0b969_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MIMEDX GROUP, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.710%"><tr><td style="width:1.0%"></td><td style="width:66.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.743%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMy0xLTEtMS0w_920bf0f0-9ec4-4ca7-80a3-d3402eec878b">10,161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMy0zLTEtMS0w_c47a817c-ed97-4271-a7f7-1ce1c1572c87">13,287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash flows used in operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNS0xLTEtMS0w_eb6bac43-d113-4110-98d4-f7eb02d8450b">7,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNS0zLTEtMS0w_6575dcfe-9da1-4cc2-ae6c-8b9174936dc9">7,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNy0xLTEtMS0w_bf4babf2-b66e-4af8-9170-a285c445e955">2,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNy0zLTEtMS0w_1043a2cc-7b81-4197-8c5f-e62168460919">2,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfOC0xLTEtMS0w_73134702-df5e-471d-a1cf-4a09fb0a77bd">454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfOC0zLTEtMS0w_2e596522-6b7e-40eb-94bf-18bad846dd22">542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTAtMS0xLTEtMA_b76bf98c-d0a4-4a6f-871a-c7c0c2aae468">833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTAtMy0xLTEtMA_02ecd1bd-f611-46a2-9227-6d6956e22d33">1,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash lease expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="mdxg:OperatingLeaseRightofuseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTItMS0xLTEtMA_f25fd5f8-f05a-4035-a4db-1e7568fc565f">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" name="mdxg:OperatingLeaseRightofuseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTItMy0xLTEtMA_42368239-14ab-4fa2-b294-951dd220d17a">486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of asset retirement obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="us-gaap:AssetRetirementObligationAccretionExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTMtMS0xLTEtMA_31871d1f-8e70-41bc-9986-b8f509f5e97d">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetRetirementObligationAccretionExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTMtMy0xLTEtMA_c592d5cd-1853-4547-a817-bc546b6e6d84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on fixed asset disposal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTUtMS0xLTEtMA_f0e62e34-dda3-4068-bfef-d1e29d537641">236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTUtMy0xLTEtMA_1203e983-fd7b-436e-8729-53dcc2d20707">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in cash resulting from changes in:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTktMS0xLTEtMA_3fef4857-7a80-451b-8a45-bcc07e0de2d4">1,820</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTktMy0xLTEtMA_7ff17a04-8700-46b5-b891-8f4be1546d05">2,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjAtMS0xLTEtMA_c2ae6818-7ed8-4f73-9e2f-142e1a239681">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjAtMy0xLTEtMA_9fb4083d-04c3-4fe3-92bb-f54692dfdbf6">1,460</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjEtMS0xLTEtMA_5c8a0544-2a73-4024-86b6-e063968bfa38">2,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjEtMy0xLTEtMA_a0fb745a-60af-440f-85a9-18ce46cc746d">3,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjItMS0xLTEtMA_c3e1383a-ec6a-4bc4-bc42-029b5a416812">93</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjItMy0xLTEtMA_619cbf49-5fda-4106-a044-97334b17bf22">10,682</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjMtMS0xLTEtMA_76de417e-0fe6-4b74-846b-946fbf22758d">1,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjMtMy0xLTEtMA_df781ada-fa0c-4573-922b-217541e552c9">821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjQtMS0xLTEtMA_ac9fb6ea-700c-4890-b802-fb964fadd1e7">2,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjQtMy0xLTEtMA_9a4ecf13-bb5d-423c-9951-132840896ab8">3,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjUtMS0xLTEtMA_cf6a22c6-992f-45c0-86da-22415e8f14d1">2,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjUtMy0xLTEtMA_c937c565-2fa5-4544-8eab-c263eb850afe">518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjYtMS0xLTEtMA_a9debd03-b3f7-40d3-94fd-ba4dbab3b8c5">13,752</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjYtMy0xLTEtMA_e782c0c4-e005-42d7-bdce-fa44c4b9de69">12,109</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjctMS0xLTEtMA_5f8576a8-6073-4990-b242-bcf84e42c942">514</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjctMy0xLTEtMA_7dd01708-4e6e-4a8a-b2dd-81f49fcc29ac">609</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash flows used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjgtMS0xLTEtMA_f3b75286-ab19-458f-9150-ff32d51e3cd9">5,080</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjgtMy0xLTEtMA_75e45d9a-c271-4af4-a7d9-754cb0ddb904">15,378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash&#160;flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireMachineryAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzEtMS0xLTEtMA_376147f9-b6ee-455e-a078-4253d49f1d4a">2,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireMachineryAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzEtMy0xLTEtMA_33da77e3-78a7-4cc3-badf-0d5abb1ba333">1,421</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments from note receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzItMS0xLTEtMA_8cf08a43-25e8-4f51-bf29-cdfd04af6e93">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzItMy0xLTEtMA_5ac80fe1-5c8d-4ae0-bc9f-d368c5033ce9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patent application costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="mdxg:PaymentsforApplicationCostsPatent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzQtMS0xLTEtMA_12e6aec2-e784-41b8-b14e-8a2b7ca2b8eb">200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" name="mdxg:PaymentsforApplicationCostsPatent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzQtMy0xLTEtMA_1e98bdf1-0e8d-4c76-ae5a-d6e0a60bfdba">151</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash flows used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzUtMS0xLTEtMA_b0c3094a-5040-4ede-9efc-fe4399818c82">2,501</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzUtMy0xLTEtMA_846de24f-f161-499a-b6eb-01887e69dad3">1,572</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzgtMS0xLTEtMA_8d9bd251-e830-45f4-9215-31450b508524">1,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzgtMy0xLTEtMA_5425171c-6ea2-4371-93bf-61cca6694ddf">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchased for tax withholdings on vesting of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzktMS0xLTEtMA_5297812f-f34f-47cc-8394-e2f59b13aefd">4,563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzktMy0xLTEtMA_50f3ebb2-db20-4abf-b150-333e01ea8cff">2,330</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments on finance lease</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDAtMS0xLTEtMA_5b461fd4-38a0-4ce4-b894-38bf27efa7ed">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDAtMy0xLTEtMA_a8ca337a-dc18-48cd-b1c2-d7c8203435a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDEtMS0xLTEtMA_5ee5ac7a-44f0-40a7-82ab-ffdec667734f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDEtMy0xLTEtMA_99375558-0669-413c-b1fb-e8a280a0f1f6">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of term loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RepaymentsOfMediumTermNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDItMS0xLTEtMA_2c2f291e-fff1-432c-a443-ee40d67b3fca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfMediumTermNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDItMy0xLTEtMA_8ed00fca-3843-44f5-9cb1-11547f439b9b">11,875</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from term loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfMediumTermNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDMtMS0xLTEtMjM3MQ_68b51bfd-1c39-496b-a303-b75417400a51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfMediumTermNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDMtMy0xLTEtMjM3NQ_6dd6a27f-04be-467d-aea0-7c23f65c989b">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash flows used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDMtMS0xLTEtMA_ca1aac8c-e685-4408-8695-d861ec6a9211">3,224</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDMtMy0xLTEtMA_ad943fb3-fa0e-4d9a-b395-9f3714b04bd7">3,930</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDUtMS0xLTEtMA_cf930e92-fb93-4e3f-9243-eff93a1eacc2">10,805</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDUtMy0xLTEtMA_da6191dc-3004-41db-8bba-9abc8c1cf89a">20,880</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDctMS0xLTEtMA_73e85413-6b20-4275-a176-f193d6495da4">95,812</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e24f6442afe457aa2166e8538c1e212_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDctMy0xLTEtMA_3a581076-5fd8-4a07-b86e-eafe87346b5d">69,069</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDgtMS0xLTEtMA_0ae4f6ae-e1a9-4801-ad7b-ba0608c83a9a">85,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1e691baee849e4b5421dd9318cfdaa_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDgtMy0xLTEtMA_cf96e7d7-09a6-4158-a90c-1a5f7431780d">48,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i586f4d48e4324b41820aaf3f28c0b969_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MIMEDX GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE AND SIX MONTHS ENDED JUNE&#160;30, 2021 AND 2020</span></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_34"></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMzg2Mw_c7c90929-594e-4e02-9208-197931046777" continuedAt="iadb071009f844c85944edeca06bd3df1" escape="true">Nature of Business</ix:nonNumeric></span></div><ix:continuation id="iadb071009f844c85944edeca06bd3df1" continuedAt="i7966c77bd86347f68a635b3082d1984a"><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MiMedx Group, Inc. (together with its subsidiaries, except where the context otherwise requires, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MiMedx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; or the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, MiMedx has both a base business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-state pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. The Company derives its products from human placental tissues and processes these tissues using its proprietary methods, including the PURION&#174; process. MiMedx employs Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce its allografts. MiMedx provides products primarily in the wound care, burn, and surgical sectors of healthcare. All of its products are regulated by the United State Food and Drug Administration (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business model is focused primarily on the United States of America but the Company is pursuing opportunities for international expansion.</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Enforcement Discretion</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, the FDA published a series of guidances that established an updated framework for the regulation of cellular and tissue-based products. These guidances clarified the FDA&#8217;s views about the criteria that differentiate those products subject to regulation under Section 361 of the Public Health Service Act from those considered to be drugs, devices, and/or biological products subject to licensure under Section 351 of the Public Health Service Act and related regulations. The Company identified its micronized and particulate products as being subject to regulation under Section 351, requiring pre-market approval from the FDA for a specified indication with demonstrated clinical efficacy.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA exercised enforcement discretion with respect to Investigative New Drug (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) applications and pre-market approval requirements through May 31, 2021. As of May 31, 2021, the Company stopped marketing its Section 351 products and will be precluded from marketing its Section 351 products in the United States until a Biologics License Application (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BLA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is granted. If and when the FDA approves a BLA, we expect to be allowed to market the Section 351 products again, but only for specific indications as permitted by the FDA. Sales of the Company&#8217;s Section 351 products were $<ix:nonFraction unitRef="usd" contextRef="i32d60e88dd1c4b5dad71c5e90be4b433_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTYzOTY2NQ_41f1cc6b-469a-4ac3-9c6f-79fbc0527c5f">8.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2f69b69d3f9a4ac2b110d37dcc110405_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTYzOTY4Ng_921911b6-7c20-4d07-b83e-0dc8ada2081c">6.2</ix:nonFraction> million for the three months ended June&#160;30, 2021 and 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i90e644d3bd014f92ba1bb40b0b78d305_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTYzOTc1OA_f7892a55-556f-49b4-818b-22b1cc400b91">16.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4c9b39d7c36e4c6f960af71b46e8ca65_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTYzOTc4Mg_36b037bc-7ef7-49a7-bbf6-17cca4d65f81">14.9</ix:nonFraction> million for the six months ended June&#160;30, 2021 and 2020, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently markets EPICORD and AMNIOCORD tissue products derived from human umbilical cord, as providing a protective environment or as a barrier. If the FDA were to determine that EPICORD and AMNIOCORD do not meet the requirements for regulation solely under Section 361, then pre-market clearance or approval would be required. The loss of the Company&#8217;s ability to market and sell its umbilical cord-derived products would have an adverse effect on the Company&#8217;s revenue, business, financial condition, and results of operations. Net sales of the Company&#8217;s umbilical cord-derived products were $<ix:nonFraction unitRef="usd" contextRef="ib148d38e25b94492bf90c7d639339309_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTYzOTg1OQ_3b47ba9b-3c74-4944-beb4-cdf58aa8d1e3">5.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4419ab9cc84f446692df129d313037a1_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTYzOTg3Mw_736cab4b-39cf-4c6e-85b9-71d8c4ac17a4">3.3</ix:nonFraction> million for the three months ended June&#160;30, 2021 and 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i66be1c10c07c47af8bcae86ad35148ae_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTYzOTgwNg_d06da6c6-59b2-4693-83fb-8e7142d67e9f">10.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3cbcb788b0524138bc71b680f77362cc_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTYzOTgyOQ_c5927482-8b19-41a2-b055-82920fb984d3">7.2</ix:nonFraction> million for the six months ended June&#160;30, 2021 and 2020, respectively. Cord inventory, which would be at risk for write-down as a result of this determination, was $<ix:nonFraction unitRef="usd" contextRef="i54f3fa70af5b41b893e305ac0470f535_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTY0MDY2Ng_f487cc50-e2b0-4fac-b378-bcfb33e29136">0.8</ix:nonFraction> million as of June&#160;30, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Out-of-Period Adjustment</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2021, the Company identified certain Restricted Stock Unit and Performance Stock Unit awards which were not appropriately reflected in the Company&#8217;s balance of common stock outstanding beginning in 2019. The effects of these errors caused misstatements in the Company&#8217;s balance of treasury stock, additional paid-in capital, and common stock outstanding on each of the Company&#8217;s reported consolidated balance sheets and consolidated statements of stockholders&#8217; (deficit) equity for interim and annual periods beginning with those statements as of and for the year ended December 31, 2019. The identified errors did not affect total stockholders&#8217; (deficit) equity or earnings per share in any period.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded an out-of-period adjustment during the three and six months ended June&#160;30, 2021, which resulted in decreases of $<ix:nonFraction unitRef="usd" contextRef="ibb5f8c6fa26a4473999a549b0860daa7_D20210401-20210630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMjc0ODc3OTA4Njk5NA_47864e48-3dbf-4b91-957e-fd8f1e50f006">0.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ieac267072afd40b5973cebef23f08bc7_D20210101-20210630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMjc0ODc3OTA4NzAwMg_ab9e4575-2e23-4fe1-b224-43b8d76b65b5">2.0</ix:nonFraction> million to the balance of additional paid-in capital for the three and six months ended June&#160;30, 2021, respectively, and increases of $<ix:nonFraction unitRef="usd" contextRef="i57d5766bcb174f22a384db94fb1662dc_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMjE5OTAyMzI3Mzk1NQ_34de3cd5-2e9f-4796-b578-ae3efd163a01">0.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i4c45415d8d674cdcb88b2754e8ca0f7a_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMjE5OTAyMzI3Mzk2OQ_66134a31-d740-444b-ab5a-d3250977fda0">2.0</ix:nonFraction>&#160;million to the balance of treasury stock during those same periods. The balance of common shares outstanding at June&#160;30, 2021 of <ix:nonFraction unitRef="shares" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMjc0ODc3OTA4NzIzNQ_864964a0-9723-4d6e-b6c0-c614e1444e94">111,881,938</ix:nonFraction> reflects a cumulative increase of <ix:nonFraction unitRef="shares" contextRef="iaca0961cc5c74e099acc7bc6fe95a9ef_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="mdxg:TreasuryStockSharesAdjustment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMjc0ODc3OTA4NzI3Mw_958c486f-5977-4291-b0e9-ccdc60c21791">239,502</ix:nonFraction> shares relating to the adjustment.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7966c77bd86347f68a635b3082d1984a">The Company concluded the effect of the misstatement was not material, qualitatively or quantitatively, to any interim or annual period.</ix:continuation></span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_37"></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2Mzg_a836a185-e8a8-40ad-988a-68515ae7a4af" continuedAt="i6f3bf199c93f471fb1cb3e4695847e92" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i6f3bf199c93f471fb1cb3e4695847e92" continuedAt="ibf5e3e91ad07430fa9b158355bbb9596"><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see Note 2 to the Company&#8217;s Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the Securities and Exchange Commission (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SEC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) on March 8, 2021 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Form 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for a description of all significant accounting policies.</span></div><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2Mzk_1ec351ff-2733-44b2-89c4-f62ead8a9fbf" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GAAP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) from interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the results of operations for the periods presented have been included.&#160;The operating results for the three and six months ended June&#160;30, 2021 and 2020 are not necessarily indicative of the results that may be expected for the fiscal year.&#160;The balance sheet as of December&#160;31, 2020 was derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements should be read in conjunction with the historical consolidated financial statements of the Company included in the 2020 Form 10-K.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2MDc_b59a6a33-0488-4294-9230-98241bda3349" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared in accordance with GAAP. Conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported unaudited condensed consolidated statements of operations during the reporting period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment and intangible assets, estimates regarding asset retirement obligations, estimates for contingent liabilities, the measurement of right-of-use assets and lease liabilities, management&#8217;s assessment of the Company&#8217;s ability to continue as a going concern, estimates of fair value of share-based payments, and valuation of deferred tax assets.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above, the Company has considered the potential effects of the Covid-19 Pandemic and potential negative impacts resulting from the end of the FDA&#8217;s period of Enforcement Discretion with respect to its determinations surrounding impairments, increases in allowances for credit losses, increases in the Company&#8217;s returns reserve, other expenses, and changes in accounting judgments that have or are reasonably likely to have a material impact on the unaudited condensed consolidated financial statements.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2MjQ_04be9a82-607e-432d-a01f-f7d78b34167b" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of MiMedx Group, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2MjE_cbd257a0-b7f9-4c69-b925-a4b12e77bf02" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable represent amounts due from customers for which revenue has been recognized. Generally, the Company does not require collateral or any other security to support its receivables.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bad debt expense and the allowance for doubtful accounts are based on historical trends and current expectations for credit losses and reasonable and supportable forecasts. The Company&#8217;s policy to reserve for potential bad debts is based on the aging of the individual receivables as well as customer-specific qualitative factors, such as bankruptcy proceedings. The Company manages credit risk by routinely performing credit checks on customers prior to sales. The individual receivables are written-off after all reasonable efforts to collect the funds have been made. Actual write-offs may differ from the amounts reserved.</span></div></ix:nonNumeric><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for doubtful accounts was $<ix:nonFraction unitRef="usd" contextRef="i2d1e691baee849e4b5421dd9318cfdaa_I20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTA5OTUxMTY2MjQ1MQ_1a947ad3-bc36-4482-9410-45e47e1ed4e8">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTA5OTUxMTY0OTI3OQ_01483d8f-32f5-4ead-9077-5e9d64c57f38">0.7</ix:nonFraction> million as of June&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="ibf5e3e91ad07430fa9b158355bbb9596" continuedAt="i2570b389469d4f18b8d4a55f7929ba3c"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2Mzc_2be2a4b2-fcc0-41ef-a162-9545a450e119" continuedAt="ie0273778ddd646fea95e342732e286e4" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of purchase price over the fair value of net assets of acquired businesses. The Company assesses  goodwill for impairment at least annually on October 1 and whenever events or substantive changes in circumstances indicate that the asset may be impaired. The Company may first choose to assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then the Company performs a quantitative analysis. The Company may also choose to bypass the qualitative assessment and proceed directly to the quantitative analysis.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company concluded it operates as <ix:nonFraction unitRef="reportingunit" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportingUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfNTk4Mw_d3d4e67a-6320-4976-b813-27b972724a19">one</ix:nonFraction> reporting unit.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the quantitative analysis, if the carrying value of the reporting unit exceeds its fair value, goodwill impairment is recognized for the amount that the carrying value exceeds fair value, not to exceed the total amount of goodwill allocated to the reporting unit. The Company determines fair value using income and market approaches. Under the income approach, the fair value of the Company is the present value of its future economic benefits. These benefits can include revenue, cost savings, tax deductions, and proceeds from its disposition. Value indications are developed by discounting expected cash flows to their present value at a rate of return that incorporates the risk-free rate for the use of funds, industry trends, and entity-specific risks as of the goodwill impairment testing date. Under the market approach, the Company derives the fair value of the reporting unit using observed fair values of a set of companies with comparable business models to the reporting unit under evaluation. These amounts are reconciled to the Company&#8217;s market capitalization as of the test date for reasonableness.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Annual Goodwill Impairment Testing Date </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to change its annual goodwill and indefinite-lived intangible asset impairment testing date from September 30 to October 1. The change in the annual impairment testing date provides the Company with more time in identifying and calculating any impairments and to maximize the use of the Company&#8217;s available resources. </span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie0273778ddd646fea95e342732e286e4">Because GAAP does not permit more than 12 months to pass between annual goodwill impairment tests, the Company performed quantitative tests on September 30 and October 1, 2020.</ix:continuation> As a result of each of these tests, the Company concluded that the fair value of the reporting unit exceeded the carrying value and recorded <ix:nonFraction unitRef="usd" contextRef="iab79a42abcfc49bf821585364d7300c9_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfNzg0Ng_436a95ab-ecd2-4eca-bd19-a55749fe0a92">no</ix:nonFraction> impairment.</span></div><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2NTY_2acdd062-f004-4bee-9d2a-a30c644e24c2" continuedAt="ie10262708bac4e86920637bd3bd96dfe" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells its products primarily to individual customers and independent distributors (collectively referred to as &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Customers obtain and use products either through ship and bill arrangements or consignment arrangements. Under ship and bill arrangements, the customer submits an order. Upon approval of the sales order, the Company ships product to the customer and invoices them for the product sold. Under consignment arrangements, the customer takes possession of the product, but the Company retains title until the implantation, or application of the Company&#8217;s product to the patient.</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue as performance obligations are fulfilled; which generally occurs upon the shipment of product to the customers for ship and bill orders or upon implantation for consignment sales.</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized based on consideration the Company expects to be entitled to from the sale. This consists of the gross selling price of the product, less any discounts or rebates (collectively, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">deductions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">sales deductions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Gross selling price is a standard set by the Company for all customers unless a contract governing the sale provides for a specified price. Sales deductions are specified in individual contracts with customers and are generally achieved based on total sales during a specified period. The Company estimates the total sales deductions that a specific customer will achieve over the relevant term and applies the reduction to sales as they are made throughout the period. Rebates owed to customers are accrued and recorded in accrued expenses on the unaudited condensed consolidated balance sheets.</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company acts as principal in all of its customer arrangements and records revenue on a gross basis. Shipping is considered immaterial in the context of the overall customer arrangement, and damages or loss of goods in transit are rare. Therefore, shipping is not deemed a separately-recognized performance obligation and the Company has elected to treat shipping costs as activities to fulfill the promise to transfer the product. The Company maintains a returns policy that allows its customers to return product that is consigned, damaged, or non-conforming, ordered in error, or due to a recall. The estimate of the provision for returns is based on historical experience with actual returns. The Company&#8217;s payment terms for customers are typically <ix:nonNumeric contextRef="i9da3db9cb0b24a25ada54ecbe079f087_D20210101-20210630" format="ixt-sec:durday" name="mdxg:RevenueFromContractWithCustomerPaymentTerms" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMzg0ODI5MDczNTg2Nw_4a8009ab-c034-448b-9637-18f5c04f32eb">30</ix:nonNumeric> to <ix:nonNumeric contextRef="i28d0157a57fe4b55ac3580147766d8d8_D20210101-20210630" format="ixt-sec:durday" name="mdxg:RevenueFromContractWithCustomerPaymentTerms" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMzg0ODI5MDczNTg4MQ_d3ab85c7-dad5-4e36-b574-0e5265839134">60</ix:nonNumeric> days from receipt of title of the goods.</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above revenue recognition policy, the Company recognizes revenue from customers with balances outstanding as of September 30, 2019 for which all of the criteria necessary for revenue recognition were not met at the time of </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="i2570b389469d4f18b8d4a55f7929ba3c" continuedAt="i6ca369b32a214683818f459ad8cc9acf"><ix:continuation id="ie10262708bac4e86920637bd3bd96dfe"><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shipment and that such criteria would not be met until collection of such sales (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). This was in accordance with the change in the Company&#8217;s revenue recognition pattern beginning September 30, 2019 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company defers the recognition of cost of sales associated with the Remaining Contracts until revenue is recognized and cash is collected. Deferred cost of sales, included as part of other current assets on the unaudited condensed consolidated balance sheets, were $<ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTA5OTUxMTY1MjgxMg_7852d12c-4543-4c4b-a64e-6c9c5246b036">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTA5OTUxMTY1MjgyMA_5960ed17-d5cc-4b07-9fbd-40e5587dd1c3">0.2</ix:nonFraction>&#160;million as of June&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2MDk_82ef6c63-5ae2-4b33-9683-bd25c2f18a75" escape="true"><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the effects of cash collections on the Remaining Contracts on the unaudited condensed consolidated statements of operations for each of the three and six months ended June&#160;30, 2021 and 2020 are as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.554%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie18163f5013a4be0b9bd02bf40e60571_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfMi0xLTEtMS0w_3d969d1d-305a-41ee-af8c-445a19f14e38">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i326a81676c33465b89855dd27ba292da_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfMi0zLTEtMS0w_91b557f4-c1f0-4136-b9f8-49bd8389ba7e">1,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f649d4d661481e8d6a6d250cdba5f7_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfMi01LTEtMS0xNjI1_90bc6220-f26c-406c-beed-c9a6b49936fb">611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cccbdf946f0459cb7d8cd1a05b4cd5c_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfMi03LTEtMS0xNjM0_0f7197a1-8167-4b86-978d-b4db1496f94e">6,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie18163f5013a4be0b9bd02bf40e60571_D20210401-20210630" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfMy0xLTEtMS0w_f2ffd051-5af8-4f02-8e49-7e74270bb9d4">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i326a81676c33465b89855dd27ba292da_D20200401-20200630" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfMy0zLTEtMS0w_12ffe8c0-a859-42b9-a12e-a8340a1ffb27">239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f649d4d661481e8d6a6d250cdba5f7_D20210101-20210630" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfMy01LTEtMS0yODUx_3a875de8-84a6-45be-ae71-62c4438517c5">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cccbdf946f0459cb7d8cd1a05b4cd5c_D20200101-20200630" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfMy03LTEtMS0yODUx_c3b3cfaf-4ac6-4cfc-9e4d-380330d7da24">868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie18163f5013a4be0b9bd02bf40e60571_D20210401-20210630" decimals="-3" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfNC0xLTEtMS0w_947fd24f-9d3f-4653-8205-fd972ab36009">269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i326a81676c33465b89855dd27ba292da_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfNC0zLTEtMS0w_077fce08-c6a8-4bc5-a9fd-efc486787c24">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f649d4d661481e8d6a6d250cdba5f7_D20210101-20210630" decimals="-3" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfNC01LTEtMS0yODUx_e7c21684-cb21-4def-a6e0-9acb3b3c46c0">525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cccbdf946f0459cb7d8cd1a05b4cd5c_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfNC03LTEtMS0yODUx_54bc6a71-b260-4b8f-a6b8-c593052cf49a">5,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2NTA_eb019fe4-1b68-443a-b97b-71331149216f" continuedAt="id7a76ec3327848b8963e7b31bbe02770" escape="true"><div style="margin-bottom:10pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is, or contains, a lease at inception.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Lease assets and liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The lease term used in the calculation includes options to extend or terminate the lease when the exercise of such options are reasonably certain. The determination of whether the Company is reasonably certain to exercise a renewal or termination option is reassessed as new information arises and is accounted for prospectively as of the point in time the determination is made regarding the modification of the lease term. The Company uses its incremental borrowing rate in determining the present value of lease payments.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets resulting from operating leases are included in right of use asset on the unaudited condensed consolidated balance sheets as of June&#160;30, 2021 and December&#160;31, 2020. Right-of-use assets resulting from the Company&#8217;s finance leases are included in property and equipment, net on the unaudited condensed consolidated balance sheet as of June&#160;30, 2021. Associated liabilities from both operating and finance leases are included on the unaudited condensed consolidated balance sheet as part of other current liabilities, to the extent that principal payments on such obligations will be paid in the next 12 months, and other liabilities, to the extent that principal payments on such obligations will be paid more than one year in the future. As of June&#160;30, 2021, the Company has both finance and operating leases.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable components of the lease payments such as fair market value adjustments, utilities, and maintenance costs are expensed as incurred and not included in determining the present value of lease liabilities. As an accounting policy election, the Company excludes short-term leases having initial terms of 12 months or fewer. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases, lease expense is recognized on a straight-line basis over the lease term through selling, general and administrative expense on the unaudited condensed consolidated statements of operations. For finance leases, the right of use asset is amortized, straight-line, over the life of the lease as depreciation expense, which is included as a component of selling, general and administrative expense on the unaudited condensed consolidated statements of operations. The Company recognizes interest expense on finance lease liabilities based on the incremental borrowing rate at lease inception applied to the outstanding lease liability. The Company does not recognize interest expense on operating lease liabilities.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments on operating leases are considered cash flows from operating activities. Payments on finance leases, to the extent that the payment relates to the reduction of the principal balance of the liability, are considered cash flows from financing activities. Payments toward the interest portion of finance lease liabilities are classified as cash flows from operating activities.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; which simplifies and clarifies certain calculation and presentation matters related to convertible equity and debt instruments. Specifically, ASU simplifies the accounting for such instruments by removing requirements to separately account for conversion features as a derivative under ASC Topic 815 and removing the requirement to account for beneficial conversion </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="i6ca369b32a214683818f459ad8cc9acf"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id7a76ec3327848b8963e7b31bbe02770">features on such instruments. Accounting Standards Update 2020-06 also provides clearer guidance surrounding disclosure of such instruments and provides specific guidance for how such instruments are to be incorporated in the calculation of Diluted EPS. The guidance under ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company adopted this standard on January 1, 2021 on a modified retrospective basis. There was no impact upon adoption.</ix:continuation></span></div><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2MTU_accd0fef-a6da-40ec-8b0d-a8ef4d9beff7" escape="true"><div style="margin-bottom:10pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standards Update (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) 2020-04, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, which provides temporary, optional expedients and exceptions to accounting guidance for certain contract modifications and hedging arrangements to ease financial reporting burdens as a result of market transitions from the London Interbank Offered Rate (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LIBOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to alternative reference rates. The guidance is available for prospective application upon its issuance and can generally be applied to contract modifications and hedging relationships entered into beginning March 12, 2020 through December 31, 2022. As of June&#160;30, 2021, the Company has long-term debt outstanding which carries an interest rate tied to LIBOR, the agreement for which contemplates an interest rate alternative in the event that LIBOR is unavailable. The Company is evaluating the possibility of adoption and the related impact on its financial statements. If adopted, the Company does not expect the provisions of this ASU to have a material impact on its consolidated financial statements.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other ASUs issued and not yet effective for the six months ended June 30, 2021, and through the date of this report, were assessed and determined to be either not applicable or are expected to have minimal impact on the Company&#8217;s financial position or results of operations.</span></div></ix:nonNumeric></ix:continuation><div id="i586f4d48e4324b41820aaf3f28c0b969_43"></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RleHRyZWdpb246YTU4NmM2ZmFjN2U1NGM3ZThlMTQ0ZjAwMDdjOTI4MDlfNzc_659c5c04-a834-456c-a77b-c79f6cdcbddf" continuedAt="id5ca9a61f2f54d81b807ca4962638cdd" escape="true">Inventory</ix:nonNumeric></span></div><ix:continuation id="id5ca9a61f2f54d81b807ca4962638cdd"><div style="margin-bottom:9pt;margin-top:6pt"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RleHRyZWdpb246YTU4NmM2ZmFjN2U1NGM3ZThlMTQ0ZjAwMDdjOTI4MDlfODI_664604dd-690d-45f8-9a07-d8f5d8aa0110" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.228%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" name="us-gaap:InventoryRawMaterials" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RhYmxlOjE0NmUyZjM3MDRlYzQ1MWJiZWZmMDkwYWM0NDFiOTNjL3RhYmxlcmFuZ2U6MTQ2ZTJmMzcwNGVjNDUxYmJlZmYwOTBhYzQ0MWI5M2NfMS0xLTEtMS0w_1f65f3a8-a4ff-49db-8b46-334b219f3122">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" name="us-gaap:InventoryRawMaterials" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RhYmxlOjE0NmUyZjM3MDRlYzQ1MWJiZWZmMDkwYWM0NDFiOTNjL3RhYmxlcmFuZ2U6MTQ2ZTJmMzcwNGVjNDUxYmJlZmYwOTBhYzQ0MWI5M2NfMS0zLTEtMS0w_f2a00cff-c8ec-4f40-be48-a3e86635b1a8">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RhYmxlOjE0NmUyZjM3MDRlYzQ1MWJiZWZmMDkwYWM0NDFiOTNjL3RhYmxlcmFuZ2U6MTQ2ZTJmMzcwNGVjNDUxYmJlZmYwOTBhYzQ0MWI5M2NfMi0xLTEtMS0w_ac5023be-d13b-44e9-92b9-f1121b63457e">6,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RhYmxlOjE0NmUyZjM3MDRlYzQ1MWJiZWZmMDkwYWM0NDFiOTNjL3RhYmxlcmFuZ2U6MTQ2ZTJmMzcwNGVjNDUxYmJlZmYwOTBhYzQ0MWI5M2NfMi0zLTEtMS0w_99a8ba3a-6a13-4e0b-ba46-9c3a3a4c787e">4,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoods" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RhYmxlOjE0NmUyZjM3MDRlYzQ1MWJiZWZmMDkwYWM0NDFiOTNjL3RhYmxlcmFuZ2U6MTQ2ZTJmMzcwNGVjNDUxYmJlZmYwOTBhYzQ0MWI5M2NfMy0xLTEtMS0w_6980fd4e-2974-4111-8056-bcbd15ebebe0">3,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoods" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RhYmxlOjE0NmUyZjM3MDRlYzQ1MWJiZWZmMDkwYWM0NDFiOTNjL3RhYmxlcmFuZ2U6MTQ2ZTJmMzcwNGVjNDUxYmJlZmYwOTBhYzQ0MWI5M2NfMy0zLTEtMS0w_b0e98d3c-d1a1-48c6-a48b-3b62be7d22a2">5,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RhYmxlOjE0NmUyZjM3MDRlYzQ1MWJiZWZmMDkwYWM0NDFiOTNjL3RhYmxlcmFuZ2U6MTQ2ZTJmMzcwNGVjNDUxYmJlZmYwOTBhYzQ0MWI5M2NfNi0xLTEtMS0w_c249429b-aca2-4e7f-a73a-b04058c10d67">10,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RhYmxlOjE0NmUyZjM3MDRlYzQ1MWJiZWZmMDkwYWM0NDFiOTNjL3RhYmxlcmFuZ2U6MTQ2ZTJmMzcwNGVjNDUxYmJlZmYwOTBhYzQ0MWI5M2NfNi0zLTEtMS0w_1b8c0bdd-a876-4bb6-beab-54949f3f18d0">10,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the conclusion of the FDA&#8217;s period of Enforcement Discretion on May 31, 2021, the Company fully reserved $<ix:nonFraction unitRef="usd" contextRef="i90e644d3bd014f92ba1bb40b0b78d305_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RleHRyZWdpb246YTU4NmM2ZmFjN2U1NGM3ZThlMTQ0ZjAwMDdjOTI4MDlfMTA5OTUxMTYyODc4NQ_dba8553d-cff2-48b7-85ad-819f19c8ce3f"><ix:nonFraction unitRef="usd" contextRef="i32d60e88dd1c4b5dad71c5e90be4b433_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RleHRyZWdpb246YTU4NmM2ZmFjN2U1NGM3ZThlMTQ0ZjAwMDdjOTI4MDlfMTA5OTUxMTYyODc4NQ_dbe06e54-b53d-4f02-b6ab-fc04317a1282">1.0</ix:nonFraction></ix:nonFraction> million of its Section 351 product inventory during the three and six months ended June&#160;30, 2021. This amount is included as part of cost of sales on the unaudited condensed consolidated statements of operations for those periods.</span></div></ix:continuation><div id="i586f4d48e4324b41820aaf3f28c0b969_46"></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RleHRyZWdpb246ZjM3ZTI0MTE5NDkzNGViYWIyNWYxYmNmMTE3NmI1Y2NfNDMw_10373f9f-ae3b-4f76-aa08-0b1b5da07dc3" continuedAt="i2fffcf826cc245f892137eed42de03b7" escape="true">Property and Equipment&#160;</ix:nonNumeric></span></div><ix:continuation id="i2fffcf826cc245f892137eed42de03b7" continuedAt="i4a7cad92dc6a4c39a30b23d795415c54"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RleHRyZWdpb246ZjM3ZTI0MTE5NDkzNGViYWIyNWYxYmNmMTE3NmI1Y2NfNDIx_09978434-c4d7-404f-88de-df392677d072" escape="true"><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:61.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ffcb532f3f045a79f3f2a726bce2285_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfMS0xLTEtMS0w_3205ff5d-efef-4dcc-866e-f94747cfd91c">8,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a35085d43841c29afd03db8ea30feb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfMS0zLTEtMS0w_429b5b31-3720-4184-b984-34e91e62247c">6,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and clean room equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0cec0ff165d410fb950f0fe592b80e5_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfMi0xLTEtMS0w_1d27fe49-3792-451c-8e7e-271753f6b2e8">15,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7887f65880b416a9a1b7b135b38514d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfMi0zLTEtMS0w_72380a30-e9d1-47df-9b11-5ee795bc62b2">15,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a82046d4b9b4effaec4f006f2703487_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfMy0xLTEtMS0w_3d219a82-0183-4a7c-92ab-09bca7483ea6">15,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i804fe80afd1c4483a92cd48a806655ec_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfMy0zLTEtMS0w_d5c35057-1c55-47b1-b05d-f5a5a9f7e542">15,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa1ee6b8d8d4beeabdc8444cf7a0a97_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNC0xLTEtMS0w_78f70ac6-b541-4d7d-b738-78e487ce2b7e">1,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec2d038f80894231a4c3c16bcb971517_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNC0zLTEtMS0w_142c8678-0129-4e25-bae4-a18e17b73fce">3,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset retirement cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76c421a22e8847a89a5ee26247adacac_I20210630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNS0xLTEtMS0w_009929fa-a540-497f-a02e-1a476f486e6f">860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87db49da4123419b8897eb063c0b4c9c_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNS0zLTEtMS0w_0a51326c-fb8d-4930-a7b6-551e120e97f4">785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5140cbcb67b477eae5103576b9d79ec_I20210630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNi0xLTEtMS0xMzE3_42ab2d60-12ad-4f1c-9463-e34a2933c523">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i455d7d410196418eba05ebd95eca8809_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNi0zLTEtMS0xMzI3_9e9e493d-ef5f-4e4d-8050-633bbb0de768">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Property and equipment, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNi0xLTEtMS0w_ee783636-a96a-49df-af60-51430811eb56">41,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNi0zLTEtMS0w_ae3a345c-bbb4-437e-8a7b-8a7fc6eba481">40,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNy0xLTEtMS0w_ca9776ef-c738-435b-98a9-43a2d4638942">31,273</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNy0zLTEtMS0w_130cd5bb-204f-48ec-8a7b-dc1d6621645d">29,498</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfOC0xLTEtMS0w_5aa6968f-64bf-41f2-a667-0d46edbdfc34">10,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfOC0zLTEtMS0w_2c2e539c-3302-4302-878c-8e5ab584fd3a">11,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="mdxg:ScheduleOfDepreciationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RleHRyZWdpb246ZjM3ZTI0MTE5NDkzNGViYWIyNWYxYmNmMTE3NmI1Y2NfNDI3_0b025348-f298-4bfd-a8c2-b85597f4bb9b" continuedAt="ia61ff9a6cd6042c0ad50d1cbd4dbf154" escape="true">Depreciation expense for each of the three and six months ended June&#160;30, 2021 and 2020 is summarized in the table below (amounts in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="i4a7cad92dc6a4c39a30b23d795415c54"><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><ix:continuation id="ia61ff9a6cd6042c0ad50d1cbd4dbf154"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"></td><td style="width:24.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.056%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.056%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjMwMzg3ODVkYTViNTQxODM4Yjk3NTIxMTVkZWY0ZjNlL3RhYmxlcmFuZ2U6MzAzODc4NWRhNWI1NDE4MzhiOTc1MjExNWRlZjRmM2VfMi0xLTEtMS0xMzMy_d3b35a30-e1d9-4ae3-930b-fecab6f955fa">1,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjMwMzg3ODVkYTViNTQxODM4Yjk3NTIxMTVkZWY0ZjNlL3RhYmxlcmFuZ2U6MzAzODc4NWRhNWI1NDE4MzhiOTc1MjExNWRlZjRmM2VfMi0zLTEtMS0yODY3_bde35fca-b24f-492b-8cfd-82b0f7f7c04a">1,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjMwMzg3ODVkYTViNTQxODM4Yjk3NTIxMTVkZWY0ZjNlL3RhYmxlcmFuZ2U6MzAzODc4NWRhNWI1NDE4MzhiOTc1MjExNWRlZjRmM2VfMi0yLTEtMS0w_7980fdc2-db0b-41b7-bdb2-5d828a2f2ddf">2,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjMwMzg3ODVkYTViNTQxODM4Yjk3NTIxMTVkZWY0ZjNlL3RhYmxlcmFuZ2U6MzAzODc4NWRhNWI1NDE4MzhiOTc1MjExNWRlZjRmM2VfMi00LTEtMS0w_b4e5c78e-3c49-45f3-ae59-4a49ba7f014a">2,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense is allocated amongst cost of sales, research and development, and selling, general, and administrative expense on the unaudited condensed consolidated statements of operations.</span></div></ix:continuation><div id="i586f4d48e4324b41820aaf3f28c0b969_52"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">       5. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RleHRyZWdpb246YjM4YzY3ZGRkM2FlNGFkMDgyNjJiZjlmM2RjOGVjMmVfMzAy_0d86eeff-ffca-4a6c-b600-1ae5b1f694fa" continuedAt="i306e3f8965694ed4b86c58ca612372ca" escape="true">Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="i306e3f8965694ed4b86c58ca612372ca"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RleHRyZWdpb246YjM4YzY3ZGRkM2FlNGFkMDgyNjJiZjlmM2RjOGVjMmVfMjg3_04e1b79b-764b-467d-8020-2c75d1a9cc97" escape="true"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RleHRyZWdpb246YjM4YzY3ZGRkM2FlNGFkMDgyNjJiZjlmM2RjOGVjMmVfMjk0_82174884-33e7-457a-8bea-10654bf9fd9c" escape="true"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are summarized as follows (in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:38.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.762%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.762%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and know how</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af507b3d6eb4a15b70f0d9de1dfba91_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMy0xLTEtMS0w_00c3f5e8-b936-49c1-be43-8319c8bff8bb">9,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af507b3d6eb4a15b70f0d9de1dfba91_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMy0yLTEtMS0w_d159bd3f-5e57-4177-9329-98195c5403b7">6,069</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5af507b3d6eb4a15b70f0d9de1dfba91_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMy0zLTEtMS0w_1b4ccab7-68ff-44bc-a028-8a6652cb20e4">3,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if023d360bddb4609ba7c01984189031c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMy01LTEtMS0w_3f26abfb-8c8d-44c7-ae19-b0c9f10c5bd4">9,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if023d360bddb4609ba7c01984189031c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMy02LTEtMS0w_ea65ac7d-90a2-4195-813c-4ed19351aeeb">5,730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if023d360bddb4609ba7c01984189031c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMy03LTEtMS0w_487ee2e3-f507-45fc-94d9-2b7b660f7007">3,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bff240b04449a29fba2137bf43f2a5_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNC0xLTEtMS0w_714b44ec-91bc-4839-bd33-360fcfa17e43">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2bff240b04449a29fba2137bf43f2a5_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNC0yLTEtMS0w_8a1f1f9d-123d-4edc-bd16-387865fca4e3">1,403</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bff240b04449a29fba2137bf43f2a5_I20210630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNC0zLTEtMS0w_271c2de0-1a36-4948-936e-d14868c96670">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id528f8cf639346baa0d5733e68b0a62f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNC01LTEtMS0w_4ec75862-4eeb-439e-9293-802a75a28125">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id528f8cf639346baa0d5733e68b0a62f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNC02LTEtMS0w_16d1c7a3-3889-4e9c-b97c-ef78ccee795d">1,334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id528f8cf639346baa0d5733e68b0a62f_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNC03LTEtMS0w_1be41044-3d16-41ce-8ca8-653d742359e7">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer and supplier relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d57cdcc92e54b889ac2aebd6d6a1bd5_I20210630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNS0xLTEtMS0w_267ca163-2048-4f14-83f2-ee50525eda47">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d57cdcc92e54b889ac2aebd6d6a1bd5_I20210630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNS0yLTEtMS0w_6ea54099-c311-44db-81eb-9447b4baa072">181</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d57cdcc92e54b889ac2aebd6d6a1bd5_I20210630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNS0zLTEtMS0w_5d308645-8920-4a7d-be57-6d169c243c29">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb2b2d4264234ed0a37f95b5dd66ce05_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNS01LTEtMS0w_b1bf9900-5d1c-4f57-9eac-3fcaff68afa2">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb2b2d4264234ed0a37f95b5dd66ce05_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNS02LTEtMS0w_9c579b0d-d7c0-4262-8ae9-1113a9426bb2">172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb2b2d4264234ed0a37f95b5dd66ce05_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNS03LTEtMS0w_97d16ac6-1435-43ec-9fc2-1fd45319e30f">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb88a22bf81946bb95ccd3c5b11de65f_I20210630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNi0xLTEtMS0w_da999768-da0d-4e07-bb20-a4c67d923422">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb88a22bf81946bb95ccd3c5b11de65f_I20210630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNi0yLTEtMS0w_d45338b9-414f-4b09-a720-a05f0996edcf">113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb88a22bf81946bb95ccd3c5b11de65f_I20210630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNi0zLTEtMS0w_ca4bdbd9-7841-4265-a4e2-3fb2b536bdaa">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i730a400496914c0995bd54501e4e7e6f_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNi01LTEtMS0w_3ae0cac7-8c16-48bd-962e-867971514848">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i730a400496914c0995bd54501e4e7e6f_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNi02LTEtMS0w_ebd41e29-2d05-464e-9a62-80d05bda70fe">98</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i730a400496914c0995bd54501e4e7e6f_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNi03LTEtMS0w_11aea2dd-4be1-4fb5-80bf-68e5ddf4f614">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNy0xLTEtMS0w_f482f34b-44da-4ac9-bd98-d2496c2ddc04">11,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNy0yLTEtMS0w_4d4b606b-3be2-4414-804d-f5ccd586bdec">7,766</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNy0zLTEtMS0w_96ebb119-bc33-4f1d-9ee9-39749bf833d0">3,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNy01LTEtMS0w_19e8b657-b576-45c6-a7ba-783562d7f811">11,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNy02LTEtMS0w_2477c753-eb26-4043-8587-b3596689f14e">7,334</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNy03LTEtMS0w_776d0454-e893-4236-9bed-792f1a08bde4">3,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names and trademarks</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id51bf5d57c5e4be793cdd487a6614d13_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTAtMS0xLTEtMA_4c6a2ee7-e06a-47bd-9913-db2c44f45f01">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id51bf5d57c5e4be793cdd487a6614d13_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTAtMy0xLTEtMA_b59d96d8-f61b-44bf-8286-2609b845f51f">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cf6e76c76f74939bf341b622ea02bbc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTAtNS0xLTEtMA_f7321177-5fa8-436e-a709-6a97a854895d">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cf6e76c76f74939bf341b622ea02bbc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTAtNy0xLTEtMA_eed7aeb7-274c-42c6-8096-db109db6d02d">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee3d4e93e5e14202a11a01a6f5173801_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTEtMS0xLTEtMA_d7c04e65-5928-4e76-8484-a1b7bdfa87db">1,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee3d4e93e5e14202a11a01a6f5173801_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTEtMy0xLTEtMA_9e7c102b-43b0-49ef-8f4b-8a469697a033">1,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900de095b8b74867bd9ff846daf9e193_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTEtNS0xLTEtMA_7c1c4130-9c63-4cf6-944c-814da2b045d9">1,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900de095b8b74867bd9ff846daf9e193_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTEtNy0xLTEtMA_1f900053-5872-4e43-a85e-5bd300d8c0c2">1,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTItMS0xLTEtMA_4182ced7-f8f2-478e-9e1f-fffb40d1c189">13,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTItMy0xLTEtMA_7644564e-0d85-4313-8848-847ed4d638ef">5,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTItNS0xLTEtMA_0d5ba2e8-128e-40a6-9172-62cda3fd980d">13,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTItNy0xLTEtMA_ddd605cb-f58e-43df-a806-e3e6bd79f9c0">6,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for the three and six months ended June 30, 2021 and 2020 is summarized in the table below (amounts in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:28.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmIzZDUwYzc1YjZiZDRhYzc5MDMzZDk4ZjRjYzg5NDYzL3RhYmxlcmFuZ2U6YjNkNTBjNzViNmJkNGFjNzkwMzNkOThmNGNjODk0NjNfMi0xLTEtMS0w_9837a77c-853f-4c68-8b4a-39d7bcf2807e">215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmIzZDUwYzc1YjZiZDRhYzc5MDMzZDk4ZjRjYzg5NDYzL3RhYmxlcmFuZ2U6YjNkNTBjNzViNmJkNGFjNzkwMzNkOThmNGNjODk0NjNfMi0zLTEtMS0w_45cec807-3333-4a4a-b636-37362d523ad7"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmIzZDUwYzc1YjZiZDRhYzc5MDMzZDk4ZjRjYzg5NDYzL3RhYmxlcmFuZ2U6YjNkNTBjNzViNmJkNGFjNzkwMzNkOThmNGNjODk0NjNfMi0zLTEtMS0w_f0eccecb-d312-45c6-bcbc-4fca1e52709f">271</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmIzZDUwYzc1YjZiZDRhYzc5MDMzZDk4ZjRjYzg5NDYzL3RhYmxlcmFuZ2U6YjNkNTBjNzViNmJkNGFjNzkwMzNkOThmNGNjODk0NjNfMi01LTEtMS0yMTM3_e47c3bd9-ba85-4a4a-8eab-4f2a3df06640">454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmIzZDUwYzc1YjZiZDRhYzc5MDMzZDk4ZjRjYzg5NDYzL3RhYmxlcmFuZ2U6YjNkNTBjNzViNmJkNGFjNzkwMzNkOThmNGNjODk0NjNfMi03LTEtMS0yMTM3_ddbb4f15-1ba1-43ce-98d5-f799b65ce609">542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RleHRyZWdpb246YjM4YzY3ZGRkM2FlNGFkMDgyNjJiZjlmM2RjOGVjMmVfMjg0_f80893b3-5b13-4fc4-bc12-64429e92cac2" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected future amortization of intangible assets as of June&#160;30, 2021, is as follows (in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated<br/>Amortization <br/>Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (excluding the six months ended June 30, 2021)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmRhYzUwZTAyM2Y2ODQ3OGQ5OTE5NTgyODBkODQ5YjM4L3RhYmxlcmFuZ2U6ZGFjNTBlMDIzZjY4NDc4ZDk5MTk1ODI4MGQ4NDliMzhfMS0xLTEtMS0w_245bfbac-1997-43aa-8ee7-a9c71e4ccd37">366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmRhYzUwZTAyM2Y2ODQ3OGQ5OTE5NTgyODBkODQ5YjM4L3RhYmxlcmFuZ2U6ZGFjNTBlMDIzZjY4NDc4ZDk5MTk1ODI4MGQ4NDliMzhfMi0xLTEtMS0w_01d46a04-0026-4d72-bf35-047ca1447370">694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmRhYzUwZTAyM2Y2ODQ3OGQ5OTE5NTgyODBkODQ5YjM4L3RhYmxlcmFuZ2U6ZGFjNTBlMDIzZjY4NDc4ZDk5MTk1ODI4MGQ4NDliMzhfMy0xLTEtMS0w_d47428e1-9d02-4bee-ac38-36d3bb014b58">694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmRhYzUwZTAyM2Y2ODQ3OGQ5OTE5NTgyODBkODQ5YjM4L3RhYmxlcmFuZ2U6ZGFjNTBlMDIzZjY4NDc4ZDk5MTk1ODI4MGQ4NDliMzhfNC0xLTEtMS0w_fb44c19a-bce9-4d26-9352-18f3920d9429">694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmRhYzUwZTAyM2Y2ODQ3OGQ5OTE5NTgyODBkODQ5YjM4L3RhYmxlcmFuZ2U6ZGFjNTBlMDIzZjY4NDc4ZDk5MTk1ODI4MGQ4NDliMzhfNS0xLTEtMS0w_dd4106c1-53c6-4a8a-a693-6a4ec2ed84cc">282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" name="mdxg:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmRhYzUwZTAyM2Y2ODQ3OGQ5OTE5NTgyODBkODQ5YjM4L3RhYmxlcmFuZ2U6ZGFjNTBlMDIzZjY4NDc4ZDk5MTk1ODI4MGQ4NDliMzhfNi0xLTEtMS0w_9168465c-c5fc-491b-8be9-8d81bec71320">825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmRhYzUwZTAyM2Y2ODQ3OGQ5OTE5NTgyODBkODQ5YjM4L3RhYmxlcmFuZ2U6ZGFjNTBlMDIzZjY4NDc4ZDk5MTk1ODI4MGQ4NDliMzhfNy0xLTEtMS0w_670590ae-2ae3-467f-a95c-033c6f77ecde">3,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i586f4d48e4324b41820aaf3f28c0b969_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.     <ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RleHRyZWdpb246ZjBmMTdiMDE5NDYxNDY3ZWE3ZGFmMzYyNTM3ZmI5YWVfODg_c88d4865-dace-4bfe-9a24-7925b5797c15" continuedAt="i1e4d420122ed4d769fea91ed740aa86f" escape="true">Accrued Expenses</ix:nonNumeric></span></div><ix:continuation id="i1e4d420122ed4d769fea91ed740aa86f"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RleHRyZWdpb246ZjBmMTdiMDE5NDYxNDY3ZWE3ZGFmMzYyNTM3ZmI5YWVfODY_14051c49-d825-414a-b1dc-1127e3c3963a" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses&#160;consisted of the following&#160;(in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.485%"><tr><td style="width:1.0%"></td><td style="width:53.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.541%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.743%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal costs</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfMS0xLTEtMS0w_9ffbc6ce-1a21-4e20-80eb-fe9ce7a5bbb1">7,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfMS0zLTEtMS0w_68d1dc6c-28fe-496b-8910-ede829794921">14,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="mdxg:AccruedSettlementCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfMi0xLTEtMS0w_3e101743-b423-43ff-a2b3-0544c66f73e7">4,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mdxg:AccruedSettlementCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfMi0zLTEtMS0w_a08fdb77-3f7d-4a0b-838d-8137d9442ac6">9,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commissions to sales agents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedSalesCommissionCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfMy0xLTEtMS00MDgz_6782c380-3c84-4142-8b7d-e743fa908bdd">1,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedSalesCommissionCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfMy0zLTEtMS00MDgz_c7b00668-7243-4274-b246-bafce3421028">2,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfMy0xLTEtMS0w_d9534b21-f3e7-4b20-97a7-a5aedcf23c88">777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfMy0zLTEtMS0w_58281596-d840-4bd0-b1bc-0741abf319a9">688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued clinical trials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" name="mdxg:AccruedClinicalTrialsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfNS0xLTEtMS0w_6cb50cc4-7a0c-43f6-bca2-c93bcd0bde83">686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" name="mdxg:AccruedClinicalTrialsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfNS0zLTEtMS0w_be653b76-7c73-4eb6-a7a1-c21ee56153f8">651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued GPO fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfNi0xLTEtMS00MDkx_a15dd123-7bca-4688-a6a4-8e61e905c2f6">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfNi0zLTEtMS00MDkx_d24899bc-18b0-4f26-b80c-f4981484dedd">554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" name="mdxg:AccruedRebates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfNi0xLTEtMS0w_51b4b7a2-f9f7-4054-8059-409aa6b10845">372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" name="mdxg:AccruedRebates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfNi0zLTEtMS0w_5b7d311c-1716-4065-8d43-d5f49a08eb22">886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfOC0xLTEtMS0zNDEx_f4f81504-5536-4e77-a93c-c14e8efec443">1,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfOC0zLTEtMS0zNDEz_e3354676-941b-40e0-bdd7-661a06ac0feb">743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfOC0xLTEtMS0w_fe999a4d-26c9-4f4e-b64b-413b3b7ff27c">17,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfOC0zLTEtMS0w_e3a387e2-f8e2-41b0-8706-195a42d0aa21">30,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i586f4d48e4324b41820aaf3f28c0b969_58"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">        7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTAxNTY_0236b48c-6bab-42a1-8de1-05cb1b08a614" continuedAt="i08cdf0747b444b17a64d3137652c7ffe" escape="true">Long Term Debt</ix:nonNumeric></span></div><ix:continuation id="i08cdf0747b444b17a64d3137652c7ffe" continuedAt="if643b22902a0498497df1ae2c3aa130d"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin Term Loan Agreement</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020, the Company entered into a Loan Agreement with, among others, Hayfin Services, LLP, (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) an affiliate of Hayfin Capital Management LLP (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin Loan Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), which Hayfin funded (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin Loan Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) on July 2, 2020 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Closing Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and provided the Company with a senior secured term loan in an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="i6d8cb358a527440ca633e34b0e64c145_I20200702" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfNDA3_d77e59f6-5a9e-49c0-b838-838d73fc11f1">50</ix:nonFraction> million (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The Term Loan matures on June 30, 2025 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maturity Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Interest is payable on the Term Loan for the balance outstanding quarterly through the Maturity Date. No principal payments on the Term Loan are due and payable until the Maturity Date.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Hayfin Loan Agreement also provided for an additional delayed draw term loan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DD TL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; collectively with the Term Loan, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in the form of a committed but undrawn facility. The Company had the option to borrow on the DD TL through June 30, 2021. The Company did not borrow on the DD TL prior to June 30, 2021 and the Company&#8217;s option to draw upon these funds has expired.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facilities, which are senior secured obligations, were entered into together with the sale of the Company&#8217;s Series B Convertible Preferred Stock (as defined and described in Note 9, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in an aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="i36fba5a1c02d4b94be2074d914f99d5f_I20200702" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTEwNQ_caca2384-2561-48b4-b36f-95cbe48ac479">100</ix:nonFraction> million (collectively, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in order to:</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;refinance the outstanding indebtedness (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Refinancing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) under the Loan Agreement, dated as of June 10, 2019 (as amended and restated, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BT Term Loan Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), among the Company, the lenders and Blue Torch Finance LLC as administrative agent and collateral agent for such lenders,</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) &#160;&#160;&#160;&#160;pay fees and expenses incurred with certain financing transactions, and</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) &#160;&#160;&#160;&#160;finance the working capital, capital expenditures, and other general corporate purposes of the Company.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate applicable to any borrowings under the Term Loan accrues at a rate equal to LIBOR (subject to a floor of <ix:nonFraction unitRef="number" contextRef="i988d17ea85c647989e6243f2f3379dbe_D20200702-20200702" decimals="INF" name="mdxg:DebtInstrumentInterestRateFloorPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTc2OQ_986ffa28-cb5d-40a8-bd29-069a0dbb88a3">1.5</ix:nonFraction>%) plus a margin of <ix:nonFraction unitRef="number" contextRef="i988d17ea85c647989e6243f2f3379dbe_D20200702-20200702" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTc5MA_1a639345-797a-4e14-9f95-5f307d0ab8e2">6.75</ix:nonFraction>% per annum (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). If LIBOR is unavailable, the loan will carry interest at the Margin plus the greatest of the Prime Rate, the Federal Funds Rate plus <ix:nonFraction unitRef="number" contextRef="i3a655ae7f78948dc884c2536cdf9fd11_D20200702-20200702" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTk1Mg_ced0803c-a116-4964-bfed-c379c65c1d0c">0.5</ix:nonFraction>% per annum, and <ix:nonFraction unitRef="number" contextRef="iafe464ecd0c245028772137cfcf6b7a0_D20200702-20200702" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTk3MA_e8097392-9d0a-4415-bd4f-59309b543679">2.5</ix:nonFraction>%. The Margin is eligible for a reduction depending on the Total Net Leverage Ratio for the quarter; as follows:</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"><ix:nonFraction unitRef="number" contextRef="i973342a619924d6ab0a08e0c4e94b963_D20220101-20220630" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjA4NQ_66d414be-4df4-429e-8edb-016d9d3025e4">6.5</ix:nonFraction>% per annum if the Total Net Leverage Ratio (as defined in the Hayfin Loan Agreement) is less than <ix:nonFraction unitRef="number" contextRef="ida1580ac0a56414d8129f9f379f10f0b_D20220101-20220630" decimals="INF" name="mdxg:TotalNetLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjE4NQ_7caad0f9-c217-4c6f-aef8-210bf3609c15">2.0</ix:nonFraction>x but greater than or equal to <ix:nonFraction unitRef="number" contextRef="i5f29d38c99bd445aa0e38a3711d8885e_D20220101-20220630" decimals="INF" name="mdxg:TotalNetLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjIxOA_c6f3bfdc-45a2-4f91-907d-6015d239e9bd">1.0</ix:nonFraction>x, or</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"><ix:nonFraction unitRef="number" contextRef="ib9bfddcbaf8f4b90bb405439470f7519_D20220101-20220630" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjIyNg_1c9d60f9-27e7-4a9a-89e1-c9ac6388cf7b">6.0</ix:nonFraction>% per annum if the Total Net Leverage Ratio is less than <ix:nonFraction unitRef="number" contextRef="ib9bfddcbaf8f4b90bb405439470f7519_D20220101-20220630" decimals="INF" name="mdxg:TotalNetLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjI4NA_a4c69cc0-583b-4960-b1b9-6d32ed96a2f2">1.0</ix:nonFraction>x.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional <ix:nonFraction unitRef="number" contextRef="i988d17ea85c647989e6243f2f3379dbe_D20200702-20200702" decimals="INF" name="mdxg:DebtInstrumentDefaultInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjMwMw_b020fcb3-1711-4a75-94b4-307adb2d6d0c">3.0</ix:nonFraction>% margin is applied to the interest rate in the event of default as defined by the Hayfin Loan Agreement. At issuance and as of June&#160;30, 2021, the Term Loan carried an interest rate of <ix:nonFraction unitRef="number" contextRef="i8cfe91ee3d3e4b3d9edcd8c90d48aad2_D20210101-20210630" decimals="3" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjQ3OA_fd7ff1af-e919-435a-9320-cf061e54d60e">8.3</ix:nonFraction>%.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facilities contain financial covenants requiring the Company, on a consolidated basis, to maintain the following:</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="if643b22902a0498497df1ae2c3aa130d" continuedAt="i2e265a3f61e340108afd0ac935e16f0f"><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Maximum Total Net Leverage Ratio of <ix:nonFraction unitRef="number" contextRef="i2aaba77a0a5f47b5a0450a1a8b2b3ea4_D20210101-20210630" decimals="INF" name="mdxg:TotalNetLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjY0NA_7ad48c7b-b869-49a1-8e1a-e141372e9f67">4.5</ix:nonFraction>x through June 30, 2021, further reduced to <ix:nonFraction unitRef="number" contextRef="i37aa6fed4311472bb500b5fe0dc149d2_D20210701-20250702" decimals="INF" name="mdxg:TotalNetLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjY5MA_73a0c306-389e-44eb-a63d-27a9ff29618c">4.0</ix:nonFraction>x thereafter for the life of the loans, required to be calculated on a quarterly basis.</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Minimum Liquidity (as defined in the Hayfin Loan Agreement) of $<ix:nonFraction unitRef="usd" contextRef="ie28e9a5ef3004dc196ad8be7ab8d8836_D20200702-20200702" decimals="INF" format="ixt:numdotdecimal" name="mdxg:DebtCovenantMinimumLiquidity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjg0Mw_d94c5233-2883-4829-bac5-bfde22b225e6">10</ix:nonFraction> million, an at-all-times financial covenant tested monthly.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company is in compliance with all financial covenants required under the Hayfin Loan Agreement.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facilities also specify that any prepayment of the Term Loan, voluntary or mandatory, as defined in the Term Loan Agreement, will subject MiMedx to a prepayment premium applicable as of the date of the prepayment:</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On or before the first anniversary of the Closing Date:</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">A make-whole premium, equal to the greater of:</span></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"><ix:nonFraction unitRef="number" contextRef="i2750d4e108d4450589ec176ea4bc1a68_D20200703-20210702" decimals="INF" name="mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMzIzMA_a8a5ce88-303d-409f-838e-2e29eb00ffd4">5</ix:nonFraction>% of the principal balance repaid, and</span></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"><ix:nonFraction unitRef="number" contextRef="i2750d4e108d4450589ec176ea4bc1a68_D20200703-20210702" decimals="INF" name="mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMzI3MA_afbd7d43-e91c-4ff6-8969-0258f9116ccc">102</ix:nonFraction>% of the principal balance plus interest that would have been accrued from the repayment date to 12 months following the Closing Date.</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After the first anniversary of the Closing Date but on or before the second anniversary of the Closing Date: <ix:nonFraction unitRef="number" contextRef="i1cc550f11ce34dab8a1ee5533fd2f5d8_D20210703-20220702" decimals="INF" name="mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMzUxNQ_9ee37509-5a5a-4c2e-8d3a-d5d195e864b3">2</ix:nonFraction>% of the principal balance repaid.</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After the second anniversary of the Closing Date: <ix:nonFraction unitRef="number" contextRef="i3c88e9fdfe1944b3a4fb9430459677f4_D20220703-20230702" decimals="INF" name="mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMzYwMQ_d46e9456-d73c-4189-87d5-d3e57874b3b4">1</ix:nonFraction>% of the principal balance repaid.</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After the third anniversary of the Closing Date: <ix:nonFraction unitRef="number" contextRef="ieb2ea45a6256434aa77aa52d97c892eb_D20230703-20250702" decimals="INF" name="mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMzY4Ng_d50d76e0-fbc1-4877-8678-6baa5cf0fa09">0</ix:nonFraction>% of the principal balance repaid.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan Agreement also includes events of default customary for facilities of this type, and upon the occurrence of such events of default, subject to customary cure rights, all outstanding loans under the Credit Facilities may be accelerated or the lenders&#8217; commitments terminated. The mandatory prepayments are also required in the event of a change in control, incurring other indebtedness, certain proceeds from disposal of assets and insured casualty event. Annually, beginning with the fiscal year ending December 31, 2021, the Company is required to prepay the outstanding loans based on the percentage of the Excess Cash Flow (as defined in the Hayfin Loan Agreement), if such is generated, with the percentage determined based on the Total Net Leverage thresholds. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hayfin maintains a first-priority security interest in substantially all of the Company&#8217;s assets.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Original issue discount and deferred financing costs incurred as part of the Financing Transactions were allocated between the sale of the Series B Convertible Preferred Stock and the Hayfin Term Loan on the basis of the relative fair values of the transactions. The costs allocated to the Hayfin Term Loan were further allocated between the Term Loan and the DD TL on the basis of the maximum potential principal outstanding between the Credit Facilities. <ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="mdxg:ScheduleofDebtIssuanceCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTAxNjQ_f1558f6f-92bc-4c79-9e18-343303290b32" continuedAt="i5e7f601871b04af9b8968cad8df480b7" escape="true">A summary of the allocation of the deferred financing costs and original issue discount between the Term Loan and the DD TL on July 2, 2020 was as follows (amounts in thousands):</ix:nonNumeric></span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><ix:continuation id="i5e7f601871b04af9b8968cad8df480b7"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.263%"><tr><td style="width:1.0%"></td><td style="width:24.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.125%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.125%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD TL</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Long term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Original issue discount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfaa87d5ef5044f39cfb5c90c4cea4d3_I20200702" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjFkYWI5MjVmOWUxNDRkMGU4MTE0ODUxY2QzMmNhOTA2L3RhYmxlcmFuZ2U6MWRhYjkyNWY5ZTE0NGQwZTgxMTQ4NTFjZDMyY2E5MDZfMy0xLTEtMS0w_6b706c7d-6649-42a8-ac80-23b638652bcc">333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f958b3caaef429182bf8441abc2cad2_I20200702" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjFkYWI5MjVmOWUxNDRkMGU4MTE0ODUxY2QzMmNhOTA2L3RhYmxlcmFuZ2U6MWRhYjkyNWY5ZTE0NGQwZTgxMTQ4NTFjZDMyY2E5MDZfMy0zLTEtMS0w_40d3ab8d-be4d-4ebf-8e40-c48cf1df2fbc">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a0a54ed1a52415a881e9947529ad09f_I20200702" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjFkYWI5MjVmOWUxNDRkMGU4MTE0ODUxY2QzMmNhOTA2L3RhYmxlcmFuZ2U6MWRhYjkyNWY5ZTE0NGQwZTgxMTQ4NTFjZDMyY2E5MDZfMy01LTEtMS0w_3d87c4da-0c26-4f96-94c0-9091c634fd1f">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfaa87d5ef5044f39cfb5c90c4cea4d3_I20200702" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjFkYWI5MjVmOWUxNDRkMGU4MTE0ODUxY2QzMmNhOTA2L3RhYmxlcmFuZ2U6MWRhYjkyNWY5ZTE0NGQwZTgxMTQ4NTFjZDMyY2E5MDZfNC0xLTEtMS0w_82cab07c-efa4-44a1-bdab-417be2b04e3b">2,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f958b3caaef429182bf8441abc2cad2_I20200702" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjFkYWI5MjVmOWUxNDRkMGU4MTE0ODUxY2QzMmNhOTA2L3RhYmxlcmFuZ2U6MWRhYjkyNWY5ZTE0NGQwZTgxMTQ4NTFjZDMyY2E5MDZfNC0zLTEtMS0w_4424c9ed-b4c4-4d2a-bb6e-c4a36e4ff251">1,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a0a54ed1a52415a881e9947529ad09f_I20200702" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjFkYWI5MjVmOWUxNDRkMGU4MTE0ODUxY2QzMmNhOTA2L3RhYmxlcmFuZ2U6MWRhYjkyNWY5ZTE0NGQwZTgxMTQ4NTFjZDMyY2E5MDZfNC01LTEtMS0w_21de1c9c-6d48-4597-99ce-28bf7e2cdf58">3,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred financing costs and original issue discount associated with the Term Loan are amortized using the effective interest method through the Maturity Date. The amortization of such amounts are presented as part of interest expense, net on the unaudited condensed consolidated statement of operations for the three and six months ended June&#160;30, 2021. Unamortized deferred financing costs and original issue discount associated with the Term Loan are presented as a reduction to the principal balance on the Term Loan as part of long term debt, net on the unaudited condensed consolidated balance sheet as of June&#160;30, 2021.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="i2e265a3f61e340108afd0ac935e16f0f" continuedAt="ib20d732144f546b1acd89a5e2f5f6fd6"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred financing costs and original issue discount associated with the DD TL were amortized using the straight line method through the expiration of the DD TL commitment term on June 30, 2021. Amortization of these amounts are presented as part of interest expense, net on the unaudited condensed consolidated statement of operations for the three and six months ended June&#160;30, 2021. Unamortized deferred financing costs and original issue discount associated with the DD TL are presented as other current assets on the unaudited condensed consolidated balance sheet as of December&#160;31, 2020. There were no such amounts outstanding as of June&#160;30, 2021. In addition, the DD TL was subject to an additional commitment fee of <ix:nonFraction unitRef="number" contextRef="ia4f4a7fffef64fbfb835915c94681b34_D20200702-20200702" decimals="INF" name="mdxg:DebtInstrumentUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfNjcxNQ_9d44496a-3c89-49c4-8e2e-ce4a8779630e">1</ix:nonFraction>% per annum of the amount undrawn, which is recognized as interest expense. The DD TL was not drawn upon as of June&#160;30, 2021.</span></div><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTAxNTc_6919e69c-f9d7-4153-ae20-6b3f3af450d5" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balances of the Term Loan as of June&#160;30, 2021 and December&#160;31, 2020 were as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.941%"><tr><td style="width:1.0%"></td><td style="width:33.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.775%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.340%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if47b0734d0cf4bd2a2b9d44595fbacaf_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjNjYTI1MDdiN2MxMzRiYjJiNGNmZjg2ZjdmOTUyMmMyL3RhYmxlcmFuZ2U6M2NhMjUwN2I3YzEzNGJiMmI0Y2ZmODZmN2Y5NTIyYzJfMS0xLTEtMS0w_b33218b4-67ca-418a-9d6e-cd0a985384dc">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24e573531fad49c7b4a1c7704442ac21_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjNjYTI1MDdiN2MxMzRiYjJiNGNmZjg2ZjdmOTUyMmMyL3RhYmxlcmFuZ2U6M2NhMjUwN2I3YzEzNGJiMmI0Y2ZmODZmN2Y5NTIyYzJfMS0zLTEtMS0w_e8bff143-2d08-44df-9fc9-38677a2d2d8c">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if47b0734d0cf4bd2a2b9d44595fbacaf_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjNjYTI1MDdiN2MxMzRiYjJiNGNmZjg2ZjdmOTUyMmMyL3RhYmxlcmFuZ2U6M2NhMjUwN2I3YzEzNGJiMmI0Y2ZmODZmN2Y5NTIyYzJfMi0xLTEtMS0w_8895e9b7-ed98-4b04-98e6-8d91f5f99e58">1,816</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24e573531fad49c7b4a1c7704442ac21_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjNjYTI1MDdiN2MxMzRiYjJiNGNmZjg2ZjdmOTUyMmMyL3RhYmxlcmFuZ2U6M2NhMjUwN2I3YzEzNGJiMmI0Y2ZmODZmN2Y5NTIyYzJfMi0zLTEtMS0w_2f1cadd0-0e47-4559-af89-6b461b029ad7">1,996</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if47b0734d0cf4bd2a2b9d44595fbacaf_I20210630" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjNjYTI1MDdiN2MxMzRiYjJiNGNmZjg2ZjdmOTUyMmMyL3RhYmxlcmFuZ2U6M2NhMjUwN2I3YzEzNGJiMmI0Y2ZmODZmN2Y5NTIyYzJfMy0xLTEtMS0w_c5d8b029-9392-411d-a521-45a2ca61cad9">279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24e573531fad49c7b4a1c7704442ac21_I20201231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjNjYTI1MDdiN2MxMzRiYjJiNGNmZjg2ZjdmOTUyMmMyL3RhYmxlcmFuZ2U6M2NhMjUwN2I3YzEzNGJiMmI0Y2ZmODZmN2Y5NTIyYzJfMy0zLTEtMS0w_51aaeba8-0f6b-44be-864a-596df667e510">307</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if47b0734d0cf4bd2a2b9d44595fbacaf_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjNjYTI1MDdiN2MxMzRiYjJiNGNmZjg2ZjdmOTUyMmMyL3RhYmxlcmFuZ2U6M2NhMjUwN2I3YzEzNGJiMmI0Y2ZmODZmN2Y5NTIyYzJfNC0xLTEtMS0w_7f482edf-1d11-4985-8ef5-9fa37ab3ba44">47,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24e573531fad49c7b4a1c7704442ac21_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjNjYTI1MDdiN2MxMzRiYjJiNGNmZjg2ZjdmOTUyMmMyL3RhYmxlcmFuZ2U6M2NhMjUwN2I3YzEzNGJiMmI0Y2ZmODZmN2Y5NTIyYzJfNC0zLTEtMS0w_44be6e4c-1345-43a7-b8b9-d71eb9366eb8">47,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="mdxg:ScheduleofInterestExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTAxNjU_9dc76566-1d4b-4c52-a377-80eb007098ce" continuedAt="i787e4ff1e257478f8d1b666e1dca5d29" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the Term Loan, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"><tr><td style="width:1.0%"></td><td style="width:40.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.499%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stated interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5df4f4bf6ea45a98669bcf3e1a28aef_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjdlZTc4NGY1YjBmNjQ0NGVhN2VmY2EzMTg4MTE1MmVjL3RhYmxlcmFuZ2U6N2VlNzg0ZjViMGY2NDQ0ZWE3ZWZjYTMxODgxMTUyZWNfMi0xLTEtMS0w_883d70f9-94d0-431d-bd07-1741c2f1b3b7">1,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0796339395b546c6950867927cd6139b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjdlZTc4NGY1YjBmNjQ0NGVhN2VmY2EzMTg4MTE1MmVjL3RhYmxlcmFuZ2U6N2VlNzg0ZjViMGY2NDQ0ZWE3ZWZjYTMxODgxMTUyZWNfMi0zLTEtMS03MTA_20a595fe-fec3-4bdf-946e-423e638d1686">2,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5df4f4bf6ea45a98669bcf3e1a28aef_D20210401-20210630" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjdlZTc4NGY1YjBmNjQ0NGVhN2VmY2EzMTg4MTE1MmVjL3RhYmxlcmFuZ2U6N2VlNzg0ZjViMGY2NDQ0ZWE3ZWZjYTMxODgxMTUyZWNfMy0xLTEtMS0w_74cd8be9-7141-4685-b5bc-41f420dc5e21">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0796339395b546c6950867927cd6139b_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjdlZTc4NGY1YjBmNjQ0NGVhN2VmY2EzMTg4MTE1MmVjL3RhYmxlcmFuZ2U6N2VlNzg0ZjViMGY2NDQ0ZWE3ZWZjYTMxODgxMTUyZWNfMy0zLTEtMS03MTk_74e1d98f-5b10-42e6-a3c3-69ed2519a802">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5df4f4bf6ea45a98669bcf3e1a28aef_D20210401-20210630" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjdlZTc4NGY1YjBmNjQ0NGVhN2VmY2EzMTg4MTE1MmVjL3RhYmxlcmFuZ2U6N2VlNzg0ZjViMGY2NDQ0ZWE3ZWZjYTMxODgxMTUyZWNfNC0xLTEtMS0w_51f68060-14b6-4427-9c6d-4d10cb5a6467">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0796339395b546c6950867927cd6139b_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjdlZTc4NGY1YjBmNjQ0NGVhN2VmY2EzMTg4MTE1MmVjL3RhYmxlcmFuZ2U6N2VlNzg0ZjViMGY2NDQ0ZWE3ZWZjYTMxODgxMTUyZWNfNC0zLTEtMS03MzY_0e4a13ec-8802-4d10-bb2c-afd0e922906e">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5df4f4bf6ea45a98669bcf3e1a28aef_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjdlZTc4NGY1YjBmNjQ0NGVhN2VmY2EzMTg4MTE1MmVjL3RhYmxlcmFuZ2U6N2VlNzg0ZjViMGY2NDQ0ZWE3ZWZjYTMxODgxMTUyZWNfNS0xLTEtMS0w_ca6a295a-48b8-4c14-b455-4ae5036ae5d2">1,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0796339395b546c6950867927cd6139b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjdlZTc4NGY1YjBmNjQ0NGVhN2VmY2EzMTg4MTE1MmVjL3RhYmxlcmFuZ2U6N2VlNzg0ZjViMGY2NDQ0ZWE3ZWZjYTMxODgxMTUyZWNfNS0zLTEtMS0yOTAz_c2e488cd-0f29-4c55-a76c-3c121cf4f4cc">2,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the DD TL, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"><tr><td style="width:1.0%"></td><td style="width:40.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.499%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment fee</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942e6e118deb4bf993725d0b8307938d_D20210401-20210630" decimals="-3" name="mdxg:DebtInstrumentCommitmentFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjZjNjhmNTQ2MWZmYzQ0YWI4OGQ2OGFhNGY0NDhiYzJiL3RhYmxlcmFuZ2U6NmM2OGY1NDYxZmZjNDRhYjg4ZDY4YWE0ZjQ0OGJjMmJfMi0xLTEtMS0w_62952cc5-bd77-43d2-b5b7-e6ab3de033d8">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5ea19804b864811aa3bd0894d4736be_D20210101-20210630" decimals="-3" name="mdxg:DebtInstrumentCommitmentFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjZjNjhmNTQ2MWZmYzQ0YWI4OGQ2OGFhNGY0NDhiYzJiL3RhYmxlcmFuZ2U6NmM2OGY1NDYxZmZjNDRhYjg4ZDY4YWE0ZjQ0OGJjMmJfMi0zLTEtMS03NjU_023f2ee8-ba8e-4036-8f58-8c10903c067d">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942e6e118deb4bf993725d0b8307938d_D20210401-20210630" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjZjNjhmNTQ2MWZmYzQ0YWI4OGQ2OGFhNGY0NDhiYzJiL3RhYmxlcmFuZ2U6NmM2OGY1NDYxZmZjNDRhYjg4ZDY4YWE0ZjQ0OGJjMmJfMy0xLTEtMS0w_431a1bb5-643d-4e08-962a-f0d2877c356d">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5ea19804b864811aa3bd0894d4736be_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjZjNjhmNTQ2MWZmYzQ0YWI4OGQ2OGFhNGY0NDhiYzJiL3RhYmxlcmFuZ2U6NmM2OGY1NDYxZmZjNDRhYjg4ZDY4YWE0ZjQ0OGJjMmJfMy0zLTEtMS03NzI_b3e3c30e-bf9d-49af-a101-057e8eb3b5ac">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942e6e118deb4bf993725d0b8307938d_D20210401-20210630" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjZjNjhmNTQ2MWZmYzQ0YWI4OGQ2OGFhNGY0NDhiYzJiL3RhYmxlcmFuZ2U6NmM2OGY1NDYxZmZjNDRhYjg4ZDY4YWE0ZjQ0OGJjMmJfNC0xLTEtMS0w_35b2f630-217a-491e-a8e2-1a4ad16d7910">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5ea19804b864811aa3bd0894d4736be_D20210101-20210630" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjZjNjhmNTQ2MWZmYzQ0YWI4OGQ2OGFhNGY0NDhiYzJiL3RhYmxlcmFuZ2U6NmM2OGY1NDYxZmZjNDRhYjg4ZDY4YWE0ZjQ0OGJjMmJfNC0zLTEtMS03Nzg_08424f0a-2f77-43ba-b790-c836551e2cd7">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942e6e118deb4bf993725d0b8307938d_D20210401-20210630" decimals="-3" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjZjNjhmNTQ2MWZmYzQ0YWI4OGQ2OGFhNGY0NDhiYzJiL3RhYmxlcmFuZ2U6NmM2OGY1NDYxZmZjNDRhYjg4ZDY4YWE0ZjQ0OGJjMmJfNS0xLTEtMS0w_6173fa88-306e-41c0-8aac-a11ab0af6940">376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5ea19804b864811aa3bd0894d4736be_D20210101-20210630" decimals="-3" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjZjNjhmNTQ2MWZmYzQ0YWI4OGQ2OGFhNGY0NDhiYzJiL3RhYmxlcmFuZ2U6NmM2OGY1NDYxZmZjNDRhYjg4ZDY4YWE0ZjQ0OGJjMmJfNS0zLTEtMS0yOTA1_7ce27ca8-5bf7-48ff-969b-b359253666ab">751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTAxNjY_c913d81b-d36e-4ed2-a496-6c62c3532882" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on the Term Loan as of June&#160;30, 2021 are as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (excluding the six months ended June&#160;30, 2021)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOmM3NzM1YTk3ZGU0MzQwNzQ5NDJkODRkN2UxYTJjMWE4L3RhYmxlcmFuZ2U6Yzc3MzVhOTdkZTQzNDA3NDk0MmQ4NGQ3ZTFhMmMxYThfMS0xLTEtMS0w_30fabc69-bcd2-4fbb-b51c-ae991782e063">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOmM3NzM1YTk3ZGU0MzQwNzQ5NDJkODRkN2UxYTJjMWE4L3RhYmxlcmFuZ2U6Yzc3MzVhOTdkZTQzNDA3NDk0MmQ4NGQ3ZTFhMmMxYThfMi0xLTEtMS0w_7bc8c802-cf2d-45d8-8eab-14e1ac2ca29a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOmM3NzM1YTk3ZGU0MzQwNzQ5NDJkODRkN2UxYTJjMWE4L3RhYmxlcmFuZ2U6Yzc3MzVhOTdkZTQzNDA3NDk0MmQ4NGQ3ZTFhMmMxYThfMy0xLTEtMS0w_de964046-2dc8-43da-b389-8ebfc4653211">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOmM3NzM1YTk3ZGU0MzQwNzQ5NDJkODRkN2UxYTJjMWE4L3RhYmxlcmFuZ2U6Yzc3MzVhOTdkZTQzNDA3NDk0MmQ4NGQ3ZTFhMmMxYThfNC0xLTEtMS0w_707fcfc7-36e1-446a-bfe9-f49183065aa2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOmM3NzM1YTk3ZGU0MzQwNzQ5NDJkODRkN2UxYTJjMWE4L3RhYmxlcmFuZ2U6Yzc3MzVhOTdkZTQzNDA3NDk0MmQ4NGQ3ZTFhMmMxYThfNS0xLTEtMS0w_c9b50fe6-5be2-4be6-8005-26a0600d504c">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:zerodash" name="mdxg:LongTermDebtMaturityAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOmM3NzM1YTk3ZGU0MzQwNzQ5NDJkODRkN2UxYTJjMWE4L3RhYmxlcmFuZ2U6Yzc3MzVhOTdkZTQzNDA3NDk0MmQ4NGQ3ZTFhMmMxYThfNi0xLTEtMS0w_dace6d5f-33f3-4ec4-940f-05a945362724">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOmM3NzM1YTk3ZGU0MzQwNzQ5NDJkODRkN2UxYTJjMWE4L3RhYmxlcmFuZ2U6Yzc3MzVhOTdkZTQzNDA3NDk0MmQ4NGQ3ZTFhMmMxYThfNy0xLTEtMS0w_5448df09-9346-40a2-9b5e-ba5cd6d40eb5">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the fair value of the Term Loan was $<ix:nonFraction unitRef="usd" contextRef="ia1e47a6e2d7b4dc0872d79087da38fa4_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTA5OTUxMTYzOTMxMw_0ee1892b-c6da-4f89-b70c-0cecba7c62a3">52.0</ix:nonFraction>&#160;million. This valuation was calculated based on a series of Level 2 and Level 3 inputs, including a discount rate based on the credit risk spread of debt instruments of similar risk character in reference to U.S. Treasury instruments with similar maturities, with an incremental risk premium for risk factors specific to the Company. To derive the fair value of the Term Loan, the remaining cash flows associated with the Term Loan were discounted to June&#160;30, 2021 using this discount rate.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="ib20d732144f546b1acd89a5e2f5f6fd6"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BT Term Loan</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2019, the Company entered into a loan agreement (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BT Term Loan Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) with the subsidiaries of the Company as guarantors and party thereto from time to time, the lenders party thereto from time to time and Blue Torch Finance LLC (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blue Torch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), as administrative agent and collateral agent, pursuant to which the full amount of $<ix:nonFraction unitRef="usd" contextRef="i127934462af147b1b7b36883a1681b77_I20190610" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfODMyMg_a2699a72-cad8-4c70-8714-c01a27bc3aa3">75</ix:nonFraction> million was borrowed and funded (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BT Term Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The proceeds from the BT Term Loan were used (i) for working capital and general corporate purposes and (ii) to pay transaction fees, costs and expenses incurred in connection with the BT Term Loan and the related transactions. The BT Term Loan would have matured on June 20, 2022 and was repayable in quarterly installments of $<ix:nonFraction unitRef="usd" contextRef="i202be97ddd3241418491fe12bce8c12f_D20190610-20190610" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentPeriodicPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfODY5OQ_4e37756d-28b4-4f41-9acd-fcd482ac63fa">0.9</ix:nonFraction> million; the balance was due on June 20, 2022. Blue Torch maintained a first-priority security interest in substantially all the Company&#8217;s assets. The BT Term Loan was issued net of the original issue discount of $<ix:nonFraction unitRef="usd" contextRef="i127934462af147b1b7b36883a1681b77_I20190610" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfODkwNw_e6a30025-3fa7-4c09-b05c-c2982309b98a">2.3</ix:nonFraction> million. The Company also incurred $<ix:nonFraction unitRef="usd" contextRef="i127934462af147b1b7b36883a1681b77_I20190610" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfODkzNw_f7c22622-6ab9-46d1-950e-0cd6a0007dce">6.7</ix:nonFraction> million of deferred financing costs.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2020, the Company amended its BT Loan Agreement with Blue Torch. The amendment provided for an increase in the maximum Total Leverage Ratio, which was a quarterly test, for the remainder of 2020, and also provided for a reduction in the minimum Liquidity requirement from&#160;April 2020&#160;through and including&#160;November 2020. In connection with the amendment, the Company agreed to pay a one-time fee of $<ix:nonFraction unitRef="usd" contextRef="iea093603b31a44c6b009a07438c52b17_I20200422" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfOTM4MA_dd45b3b3-cde9-48d6-9149-a4af87ae862f">0.7</ix:nonFraction> million, added to the principal balance, and a <ix:nonFraction unitRef="number" contextRef="i42392901e13144e0b50ffcaa3b266c87_D20200422-20200422" decimals="INF" name="us-gaap:DebtInstrumentInterestRateIncreaseDecrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfOTQyMg_29ca6587-530e-4006-99b9-cb4df192eafb">1</ix:nonFraction> percentage point increase in the interest rate to LIBOR plus <ix:nonFraction unitRef="number" contextRef="i42392901e13144e0b50ffcaa3b266c87_D20200422-20200422" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfOTQ4Ng_0fbaefda-c8ef-4991-8411-d2bcce8c9ec3">9</ix:nonFraction>%.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 2, 2020, a portion of the proceeds from each of the sales of the Company&#8217;s Series B Convertible Preferred Stock and the borrowings from the Hayfin Loan Transaction were used to repay the outstanding balance of principal, accrued but unpaid interest, and prepayment premium under the BT Loan Agreement. In connection with the repayment of the BT Term Loan, the Company terminated the BT Loan Agreement. The Company has no continuing obligations related to the BT Term Loan. </span></div><ix:continuation id="i787e4ff1e257478f8d1b666e1dca5d29"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the BT Term Loan, included in interest expense, net in the unaudited condensed consolidated statements of operations was as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"><tr><td style="width:1.0%"></td><td style="width:41.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:27.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.183%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on principal balance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8de3a02e7144468ba0178c4374d8f4a_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfMi0zLTEtMS0w_2fc8335b-432d-4a22-aeaf-cef0d43e5888">1,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6299c3dc628d43df867e4bad14106f97_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfMi01LTEtMS0yOTA3_fdb0e722-2bde-49f3-b487-6946440ef04d">3,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of original issue discount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8de3a02e7144468ba0178c4374d8f4a_D20200401-20200630" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfMy0zLTEtMS0w_6ee612e0-9428-4e71-acb0-8f2d753bbb2e">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6299c3dc628d43df867e4bad14106f97_D20200101-20200630" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfMy01LTEtMS0yOTA3_a4efe6f6-90ad-44d2-8e29-d510d038599c">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of amendment fee</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" name="us-gaap:AmortizationOfDeferredLoanOriginationFeesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfNC0zLTEtMS0yOTk1_d7abc584-b65e-449d-b10e-8e3d9b2d97fd">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" name="us-gaap:AmortizationOfDeferredLoanOriginationFeesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfNC01LTEtMS0yOTk3_dbf915b5-d44e-4b0e-8ecf-fd3454ac5786">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8de3a02e7144468ba0178c4374d8f4a_D20200401-20200630" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfNC0zLTEtMS0w_10236cf1-0b96-4b3c-be96-fd25daa00565">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6299c3dc628d43df867e4bad14106f97_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfNS01LTEtMS0yOTA3_75dba1a5-2834-4b79-89ab-95efa7ecd60f">1,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total BT Term Loan interest expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8de3a02e7144468ba0178c4374d8f4a_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfNS0zLTEtMS0w_76f14a7e-fbcc-4cad-a176-4be88da63c93">2,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6299c3dc628d43df867e4bad14106f97_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfNi01LTEtMS0yOTA3_58877636-e0cb-4462-8095-144c49d8db63">5,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Paycheck Protection Program Loan</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applied for and on April 24, 2020 received proceeds of $<ix:nonFraction unitRef="usd" contextRef="i065ebf02aa6941e1bdf67379b756096e_D20200424-20200424" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMzg0ODI5MDcwOTU5Nw_2efe261e-5f45-4bec-a14d-0d2314d2b692">10</ix:nonFraction>&#160;million in the form of a loan under the Paycheck Protection Program (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PPP Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 11, 2020, the Company repaid the PPP Loan in full. There are no continuing obligations under the PPP Loan as of June&#160;30, 2021.</span></div></ix:continuation><div id="i586f4d48e4324b41820aaf3f28c0b969_61"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.   <ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RleHRyZWdpb246ZjRlMmJkMzA0NzkxNDI5NTkzYWJlZjg1ZTZkNzc2NjhfMjQ5Mg_d5f7c10d-c63d-4c7f-af52-97902cbf2d4b" continuedAt="i64dc7711adbf4ee3ac63f6cfb607f442" escape="true">Net Loss Per Common Share</ix:nonNumeric></span></div><ix:continuation id="i64dc7711adbf4ee3ac63f6cfb607f442" continuedAt="if8b26b76926c411088c1a4f6581856d3"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per common share is calculated using two methods: basic and diluted.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basic Net Loss Per Common Share</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per common share is calculated as net loss available to common stockholders divided by weighted average common shares outstanding. Net loss available to common stockholders is calculated as net loss less (i) dividends accumulated on the Company&#8217;s Series B Convertible Preferred Stock during the period, and (ii) periodic accretion of the increasing-rate dividend feature.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RleHRyZWdpb246ZjRlMmJkMzA0NzkxNDI5NTkzYWJlZjg1ZTZkNzc2NjhfMjQ4OQ_9c6d5b8d-affd-4338-82ba-13a3f27e0fbe" continuedAt="i397d65a6a2d6445ca3531939c68414e4" escape="true">The following table provides a reconciliation of net loss to net loss available to common stockholders and calculation of basic net loss per common share for each of the three and six months ended June&#160;30, 2021 and 2020 (amounts in thousands, except share and per share amounts):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="if8b26b76926c411088c1a4f6581856d3" continuedAt="i740955944c264c7186113c1e49cc294f"><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><ix:continuation id="i397d65a6a2d6445ca3531939c68414e4"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:41.275%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.832%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMi0xLTEtMS0w_6a272aff-9408-4377-82b4-48731bd02157">1,779</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMi0zLTEtMS0w_4547fee4-c0b4-44d3-a533-11b0a81faa9c"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMi0zLTEtMS0w_e8f00e35-0717-4ffd-81e3-85d89639053e">8,466</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMi01LTEtMS0w_9ded7a20-518c-4710-8cee-08ecc0dddfd2">10,161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMi03LTEtMS0w_b2ea3acb-bc5c-4ab5-8287-90be469a9b2e">13,287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile to net (loss) income available to common stockholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated dividend on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="mdxg:TemporaryEquityAccretedbutUnrecordedDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNC0xLTEtMS0w_6f258700-3786-4203-8450-46bb5145d8d4">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="mdxg:TemporaryEquityAccretedbutUnrecordedDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNC0zLTEtMS0w_27941400-519e-40f3-a75f-57dc2326af88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="mdxg:TemporaryEquityAccretedbutUnrecordedDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNC01LTEtMS0w_92d900b9-6922-4d66-a487-3b776d97b326">2,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="mdxg:TemporaryEquityAccretedbutUnrecordedDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNC03LTEtMS0w_22fc3e69-5a6a-4d9a-9666-c55e5bbaed86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of increasing-rate dividend feature</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" name="mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNi0xLTEtMS0w_25ceb438-a8bf-41a1-bc90-bc86931a5272">464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNi0zLTEtMS0w_187c3661-30cd-4559-aeb2-1d2ad94fdbe6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNi01LTEtMS0w_1b3433e5-cf33-4a4c-98b0-aa2addc4f54b">926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNi03LTEtMS0w_797b5f36-993e-4bf7-bf67-fee3ccb962bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total adjustments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNy0xLTEtMS0w_0f2dc312-982f-4212-a394-77bec933cef8">1,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNy0zLTEtMS0w_3756f58a-5051-4b36-9b20-47949fd652b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNy01LTEtMS0w_899b3f52-1663-4bc6-b756-05e8512cd6ef">2,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNy03LTEtMS0w_346a8480-0bb1-4b52-b494-029a40c2d319">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss available to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOC0xLTEtMS0w_85c8ac5d-bc90-465d-b397-defc416ce8ff">3,276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOC0zLTEtMS0w_58ba38b2-1548-4d5b-8bbe-daebcfde358f">8,466</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOC01LTEtMS0w_d0e520ae-0fef-4854-bd43-2944c39defd8">13,126</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOC03LTEtMS0w_5c665667-7ee8-423a-8f97-63a4e93558e8">13,287</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS0xLTEtMS0w_f5bddecb-6180-49ff-933c-8243b2dc142e"><ix:nonFraction unitRef="shares" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS0xLTEtMS0w_f5d937dc-14be-442a-b8e5-3e6a6198a841"><ix:nonFraction unitRef="shares" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS0xLTEtMS0w_fbd3bfce-59f9-48dc-a53c-9125d0d868dc">110,276,636</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS0zLTEtMS0w_92be8069-f672-4e66-9d39-ad763174062f"><ix:nonFraction unitRef="shares" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS0zLTEtMS0w_bdf4c466-4d49-47d3-a19c-e4e697bcdccd"><ix:nonFraction unitRef="shares" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS0zLTEtMS0w_e64fc3c8-39f3-4eb3-a698-006835fccebd">108,119,461</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS01LTEtMS0w_2feaace4-e7f0-4d44-9c05-edc84b830e0a"><ix:nonFraction unitRef="shares" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS01LTEtMS0w_67d93b88-69c1-46ae-909b-55f8467630f5"><ix:nonFraction unitRef="shares" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS01LTEtMS0w_6cb305a7-3ddc-4fa4-b92f-3ef94b359694">109,841,428</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS03LTEtMS0w_4b150d1b-43d9-4e6e-be3b-614efc84e099"><ix:nonFraction unitRef="shares" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS03LTEtMS0w_a8e4888c-ef3c-4225-a2e2-e3232b652f41"><ix:nonFraction unitRef="shares" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS03LTEtMS0w_eeed6b3f-e9d5-45a1-905b-41dc7ab36bde">108,081,625</ix:nonFraction></ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net loss per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMTAtMS0xLTEtMA_b57c1f02-c55d-4a4c-a1a7-c8c7194e4eed">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMTAtMy0xLTEtMA_13f9916d-6d6a-4ce9-a0f3-fe2ae116d756">0.08</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMTAtNS0xLTEtMA_cd497db7-210b-4529-9fbb-51e543dcde31">0.12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMTAtNy0xLTEtMA_5bd643b3-cffa-41ee-a20e-18a0e6274d5a">0.12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diluted Net Loss Per Common Share</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted net loss per common share is calculated as net loss available to common stockholders, adjusted for dividends on convertible preferred stock (to the extent such conversions would be dilutive), divided by weighted average common shares outstanding plus potential common shares. The calculation of potential common shares considers incremental shares resulting from certain transactions, including the exercise of stock options and the issuance of restricted stock using the treasury stock method, as well as the hypothetical conversion of the Company&#8217;s Series B Convertible Preferred Stock using the if-converted method. The treasury stock method assumes that proceeds from the transaction are used to purchase common stock at the average market price throughout the period. The if-converted method adds back dividends accrued or deemed on the Company&#8217;s Series B Convertible Preferred Stock and assumes conversion as of the later of the beginning of the period or the original transaction date.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each individual transaction is assessed for its dilutive effect on net loss per common share. To the extent that the transaction is antidilutive, or does not reduce net loss per common share, the effect is excluded from the calculation.</span></div><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RleHRyZWdpb246ZjRlMmJkMzA0NzkxNDI5NTkzYWJlZjg1ZTZkNzc2NjhfMjQ5Ng_f19f0595-5925-44af-aa8f-ff3c2fd413e6" continuedAt="id4e40db953644db79a04e9eb783f2524" escape="true"><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of diluted net loss per common share (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:41.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfMi0xLTEtMS0w_2c24b7d7-66db-497d-84be-71ab5ef62735">3,276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfMi0zLTEtMS0w_58ba38b2-1548-4d5b-8bbe-daebcfde358f">8,466</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfMi01LTEtMS0w_d0e520ae-0fef-4854-bd43-2944c39defd8">13,126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfMi03LTEtMS0w_5c665667-7ee8-423a-8f97-63a4e93558e8">13,287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfMy0xLTEtMS0w_e5a670d9-4e27-4175-bfd5-7d95a2c65fa8">1,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfMy0zLTEtMS0w_2726a856-a693-4841-acd7-0cafeecc1c51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfMy01LTEtMS0w_899b3f52-1663-4bc6-b756-05e8512cd6ef">2,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfMy03LTEtMS0w_346a8480-0bb1-4b52-b494-029a40c2d319">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNC0xLTEtMS0w_73a57c05-d02e-4843-98de-15d0eeabf0d7">3,276</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNC0zLTEtMS0w_c2b8a1e7-5021-4c13-968c-e0d55a4ef71a">8,466</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNC01LTEtMS0w_69e0cc54-600e-49ff-9526-eb2035523679">13,126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNC03LTEtMS0w_0cdf7616-09b0-4333-a430-2a11d83cd86b">13,287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNS0xLTEtMS0w_b3e3bcd5-3134-486c-963d-a23f933f82bf">110,276,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNS0zLTEtMS0w_c029577b-d376-4123-984e-b61f9b0d3310">108,119,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNS01LTEtMS0w_bdd816bf-4b56-47f5-84c9-ed7ee1197e65">109,841,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNS03LTEtMS0w_7d090e18-575f-4e15-babc-16d0ccdafd84">108,081,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNi0xLTEtMS0w_54964c21-897a-4080-b80d-17e034b85abc">30,373,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNi0zLTEtMS0w_8657672c-828b-49f4-bef2-d21b31216d42">1,635,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNi01LTEtMS0w_7b14e897-7d5b-46a2-8b71-a176adc90904">30,232,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNi03LTEtMS0w_05bbc296-f6f3-4f88-b6fc-aa47a22f9ca2">2,117,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding adjusted for potential common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNy0xLTEtMS0w_dcfababc-52ff-4d38-9566-090fa3c8e8b2">110,276,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNy0zLTEtMS0w_b97b7418-58df-47b3-9681-94181124983f">108,119,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNy01LTEtMS0w_62b93e99-f432-48f8-8b55-51e3687b5f60">109,841,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNy03LTEtMS0w_044485c1-e240-4772-84bb-722fbe376dbe">108,081,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net loss per common share</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfOC0xLTEtMS0w_b833012b-448c-48d8-986c-7a0b952e94c7">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfOC0zLTEtMS0w_b5de18ae-b6bd-49a7-9cab-bfb6acae66f2">0.08</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfOC01LTEtMS0w_08c6326e-c3fb-498b-b418-4800101faaa0">0.12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfOC03LTEtMS0w_5186db26-b495-40b6-a4ae-ecae3bbe43c6">0.12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="i740955944c264c7186113c1e49cc294f"><ix:continuation id="id4e40db953644db79a04e9eb783f2524"><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Potential common shares reflects hypothetical transactions involving convertible securities and share-based payment awards using the if-converted and treasury stock methods, respectively. The effect of each of these adjustments on the calculation is presented in the table below:</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.116%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5d9cce6f74d4093affc241694089467_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfMi0xLTEtMS0w_f823db86-198b-4fad-879b-11cdf3b1a4a9">26,758,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8bce3a37af914ed9bc5f8c6c3bc59d45_D20200401-20200630" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfMi0zLTEtMS0w_8215d524-66fc-4df1-aa54-aadbd6cb51eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic4f8987ea15d4408a2035650b2c87f80_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfMi01LTEtMS0w_5cfd973d-68e8-46ec-97a4-8cfac40de93a">26,497,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ed571a8257d42d0a215125b4da04164_D20200101-20200630" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfMi03LTEtMS0w_1b880bbb-c2df-492a-94a1-e73afeb32523">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e66c91f80be4fd983fd0e3efb808448_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfMy0xLTEtMS0w_5ebb876a-f7d5-4b45-9a68-a64f2fc2dc61">1,271,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8010a62ee3794b6c895396a9baf80f0b_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfMy0zLTEtMS0w_e2767f34-74d5-4d7d-932b-0a077ebb171a">1,044,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7c826330d9d41ec9b4befdcda0afa9b_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfMy01LTEtMS0w_c5bb0b08-9781-4974-a9ef-cc29cd0a184f">1,450,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d26eec9d61c46dc81a087e6461dcb69_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfMy03LTEtMS0w_144e7e07-72eb-4e95-8d0b-77d458d0ac9d">1,386,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock unit awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida46e7ad09274073ab420623ea4c37dd_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNC0xLTEtMS0w_1bc98383-0dc4-4c21-85e7-0cc43ff61d8c">1,471,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i47d7bba684bf44828fe6f1b9f07feeff_D20200401-20200630" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNC0zLTEtMS0w_1db7792b-2855-4006-a379-f1b763bc1bee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a894936a837468783a21f9dfa898b71_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNC01LTEtMS0w_e6b22e11-89c9-4a38-af48-1596387a9246">1,345,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9fd65f6db4c84b2584ef68fc69fd6b76_D20200101-20200630" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNC03LTEtMS0w_a92db18c-e066-4194-b96c-7950f29453b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3bc25263e6e64af3b15df41c8754ccca_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNS0xLTEtMS0w_50c7f009-6769-417a-9aaa-f019fb8caef9">838,644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c4217efe8eb4763aa03a1421b865da2_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNS0zLTEtMS0w_c70a4e5f-c25b-417b-919a-2b2afb6b1b93">562,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if97f9edcdca840aa946e43c3245c6e72_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNS01LTEtMS0w_16bab86e-f72a-48be-b3bd-a7d489d8b571">906,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie877a21137404e27bf43f4596c236a0b_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNS03LTEtMS0w_63e75377-170a-4bd3-b5a3-22efc0049c37">714,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock unit awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i559662d3c9bb44b2ac2b0a2d023a981b_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNi0xLTEtMS0w_7587ee16-1d8b-4c85-ad10-012f0299134e">33,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e6cb875ef234a24a387547a3a122428_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNi0zLTEtMS0w_a0ed03a5-f0e9-461e-ac2f-2940a636e475">28,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i89c45fca675442c183fc2fb72b865f09_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNi01LTEtMS0w_5fba5a51-31e4-461d-a750-8503895fa98a">31,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21cedcbc67b9433fb42883dc4ec104eb_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNi03LTEtMS0w_f1a3c2f0-880e-4ee7-945a-ab4ab1d5d5e2">16,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNy0xLTEtMS0w_54964c21-897a-4080-b80d-17e034b85abc">30,373,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNy0zLTEtMS0w_2c135671-f825-45a1-95ad-fc3d2b965ba1">1,635,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNy01LTEtMS0w_1d8a67f3-17dd-4fb4-92cb-3ccc28e21b9f">30,232,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNy03LTEtMS0w_25fa6f95-547b-4069-b258-6d5eea58e2e1">2,117,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div id="i586f4d48e4324b41820aaf3f28c0b969_64"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">        9.  <ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfNTE2MQ_45708137-de3d-4260-a1d8-ee07d95eb933" continuedAt="i16a67c357a4c449da48d24438180b68c" escape="true">Equity</ix:nonNumeric></span></div><ix:continuation id="i16a67c357a4c449da48d24438180b68c" continuedAt="i719fe3f078334bf3a04ed72799fcdd10"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series B Convertible Preferred Stock </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 2, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTA1_6a1a79e5-7146-4f9a-be4e-11a90eb26a47">100</ix:nonFraction> million of the Company&#8217;s Series B Convertible Preferred Stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i7a8becc5cd6748029d491e754d21f558_I20200702" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTcz_bb0d098e-e001-4943-8c12-eaee952893c2">0.001</ix:nonFraction> per share (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series B Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), to an affiliate of EW Healthcare Partners and to certain funds managed by Hayfin Capital Management LLP (individually, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; collectively the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) pursuant to a Securities Purchase Agreement with Falcon Fund 2 Holding Company, L.P., an affiliate of EW Healthcare Partners, and certain funds managed by Hayfin, dated as of June 30, 2020 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Purchase Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702" decimals="INF" format="ixt:numdotdecimal" name="mdxg:ProceedsfromIssuanceofTemporaryEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfNjQ0_a2b07691-08eb-4d82-bab0-0cd4f3d2c39f">100</ix:nonFraction> million (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Preferred Stock paid a <ix:nonFraction unitRef="number" contextRef="i921b8b2918b843b0957acbb1acd7cb40_D20200702-20200702" decimals="INF" name="mdxg:TemporaryEquityDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfNzIx_63838622-c1c4-4bc9-961f-2a4e0e90e144">4.0</ix:nonFraction>% cumulative dividend per annum prior to the quarterly dividend payment ending on June 30, 2021, and pays a <ix:nonFraction unitRef="number" contextRef="ib585d269397a4280a16c10b8e637430b_D20200702-20200702" decimals="INF" name="mdxg:TemporaryEquityDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfODI1_1dbe6b48-5c43-4f13-96fb-449a77059182">6.0</ix:nonFraction>% cumulative dividend per annum thereafter. Dividends are declared at the sole discretion of the Company&#8217;s board of directors. Dividends are paid at the end of each quarter based for dividend amounts that accumulate beginning on the last payment date through the day prior to the end of each quarter. In lieu of paying a dividend, the Company may elect to accrue the dividend owed to shareholders. Accrued dividend balances accumulate dividends at the prevailing dividend rate for each dividend period for which they are outstanding.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of Series B Preferred Stock, including any accumulated and unpaid dividends, is convertible into Company&#8217;s common stock at any time at the option of the Holder at a conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702" decimals="INF" name="mdxg:TemporaryEquityConversionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTU1Ng_626d585a-2d96-4c24-bb40-16bc4070f94f">3.85</ix:nonFraction> per common share, or <ix:nonFraction unitRef="number" contextRef="i7a8becc5cd6748029d491e754d21f558_I20200702" decimals="INF" name="mdxg:TemporaryEquityConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTU4MA_c88e7956-ad24-479f-804c-d478de80cbc1">259.74</ix:nonFraction> common shares for each share of Series B Preferred Stock prior to any accumulated and unpaid dividends. The Series B Preferred Stock, including any accumulated and unpaid dividends, automatically converts into common stock at any time after the third anniversary of the issuance date, provided that the common stock has traded at <ix:nonFraction unitRef="number" contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702" decimals="INF" name="mdxg:TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTkxMw_28f9d561-59bc-4061-aa4e-0c3a1c2a51b2">200</ix:nonFraction>% or more of the conversion price for <ix:nonFraction unitRef="day" contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702" decimals="INF" name="mdxg:TemporaryEquityConversionThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTk1Mg_d4e72038-5e6c-4428-bf60-8a2643190b54">20</ix:nonFraction> out of <ix:nonFraction unitRef="day" contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702" decimals="INF" name="mdxg:TemporaryEquityThresholdConsecutiveTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTk2Mg_92287373-f502-4715-98d8-9d55cf419467">30</ix:nonFraction> consecutive trading days and on such date of conversion the common stock has traded at <ix:nonFraction unitRef="number" contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702" decimals="INF" name="mdxg:TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMjA1Mg_0cda5e43-a372-4aae-9563-793bb41ae100">200</ix:nonFraction>% or more of the conversion price.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Series B Preferred Stock, voting as a class, generally are entitled to elect <ix:nonFraction unitRef="director" contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702" decimals="INF" format="ixt-sec:numwordsen" name="mdxg:NumberofBoardSeatsElectedbyTemporaryEquityHolders" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMjE3MA_0f973d01-4336-4849-b03a-396cf4e34785">two</ix:nonFraction> members to the board of directors. Holders of the Series B Preferred Stock are entitled to vote on all matters to be voted on by the Company&#8217;s shareholders on an as-converted basis as a single class with the common stock not to exceed <ix:nonFraction unitRef="number" contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702" decimals="INF" name="mdxg:TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMjQwOA_5407f6d1-4079-4cbe-8609-88d3fd94384d">19.9</ix:nonFraction>% of the total voting stock of the Company. Holders of the Series B Preferred Stock are also entitled to a liquidation preference in an amount equal to the original issue price plus all accumulated and unpaid dividends in the event of a liquidation, dissolution, or winding-up of the Company.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Preferred Stock instrument contains an increasing-rate cumulative dividend feature. The Company determined the present value of the difference between the (1) dividends that will be payable, in the period preceding commencement of the perpetual dividend; and (2) the perpetual dividend amount for a corresponding number of periods to ascribe a fair value to this feature. The present value is calculated using a market rate for dividend yield. The Company calculated the amount of the increasing-rate dividend feature as $<ix:nonFraction unitRef="usd" contextRef="i7a8becc5cd6748029d491e754d21f558_I20200702" decimals="-5" format="ixt:numdotdecimal" name="mdxg:TemporaryEquityIncreasingrateDividendFeature" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMzIzNg_b9594578-b9ed-47db-94b5-c083c688ad14">1.8</ix:nonFraction> million. This amount is amortized as a deemed dividend to preferred shareholders using the effective interest method through the commencement date of the Perpetual Dividend Rate. During the three and six months ended June&#160;30, 2021, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i6be9faea4b8c45d299d9f176ac10cfcd_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMzQ2NA_313c9239-4ae5-43f9-b0d8-9325ee5367f2">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3cb990ced5454e60b46fb9974649db9f_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTA5OTUxMTYzMzkxOA_91d94b62-fb04-4c06-b1e6-d0af26e1cd2b">0.9</ix:nonFraction> million of deemed dividends related to the amortization of the increasing rate dividend feature.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company undergoes a change of control, the Company will have the option to repurchase some or all of the then-outstanding shares of Series B Preferred Stock for cash in an amount equal to the liquidation preference, subject to the rights of the holders of the Series B Preferred Stock in connection with such change in control. If the Company does not exercise such repurchase right, holders of the Series B Preferred Stock will have the option to (1) require the Company to repurchase any or </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="i719fe3f078334bf3a04ed72799fcdd10" continuedAt="ieea5f9d06eaf468aaff64fa28e0829cd"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">all of their then-outstanding shares of Series B Preferred Stock for cash in an amount equal to the liquidation preference or (2) convert the Series B Preferred Stock, including accumulated and unpaid dividends into common stock and receive their pro rata consideration thereunder. Because the contingent redemption of the Series B Preferred Stock by the holders in the event of change in control is outside the Company&#8217;s control, the Series B Preferred Stock is classified as temporary equity.</span></div><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:TemporaryEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfNTE2Mg_0d2a957e-b5ab-4f35-8ae6-c1f5140a4821" escape="true"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the three months ended June&#160;30, 2021 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"><tr><td style="width:1.0%"></td><td style="width:42.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.608%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i16cc01f782b84ac9b6f4b691a457573d_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk2ZDc4ZmY1NjMzNjRlYzk4NjYzZDRhMDljNDY2OWYxL3RhYmxlcmFuZ2U6OTZkNzhmZjU2MzM2NGVjOTg2NjNkNGEwOWM0NjY5ZjFfMi0xLTEtMS0w_808e04a1-d0da-424d-951e-c4957435dba4">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16cc01f782b84ac9b6f4b691a457573d_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk2ZDc4ZmY1NjMzNjRlYzk4NjYzZDRhMDljNDY2OWYxL3RhYmxlcmFuZ2U6OTZkNzhmZjU2MzM2NGVjOTg2NjNkNGEwOWM0NjY5ZjFfMi0zLTEtMS0w_e62a83a3-c5d4-401e-9782-8e8976eafb8f">92,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6be9faea4b8c45d299d9f176ac10cfcd_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk2ZDc4ZmY1NjMzNjRlYzk4NjYzZDRhMDljNDY2OWYxL3RhYmxlcmFuZ2U6OTZkNzhmZjU2MzM2NGVjOTg2NjNkNGEwOWM0NjY5ZjFfMy0zLTEtMS0w_151eb878-f121-4bc1-8f13-bf6f60d76336">464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i737e0eaa5bad434fa72a35230884fc03_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk2ZDc4ZmY1NjMzNjRlYzk4NjYzZDRhMDljNDY2OWYxL3RhYmxlcmFuZ2U6OTZkNzhmZjU2MzM2NGVjOTg2NjNkNGEwOWM0NjY5ZjFfNC0xLTEtMS0w_9b8350ca-8700-4acc-b3d6-74b51cb223f4">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i737e0eaa5bad434fa72a35230884fc03_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk2ZDc4ZmY1NjMzNjRlYzk4NjYzZDRhMDljNDY2OWYxL3RhYmxlcmFuZ2U6OTZkNzhmZjU2MzM2NGVjOTg2NjNkNGEwOWM0NjY5ZjFfNC0zLTEtMS0w_52f1fe41-6f52-4807-86f4-dcd1371f4ff3">92,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the six months ended June&#160;30, 2021 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"><tr><td style="width:1.0%"></td><td style="width:42.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.608%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaddd4342ea2443bb9b81a46e5ee973a5_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk5OTg3N2ZiNjY4ODRmYWM5MDcyYWZhNjNlZmY5MDc1L3RhYmxlcmFuZ2U6OTk5ODc3ZmI2Njg4NGZhYzkwNzJhZmE2M2VmZjkwNzVfMi0xLTEtMS0yODYy_3495f2cc-8d2a-400e-99f5-74552c96757a">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaddd4342ea2443bb9b81a46e5ee973a5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk5OTg3N2ZiNjY4ODRmYWM5MDcyYWZhNjNlZmY5MDc1L3RhYmxlcmFuZ2U6OTk5ODc3ZmI2Njg4NGZhYzkwNzJhZmE2M2VmZjkwNzVfMi0zLTEtMS0yODYy_147d5e94-7d16-4c13-bcf3-8bf5e517179f">91,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cb990ced5454e60b46fb9974649db9f_D20210101-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk5OTg3N2ZiNjY4ODRmYWM5MDcyYWZhNjNlZmY5MDc1L3RhYmxlcmFuZ2U6OTk5ODc3ZmI2Njg4NGZhYzkwNzJhZmE2M2VmZjkwNzVfMy0zLTEtMS0yODYy_5f5f03ff-f967-46ad-83bf-441a8a90df6f">926</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i737e0eaa5bad434fa72a35230884fc03_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk5OTg3N2ZiNjY4ODRmYWM5MDcyYWZhNjNlZmY5MDc1L3RhYmxlcmFuZ2U6OTk5ODc3ZmI2Njg4NGZhYzkwNzJhZmE2M2VmZjkwNzVfNC0xLTEtMS0yOTE3_5d1610e7-f221-41eb-a274-3e9eee8d325d">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i737e0eaa5bad434fa72a35230884fc03_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk5OTg3N2ZiNjY4ODRmYWM5MDcyYWZhNjNlZmY5MDc1L3RhYmxlcmFuZ2U6OTk5ODc3ZmI2Njg4NGZhYzkwNzJhZmE2M2VmZjkwNzVfNC0zLTEtMS0yOTIx_78cf613d-7d92-4d7d-86d3-36200257f135">92,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not declared or paid any dividends on the Series B Convertible Preferred Stock since issuance. Dividends in accumulated but not paid as of June&#160;30, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i3cb990ced5454e60b46fb9974649db9f_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="mdxg:TemporaryEquityAccretedbutUnrecordedDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTA5OTUxMTYzNDIxNg_0159d1f7-0c09-49cf-a011-aafe9642b85f">4.1</ix:nonFraction> million. As this amount has not been declared, the Company has not recorded this amount on its unaudited condensed consolidated balance sheet as of June&#160;30, 2021. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on accumulated dividends as of June&#160;30, 2021, the Series B Convertible Preferred Stock was convertible into an aggregate of <ix:nonFraction unitRef="shares" contextRef="i737e0eaa5bad434fa72a35230884fc03_I20210630" decimals="INF" format="ixt:numdotdecimal" name="mdxg:TemporaryEquitySharesIssueduponConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTA5OTUxMTYzNDI1MA_7b429fe1-231b-4db2-8dde-1ee33e5861b0">27,027,252</ix:nonFraction> shares of the Company&#8217;s common stock.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued several classes of restricted stock awards to employees: restricted stock (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSAs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), restricted stock unit awards (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and performance stock unit awards (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The following is summary information for restricted stock awards for the six months ended June 30, 2021.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTA5OTUxMTYzMzI2MA_30afeed0-93fa-4192-940d-bb2e631cd4c0">33.0</ix:nonFraction>&#160;million of unrecognized share-based compensation expense related to restricted stock awards. That expense is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTA5OTUxMTYzMzQyMg_bca773bd-b0bc-46b3-b0ea-0161f95e8e17">2.41</ix:nonNumeric> years, which approximates the remaining vesting period of these grants.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="ieea5f9d06eaf468aaff64fa28e0829cd"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfNDk0NzgwMjMzMTEwMw_03356514-207b-4f8b-bffa-0a4a5c6b0e31" escape="true"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table summarizes activity of unvested restricted stock awards by award type from January 1, 2021 through June&#160;30, 2021. Unvested RSA awards noted below are included in issued and outstanding common stock as of June&#160;30, 2021, while unvested RSUs and PSUs are not included in issued or outstanding common stock as of June&#160;30, 2021.</span></div><div style="margin-bottom:10pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"><tr><td style="width:1.0%"></td><td style="width:31.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.288%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.288%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.291%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at January 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4546c782bd4c4b0d9660d32d5de807aa_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMi0xLTEtMS0yNQ_72cce751-e693-4ad3-a282-2f361e343fb9">2,175,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4546c782bd4c4b0d9660d32d5de807aa_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMi0yLTEtMS0yNQ_e55a42a5-1484-4d2c-90c0-96c414ff2822">4.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ff6f3016254469984a003f5d14d5292_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMi00LTEtMS0yNQ_aa945404-7af2-420c-80df-27e9760b23f3">2,325,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7ff6f3016254469984a003f5d14d5292_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMi01LTEtMS0yNQ_c1dd7cec-ccec-418d-be6c-9181007389c9">5.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia78110d12796433b9330985e2b4ef783_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMi03LTEtMS0yNQ_abbfcfff-4d09-4274-b679-a29c4c1d4fc8">35,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia78110d12796433b9330985e2b4ef783_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMi04LTEtMS0yNQ_62e69f0f-151f-4ba5-9aad-64fa490a1cb0">7.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31a08061cd074967ac410fd896f93157_D20210101-20210630" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMy0xLTEtMS0yNQ_8bf31d3e-bcd5-4f3d-91c8-004288a33006">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i31a08061cd074967ac410fd896f93157_D20210101-20210630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMy0yLTEtMS0yNQ_188f52e8-eebd-4bf3-9146-bd70980291ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00bd0e49ae8e4e4293bd95e2e845969d_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMy00LTEtMS0yNQ_24138a66-976d-42f6-b839-ea6879cf2f1c">2,957,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00bd0e49ae8e4e4293bd95e2e845969d_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMy01LTEtMS0yNQ_8c9a9e4d-53ab-4625-8482-9a4e70344eaf">10.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94b5714cc2e94fc681505d6f23aecd98_D20210101-20210630" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMy03LTEtMS0yNQ_78d4144a-1f6e-4003-8728-75944b66f8d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i94b5714cc2e94fc681505d6f23aecd98_D20210101-20210630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMy04LTEtMS0yNQ_d5ea4d73-b321-43cf-bd42-c6a6bf0479b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i31a08061cd074967ac410fd896f93157_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNC0xLTEtMS0yNQ_51d57be7-a57d-4b87-ae71-a5e98053cb76">862,790</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i31a08061cd074967ac410fd896f93157_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNC0yLTEtMS0yNQ_38dd8492-29c4-41a0-a5fe-882b6fda7bf5">4.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i00bd0e49ae8e4e4293bd95e2e845969d_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNC00LTEtMS0yNQ_f1ffb9e1-3b25-464d-92df-5ca37f4f975f">761,775</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00bd0e49ae8e4e4293bd95e2e845969d_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNC01LTEtMS0yNQ_680744e1-19f0-44c4-be06-78113209c56f">5.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94b5714cc2e94fc681505d6f23aecd98_D20210101-20210630" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNC03LTEtMS0yNQ_8402849f-80f8-4999-bee7-f83ebb63eb13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i94b5714cc2e94fc681505d6f23aecd98_D20210101-20210630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNC04LTEtMS0yNQ_92b7757a-f08a-4cf8-bef6-625fd1df4df6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i31a08061cd074967ac410fd896f93157_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNS0xLTEtMS0yNQ_4e3e513d-13eb-441b-a8c3-d7b997399cfd">48,026</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i31a08061cd074967ac410fd896f93157_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNS0yLTEtMS0yNQ_c045c75e-4d56-4aa0-a87a-78497b055a96">3.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i00bd0e49ae8e4e4293bd95e2e845969d_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNS00LTEtMS0yNQ_df03f67b-a7fe-4386-ad36-70587aec15ff">116,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00bd0e49ae8e4e4293bd95e2e845969d_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNS01LTEtMS0yNQ_80e4b0d5-d4c6-481c-b190-4151ba400a03">8.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i94b5714cc2e94fc681505d6f23aecd98_D20210101-20210630" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNS03LTEtMS0yNQ_d09c67a1-04ae-47ee-8d05-53ee4b0b6406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i94b5714cc2e94fc681505d6f23aecd98_D20210101-20210630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNS04LTEtMS0yNQ_48bb3b1e-d93c-41ec-a1e9-7f4e30ed2757">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at June&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic8dea383f42948e8b56cf4145aeb42f1_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNi0xLTEtMS0yNQ_1c7271b2-2897-4067-a550-562e8e2a7317">1,265,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic8dea383f42948e8b56cf4145aeb42f1_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNi0yLTEtMS0yNQ_7a14d9e1-f74b-4efc-ad15-82e604761b2d">4.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie805768234ab4942a5d4fb8ca1a8f3d8_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNi00LTEtMS0yNQ_e46f28d8-09cf-4d96-b991-e076b4bd32ae">4,405,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie805768234ab4942a5d4fb8ca1a8f3d8_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNi01LTEtMS0yNQ_41cb25b4-f877-441d-aa0f-24ffe359dc37">8.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia78947d6c8ca4e8ba3edb9ac39391648_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNi03LTEtMS0yNQ_04d41f4f-ccae-40a9-b5ad-b37486db7964">35,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia78947d6c8ca4e8ba3edb9ac39391648_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNi04LTEtMS0yNQ_1941dd46-9240-434e-a2fc-3bc7be0f7919">7.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfNDk0NzgwMjMzMTEwNA_727c1e46-81c9-48a6-a182-4203aa464520" escape="true"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity for the three months ended June 30, 2021 is presented below:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:48.015%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfMS0xLTEtMS0yNQ_61ed9b0c-80e9-45b4-8d4d-c5f5e304ae9b">2,025,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfMS0zLTEtMS0yNQ_bf6d2b33-a32c-4e43-ac03-1aa219f0d405">4.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfMi0xLTEtMS0yNQ_f76cdb56-ebfc-466f-acb1-622f68a39be3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfMi0zLTEtMS0yNQ_282f4a25-744a-4634-a848-cb06f409869b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfMy0xLTEtMS0yNQ_dce30f7a-1a86-4ae4-a875-2895da5182ba">494,139</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfMy0zLTEtMS0yNQ_b90e82fc-c9e0-4b4e-b7f1-2ae22d839f74">3.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested options forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNC0xLTEtMS0yNQ_324ada67-b785-49c0-8640-018c5f4d9d65">50,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNC0zLTEtMS0yNQ_0c2124c2-202d-4ca2-a519-15359c196b6f">1.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested options expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNS0xLTEtMS0yNQ_92ea29ac-67b1-47d5-990e-4fc1fe5bfd23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNS0zLTEtMS0yNQ_72338cd1-0c99-4583-a22a-9b09b044f8e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNi0xLTEtMS0yNQ_5b580d9a-b231-4163-8cb1-47d0e958418b">1,481,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNi0zLTEtMS0yNQ_02145e51-106e-49fa-83d0-a17e3a8d3e87">5.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNi01LTEtMS0yNQ_7136924e-688d-43c1-b4fb-9485911bce84">2.00</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNi03LTEtMS0yNQ_e657f5a5-c6d4-4f6e-88e9-09c1573c1ddf">10,974,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at June&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNy0xLTEtMS0yNQ_09ba5359-e5d3-4d65-8747-fb5ffa910f37">1,481,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNy0zLTEtMS0yNQ_73fbbcbb-8458-4f11-87af-1059f6250ded">5.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNy01LTEtMS0yNQ_6850fbca-1f3d-405a-ac45-96d622102e7c">2.00</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNy03LTEtMS0yNQ_a7fac14b-bf38-41fa-9897-dedb71a30d21">10,974,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i586f4d48e4324b41820aaf3f28c0b969_67"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.  <ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfODE4_5b7bda02-413c-4790-be67-c64cc18e2ee4" continuedAt="idf4d281a28084037b4273b536705f6fd" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="idf4d281a28084037b4273b536705f6fd"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the Company were <ix:nonFraction unitRef="number" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfNjQ_7ee16064-04a5-404e-ae60-003ffdd6665f">0.3</ix:nonFraction>% and (<ix:nonFraction unitRef="number" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfNzE_13066b22-dc6f-456b-89f9-413b87b3de61">0.3</ix:nonFraction>)% for the three months ended June&#160;30, 2021 and June&#160;30, 2020, respectively. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the Company were (<ix:nonFraction unitRef="number" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfMjc0ODc3OTA3MzMwMA_8dbaf5e5-fd3b-4c37-94cf-5b7628acca5e">0.5</ix:nonFraction>)% and <ix:nonFraction unitRef="number" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfMTA5OTUxMTYyOTQ1OA_e067597d-7ffc-4469-9de4-7041ddab2a0e">45.9</ix:nonFraction>%, for the six months ended June&#160;30, 2021 and June&#160;30, 2020, respectively. These effective tax rates include the impact of discrete items of $<ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="INF" name="mdxg:EffectiveIncomeTaxRateReconciliationDiscreteItems" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfMTky_3f89c10f-17cf-4e74-91fa-7fe613bddfd6">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="mdxg:EffectiveIncomeTaxRateReconciliationDiscreteItems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfMTk5_c9c22462-c747-46f3-81b8-bc2c3b70d627">11.4</ix:nonFraction> million for the three months ended June&#160;30, 2021 and June&#160;30, 2020, respectively. The discrete items recorded for the six months ended June&#160;30, 2020 were primarily related to modifications to the tax rules for carryback of net operating losses as a result of the CARES Act which resulted in a federal tax refund of $<ix:nonFraction unitRef="usd" contextRef="ia54e27be716048c4b4d253e772d6aca1_D20210401-20210630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfNjQ5_0221a84b-e35e-41aa-a8cf-4059cbf57624">11.3</ix:nonFraction> million and an income tax benefit of the same amount. Of this amount, the Company has collected $<ix:nonFraction unitRef="usd" contextRef="i41bb6f1393b14bd2b5dfaa6483ec1fd7_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIncomeTaxRefunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfMTA5OTUxMTYzMDQ5Mw_0ca5e6fc-5682-4272-a814-478b5ee33342">1.2</ix:nonFraction> million as of June&#160;30, 2021. <ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="INF" format="ixt-sec:numwordsen" name="mdxg:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfNjk4_dfef0e52-a62f-4ad1-ae4d-430cfde81d64">No</ix:nonFraction> benefit had been recognized with respect to the net operating losses due to a previously-recorded valuation allowance.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i586f4d48e4324b41820aaf3f28c0b969_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">      11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RleHRyZWdpb246OGNlMDNhOGUwNjBmNGIyMDkyZjQwZWUzZWE3NjY3MGVfMTgw_05b7faef-a26e-4d9b-8eb0-f08463d0b4a0" continuedAt="i6d822fc38f4146a9820c56c0fb0f42b0" escape="true">Supplemental Disclosure of Cash Flow and Non-cash Investing and Financing Activities</ix:nonNumeric></span></div><ix:continuation id="i6d822fc38f4146a9820c56c0fb0f42b0"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RleHRyZWdpb246OGNlMDNhOGUwNjBmNGIyMDkyZjQwZWUzZWE3NjY3MGVfMTkw_396e9568-67c4-4313-999e-24685f6bd71e" escape="true"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected cash payments, receipts, and non-cash activities are as follows (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:72.045%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.365%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfMi0xLTEtMS0w_09a76893-f95f-42c9-9c06-42ce93078b13">2,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfMi0zLTEtMS0w_e821b004-4880-410f-858c-4cda486f3b5b">3,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfMy0xLTEtMS0w_10161582-ab05-4be3-863c-64603bf30a3d">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfMy0zLTEtMS0w_03955c8a-82cb-493e-a3ce-648c90d2d591">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right of use asset and liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="mdxg:LeaseRightOfUseAssetAndLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfNS0xLTEtMS0w_a0ed9c03-32c5-4715-9749-a1aa20cea777">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="mdxg:LeaseRightOfUseAssetAndLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfNS0zLTEtMS0w_e3c9c297-021a-419e-83ea-3b89d294796f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note receivable for sale of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="mdxg:NotesReceivableForSaleOfPropertyAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfNi0xLTEtMS0w_b4323d6c-18a7-42d0-aa1b-8e8ae349e7e8">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="mdxg:NotesReceivableForSaleOfPropertyAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfNi0zLTEtMS0w_a7de694c-62ba-47c2-8fef-eb5a4c512529">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of equipment in accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfNy0xLTEtMS0w_ccfac8dc-3607-4872-b846-92828fcf5a29">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfNy0zLTEtMS0w_72293ddf-d565-4556-b205-f96b1263d610">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of non-cash consideration received for option exercise</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="mdxg:FairValueOfNonCashConsiderationReceivedForOptionExercise" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfOC0xLTEtMS0w_27b2ff0a-4082-4fd3-be60-918613dac25d">380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="mdxg:FairValueOfNonCashConsiderationReceivedForOptionExercise" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfOC0zLTEtMS0w_5c9d01b9-4462-4a63-a529-1115bd53cc40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" name="mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfOS0xLTEtMS0w_1b3433e5-cf33-4a4c-98b0-aa2addc4f54b">926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfOS0zLTEtMS0w_ec23178a-5ee4-4adc-9a1d-2125f6477ec1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="mdxg:NoncashActivitiesDeferredFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfMTAtMS0xLTEtNTE5Nw_3fb2be4f-a9a8-4753-9bed-759bf28eab42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="mdxg:NoncashActivitiesDeferredFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfMTAtMy0xLTEtNTE5Nw_f1abce08-313f-44ad-8631-59daec5f3ca0">1,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment fee on BT Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="mdxg:NoncashActivitiesDebtInstrumentAmendmentFee" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfMTEtMS0xLTEtNTE5Nw_0a8a6d5c-f54e-4950-9d72-8c143b5614ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" name="mdxg:NoncashActivitiesDebtInstrumentAmendmentFee" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfMTEtMy0xLTEtNTE5Nw_f128090a-1b58-4592-82d2-d4d143b0450d">722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i586f4d48e4324b41820aaf3f28c0b969_73"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">        12.  <ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83My9mcmFnOmEzZjcxZjRmZDBiZTQwMTdhMzJiNzQ3ZGU3ODI5OTY5L3RleHRyZWdpb246YTNmNzFmNGZkMGJlNDAxN2EzMmI3NDdkZTc4Mjk5NjlfMTMxMjQ_d2e7f3b5-1485-488f-9d00-e25f88b0b346" continuedAt="ib0edaf5912e7455c88e8934d5a837a33" escape="true">Contractual Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="ib0edaf5912e7455c88e8934d5a837a33" continuedAt="icaed4b436dbf4d52a5d1e3ca94e3439a"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Matters</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company and its subsidiaries are parties to numerous civil claims and lawsuits and subject to regulatory examinations, investigations, and requests for information. Some of these matters involve claims for substantial amounts. The Company&#8217;s experience has shown that the damages alleged by plaintiffs or claimants are often overstated, based on unsubstantiated legal theories, unsupported by facts, and/or bear no relation to the ultimate award that a court might grant. Additionally, the outcome of litigation and regulatory matters and the timing of ultimate resolution are inherently difficult to predict. These factors make it difficult for the Company to provide a meaningful estimate of the range of reasonably possible outcomes of claims in the aggregate or by individual claim. However, on a case-by-case basis, reserves are established for those legal claims in which it is probable that a loss will be incurred and the amount of such loss can be reasonably estimated. The Company's unaudited condensed consolidated financial statements as of June&#160;30, 2021&#160;reflect the Company's current best estimate of probable losses associated with these matters, including costs to comply with various settlement agreements, where applicable. The actual costs of resolving these claims, as well as the cost to resolve claims that are either not probable or not estimable at this time, may be substantially higher or lower than the amounts reserved. For more information regarding the Company&#8217;s legal proceedings, refer to Note 14, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the 2020 Form 10-K.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company has accrued $<ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83My9mcmFnOmEzZjcxZjRmZDBiZTQwMTdhMzJiNzQ3ZGU3ODI5OTY5L3RleHRyZWdpb246YTNmNzFmNGZkMGJlNDAxN2EzMmI3NDdkZTc4Mjk5NjlfMTA5OTUxMTY2NTA1NQ_5477d5b7-347b-4935-b1e9-078e569bb24c">4.5</ix:nonFraction> million related to the legal proceedings. The Company is entitled to indemnification from insurance companies in connection with legal proceedings of $<ix:nonFraction unitRef="usd" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InsuranceSettlementsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83My9mcmFnOmEzZjcxZjRmZDBiZTQwMTdhMzJiNzQ3ZGU3ODI5OTY5L3RleHRyZWdpb246YTNmNzFmNGZkMGJlNDAxN2EzMmI3NDdkZTc4Mjk5NjlfMTA5OTUxMTY0MzA0Mw_98c79362-d152-423c-bce5-f75f0e2393e7">0.4</ix:nonFraction> million. This indemnification receivable is recorded as part of other current assets in the unaudited condensed consolidated balance sheet as of June&#160;30, 2021. The Company paid $<ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsForLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83My9mcmFnOmEzZjcxZjRmZDBiZTQwMTdhMzJiNzQ3ZGU3ODI5OTY5L3RleHRyZWdpb246YTNmNzFmNGZkMGJlNDAxN2EzMmI3NDdkZTc4Mjk5NjlfMTA5OTUxMTY0MzIyMQ_99f91b10-3dcc-4739-a303-f843142bdfb6">6.5</ix:nonFraction> million toward the resolution of legal matters involving the Company during the six months ended June&#160;30, 2021. In addition, $<ix:nonFraction unitRef="usd" contextRef="i65bb668e9dae4047a84b02a215986f46_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InsuranceRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83My9mcmFnOmEzZjcxZjRmZDBiZTQwMTdhMzJiNzQ3ZGU3ODI5OTY5L3RleHRyZWdpb246YTNmNzFmNGZkMGJlNDAxN2EzMmI3NDdkZTc4Mjk5NjlfMTA5OTUxMTY0MzI4MQ_a10078df-c62b-4dbe-8a45-75d166df79df">0.7</ix:nonFraction> million was paid on the Company&#8217;s behalf through insurance providers during the six months ended June&#160;30, 2021.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company received funds from certain director and officer insurance policies for previously-incurred legal expenses under the Company&#8217;s indemnification agreements. These funds were recognized as a reduction to investigation, restatement, and related expense during each of the three and six months ended June&#160;30, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of certain litigation and regulatory matters:</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Securities Class Action</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 16, 2019, the United States District Court for the Northern District of Georgia entered an order consolidating <ix:nonFraction unitRef="securityclassaction" contextRef="i3cb4c6f5e91944bc98bf3dad39781578_D20190116-20190116" decimals="INF" format="ixt-sec:numwordsen" name="mdxg:ContingencyLossNumberOfSecuritiesClassActions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83My9mcmFnOmEzZjcxZjRmZDBiZTQwMTdhMzJiNzQ3ZGU3ODI5OTY5L3RleHRyZWdpb246YTNmNzFmNGZkMGJlNDAxN2EzMmI3NDdkZTc4Mjk5NjlfMjU2Mg_a9e4ebfd-e7b3-4df9-b855-cae4b86027bf">two</ix:nonFraction> purported securities class actions (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">MacPhee v. MiMedx Group, Inc., et al.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> filed February 23, 2018 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Kline v. MiMedx Group, Inc., et al.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> filed February 26, 2018). The order also appointed Carpenters Pension Fund of Illinois (&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">CPFI</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) as lead plaintiff. On May 1, 2019, CPFI filed a consolidated amended complaint, naming as defendants the Company, Michael J. Senken, Parker H. &#8220;Pete&#8221; Petit, William C. Taylor, Christopher M. Cashman and Cherry Bekaert &amp; Holland LLP. The amended complaint (the &#8220;Securities Class Action Complaint&#8221;) alleged violations of Section 10(b) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), Rule 10b-5 promulgated thereunder, and Section 20(a) of the Exchange Act. It asserted a class period of </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="icaed4b436dbf4d52a5d1e3ca94e3439a" continuedAt="if76af272f256468296770cb3cbca1898"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">March 7, 2013 through June 29, 2018. Following the filing of motions to dismiss by the various defendants, CPFI was granted leave to file an amended complaint. CPFI filed its amended complaint against the Company, Michael J. Senken, Parker H. Petit, William C. Taylor, and Cherry Bekaert &amp; Holland (Christopher Cashman was dropped as a defendant) on March 30, 2020; defendants filed motions to dismiss on May 29, 2020. On March 25, 2021, the Court granted defendants&#8217; respective motions to dismiss, finding that CPFI lacked standing to bring the underlying claims and also could not establish loss causation because it sold all of its shares in MiMedx prior to any corrective disclosures, and dismissed the case. On April 22, 2021, CPFI filed a motion for reconsideration of the dismissal and for leave to amend to add a new plaintiff to attempt to cure the standing and loss causation issues. The Company has opposed CPFI&#8217;s motions and the hearing on the same scheduled for July 28, 2021 has been postponed; no new date has yet been set.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Investigations</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Department of Veterans&#8217; Affairs Office of Inspector General (&#8220;VA-OIG&#8221;) and Civil Division of the Department of Justice (&#8220;DOJ-Civil&#8221;) Subpoenas and/or Investigations</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VA-OIG has issued subpoenas to the Company seeking, among other things, information concerning the Company&#8217;s financial relationships with VA clinicians. DOJ-Civil has requested similar information. The Company has cooperated fully and produced responsive information to VA-OIG and DOJ-Civil. Periodically, VA-OIG has requested additional documents and information regarding payments to individual VA clinicians. Most recently, on June 3, 2020, the Company received a subpoena from the VA-OIG requesting information regarding the Company&#8217;s financial relationships and interactions with <ix:nonFraction unitRef="healthcareprovider" contextRef="ib237d9ecb84f4d6ab8dfb6cb01b37609_D20200603-20200603" decimals="INF" format="ixt-sec:numwordsen" name="mdxg:ContingencyLossNumberOfFormerHealthcareProviders" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83My9mcmFnOmEzZjcxZjRmZDBiZTQwMTdhMzJiNzQ3ZGU3ODI5OTY5L3RleHRyZWdpb246YTNmNzFmNGZkMGJlNDAxN2EzMmI3NDdkZTc4Mjk5NjlfNDk0OQ_fd763d68-5312-45ce-bb81-3feb1943ba85">two</ix:nonFraction> healthcare providers at the VA Long Beach Healthcare System. The Company has continued to cooperate and respond to these requests. At this time the Company is unable to predict the outcome of the investigation, including whether the investigation will result in any action or proceeding against us. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Department of Defense Office of Inspector General Investigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 8, 2021, the Company received a subpoena issued by the Department of Defense Office of Inspector General seeking records regarding the sales of the Company&#8217;s micronized and other products to federal medical facilities and federal contracting offices, including those operated by the Department of Veterans Affairs or the Department of Defense. The subpoena also seeks information regarding the Company&#8217;s communications with the FDA regarding its products. The Company understands that the Office of the United States Attorney for the Western District of Washington Civil Division is overseeing the investigation, which is being conducted principally by agents employed by the Department of the Army Criminal Investigation Command. The Company is cooperating with the government&#8217;s investigation and at this time the Company is unable to predict the outcome of the investigation, including whether the investigation will result in any action or proceeding against us. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Former Employee Litigation and Related Matters</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2018, the Company&#8217;s former Chief Financial Officer filed a complaint in the Superior Court for Cobb County, Georgia (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Michael J. Senken v. MiMedx Group, Inc.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) in which he claims that the Company has breached its obligations under the Company&#8217;s charter and bylaws to advance to him, and indemnify him for, his legal fees and costs that he incurred in connection with certain Company internal investigations and litigation. The Company filed its answer denying the plaintiff&#8217;s claims on April 19, 2019. To date, no deadlines have been established by the court. </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 12, 2021, the Company filed suit in the Circuit Court of the Eleventh Judicial District in and for Miami-Dade County, Florida (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">MiMedx Group, Inc. v. Petit, et. al.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) against its former CEO, Parker H. &#8220;Pete&#8221; Petit, and its former COO, William C. Taylor, seeking a determination of its rights and obligations under indemnification agreements with Petit and Taylor following a federal jury&#8217;s guilty verdict against Petit for securities fraud and Taylor for conspiracy to commit securities fraud. The Company is seeking a declaratory judgment that it is not obligated to indemnify or advance expenses to Petit and Taylor in connection with certain cases to which Petit and Taylor are parties and also seeking to recoup amounts previously paid on behalf of Petit and Taylor in connection with such cases.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 22, 2021, Petit and Taylor filed an answer and asserted counterclaims against the Company alleging breach of their indemnification agreements, breach of the covenant of good faith and fair dealing with respect to their indemnification agreements, and seeking a declaration that the Company remains obligated to indemnify and advance fees in connection with certain cases.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Petit and Taylor simultaneously also filed a motion seeking to compel the Company to advance and reinstate its payments of Petit and Taylor&#8217;s legal expenses. The Company opposed Petit and Taylor&#8217;s motion and a hearing was set for June 23, 2021. At the joint request of the parties, the hearing was cancelled to allow the parties to attend a mediation to attempt a resolution of this matter; such mediation is currently scheduled for August 11, 2021.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="if76af272f256468296770cb3cbca1898"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 15, 2021, Quinn Emanuel Urquhart &amp; Sullivan, LLP, Freshfields Bruckhaus Deringer US LLP, and Kobre Kim, LLP, law firms who have represented Mr. Petit and Mr. Taylor in various legal actions, including their criminal trial, filed suit in the Supreme Court of the State of New York County of New York against the Company (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Quinn Emanuel Urquhart &amp; Sullivan, LLP, et al. v. MiMedx Group, Inc.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) for breach of contract, breach of implied-in-fact contract, quasi-contract/unjust enrichment, promissory estoppel, equitable estoppel, and account stated seeking to enforce the Company&#8217;s alleged obligation to pay the firms for the legal fees and expenses incurred during their representations of Mr. Petit and Mr. Taylor. The parties have settled this matter and the case has been dismissed. The settlement reduced the Company&#8217;s liability to the plaintiffs, with respect to their representations of Messrs. Petit and Taylor, by $<ix:nonFraction unitRef="usd" contextRef="ia6a7a1b394c249888a94eef3b4a3a19f_D20210415-20210415" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83My9mcmFnOmEzZjcxZjRmZDBiZTQwMTdhMzJiNzQ3ZGU3ODI5OTY5L3RleHRyZWdpb246YTNmNzFmNGZkMGJlNDAxN2EzMmI3NDdkZTc4Mjk5NjlfMTA5OTUxMTY2Mzc2OQ_6e9e530b-9024-494f-8397-cd8295544ad6">2.4</ix:nonFraction> million. This reduction was included in investigation, restatement, and related expense on the unaudited condensed consolidated statements of operations for each of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">three and six months ended June&#160;30, 2021. The Company has paid the settlement amount and has no continuing obligations to the plaintiffs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defamation Claims</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 4, 2018, Sparrow Fund Management, LP (&#8220;Sparrow&#8221;) filed a complaint against the Company and Mr. Petit, including claims for defamation and civil conspiracy in the United States District Court for the Southern District of New York (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sparrow Fund Management, L.P. v. MiMedx Group, Inc. et. al.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The complaint seeks monetary damages and injunctive relief and alleges the defendants commenced a campaign to publicly discredit Sparrow by falsely claiming it was a short seller who engaged in illegal and criminal behavior by spreading false information in an attempt to manipulate the price of our common stock. On March 31, 2019, a judge granted defendants&#8217; motions to dismiss in full, but allowed Sparrow the ability to file an amended complaint. The Magistrate has recommended Sparrow&#8217;s motion for leave to amend be granted in part and denied in part and the Judge adopted the Magistrate&#8217;s recommendation. Sparrow filed its amended complaint against MiMedx (Mr. Petit has been dropped from the lawsuit) on April 3, 2020 and the Company filed its answer. This case is in discovery. </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 17, 2019, the principals of Viceroy Research (&#8220;Viceroy&#8221;), filed suit in the Circuit Court for the Seventeenth Judicial Circuit in Broward County, Florida (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Fraser John Perring et. al. v. MiMedx Group, Inc. et. al.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) against the Company and Mr. Petit, alleging defamation and malicious prosecution based on the defendants&#8217; alleged campaign to publicly discredit Viceroy and the lawsuit the Company previously filed against the plaintiffs, but which the Company subsequently dismissed without prejudice. On November 1, 2019, the Court granted Mr. Petit&#8217;s motion to dismiss on jurisdictional grounds, denied the Company&#8217;s motion to dismiss, and granted plaintiffs leave to file an amended complaint to address the deficiencies in its claims against Mr. Petit, which they did on November 21, 2019. The parties have settled this matter and the case has been dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Matters</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Florida Business Corporation Act and agreements with its current and former officers and directors, the Company is obligated to indemnify its current and former officers and directors who are made party to a proceeding, including a proceeding brought by or in the right of the corporation, with certain exceptions, and to advance expenses to defend such matters. The Company has already borne substantial costs to satisfy these indemnification and expense advance obligations and may continue to do so in the future. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the matters described above, the Company is a party to a variety of other legal matters that arise in the ordinary course of the Company&#8217;s business, none of which is deemed to be individually material at this time. Due to the inherent uncertainty of litigation, there can be no assurance that the resolution of any particular claim or proceeding would not have a material adverse effect on the Company&#8217;s business, results of operations, financial position or liquidity.</span></div></ix:continuation><div id="i586f4d48e4324b41820aaf3f28c0b969_76"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">      13. <ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RleHRyZWdpb246NDlhY2UyMzM5OTNkNGFkNzg3OWJjYzVkOTI3ZjRiZmNfNDY3_6ece1418-1e62-4cca-9935-b5de7b083854" continuedAt="ic2f4cf724f804275b3ebe2967134be63" escape="true">Revenue</ix:nonNumeric></span></div><ix:continuation id="ic2f4cf724f804275b3ebe2967134be63" continuedAt="i153ed1c12ebb446ab688a865b1d69ef1"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue by Product</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MiMedx has <ix:nonFraction unitRef="product" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="mdxg:NumberOfProducts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RleHRyZWdpb246NDlhY2UyMzM5OTNkNGFkNzg3OWJjYzVkOTI3ZjRiZmNfNDc_6fa6a162-74c8-4009-b8a0-6ad2bc9fc0a5">two</ix:nonFraction> primary classes of products: (1) Advanced Wound Care, or Section 361, products, consisting of its sheet allograft products, and (2) Section 351 products, consisting of the Company&#8217;s micronized and particulate products. Advanced Wound Care is further disaggregated between the Company&#8217;s Tissue/Other and Cord products.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><ix:continuation id="i153ed1c12ebb446ab688a865b1d69ef1"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RleHRyZWdpb246NDlhY2UyMzM5OTNkNGFkNzg3OWJjYzVkOTI3ZjRiZmNfNDY5_b896a8cf-9753-4f65-b804-ce0e5c31a62d" continuedAt="ie83d646bf8164f7db7e2ff020cc8079b" escape="true"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of net sales by each class of product (in thousands): </span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"><tr><td style="width:1.0%"></td><td style="width:29.632%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Wound Care</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Tissue/Other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4efd76f6ada46ba8946b7513a22f04a_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfMy0xLTEtMS00OTc1_3ad73893-08d6-4de8-973b-540e9423daeb">53,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if46c195635a441178204ec28dde34b01_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfMy0zLTEtMS00OTc1_922cd654-102a-48d5-b009-7c12a81ebf29">42,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89a37b3906b04310b236e33525aaa95c_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfMy01LTEtMS00OTc1_20304783-79c3-4276-88ac-d636b25a9821">99,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f2bacc597854374bcc516e82f0c5eed_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfMy03LTEtMS00OTc1_bd60ca49-d265-4cd7-9fb4-1a7158748172">87,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cord</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib148d38e25b94492bf90c7d639339309_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNC0xLTEtMS00NjYz_5216eb6c-5dc2-4c25-b8e1-95acd1b8fa70">5,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4419ab9cc84f446692df129d313037a1_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNC0zLTEtMS00Njc0_7b263a5e-4fef-480d-9b09-935d32b5b555">3,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66be1c10c07c47af8bcae86ad35148ae_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNC01LTEtMS00Njk3_7071b74c-43d1-48ea-8ea6-169ad692bdd9">10,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cbcb788b0524138bc71b680f77362cc_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNC03LTEtMS00NzA0_6c8f7765-a9b2-4acc-abbb-9e820f50a700">7,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Advanced Wound Care</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbf94484fb9640fc95e9891697e411dd_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNS0xLTEtMS00OTgx_07020c0d-77ed-4ad2-aa2a-d209829b98fd">59,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie638d9289b64407d97b93fe9e2db87ff_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNS0zLTEtMS00OTgx_fd827746-c5c2-4397-9639-3c7b9289162c">45,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i609c12eea03c4236afb3906bceaa436a_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNS01LTEtMS00OTgx_042bd221-1fb7-498f-b513-5e1779959346">110,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idad418953507466e82cdd357b1a16e0b_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNS03LTEtMS00OTgx_c33a8025-202d-4f55-b72e-a6128aef9a0d">94,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 351</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32d60e88dd1c4b5dad71c5e90be4b433_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfMy0xLTEtMS0w_812dbe95-c9a9-4166-88f9-fb1400f9198a">8,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f69b69d3f9a4ac2b110d37dcc110405_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfMy0zLTEtMS0w_90e74fbc-600b-4126-8935-4856acc95e46">6,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90e644d3bd014f92ba1bb40b0b78d305_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfMy01LTEtMS0w_44717802-8086-451c-aafe-6d08eb829607">16,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c9b39d7c36e4c6f960af71b46e8ca65_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfMy03LTEtMS0w_b43477b4-1adb-4054-9f56-5f1dd7565379">14,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf8f1fdd25a54565b673685695a81bfa_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNC0xLTEtMS00MzM_d6b945a8-805c-474a-ade5-d606740f666d">313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dac69150d044c06bb537de5bc9ec0e2_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNC0zLTEtMS00MzM_f25d8647-09d8-4fd1-bbe5-9e4fd6f3734a">1,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab79f8b8ff3646738e954901d9a7200a_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNC01LTEtMS00MzM_f91577bb-6f7a-4ad1-beaa-a1b4cabc5ac8">611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4687e4322dec454fa997eabfa8d90145_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNC03LTEtMS00MzM_fedfbe9a-4abf-49b5-8b9e-60caa296c1b0">6,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNS0xLTEtMS0w_3faf3582-213c-410b-a306-2bd7b192a6f1">68,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNS0zLTEtMS0w_891bf166-3f74-41ed-ae38-09252f6da0de">53,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNS01LTEtMS0w_3a56dd20-4cfb-4a6a-b6fb-66f68aa06b34">128,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNS03LTEtMS0w_f4008690-8f08-45ba-b3e5-11b411769bff">115,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1) &#8220;Other&#8221; represents cash collections on the Remaining Contracts. Remaining Contracts are those contracts for which performance obligations have been satisfied as of September 30, 2019, but for which the criteria required for revenue recognition had not been met and would not be met until the ultimate collection of cash. For all practicable purposes, the Company is not able to allocate these revenues to different product groups.</span></div></ix:nonNumeric><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue by Customer</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MiMedx has <ix:nonFraction unitRef="distributionchannel" contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="mdxg:RevenueFromContractWithCustomerNumberOfDistributionChannels" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RleHRyZWdpb246NDlhY2UyMzM5OTNkNGFkNzg3OWJjYzVkOTI3ZjRiZmNfMzg0ODI5MDcwNjExOQ_80732b1f-ad12-4a65-b2a7-a59165973a46">two</ix:nonFraction> primary distribution channels: (1) direct to customers (healthcare professionals and/or facilities) (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Direct Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and (2) sales through distributors (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distributors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</span></div><ix:continuation id="ie83d646bf8164f7db7e2ff020cc8079b"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of net sales by each customer type (in thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.233%"><tr><td style="width:1.0%"></td><td style="width:24.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct Customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a9f6a871fa4fed9fca89e62057ca76_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfMi0xLTEtMS0yOTU2_1ecf2a67-2843-4a91-89aa-a67544e636f2">66,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45054bede241426187915c74a28a6005_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfMi0zLTEtMS0yOTU4_eba5fd37-b5f1-445c-aa5c-824d83600dbf">52,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i279daae437cf44a19a94bd273c1d1703_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfMi01LTEtMS0yOTYw_9e456407-6b3e-4084-829e-a942627f0890">123,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bf9f8f4f2bb4f39ba8d91db9fb20a2a_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfMi03LTEtMS0yOTYy_9dadb43c-27d1-49ef-9678-c5d9d220aef0">112,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf429a45cf5f420a848a9ed4775b39e4_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfMy0xLTEtMS0yOTU2_007fcf55-6dbb-4edf-9451-fbd150d31bf3">2,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b2c8606605244ffa5589d29bede8a28_D20200401-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfMy0zLTEtMS0yOTU4_68e6d628-4f43-4db1-a0d2-98465d491a46">892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c73051b417433f810f88637d373bcf_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfMy01LTEtMS0yOTYw_553015a7-9614-4ea0-97b2-bf886be5d37f">4,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c204e277321442bbfb6659be2a31d13_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfMy03LTEtMS0yOTYy_469607a9-9d5a-450a-a520-d9c10e029701">2,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfNC0xLTEtMS0yOTU2_5a0c55c6-62f2-4b3d-82e0-3e79ea068078">68,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfNC0zLTEtMS0yOTU4_9cee922c-e688-4611-959a-0ea9a874c009">53,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfNC01LTEtMS0yOTYw_a0679eb3-0e63-4ff3-977b-8d0bcdf14596">128,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfNC03LTEtMS0yOTYy_80bebb8a-56b4-4480-96f8-d490050b366d">115,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have significant foreign operations or a single external customer from which 10% or more of revenues were derived during the three or six months ended June&#160;30, 2021 or 2020.</span></div></ix:continuation><div id="i586f4d48e4324b41820aaf3f28c0b969_82"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV84Mi9mcmFnOmU2N2E0Yzc4YTEyMTRlZDRhNWRlYjNjYThhNjEyNTkxL3RleHRyZWdpb246ZTY3YTRjNzhhMTIxNGVkNGE1ZGViM2NhOGE2MTI1OTFfMjgx_d9adc532-11a1-45ec-b4e2-874e0e17575d" continuedAt="i98206f7e0ed64b758d0a2b0b8ea98556" escape="true">Subsequent Events</ix:nonNumeric></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i98206f7e0ed64b758d0a2b0b8ea98556">None noted.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i586f4d48e4324b41820aaf3f28c0b969_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_88"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MiMedx is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, we have both a base business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. We derive our products from human placental tissues and process these tissues using our proprietary methods, including the PURION&#174; process. We employ Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce our allografts. MiMedx provides products primarily in the wound care, burn, and surgical sectors of healthcare. All of our products are regulated by the United States Food and Drug Administration (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MiMedx is a leading supplier of human placental allografts, which are human tissues that are derived from one person (the donor) and used to produce therapies to treat another person (the recipient). MiMedx has supplied over two million allografts, through both direct and consignment shipments. Our platform technologies include AMNIOFIX&#174;, EPIFIX&#174;, EPICORD&#174;, AMNIOCORD&#174; and AMNIOFILL&#174;. AMNIOFIX and EPIFIX are our tissue allografts derived from the amnion and chorion layers of the human placental membrane. EPICORD and AMNIOCORD are tissue allografts derived from umbilical cord tissue. AMNIOFILL is a particulate product comprised of placental connective tissue matrix, derived from the placental disc and placental membranes.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our EPIFIX and EPICORD sheet product lines are promoted for external use, such as in advanced wound care applications, while our AMNIOFIX, and AMNIOCORD products are positioned for surgical applications, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two classes of product historically: (1) Advanced Wound Care products, or Section 361 products, consisting of our sheet allograft products, and (2) Section 351 products, consisting of our micronized and particulate products. Our Advanced Wound Care business includes two product categories, Tissue/Other and Cord products. We sell product through two distribution channels: (1) direct to customers (healthcare professionals and/or facilities); and (2) sales through distributors.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the FDA&#8217;s decision regarding Enforcement Discretion, we do not currently market our Section 351 products. If and when a BLA is granted by the FDA, we will market these products again. Refer to the section titled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of the end of the FDA&#8217;s Enforcement Discretion on our business&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trends and Developments Affecting Our Business</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are actively pursuing growth strategies by expanding our geographic reach</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are focused on growth opportunities in the marketplace by expanding our Advanced Wound Care products into international markets. On June 8, 2021, we received regulatory approval from the Japanese Ministry of Health, Labour, and Welfare (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">JMHLW</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to market our EPIFIX product in Japan. The Company is currently working with JMHLW to establish reimbursement pricing. Once a reimbursement rate is listed, the Company can begin offering EPIFIX to patients and providers in Japan. See Part II, Item 1A, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">- </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our international expansion and operations outside the U.S. expose us to risks associated with international sales and operations.&#8221;</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Demographic shifts are creating opportunities in the advanced wound care and musculoskeletal sectors</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sectors where our products are used are expected to continue growing due to certain demographic trends. Within the advanced wound care sector, there is significant unmet patient need, due to an aging population, an increasing incidence of obesity and diabetes, and other contributing comorbidities that result in higher susceptibility to non-healing chronic wounds. These demographics extend into the musculoskeletal sector as well, and the increasing number of patients requiring advanced treatment represents a significant cost burden on the healthcare system. We expect that these shifts will benefit our business.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We plan to make substantial investments in research &amp; development</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are focused on advancing our late-stage pipeline and are accelerating our internal timelines for seeking FDA approval for AMNIOFIX Injectable, or mdHACM, to treat musculoskeletal degeneration across multiple indications. Our planned investments in research and development throughout 2021 are designed to advance our late-stage pipeline and support our planned growth objectives in Advanced Wound Care. We intend to publish additional peer-reviewed clinical, scientific and economic data that further reinforce the differentiation of our products and expand the utility of the Company&#8217;s placental-</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">derived products in other clinical applications throughout the care continuum. In addition, we are enhancing business and product development efforts, targeting new applications and potential products that fit within our framework of innovative technologies backed by rigorous science that elevate the standard of care.</span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_91"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of the end of the FDA&#8217;s Enforcement Discretion on our business</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, the FDA published a series of guidances that established an updated framework for the regulation of cellular and tissue-based products. These guidances clarified the FDA&#8217;s views about the criteria that differentiate those products subject to regulation under Section 361 of the Public Health Service Act from those considered to be drugs, devices, and/or biological products subject to licensure under Section 351 of the Public Health Service Act and related regulations. The FDA exercised enforcement discretion under limited conditions with respect to Investigative New Drug (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) applications and pre-market approval requirements through May 31, 2021. The enforcement discretion period ceased on May 31, 2021. At that time, the FDA began regulating certain of our products, including our micronized and particulate products, under Section 351.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales and Marketing</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sold our micronized and particulate products during the period of enforcement discretion, but ceased such sales after May 31, 2021 and will not market these products again unless and until the FDA approves a Biologics License Application for a specific product and indication. See Part II, Item 1A, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Obtaining and maintaining the necessary regulatory approvals for certain of our products will be expensive and time consuming and may impede our ability to fully exploit our technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; Net sales of our micronized and particulate products were $8.6 million and $16.7 million for the three and six months ended June&#160;30, 2021, respectively, and $31.9 million for the year ended December 31, 2020, representing approximately 13% of our net sales in each of those periods. We intend to comply with FDA guidance about future sales of these products.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expenses</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that certain variable direct selling expenses will decrease due to the expected reduction in sales of our products subject to Section 351 regulation with the end of enforcement discretion. While we are working to mitigate the impact, in the absence of these mitigations, we expect selling, general and administrative expenses as a percentage of net sales to increase after the end of enforcement discretion.</span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_94"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effect of Covid-19 Pandemic</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the outbreak of a novel strain of coronavirus (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Covid-19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Covid-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is still ongoing, the effects on our operations, such as access restrictions to hospitals and difficulties obtaining donor materials, have largely been ameliorated as of June&#160;30, 2021 and did not have a material effect on our operations during the three months ended June&#160;30, 2021. We are continuously monitoring developments with respect to novel variants of the virus and government and societal responses to mitigate continued spread in the event we need to enact measures to mitigate such effects.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the health and well-being of our employees, we are still exercising an abundance of caution. We are allowing our non-essential employees to work from home through September 7, 2021, limiting non-essential travel, and advising all employees to receive a Covid-19 vaccine as soon as reasonably possible. None of these efforts have materially affected the Company&#8217;s operations as of or for the three months ended June&#160;30, 2021.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span><br/></span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_97"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_100"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended June&#160;30, 2021 Compared to the Three Months Ended June&#160;30, 2020</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"></td><td style="width:38.476%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.395%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.395%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.395%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,165&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,647&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,198</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investigation, restatement and related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,062)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,508)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(118.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,371)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,574)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(118.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,779)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,466)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(79.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Sales</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We recorded net sales for the three months ended June 30, 2021 of $68.2 million, a $14.6 million, or 27.1%, increase compared to the three months ended June 30, 2020, in which we recognized revenue of $53.6 million. Net sales for the three months ended June 30, 2021 includes revenue recognized on the Remaining Contracts of $0.3 million, compared to $1.7 million for the three months ended June 30, 2020. Sales volumes increased over last year&#8217;s second quarter, which was impacted by access restrictions to hospitals and travel restrictions enacted, both in response to the Covid-19 Pandemic.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted Net Sales, which excludes cash collected on the Remaining Contracts, were $67.9 million for the three months ended June 30, 2021, compared to $51.9 million for the three months ended June 30, 2020, an increase of $15.9 million or 30.6%. The increase was primarily the result of an increase in sales volume over the three months ended June 30, 2020, which was  impacted by the effects of the Covid-19 Pandemic.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The 30.6% increase in second quarter adjusted net sales includes 29.5% growth in Advanced Wound Care products, including a positive impact from the sales of EPICORD&#174; Expandable, which we launched in the third quarter of 2020, and growth in our flagship EPIFIX&#174; sheet portfolio. Finally, sales of Section 351 products prior to the end of Enforcement Discretion contributed to the year-over-year increase in net sales.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales and Gross Profit Margin</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales for the three months ended June 30, 2021 and 2020 was $12.8 million and $8.2 million, respectively, an increase of $4.6 million or 55.6%. The increase was primarily driven by year-over-year increases in sales volume. In addition, we recorded $1.0 million of inventory write-downs during the three months ended June 30, 2021, specifically related to Section 351 product, resulting from the end of the FDA&#8217;s Enforcement Discretion period. We do not anticipate these write-downs to continue in the future.</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit margin for the three months ended June 30, 2021 was 81.3% compared to 84.7% for the three months ended June 30, 2020. The decrease in gross profit margin was primarily due to reserves recorded during the three months ended June 30, 2021, specifically related to Section 351 product, resulting from the end of the FDA&#8217;s Enforcement Discretion period. Additionally, negative production variances from lower than planned production volumes affected gross profit margin.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expenses</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the three months ended June 30, 2021 increased $16.3 million, or 43.6%, to $53.6 million compared to $37.3 million for the three months ended June 30, 2020. The increase in selling, general and administrative expenses during the period reflects the restoration of full-salary levels and merit increase that were previously restricted during the prior period, along with significantly reduced travel costs in the midst of the Covid-19 Pandemic. We also </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">saw consulting and advisory expenses rise, year-over-year, including $3.8 million related to the proxy contest during the three months ended June 30, 2021. Furthermore, the increase in selling, general and administrative expense was driven by year-over-year increases in commission expenses resulting from the increases in sales volume.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investigation, Restatement and Related Expenses</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investigation, restatement and related expenses for the three months ended June 30, 2021 was a benefit of $2.1 million compared to expense of $11.4 million for the three months ended June 30, 2020. The benefit incurred during the three months ended June 30, 2021 was the result of funds received from certain director and officer insurance policies, as well as negotiated reductions in previously-recognized legal expenses advanced on behalf of certain former members of management.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2020, we incurred expenses toward the restatement of our prior period financial information and the advancement of legal fees of certain former officers and directors of the Company. Activities related to the Restatement ceased in mid-2020. We do not anticipate incurring any more costs related to the restatement of our prior period financial information. Other decreases were driven by fewer expenses incurred relative to our obligations to advance litigation defense costs to certain former members of management. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are still subject to indemnification agreements with certain former officers and directors of the Company (other than Messrs. Petit and Taylor) for whom legal proceedings are still ongoing, but we expect such expenses to continue to decrease over time.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to incur some litigation costs moving forward, but we expect a continued reduction in investigation, restatement, and related expenses, other than costs related to resolution of the securities class action matter, the amount and timing of which are highly uncertain. See Note 12, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the unaudited condensed consolidated financial statements for additional details.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development expenses increased approximately $1.8 million, or 79.9%, to $4.1 million for the three months ended June 30, 2021, compared to approximately $2.3 million for the three months ended June 30, 2020. The increase reflects higher consulting fees and increases in personnel costs, driven both by the reversal of efforts to mitigate the effects of the Covid-19 Pandemic, as well as increases in headcount to support clinical research efforts.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as planned, we have increased our investments in preclinical studies, supportive of current and potential clinical study indications. We expect these costs to increase over time as we commence new clinical trials and continue working towards the filing of our BLAs. The amount and timing of these expenses are partially dependent on whether interim results from our ongoing IND clinical trials merit further investment.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization of Intangible Assets</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets was $0.2 million for the three months ended June 30, 2021, compared to $0.3 million for the three months ended June 30, 2020. The decrease was the result of amortization on customer relationship assets that were impaired during the fourth quarter of 2020.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense, Net</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net was $1.4 million for the three months ended June 30, 2021 compared to $2.6 million for the three months ended June 30, 2020, a decrease of $1.2 million, or 46.7%. The difference related to the lower outstanding principal balance, stated interest rate, and amortization of deferred financing costs and original issue discount on our Term Loan and DD TL compared to our previous term loan.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Expense, Net</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net, was negligible in each of the three months ended June 30, 2021 and 2020.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Provision Benefit (Expense)</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the Company were 0.3% and (0.3)% for the three months ended June&#160;30, 2021 and June&#160;30, 2020, respectively. There were no material discrete items affecting the effective tax rate in either period. Net operating losses incurred during both periods were offset by a valuation allowance.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i586f4d48e4324b41820aaf3f28c0b969_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Six Months Ended June 30, 2021 Compared to the Six Months Ended June 30, 2020 </span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.257%"><tr><td style="width:1.0%"></td><td style="width:38.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,132&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,383&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,749&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investigation, restatement and related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,904)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,844)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,961)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax provision benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Sales</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded revenue for the six months ended June 30, 2021 of $128.1 million, a $12.7 million, or 11.0%, increase compared to the six months ended June 30, 2020 revenue of $115.4 million. Net sales for the six months ended June 30, 2021 includes collections on the Remaining Contracts of $0.6 million, compared to $6.2 million of revenue for the six months ended June 30, 2020. Sales volumes increased over the prior year, which was impacted by access restrictions to hospitals and travel restrictions enacted, both in response to the Covid-19 Pandemic.</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted Net Sales, which excludes cash collected on the Remaining Contracts, were $127.5 million for the six months ended June 30, 2021, compared to $109.2 million for the six months ended June 30, 2020, an increase of $18.3 million or 16.8%. The increase was primarily the result of an increase in sales volume over the six months ended June 30, 2021, which was impacted by the effects of the Covid-19 Pandemic.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The 16.8% increase in adjusted net sales, year-over-year, includes 17.5% growth in Advanced Wound Care products, including a positive impact from the sales of EPICORD&#174; Expandable, which we launched in the third quarter of 2020, and growth in our flagship EPIFIX&#174; sheet portfolio. Finally, sales of Section 351 products prior to the end of Enforcement Discretion contributed to the year-over-year increase in net sales.</span></div><div style="margin-bottom:10pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales and Gross Profit Margin</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales for the six months ended June 30, 2021 was $22.4 million, an increase of $4.2 million, or 22.9%, compared to $18.2 million for the six months ended June 30, 2020. The increase was primarily driven by year-over-year increases in sales volume. In addition, we recognized $1.0 million of inventory write-downs during the six months ended June 30, 2021, specifically related to Section 351 product, resulting from the end of the FDA&#8217;s Enforcement Discretion period. We do not anticipate these write-downs to continue in the future.</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit margin for the six months ended June 30, 2021 was 82.5% compared to 84.2% for the six months ended June 30, 2020. The decrease in gross profit margin was primarily due to reserves recorded during the six months ended June 30, 2021, specifically related to Section 351 product, resulting from the end of the FDA&#8217;s Enforcement Discretion period. Additionally, negative production variances from lower than planned production volumes affected gross profit margin.</span></div><div style="margin-bottom:10pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expenses</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, General and Administrative expenses for the six months ended June 30, 2021 increased approximately $14.7 million, or 17.5%, to $99.0 million compared to $84.3 million for the six months ended June 30, 2020. The increase in selling, general and administrative expenses during the period reflects the restoration of full-salary levels and merit increase that were previously restricted during the prior period, along with significantly reduced travel costs in the midst of the Covid-19 Pandemic. We also saw consulting and advisory expenses rise, year-over-year, including $3.8 million related to the proxy contest during the six months ended June 30, 2021. Furthermore, the increase in selling, general and administrative expense was driven by year-over-year increases in commission expenses resulting from the increases in sales volume.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investigation, Restatement and Related Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investigation, restatement and related expenses for the six months ended June 30, 2021 decreased approximately $21.9 million, or 81.0%, to $5.1 million compared to $27.0 million for the six months ended June 30, 2020. The decrease was driven by a decrease in expenses toward the restatement of our prior period financial information and the advancement of legal fees of certain former officers and directors of the Company. We do not anticipate incurring any more costs related to the restatement of our prior period financial information. The decrease was further driven by funds received from certain director and officer insurance policies, as well as negotiated reductions in previously-recognized expenses related to legal expenses advanced on behalf of certain former members of management.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are still subject to indemnification agreements with certain former officers and directors of the Company (other than Messrs. Petit and Taylor) for whom legal proceedings are still ongoing, but we expect such expenses to continue to decrease over time.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to incur some litigation costs moving forward, but we expect a continued reduction in investigation, restatement, and related expenses, other than costs related to resolution of the securities class action matter, the amount and timing of which are highly uncertain. See Note 12, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the unaudited condensed consolidated financial statements for additional details.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development expenses increased $3.5 million, or 71.1%, to $8.4 million for the six months ended June 30, 2021, compared to $4.9 million for the six months ended June 30, 2020. The increase reflects higher consulting fees and increases in personnel costs, driven both by the reversal of efforts to mitigate the effects of the Covid-19 Pandemic, as well as increases in headcount to support clinical research efforts. In addition, we&#8217;ve increased our planned investments in preclinical studies, supportive of current and potential clinical study indications.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect these costs to increase over time as we commence new clinical trials and continue working towards the filing of our BLAs. The amount and timing of these expenses are partially dependent on whether interim results from our ongoing IND clinical trials merit further investment.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization of Intangible Assets</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense decreased $0.1 million or 16.2% from the six months ended June 30, 2020 to the six months ended June 30, 2021. The decrease was the result of amortization on customer relationship assets that were impaired during the fourth quarter of 2020.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense, Net</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net was $2.8 million for the six months ended June 30, 2021 compared to $5.0 million for the six months ended June 30, 2020. The difference related to the lower outstanding principal balance, stated interest rate, and amortization of deferred financing costs and original issue discount on our Term Loan and DD TL compared to our previous term loan.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Expense, Net</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net was negligible in each of the six months ended June 30, 2021 and 2020.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Provision Benefit</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the Company were (0.5)% and 45.9%&#160;for the six months ended June 30, 2021 and 2020, respectively. The change in effective tax rates was driven by modifications to the tax rules for carryback of net operating losses as a result of the CARES Act which resulted in a federal tax refund of $11.3 million and an income tax benefit of the same amount during the six months ended June 30, 2020. There were no discrete items affecting the effective tax rate for the six months ended June 30, 2021.</span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_106"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing financial statements, we follow accounting principles generally accepted in the United States, which require us to make certain estimates and apply judgments that affect its financial position and results of operations. Management regularly reviews our accounting policies and financial information disclosures. A summary of significant accounting policies that require the use of estimates and judgments in preparing the financial statements was provided in our 2020 Form 10-K.&#160;During the quarter covered by this report, there were no material changes to the accounting policies and assumptions previously disclosed, except as disclosed in Note 2 to the unaudited condensed consolidated financial statements contained herein.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i586f4d48e4324b41820aaf3f28c0b969_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our GAAP results, we provide certain Non-GAAP metrics including Adjusted Net Sales, Earnings Before Interest, Taxes, Depreciation and Amortization (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and Adjusted EBITDA. We believe that the presentation of these measures provides important supplemental information to management and investors regarding our performance. These measurements are not a substitute for GAAP measurements, and the manner in which we calculate such metrics may not be identical to the manner in which other companies calculate and present similar metrics. Company management uses these Non-GAAP measurements as aids in monitoring our ongoing financial performance from quarter-to-quarter and year-to-year on a regular basis and for benchmarking against comparable companies.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted Net Sales</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reported net sales between periods, specifically those reported prior to and after the Transition, led to situations where we included revenue recognized on the cash basis and the &#8220;as-shipped&#8221; basis in the same period. Refer to Note 2, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Significant Accounting Policies,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; of the unaudited condensed consolidated financial statements for additional details regarding the Transition. Adjusted Net Sales provides comparative assessments of our revenue and assists in evaluating our sales performance. Adjusted Net Sales consists of GAAP net sales less the effects of the revenue transition and allows one to understand the trend in sales irrespective of the change in revenue recognition method.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of GAAP net sales to Adjusted Net Sales is provided in the table below (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:37.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.593%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,383&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of change in revenue recognition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(313)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,706)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(611)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,201)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted net sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,941&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,521&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,182&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EBITDA and Adjusted EBITDA</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EBITDA is intended to provide a measure of the Company&#8217;s operating performance as it eliminates the effects of financing and capital expenditures. EBITDA consists of GAAP net loss excluding: (i) depreciation, (ii) amortization of intangibles, (iii) interest expense, net, and (iv) income tax provision. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is intended to provide an enduring, normalized view of EBITDA and our broader business operations that we expect to experience on an ongoing basis by removing certain non-cash items and items which may be irregular, one-time, or non-recurring from EBITDA; most significantly those expenses related to the Audit Committee Investigation and Restatement. This also includes share-based compensation, which is predominantly settled in shares. This enables us to identify underlying trends in our business that could otherwise be masked by such items.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA consists of GAAP net loss excluding: (i) depreciation, (ii) amortization of intangibles, (iii) interest expense, (iv) income tax provision, (v) (benefits) costs incurred in connection with Audit Committee Investigation and Restatement, (vi) the effect of the change in revenue recognition on net loss, and (vii) share-based compensation.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management also assesses EBITDA margin and Adjusted EBITDA margin to provide an additional layer of context to the Company&#8217;s profitability; indicating our ability to convert our sales into sustainable operating results. EBITDA margin is calculated as EBITDA divided by GAAP net sales. Similarly, Adjusted EBITDA margin is calculated as Adjusted EBITDA divided by GAAP net sales.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of GAAP net loss to EBITDA and Adjusted EBITDA appears in the table below (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:37.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,779)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,466)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,161)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,287)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Net margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(15.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP Adjustments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision (benefit) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,277)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,108&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,172)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,343)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,133)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">EBITDA margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Non-GAAP Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Benefits) costs incurred in connection with Audit Committee Investigation and Restatement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,062)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of change in revenue recognition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,467)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,333)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,837&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,241&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,570&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,355&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Adjusted EBITDA margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Adjusted EBITDA, % of Adjusted Net Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div id="i586f4d48e4324b41820aaf3f28c0b969_112"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discussion of Cash Flows</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operations during the six months ended June&#160;30, 2021 decreased approximately $10.3 million to approximately $5.1 million, compared to $15.4 million for the six months ended June&#160;30, 2020. The decrease in cash used was primarily related to decreases in investigation, restatement and related expenses, particularly those incurred with respect to the restatement of our prior period financial information and the indemnification of former officers and directors of the Company. The restatement of our prior period financial information concluded in mid-2020. Other positive effects included year-over-year increases in sales volume and year-over-year decreases in cash interest expense. These effects were offset by the reversal of our efforts to mitigate the Covid-19 Pandemic, which caused a year-over-year increase in selling, general and administrative expense, as well as year-over-year increases in research and development expenses toward the advancement of the filing of our BLAs.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used for investing activities during the six months ended June&#160;30, 2021 was $2.5 million, compared to $1.6 million for the six months ended June&#160;30, 2020. This increase was the result of a $0.9 million year-over-year increase in capital expenditures, incurred to improve our manufacturing facilities toward CGMP compliance. Year-over-year increases in cash paid for patent application costs were offset by principal payments received on our notes receivable.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities decreased $0.7 million to $3.2 million during the six months ended June&#160;30, 2021 compared to $3.9 million during the six months ended June&#160;30, 2020. The change was driven by $1.9 million of principal repayments on our previous term loan agreement during the six months ended June&#160;30, 2020. No principal payments are due on our Term Loan, as defined below, until its maturity in 2025 and we have not made any principal payments during the six months ended June&#160;30, 2021. The decrease was further driven by a year-over-year increase in cash proceeds from the exercise of stock option, offset by a year-over-year increase in cash paid for stock repurchases for tax withholding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i586f4d48e4324b41820aaf3f28c0b969_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2021, there were no significant changes to the contractual obligations from those disclosed in the section &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results from Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in our 2020 Form 10-K.</span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_118"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business requires capital for our operating activities, including costs associated with the sale of product through direct and indirect sales channels, the conduct of research and development activities, compliance costs, and legal and consulting fees in connection with ongoing litigation and other matters.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, we had $85.0 million of cash and cash equivalents. We reported total current assets of $147.7 million and total current liabilities of $50.6 million at June&#160;30, 2021, which represents a current ratio of 2.9 as of June&#160;30, 2021.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently paying our obligations in the normal course of business. We believe that our anticipated cash from operating activities, inclusive of any potential negative effects from the conclusion of the FDA&#8217;s enforcement discretion effective May 31, 2021, and existing cash and cash equivalents will enable us to meet our operational liquidity needs for the 12 months following the issuance of this Quarterly Report.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate cash requirements related to the following items within one year of the date of the filing of this Quarterly Report:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">investments and other expenditures required to advance our INDs and BLAs, possibly including expenditures relating to expanded manufacturing facilities</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lawsuits or potential settlements for which we are not able to estimate a loss, or for which our ultimate loss exceeds our estimate. In addition, it is uncertain if we would be entitled to indemnification from our insurance providers for such matters; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">indemnification agreements involving certain former members of our management team.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have analyzed our ability to address aforementioned commitments and potential liabilities for the 12 months extending from the date of the filing of this Quarterly Report, including the full impact of Enforcement Discretion discussed earlier. After completing this analysis, which included a review of updated expectations of revenue, margins, and expenses, we believe it is probable that we will meet all obligations as they come due.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020, we entered into a Loan Agreement with, among others, Hayfin Services, LLP, (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) an affiliate of Hayfin Capital Management LLP (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin Loan Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), which Hayfin funded (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin Loan Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) on July 2, 2020 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Closing Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and provided us with a senior secured term loan in an aggregate amount of $50 million (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The Term Loan matures on June 30, 2025 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maturity Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Interest is payable on the Term Loan quarterly through the Maturity Date. No principal payments on the Term Loan are due and payable until the Maturity Date.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Hayfin Loan Agreement also provided us with an additional delayed draw term loan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DD TL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in the form of a committed but undrawn facility in an amount not to exceed $25 million. We did not draw upon the DD TL prior to its expiration.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate applicable to any borrowings under the Term Loan is equal to LIBOR (subject to a floor of 1.5%) plus a margin of 6.75% per annum. If LIBOR is unavailable, the loan will carry interest at the greatest of the Prime Rate, the Federal Funds Rate plus 0.5% per annum, and 2.5%, plus the margin of 6.75%.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The margin on the interest rate is eligible for a reduction; as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">6.75% per annum if the Total Net Leverage Ratio (as defined in the Hayfin Loan Agreement) is greater than 2.0x,</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">6.5% per annum if the Total Net Leverage Ratio is less than 2.0x but greater than or equal to 1.0x, or</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">6.0% per annum if the Total Net Leverage Ratio is less than 1.0x.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021, the Total Net Leverage Ratio was 3.6x. At issuance, and as of June&#160;30, 2021, the Term Loan carried an interest rate of 8.3%.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an event of default, as defined by the Hayfin Term Loan Agreement, occurs, an additional 3.0% margin is applied to the interest rate until such event of default is cured. Alternatively, Hayfin may elect to call the loan, requiring us to repay all outstanding principal, applicable prepayment premium, and accrued interest immediately.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan contains financial covenants requiring the Company, on a consolidated basis, to maintain the following:</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Maximum Total Net Leverage Ratio of 4.5x through the quarter ending June 30, 2021, further reduced to 4.0x thereafter for the life of the loans, required to be calculated on a quarterly basis.</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Minimum Liquidity (as defined in the Hayfin Term Loan Agreement) of $10 million, an at-all-times financial covenant, tested monthly. As of June&#160;30, 2021, the Company had $85.0 million of cash and cash equivalents.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan specifies that any prepayment of the Term Loan, voluntary or mandatory, as defined in the Term Loan Agreement, would subject us to a prepayment premium applicable as of the date of the prepayment, as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On or before the first anniversary of the Closing Date:</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">A make-whole premium, equal to the greater of:</span></div><div style="margin-bottom:9pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">5% of the principal balance repaid, and</span></div><div style="margin-bottom:9pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">102% of the principal balance plus interest that would have been accrued from the repayment date to 12 months following the Closing Date.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After the first anniversary of the Closing Date but on or before the second anniversary of the Closing Date: 2% of the principal balance repaid.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After the second anniversary of the Closing Date but on or before the third anniversary of the Closing Date: 1% of the principal balance repaid.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After the third anniversary of the Closing Date: 0% of the principal balance repaid.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan Agreement also includes certain negative covenants events of default customary for facilities of this type, and upon the occurrence of such events of default, subject to customary cure rights, all outstanding loans under the Credit Facilities may be accelerated or the lenders&#8217; commitments terminated. The mandatory prepayments are also required in the event of a change in control, incurring other indebtedness, certain proceeds from disposal of assets and insured casualty event.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning with the fiscal year ending December 31, 2021, we are required to prepay the outstanding loans based on the percentage of Excess Cash Flow (as defined in the Hayfin Loan Agreement), if such is generated, with the percentage determined based on the Total Net Leverage thresholds.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series B Convertible Preferred Stock</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 2, 2020, we issued $100 million of our Series B Convertible Preferred Stock, par value $0.001 per share (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series B Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to an affiliate of EW Healthcare Partners and certain funds managed by Hayfin Capital Management LLP (individually, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holde</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r&#8221;, collectively, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) pursuant to a Securities Purchase Agreement with Falcon Fund 2 Holding Company, L.P., an affiliate of EW Healthcare Partners, and to certain funds managed by Hayfin Capital Management LLP, dated as of June 30, 2020 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Purchase Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), for an aggregate purchase price of $100 million.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Preferred Stock paid a 4.0% cumulative dividend per annum prior to the quarterly dividend payment ending on June 30, 2021, and pays a 6.0% cumulative dividend per annum thereafter. Dividends are declared at the sole discretion of our board of directors. Dividends, if declared, are paid in cash at the end of each quarter based on dividend amounts that accumulate beginning on the last payment date through the day prior to the end of each quarter. In lieu of paying a dividend in cash, we may elect to accrue the dividend owed to shareholders. Dividend balances accumulate at the prevailing dividend rate for each dividend period for which they are outstanding.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of Series B Preferred Stock, including any accrued and unpaid dividends, is convertible into our common stock at any time at the option of the Holder at a conversion price of $3.85 per common share, or 259.74 common shares for each share of Series B Preferred Stock prior to any accrued and unpaid dividends. The Series B Preferred Stock, including any accrued and unpaid dividends, automatically converts into common stock at any time after the third anniversary of the issuance date, provided that the common stock has traded at 200% or more of the conversion price (i) for 20 out of 30 consecutive trading days and (ii) on such date of conversion.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we undergo a change of control, we will have the option to repurchase some or all of the then-outstanding shares of Series B Preferred Stock for cash in an amount equal to the liquidation preference, subject to the rights of the Holders of the Series B Preferred Stock in connection with such change in control. If we do not exercise such repurchase right, Holders of the Series B Preferred Stock will have the option to (1) require us to repurchase any or all of their then-outstanding shares of Series B Preferred Stock for cash in an amount equal to the liquidation preference or (2) convert their shares of Series B Preferred Stock, including accrued and unpaid dividends into common stock and receive their pro rata consideration thereunder.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not declared or paid any cash dividends on our Series B Convertible Preferred Stock since issuance. Dividends accumulated but not paid as of June&#160;30, 2021 were approximately $4.1 million.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our anticipated cash from operating activities, existing cash and cash equivalents will enable us to meet our operational liquidity needs and fund our planned investing activities, as well as any challenges and uncertainties surrounding our operating results which may arise due to the Covid-19 Pandemic, for the 12 months from August&#160;3, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2021, we repurchased 127,046 shares surrendered by employees to satisfy tax withholding obligations upon vesting of restricted stock. Other than these transactions, we did not repurchase any shares of our common stock for the three months ended June 30, 2021. The timing and amount of future repurchases, if any, will depend upon our stock price, economic and market conditions, regulatory requirements, and other corporate considerations. We may initiate, suspend or discontinue purchases at any time.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 to our unaudited condensed consolidated financial statements in Part I, Item 1 herein.</span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_121"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no off-balance sheet arrangements as of June&#160;30, 2021.</span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_124"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the effect of recent accounting pronouncements, see Note 2 to the unaudited condensed consolidated financial statements contained herein.</span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_127"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our lack of market risk sensitive instruments outstanding at June&#160;30, 2021, we have determined that there was no material market risk exposure to our consolidated financial position, results of operations or cash flows as of such date.</span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_130"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management maintains a set of disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to management, including our CEO and CFO, to allow for timely decisions regarding required disclosure.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation of the effectiveness of the design and operation of our disclosure controls and procedures was performed under the supervision and with the participation of our management, including our CEO and CFO. As a result of this evaluation, our CEO and CFO concluded that our disclosure controls and procedures were not effective as of June 30, 2021 because of certain material weaknesses in internal control over financial reporting, as described in Item 9A, &#8220;Controls and Procedures&#8221; of our 2020 10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Exchange Act Rules 13a-15(d) and 15d-15(d), management is required to evaluate, with the participation of our principal executive officer and principal financial officer, any changes in internal control over financial reporting that occurred during each fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. As discussed &#8220;Management&#8217;s Report on Internal Control Over Financial Reporting&#8221; in Item 9A, "Controls and Procedures" of our 2020 Form 10-K, we identified unremediated material weaknesses corresponding to the control activities component of internal control as defined by in the Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (the "COSO framework") as of December 31, 2020. Other than as disclosed in the &#8220;Remediation Plan and Status&#8221; under &#8220;Item 9A: Controls and Procedures&#8221; in the 2020 Form 10-K, there were no changes in our internal control over financial reporting during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inherent Limitation on the Effectiveness of Internal Controls</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of any system of internal control over financial reporting is subject to inherent limitations, including the exercise of judgment in designing, implementing, operating, and evaluating the controls and procedures, and the inability to eliminate misconduct completely. Accordingly, any system of internal control over financial reporting can only provide reasonable, not absolute, assurance that its objectives will be met. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. We intend to continue to monitor and upgrade our internal controls as necessary or appropriate for our business, but we cannot assure that such improvements will be sufficient to provide us with effective internal control over financial reporting in 2021 or future periods.</span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i586f4d48e4324b41820aaf3f28c0b969_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_136"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its subsidiaries are parties to numerous claims and lawsuits arising in the normal course of its business activities, some of which involve claims for substantial amounts. The ultimate outcome of these suits cannot be ascertained at this time. For additional information, see </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i586f4d48e4324b41820aaf3f28c0b969_73">Note&#160;12, &#8220;Contractual Commitments and Contingencies,</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the unaudited condensed consolidated financial statements included in Part I,&#160;Item 1&#160;of this&#160;Quarterly Report, which is incorporated herein by reference.</span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_139"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of its routine review of its risk factors, the Company has amended four of its risk factors and added two new risk factors in addition to those disclosed under &#8220;Risk Factors&#8221; in Part I, Item 1A of our 2020 Form 10-K.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">We amended the following risk factors</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our international expansion and operations outside the U.S. expose us to risks associated with international sales and operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are pursuing further expansion outside the U.S. Managing a global organization is difficult, time consuming and expensive. Our ability to conduct business in foreign markets is affected by many of the same risks we face in our U.S. operations, as well as unique costs and difficulties of managing international operations. Risks inherent in international operations also include, among others, potential adverse tax consequences, greater difficulty in enforcing intellectual property rights, risks associated with the Foreign Corrupt Practices Act and local anti-bribery law compliance, difficulty in obtaining acceptable reimbursement pricing for our products, difficulty building and managing a direct sales force or the relatively greater cost of third-party distributors, and the impact of foreign currency exchange rates and fluctuations. Also, the sale and shipment of our products across international borders, as well as the purchase of components and products from international sources, subject us to extensive U.S. and foreign governmental trade, import and export and customs regulations and laws, including, without limitation, the Export Administration Regulations and trade sanctions against embargoed countries, which are administered by the Office of Foreign Assets Control within the Department of the Treasury, as well as the laws and regulations administered by the Department of Commerce. These regulations limit our ability to market, sell, distribute or otherwise transfer our products or technology to prohibited countries or persons. International regulations may also limit what promotional claims we may make for our products.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with these regulations and laws is costly, and failure to comply with applicable legal and regulatory obligations could adversely affect us in a variety of ways that include, without limitation, significant criminal, civil and administrative penalties, including imprisonment of individuals, fines and penalties, denial of export privileges, seizure of shipments and restrictions on certain business activities. Also, the failure to comply with applicable legal and regulatory obligations could result in the disruption of our distribution and sales activities.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks may limit or disrupt our expansion, restrict the movement of funds or result in the deprivation of contractual rights or the taking of property by nationalization or expropriation without fair compensation. Operating outside of the U.S. also requires significant management attention and financial resources.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 8, 2021, the Company announced that it had received </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulatory approval by the Japanese Ministry of Health, Labour and Welfare (JMHLW) to market EPIFIX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Japan. However, reimbursement pricing approval from the Japanese government remains pending at this time and requires the satisfaction of various conditions; is often subject to detailed rules; and the timing, amount, and final approval decision rests with the JMHLW. Further, successful sales of our products in Japan requires consumer acceptance, which might not be forthcoming.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">To the extent our products do not qualify for regulation as human cells, tissues and cellular and tissue-based products solely under Section 361 of the Public Health Service Act (&#8220;Section 361&#8221;), this will result in removal of the applicable products from the market, would make the introduction of some new tissue products more expensive, and could significantly delay the expansion of our tissue product offerings and subject us to additional post-market regulatory requirements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The products we manufacture and process are derived from human tissue. Amniotic and other birth membrane are generally regulated as Human Cells, Tissues and Cellular and Tissue - Based Products (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">HCT/P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and are therefore eligible to be subject to regulation solely under Section 361 (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Section 361 HCT/P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) depending on whether the specific product at issue and the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">claims made for it are consistent with the applicable criteria. HCT/Ps that do not meet these criteria are subject to more extensive regulation as drugs, medical devices, biological products, or combination products. These HCT/Ps must comply with both the FDA&#8217;s requirements for HCT/Ps and the requirements applicable to biologics, devices or drugs, including pre-market clearance or approval from the FDA. Obtaining FDA pre-market clearance or approval involves significant time and investment by the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, the FDA released a guidance document entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue - Based Products: Minimal Manipulation and Homologous Use - Guidance for Industry and Food and Drug Administration Staff.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; The document confirmed the FDA&#8217;s stance that all micronized amniotic products require a biologics license to be lawfully marketed in the United States. We also interpret the guidance document as confirming our position that sheet forms of amniotic tissue are appropriately regulated as solely Section 361 HCT/Ps when manufactured in accordance with 21 CFR Part 1271 and intended for use as a barrier or covering. The final guidance also stated that the FDA would exercise enforcement discretion under limited conditions with respect to the IND application and pre-market approval requirements for certain HCT/Ps for a limited period following the date of the Guidance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the FDA extended its period of enforcement discretion to May 31, 2021. In April 2021, the FDA confirmed that there would be no further extensions to its period of enforcement discretion and that following the period of enforcement discretion under the Guidance, the industry would be required to cease selling products that require pre-approval under applicable biologics or medical device laws and regulations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">MiMedx ceased marketing our micronized and particulate products on May 31, 2021 and requested the return of unused consignment inventory as of that date. At the same time, we are pursuing the BLA pre-market approval process for certain of our micronized products, as more fully discussed under &#8220;Business - Government Regulation.&#8221; The loss of our ability to market and sell our micronized products will have an adverse impact on our revenues, business, financial condition and results of operations. Our net sales of such products for all uses was $31.7 million in 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Also, the Company currently markets EPICORD and AMNIOCORD, tissue products derived from human umbilical cord, as providing a protective environment or as a barrier. In warning letters to several companies marketing human umbilical cord derived products for a variety of uses, the FDA has stated that those products fail to meet the homologous use criterion, as &#8220;the product is not intended to perform the same basic function or functions of umbilical cord in the recipient as in the donor, such as serving as a conduit.&#8221; If the FDA takes the position that there is a single basic function of umbilical cord and that cord products may only serve in a conduit function, this may impact MiMedx&#8217;s marketing of human umbilical cord products. To our knowledge, the FDA has not indicated this publicly or to MiMedx. If the FDA were to determine that EPICORD and AMNIOCORD do not meet the requirements for regulation solely under Section 361, then FDA pre-market clearance or approval would be required. The loss of our ability to market and sell our umbilical cord derived products would have an adverse impact on our revenues, business, financial condition and results of operations. Included in net sales were sales of umbilical cord derived products totaling $16.6 million, $17.9 million, and $14.7 million, respectively, in 2020, 2019, and 2018. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any regulatory changes could have adverse consequences for us and make it more difficult or expensive for us to conduct our business by requiring pre-market clearance or approval and compliance with additional post-market regulatory requirements with respect to those products. Moreover, increased regulatory scrutiny within the industry in which we operate could lead to increased regulation of HCT/Ps, including Section 361 HCT/Ps, which could ultimately increase our costs and adversely impact our business, results of operations and financial condition. If the FDA approves the BLAs we seek, we will incur increased compliance costs on an ongoing basis. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">If any of the BLAs are approved, the Company would be subject to additional regulation which will increase costs and could result in adverse sanctions for non-compliance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.&#8221;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Obtaining and maintaining the necessary regulatory approvals for certain of our products will be expensive and time consuming and may impede our ability to fully exploit our technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The process of obtaining regulatory clearances or approvals to market a biological product or medical device from the FDA or similar regulatory authorities outside of the U.S. may be costly and time consuming, and such clearances or approvals may not be granted on a timely basis, or at all. We are pursuing approval of BLAs for certain of our micronized products, but have not yet submitted a BLA for review. Additionally, the FDA may take the position that some of the other products that we currently market require a BLA as well. Some of the future products and enhancements to our current products that we expect to develop or may acquire and market may require marketing clearance or approval from the FDA. However, clearance or approval may not be granted with respect to any of our products or enhancements and further FDA review may add delays that could adversely affect our ability to market such products or enhancements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The process of obtaining an approved BLA, including clinical trial development and execution as well as manufacturing processes, requires the expenditure of substantial time, effort and financial resources and may take years to complete. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, there are significant costs associated with clinical trials that can be difficult to estimate accurately until a BLA is approved. Clinical trials may not be successful or may return results that do not support approval. Moreover, data obtained from clinical trials are not always conclusive and may be susceptible to varying interpretations, which could delay, limit or prevent regulatory approval. The FDA may not grant approval of our BLA on a timely basis, or at all, or we may decide not to pursue a BLA for certain products or indications, or may need to conduct additional trials for a given indication. Additionally, the FDA may limit the indications for use, dosages, or place other conditions on any approvals that could restrict the commercial application of the products. If we do receive approval, some types of changes to the approved product, such as adding new indications or doses, manufacturing changes and additional labeling claims, are subject to further testing requirements and FDA review and approval. Our revenues will be adversely affected if we fail to obtain BLA approvals on a timely basis or at all, or if the FDA limits the indications for use or requires other conditions that restrict the commercial application of our products. In addition, the fee for filing a BLA and program fees payable with respect to any establishment that manufactures biologics are substantial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Securities analysts may elect not to report on our common stock or may issue negative reports that adversely affect the stock price.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have conducted extensive investor relations outreach to the investment analysts community with the goal of attracting analyst coverage. However, at this time, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">only three securities analysts provide coverage on us, and one of these firms is compensated by us. T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">here can be no assurance that any other analysts will cover our stock or, if they do, that they will continue to report on our common stock or that additional analysts will initiate reporting on our common stock. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to attract the coverage from securities analysts, or if securities analysts discontinue covering our common stock, the lack of research coverage may adversely affect the actual and potential market price of our common stock. The trading market for our common stock may be affected in part by the research and reports that industry participants, industry analysts or financial analysts publish about our business. If one or more analysts elect to cover us and then downgrade the stock, the stock price would likely decline rapidly. If one or more of these analysts cease coverage of us, we could lose visibility in the market, which in turn could cause our stock price to decline.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">We also added two new risk factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Clinical trials will be necessary to support future BLA submissions and potential product approvals by the FDA. The clinical trial process is lengthy and expensive with uncertain outcomes, and often requires the enrollment of large numbers of patients, and suitable patients may be difficult to identify and recruit. Delays or failures in our clinical trials could prevent us from commercializing any modified or new products and will adversely affect our business, operating results and prospects.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The results of early clinical trials are not necessarily predictive of future results, and any product we advance into clinical trials may not have favorable results in later clinical trials. Our interpretation of data and results from our clinical trials does not ensure that we will achieve similar results in future clinical trials. In addition, clinical data are often susceptible to various interpretations and analyses, and many companies that have believed their products performed satisfactorily in earlier clinical trials or retrospective studies have nonetheless failed to replicate results in later clinical trials. Products in later stages of clinical trials may fail to show the desired safety and efficacy despite having progressed through nonclinical studies and earlier clinical trials and retrospective studies, and such failures can occur at any stage of clinical testing. Our clinical studies may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical and non-clinical testing in addition to those we have planned. For example, preliminary results from our Phase 3 trial of mdHACM for the treatment of Achilles tendonitis suggest that the trial may not have been designed to allow sufficient confidence in the efficacy of the therapy.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The initiation and completion of a trial may be prevented, delayed, or halted for numerous reasons, including, but not limited to, the following:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">regulatory authorities do not approve a clinical study protocol, force us to modify a previously approved protocol, or place a clinical study on hold;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">patients do not enroll in, or enroll at a lower rate than we expect or need, or do not complete a clinical study. During 2020, the time necessary to complete our studies was longer than expected as a result of access restrictions at hospitals and health care provider facilities as a result of the Covid-19 Pandemic;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">patients or investigators do not comply with study protocols;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the FDA may require us to submit data on a greater number of patients than we originally anticipated and/or for a longer follow-up period or change the data collection requirements or data analysis applicable to our clinical trials;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">patients do not return for post-treatment follow-up at the expected rate;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">patients may experience serious or unexpected adverse side effects for a variety of reasons that may or may not be related to our product causing a clinical trial study to be put on hold;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may be unable to recruit a sufficient number of clinical trial sites;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">sites participating in an ongoing clinical study withdraw, requiring us to engage new sites;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">third-party clinical investigators decline to participate in our clinical studies, do not perform the clinical studies on the anticipated schedule, or act in ways inconsistent with the investigator agreement, clinical study protocol, good clinical practices, and other regulatory requirements;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">third-party entities do not perform data collection and analysis in a timely or accurate manner;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">we may have to amend clinical trial protocols or conduct additional studies to reflect changes in regulatory requirements or guidance, which we may be required to submit to regulatory authorities for approval;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the cost of clinical trials may be greater than we anticipate; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">regulators or other reviewing bodies may fail to approve or subsequently find fault with our manufacturing processes or facilities, the supply of materials necessary to conduct clinical trials may be insufficient, inadequate or not available at an acceptable cost, or we may experience interruptions in supply.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any of these occurrences may significantly harm our business, financial condition and prospects. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of certification or regulatory approval of our product candidates.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our ability to consistently and reliably manufacture our biologic products will be key to the marketing of any future Section 351 products. Also, our current manufacturing facilities may be inadequate to produce sufficient quantities if all of our planned BLAs are approved. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The manufacture of biologic products requires significant expertise and capital investment, including the development of advanced manufacturing techniques and process controls, and the approval of BLAs require one to demonstrate the ability to manufacture pursuant to specified chemistry and manufacturing controls. Manufacturers of biologic products often encounter difficulties in production, particularly in scaling up initial production as would be the case at any new facility.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These problems can include difficulties with production costs and yields, quality control (including stability of the product candidate and quality assurance testing), shortages of qualified personnel, and compliance with strictly enforced federal, state and foreign regulations. If we were to encounter any of these difficulties, or otherwise fail to comply with our obligations under applicable regulations, then our ability to provide product candidates to patients in our clinical trials or commercially would be jeopardized, and any delay or interruption in the supply of product could delay the commercial launch of the product or impair our ability to meet demand for the product. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our products can be manufactured only in a facility that has undergone a satisfactory inspection by the FDA and other relevant regulatory authorities. While we currently possess redundant manufacturing capacity, we may not be able to replace manufacturing capacity for our products quickly if we were unable to use manufacturing facilities as a result of a fire, natural disaster (including an earthquake), equipment failure, or other difficulty, or if such facilities were deemed not in compliance with the regulatory requirements and such non-compliance could not be rapidly rectified. An inability or reduced capacity to manufacture our products could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our existing manufacturing facilities have been adequate but may become inadequate if our planned BLA for knee osteoarthritis is approved. Therefore, we have begun planning for additional manufacturing capacity. Failure to adequately expand capacity could delay commercialization of our current or future product candidates, depriving us of potential product revenue. Any manufacturing problem could be disruptive to our operations and result in lost sales. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i586f4d48e4324b41820aaf3f28c0b969_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="text-align:justify"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) None.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) None.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) The following table sets forth information regarding the purchases of the Company&#8217;s equity securities made by or on behalf of the Company or any affiliated purchaser (as defined in Exchange Act Rule 10b-18) during the three month period ended&#160;June&#160;30, 2021:</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"></td><td style="width:32.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.752%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of<br/>shares purchased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price paid<br/>&#160;per share </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares purchased under publicly announced plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approximate Dollar Value of Shares that May Yet Be Purchased Under Plans or Programs</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1 - April 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,613&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.63&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1 - May 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1 - June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total for the quarter</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,046&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.59&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a) Shares repurchased during the quarter include shares surrendered by employees to satisfy tax withholding obligations upon vesting of restricted stock.</span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_145"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Arrearages. As of June 30, 2021, the Company calculated accumulated dividends of $4,054,921 in respect of the outstanding shares of Series B Preferred Stock. In accordance with the terms thereof, the Company elected to accumulate, rather than pay, such accumulated dividends.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_148"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_151"></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Proxy Access. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 27, 2021, the Shareholders approved an amendment to the Company&#8217;s Bylaws to provide for proxy access, which will allow eligible shareholders (as defined in the Proxy Access Bylaw) who comply with the requirements set forth in the Bylaws to include their own nominees for director in the Company&#8217;s proxy materials along with the candidates nominated by the Board. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A shareholder or group of up to 20 shareholders (such shareholder or shareholder group, an &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Eligible Shareholder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) that has maintained continuous qualifying ownership of at least 3% of the issued and outstanding Company common stock for at least the previous three years would be permitted to nominate and include up to a specified number of proxy access nominees in the Company&#8217;s proxy materials for its annual meeting of shareholders provided that the Eligible Shareholder and proxy access nominee(s) satisfy the requirements of the Proxy Access Amendments. The maximum number of proxy access nominees that the Company would be required to include in its proxy materials would not exceed the greater of (i) two (2) or (ii) 20% of the directors in office on the last day on which a nomination could be submitted (rounded down to the nearest whole number). Each Eligible Shareholder seeking to include a proxy access nominee in the Company&#8217;s proxy materials would be required to provide certain information to the Company specified in the Proxy Access Bylaw. The foregoing summary of the Proxy Access Bylaw is qualified in its entirety by reference to the full text of the Bylaws which are filed as Exhibit 3.2 to this report.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_154"></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restated Articles of Incorporation of MiMedx Group, Inc., adopted March 4, 2021, effective March 5, 2021 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000011/ex31restatedarticlesofinco.htm">incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Form 10-K filed March 8, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">), together with Articles of Amendment to Restated Articles of Incorporation, effective June 3, 2021 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000085/a202105278-kex31declassify.htm">incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000085/a202105278-kex31declassify.htm">Current </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000085/a202105278-kex31declassify.htm">Report on Form 8-</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000085/a202105278-kex31declassify.htm">K filed </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000085/a202105278-kex31declassify.htm">June 10</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000085/a202105278-kex31declassify.htm">, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) and Articles of Amendment to Restated Articles of Incorporation, effective June 3, 2021 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000085/a20210527ex32specialmeeting.htm">incorporated by reference to Exhibit 3.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000085/a20210527ex32specialmeeting.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000085/a20210527ex32specialmeeting.htm"> to the Registrant&#8217;s Current Report on Form 8-K filed June 10, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bylaws of MiMedx Group, Inc., as amended and restated as of April 19, 2021 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000119312521123689/d149033dex31.htm">incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Form&#160;8-K&#160;filed on April 21, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">), together with Amendment No. 1 to the Company&#8217;s Bylaws effective May 27, 2021 (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000083/a20210527ex31proxyaccessby.htm">incorporate</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000083/a20210527ex31proxyaccessby.htm">d</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000083/a20210527ex31proxyaccessby.htm"> by ref</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000083/a20210527ex31proxyaccessby.htm">erence to Exh</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000083/a20210527ex31proxyaccessby.htm">ibit 3.1 to </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000083/a20210527ex31proxyaccessby.htm">the Regis</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000083/a20210527ex31proxyaccessby.htm">trant</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000083/a20210527ex31proxyaccessby.htm">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000083/a20210527ex31proxyaccessby.htm">s </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000083/a20210527ex31proxyaccessby.htm">Current Report on Form 8-K Fi</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000083/a20210527ex31proxyaccessby.htm">led</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1376339/000137633921000083/a20210527ex31proxyaccessby.htm"> June 3, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).</span></div></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1#</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101carlsonarofferletter.htm">Employment Offer Letter between the Company and Peter M. Carlson, as amended and restated on June 30, 2021.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2#</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex102formofdirectorrsaawar.htm">Form of Director Restricted Stock Unit Award Agreement (Type I - Initial Grant, Full Amount).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3#</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103formofdirectorrsaawar.htm">Form of Director Restricted Stock Unit Award Agreement (Type II - Initial Grant, Pro Rata Amount).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4#</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex104formofdirectorrsaawar.htm">Form of Director Restricted Stock Unit Award Agreement (Type III - Annual Grant).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1 #</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-20210630.htm">Certification of Chief Executive Officer</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2 #</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-20210630.htm">Certification of Chief Financial Officer</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></div></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1 #</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-20210630.htm">Certification of Chief Executive Officer</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2 #</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-20210630.htm">Certification of Chief Financial Officer</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></div></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS #</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH #</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL #</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF #</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB #</span></td><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"></td><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE #</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:38.157%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:25.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:481.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicates a management contract or compensatory plan or arrangement</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div id="i586f4d48e4324b41820aaf3f28c0b969_157"></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.167%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August&#160;3, 2021</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MIMEDX GROUP, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Peter M. Carlson</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter M. Carlson</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer and Principal Financial Officer</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101carlsonarofferletter.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ic7fd0b2e925c41b5a410d599df38fa07_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt;text-align:right"><img alt="a1029carlsonpetearoff_imag.jpg" src="a1029carlsonpetearoff_imag.jpg" style="height:48px;margin-bottom:5pt;vertical-align:text-bottom;width:177px"></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit 10.1</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(as amended and restated as of June 30, 2021)</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mr. Peter M. Carlson</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;**&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dear Pete,</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I am pleased to confirm our offer of employment to you for the position of Chief Financial Officer on behalf of MiMedx Group, Inc. (&#8220;MiMedx&#8221; or &#8220;Company&#8221;), which employment is to commence on or around December 16, 2019. In this position, you will report directly to Timothy R. Wright, Chief Executive Officer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon commencement of employment with the Company, you shall have the title &#8220;Senior Vice President - Finance.&#8221;&#160; However, during the period commencing on the first date of employment with the Company and ending on the first business day after the Company files with the Securities and Exchange Commission the Company&#8217;s annual report on Form 10-K for the fiscal years ended December 31, 2018 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Transition Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Company currently intends that Ed Borkowski (&#8220;Borkowski&#8221;) shall remain principal financial and accounting officer of the Company and perform all functions commensurate with that role.  During the Transition Period, you shall not enter into any agreement that creates any binding obligation on behalf of Company without the express prior written consent of the Company&#8217;s Chief Executive Officer. During the Transition Period, Borkowski will perform the duties of the Company&#8217;s  principal financial and accounting officer and execute and deliver to Company the signatures and certifications required  in connection with the filing of the Super 10-K with the SEC in his capacity as principal financial officer and principal accounting officer of Company.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Following the filing of the Form 10-K for the year ended December 31, 2018, the Company expects that you will assume the role of principal financial and accounting officer. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Your initial base salary will be $20,192 (gross before deductions) per biweekly pay period, which is equivalent to the gross amount of $525,000 on an annualized basis. Your salary will be payable on a biweekly basis. Your future salary adjustments will be in accordance with Company policy and based upon individual and Company performance.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As an incentive to enter into the employ of the Company, you will be eligible to receive a one-time bonus payment in the amount of $50,000 (gross before deductions). This amount will be payable within forty-five (45) days following the commencement of your employment with MiMedx. You must be an active employee with the Company on the date of payment in order to remain eligible for the above referenced one-time bonus. In accordance with Company policy, should you voluntarily elect to discontinue employment with MiMedx within twelve (12) months following the date that the above-described one-time bonus was paid, you agree to repay to MiMedx the full amount of the one-time bonus paid to you.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You will be eligible to participate in the MiMedx Group Management Incentive Plan (&#8220;MIP&#8221;) with an annual target bonus amount equal to fifty-five percent (55%) of the base salary paid to you in accordance with the terms of such program in effect from time-to-time. You will be eligible to begin participating in the MIP effective January 1, 2020. Your 2020 MIP incentive will be calculated based on the achievement of MiMedx financial targets and your individual objectives.  The individual objectives will be comprised of one or more key operational measures and&#47;or outcomes that are specific to your position and directly influenced by your performance. In the 2020 MIP, specified portions of your above-referenced target </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><font style="color:#1e60ad;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Innovations In Regenerative Biomaterials</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">MiMedx Group, Inc.  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;  </font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1775 West Oak Commons Ct NE  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  Marietta, GA 30062  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  770.651.9100  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  Fax 770.590.3550  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  </font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.mimedx.com</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt;text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">bonus are expected to be allocated to a) MiMedx revenue performance, b) MiMedx Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (&#8220;Adjusted EBITDA&#8221;) and c) your performance in the attainment of your 2020 individual objectives. Following the final approval of the 2020 MIP by the MiMedx Board of Directors, you will receive further confirmation of the details of the 2020 MIP.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Based on the Company&#8217;s analysis of competitive data, the Company has established a target annual long-term incentive value for each position eligible to participate in the Company&#8217;s stock incentive program. This target is expressed as a percentage of the participant&#8217;s annual base salary, and is used as a guide by which to measure the appropriate and competitive value of the annual equity grant to be proposed by the Company for approval by the Compensation committee. In your position, your target annual long-term incentive value is two hundred percent (200%) of your annual base salary.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As an incentive to enter into employ of the Company, you will be eligible for a restricted stock grant with a value of $350,000 dollars&#59; the grant is contingent upon approval of the Board of Directors, but the Company agrees to recommend the grant to the Board no later than the next meeting of the Board. The grant will be made on later of the date your employment commences or the date the Board approves the grant (the &#8220;Grant Date&#8221;). The award will vest pro rata annually over three years, provided that you continue to be employed by the Company on each vesting date. The number of shares granted will be equal to such value divided by our closing stock price on the Grant Date.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As an additional incentive to enter into employ of the Company, you will be eligible for an additional restricted stock grant with a value of $1 million dollars.  The grant is contingent upon approval of the Board of Directors, but the Company agrees to recommend the grant to the Board no later than the next meeting of the Board. The grant will be made on later of the date your employment commences or the date the Board approves the grant (the &#8220;Grant Date&#8221;). The number of shares granted will be equal to such value divided by our closing stock price on the Grant Date. One quarter of the shares granted will vest upon the achievement of each of the following milestones&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">The Company files its annual report on Form 10-K for the year ended December 31, 2019 no later than 100 days following the date it filed its annual report on Form 10-K for the year ended December 31, 2018&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">MiMedx is relisted on either the NASDAQ or NYSE no later than 6 months following the filing of the 2019 Form 10-K&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">With the consent of the Company&#8217;s independent registered accountants, the Company transitions from cash accounting to accrual based accounting no later than October 1, 2020&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">You submit an ERM plan which is approved in full by the Board of Directors no later than July 31, 2021.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company will not require your relocation to the Marietta, Georgia area, but rather allow you to commute on a weekly basis from your residence in Charlotte, North Carolina to Marietta, Georgia. During this time, you will be expected to primarily work from the Company&#8217;s Marietta, Georgia office and maintain a schedule averaging no less than four and one-half (4.5) days per week working from the Marietta office or traveling on Company business, unless otherwise agreed between you and the CEO of MiMedx. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The MiMedx Board of Directors will review your full compensation package as you are expected to be a Section 16 officer.  The terms of your offer include the specific compensation arrangements described above as well as a Change of Control Severance and Restrictive Covenant Agreement.  This Agreement will be equal to one times your annual base compensation and one times your annual target bonus. The Company has retained a compensation consultant, which is, among other things, reviewing the Company&#8217;s severance plan(s) for executives.  The consultant will make a formal recommendation to the </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><font style="color:#1e60ad;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Innovations In Regenerative Biomaterials</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">MiMedx Group, Inc.  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;  </font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1775 West Oak Commons Ct NE  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  Marietta, GA 30062  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  770.651.9100  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  Fax 770.590.3550  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  </font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.mimedx.com</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt;text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Compensation Committee of the Board of Directors. You will be entitled to the severance benefits approved by the Compensation Committee for non-CEO executives and will be presented a retention agreement once such benefits are approved.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You will be eligible to participate in the Company&#8217;s medical, dental, vision, life insurance, and disability benefits programs the first day of the month following the date of your employment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You will be eligible to participate in the MiMedx Group 401(k) Plan effective the first day of the month following your employment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each such benefit shall be provided in accordance with the terms of the applicable benefit plans, which may be revised at any time at the Company&#8217;s discretion. A summary of the Company&#8217;s benefits is enclosed for your review. More detailed benefits eligibility and enrollment information will be sent to you shortly after you begin employment. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This offer is contingent upon a favorable background investigation and a pre-employment drug screen result. You will receive an email to complete the application process on ADP which includes the background authorization form. You must sign and complete the form before the background investigation and drug screen can commence.  Once we receive the executed </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Background Authorization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> form, you will receive an email from Pembrooke with instructions for the drug screen process and a Chain of Custody ID number for specimen collection. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To find the nearest LabCorp location, please go online to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">www.labcorp.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, go to the &#8220;I am a Patient&#8221; locator tab, and click on &#8220;Find a lab&#8221;. Type in your street address, city, state and zip code and make sure the testing service selection is &#8220;Routine clinical laboratory collections&#8221;, then click &#8220;Search&#8221;. The lab locations in proximity to your address will be shown. No appointments are necessary.  Please make sure that you bring the Chain of Custody ID number and photo identification, such as your driver&#8217;s license.  If you cannot find a location that is close to you, please call 1-800-247-0717, Monday &#8211; Friday from 6am to midnight (CST). </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company is committed to the highest standards of integrity and to treating its customers, employees, fellow workers, business partners and competitors in good faith and fair dealing.  We expect employees to share the same standard and values. By accepting this offer, you agree that throughout your employment, you will observe all of the Company's rules governing conduct of its business and employees, including its policies protecting employees from illegal discrimination and harassment, as those rules and policies may be amended from time to time.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As an employee of MiMedx, you are prohibited from the use or disclosure of confidential information or trade secrets obtained from your past employers. If you have any such documents in your possession, you are expected to return them to the respective organization, and during the course of your employment with the Company, not bring onto MiMedx premises or utilize in any manner such documents, confidential information or trade secrets.  While you have not made the Company aware of any such information in your possession, we urge you to abide by this prohibition if such information is currently in your possession.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This offer of employment is contingent on the absence of any restrictive covenants that would prevent you from conducting the duties and responsibilities of your position with MiMedx. By your acceptance of this offer, you represent that you are not a party to any non-disclosure, restrictive covenant or invention assignment agreements currently in effect.  If you become aware of any such agreements to which you are a party, by your acceptance of this offer, you agree to provide us with a copy of such additional agreements. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><font style="color:#1e60ad;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Innovations In Regenerative Biomaterials</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">MiMedx Group, Inc.  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;  </font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1775 West Oak Commons Ct NE  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  Marietta, GA 30062  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  770.651.9100  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  Fax 770.590.3550  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  </font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.mimedx.com</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt;text-align:right"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As a condition of your employment, you will be required to sign and comply with the enclosed MiMedx Confidentiality and Non-Solicitation Agreement, MiMedx Employee Inventions Assignment Agreement, and MiMedx Non-Competition Agreement. If the provisions of this offer are agreeable to you, please sign this letter to indicate your acceptance and return one copy along with the above-referenced agreements in the enclosed self-addressed envelope.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pete, I am delighted to extend this offer to you and look forward to an exciting and mutually rewarding business association. We look forward to your joining MiMedx. Please feel free to contact me via email or on my cell phone  at 404-796-5670 if you have any questions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Sincerely,</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Lee Ann Lawson</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Lee Ann Lawson</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Senior Vice President, Human Resources</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">cc&#58;       Timothy R. Wright</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">             </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">ACCEPTANCE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">I have read and understand the foregoing which constitutes the entire and exclusive agreement between the Company and the undersigned and supersedes all prior or contemporaneous proposals, promises, understandings, representations, conditions, oral or written, relating to the subject matter of this agreement. I understand and agree that my employment is at-will and is subject to the terms and conditions contained herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#47;s&#47; Peter M. Carlson</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Peter M. Carlson</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><font style="color:#1e60ad;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Innovations In Regenerative Biomaterials</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">MiMedx Group, Inc.  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;  </font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1775 West Oak Commons Ct NE  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  Marietta, GA 30062  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  770.651.9100  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  Fax 770.590.3550  </font><font style="color:#005a9b;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#124;</font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  </font><font style="color:#5a5a5a;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.mimedx.com</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex102formofdirectorrsaawar.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i5172de5114c848c5a463c5302dba231c_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Proposed Form of Initial Director RSU &#8211; three year vest</font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MIMEDX GROUP, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2016 EQUITY AND CASH INCENTIVE PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Non-Employee Director Restricted Stock Unit Agreement</font></div><div style="margin-bottom:12pt;margin-top:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THIS RESTRICTED STOCK UNIT AGREEMENT (this &#34;Agreement&#34;) dated as of the ____ day of ____ 20</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (the &#8220;Grant Date&#8221;), between MiMedx Group, Inc. (the &#34;Company&#34;) and _________________ (the &#34;Participant&#34;), is made pursuant and subject to the provisions of the Company's 2016 Equity and Cash Incentive Plan, amended and restated through October&#160;2, 2020 (the &#34;Plan&#34;), a copy of which is attached hereto.  All terms used herein that are defined in the Plan shall have the same meaning given them in the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:26.9pt">Grant of Restricted Stock Units.  Pursuant to the Plan, the Company, on the Grant Date granted to the Participant, subject to the terms and conditions of the Plan and subject further to the terms and conditions set forth herein, this Restricted Stock Unit Award for ______ stock units (&#8220;RSUs&#8221;).  Each RSU represents the right to receive one share of Common Stock (a &#8220;Share&#8221;) of the Company.  The RSUs will vest as set forth in Section 2, below and, upon vesting, will be settled in Shares as set forth in Section 3 below.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:26.9pt">Vesting of the RSUs.  Subject to earlier expiration or termination as provided herein, the RSUs will become vested (each date upon which the RSUs vest, a &#8220;Vesting Date&#8221;) as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.5pt">Time-Based Vesting</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The RSUs will become vested with respect to one-third (1&#47;3) of the RSUs (rounded to the nearest whole RSU) on each of the first and second anniversaries of the Date of Grant, and with respect to the remaining RSUs on the third anniversary of the Date of Grant, provided the Participant has been continuously providing services as a non-employee director of the Company from the Date of Grant until such time(s). </font></div><div style="margin-bottom:12pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:17.94pt">Change in Control</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding the foregoing, upon the occurrence of a Change in Control prior to the end of the applicable vesting period, any outstanding RSUs shall be treated in accordance with and governed by Section 14.05 of the Plan, provided that references to termination of employment shall mean termination of service as a non-employee director.  </font></div><div style="margin-bottom:12pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:19.17pt">Death and Disability</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding the foregoing,, if the Participant's service as a non-employee director of the Company is terminated on account of the Participant's death or Disability prior to the end of the applicable vesting period, the RSUs shall become fully vested upon termination of the Participant's service as a non-employee director of the Company on account of the Participant's death or Disability.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:26.9pt">Settlement of RSUs.  Except as otherwise required by applicable law or as set forth below or in the Plan, the Company shall cause one Share to be issued to Participant for each RSU that vests upon a Vesting Date, with such Shares to be delivered to Participant upon the Vesting Date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:26.9pt">Forfeiture of the RSUs.  RSUs that are not vested pursuant to Sections 2(a), (b) or (c) as of the date of termination of Participant&#8217;s service as a non-employee director of the Company will be forfeited automatically at the close of business on that date (or immediately upon notice of termination for Cause).  In no event may the RSUs become vested, in whole or in part, after forfeiture pursuant to this Section 4.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:26.9pt">Agreement to Terms of the Plan and this Agreement.  The Participant has received a copy of the Plan, has read and understands the terms of the Plan and this Agreement, and agrees to be bound by their terms and conditions.  All decisions and interpretations made by the Company or the Committee with regard to any question arising under this Agreement will be binding and conclusive on the Company and Participant and any other person who has any rights under this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:26.9pt">Tax Consequences.  The Participant acknowledges (i) that there may be adverse tax consequences upon acquisition or disposition of the Shares or, if applicable, cash payment that may be received upon vesting of the RSUs and (ii) that Participant should consult a tax adviser prior to such acquisition or disposition.  The Participant is solely responsible for determining the tax consequences of the Restricted Stock Unit Award and for satisfying the Participant&#8217;s tax obligations with respect to the Restricted Stock Unit Award (including, but not limited to, any income or excise tax as resulting from the application of Code Sections 409A or 4999 or related interest and penalties), and the Company and its Affiliates shall not be liable if this grant is subject to Code Sections 409A, 280G or 4999.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:26.9pt">Fractional Shares.  Fractional Shares shall not be issuable hereunder, and when any provision hereof may entitle the Participant to a fractional Share such fractional Share shall be disregarded.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:26.9pt">Change in Capital Structure.  The RSUs shall be adjusted in accordance with the terms and conditions of the Plan as the Committee determines is equitably required in the event the Company effects one or more stock dividends, stock splits, subdivisions or consolidations of shares or other similar changes in capitalization.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:26.9pt">Notice.  Any notice or other communication given pursuant to this Agreement, or in any way with respect to the RSUs, shall be in writing and shall be personally delivered or mailed by United States registered or certified mail, postage prepaid, return receipt requested, to the following addresses&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If to the Company&#58;&#160;&#160;&#160;&#160;MiMedx Group, Inc.</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;1775 West Oak Commons Ct. NE</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Marietta, Georgia 30062</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Attn&#58; General Counsel</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If to the Participant&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:20.82pt">Shareholder Rights.  Except as provided below, Participant shall have no rights as a shareholder of the Company with respect to Shares underlying the RSUs unless and until Shares are delivered to Participant in respect of such RSUs upon vesting.  The RSUs will be entitled to accrue Dividend Equivalents, which will be subject to all conditions and restrictions applicable to the underlying RSUs to which they relate, and which may not be paid until and unless the underlying RSUs have vested.  Dividend Equivalents will accrue prior to the issuance of Shares with respect to the RSUs or their earlier forfeiture.  Dividend Equivalents will be earned only for RSUs that are earned or deemed earned under this Agreement.  With respect to RSUs that are not earned (because the applicable vesting restrictions do not lapse or otherwise), Dividend Equivalents that were accrued for those RSUs will be cancelled and forfeited along with the RSUs and underlying Shares, without payment therefor by the Company or any Affiliate.  Dividend Equivalents will be paid at such time as the underlying RSUs to which they relate are paid.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:20.82pt">No Right to Continued Service.  Neither the Plan, the granting of the RSUs nor any other action taken pursuant to the Plan or this Agreement constitutes or is evidence of any agreement or understanding, expressed or implied, that the Company or any Affiliate shall retain the Participant as a service provider for any period of time or at any particular rate of compensation.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:20.82pt">Binding Effect.  Subject to the limitations stated above and in the Plan, this Agreement shall be binding upon and inure to the benefit of the legatees, distributees, and personal representatives of the Participant and the successors of the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:20.82pt">Conflicts.  In the event of any conflict between the provisions of the Plan and the provisions of this Agreement, the provisions of the Plan shall govern.  All references herein to the Plan shall mean the Plan as in effect on the date hereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:20.82pt">Counterparts.  This Agreement may be executed in a number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one in the same instrument.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:20.82pt">Miscellaneous.  The parties agree to execute such further instruments and take such further actions as may be necessary to carry out the intent of the Plan and this Agreement.  This Agreement and the Plan shall constitute the entire agreement of the parties with respect to the subject matter hereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:20.82pt">Section 409A.  Notwithstanding any of the provisions of this Agreement, it is intended that the RSUs granted pursuant to this Agreement be exempt from Section 409A of the Code as short term deferrals, pursuant to Treasury regulation &#167;1.409A-1(b)(4), or otherwise comply with Section 409A of the Code.  Notwithstanding the preceding, neither the Company nor any Affiliate shall be liable to the Participant or any other person if the Internal Revenue Service or any court or other authority have any jurisdiction over such matter determines for any reason that the RSUs are subject to taxes, penalties or interest as a result of failing to be exempt from, or comply with, Section 409A of the Code.  For the avoidance of doubt, the provisions of this Agreement shall be construed and interpreted consistent with Article XXII of the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:20.82pt">Compensation Recoupment Policy.  Notwithstanding any other provision of this Agreement, the rights, payments and benefits with respect to the RSUs (including any amounts received by Participant in connection with a sale of Shares received upon the vesting of RSUs) shall be subject to reduction, reimbursement, cancellation, forfeiture, recoupment or return by the Company, to the extent any reduction, reimbursement, cancellation, forfeiture, recoupment or return is required under applicable law or the Company&#8217;s Compensation Recoupment Policy or any similar policy that the Company may adopt.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">18.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:20.82pt">Governing Law.  This Agreement shall be governed by the governing laws applicable to the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;Signature Page to Follow&#93;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:10.5pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Company has caused this Agreement to be signed by a duly authorized officer, and the Participant has affixed the Participant&#8217;s signature hereto.</font></div><div style="margin-bottom:6pt;text-indent:10.5pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">COMPANY&#58;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MIMEDX GROUP, INC.</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Name&#58;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                           Title&#58; </font></div><div style="margin-bottom:24pt;padding-left:216pt"><font><br></font></div><div style="margin-bottom:24pt;padding-left:216pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">PARTICIPANT&#58;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:24pt;padding-left:216pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;Participant&#8217;s Name&#93;</font></div><div style="margin-bottom:24pt;padding-left:216pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ex103formofdirectorrsaawar.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i9ff655cadb264562857f55410fd49fa1_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Proposed Form of Initial Pro-rata Director RSU &#8211; one year vest</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MIMEDX GROUP, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2016 EQUITY AND CASH INCENTIVE PLAN</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Non-Employee Director Restricted Stock Unit Agreement&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THIS RESTRICTED STOCK UNIT AGREEMENT (this &#34;Agreement&#34;) dated as of the ___ day of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, 20___ (the &#8220;Grant Date&#8221;), between MiMedx Group, Inc. (the &#34;Company&#34;) and _________________ (the &#34;Participant&#34;), is made pursuant and subject to the provisions of the Company's 2016 Equity and Cash Incentive Plan, amended and restated through October 2, 2020 (the &#34;Plan&#34;), a copy of which is attached hereto. All terms used herein that are defined in the Plan shall have the same meaning given them in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Grant of Restricted Stock Units. Pursuant to the Plan, the Company, on the Grant Date granted to the Participant, subject to the terms and conditions of the Plan and subject further to the terms and conditions set forth herein, this Restricted Stock Unit Award for __________ stock units (&#8220;RSU&#8221;s). Each RSU represents the right to receive one share of Common Stock (a &#34;Share&#34;) of the Company. The RSUs will vest as set forth in Section 2 below and, upon vesting, will be settled in Shares as set forth in Section 3 below.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Vesting of the RSUs.  Subject to earlier expiration or termination as provided herein, the RSUs will become vested (such date upon which the RSUs vest in full, the &#8220;Vesting Date&#8221;) as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.08pt">Time-Based Vesting</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The RSUs will become vested in full upon the first anniversary of the Date of Grant, provided the Participant has been continuously providing services as a non-employee director of the Company from the Date of Grant until such time.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.57pt">Change in Control</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding the foregoing, upon the occurrence of a Change in Control prior to the end of the applicable vesting period, any outstanding RSUs shall be treated in accordance with and governed by Section 14.05 of the Plan, provided that references to termination of employment shall mean termination of service as a non-employee director.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.69pt">Death and Disability</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding the foregoing, if the Participant's service as a non-employee director of the Company is terminated on account of the Participant's death or Disability prior to the end of the applicable vesting period, the RSUs shall become fully vested upon termination of the Participant's service as a non-employee director of the Company on account of the Participant's death or Disability.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Settlement of RSUs.  Except as otherwise required by applicable law or as set forth below or in the Plan, the Company shall cause one Share to be issued to Participant for each RSU that vests upon the Vesting Date, with such Shares to be delivered to Participant upon the Vesting Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Forfeiture of the RSUs.  RSUs that are not vested pursuant to Sections 2(a), (b) or (c) as of the date of termination of Participant&#8217;s service as a non-employee director of the Company will be forfeited automatically at the close of business on that date (or immediately upon notice of termination for Cause).  In no event may the RSUs become vested, in whole or in part, after forfeiture pursuant to this Section 4.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Agreement to Terms of the Plan and this Agreement.  The Participant has received a copy of the Plan, has read and understands the terms of the Plan and this Agreement, and agrees to be bound by their terms and conditions.  All decisions and interpretations made by the Company or the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Committee with regard to any question arising under this Agreement will be binding and conclusive on the Company and Participant and any other person who has any rights under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Tax Consequences.  The Participant acknowledges (i) that there may be adverse tax consequences upon acquisition or disposition of the Shares or, if applicable, cash payment that may be received upon vesting of the RSUs and (ii) that Participant should consult a tax adviser prior to such acquisition or disposition.  The Participant is solely responsible for determining the tax consequences of the Restricted Stock Unit Award and for satisfying the Participant&#8217;s tax obligations with respect to the Restricted Stock Unit Award (including, but not limited to, any income or excise tax as resulting from the application of Code Sections 409A or 4999 or related interest and penalties), and the Company and its Affiliates shall not be liable if this grant is subject to Code Sections 409A, 280G or 4999.    </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Fractional Shares.  Fractional Shares shall not be issuable hereunder, and when any provision hereof may entitle the Participant to a fractional Share such fractional Share shall be disregarded.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Change in Capital Structure.  The RSUs shall be adjusted in accordance with the terms and conditions of the Plan as the Committee determines is equitably required in the event the Company effects one or more stock dividends, stock splits, subdivisions or consolidations of shares or other similar changes in capitalization.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Notice.  Any notice or other communication given pursuant to this Agreement, or in any way with respect to the RSUs, shall be in writing and shall be personally delivered or mailed by United States registered or certified mail, postage prepaid, return receipt requested, to the following addresses&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If to the Company&#58;&#160;&#160;&#160;&#160;MiMedx Group, Inc.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;1775 West Oak Commons Ct. NE</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Marietta, Georgia 30062</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Attn&#58; General Counsel</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If to the Participant&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">Shareholder Rights.  Except as provided below, Participant shall have no rights as a shareholder of the Company with respect to Shares underlying the RSUs unless and until Shares are delivered to Participant in respect of such RSUs upon vesting.  The RSUs will be entitled to accrue Dividend Equivalents, which will be subject to all conditions and restrictions applicable to the underlying RSUs to which they relate, and which may not be paid until and unless the underlying RSUs have vested.  Dividend Equivalents will accrue prior to the issuance of Shares with respect to the RSUs or their earlier forfeiture.  Dividend Equivalents will be earned only for RSUs that are earned or deemed earned under this Agreement.  With respect to RSUs that are not earned (because the applicable vesting restrictions do not lapse or otherwise), Dividend Equivalents that were accrued for those RSUs will be cancelled and forfeited along with the RSUs and underlying Shares, without payment therefor by the Company or any Affiliate.  Dividend Equivalents will be paid at such time as the underlying RSUs to which they relate are paid.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">No Right to Continued Service.  Neither the Plan, the granting of the RSUs nor any other action taken pursuant to the Plan or this Agreement constitutes or is evidence of any agreement or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">understanding, expressed or implied, that the Company or any Affiliate shall retain the Participant as a service provider for any period of time or at any particular rate of compensation.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">Binding Effect.  Subject to the limitations stated above and in the Plan, this Agreement shall be binding upon and inure to the benefit of the legatees, distributees, and personal representatives of the Participant and the successors of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">Conflicts.  In the event of any conflict between the provisions of the Plan and the provisions of this Agreement, the provisions of the Plan shall govern.  All references herein to the Plan shall mean the Plan as in effect on the date hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">Counterparts.  This Agreement may be executed in a number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one in the same instrument.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">Miscellaneous.  The parties agree to execute such further instruments and take such further actions as may be necessary to carry out the intent of the Plan and this Agreement.  This Agreement and the Plan shall constitute the entire agreement of the parties with respect to the subject matter hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">Section 409A.  Notwithstanding any of the provisions of this Agreement, it is intended that the RSUs granted pursuant to this Agreement be exempt from Section 409A of the Code as shortterm deferrals, pursuant to Treasury regulation &#167;1.409A-1(b)(4), or otherwise comply with Section 409A of the Code.  Notwithstanding the preceding, neither the Company nor any Affiliate shall be liable to the Participant or any other person if the Internal Revenue Service or any court or other authority have any jurisdiction over such matter determines for any reason that the RSUs are subject to taxes, penalties or interest as a result of failing to be exempt from, or comply with, Section 409A of the Code.  For the avoidance of doubt, the provisions of this Agreement shall be construed and interpreted consistent with Article XXII of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">Compensation Recoupment Policy.  Notwithstanding any other provision of this Agreement, the rights, payments and benefits with respect to the RSUs (including any amounts received by Participant in connection with a sale of Shares received upon the vesting of RSUs) shall be subject to reduction, reimbursement, cancellation, forfeiture, recoupment or return by the Company, to the extent any reduction, reimbursement, cancellation, forfeiture, recoupment or return is required under applicable law or the Company&#8217;s Compensation Recoupment Policy or any similar policy that the Company may adopt.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">18.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">Governing Law.  This Agreement shall be governed by the governing laws applicable to the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Signature Page to Follow&#93;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Company has caused this Agreement to be signed by a duly authorized officer, and the Participant has affixed the Participant&#8217;s signature hereto.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:10.5pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">COMPANY&#58;</font></div><div style="margin-bottom:24pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MIMEDX GROUP, INC.</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:36pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:24pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PARTICIPANT&#58;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:24pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Participant&#8217;s Name&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>ex104formofdirectorrsaawar.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib427df9cd73448d4a4b40c6370178ec6_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Proposed Form of Director RSU &#8211; one year vest</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MIMEDX GROUP, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2016 EQUITY AND CASH INCENTIVE PLAN</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Non-Employee Director Restricted Stock Unit Agreement&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THIS RESTRICTED STOCK UNIT AGREEMENT (this &#34;Agreement&#34;) dated as of the ___ day of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, 20___ (the &#8220;Grant Date&#8221;), between MiMedx Group, Inc. (the &#34;Company&#34;) and _________________ (the &#34;Participant&#34;), is made pursuant and subject to the provisions of the Company's 2016 Equity and Cash Incentive Plan, amended and restated through October 2, 2020 (the &#34;Plan&#34;), a copy of which is attached hereto. All terms used herein that are defined in the Plan shall have the same meaning given them in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Grant of Restricted Stock Units. Pursuant to the Plan, the Company, on the Grant Date granted to the Participant, subject to the terms and conditions of the Plan and subject further to the terms and conditions set forth herein, this Restricted Stock Unit Award for __________ stock units (&#8220;RSU&#8221;s). Each RSU represents the right to receive one share of Common Stock (a &#34;Share&#34;) of the Company. The RSUs will vest as set forth in Section 2 below and, upon vesting, will be settled in Shares as set forth in Section 3 below.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Vesting of the RSUs.  Subject to earlier expiration or termination as provided herein, the RSUs will become vested (such date upon which the RSUs vest in full, the &#8220;Vesting Date&#8221;) as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.08pt">Time-Based Vesting</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The RSUs will become vested in full upon the first anniversary of the Date of Grant or, if earlier, the first annual meeting of Company shareholders occurring after the Grant Date, provided the Participant has been continuously providing services as a non-employee director of the Company from the Date of Grant until such time.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.57pt">Change in Control</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding the foregoing, upon the occurrence of a Change in Control prior to the end of the applicable vesting period, any outstanding RSUs shall be treated in accordance with and governed by Section 14.05 of the Plan, provided that references to termination of employment shall mean termination of service as a non-employee director.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.69pt">Death and Disability</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding the foregoing, if the Participant's service as a non-employee director of the Company is terminated on account of the Participant's death or Disability prior to the end of the applicable vesting period, the RSUs shall become fully vested upon termination of the Participant's service as a non-employee director of the Company on account of the Participant's death or Disability.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Settlement of RSUs.  Except as otherwise required by applicable law or as set forth below or in the Plan, the Company shall cause one Share to be issued to Participant for each RSU that vests upon the Vesting Date, with such Shares to be delivered to Participant upon the Vesting Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Forfeiture of the RSUs.  RSUs that are not vested pursuant to Sections 2(a), (b) or (c) as of the date of termination of Participant&#8217;s service as a non-employee director of the Company will be forfeited automatically at the close of business on that date (or immediately upon notice of termination for Cause).  In no event may the RSUs become vested, in whole or in part, after forfeiture pursuant to this Section 4.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Agreement to Terms of the Plan and this Agreement.  The Participant has received a copy of the Plan, has read and understands the terms of the Plan and this Agreement, and agrees to be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">bound by their terms and conditions.  All decisions and interpretations made by the Company or the Committee with regard to any question arising under this Agreement will be binding and conclusive on the Company and Participant and any other person who has any rights under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Tax Consequences.  The Participant acknowledges (i) that there may be adverse tax consequences upon acquisition or disposition of the Shares or, if applicable, cash payment that may be received upon vesting of the RSUs and (ii) that Participant should consult a tax adviser prior to such acquisition or disposition.  The Participant is solely responsible for determining the tax consequences of the Restricted Stock Unit Award and for satisfying the Participant&#8217;s tax obligations with respect to the Restricted Stock Unit Award (including, but not limited to, any income or excise tax as resulting from the application of Code Sections 409A or 4999 or related interest and penalties), and the Company and its Affiliates shall not be liable if this grant is subject to Code Sections 409A, 280G or 4999.    </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Fractional Shares.  Fractional Shares shall not be issuable hereunder, and when any provision hereof may entitle the Participant to a fractional Share such fractional Share shall be disregarded.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Change in Capital Structure.  The RSUs shall be adjusted in accordance with the terms and conditions of the Plan as the Committee determines is equitably required in the event the Company effects one or more stock dividends, stock splits, subdivisions or consolidations of shares or other similar changes in capitalization.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:27.66pt">Notice.  Any notice or other communication given pursuant to this Agreement, or in any way with respect to the RSUs, shall be in writing and shall be personally delivered or mailed by United States registered or certified mail, postage prepaid, return receipt requested, to the following addresses&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If to the Company&#58;&#160;&#160;&#160;&#160;MiMedx Group, Inc.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;1775 West Oak Commons Ct. NE</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Marietta, Georgia 30062</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Attn&#58; General Counsel</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If to the Participant&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">Shareholder Rights.  Except as provided below, Participant shall have no rights as a shareholder of the Company with respect to Shares underlying the RSUs unless and until Shares are delivered to Participant in respect of such RSUs upon vesting.  The RSUs will be entitled to accrue Dividend Equivalents, which will be subject to all conditions and restrictions applicable to the underlying RSUs to which they relate, and which may not be paid until and unless the underlying RSUs have vested.  Dividend Equivalents will accrue prior to the issuance of Shares with respect to the RSUs or their earlier forfeiture.  Dividend Equivalents will be earned only for RSUs that are earned or deemed earned under this Agreement.  With respect to RSUs that are not earned (because the applicable vesting restrictions do not lapse or otherwise), Dividend Equivalents that were accrued for those RSUs will be cancelled and forfeited along with the RSUs and underlying Shares, without payment therefor by the Company or any Affiliate.  Dividend Equivalents will be paid at such time as the underlying RSUs to which they relate are paid.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">No Right to Continued Service.  Neither the Plan, the granting of the RSUs nor any other action taken pursuant to the Plan or this Agreement constitutes or is evidence of any agreement or understanding, expressed or implied, that the Company or any Affiliate shall retain the Participant as a service provider for any period of time or at any particular rate of compensation.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">Binding Effect.  Subject to the limitations stated above and in the Plan, this Agreement shall be binding upon and inure to the benefit of the legatees, distributees, and personal representatives of the Participant and the successors of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">Conflicts.  In the event of any conflict between the provisions of the Plan and the provisions of this Agreement, the provisions of the Plan shall govern.  All references herein to the Plan shall mean the Plan as in effect on the date hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">Counterparts.  This Agreement may be executed in a number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one in the same instrument.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">Miscellaneous.  The parties agree to execute such further instruments and take such further actions as may be necessary to carry out the intent of the Plan and this Agreement.  This Agreement and the Plan shall constitute the entire agreement of the parties with respect to the subject matter hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">Section 409A.  Notwithstanding any of the provisions of this Agreement, it is intended that the RSUs granted pursuant to this Agreement be exempt from Section 409A of the Code as shortterm deferrals, pursuant to Treasury regulation &#167;1.409A-1(b)(4), or otherwise comply with Section 409A of the Code.  Notwithstanding the preceding, neither the Company nor any Affiliate shall be liable to the Participant or any other person if the Internal Revenue Service or any court or other authority have any jurisdiction over such matter determines for any reason that the RSUs are subject to taxes, penalties or interest as a result of failing to be exempt from, or comply with, Section 409A of the Code.  For the avoidance of doubt, the provisions of this Agreement shall be construed and interpreted consistent with Article XXII of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">Compensation Recoupment Policy.  Notwithstanding any other provision of this Agreement, the rights, payments and benefits with respect to the RSUs (including any amounts received by Participant in connection with a sale of Shares received upon the vesting of RSUs) shall be subject to reduction, reimbursement, cancellation, forfeiture, recoupment or return by the Company, to the extent any reduction, reimbursement, cancellation, forfeiture, recoupment or return is required under applicable law or the Company&#8217;s Compensation Recoupment Policy or any similar policy that the Company may adopt.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">18.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.09pt">Governing Law.  This Agreement shall be governed by the governing laws applicable to the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Signature Page to Follow&#93;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Company has caused this Agreement to be signed by a duly authorized officer, and the Participant has affixed the Participant&#8217;s signature hereto.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:10.5pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">COMPANY&#58;</font></div><div style="margin-bottom:24pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MIMEDX GROUP, INC.</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:36pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:24pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PARTICIPANT&#58;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:24pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Participant&#8217;s Name&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>exhibit311-20210630.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i806bce0b45034793964dad5a993de3ea_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO RULES 13a-14(A) AND 15d-14(A)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Timothy R. Wright, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2021, of MiMedx Group, Inc.&#59;&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.643%"><tr><td style="width:1.0%"></td><td style="width:6.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.675%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Timothy R. Wright</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Timothy R. Wright</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>exhibit312-20210630.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie9b750821df349c4ad85460f6fbb546a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO RULES 13a-14(A) AND 15d-14(A)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Peter M. Carlson, certify that&#58;</font></div><div><font><br></font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2021, of MiMedx Group, Inc.&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:6.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.804%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.822%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Peter M. Carlson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter M. Carlson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>exhibit321-20210630.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i020a4e3ba6f24c1a97057498c2890f1e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The undersigned Timothy R. Wright, the Chief Executive Officer of MiMedx Group, Inc. (the &#8220;Company&#8221;), has executed this certification in connection with the filing with the Securities and Exchange Commission of the Company&#8217;s Quarterly Report on Form 10-Q for the period ending June&#160;30, 2021 (the &#8220;Report&#8221;). Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned hereby certifies, to his knowledge, that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.822%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Timothy R. Wright</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Timothy R. Wright</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>exhibit322-20210630.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i9fb802da0553428d9d837c29bb4a388d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The undersigned Peter M. Carlson, the Chief Financial Officer of MiMedx Group, Inc. (the &#8220;Company&#8221;), has executed this certification in connection with the filing with the Securities and Exchange Commission of the Company&#8217;s Quarterly Report on Form 10-Q for the period ending June&#160;30, 2021 (the &#8220;Report&#8221;). Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned hereby certifies, to his knowledge, that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.821%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 3, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Peter M. Carlson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter M. Carlson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>mdxg-20210630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:2348d07d-1fe7-4f85-b08a-d7c74be22bf0,g:fbe44d2f-ecde-4c93-87d4-07ca0cdbb039-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mdxg="http://mimedx.com/20210630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://mimedx.com/20210630">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdxg-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdxg-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdxg-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdxg-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://mimedx.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT" roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofBusiness" roleURI="http://mimedx.com/role/NatureofBusiness">
        <link:definition>2101101 - Disclosure - Nature of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofBusinessDetails" roleURI="http://mimedx.com/role/NatureofBusinessDetails">
        <link:definition>2402401 - Disclosure - Nature of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://mimedx.com/role/SignificantAccountingPolicies">
        <link:definition>2103102 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://mimedx.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>2204201 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesSignificantAccountingPoliciesTables" roleURI="http://mimedx.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables">
        <link:definition>2305301 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2406402 - Disclosure - Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details" roleURI="http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details">
        <link:definition>2407403 - Disclosure - Significant Accounting Policies - Assessment of Revenue under ASC 606 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventory" roleURI="http://mimedx.com/role/Inventory">
        <link:definition>2108103 - Disclosure - Inventory</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryTables" roleURI="http://mimedx.com/role/InventoryTables">
        <link:definition>2309302 - Disclosure - Inventory (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryDetails" roleURI="http://mimedx.com/role/InventoryDetails">
        <link:definition>2410404 - Disclosure - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipment" roleURI="http://mimedx.com/role/PropertyandEquipment">
        <link:definition>2111104 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://mimedx.com/role/PropertyandEquipmentTables">
        <link:definition>2312303 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentSummaryofPropertyandEquipmentDetails" roleURI="http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails">
        <link:definition>2413405 - Disclosure - Property and Equipment - Summary of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentDepreciationExpenseDetails" roleURI="http://mimedx.com/role/PropertyandEquipmentDepreciationExpenseDetails">
        <link:definition>2414406 - Disclosure - Property and Equipment - Depreciation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://mimedx.com/role/IntangibleAssets">
        <link:definition>2115105 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsTables" roleURI="http://mimedx.com/role/IntangibleAssetsTables">
        <link:definition>2316304 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsActivitySummaryDetails" roleURI="http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails">
        <link:definition>2417407 - Disclosure - Intangible Assets - Activity Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAmortizationExpenseDetails" roleURI="http://mimedx.com/role/IntangibleAssetsAmortizationExpenseDetails">
        <link:definition>2418408 - Disclosure - Intangible Assets - Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails" roleURI="http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails">
        <link:definition>2419409 - Disclosure - Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpenses" roleURI="http://mimedx.com/role/AccruedExpenses">
        <link:definition>2120106 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesTables" roleURI="http://mimedx.com/role/AccruedExpensesTables">
        <link:definition>2321305 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesDetails" roleURI="http://mimedx.com/role/AccruedExpensesDetails">
        <link:definition>2422410 - Disclosure - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://mimedx.com/role/LongTermDebt">
        <link:definition>2123107 - Disclosure - Long Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://mimedx.com/role/LongTermDebtTables">
        <link:definition>2324306 - Disclosure - Long Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTermLoanDetails" roleURI="http://mimedx.com/role/LongTermDebtTermLoanDetails">
        <link:definition>2425411 - Disclosure - Long Term Debt - Term Loan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTermLoanDebtIssuanceCostsDetails" roleURI="http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails">
        <link:definition>2426412 - Disclosure - Long Term Debt - Term Loan Debt Issuance Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTermLoanBalancesDetails" roleURI="http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails">
        <link:definition>2427413 - Disclosure - Long Term Debt - Term Loan Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTermLoanInterestExpenseDetails" roleURI="http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails">
        <link:definition>2428414 - Disclosure - Long Term Debt - Term Loan Interest Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTermLoanMaturityDetails" roleURI="http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails">
        <link:definition>2429415 - Disclosure - Long Term Debt - Term Loan Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtPaycheckProtectionProgramLoanDetails" roleURI="http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails">
        <link:definition>2430416 - Disclosure - Long Term Debt - Paycheck Protection Program Loan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerCommonShare" roleURI="http://mimedx.com/role/NetLossPerCommonShare">
        <link:definition>2131108 - Disclosure - Net Loss Per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerCommonShareTables" roleURI="http://mimedx.com/role/NetLossPerCommonShareTables">
        <link:definition>2332307 - Disclosure - Net Loss Per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerCommonShareBasicNetLossPerCommonShareDetails" roleURI="http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails">
        <link:definition>2433417 - Disclosure - Net Loss Per Common Share - Basic Net Loss Per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerCommonShareDilutedNetLossPerCommonShareDetails" roleURI="http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails">
        <link:definition>2434418 - Disclosure - Net Loss Per Common Share - Diluted Net Loss Per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Equity" roleURI="http://mimedx.com/role/Equity">
        <link:definition>2135109 - Disclosure - Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityEquityTables" roleURI="http://mimedx.com/role/EquityEquityTables">
        <link:definition>2336308 - Disclosure - Equity Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityNarrativeDetails" roleURI="http://mimedx.com/role/EquityNarrativeDetails">
        <link:definition>2437419 - Disclosure - Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityChangesinSeriesBPreferredStockDetails" roleURI="http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails">
        <link:definition>2438420 - Disclosure - Equity - Changes in Series B Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityRestrictedStockAwardsDetails" roleURI="http://mimedx.com/role/EquityRestrictedStockAwardsDetails">
        <link:definition>2439421 - Disclosure - Equity - Restricted Stock Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityStockIncentivePlansDetails" roleURI="http://mimedx.com/role/EquityStockIncentivePlansDetails">
        <link:definition>2440422 - Disclosure - Equity - Stock Incentive Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Incometaxes" roleURI="http://mimedx.com/role/Incometaxes">
        <link:definition>2141110 - Disclosure - Income taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesDetails" roleURI="http://mimedx.com/role/IncometaxesDetails">
        <link:definition>2442423 - Disclosure - Income taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities" roleURI="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities">
        <link:definition>2143111 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables" roleURI="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables">
        <link:definition>2344309 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails" roleURI="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails">
        <link:definition>2445424 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualCommitmentsandContingencies" roleURI="http://mimedx.com/role/ContractualCommitmentsandContingencies">
        <link:definition>2146112 - Disclosure - Contractual Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContractualCommitmentsandContingenciesNarrativeDetails" roleURI="http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails">
        <link:definition>2447425 - Disclosure - Contractual Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://mimedx.com/role/Revenue">
        <link:definition>2148113 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://mimedx.com/role/RevenueTables">
        <link:definition>2349310 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueSummaryofRevenuebyProductTypeDetails" roleURI="http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails">
        <link:definition>2450426 - Disclosure - Revenue - Summary of Revenue by Product Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueSummaryofRevenuebyCustomerTypeDetails" roleURI="http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails">
        <link:definition>2451427 - Disclosure - Revenue - Summary of Revenue by Customer Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://mimedx.com/role/SubsequentEvents">
        <link:definition>2152114 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" abstract="false" name="DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mdxg_TemporaryEquityIncreasingrateDividendFeature" abstract="false" name="TemporaryEquityIncreasingrateDividendFeature" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_TemporaryEquityConversionPricePerShare" abstract="false" name="TemporaryEquityConversionPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember" abstract="true" name="HayfinLoanAgreementDelayedDrawTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_FinanceLeaseAssetsMember" abstract="true" name="FinanceLeaseAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_InvestigationRestatementandRelated" abstract="false" name="InvestigationRestatementandRelated" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_OperatingLeaseRightofuseAssetAmortization" abstract="false" name="OperatingLeaseRightofuseAssetAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise" abstract="false" name="FairValueOfNonCashConsiderationReceivedForOptionExercise" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_AmendedTermLoanAgreementMember" abstract="true" name="AmendedTermLoanAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage" abstract="false" name="DebtInstrumentUnusedCapacityCommitmentFeePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mdxg_LegalProceedingsMember" abstract="true" name="LegalProceedingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_TreasuryStockSharesAdjustment" abstract="false" name="TreasuryStockSharesAdjustment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mdxg_DebtInstrumentCommitmentFees" abstract="false" name="DebtInstrumentCommitmentFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_ScheduleOfDepreciationTableTextBlock" abstract="false" name="ScheduleOfDepreciationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mdxg_ScheduleofDebtIssuanceCostsTableTextBlock" abstract="false" name="ScheduleofDebtIssuanceCostsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mdxg_TemporaryEquityConversionThresholdTradingDays" abstract="false" name="TemporaryEquityConversionThresholdTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent" abstract="false" name="DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mdxg_LeaseRightOfUseAssetAndLiability" abstract="false" name="LeaseRightOfUseAssetAndLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" abstract="false" name="TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mdxg_ScheduleofInterestExpenseTableTextBlock" abstract="false" name="ScheduleofInterestExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mdxg_Section351Member" abstract="true" name="Section351Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_ProceedsfromIssuanceofTemporaryEquity" abstract="false" name="ProceedsfromIssuanceofTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_AssetRetirementCostMember" abstract="true" name="AssetRetirementCostMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_AccruedSettlementCostsCurrent" abstract="false" name="AccruedSettlementCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_CARESActMember" abstract="true" name="CARESActMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_FinancingTransactionsMember" abstract="true" name="FinancingTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_TotalNetLeverageRatio" abstract="false" name="TotalNetLeverageRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mdxg_AdvancedWoundCareUmbilicalCordDerivedMember" abstract="true" name="AdvancedWoundCareUmbilicalCordDerivedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_PaycheckProtectionProgramLoanMember" abstract="true" name="PaycheckProtectionProgramLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_NotesReceivableForSaleOfPropertyAndEquipment" abstract="false" name="NotesReceivableForSaleOfPropertyAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_PaymentsforApplicationCostsPatent" abstract="false" name="PaymentsforApplicationCostsPatent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_StockAwardMisstatementsMember" abstract="true" name="StockAwardMisstatementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_CustomerAndSupplierRelationshipsMember" abstract="true" name="CustomerAndSupplierRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_AccruedClinicalTrialsCurrent" abstract="false" name="AccruedClinicalTrialsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_ContingencyLossNumberOfSecuritiesClassActions" abstract="false" name="ContingencyLossNumberOfSecuritiesClassActions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member" abstract="true" name="PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_TemporaryEquityAccretedbutUnrecordedDividends" abstract="false" name="TemporaryEquityAccretedbutUnrecordedDividends" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems" abstract="false" name="EffectiveIncomeTaxRateReconciliationDiscreteItems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_TemporaryEquityConversionRatio" abstract="false" name="TemporaryEquityConversionRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mdxg_ContingencyLossNumberOfFormerHealthcareProviders" abstract="false" name="ContingencyLossNumberOfFormerHealthcareProviders" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdxg_DebtInstrumentDefaultInterestRate" abstract="false" name="DebtInstrumentDefaultInterestRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mdxg_NumberOfProducts" abstract="false" name="NumberOfProducts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" abstract="false" name="AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_TemporaryEquityDividendRatePercentage" abstract="false" name="TemporaryEquityDividendRatePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract" abstract="true" name="ComputationOfBasicAndDilutedNetLossPerShareAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mdxg_NoncashActivitiesDeferredFinancingCosts" abstract="false" name="NoncashActivitiesDeferredFinancingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_CreditFacilitiesMember" abstract="true" name="CreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_AdvancedWoundCareTissueAndOtherMember" abstract="true" name="AdvancedWoundCareTissueAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_AccruedRebates" abstract="false" name="AccruedRebates" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_TemporaryEquitySharesIssueduponConversion" abstract="false" name="TemporaryEquitySharesIssueduponConversion" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders" abstract="false" name="NumberofBoardSeatsElectedbyTemporaryEquityHolders" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember" abstract="true" name="HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_RevenueFromContractWithCustomerPaymentTerms" abstract="false" name="RevenueFromContractWithCustomerPaymentTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mdxg_DebtInstrumentInterestRateFloorPercentage" abstract="false" name="DebtInstrumentInterestRateFloorPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mdxg_TermLoanAgreementMember" abstract="true" name="TermLoanAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels" abstract="false" name="RevenueFromContractWithCustomerNumberOfDistributionChannels" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" abstract="false" name="TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature" abstract="false" name="TemporaryEquityAccretionofIncreasingrateDividendFeature" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_NoncashActivitiesDebtInstrumentAmendmentFee" abstract="false" name="NoncashActivitiesDebtInstrumentAmendmentFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" abstract="false" name="EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset" abstract="false" name="OperatingLeaseAndFinancingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_DebtCovenantMinimumLiquidity" abstract="false" name="DebtCovenantMinimumLiquidity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" abstract="false" name="TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mdxg_HayfinLoanAgreementTermLoanMember" abstract="true" name="HayfinLoanAgreementTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_PatentsinProcessMember" abstract="true" name="PatentsinProcessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember" abstract="true" name="HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member" abstract="true" name="DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_LongTermDebtMaturityAfterYearFour" abstract="false" name="LongTermDebtMaturityAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mdxg_TemporaryEquityThresholdConsecutiveTradingDays" abstract="false" name="TemporaryEquityThresholdConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>mdxg-20210630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:2348d07d-1fe7-4f85-b08a-d7c74be22bf0,g:fbe44d2f-ecde-4c93-87d4-07ca0cdbb039-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mdxg-20210630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_568c9a9d-9c0a-4c55-b315-d5271db806ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_bf1bc14d-c9be-4e12-8c27-4d11e7af314f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_568c9a9d-9c0a-4c55-b315-d5271db806ec" xlink:to="loc_us-gaap_PreferredStockValue_bf1bc14d-c9be-4e12-8c27-4d11e7af314f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8d1aea32-0c04-408e-aa36-341b075d91ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_568c9a9d-9c0a-4c55-b315-d5271db806ec" xlink:to="loc_us-gaap_CommonStockValue_8d1aea32-0c04-408e-aa36-341b075d91ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_ceb4576e-fff5-47e8-be52-d58734a0de8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_568c9a9d-9c0a-4c55-b315-d5271db806ec" xlink:to="loc_us-gaap_AdditionalPaidInCapital_ceb4576e-fff5-47e8-be52-d58734a0de8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_728fe0a5-38ba-4ef1-9a03-1a227c996034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_568c9a9d-9c0a-4c55-b315-d5271db806ec" xlink:to="loc_us-gaap_TreasuryStockValue_728fe0a5-38ba-4ef1-9a03-1a227c996034" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cefecdd1-9f76-47c7-8b97-b784d4f1e9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_568c9a9d-9c0a-4c55-b315-d5271db806ec" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cefecdd1-9f76-47c7-8b97-b784d4f1e9d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_937fa811-ab96-439b-942e-bc56c82d5c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ee2a3a44-ed45-4af8-9cc2-d6002b059e42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_937fa811-ab96-439b-942e-bc56c82d5c3a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ee2a3a44-ed45-4af8-9cc2-d6002b059e42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_bf109fdf-ea01-4337-89a1-9063f1c3080f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_937fa811-ab96-439b-942e-bc56c82d5c3a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_bf109fdf-ea01-4337-89a1-9063f1c3080f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c0a851ee-8d5d-4420-88ca-27d55fae12c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_937fa811-ab96-439b-942e-bc56c82d5c3a" xlink:to="loc_us-gaap_LiabilitiesCurrent_c0a851ee-8d5d-4420-88ca-27d55fae12c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c2018ed6-2d39-4b93-8dbe-d34fcd2f4082" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e8d75f9d-ec59-4bc2-9649-bcb092ebdaac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2018ed6-2d39-4b93-8dbe-d34fcd2f4082" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e8d75f9d-ec59-4bc2-9649-bcb092ebdaac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f25d368d-a741-411d-ac4a-e0d206b60cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2018ed6-2d39-4b93-8dbe-d34fcd2f4082" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f25d368d-a741-411d-ac4a-e0d206b60cd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_9c8f9eb2-919e-4760-bd0b-f7f79b5ffc35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2018ed6-2d39-4b93-8dbe-d34fcd2f4082" xlink:to="loc_us-gaap_IncomeTaxesReceivable_9c8f9eb2-919e-4760-bd0b-f7f79b5ffc35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_fa80c5e5-474b-47d6-b4f2-828b30e70bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2018ed6-2d39-4b93-8dbe-d34fcd2f4082" xlink:to="loc_us-gaap_InventoryNet_fa80c5e5-474b-47d6-b4f2-828b30e70bdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_33b50d21-431b-4a90-a43b-d2a5e0115570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2018ed6-2d39-4b93-8dbe-d34fcd2f4082" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_33b50d21-431b-4a90-a43b-d2a5e0115570" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_c190f04d-040a-4165-a902-4c0a2a9247df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2018ed6-2d39-4b93-8dbe-d34fcd2f4082" xlink:to="loc_us-gaap_OtherAssetsCurrent_c190f04d-040a-4165-a902-4c0a2a9247df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f22680f4-6283-46a2-a119-1aa0f2c09a37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_0c48e727-3e10-4846-a0d3-504e0625006f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f22680f4-6283-46a2-a119-1aa0f2c09a37" xlink:to="loc_us-gaap_AccountsPayableCurrent_0c48e727-3e10-4846-a0d3-504e0625006f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6a8704da-b948-4972-b321-8c68c763539f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f22680f4-6283-46a2-a119-1aa0f2c09a37" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_6a8704da-b948-4972-b321-8c68c763539f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_257f03b2-b1e1-44f5-9ceb-6a0fdf05cd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f22680f4-6283-46a2-a119-1aa0f2c09a37" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_257f03b2-b1e1-44f5-9ceb-6a0fdf05cd0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_42cf040f-e53a-4699-b729-c3400253a620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f22680f4-6283-46a2-a119-1aa0f2c09a37" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_42cf040f-e53a-4699-b729-c3400253a620" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8afa7773-56d7-4ed2-b421-6c409431b622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1f30c4e8-7859-4f3d-af8b-fae1825d6f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8afa7773-56d7-4ed2-b421-6c409431b622" xlink:to="loc_us-gaap_AssetsCurrent_1f30c4e8-7859-4f3d-af8b-fae1825d6f5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7381617a-bdeb-4d03-8b71-dc74ac16ed0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8afa7773-56d7-4ed2-b421-6c409431b622" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7381617a-bdeb-4d03-8b71-dc74ac16ed0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0c2d1548-7f03-48c5-8250-925a950c51e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8afa7773-56d7-4ed2-b421-6c409431b622" xlink:to="loc_us-gaap_Goodwill_0c2d1548-7f03-48c5-8250-925a950c51e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0308a6db-439e-4d28-b758-8543abbbbc74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8afa7773-56d7-4ed2-b421-6c409431b622" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0308a6db-439e-4d28-b758-8543abbbbc74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_afc74774-b3dc-4434-a248-cca9eabd2872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8afa7773-56d7-4ed2-b421-6c409431b622" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_afc74774-b3dc-4434-a248-cca9eabd2872" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset_e8d2a795-7c97-4aaf-bc7b-84703b2b0d68" xlink:href="mdxg-20210630.xsd#mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8afa7773-56d7-4ed2-b421-6c409431b622" xlink:to="loc_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset_e8d2a795-7c97-4aaf-bc7b-84703b2b0d68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_761c43b4-4705-477b-8e20-dd06ae04df63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c572ffb7-5483-4c50-bb11-f54be32965c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_761c43b4-4705-477b-8e20-dd06ae04df63" xlink:to="loc_us-gaap_Liabilities_c572ffb7-5483-4c50-bb11-f54be32965c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_135a1bd4-986d-4284-aae7-d34b1a9a8a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_761c43b4-4705-477b-8e20-dd06ae04df63" xlink:to="loc_us-gaap_StockholdersEquity_135a1bd4-986d-4284-aae7-d34b1a9a8a83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_fa1873f2-9863-4219-994a-81f7e9b7603e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_761c43b4-4705-477b-8e20-dd06ae04df63" xlink:to="loc_us-gaap_CommitmentsAndContingencies_fa1873f2-9863-4219-994a-81f7e9b7603e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_4ac0ee31-99a9-4e57-a8bf-ed098d31746f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_761c43b4-4705-477b-8e20-dd06ae04df63" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_4ac0ee31-99a9-4e57-a8bf-ed098d31746f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mdxg-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_62fc733a-80e2-48a3-9946-52527d2a64d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b8ed114b-37e6-4f19-bdf9-ff84bf015ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_62fc733a-80e2-48a3-9946-52527d2a64d2" xlink:to="loc_us-gaap_OperatingIncomeLoss_b8ed114b-37e6-4f19-bdf9-ff84bf015ba9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_098ec8f5-171f-4db5-a186-812931b5b800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_62fc733a-80e2-48a3-9946-52527d2a64d2" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_098ec8f5-171f-4db5-a186-812931b5b800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e904c6ca-878b-49da-849a-628cf0917823" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_62fc733a-80e2-48a3-9946-52527d2a64d2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e904c6ca-878b-49da-849a-628cf0917823" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_784236df-6876-4041-a16a-e2f983138e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_InvestigationRestatementandRelated_4f48d0ee-97c9-4965-a85c-227489db8f81" xlink:href="mdxg-20210630.xsd#mdxg_InvestigationRestatementandRelated"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_784236df-6876-4041-a16a-e2f983138e47" xlink:to="loc_mdxg_InvestigationRestatementandRelated_4f48d0ee-97c9-4965-a85c-227489db8f81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_572cc882-e77f-4e69-93b3-e2fcc39f7d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_784236df-6876-4041-a16a-e2f983138e47" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_572cc882-e77f-4e69-93b3-e2fcc39f7d47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_a6f7dc91-eb54-4d89-bccd-32d4ee6878b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_784236df-6876-4041-a16a-e2f983138e47" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_a6f7dc91-eb54-4d89-bccd-32d4ee6878b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_12baffac-96ea-4850-9fa1-fbe3d4f62e25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_784236df-6876-4041-a16a-e2f983138e47" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_12baffac-96ea-4850-9fa1-fbe3d4f62e25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_09bb010d-1a4c-4ddd-a57f-473e43d90d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_784236df-6876-4041-a16a-e2f983138e47" xlink:to="loc_us-gaap_GrossProfit_09bb010d-1a4c-4ddd-a57f-473e43d90d8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9c08a9d4-f8ae-4589-82dd-55983150cd54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d15d37cc-cafc-45d4-9805-4fc283194675" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_9c08a9d4-f8ae-4589-82dd-55983150cd54" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d15d37cc-cafc-45d4-9805-4fc283194675" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_eb9b8db5-b031-4585-b571-50b2558611f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_9c08a9d4-f8ae-4589-82dd-55983150cd54" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_eb9b8db5-b031-4585-b571-50b2558611f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_9315a1cc-ce31-481f-b8d5-549b4875f05f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5640609c-a85b-4031-8469-4ea29d420d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_9315a1cc-ce31-481f-b8d5-549b4875f05f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5640609c-a85b-4031-8469-4ea29d420d73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_96c17095-66cf-4bd8-87d1-46a99191aa2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_9315a1cc-ce31-481f-b8d5-549b4875f05f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_96c17095-66cf-4bd8-87d1-46a99191aa2e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mdxg-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5a233e58-5e39-4932-95fa-e3ce71ae9b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_b1e63ad8-5496-418a-ab9f-0bea282dd77c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5a233e58-5e39-4932-95fa-e3ce71ae9b02" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_b1e63ad8-5496-418a-ab9f-0bea282dd77c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0bdfb9a7-6ee8-493f-92a8-52846d5e7aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5a233e58-5e39-4932-95fa-e3ce71ae9b02" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0bdfb9a7-6ee8-493f-92a8-52846d5e7aaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_19267ecd-3698-44f7-bcdc-9d18b163b342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5a233e58-5e39-4932-95fa-e3ce71ae9b02" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_19267ecd-3698-44f7-bcdc-9d18b163b342" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_c68ea843-a8cd-4beb-a902-380495431981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfMediumTermNotes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5a233e58-5e39-4932-95fa-e3ce71ae9b02" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_c68ea843-a8cd-4beb-a902-380495431981" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes_68478787-093e-47a9-b2cb-a3dd48afb2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfMediumTermNotes"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5a233e58-5e39-4932-95fa-e3ce71ae9b02" xlink:to="loc_us-gaap_RepaymentsOfMediumTermNotes_68478787-093e-47a9-b2cb-a3dd48afb2e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_fde6712f-a0ef-4fdf-a519-0e17a584ca3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5a233e58-5e39-4932-95fa-e3ce71ae9b02" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_fde6712f-a0ef-4fdf-a519-0e17a584ca3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_26d8200b-05d4-4047-988d-15823612302f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_26d8200b-05d4-4047-988d-15823612302f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_f2cb4e95-66a2-4492-802f-66aa7b93f80a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_f2cb4e95-66a2-4492-802f-66aa7b93f80a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_9d5a5958-7cd6-4b41-ac8b-4d370ddec366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_9d5a5958-7cd6-4b41-ac8b-4d370ddec366" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationAccretionExpense_53078880-8762-4426-9194-46649668568e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetRetirementObligationAccretionExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:to="loc_us-gaap_AssetRetirementObligationAccretionExpense_53078880-8762-4426-9194-46649668568e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_c66d95a2-ddc1-4313-8382-9d9b8c0266ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_c66d95a2-ddc1-4313-8382-9d9b8c0266ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_OperatingLeaseRightofuseAssetAmortization_32382382-2bf3-42cc-8034-417c3bf2879e" xlink:href="mdxg-20210630.xsd#mdxg_OperatingLeaseRightofuseAssetAmortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:to="loc_mdxg_OperatingLeaseRightofuseAssetAmortization_32382382-2bf3-42cc-8034-417c3bf2879e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_469bd155-a7c3-4d3e-9349-11e300e2264f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_469bd155-a7c3-4d3e-9349-11e300e2264f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2cf45018-45f2-44f7-a86d-931bfb63f0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:to="loc_us-gaap_ShareBasedCompensation_2cf45018-45f2-44f7-a86d-931bfb63f0a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_75908984-da10-465f-b3b3-5b75f5103a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_75908984-da10-465f-b3b3-5b75f5103a2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_4c806bd5-ec8b-4e20-a8f6-63ade4730231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_4c806bd5-ec8b-4e20-a8f6-63ade4730231" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_34ce284b-b910-4282-94a5-ce624b28c3ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:to="loc_us-gaap_NetIncomeLoss_34ce284b-b910-4282-94a5-ce624b28c3ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_8516720a-3657-4865-bca4-4595979b2d43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:to="loc_us-gaap_Depreciation_8516720a-3657-4865-bca4-4595979b2d43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c6404e25-7bf8-442e-acf2-a67df85a03ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c6404e25-7bf8-442e-acf2-a67df85a03ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_af07e8ef-2589-43c7-9a79-ae08892b0084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_af07e8ef-2589-43c7-9a79-ae08892b0084" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_ad04ee77-4912-49cb-ab8c-761ee3b57448" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_ad04ee77-4912-49cb-ab8c-761ee3b57448" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ed5464bd-b4c1-481f-b464-d8c00eec7b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ed5464bd-b4c1-481f-b464-d8c00eec7b1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_385d5310-e689-450f-b858-383d7a446e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b29e34fd-098d-4182-bb47-1b7abf3832e3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_385d5310-e689-450f-b858-383d7a446e7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dffd309b-0f56-4281-855a-202229c9d494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ce549f-28b1-40d5-a91f-0074aea211c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dffd309b-0f56-4281-855a-202229c9d494" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_24ce549f-28b1-40d5-a91f-0074aea211c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4fb9a44c-a100-467e-a2e6-947fdddee096" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dffd309b-0f56-4281-855a-202229c9d494" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4fb9a44c-a100-467e-a2e6-947fdddee096" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d0ac454c-fd67-4ef4-951c-72a777a3fcf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dffd309b-0f56-4281-855a-202229c9d494" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d0ac454c-fd67-4ef4-951c-72a777a3fcf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f106a0a9-ca65-470b-93e6-cb901e11a48e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_b15857e4-26b5-42c6-8784-1e8433f81b55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f106a0a9-ca65-470b-93e6-cb901e11a48e" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_b15857e4-26b5-42c6-8784-1e8433f81b55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PaymentsforApplicationCostsPatent_6690788e-4704-42c2-9076-16fc5571d3fd" xlink:href="mdxg-20210630.xsd#mdxg_PaymentsforApplicationCostsPatent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f106a0a9-ca65-470b-93e6-cb901e11a48e" xlink:to="loc_mdxg_PaymentsforApplicationCostsPatent_6690788e-4704-42c2-9076-16fc5571d3fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment_37d26127-7da5-4bcd-9171-ddd188e207cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f106a0a9-ca65-470b-93e6-cb901e11a48e" xlink:to="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment_37d26127-7da5-4bcd-9171-ddd188e207cf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/InventoryDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#InventoryDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/InventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_01b1d058-2c32-4b0d-bcdf-a80bf762dc76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_47db41d1-1b39-42bd-9ab4-e96c3c5262e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_01b1d058-2c32-4b0d-bcdf-a80bf762dc76" xlink:to="loc_us-gaap_InventoryRawMaterials_47db41d1-1b39-42bd-9ab4-e96c3c5262e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_6a2d45f0-55ab-4cb8-bb21-43ac5318725f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_01b1d058-2c32-4b0d-bcdf-a80bf762dc76" xlink:to="loc_us-gaap_InventoryWorkInProcess_6a2d45f0-55ab-4cb8-bb21-43ac5318725f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_5dc275ec-2e57-4954-b9a6-9531c62d1147" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_01b1d058-2c32-4b0d-bcdf-a80bf762dc76" xlink:to="loc_us-gaap_InventoryFinishedGoods_5dc275ec-2e57-4954-b9a6-9531c62d1147" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#PropertyandEquipmentSummaryofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_55a73bc9-d3bf-4967-96f3-597d94cf5b35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_566ad9ca-b245-4763-81aa-2d8bd29f99b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_55a73bc9-d3bf-4967-96f3-597d94cf5b35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_566ad9ca-b245-4763-81aa-2d8bd29f99b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_97f1180b-fe60-425a-8f54-f5331ae36dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_55a73bc9-d3bf-4967-96f3-597d94cf5b35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_97f1180b-fe60-425a-8f54-f5331ae36dc9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#IntangibleAssetsActivitySummaryDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_20c198e3-ac74-46f3-80e0-9d1f92e31061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4461e0e9-5158-4aa2-8cdf-6543f4accaf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_20c198e3-ac74-46f3-80e0-9d1f92e31061" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4461e0e9-5158-4aa2-8cdf-6543f4accaf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_cc22469d-e67b-4af9-98e6-bf3161170fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_20c198e3-ac74-46f3-80e0-9d1f92e31061" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_cc22469d-e67b-4af9-98e6-bf3161170fb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b4a38d5a-2aa6-4b7e-bc8c-daa5f13215c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7ad34f2e-631e-4766-b66d-64ca815c9dde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b4a38d5a-2aa6-4b7e-bc8c-daa5f13215c1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7ad34f2e-631e-4766-b66d-64ca815c9dde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6155bf7c-03aa-4f6f-82a9-e6b1685d980a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b4a38d5a-2aa6-4b7e-bc8c-daa5f13215c1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6155bf7c-03aa-4f6f-82a9-e6b1685d980a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cc5907c3-47e3-494d-b9b5-7cadf5df566c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_350bf8f2-0156-48e5-9cd8-1935cb296f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cc5907c3-47e3-494d-b9b5-7cadf5df566c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_350bf8f2-0156-48e5-9cd8-1935cb296f61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_02fcf3f2-ee7a-4b98-b201-4986ff39c3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cc5907c3-47e3-494d-b9b5-7cadf5df566c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_02fcf3f2-ee7a-4b98-b201-4986ff39c3ba" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8eeccab8-77eb-4065-9c85-079d839ad592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5fe2f2ab-f694-4db4-be62-c265e0945de5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8eeccab8-77eb-4065-9c85-079d839ad592" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5fe2f2ab-f694-4db4-be62-c265e0945de5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_53eb12ed-0545-4511-8def-a6742ab7e92c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8eeccab8-77eb-4065-9c85-079d839ad592" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_53eb12ed-0545-4511-8def-a6742ab7e92c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_81a4cb67-1ade-4b97-bdb8-a4a69f4820cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8eeccab8-77eb-4065-9c85-079d839ad592" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_81a4cb67-1ade-4b97-bdb8-a4a69f4820cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_e3629181-2216-46ab-bafb-3eebd1835f24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8eeccab8-77eb-4065-9c85-079d839ad592" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_e3629181-2216-46ab-bafb-3eebd1835f24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_546cbe55-b03d-4c0b-95e2-cea633213c99" xlink:href="mdxg-20210630.xsd#mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8eeccab8-77eb-4065-9c85-079d839ad592" xlink:to="loc_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_546cbe55-b03d-4c0b-95e2-cea633213c99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_02e67639-3eeb-4bf1-b96c-ae35c21a610e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8eeccab8-77eb-4065-9c85-079d839ad592" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_02e67639-3eeb-4bf1-b96c-ae35c21a610e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#AccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4d80a8ca-0841-496c-80a2-c5d542143fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AccruedRebates_2d170981-5780-40bc-80cf-c7cf27dc4d8f" xlink:href="mdxg-20210630.xsd#mdxg_AccruedRebates"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4d80a8ca-0841-496c-80a2-c5d542143fc9" xlink:to="loc_mdxg_AccruedRebates_2d170981-5780-40bc-80cf-c7cf27dc4d8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d299731e-c72b-43f0-bb3b-3eafbc8fca61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4d80a8ca-0841-496c-80a2-c5d542143fc9" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d299731e-c72b-43f0-bb3b-3eafbc8fca61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_11dba720-67e0-44ad-bd8f-0e816d5a3013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4d80a8ca-0841-496c-80a2-c5d542143fc9" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_11dba720-67e0-44ad-bd8f-0e816d5a3013" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AccruedClinicalTrialsCurrent_37d4d90c-a2a4-499c-ba15-a33605c0a429" xlink:href="mdxg-20210630.xsd#mdxg_AccruedClinicalTrialsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4d80a8ca-0841-496c-80a2-c5d542143fc9" xlink:to="loc_mdxg_AccruedClinicalTrialsCurrent_37d4d90c-a2a4-499c-ba15-a33605c0a429" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_9b1e8a25-65a3-4948-bbdb-b6b68478af91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4d80a8ca-0841-496c-80a2-c5d542143fc9" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_9b1e8a25-65a3-4948-bbdb-b6b68478af91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_de054feb-af6f-4f7e-86ca-3974b60d4752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4d80a8ca-0841-496c-80a2-c5d542143fc9" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_de054feb-af6f-4f7e-86ca-3974b60d4752" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AccruedSettlementCostsCurrent_07912b82-6ff7-4cae-be25-3c8b607c0e38" xlink:href="mdxg-20210630.xsd#mdxg_AccruedSettlementCostsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4d80a8ca-0841-496c-80a2-c5d542143fc9" xlink:to="loc_mdxg_AccruedSettlementCostsCurrent_07912b82-6ff7-4cae-be25-3c8b607c0e38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_31ec7ded-afd0-4569-9c29-375385bfe713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_4d80a8ca-0841-496c-80a2-c5d542143fc9" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_31ec7ded-afd0-4569-9c29-375385bfe713" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#LongTermDebtTermLoanBalancesDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_fdd0844c-50ab-4ca8-be3c-573d59dca662" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_420776a3-014a-4ec0-8444-1fd6a81c910a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_fdd0844c-50ab-4ca8-be3c-573d59dca662" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_420776a3-014a-4ec0-8444-1fd6a81c910a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_5ab45d24-6f7f-4a3c-a795-4e5f14d64474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_fdd0844c-50ab-4ca8-be3c-573d59dca662" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_5ab45d24-6f7f-4a3c-a795-4e5f14d64474" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_36249ca9-f696-4b23-a537-4267ebcef89e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_fdd0844c-50ab-4ca8-be3c-573d59dca662" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_36249ca9-f696-4b23-a537-4267ebcef89e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#LongTermDebtTermLoanInterestExpenseDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_2770d886-170e-4398-a43f-ca953c65c434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_fecc12b3-d25d-4bf4-a989-72ca400efdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_2770d886-170e-4398-a43f-ca953c65c434" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_fecc12b3-d25d-4bf4-a989-72ca400efdfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_2ad5da03-1939-4c4c-8562-6232059e45e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_2770d886-170e-4398-a43f-ca953c65c434" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_2ad5da03-1939-4c4c-8562-6232059e45e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_8fcb6d97-9a12-414c-bb68-ca37088c1f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_2770d886-170e-4398-a43f-ca953c65c434" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_8fcb6d97-9a12-414c-bb68-ca37088c1f6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentCommitmentFees_7be7fa1c-2980-496a-ae3f-c4fdc0be8f91" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentCommitmentFees"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_2770d886-170e-4398-a43f-ca953c65c434" xlink:to="loc_mdxg_DebtInstrumentCommitmentFees_7be7fa1c-2980-496a-ae3f-c4fdc0be8f91" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#LongTermDebtTermLoanMaturityDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1c83119a-6f6f-47ca-856f-1b7e1fadeb12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_068f5fba-d93c-4a6a-96a2-6dff4ebe45b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_1c83119a-6f6f-47ca-856f-1b7e1fadeb12" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_068f5fba-d93c-4a6a-96a2-6dff4ebe45b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_ce5677be-f69c-41bc-ac72-46c1424fa96d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_1c83119a-6f6f-47ca-856f-1b7e1fadeb12" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_ce5677be-f69c-41bc-ac72-46c1424fa96d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_3f7b7a61-291f-4976-af24-f25ae2571f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_1c83119a-6f6f-47ca-856f-1b7e1fadeb12" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_3f7b7a61-291f-4976-af24-f25ae2571f45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_cc9645cb-2a9d-4e3f-a2e0-909d7f6ca48f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_1c83119a-6f6f-47ca-856f-1b7e1fadeb12" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_cc9645cb-2a9d-4e3f-a2e0-909d7f6ca48f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_LongTermDebtMaturityAfterYearFour_7cdbe31f-9d3c-4ba9-83ce-75ea25c5a6b8" xlink:href="mdxg-20210630.xsd#mdxg_LongTermDebtMaturityAfterYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_1c83119a-6f6f-47ca-856f-1b7e1fadeb12" xlink:to="loc_mdxg_LongTermDebtMaturityAfterYearFour_7cdbe31f-9d3c-4ba9-83ce-75ea25c5a6b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3e598a7a-2f33-4c73-8641-2b8243eb1311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_1c83119a-6f6f-47ca-856f-1b7e1fadeb12" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3e598a7a-2f33-4c73-8641-2b8243eb1311" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#NetLossPerCommonShareBasicNetLossPerCommonShareDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_d993f8ce-4d41-46da-a5f4-4333f814a26d" xlink:href="mdxg-20210630.xsd#mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_0d7945a6-4f49-4970-bbc9-b0484845940d" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityAccretedbutUnrecordedDividends"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_d993f8ce-4d41-46da-a5f4-4333f814a26d" xlink:to="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_0d7945a6-4f49-4970-bbc9-b0484845940d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature_325d242b-73ad-4c85-8114-6d4edb684a16" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_d993f8ce-4d41-46da-a5f4-4333f814a26d" xlink:to="loc_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature_325d242b-73ad-4c85-8114-6d4edb684a16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_6983d853-ebff-4f49-8468-e5f99847ffec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_419d29c9-c607-401f-8ced-fa01161c1b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_6983d853-ebff-4f49-8468-e5f99847ffec" xlink:to="loc_us-gaap_NetIncomeLoss_419d29c9-c607-401f-8ced-fa01161c1b02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_815c7ef4-c23f-4553-abe3-bb2d1ed26c97" xlink:href="mdxg-20210630.xsd#mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_6983d853-ebff-4f49-8468-e5f99847ffec" xlink:to="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_815c7ef4-c23f-4553-abe3-bb2d1ed26c97" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"/>
  <link:calculationLink xlink:role="http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_885d5eda-e0b2-467c-94c0-7ac4ea9355cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_eb6ceab3-6045-4bf2-afe1-885ef8c827bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_885d5eda-e0b2-467c-94c0-7ac4ea9355cc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_eb6ceab3-6045-4bf2-afe1-885ef8c827bf" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>mdxg-20210630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:2348d07d-1fe7-4f85-b08a-d7c74be22bf0,g:fbe44d2f-ecde-4c93-87d4-07ca0cdbb039-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT" xlink:type="simple" xlink:href="mdxg-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT" xlink:type="extended" id="id047ab6c741c459ea0c83165a0341c95_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a093f003-9684-4c0f-a677-8d2bfdf96f96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a093f003-9684-4c0f-a677-8d2bfdf96f96" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_85f97108-66a6-41fe-b014-ba24a595fa33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_CommonStockSharesIssued_85f97108-66a6-41fe-b014-ba24a595fa33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bac0d799-9cfe-43ec-ba2e-9494955e0d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_StockholdersEquity_bac0d799-9cfe-43ec-ba2e-9494955e0d8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_f819d2c0-97a7-4485-97ca-01bd4e02d8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_f819d2c0-97a7-4485-97ca-01bd4e02d8ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TreasuryStockSharesAdjustment_48b974d2-4a9b-434b-8966-d821825ca161" xlink:href="mdxg-20210630.xsd#mdxg_TreasuryStockSharesAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_mdxg_TreasuryStockSharesAdjustment_48b974d2-4a9b-434b-8966-d821825ca161" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_72b6e693-fb02-4bdb-8361-1e1add373f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_72b6e693-fb02-4bdb-8361-1e1add373f0a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_056a214a-9748-4328-8262-f61ff815d4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_056a214a-9748-4328-8262-f61ff815d4a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_476cdd9e-f354-4662-86e7-9583c59157d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_476cdd9e-f354-4662-86e7-9583c59157d2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2d419015-9950-41f9-a2bb-052f47192b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2d419015-9950-41f9-a2bb-052f47192b2e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_ae61b80c-e0c8-46c0-8002-41b0175be587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_ae61b80c-e0c8-46c0-8002-41b0175be587" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_7b88de65-0362-4687-830e-7bcbd7de62c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_7b88de65-0362-4687-830e-7bcbd7de62c8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_b4760961-416a-4368-befe-88f8b8cd5e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_b4760961-416a-4368-befe-88f8b8cd5e1c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_a6221a88-a734-4b34-b6a3-c34cf2c72e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_a6221a88-a734-4b34-b6a3-c34cf2c72e28" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_0e53fb1e-c4e1-4aac-a646-5d472bb1f393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_0e53fb1e-c4e1-4aac-a646-5d472bb1f393" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_d0b2263d-a819-4f53-b5c0-0875a8e6dd9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_d0b2263d-a819-4f53-b5c0-0875a8e6dd9c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_034eaf4e-ab3f-4747-b01e-5879b9645f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_NetIncomeLoss_034eaf4e-ab3f-4747-b01e-5879b9645f4c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_6d957369-4062-4659-8861-8cca53476f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9f80f4ee-937a-4e34-a4c4-fda833133b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2f839a37-0f97-4f00-a89c-4e73b975f9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a093f003-9684-4c0f-a677-8d2bfdf96f96" xlink:to="loc_us-gaap_StatementTable_2f839a37-0f97-4f00-a89c-4e73b975f9fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b8edef6f-757b-451e-9c67-ecb7087d4b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2f839a37-0f97-4f00-a89c-4e73b975f9fb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b8edef6f-757b-451e-9c67-ecb7087d4b7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b8edef6f-757b-451e-9c67-ecb7087d4b7b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b8edef6f-757b-451e-9c67-ecb7087d4b7b" xlink:to="loc_us-gaap_EquityComponentDomain_b8edef6f-757b-451e-9c67-ecb7087d4b7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c9fd8a7c-1ce9-4c98-bd9e-791d8abdc5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b8edef6f-757b-451e-9c67-ecb7087d4b7b" xlink:to="loc_us-gaap_EquityComponentDomain_c9fd8a7c-1ce9-4c98-bd9e-791d8abdc5d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_acd9d397-553e-49de-ae9f-280b4a68e979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c9fd8a7c-1ce9-4c98-bd9e-791d8abdc5d8" xlink:to="loc_us-gaap_CommonStockMember_acd9d397-553e-49de-ae9f-280b4a68e979" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b3f653e4-1ffc-4798-9112-ed1f11b163fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c9fd8a7c-1ce9-4c98-bd9e-791d8abdc5d8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b3f653e4-1ffc-4798-9112-ed1f11b163fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_dbf6a193-6a0f-49f1-81d9-9509419c99c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c9fd8a7c-1ce9-4c98-bd9e-791d8abdc5d8" xlink:to="loc_us-gaap_TreasuryStockMember_dbf6a193-6a0f-49f1-81d9-9509419c99c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e44e75d4-67c0-4ed3-8864-a54f296367a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c9fd8a7c-1ce9-4c98-bd9e-791d8abdc5d8" xlink:to="loc_us-gaap_RetainedEarningsMember_e44e75d4-67c0-4ed3-8864-a54f296367a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_6f32a795-55c8-4581-b598-c77cb37f4c6f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2f839a37-0f97-4f00-a89c-4e73b975f9fb" xlink:to="loc_srt_RestatementAxis_6f32a795-55c8-4581-b598-c77cb37f4c6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_6f32a795-55c8-4581-b598-c77cb37f4c6f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_6f32a795-55c8-4581-b598-c77cb37f4c6f" xlink:to="loc_srt_RestatementDomain_6f32a795-55c8-4581-b598-c77cb37f4c6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_5b8459f2-1c42-4216-a328-8d4033259a9b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_6f32a795-55c8-4581-b598-c77cb37f4c6f" xlink:to="loc_srt_RestatementDomain_5b8459f2-1c42-4216-a328-8d4033259a9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_b785d40d-4e3a-44e9-85bd-bb9d95e62ebc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_5b8459f2-1c42-4216-a328-8d4033259a9b" xlink:to="loc_srt_RestatementAdjustmentMember_b785d40d-4e3a-44e9-85bd-bb9d95e62ebc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_4d7f80d2-c2b7-4514-8fbd-35904fcfde99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2f839a37-0f97-4f00-a89c-4e73b975f9fb" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_4d7f80d2-c2b7-4514-8fbd-35904fcfde99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_4d7f80d2-c2b7-4514-8fbd-35904fcfde99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_4d7f80d2-c2b7-4514-8fbd-35904fcfde99" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_4d7f80d2-c2b7-4514-8fbd-35904fcfde99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_b25f43c5-432e-4f1c-9129-8cd3b45d2a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_4d7f80d2-c2b7-4514-8fbd-35904fcfde99" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_b25f43c5-432e-4f1c-9129-8cd3b45d2a74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_StockAwardMisstatementsMember_25abda69-9fa5-4c5c-922c-97f92e9e0065" xlink:href="mdxg-20210630.xsd#mdxg_StockAwardMisstatementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_b25f43c5-432e-4f1c-9129-8cd3b45d2a74" xlink:to="loc_mdxg_StockAwardMisstatementsMember_25abda69-9fa5-4c5c-922c-97f92e9e0065" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/NatureofBusinessDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#NatureofBusinessDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/NatureofBusinessDetails" xlink:type="extended" id="iab70b1a009ee49f5b4be144059157be0_NatureofBusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5724dc78-9faa-46e8-90e9-b0add3490aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5724dc78-9faa-46e8-90e9-b0add3490aa1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_13a29793-98c0-4852-98a2-407078977642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:to="loc_us-gaap_InventoryNet_13a29793-98c0-4852-98a2-407078977642" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_af97017e-2d0f-45cd-8d8e-62b31fd557ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_af97017e-2d0f-45cd-8d8e-62b31fd557ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_9ef6af8d-6ccb-4265-b6fe-559368c6a55f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_9ef6af8d-6ccb-4265-b6fe-559368c6a55f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_218e979b-8f73-462c-bb73-cb2c9c5cbe2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_218e979b-8f73-462c-bb73-cb2c9c5cbe2f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_8d08eb5b-1a30-486f-a599-ffe9c66bcdd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_8d08eb5b-1a30-486f-a599-ffe9c66bcdd9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TreasuryStockSharesAdjustment_3f7bb73d-532b-432e-b9b5-f4c499ffeabf" xlink:href="mdxg-20210630.xsd#mdxg_TreasuryStockSharesAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:to="loc_mdxg_TreasuryStockSharesAdjustment_3f7bb73d-532b-432e-b9b5-f4c499ffeabf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable_8da82bae-1920-448a-8c6c-4d47d5250273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:to="loc_us-gaap_UnusualOrInfrequentItemTable_8da82bae-1920-448a-8c6c-4d47d5250273" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_15219b8b-db54-418e-933d-57369fc35035" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_8da82bae-1920-448a-8c6c-4d47d5250273" xlink:to="loc_srt_ProductOrServiceAxis_15219b8b-db54-418e-933d-57369fc35035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_15219b8b-db54-418e-933d-57369fc35035_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_15219b8b-db54-418e-933d-57369fc35035" xlink:to="loc_srt_ProductsAndServicesDomain_15219b8b-db54-418e-933d-57369fc35035_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c4ac2f80-2089-44b8-9008-27bc3aa45fd0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_15219b8b-db54-418e-933d-57369fc35035" xlink:to="loc_srt_ProductsAndServicesDomain_c4ac2f80-2089-44b8-9008-27bc3aa45fd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_Section351Member_cfec40c8-ba60-4fbc-8f51-8230fc66997b" xlink:href="mdxg-20210630.xsd#mdxg_Section351Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c4ac2f80-2089-44b8-9008-27bc3aa45fd0" xlink:to="loc_mdxg_Section351Member_cfec40c8-ba60-4fbc-8f51-8230fc66997b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_04f82b3d-913a-4400-b22b-be08978429ae" xlink:href="mdxg-20210630.xsd#mdxg_AdvancedWoundCareUmbilicalCordDerivedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c4ac2f80-2089-44b8-9008-27bc3aa45fd0" xlink:to="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_04f82b3d-913a-4400-b22b-be08978429ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_873700d7-a5ff-4868-800f-e38a721e7a85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_8da82bae-1920-448a-8c6c-4d47d5250273" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_873700d7-a5ff-4868-800f-e38a721e7a85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_873700d7-a5ff-4868-800f-e38a721e7a85_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_873700d7-a5ff-4868-800f-e38a721e7a85" xlink:to="loc_us-gaap_EquityComponentDomain_873700d7-a5ff-4868-800f-e38a721e7a85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_42c34d54-ae1d-4fc0-a2c1-399019b3e4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_873700d7-a5ff-4868-800f-e38a721e7a85" xlink:to="loc_us-gaap_EquityComponentDomain_42c34d54-ae1d-4fc0-a2c1-399019b3e4d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ee44fce0-a44b-4883-8279-71199502e3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_42c34d54-ae1d-4fc0-a2c1-399019b3e4d4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ee44fce0-a44b-4883-8279-71199502e3eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_c7eb9570-1ce0-4769-9de8-7c136719a51b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_42c34d54-ae1d-4fc0-a2c1-399019b3e4d4" xlink:to="loc_us-gaap_TreasuryStockMember_c7eb9570-1ce0-4769-9de8-7c136719a51b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8c80f958-65f7-4674-bdf8-cf82c85aab00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_42c34d54-ae1d-4fc0-a2c1-399019b3e4d4" xlink:to="loc_us-gaap_CommonStockMember_8c80f958-65f7-4674-bdf8-cf82c85aab00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_349f96f6-0ab5-4211-8a1a-fc8fbd3b94f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_8da82bae-1920-448a-8c6c-4d47d5250273" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_349f96f6-0ab5-4211-8a1a-fc8fbd3b94f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_349f96f6-0ab5-4211-8a1a-fc8fbd3b94f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_349f96f6-0ab5-4211-8a1a-fc8fbd3b94f5" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_349f96f6-0ab5-4211-8a1a-fc8fbd3b94f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_b7766283-ea1a-4eff-9dc2-b616cf8c6221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_349f96f6-0ab5-4211-8a1a-fc8fbd3b94f5" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_b7766283-ea1a-4eff-9dc2-b616cf8c6221" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_StockAwardMisstatementsMember_06211fdc-98eb-41ff-acfc-4879aa5eb8a8" xlink:href="mdxg-20210630.xsd#mdxg_StockAwardMisstatementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_b7766283-ea1a-4eff-9dc2-b616cf8c6221" xlink:to="loc_mdxg_StockAwardMisstatementsMember_06211fdc-98eb-41ff-acfc-4879aa5eb8a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_f27e324c-e09b-4177-b88b-caf076cd3b58" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_8da82bae-1920-448a-8c6c-4d47d5250273" xlink:to="loc_srt_RestatementAxis_f27e324c-e09b-4177-b88b-caf076cd3b58" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_f27e324c-e09b-4177-b88b-caf076cd3b58_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_f27e324c-e09b-4177-b88b-caf076cd3b58" xlink:to="loc_srt_RestatementDomain_f27e324c-e09b-4177-b88b-caf076cd3b58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_0cb1e380-374b-46ad-af4c-57ab850d8071" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_f27e324c-e09b-4177-b88b-caf076cd3b58" xlink:to="loc_srt_RestatementDomain_0cb1e380-374b-46ad-af4c-57ab850d8071" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_1767bf4c-646f-4044-85d6-f71d208b1834" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_0cb1e380-374b-46ad-af4c-57ab850d8071" xlink:to="loc_srt_RestatementAdjustmentMember_1767bf4c-646f-4044-85d6-f71d208b1834" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i24635a52d415434d90330a44299a8493_SignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_91d42b76-911b-436c-b2ce-cd166bed85fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_a2fa230b-6abf-4ca1-889b-a88e582a6e55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_91d42b76-911b-436c-b2ce-cd166bed85fc" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_a2fa230b-6abf-4ca1-889b-a88e582a6e55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_c17ce856-d71c-412c-87b1-cb246dd530e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_91d42b76-911b-436c-b2ce-cd166bed85fc" xlink:to="loc_us-gaap_NumberOfReportingUnits_c17ce856-d71c-412c-87b1-cb246dd530e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_814fede4-97af-446c-b7ce-bbb4ea717c38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_91d42b76-911b-436c-b2ce-cd166bed85fc" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_814fede4-97af-446c-b7ce-bbb4ea717c38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_RevenueFromContractWithCustomerPaymentTerms_73225d74-f951-4c16-adfc-b3fc1fcad8ad" xlink:href="mdxg-20210630.xsd#mdxg_RevenueFromContractWithCustomerPaymentTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_91d42b76-911b-436c-b2ce-cd166bed85fc" xlink:to="loc_mdxg_RevenueFromContractWithCustomerPaymentTerms_73225d74-f951-4c16-adfc-b3fc1fcad8ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_ce079d51-20af-4bbf-a120-e188cb35ed0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_91d42b76-911b-436c-b2ce-cd166bed85fc" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_ce079d51-20af-4bbf-a120-e188cb35ed0f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a33a8f94-99f7-4053-a0b5-875b705a8452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_91d42b76-911b-436c-b2ce-cd166bed85fc" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a33a8f94-99f7-4053-a0b5-875b705a8452" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6e6b1e74-f6ef-43ee-8982-6f7c80b32fde" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a33a8f94-99f7-4053-a0b5-875b705a8452" xlink:to="loc_srt_RangeAxis_6e6b1e74-f6ef-43ee-8982-6f7c80b32fde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6e6b1e74-f6ef-43ee-8982-6f7c80b32fde_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6e6b1e74-f6ef-43ee-8982-6f7c80b32fde" xlink:to="loc_srt_RangeMember_6e6b1e74-f6ef-43ee-8982-6f7c80b32fde_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c701ee43-e534-4200-a7a9-43e3b66b3250" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6e6b1e74-f6ef-43ee-8982-6f7c80b32fde" xlink:to="loc_srt_RangeMember_c701ee43-e534-4200-a7a9-43e3b66b3250" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7ca8c80e-e624-44ab-96a8-64d4ebb1b14a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c701ee43-e534-4200-a7a9-43e3b66b3250" xlink:to="loc_srt_MinimumMember_7ca8c80e-e624-44ab-96a8-64d4ebb1b14a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_469e6574-73df-4f50-9ae7-82cd750897e2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c701ee43-e534-4200-a7a9-43e3b66b3250" xlink:to="loc_srt_MaximumMember_469e6574-73df-4f50-9ae7-82cd750897e2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details" xlink:type="simple" xlink:href="mdxg-20210630.xsd#SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details" xlink:type="extended" id="i1df6a34e9fc84ecf9ea32fd37dc0a3be_SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_f0811232-74d9-482e-a098-8178ac56e842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c3ddb18a-89b3-4320-9d25-3eaaa11cb590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_f0811232-74d9-482e-a098-8178ac56e842" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c3ddb18a-89b3-4320-9d25-3eaaa11cb590" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_40fb5eec-5457-4638-b543-bfa17b774631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_f0811232-74d9-482e-a098-8178ac56e842" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_40fb5eec-5457-4638-b543-bfa17b774631" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_b851d1a0-3b2c-4246-87e6-725316e0ce7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_f0811232-74d9-482e-a098-8178ac56e842" xlink:to="loc_us-gaap_GrossProfit_b851d1a0-3b2c-4246-87e6-725316e0ce7c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_4d31f02d-588f-4eaf-a62b-c64978086d75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_f0811232-74d9-482e-a098-8178ac56e842" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_4d31f02d-588f-4eaf-a62b-c64978086d75" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_81154c77-571f-4cda-b3ff-847a6e592903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_4d31f02d-588f-4eaf-a62b-c64978086d75" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_81154c77-571f-4cda-b3ff-847a6e592903" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_81154c77-571f-4cda-b3ff-847a6e592903_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_81154c77-571f-4cda-b3ff-847a6e592903" xlink:to="loc_us-gaap_TypeOfAdoptionMember_81154c77-571f-4cda-b3ff-847a6e592903_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_9348f1f7-f71e-4bca-a7fd-60d364b2695c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_81154c77-571f-4cda-b3ff-847a6e592903" xlink:to="loc_us-gaap_TypeOfAdoptionMember_9348f1f7-f71e-4bca-a7fd-60d364b2695c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_060941a7-532c-46c0-b239-c0443941786a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_9348f1f7-f71e-4bca-a7fd-60d364b2695c" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_060941a7-532c-46c0-b239-c0443941786a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/InventoryDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#InventoryDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/InventoryDetails" xlink:type="extended" id="i00bb1adf11354f74a7b466d078c6ecdd_InventoryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_fe1bb5a6-bccb-4c5e-9860-789de76138da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_010b7884-e9aa-4e5a-ab78-d4159a1798fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_fe1bb5a6-bccb-4c5e-9860-789de76138da" xlink:to="loc_us-gaap_InventoryWriteDown_010b7884-e9aa-4e5a-ab78-d4159a1798fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_e12692a1-46e0-4abf-a528-c8521cac4f69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InventoryLineItems_fe1bb5a6-bccb-4c5e-9860-789de76138da" xlink:to="loc_us-gaap_InventoryCurrentTable_e12692a1-46e0-4abf-a528-c8521cac4f69" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ed3ba8bc-c574-4637-b46b-54739c5bf3ca" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_e12692a1-46e0-4abf-a528-c8521cac4f69" xlink:to="loc_srt_ProductOrServiceAxis_ed3ba8bc-c574-4637-b46b-54739c5bf3ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ed3ba8bc-c574-4637-b46b-54739c5bf3ca_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ed3ba8bc-c574-4637-b46b-54739c5bf3ca" xlink:to="loc_srt_ProductsAndServicesDomain_ed3ba8bc-c574-4637-b46b-54739c5bf3ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fd6f2220-b5c0-4869-9a7b-243ce7a1f8a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ed3ba8bc-c574-4637-b46b-54739c5bf3ca" xlink:to="loc_srt_ProductsAndServicesDomain_fd6f2220-b5c0-4869-9a7b-243ce7a1f8a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_Section351Member_849e986a-4674-417d-bec8-86171121c57c" xlink:href="mdxg-20210630.xsd#mdxg_Section351Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_fd6f2220-b5c0-4869-9a7b-243ce7a1f8a1" xlink:to="loc_mdxg_Section351Member_849e986a-4674-417d-bec8-86171121c57c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#PropertyandEquipmentSummaryofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="extended" id="ie49b1e37cef7429db8229c766c7d2486_PropertyandEquipmentSummaryofPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c7dc779-c4ff-49c0-84fb-155edf567e99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e1518ba0-c008-4f36-8f65-6b94d6a44b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c7dc779-c4ff-49c0-84fb-155edf567e99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e1518ba0-c008-4f36-8f65-6b94d6a44b11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_bcb74694-8949-488a-8766-18bec2351e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c7dc779-c4ff-49c0-84fb-155edf567e99" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_bcb74694-8949-488a-8766-18bec2351e90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_8274a1d5-8d6e-4891-8818-fc51d90f4a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c7dc779-c4ff-49c0-84fb-155edf567e99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_8274a1d5-8d6e-4891-8818-fc51d90f4a3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_657bef09-c150-4657-827d-c7f834a00e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c7dc779-c4ff-49c0-84fb-155edf567e99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_657bef09-c150-4657-827d-c7f834a00e4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_73d8b67c-8765-46be-a4f9-5a8b90e9bdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c7dc779-c4ff-49c0-84fb-155edf567e99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_73d8b67c-8765-46be-a4f9-5a8b90e9bdbd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7de5d3f9-0bed-404d-a935-9840648dc89f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c7dc779-c4ff-49c0-84fb-155edf567e99" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7de5d3f9-0bed-404d-a935-9840648dc89f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c18101a1-f675-4b6c-8279-3a381f5c8d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7de5d3f9-0bed-404d-a935-9840648dc89f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c18101a1-f675-4b6c-8279-3a381f5c8d99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c18101a1-f675-4b6c-8279-3a381f5c8d99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c18101a1-f675-4b6c-8279-3a381f5c8d99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c18101a1-f675-4b6c-8279-3a381f5c8d99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24862c5f-609c-43ea-b411-9bf166133e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c18101a1-f675-4b6c-8279-3a381f5c8d99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24862c5f-609c-43ea-b411-9bf166133e80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_ff5084d0-734d-433a-87c1-b3179cb85209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24862c5f-609c-43ea-b411-9bf166133e80" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_ff5084d0-734d-433a-87c1-b3179cb85209" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_4d4beb4a-8597-4d32-a5d4-95e978e541aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24862c5f-609c-43ea-b411-9bf166133e80" xlink:to="loc_us-gaap_EquipmentMember_4d4beb4a-8597-4d32-a5d4-95e978e541aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_d74804c8-2fc6-4554-8b75-844f9bc97fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24862c5f-609c-43ea-b411-9bf166133e80" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_d74804c8-2fc6-4554-8b75-844f9bc97fa3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_eaa01dbc-e548-43ca-9c1f-25a1418134da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24862c5f-609c-43ea-b411-9bf166133e80" xlink:to="loc_us-gaap_ConstructionInProgressMember_eaa01dbc-e548-43ca-9c1f-25a1418134da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AssetRetirementCostMember_03d09a85-3daa-41ce-aceb-e7883e06d0f2" xlink:href="mdxg-20210630.xsd#mdxg_AssetRetirementCostMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24862c5f-609c-43ea-b411-9bf166133e80" xlink:to="loc_mdxg_AssetRetirementCostMember_03d09a85-3daa-41ce-aceb-e7883e06d0f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FinanceLeaseAssetsMember_4b140b64-6237-47fb-bc52-097bcb43271d" xlink:href="mdxg-20210630.xsd#mdxg_FinanceLeaseAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24862c5f-609c-43ea-b411-9bf166133e80" xlink:to="loc_mdxg_FinanceLeaseAssetsMember_4b140b64-6237-47fb-bc52-097bcb43271d" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#IntangibleAssetsActivitySummaryDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails" xlink:type="extended" id="i5accda6d1212428e9f47139742585c91_IntangibleAssetsActivitySummaryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_32d9740d-7ece-4565-9b90-d0a9d89ed826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d75f0bec-70ba-46c0-8f18-d2cccf7dc367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_32d9740d-7ece-4565-9b90-d0a9d89ed826" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d75f0bec-70ba-46c0-8f18-d2cccf7dc367" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3b1924ab-064c-4297-85a2-efd4986c4f33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_32d9740d-7ece-4565-9b90-d0a9d89ed826" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3b1924ab-064c-4297-85a2-efd4986c4f33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f5f0869c-7023-4b94-98f7-52ae2f856bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_32d9740d-7ece-4565-9b90-d0a9d89ed826" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f5f0869c-7023-4b94-98f7-52ae2f856bc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_12870b76-0fa7-492e-a593-76f29dbf9039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_32d9740d-7ece-4565-9b90-d0a9d89ed826" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_12870b76-0fa7-492e-a593-76f29dbf9039" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a049feaf-783c-4966-9a9d-8f8582707015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_12870b76-0fa7-492e-a593-76f29dbf9039" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a049feaf-783c-4966-9a9d-8f8582707015" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a049feaf-783c-4966-9a9d-8f8582707015_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a049feaf-783c-4966-9a9d-8f8582707015" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a049feaf-783c-4966-9a9d-8f8582707015_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fbb9c883-a7dc-401d-9ecb-17c6b07d691b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a049feaf-783c-4966-9a9d-8f8582707015" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fbb9c883-a7dc-401d-9ecb-17c6b07d691b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_46611be8-1f16-45ad-be77-3f121cd11085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fbb9c883-a7dc-401d-9ecb-17c6b07d691b" xlink:to="loc_us-gaap_PatentsMember_46611be8-1f16-45ad-be77-3f121cd11085" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_d0ec3881-623c-461b-b371-364872019bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fbb9c883-a7dc-401d-9ecb-17c6b07d691b" xlink:to="loc_us-gaap_LicensingAgreementsMember_d0ec3881-623c-461b-b371-364872019bd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CustomerAndSupplierRelationshipsMember_085ce558-46dd-4929-9e3a-96b1385fd0db" xlink:href="mdxg-20210630.xsd#mdxg_CustomerAndSupplierRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fbb9c883-a7dc-401d-9ecb-17c6b07d691b" xlink:to="loc_mdxg_CustomerAndSupplierRelationshipsMember_085ce558-46dd-4929-9e3a-96b1385fd0db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_d70d16ae-c15d-4d92-a622-ed3031d62b58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fbb9c883-a7dc-401d-9ecb-17c6b07d691b" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_d70d16ae-c15d-4d92-a622-ed3031d62b58" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_e9209217-36f2-47b1-a185-f9ff27e1a797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a60dfbac-01fa-4c64-9d3f-ca5b7f47331e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_e9209217-36f2-47b1-a185-f9ff27e1a797" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a60dfbac-01fa-4c64-9d3f-ca5b7f47331e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2fa9156c-cb13-4a6f-a44c-c3ba7a7c47b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_e9209217-36f2-47b1-a185-f9ff27e1a797" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2fa9156c-cb13-4a6f-a44c-c3ba7a7c47b0" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8e58536a-0c75-497e-86af-6989980b1cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2fa9156c-cb13-4a6f-a44c-c3ba7a7c47b0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8e58536a-0c75-497e-86af-6989980b1cd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8e58536a-0c75-497e-86af-6989980b1cd6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8e58536a-0c75-497e-86af-6989980b1cd6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8e58536a-0c75-497e-86af-6989980b1cd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f3f00af8-c3f0-4166-a31d-8c6374f1eeaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8e58536a-0c75-497e-86af-6989980b1cd6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f3f00af8-c3f0-4166-a31d-8c6374f1eeaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_fb656c4c-9609-4755-934a-d71d9adca251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f3f00af8-c3f0-4166-a31d-8c6374f1eeaa" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_fb656c4c-9609-4755-934a-d71d9adca251" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PatentsinProcessMember_fdafef45-1cae-43b9-ba96-ce2a3d76aab3" xlink:href="mdxg-20210630.xsd#mdxg_PatentsinProcessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f3f00af8-c3f0-4166-a31d-8c6374f1eeaa" xlink:to="loc_mdxg_PatentsinProcessMember_fdafef45-1cae-43b9-ba96-ce2a3d76aab3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#LongTermDebtTermLoanDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanDetails" xlink:type="extended" id="i36f3ce60efbb44e0a996eb61dbb2bedd_LongTermDebtTermLoanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_0d489200-7c6b-401f-87fa-3361c61a342a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_0d489200-7c6b-401f-87fa-3361c61a342a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentInterestRateFloorPercentage_e06ec100-55d9-4bd9-8a9f-3eb3703cf89a" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentInterestRateFloorPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_mdxg_DebtInstrumentInterestRateFloorPercentage_e06ec100-55d9-4bd9-8a9f-3eb3703cf89a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d691848b-574f-4d3e-b2dd-515bca5b6f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d691848b-574f-4d3e-b2dd-515bca5b6f8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TotalNetLeverageRatio_b2f4dde3-ae35-4eea-a398-342068ae8ebe" xlink:href="mdxg-20210630.xsd#mdxg_TotalNetLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_mdxg_TotalNetLeverageRatio_b2f4dde3-ae35-4eea-a398-342068ae8ebe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentDefaultInterestRate_e52b568b-4d30-4d5e-a7e9-db3f77b99076" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentDefaultInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_mdxg_DebtInstrumentDefaultInterestRate_e52b568b-4d30-4d5e-a7e9-db3f77b99076" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_aaa9779b-0693-472d-97dc-a0676a720266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_aaa9779b-0693-472d-97dc-a0676a720266" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtCovenantMinimumLiquidity_475bf6ae-d1cd-402f-a190-2e7373eece85" xlink:href="mdxg-20210630.xsd#mdxg_DebtCovenantMinimumLiquidity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_mdxg_DebtCovenantMinimumLiquidity_475bf6ae-d1cd-402f-a190-2e7373eece85" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent_a133a541-712d-4b2d-b8fa-1be15c41cd5f" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent_a133a541-712d-4b2d-b8fa-1be15c41cd5f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent_5ce52d92-4018-43f3-86ba-93d01f041a73" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent_5ce52d92-4018-43f3-86ba-93d01f041a73" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage_ee6c6398-b9a9-4e8d-85ed-eb620bee2b42" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage_ee6c6398-b9a9-4e8d-85ed-eb620bee2b42" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_6fc06db0-c33a-4e7a-8b55-0ca7943d4a69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_us-gaap_LongTermDebtFairValue_6fc06db0-c33a-4e7a-8b55-0ca7943d4a69" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_e64472ea-772a-4d1c-8835-dcd70ceaa0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_e64472ea-772a-4d1c-8835-dcd70ceaa0ed" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_321647fc-6960-4680-916f-fc54c72c947c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_321647fc-6960-4680-916f-fc54c72c947c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_f1d70418-df2d-4a05-a4e7-5b82b7c82549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_f1d70418-df2d-4a05-a4e7-5b82b7c82549" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_219088e6-7646-4289-9f4b-92e9cc2c2349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_219088e6-7646-4289-9f4b-92e9cc2c2349" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_16753035-bf55-4b33-9a75-712ffbb8d16f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_us-gaap_DebtInstrumentTable_16753035-bf55-4b33-9a75-712ffbb8d16f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ea0721eb-84ef-4b6b-b380-fd01da67591f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_16753035-bf55-4b33-9a75-712ffbb8d16f" xlink:to="loc_srt_RangeAxis_ea0721eb-84ef-4b6b-b380-fd01da67591f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ea0721eb-84ef-4b6b-b380-fd01da67591f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ea0721eb-84ef-4b6b-b380-fd01da67591f" xlink:to="loc_srt_RangeMember_ea0721eb-84ef-4b6b-b380-fd01da67591f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e9f3a0a9-7dcf-4300-afd2-08bf9a241fae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ea0721eb-84ef-4b6b-b380-fd01da67591f" xlink:to="loc_srt_RangeMember_e9f3a0a9-7dcf-4300-afd2-08bf9a241fae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_42949a58-ab46-4f03-88f2-5e872caa35d6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e9f3a0a9-7dcf-4300-afd2-08bf9a241fae" xlink:to="loc_srt_MinimumMember_42949a58-ab46-4f03-88f2-5e872caa35d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bd81aa91-1869-4aab-998a-bd573e75d926" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e9f3a0a9-7dcf-4300-afd2-08bf9a241fae" xlink:to="loc_srt_MaximumMember_bd81aa91-1869-4aab-998a-bd573e75d926" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4abaf3a9-31bb-43c8-af8d-a87d9a89f93c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_16753035-bf55-4b33-9a75-712ffbb8d16f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4abaf3a9-31bb-43c8-af8d-a87d9a89f93c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4abaf3a9-31bb-43c8-af8d-a87d9a89f93c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4abaf3a9-31bb-43c8-af8d-a87d9a89f93c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4abaf3a9-31bb-43c8-af8d-a87d9a89f93c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c7e433a8-9e8c-4c27-a28a-e1a38db2b52d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4abaf3a9-31bb-43c8-af8d-a87d9a89f93c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c7e433a8-9e8c-4c27-a28a-e1a38db2b52d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e6def081-6b56-40e2-a547-ec3c81bc27b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c7e433a8-9e8c-4c27-a28a-e1a38db2b52d" xlink:to="loc_us-gaap_SubsequentEventMember_e6def081-6b56-40e2-a547-ec3c81bc27b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7c5b0421-3196-4d85-807a-a9bd0a5efbfd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_16753035-bf55-4b33-9a75-712ffbb8d16f" xlink:to="loc_srt_StatementScenarioAxis_7c5b0421-3196-4d85-807a-a9bd0a5efbfd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_7c5b0421-3196-4d85-807a-a9bd0a5efbfd_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_7c5b0421-3196-4d85-807a-a9bd0a5efbfd" xlink:to="loc_srt_ScenarioUnspecifiedDomain_7c5b0421-3196-4d85-807a-a9bd0a5efbfd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_64216635-fdac-4d09-b6a6-d1bd9e51427f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_7c5b0421-3196-4d85-807a-a9bd0a5efbfd" xlink:to="loc_srt_ScenarioUnspecifiedDomain_64216635-fdac-4d09-b6a6-d1bd9e51427f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_270bd868-756d-457a-b39c-8eb29dbd832a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_64216635-fdac-4d09-b6a6-d1bd9e51427f" xlink:to="loc_srt_ScenarioForecastMember_270bd868-756d-457a-b39c-8eb29dbd832a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_139db035-8289-4533-9d50-8306e338ade4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_16753035-bf55-4b33-9a75-712ffbb8d16f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_139db035-8289-4533-9d50-8306e338ade4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_139db035-8289-4533-9d50-8306e338ade4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_139db035-8289-4533-9d50-8306e338ade4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_139db035-8289-4533-9d50-8306e338ade4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_925dea43-8252-4f94-aed8-43fed57c1411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_139db035-8289-4533-9d50-8306e338ade4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_925dea43-8252-4f94-aed8-43fed57c1411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_63515ee4-5ffd-4474-95f6-9c70f561ddfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_925dea43-8252-4f94-aed8-43fed57c1411" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_63515ee4-5ffd-4474-95f6-9c70f561ddfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f845f71a-8b40-4f2d-8fe3-b7a9cb4b15e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_16753035-bf55-4b33-9a75-712ffbb8d16f" xlink:to="loc_us-gaap_DebtInstrumentAxis_f845f71a-8b40-4f2d-8fe3-b7a9cb4b15e9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f845f71a-8b40-4f2d-8fe3-b7a9cb4b15e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f845f71a-8b40-4f2d-8fe3-b7a9cb4b15e9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f845f71a-8b40-4f2d-8fe3-b7a9cb4b15e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f845f71a-8b40-4f2d-8fe3-b7a9cb4b15e9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember_b7d4c2a8-0410-4542-a308-61e91df06653" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanMember_b7d4c2a8-0410-4542-a308-61e91df06653" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FinancingTransactionsMember_aa6411b1-2012-40ec-8067-17b650571721" xlink:href="mdxg-20210630.xsd#mdxg_FinancingTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:to="loc_mdxg_FinancingTransactionsMember_aa6411b1-2012-40ec-8067-17b650571721" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember_e175dfe3-369a-4a73-a050-6f8579074e93" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember_e175dfe3-369a-4a73-a050-6f8579074e93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember_ad54c73a-e613-4d0e-9579-04470e628bfe" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember_ad54c73a-e613-4d0e-9579-04470e628bfe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CreditFacilitiesMember_fe7a1053-ba62-4b8c-ac32-c6026869cb24" xlink:href="mdxg-20210630.xsd#mdxg_CreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:to="loc_mdxg_CreditFacilitiesMember_fe7a1053-ba62-4b8c-ac32-c6026869cb24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_6e25cb3f-5b8b-4499-9948-7350c7e2cce2" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:to="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_6e25cb3f-5b8b-4499-9948-7350c7e2cce2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TermLoanAgreementMember_62f9cbba-2ce0-4336-87c7-58453fd9a496" xlink:href="mdxg-20210630.xsd#mdxg_TermLoanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:to="loc_mdxg_TermLoanAgreementMember_62f9cbba-2ce0-4336-87c7-58453fd9a496" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AmendedTermLoanAgreementMember_998c82fc-9670-48eb-bbe0-c11f88b82a37" xlink:href="mdxg-20210630.xsd#mdxg_AmendedTermLoanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:to="loc_mdxg_AmendedTermLoanAgreementMember_998c82fc-9670-48eb-bbe0-c11f88b82a37" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_5cb42898-5305-4364-abef-8d95a4092216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_16753035-bf55-4b33-9a75-712ffbb8d16f" xlink:to="loc_us-gaap_VariableRateAxis_5cb42898-5305-4364-abef-8d95a4092216" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_5cb42898-5305-4364-abef-8d95a4092216_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_5cb42898-5305-4364-abef-8d95a4092216" xlink:to="loc_us-gaap_VariableRateDomain_5cb42898-5305-4364-abef-8d95a4092216_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_5aee25f0-d8b2-43b9-bb35-0d7c2355bea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_5cb42898-5305-4364-abef-8d95a4092216" xlink:to="loc_us-gaap_VariableRateDomain_5aee25f0-d8b2-43b9-bb35-0d7c2355bea5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_51a49cfc-3172-4e85-9e7e-e0f400262553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_5aee25f0-d8b2-43b9-bb35-0d7c2355bea5" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_51a49cfc-3172-4e85-9e7e-e0f400262553" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_5c959235-bbc7-484e-8028-1382fcf35abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_5aee25f0-d8b2-43b9-bb35-0d7c2355bea5" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_5c959235-bbc7-484e-8028-1382fcf35abd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_4f373c31-213b-4530-818e-ac0c32c6b3af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_5aee25f0-d8b2-43b9-bb35-0d7c2355bea5" xlink:to="loc_us-gaap_PrimeRateMember_4f373c31-213b-4530-818e-ac0c32c6b3af" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#LongTermDebtTermLoanDebtIssuanceCostsDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails" xlink:type="extended" id="i67b2e990b98b438b8d00722cf4b499ef_LongTermDebtTermLoanDebtIssuanceCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_420c27b5-e96e-46fe-a7dd-d158f220fd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_a3cbbd7f-e383-4377-a752-131b82c1da6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_420c27b5-e96e-46fe-a7dd-d158f220fd7e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_a3cbbd7f-e383-4377-a752-131b82c1da6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_2f33c99d-df30-4dba-9c23-184b654c1284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_420c27b5-e96e-46fe-a7dd-d158f220fd7e" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_2f33c99d-df30-4dba-9c23-184b654c1284" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_21e4efd5-d887-44df-b476-c8bf92a29078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_420c27b5-e96e-46fe-a7dd-d158f220fd7e" xlink:to="loc_us-gaap_DebtInstrumentTable_21e4efd5-d887-44df-b476-c8bf92a29078" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f876d2d3-eba4-444f-8d57-ec65449f443a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_21e4efd5-d887-44df-b476-c8bf92a29078" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f876d2d3-eba4-444f-8d57-ec65449f443a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f876d2d3-eba4-444f-8d57-ec65449f443a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f876d2d3-eba4-444f-8d57-ec65449f443a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f876d2d3-eba4-444f-8d57-ec65449f443a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9bd0cfe8-cdae-4cc9-b821-fcdf4dd88b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f876d2d3-eba4-444f-8d57-ec65449f443a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9bd0cfe8-cdae-4cc9-b821-fcdf4dd88b30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_c9139218-673d-4064-830f-26b6fb4efd03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9bd0cfe8-cdae-4cc9-b821-fcdf4dd88b30" xlink:to="loc_us-gaap_LongTermDebtMember_c9139218-673d-4064-830f-26b6fb4efd03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_eaa67e6f-2411-48de-bf48-f53bd35846c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9bd0cfe8-cdae-4cc9-b821-fcdf4dd88b30" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_eaa67e6f-2411-48de-bf48-f53bd35846c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e4f0dd3c-df9b-49ec-8ea9-790b97cd2f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_21e4efd5-d887-44df-b476-c8bf92a29078" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e4f0dd3c-df9b-49ec-8ea9-790b97cd2f4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e4f0dd3c-df9b-49ec-8ea9-790b97cd2f4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e4f0dd3c-df9b-49ec-8ea9-790b97cd2f4c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e4f0dd3c-df9b-49ec-8ea9-790b97cd2f4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4a139d97-5a25-4c81-a148-87079e36da3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e4f0dd3c-df9b-49ec-8ea9-790b97cd2f4c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4a139d97-5a25-4c81-a148-87079e36da3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_e9e6989b-a0d2-4bfc-be5c-b5f34349a03e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4a139d97-5a25-4c81-a148-87079e36da3e" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_e9e6989b-a0d2-4bfc-be5c-b5f34349a03e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_403979dd-d076-4f1f-a589-e8d021aa98bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_21e4efd5-d887-44df-b476-c8bf92a29078" xlink:to="loc_us-gaap_DebtInstrumentAxis_403979dd-d076-4f1f-a589-e8d021aa98bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_403979dd-d076-4f1f-a589-e8d021aa98bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_403979dd-d076-4f1f-a589-e8d021aa98bf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_403979dd-d076-4f1f-a589-e8d021aa98bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_917bbc11-d2e7-4cd7-8a8c-6008d106a8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_403979dd-d076-4f1f-a589-e8d021aa98bf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_917bbc11-d2e7-4cd7-8a8c-6008d106a8a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CreditFacilitiesMember_35e075fb-ef2c-46fc-b757-7a3e2d55c336" xlink:href="mdxg-20210630.xsd#mdxg_CreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_917bbc11-d2e7-4cd7-8a8c-6008d106a8a7" xlink:to="loc_mdxg_CreditFacilitiesMember_35e075fb-ef2c-46fc-b757-7a3e2d55c336" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember_0ce1bf12-3e7c-4ebf-8fd8-7563a0bd4320" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdxg_CreditFacilitiesMember_35e075fb-ef2c-46fc-b757-7a3e2d55c336" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanMember_0ce1bf12-3e7c-4ebf-8fd8-7563a0bd4320" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_a7a0a7c8-ca8a-429e-ac9f-e3c9ec0fcfa6" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdxg_CreditFacilitiesMember_35e075fb-ef2c-46fc-b757-7a3e2d55c336" xlink:to="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_a7a0a7c8-ca8a-429e-ac9f-e3c9ec0fcfa6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#LongTermDebtTermLoanBalancesDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails" xlink:type="extended" id="ib958f8c7683940deb1d42b513e640275_LongTermDebtTermLoanBalancesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_91ee6e8b-b961-480d-a32a-718845289e46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f446a6c1-1193-4cb8-b4de-c7a894df1a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_91ee6e8b-b961-480d-a32a-718845289e46" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f446a6c1-1193-4cb8-b4de-c7a894df1a9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_2abec197-56dc-4e77-bb4a-3605907be2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_91ee6e8b-b961-480d-a32a-718845289e46" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_2abec197-56dc-4e77-bb4a-3605907be2ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2accb0b4-62ad-444d-9ad8-86c2d62ad8ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_91ee6e8b-b961-480d-a32a-718845289e46" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2accb0b4-62ad-444d-9ad8-86c2d62ad8ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_53853efb-ab65-4d9e-ad8d-60d966e20799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_91ee6e8b-b961-480d-a32a-718845289e46" xlink:to="loc_us-gaap_LongTermDebt_53853efb-ab65-4d9e-ad8d-60d966e20799" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7f1f7aa5-f0d1-49c2-80ad-742f7ce1c766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_91ee6e8b-b961-480d-a32a-718845289e46" xlink:to="loc_us-gaap_DebtInstrumentTable_7f1f7aa5-f0d1-49c2-80ad-742f7ce1c766" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0a185dc4-f33e-4055-bd72-9554366980bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7f1f7aa5-f0d1-49c2-80ad-742f7ce1c766" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0a185dc4-f33e-4055-bd72-9554366980bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0a185dc4-f33e-4055-bd72-9554366980bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0a185dc4-f33e-4055-bd72-9554366980bf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0a185dc4-f33e-4055-bd72-9554366980bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d4a9ec13-e128-46b1-9897-5fedb3965995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0a185dc4-f33e-4055-bd72-9554366980bf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d4a9ec13-e128-46b1-9897-5fedb3965995" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_ce85f8ac-dd30-4a15-9218-51ac4e3888c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d4a9ec13-e128-46b1-9897-5fedb3965995" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_ce85f8ac-dd30-4a15-9218-51ac4e3888c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c4f6b96b-89a7-4450-95bb-5400f41aaa01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7f1f7aa5-f0d1-49c2-80ad-742f7ce1c766" xlink:to="loc_us-gaap_DebtInstrumentAxis_c4f6b96b-89a7-4450-95bb-5400f41aaa01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c4f6b96b-89a7-4450-95bb-5400f41aaa01_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c4f6b96b-89a7-4450-95bb-5400f41aaa01" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c4f6b96b-89a7-4450-95bb-5400f41aaa01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d9c2d33a-e07c-4ab4-84b2-98fe56a4fe77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c4f6b96b-89a7-4450-95bb-5400f41aaa01" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d9c2d33a-e07c-4ab4-84b2-98fe56a4fe77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember_b08fa160-f54d-4fe4-b1a7-88bd521aadd3" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9c2d33a-e07c-4ab4-84b2-98fe56a4fe77" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanMember_b08fa160-f54d-4fe4-b1a7-88bd521aadd3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#LongTermDebtTermLoanInterestExpenseDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails" xlink:type="extended" id="i1d9795791d8b4a00a15f4417ee8dceaf_LongTermDebtTermLoanInterestExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d39bb340-a127-4b21-9dd3-28b7ef003484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentCommitmentFees_9ee2acc3-ec7a-42d2-9ee7-5b32fbf91d7b" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentCommitmentFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d39bb340-a127-4b21-9dd3-28b7ef003484" xlink:to="loc_mdxg_DebtInstrumentCommitmentFees_9ee2acc3-ec7a-42d2-9ee7-5b32fbf91d7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_db210b59-2512-40ca-a742-c96ae2d177af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d39bb340-a127-4b21-9dd3-28b7ef003484" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_db210b59-2512-40ca-a742-c96ae2d177af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_51854d14-4087-4086-b26f-72af2bea1511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d39bb340-a127-4b21-9dd3-28b7ef003484" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_51854d14-4087-4086-b26f-72af2bea1511" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet_f7ce4ee8-6bd0-4270-b1a2-89a568e9cb71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredLoanOriginationFeesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d39bb340-a127-4b21-9dd3-28b7ef003484" xlink:to="loc_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet_f7ce4ee8-6bd0-4270-b1a2-89a568e9cb71" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_403add06-0b71-40e0-bf71-4fb512e10ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d39bb340-a127-4b21-9dd3-28b7ef003484" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_403add06-0b71-40e0-bf71-4fb512e10ef9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_e89c0ea8-081c-46f9-aebe-ee156a99b711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d39bb340-a127-4b21-9dd3-28b7ef003484" xlink:to="loc_us-gaap_InterestExpenseDebt_e89c0ea8-081c-46f9-aebe-ee156a99b711" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_745ddef4-d6af-4a33-a38a-71e75867b66d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d39bb340-a127-4b21-9dd3-28b7ef003484" xlink:to="loc_us-gaap_DebtInstrumentTable_745ddef4-d6af-4a33-a38a-71e75867b66d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_02dacd96-271b-43eb-8b4f-0fcb0b2c1459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_745ddef4-d6af-4a33-a38a-71e75867b66d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_02dacd96-271b-43eb-8b4f-0fcb0b2c1459" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_02dacd96-271b-43eb-8b4f-0fcb0b2c1459_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_02dacd96-271b-43eb-8b4f-0fcb0b2c1459" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_02dacd96-271b-43eb-8b4f-0fcb0b2c1459_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b1b09665-b072-4b6f-a7a5-b8c748ed3ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_02dacd96-271b-43eb-8b4f-0fcb0b2c1459" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b1b09665-b072-4b6f-a7a5-b8c748ed3ab8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_a3686ef8-0acb-4729-89d8-892cf999e88a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b1b09665-b072-4b6f-a7a5-b8c748ed3ab8" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_a3686ef8-0acb-4729-89d8-892cf999e88a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b4722757-0a3a-4588-8a23-2f69aa8e271c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_745ddef4-d6af-4a33-a38a-71e75867b66d" xlink:to="loc_us-gaap_DebtInstrumentAxis_b4722757-0a3a-4588-8a23-2f69aa8e271c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b4722757-0a3a-4588-8a23-2f69aa8e271c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b4722757-0a3a-4588-8a23-2f69aa8e271c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b4722757-0a3a-4588-8a23-2f69aa8e271c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1f155b9d-feef-43c6-97b0-c7e3b2dc3a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b4722757-0a3a-4588-8a23-2f69aa8e271c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1f155b9d-feef-43c6-97b0-c7e3b2dc3a8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember_e431a150-a643-40cf-b9bd-ff898b66b845" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1f155b9d-feef-43c6-97b0-c7e3b2dc3a8f" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanMember_e431a150-a643-40cf-b9bd-ff898b66b845" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_48862669-15fe-4603-9fd6-2eb7fb23c32b" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1f155b9d-feef-43c6-97b0-c7e3b2dc3a8f" xlink:to="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_48862669-15fe-4603-9fd6-2eb7fb23c32b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TermLoanAgreementMember_87abf62f-f198-4051-a4d6-28957acedf1e" xlink:href="mdxg-20210630.xsd#mdxg_TermLoanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1f155b9d-feef-43c6-97b0-c7e3b2dc3a8f" xlink:to="loc_mdxg_TermLoanAgreementMember_87abf62f-f198-4051-a4d6-28957acedf1e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#LongTermDebtPaycheckProtectionProgramLoanDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails" xlink:type="extended" id="i72ae538599aa42248ee1951bb8b16d41_LongTermDebtPaycheckProtectionProgramLoanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_60a49d30-f95f-4dfb-8417-d1a7f8d451a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_38744359-bd14-4c44-8ee3-9976e71147d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_60a49d30-f95f-4dfb-8417-d1a7f8d451a1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_38744359-bd14-4c44-8ee3-9976e71147d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_837fae1d-faa8-4fde-9e06-3fad45e53ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_60a49d30-f95f-4dfb-8417-d1a7f8d451a1" xlink:to="loc_us-gaap_DebtInstrumentTable_837fae1d-faa8-4fde-9e06-3fad45e53ab9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6c71de6c-02b7-41c3-929a-8399e5d4d3df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_837fae1d-faa8-4fde-9e06-3fad45e53ab9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6c71de6c-02b7-41c3-929a-8399e5d4d3df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6c71de6c-02b7-41c3-929a-8399e5d4d3df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6c71de6c-02b7-41c3-929a-8399e5d4d3df" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6c71de6c-02b7-41c3-929a-8399e5d4d3df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fb2a4eab-4f4d-44da-8b81-11da2b42199a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6c71de6c-02b7-41c3-929a-8399e5d4d3df" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fb2a4eab-4f4d-44da-8b81-11da2b42199a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_461ea97d-4634-4ce7-b35a-4ca7167552e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fb2a4eab-4f4d-44da-8b81-11da2b42199a" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_461ea97d-4634-4ce7-b35a-4ca7167552e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d9f55382-c2ef-4731-a5e1-68bfc9e2fa70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_837fae1d-faa8-4fde-9e06-3fad45e53ab9" xlink:to="loc_us-gaap_DebtInstrumentAxis_d9f55382-c2ef-4731-a5e1-68bfc9e2fa70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d9f55382-c2ef-4731-a5e1-68bfc9e2fa70_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d9f55382-c2ef-4731-a5e1-68bfc9e2fa70" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d9f55382-c2ef-4731-a5e1-68bfc9e2fa70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_45ee9fea-c4c2-46ac-ab33-599d72d4d710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d9f55382-c2ef-4731-a5e1-68bfc9e2fa70" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_45ee9fea-c4c2-46ac-ab33-599d72d4d710" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PaycheckProtectionProgramLoanMember_cd2bd25e-e911-4144-afa8-3bfa5902f5d1" xlink:href="mdxg-20210630.xsd#mdxg_PaycheckProtectionProgramLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_45ee9fea-c4c2-46ac-ab33-599d72d4d710" xlink:to="loc_mdxg_PaycheckProtectionProgramLoanMember_cd2bd25e-e911-4144-afa8-3bfa5902f5d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_beba51d7-d8a5-4e3b-bcb0-77f3d9f99ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_837fae1d-faa8-4fde-9e06-3fad45e53ab9" xlink:to="loc_us-gaap_VariableRateAxis_beba51d7-d8a5-4e3b-bcb0-77f3d9f99ba9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_beba51d7-d8a5-4e3b-bcb0-77f3d9f99ba9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_beba51d7-d8a5-4e3b-bcb0-77f3d9f99ba9" xlink:to="loc_us-gaap_VariableRateDomain_beba51d7-d8a5-4e3b-bcb0-77f3d9f99ba9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6ac568ae-c9ad-4357-bc24-e9fd58f4cbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_beba51d7-d8a5-4e3b-bcb0-77f3d9f99ba9" xlink:to="loc_us-gaap_VariableRateDomain_6ac568ae-c9ad-4357-bc24-e9fd58f4cbc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_1c3b444f-80e5-4d24-92be-464e12d62aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_837fae1d-faa8-4fde-9e06-3fad45e53ab9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_1c3b444f-80e5-4d24-92be-464e12d62aaf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1c3b444f-80e5-4d24-92be-464e12d62aaf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_1c3b444f-80e5-4d24-92be-464e12d62aaf" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1c3b444f-80e5-4d24-92be-464e12d62aaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_38f9e555-b9e8-4892-8a36-187737a0632f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_1c3b444f-80e5-4d24-92be-464e12d62aaf" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_38f9e555-b9e8-4892-8a36-187737a0632f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9e4bd0fd-01b6-4810-9de8-0166a468c16e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_837fae1d-faa8-4fde-9e06-3fad45e53ab9" xlink:to="loc_srt_RangeAxis_9e4bd0fd-01b6-4810-9de8-0166a468c16e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9e4bd0fd-01b6-4810-9de8-0166a468c16e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9e4bd0fd-01b6-4810-9de8-0166a468c16e" xlink:to="loc_srt_RangeMember_9e4bd0fd-01b6-4810-9de8-0166a468c16e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b4f26ebd-4379-4623-bd01-8e044f128f45" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9e4bd0fd-01b6-4810-9de8-0166a468c16e" xlink:to="loc_srt_RangeMember_b4f26ebd-4379-4623-bd01-8e044f128f45" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails" xlink:type="extended" id="id3a09d89e18a47b1b6ee71b818605903_NetLossPerCommonShareDilutedNetLossPerCommonShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13688ad4-698e-45e6-9549-94b2bb96d394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_054de175-058f-42f1-894a-35ce5723bdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13688ad4-698e-45e6-9549-94b2bb96d394" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_054de175-058f-42f1-894a-35ce5723bdfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_fdc67cdb-040b-4a85-a1c1-e427950264d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13688ad4-698e-45e6-9549-94b2bb96d394" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_fdc67cdb-040b-4a85-a1c1-e427950264d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_e0a6039b-7eac-4ea9-bfa9-61b7ec8a8b45" xlink:href="mdxg-20210630.xsd#mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13688ad4-698e-45e6-9549-94b2bb96d394" xlink:to="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_e0a6039b-7eac-4ea9-bfa9-61b7ec8a8b45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_708b99d9-4371-466c-8a7b-f3d963f05879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13688ad4-698e-45e6-9549-94b2bb96d394" xlink:to="loc_us-gaap_EarningsPerShareDiluted_708b99d9-4371-466c-8a7b-f3d963f05879" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e8729280-4f9f-46f9-ac8d-6c3f8e810d00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13688ad4-698e-45e6-9549-94b2bb96d394" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e8729280-4f9f-46f9-ac8d-6c3f8e810d00" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a9928586-e20a-43c3-99e5-b38c1572793d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13688ad4-698e-45e6-9549-94b2bb96d394" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a9928586-e20a-43c3-99e5-b38c1572793d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0bf80ec0-c1a9-4644-bbef-13408ba92526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13688ad4-698e-45e6-9549-94b2bb96d394" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0bf80ec0-c1a9-4644-bbef-13408ba92526" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_76d28b72-2d8f-4a3f-ac4c-8818e9d60469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0bf80ec0-c1a9-4644-bbef-13408ba92526" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_76d28b72-2d8f-4a3f-ac4c-8818e9d60469" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_76d28b72-2d8f-4a3f-ac4c-8818e9d60469_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_76d28b72-2d8f-4a3f-ac4c-8818e9d60469" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_76d28b72-2d8f-4a3f-ac4c-8818e9d60469_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ca9e0e8-43de-4965-aee9-6f135606a916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_76d28b72-2d8f-4a3f-ac4c-8818e9d60469" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ca9e0e8-43de-4965-aee9-6f135606a916" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_bb4ac544-bdfe-4e15-b433-d0732a1b6f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ca9e0e8-43de-4965-aee9-6f135606a916" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_bb4ac544-bdfe-4e15-b433-d0732a1b6f2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_4fb70bf4-affe-43cc-8c7b-b0c5bc15de2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ca9e0e8-43de-4965-aee9-6f135606a916" xlink:to="loc_us-gaap_RestrictedStockMember_4fb70bf4-affe-43cc-8c7b-b0c5bc15de2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0e2c1662-39ad-4135-86d0-37dc94589f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ca9e0e8-43de-4965-aee9-6f135606a916" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0e2c1662-39ad-4135-86d0-37dc94589f3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_46eb4c1b-d628-4202-82b8-7e194ceb5348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ca9e0e8-43de-4965-aee9-6f135606a916" xlink:to="loc_us-gaap_EmployeeStockOptionMember_46eb4c1b-d628-4202-82b8-7e194ceb5348" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_6674df51-5429-4bae-adff-98ce2fa4532d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ca9e0e8-43de-4965-aee9-6f135606a916" xlink:to="loc_us-gaap_PerformanceSharesMember_6674df51-5429-4bae-adff-98ce2fa4532d" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/EquityNarrativeDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#EquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/EquityNarrativeDetails" xlink:type="extended" id="i16f878ca5b904d329e151be1b690b40b_EquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_4106afc6-9fe9-401c-af91-de46ec40f73b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_4106afc6-9fe9-401c-af91-de46ec40f73b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_ef60b93e-9949-41d5-806c-b7786ff483a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_ef60b93e-9949-41d5-806c-b7786ff483a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ProceedsfromIssuanceofTemporaryEquity_a60cbc8d-439b-4172-bad0-f7b9dc014429" xlink:href="mdxg-20210630.xsd#mdxg_ProceedsfromIssuanceofTemporaryEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_ProceedsfromIssuanceofTemporaryEquity_a60cbc8d-439b-4172-bad0-f7b9dc014429" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityDividendRatePercentage_871e9942-e08d-4299-b45c-ce8f13b20b88" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityDividendRatePercentage_871e9942-e08d-4299-b45c-ce8f13b20b88" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionPricePerShare_8327b5b1-b19e-47af-9f7d-797df91fd109" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityConversionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityConversionPricePerShare_8327b5b1-b19e-47af-9f7d-797df91fd109" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionRatio_44015f64-92a9-4808-83fd-860cab80376e" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityConversionRatio_44015f64-92a9-4808-83fd-860cab80376e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger_c53d96ec-c76e-4dc9-9157-73781d95d44c" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger_c53d96ec-c76e-4dc9-9157-73781d95d44c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdTradingDays_88721f5c-5de2-48e2-995e-3911367c06a8" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityConversionThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityConversionThresholdTradingDays_88721f5c-5de2-48e2-995e-3911367c06a8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityThresholdConsecutiveTradingDays_c69562be-c32f-4744-9a04-a9afa0f9dcf8" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityThresholdConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityThresholdConsecutiveTradingDays_c69562be-c32f-4744-9a04-a9afa0f9dcf8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion_00a1a44e-0cb8-412a-a7b1-6ee058afda64" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion_00a1a44e-0cb8-412a-a7b1-6ee058afda64" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders_d1619ace-f00e-4fa0-92eb-f844c7970407" xlink:href="mdxg-20210630.xsd#mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders_d1619ace-f00e-4fa0-92eb-f844c7970407" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis_0c1a3079-0c58-4e88-afd5-4f0e1f55e434" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis_0c1a3079-0c58-4e88-afd5-4f0e1f55e434" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityIncreasingrateDividendFeature_234e8a82-ec39-4337-a5f2-048591a0c125" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityIncreasingrateDividendFeature"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityIncreasingrateDividendFeature_234e8a82-ec39-4337-a5f2-048591a0c125" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_b9a124f3-6bc9-4d0e-96f8-da5f45db9a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_b9a124f3-6bc9-4d0e-96f8-da5f45db9a44" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_f3c34112-9993-40b7-aa28-da080503d5ae" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityAccretedbutUnrecordedDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_f3c34112-9993-40b7-aa28-da080503d5ae" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquitySharesIssueduponConversion_9b84021a-ab64-4945-bd3b-9d6e4b576a14" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquitySharesIssueduponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquitySharesIssueduponConversion_9b84021a-ab64-4945-bd3b-9d6e4b576a14" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_d214da80-ee28-4c9f-a9e0-d5557d91ff6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_us-gaap_DividendsPayableTable_d214da80-ee28-4c9f-a9e0-d5557d91ff6e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_74a5d6ea-884e-4a0b-8765-66790b6eb884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_d214da80-ee28-4c9f-a9e0-d5557d91ff6e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_74a5d6ea-884e-4a0b-8765-66790b6eb884" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_74a5d6ea-884e-4a0b-8765-66790b6eb884_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_74a5d6ea-884e-4a0b-8765-66790b6eb884" xlink:to="loc_us-gaap_ClassOfStockDomain_74a5d6ea-884e-4a0b-8765-66790b6eb884_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3a665876-63be-4198-9f55-5ded4442a6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_74a5d6ea-884e-4a0b-8765-66790b6eb884" xlink:to="loc_us-gaap_ClassOfStockDomain_3a665876-63be-4198-9f55-5ded4442a6fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredClassBMember_fd448eca-516b-4174-b629-43c8241807a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3a665876-63be-4198-9f55-5ded4442a6fc" xlink:to="loc_us-gaap_PreferredClassBMember_fd448eca-516b-4174-b629-43c8241807a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_9ba63b0d-ddfb-4e6c-ae1e-12d318a41b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3a665876-63be-4198-9f55-5ded4442a6fc" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_9ba63b0d-ddfb-4e6c-ae1e-12d318a41b07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis_4a4b3a7e-aa03-4714-aa3b-a8ca45b783d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_d214da80-ee28-4c9f-a9e0-d5557d91ff6e" xlink:to="loc_us-gaap_DividendsAxis_4a4b3a7e-aa03-4714-aa3b-a8ca45b783d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_4a4b3a7e-aa03-4714-aa3b-a8ca45b783d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DividendsAxis_4a4b3a7e-aa03-4714-aa3b-a8ca45b783d5" xlink:to="loc_us-gaap_DividendsDomain_4a4b3a7e-aa03-4714-aa3b-a8ca45b783d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_c3f835ae-4005-4826-b2ae-6606db19673b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DividendsAxis_4a4b3a7e-aa03-4714-aa3b-a8ca45b783d5" xlink:to="loc_us-gaap_DividendsDomain_c3f835ae-4005-4826-b2ae-6606db19673b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member_334cfdab-00cb-48a3-b6c1-2dcb56dcd42b" xlink:href="mdxg-20210630.xsd#mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsDomain_c3f835ae-4005-4826-b2ae-6606db19673b" xlink:to="loc_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member_334cfdab-00cb-48a3-b6c1-2dcb56dcd42b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member_0edeead7-931a-4785-8ca3-c99723b004ff" xlink:href="mdxg-20210630.xsd#mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsDomain_c3f835ae-4005-4826-b2ae-6606db19673b" xlink:to="loc_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member_0edeead7-931a-4785-8ca3-c99723b004ff" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#EquityChangesinSeriesBPreferredStockDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails" xlink:type="extended" id="i99f8223cd9634d3dab3c1641bc70a7f7_EquityChangesinSeriesBPreferredStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_53c8aaa0-f1b2-4e27-94b2-9f555b6104e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_14efa84c-3efc-4289-a449-d592f3ac37df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_53c8aaa0-f1b2-4e27-94b2-9f555b6104e4" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_14efa84c-3efc-4289-a449-d592f3ac37df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_46881800-7061-4391-9f7a-9ec618e3403e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_14efa84c-3efc-4289-a449-d592f3ac37df" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_46881800-7061-4391-9f7a-9ec618e3403e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_23d10769-a269-4140-b68d-8eaca5206595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_14efa84c-3efc-4289-a449-d592f3ac37df" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_23d10769-a269-4140-b68d-8eaca5206595" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_31966ef1-ca16-4978-8923-7c71d3d84186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_14efa84c-3efc-4289-a449-d592f3ac37df" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_31966ef1-ca16-4978-8923-7c71d3d84186" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_82a5f5c5-aa83-4809-9199-6984ac236c84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d1f50fb1-ff51-4069-8207-d0502dd71e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_d0b7bb13-39eb-490b-9f46-3ff60e0ee857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_53c8aaa0-f1b2-4e27-94b2-9f555b6104e4" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_d0b7bb13-39eb-490b-9f46-3ff60e0ee857" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e3a104dc-6a29-46cf-9e7f-8b0578e8b716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d0b7bb13-39eb-490b-9f46-3ff60e0ee857" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e3a104dc-6a29-46cf-9e7f-8b0578e8b716" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e3a104dc-6a29-46cf-9e7f-8b0578e8b716_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e3a104dc-6a29-46cf-9e7f-8b0578e8b716" xlink:to="loc_us-gaap_ClassOfStockDomain_e3a104dc-6a29-46cf-9e7f-8b0578e8b716_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2df8a31c-d336-4e81-a940-08316bc48080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e3a104dc-6a29-46cf-9e7f-8b0578e8b716" xlink:to="loc_us-gaap_ClassOfStockDomain_2df8a31c-d336-4e81-a940-08316bc48080" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_aab5fbbf-630e-40d1-a310-1d9e85439b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2df8a31c-d336-4e81-a940-08316bc48080" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_aab5fbbf-630e-40d1-a310-1d9e85439b63" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/EquityRestrictedStockAwardsDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#EquityRestrictedStockAwardsDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/EquityRestrictedStockAwardsDetails" xlink:type="extended" id="if33874b7431f45748dd478fea47846c1_EquityRestrictedStockAwardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_350b9450-8a1b-4334-a117-a9a29995e649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88203f74-2a4a-4032-8755-a0580e03a502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_350b9450-8a1b-4334-a117-a9a29995e649" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88203f74-2a4a-4032-8755-a0580e03a502" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4e1b8f8b-e4d5-426f-81f8-caef23700b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88203f74-2a4a-4032-8755-a0580e03a502" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4e1b8f8b-e4d5-426f-81f8-caef23700b63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_59d67c6d-3c56-461c-a31e-fcea7857b8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88203f74-2a4a-4032-8755-a0580e03a502" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_59d67c6d-3c56-461c-a31e-fcea7857b8bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ad6bb3fb-83a5-49f2-8ff3-e92a12b7d8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88203f74-2a4a-4032-8755-a0580e03a502" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ad6bb3fb-83a5-49f2-8ff3-e92a12b7d8a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1b11c216-5db2-4943-a970-80bd2c8acdd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88203f74-2a4a-4032-8755-a0580e03a502" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1b11c216-5db2-4943-a970-80bd2c8acdd6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c74095f9-ed25-4db9-a98e-c66bbfec15bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d36a9dc4-19d7-44d1-a496-d4ce6175dae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_350b9450-8a1b-4334-a117-a9a29995e649" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d36a9dc4-19d7-44d1-a496-d4ce6175dae1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_00fc1ef7-1c16-4f4c-bbc9-30fa005e093d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d36a9dc4-19d7-44d1-a496-d4ce6175dae1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_00fc1ef7-1c16-4f4c-bbc9-30fa005e093d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9c149a95-2aa0-4455-93b9-ce3ecfadcf52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d36a9dc4-19d7-44d1-a496-d4ce6175dae1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9c149a95-2aa0-4455-93b9-ce3ecfadcf52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_96693a8a-a9ee-455f-ad90-87bdc850b070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d36a9dc4-19d7-44d1-a496-d4ce6175dae1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_96693a8a-a9ee-455f-ad90-87bdc850b070" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_b3461288-20ee-4299-a562-bcf9758f5c64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d36a9dc4-19d7-44d1-a496-d4ce6175dae1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_b3461288-20ee-4299-a562-bcf9758f5c64" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_cf2e72e7-445a-4b21-86ac-54dd34f326eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_99b938aa-817c-49ba-abd9-5d4c507fde82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_350b9450-8a1b-4334-a117-a9a29995e649" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_99b938aa-817c-49ba-abd9-5d4c507fde82" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_51b36b16-8c79-4a6d-be82-df47c952a6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_99b938aa-817c-49ba-abd9-5d4c507fde82" xlink:to="loc_us-gaap_AwardTypeAxis_51b36b16-8c79-4a6d-be82-df47c952a6c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_51b36b16-8c79-4a6d-be82-df47c952a6c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_51b36b16-8c79-4a6d-be82-df47c952a6c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_51b36b16-8c79-4a6d-be82-df47c952a6c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b29af66-a951-48dd-8ac3-32a946d303e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_51b36b16-8c79-4a6d-be82-df47c952a6c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b29af66-a951-48dd-8ac3-32a946d303e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_376b59bb-057b-487e-8ac2-8a3c5c70552c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b29af66-a951-48dd-8ac3-32a946d303e0" xlink:to="loc_us-gaap_RestrictedStockMember_376b59bb-057b-487e-8ac2-8a3c5c70552c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_377e8964-0fbe-49ac-8f98-c0184c49e8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b29af66-a951-48dd-8ac3-32a946d303e0" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_377e8964-0fbe-49ac-8f98-c0184c49e8f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_cd89a2a4-9588-46ac-8687-206b31f14806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b29af66-a951-48dd-8ac3-32a946d303e0" xlink:to="loc_us-gaap_PerformanceSharesMember_cd89a2a4-9588-46ac-8687-206b31f14806" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/IncometaxesDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#IncometaxesDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/IncometaxesDetails" xlink:type="extended" id="i15e4bd7c683c4accb0de29d28ca2a2d1_IncometaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems_151617ff-f6bc-4f7f-90e5-f333a16a86fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d2cce165-80be-4a38-923d-ad023e2774bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_151617ff-f6bc-4f7f-90e5-f333a16a86fc" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d2cce165-80be-4a38-923d-ad023e2774bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds_e0859313-72e9-4139-a0bd-70c27b47345f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_151617ff-f6bc-4f7f-90e5-f333a16a86fc" xlink:to="loc_us-gaap_ProceedsFromIncomeTaxRefunds_e0859313-72e9-4139-a0bd-70c27b47345f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable_29fe22c6-647b-4acc-8905-7b8e627d2aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_151617ff-f6bc-4f7f-90e5-f333a16a86fc" xlink:to="loc_us-gaap_UnusualOrInfrequentItemTable_29fe22c6-647b-4acc-8905-7b8e627d2aed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_430c6cc0-1c6f-4a76-b944-20e3fc0de427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_29fe22c6-647b-4acc-8905-7b8e627d2aed" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_430c6cc0-1c6f-4a76-b944-20e3fc0de427" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_430c6cc0-1c6f-4a76-b944-20e3fc0de427_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_430c6cc0-1c6f-4a76-b944-20e3fc0de427" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_430c6cc0-1c6f-4a76-b944-20e3fc0de427_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_fc2a5b68-3d6e-44d9-9757-442b2952d25c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_430c6cc0-1c6f-4a76-b944-20e3fc0de427" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_fc2a5b68-3d6e-44d9-9757-442b2952d25c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CARESActMember_f2d1aa5e-7d3e-4c97-8e57-aaae55d50f1a" xlink:href="mdxg-20210630.xsd#mdxg_CARESActMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_fc2a5b68-3d6e-44d9-9757-442b2952d25c" xlink:to="loc_mdxg_CARESActMember_f2d1aa5e-7d3e-4c97-8e57-aaae55d50f1a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#ContractualCommitmentsandContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails" xlink:type="extended" id="i1dd83b2a16c441d185a49603a7fcf0bb_ContractualCommitmentsandContingenciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_7ab0743b-3a4b-4961-81c3-13e8af671f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_7ab0743b-3a4b-4961-81c3-13e8af671f26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivable_5b769bab-3086-4892-b46a-31347b1149ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceSettlementsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:to="loc_us-gaap_InsuranceSettlementsReceivable_5b769bab-3086-4892-b46a-31347b1149ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_34eeefe0-6c08-466d-ab36-fe4ae5e8985c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_34eeefe0-6c08-466d-ab36-fe4ae5e8985c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceRecoveries_eedfc612-18a6-458f-840f-6bacc8fc34c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceRecoveries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:to="loc_us-gaap_InsuranceRecoveries_eedfc612-18a6-458f-840f-6bacc8fc34c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ContingencyLossNumberOfSecuritiesClassActions_51a6a7a1-429c-4d2d-8b9c-f05097d1ef77" xlink:href="mdxg-20210630.xsd#mdxg_ContingencyLossNumberOfSecuritiesClassActions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:to="loc_mdxg_ContingencyLossNumberOfSecuritiesClassActions_51a6a7a1-429c-4d2d-8b9c-f05097d1ef77" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ContingencyLossNumberOfFormerHealthcareProviders_f4554218-5466-4a9d-8b1b-da8838aaa24c" xlink:href="mdxg-20210630.xsd#mdxg_ContingencyLossNumberOfFormerHealthcareProviders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:to="loc_mdxg_ContingencyLossNumberOfFormerHealthcareProviders_f4554218-5466-4a9d-8b1b-da8838aaa24c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_c4dbc2b5-ee50-4f44-9bdf-290544778f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_c4dbc2b5-ee50-4f44-9bdf-290544778f23" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable_36fc051d-c010-437a-8628-7c6bb203f92f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:to="loc_us-gaap_GainContingenciesTable_36fc051d-c010-437a-8628-7c6bb203f92f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_00dd4897-9efc-4fa8-bcba-9fa2e38c5a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_GainContingenciesTable_36fc051d-c010-437a-8628-7c6bb203f92f" xlink:to="loc_us-gaap_LitigationStatusAxis_00dd4897-9efc-4fa8-bcba-9fa2e38c5a9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_00dd4897-9efc-4fa8-bcba-9fa2e38c5a9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_00dd4897-9efc-4fa8-bcba-9fa2e38c5a9b" xlink:to="loc_us-gaap_LitigationStatusDomain_00dd4897-9efc-4fa8-bcba-9fa2e38c5a9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_bb2b95cf-32c0-49f5-8124-d3a8b869cd37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_00dd4897-9efc-4fa8-bcba-9fa2e38c5a9b" xlink:to="loc_us-gaap_LitigationStatusDomain_bb2b95cf-32c0-49f5-8124-d3a8b869cd37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_LegalProceedingsMember_9adcea6d-3ebd-49a7-91c7-cf041874a23a" xlink:href="mdxg-20210630.xsd#mdxg_LegalProceedingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_bb2b95cf-32c0-49f5-8124-d3a8b869cd37" xlink:to="loc_mdxg_LegalProceedingsMember_9adcea6d-3ebd-49a7-91c7-cf041874a23a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#RevenueSummaryofRevenuebyProductTypeDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails" xlink:type="extended" id="ib2efe8ac08744b73adca6d74bbede6b5_RevenueSummaryofRevenuebyProductTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_64bfb32d-0196-47d2-a14c-82fd4d2cb5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3096050e-911d-430a-ade7-9cc814a9c67f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_64bfb32d-0196-47d2-a14c-82fd4d2cb5a9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3096050e-911d-430a-ade7-9cc814a9c67f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c9c80746-e4ee-4470-8a6c-1ef25cd3a4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_64bfb32d-0196-47d2-a14c-82fd4d2cb5a9" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c9c80746-e4ee-4470-8a6c-1ef25cd3a4c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3f762526-96a2-4017-8418-3708f1d66e82" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c9c80746-e4ee-4470-8a6c-1ef25cd3a4c5" xlink:to="loc_srt_ProductOrServiceAxis_3f762526-96a2-4017-8418-3708f1d66e82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3f762526-96a2-4017-8418-3708f1d66e82_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_3f762526-96a2-4017-8418-3708f1d66e82" xlink:to="loc_srt_ProductsAndServicesDomain_3f762526-96a2-4017-8418-3708f1d66e82_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_eed88720-a27e-46ec-b964-46f9368f0cce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_3f762526-96a2-4017-8418-3708f1d66e82" xlink:to="loc_srt_ProductsAndServicesDomain_eed88720-a27e-46ec-b964-46f9368f0cce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareMember_24755b10-0c4c-4404-8972-ee0f38a0686e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_eed88720-a27e-46ec-b964-46f9368f0cce" xlink:to="loc_us-gaap_HealthCareMember_24755b10-0c4c-4404-8972-ee0f38a0686e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdvancedWoundCareTissueAndOtherMember_5ecea1cf-b7ad-4520-a811-c85c85312ae7" xlink:href="mdxg-20210630.xsd#mdxg_AdvancedWoundCareTissueAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareMember_24755b10-0c4c-4404-8972-ee0f38a0686e" xlink:to="loc_mdxg_AdvancedWoundCareTissueAndOtherMember_5ecea1cf-b7ad-4520-a811-c85c85312ae7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_7e651f86-b2a3-4db5-9955-5da073b41883" xlink:href="mdxg-20210630.xsd#mdxg_AdvancedWoundCareUmbilicalCordDerivedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareMember_24755b10-0c4c-4404-8972-ee0f38a0686e" xlink:to="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_7e651f86-b2a3-4db5-9955-5da073b41883" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_Section351Member_e33d2b41-414d-4fe6-923a-a5630bbee9b3" xlink:href="mdxg-20210630.xsd#mdxg_Section351Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_eed88720-a27e-46ec-b964-46f9368f0cce" xlink:to="loc_mdxg_Section351Member_e33d2b41-414d-4fe6-923a-a5630bbee9b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_2009800c-8376-48b3-8844-b7600e828276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_eed88720-a27e-46ec-b964-46f9368f0cce" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_2009800c-8376-48b3-8844-b7600e828276" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#RevenueSummaryofRevenuebyCustomerTypeDetails"/>
  <link:definitionLink xlink:role="http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails" xlink:type="extended" id="icc07e31606294fb9b0bf67b5dea5bca9_RevenueSummaryofRevenuebyCustomerTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1197d-737e-4b47-bf8d-27fc7810e748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5f7f0228-62a9-474e-b5a0-13cd03a7e4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1197d-737e-4b47-bf8d-27fc7810e748" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5f7f0228-62a9-474e-b5a0-13cd03a7e4bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_fd043407-fea5-4530-b7e8-121ceb7ac7ad" xlink:href="mdxg-20210630.xsd#mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1197d-737e-4b47-bf8d-27fc7810e748" xlink:to="loc_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_fd043407-fea5-4530-b7e8-121ceb7ac7ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_e9329c41-4587-4268-9630-30fd4576e669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1197d-737e-4b47-bf8d-27fc7810e748" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_e9329c41-4587-4268-9630-30fd4576e669" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_319ae5fa-c386-4a51-bd7f-518cb7ba2ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_e9329c41-4587-4268-9630-30fd4576e669" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_319ae5fa-c386-4a51-bd7f-518cb7ba2ffb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_319ae5fa-c386-4a51-bd7f-518cb7ba2ffb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_319ae5fa-c386-4a51-bd7f-518cb7ba2ffb" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_319ae5fa-c386-4a51-bd7f-518cb7ba2ffb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ebac7410-b579-4485-bb77-3b9ec699a6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_319ae5fa-c386-4a51-bd7f-518cb7ba2ffb" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ebac7410-b579-4485-bb77-3b9ec699a6aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_ec7720c9-ab22-42c3-8d0b-42da7a642235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ebac7410-b579-4485-bb77-3b9ec699a6aa" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_ec7720c9-ab22-42c3-8d0b-42da7a642235" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_91c0f30f-27ff-45b0-80dd-d655dea3b234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ebac7410-b579-4485-bb77-3b9ec699a6aa" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_91c0f30f-27ff-45b0-80dd-d655dea3b234" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>mdxg-20210630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:2348d07d-1fe7-4f85-b08a-d7c74be22bf0,g:fbe44d2f-ecde-4c93-87d4-07ca0cdbb039-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_DividendsAxis_56539745-4cea-4d2b-9de1-fcdef3a6d15f_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Axis]</link:label>
    <link:label id="lab_us-gaap_DividendsAxis_label_en-US" xlink:label="lab_us-gaap_DividendsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsAxis" xlink:to="lab_us-gaap_DividendsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_PaycheckProtectionProgramLoanMember_faeb17ff-bfc4-4bf9-8396-8aa22a07d082_terseLabel_en-US" xlink:label="lab_mdxg_PaycheckProtectionProgramLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP Loan</link:label>
    <link:label id="lab_mdxg_PaycheckProtectionProgramLoanMember_label_en-US" xlink:label="lab_mdxg_PaycheckProtectionProgramLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loan [Member]</link:label>
    <link:label id="lab_mdxg_PaycheckProtectionProgramLoanMember_documentation_en-US" xlink:label="lab_mdxg_PaycheckProtectionProgramLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PaycheckProtectionProgramLoanMember" xlink:href="mdxg-20210630.xsd#mdxg_PaycheckProtectionProgramLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_PaycheckProtectionProgramLoanMember" xlink:to="lab_mdxg_PaycheckProtectionProgramLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member_695994ce-1cde-4508-8988-da4190cccac2_terseLabel_en-US" xlink:label="lab_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Perpetual Dividend Rate after Quarterly Dividend Payment ending on June 30, 2021</link:label>
    <link:label id="lab_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member_label_en-US" xlink:label="lab_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Perpetual Dividend Rate after Quarterly Dividend Payment ending on June 30, 2021 [Member]</link:label>
    <link:label id="lab_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member_documentation_en-US" xlink:label="lab_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Perpetual Dividend Rate after Quarterly Dividend Payment ending on June 30, 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member" xlink:href="mdxg-20210630.xsd#mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member" xlink:to="lab_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_4878941c-7c47-4e86-9bb2-f96ff330a3c1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ccc09710-3e53-4d1a-a7ff-2d8553ce1d51_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_62560e10-e606-41d7-89a1-e5449bb07989_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names and trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_27a1f4df-2835-42d7-816a-5e3529c5a977_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_4ff7f80d-85f6-40fb-b5dd-99201d69dabe_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_ccdb96d6-11bf-4630-8367-6466019a55ae_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_3e0ac229-6f15-447c-a55f-c0c90d0efd6a_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_ece943e2-1485-4a15-a116-78d098b1cb04_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_NoncashActivitiesDeferredFinancingCosts_0dab1bf4-56c1-4692-ae5e-5a71d2d80bfd_terseLabel_en-US" xlink:label="lab_mdxg_NoncashActivitiesDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_mdxg_NoncashActivitiesDeferredFinancingCosts_label_en-US" xlink:label="lab_mdxg_NoncashActivitiesDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash Activities, Deferred Financing Costs</link:label>
    <link:label id="lab_mdxg_NoncashActivitiesDeferredFinancingCosts_documentation_en-US" xlink:label="lab_mdxg_NoncashActivitiesDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash Activities, Deferred Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NoncashActivitiesDeferredFinancingCosts" xlink:href="mdxg-20210630.xsd#mdxg_NoncashActivitiesDeferredFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_NoncashActivitiesDeferredFinancingCosts" xlink:to="lab_mdxg_NoncashActivitiesDeferredFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityConversionPricePerShare_7408d74d-bcf0-4327-bb64-ed4426242dcc_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B preferred stock, conversion price (in dollars per share)</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionPricePerShare_label_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion Price Per Share</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionPricePerShare_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionPricePerShare" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityConversionPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityConversionPricePerShare" xlink:to="lab_mdxg_TemporaryEquityConversionPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_FinanceLeaseAssetsMember_bc1fdffe-1269-4e2a-a37d-4cdb5150ef1a_terseLabel_en-US" xlink:label="lab_mdxg_FinanceLeaseAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease assets</link:label>
    <link:label id="lab_mdxg_FinanceLeaseAssetsMember_label_en-US" xlink:label="lab_mdxg_FinanceLeaseAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Assets [Member]</link:label>
    <link:label id="lab_mdxg_FinanceLeaseAssetsMember_documentation_en-US" xlink:label="lab_mdxg_FinanceLeaseAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FinanceLeaseAssetsMember" xlink:href="mdxg-20210630.xsd#mdxg_FinanceLeaseAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_FinanceLeaseAssetsMember" xlink:to="lab_mdxg_FinanceLeaseAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_d58b9998-a9c9-4cb2-abf4-d141cd9cd924_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_738d7f27-e8a6-4ca3-962e-32f95ab7df75_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_655ad37d-0e50-4c7b-8f34-8386452946a4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_eb7d34f5-86dc-48c1-9ae6-405e49d603cb_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_57aa1c8b-ba74-4615-a339-4687ee74480d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_30db6a19-d332-4b6b-8a8d-8da4163d42b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Principal Payments for the Term Loan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_dabe45ae-9810-462a-b154-cf4435bdfcfb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_11118d4b-afcb-45fe-b35c-132a0f532b46_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c7f439ad-f396-46d5-96c7-7313da814375_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested options forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_48a69a12-8a93-4671-a35c-94ca5abf6353_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B convertible preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_dd4c9f99-57fb-42be-9d61-bd366de465e1_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock, outstanding, beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_516251b3-a575-4894-baa2-283a9f56f0ba_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock, outstanding, ending (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_46f7369a-09e1-4420-a371-c019e275bf1d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_19561b26-096a-4a21-a7bf-2e886be5f0ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6c8f414a-0adb-4701-bf54-460d75116c5b_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_8e786505-b031-4403-b51a-f7afd7db1f37_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_2f1fec96-70bd-454f-96eb-019af9309f21_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 (excluding the six months ended June&#160;30, 2021)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_48e8ff65-5f2c-4055-9e16-b9181bde6227_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_bd26c56d-35ab-465c-b6f1-8e16c9ef9d50_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_RevenueFromContractWithCustomerPaymentTerms_cc2befe6-8b4b-42e6-b9e8-f0101363e938_terseLabel_en-US" xlink:label="lab_mdxg_RevenueFromContractWithCustomerPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer payment terms</link:label>
    <link:label id="lab_mdxg_RevenueFromContractWithCustomerPaymentTerms_label_en-US" xlink:label="lab_mdxg_RevenueFromContractWithCustomerPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Payment Terms</link:label>
    <link:label id="lab_mdxg_RevenueFromContractWithCustomerPaymentTerms_documentation_en-US" xlink:label="lab_mdxg_RevenueFromContractWithCustomerPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Payment Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_RevenueFromContractWithCustomerPaymentTerms" xlink:href="mdxg-20210630.xsd#mdxg_RevenueFromContractWithCustomerPaymentTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_RevenueFromContractWithCustomerPaymentTerms" xlink:to="lab_mdxg_RevenueFromContractWithCustomerPaymentTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9a0dd5a4-689b-4463-ad96-45fba2d79fc4_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_641a194b-12d6-4f4b-8f5e-2b5051c2b8c2_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_18f1297b-836b-4619-9010-c4c84fd34df9_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_beb279a0-3d36-49dd-b69f-0806dcae07ca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_074b1286-d029-46b4-ab7e-85c65e0a50eb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9e6dd8ac-4ebe-40fa-9944-ff3796c44d0d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7c633fa6-4e80-43f8-a0f6-fa3a10ca4870_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_f5c1c2c4-9fc8-45b3-b6a2-80b1aa0bcfbf_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityIncreasingrateDividendFeature_b1ca1eff-b075-4cfa-ae12-a0067f6dc87a_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityIncreasingrateDividendFeature" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B preferred stock, increasing-rate dividend feature</link:label>
    <link:label id="lab_mdxg_TemporaryEquityIncreasingrateDividendFeature_label_en-US" xlink:label="lab_mdxg_TemporaryEquityIncreasingrateDividendFeature" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increasing-rate Dividend Feature</link:label>
    <link:label id="lab_mdxg_TemporaryEquityIncreasingrateDividendFeature_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityIncreasingrateDividendFeature" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increasing-rate Dividend Feature</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityIncreasingrateDividendFeature" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityIncreasingrateDividendFeature"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityIncreasingrateDividendFeature" xlink:to="lab_mdxg_TemporaryEquityIncreasingrateDividendFeature" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_StockAwardMisstatementsMember_d81da826-09b3-47f2-957d-f19c03dbcedb_terseLabel_en-US" xlink:label="lab_mdxg_StockAwardMisstatementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Award Misstatements</link:label>
    <link:label id="lab_mdxg_StockAwardMisstatementsMember_label_en-US" xlink:label="lab_mdxg_StockAwardMisstatementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Award Misstatements [Member]</link:label>
    <link:label id="lab_mdxg_StockAwardMisstatementsMember_documentation_en-US" xlink:label="lab_mdxg_StockAwardMisstatementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Award Misstatements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_StockAwardMisstatementsMember" xlink:href="mdxg-20210630.xsd#mdxg_StockAwardMisstatementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_StockAwardMisstatementsMember" xlink:to="lab_mdxg_StockAwardMisstatementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion_bcdb1715-994c-4b4e-bf87-8f315b5e8b68_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B preferred stock, minimum percentage of conversion stock price on conversion date (percent)</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion_label_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger on Date of Conversion</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger on Date of Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" xlink:to="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_03b79c6f-430c-4c4d-b056-117683df2c1b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_3f512d31-517c-4af0-aa5a-e7ac517875d5_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributors</link:label>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:to="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_48f27f4a-1bcd-4bd3-963b-884f96fcfc5a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_d7e8f845-a6fc-4d18-ab37-432d692347c7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Activity Summary - Indefinite-lived</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fcf862b4-28be-4b9f-af6b-73fd164f93c3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_64871ec8-cdd5-40ea-8402-5f419bcf117f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated future amortization expense [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_4b3a1c31-3388-45f9-be5b-2c1c1105687d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_505e5141-3bee-4930-adac-772c91c8a066_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_label_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:to="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_5a636794-4d24-4a01-b7da-7dd5d0d79dd3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Contractual Term (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_e332cb42-3e79-4f55-9617-200c1ceeba8f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_8a610317-24cc-44ec-b5b9-887a4d6813c3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable options, vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TreasuryStockSharesAdjustment_1451c73e-5200-4523-82c6-e54bac19b0d5_terseLabel_en-US" xlink:label="lab_mdxg_TreasuryStockSharesAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Correction of out-of-period error (Note 1) (in shares)</link:label>
    <link:label id="lab_mdxg_TreasuryStockSharesAdjustment_d33c5888-7446-4765-a849-42d0be560ad5_verboseLabel_en-US" xlink:label="lab_mdxg_TreasuryStockSharesAdjustment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock adjustment (in shares)</link:label>
    <link:label id="lab_mdxg_TreasuryStockSharesAdjustment_label_en-US" xlink:label="lab_mdxg_TreasuryStockSharesAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Adjustment</link:label>
    <link:label id="lab_mdxg_TreasuryStockSharesAdjustment_documentation_en-US" xlink:label="lab_mdxg_TreasuryStockSharesAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TreasuryStockSharesAdjustment" xlink:href="mdxg-20210630.xsd#mdxg_TreasuryStockSharesAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TreasuryStockSharesAdjustment" xlink:to="lab_mdxg_TreasuryStockSharesAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_22c5b8ba-f8a1-43db-ab43-a469a153ec12_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_3fe3d8a8-11a1-4a13-884a-d6fd5a1efdb6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock Series A; $0.001 par value; 5,000,000 shares authorized, 0 issued and outstanding at June&#160;30, 2021 and December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d2d1ba35-5898-47cf-b55f-aeae698ffd69_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3959d0b8-48b1-4f2d-bc9b-cfac6b67620b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanMember_cd063de4-fde2-4040-80df-74aae3ec2947_terseLabel_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan</link:label>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanMember_label_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan [Member]</link:label>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanMember_documentation_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_HayfinLoanAgreementTermLoanMember" xlink:to="lab_mdxg_HayfinLoanAgreementTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_b2edd405-65a0-4c1b-ae20-64af7fb77d35_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_e16847ef-6671-467c-9ba8-8252d8e7a619_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_c838e09b-46da-4542-b0b5-0309ac9df8f0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_CARESActMember_19e1a285-8866-42b4-a27c-2e71bf213257_terseLabel_en-US" xlink:label="lab_mdxg_CARESActMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act</link:label>
    <link:label id="lab_mdxg_CARESActMember_label_en-US" xlink:label="lab_mdxg_CARESActMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act [Member]</link:label>
    <link:label id="lab_mdxg_CARESActMember_documentation_en-US" xlink:label="lab_mdxg_CARESActMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CARESActMember" xlink:href="mdxg-20210630.xsd#mdxg_CARESActMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_CARESActMember" xlink:to="lab_mdxg_CARESActMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligationAccretionExpense_39b5e1bc-dcc5-4174-9a21-9cb8444027f5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationAccretionExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of asset retirement obligation</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligationAccretionExpense_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationAccretionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligation, Accretion Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationAccretionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetRetirementObligationAccretionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligationAccretionExpense" xlink:to="lab_us-gaap_AssetRetirementObligationAccretionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ff588215-1fa3-4bbe-8f4b-c0661ef7df83_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1aa193c1-1809-465c-9feb-7ce92f5b05e4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Antidilutive Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryCurrentTable_ac89b05a-54f5-4a54-837b-7a118eb815f3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:label id="lab_us-gaap_InventoryCurrentTable_label_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryCurrentTable" xlink:to="lab_us-gaap_InventoryCurrentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_b63910d0-75e1-4ebd-acb0-ca56d6b92577_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_ad3479f2-3afb-4a79-a99d-4aeb74c137eb_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_cf7c8741-833e-407f-be17-c818378bf464_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of equipment in accounts payable</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_NotesReceivableForSaleOfPropertyAndEquipment_f0cd5e16-5654-4a48-a8d7-40961bbe075e_terseLabel_en-US" xlink:label="lab_mdxg_NotesReceivableForSaleOfPropertyAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note receivable for sale of property and equipment</link:label>
    <link:label id="lab_mdxg_NotesReceivableForSaleOfPropertyAndEquipment_label_en-US" xlink:label="lab_mdxg_NotesReceivableForSaleOfPropertyAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable For Sale Of Property And Equipment</link:label>
    <link:label id="lab_mdxg_NotesReceivableForSaleOfPropertyAndEquipment_documentation_en-US" xlink:label="lab_mdxg_NotesReceivableForSaleOfPropertyAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable For Sale Of Property And Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NotesReceivableForSaleOfPropertyAndEquipment" xlink:href="mdxg-20210630.xsd#mdxg_NotesReceivableForSaleOfPropertyAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_NotesReceivableForSaleOfPropertyAndEquipment" xlink:to="lab_mdxg_NotesReceivableForSaleOfPropertyAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_f154ff47-42d9-4a3c-ba98-c4fe9f0c2704_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Series B Preferred Stock</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:to="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_02f3cad8-0910-4a0e-ba2f-dfe54b973f5b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_7761b6a7-d08e-4b6c-8a46-8168554be25f_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased for tax withholding (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c22e2744-9452-4b6a-a0fb-a166182a81b3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_04f514ed-1bbe-4ecd-9940-56bba4177bf1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on finance lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_0f7f721b-11ee-4c6c-b6c1-c1a844bf71b7_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityThresholdConsecutiveTradingDays_2bd98e16-4b8a-4577-8639-79719de39706_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B preferred stock, threshold number of consecutive trading days</link:label>
    <link:label id="lab_mdxg_TemporaryEquityThresholdConsecutiveTradingDays_label_en-US" xlink:label="lab_mdxg_TemporaryEquityThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Threshold Consecutive Trading Days</link:label>
    <link:label id="lab_mdxg_TemporaryEquityThresholdConsecutiveTradingDays_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityThresholdConsecutiveTradingDays" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityThresholdConsecutiveTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityThresholdConsecutiveTradingDays" xlink:to="lab_mdxg_TemporaryEquityThresholdConsecutiveTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrimeRateMember_d379e6f7-3759-4a0b-bfb6-3857d687d31a_terseLabel_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate</link:label>
    <link:label id="lab_us-gaap_PrimeRateMember_label_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrimeRateMember" xlink:to="lab_us-gaap_PrimeRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_45512445-56c0-4b7a-bae1-45fd42ca0421_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share - basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_88d2d231-eef0-4c6e-bbfb-7c9f2e6329a8_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net loss per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9824ecb3-5008-4a3f-8a3b-60689f3426c6_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_2ae70dc9-f027-4753-ad62-e51d99e8d1ed_terseLabel_en-US" xlink:label="lab_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cord</link:label>
    <link:label id="lab_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_label_en-US" xlink:label="lab_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Wound Care, Umbilical Cord-Derived [Member]</link:label>
    <link:label id="lab_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_documentation_en-US" xlink:label="lab_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Wound Care, Umbilical Cord-Derived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember" xlink:href="mdxg-20210630.xsd#mdxg_AdvancedWoundCareUmbilicalCordDerivedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember" xlink:to="lab_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TermLoanAgreementMember_9ac6edff-4d83-4be9-b9a8-c0ea072563d4_terseLabel_en-US" xlink:label="lab_mdxg_TermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BT Term Loan</link:label>
    <link:label id="lab_mdxg_TermLoanAgreementMember_label_en-US" xlink:label="lab_mdxg_TermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement [Member]</link:label>
    <link:label id="lab_mdxg_TermLoanAgreementMember_documentation_en-US" xlink:label="lab_mdxg_TermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TermLoanAgreementMember" xlink:href="mdxg-20210630.xsd#mdxg_TermLoanAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TermLoanAgreementMember" xlink:to="lab_mdxg_TermLoanAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_56ce34a0-d207-4a8d-b3c2-e2fa0dcdd21a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:to="lab_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e5c1ab9e-293a-4527-8665-3b370c7df5a1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0e32167e-d2fa-4789-b7ce-ca811b3f78b9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_3ae14861-10dd-48c5-97fb-37286b54aa26_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_412221ab-7a50-4fe2-8015-d3739d51829c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_18fdc05a-23ad-4c96-9811-aca798e756a0_totalLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total BT Term Loan interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet_3640a0c6-ce93-4e9b-83b0-c6f58c0817aa_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of amendment fee</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Loan Origination Fees, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredLoanOriginationFeesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet" xlink:to="lab_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_8463ecc0-3b56-4456-9954-d639d20f8059_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1f34e0c4-0896-4d9e-90b0-d33d12de4e7a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingenciesLineItems_61b14f16-be1d-4433-be43-07e0cffd4585_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_GainContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_GainContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingenciesLineItems" xlink:to="lab_us-gaap_GainContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_be038c43-b8b9-4c4a-901c-2f6482a3ea67_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems_d790eb71-62d1-45a1-9a1f-f43c7313dfa6_terseLabel_en-US" xlink:label="lab_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate impact of discrete items</link:label>
    <link:label id="lab_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems_label_en-US" xlink:label="lab_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Discrete Items</link:label>
    <link:label id="lab_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems_documentation_en-US" xlink:label="lab_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Discrete Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems" xlink:href="mdxg-20210630.xsd#mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems" xlink:to="lab_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_dbaaf84d-d1a6-4a3e-aab6-2d6fe3a96cf5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_e91846d6-f13d-4edb-9637-91fcabeb9128_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased for tax withholding</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_AssetRetirementCostMember_aec01a08-4823-4c5b-a0b4-2ccd5c2ad7b2_terseLabel_en-US" xlink:label="lab_mdxg_AssetRetirementCostMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset retirement cost</link:label>
    <link:label id="lab_mdxg_AssetRetirementCostMember_label_en-US" xlink:label="lab_mdxg_AssetRetirementCostMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Cost [Member]</link:label>
    <link:label id="lab_mdxg_AssetRetirementCostMember_documentation_en-US" xlink:label="lab_mdxg_AssetRetirementCostMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AssetRetirementCostMember" xlink:href="mdxg-20210630.xsd#mdxg_AssetRetirementCostMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_AssetRetirementCostMember" xlink:to="lab_mdxg_AssetRetirementCostMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset_c926ba52-675b-4c90-becc-12b96f9c475d_terseLabel_en-US" xlink:label="lab_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use asset</link:label>
    <link:label id="lab_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease And Financing Lease, Right-Of-Use-Asset</link:label>
    <link:label id="lab_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease And Financing Lease, Right-Of-Use-Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset" xlink:href="mdxg-20210630.xsd#mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset" xlink:to="lab_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_Section351Member_073a48ca-a99b-4aee-9030-f5c3a9a4d44f_terseLabel_en-US" xlink:label="lab_mdxg_Section351Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Section 351</link:label>
    <link:label id="lab_mdxg_Section351Member_label_en-US" xlink:label="lab_mdxg_Section351Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Section 351 [Member]</link:label>
    <link:label id="lab_mdxg_Section351Member_documentation_en-US" xlink:label="lab_mdxg_Section351Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Section 351</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_Section351Member" xlink:href="mdxg-20210630.xsd#mdxg_Section351Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_Section351Member" xlink:to="lab_mdxg_Section351Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_208dc458-0e3d-44fb-949a-311849a8b391_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_c3ece354-6c39-47de-925b-a3a92b0c21f1_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B convertible preferred stock par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_0b2e7217-801c-4662-8996-0f6d2ebf0ce1_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B convertible preferred stock par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_16a785ad-7a04-4836-b0c9-b82cb415aa01_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_ContingencyLossNumberOfFormerHealthcareProviders_cc3c35a1-cb56-469f-b33d-eaa2b6c52d17_terseLabel_en-US" xlink:label="lab_mdxg_ContingencyLossNumberOfFormerHealthcareProviders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of healthcare providers</link:label>
    <link:label id="lab_mdxg_ContingencyLossNumberOfFormerHealthcareProviders_label_en-US" xlink:label="lab_mdxg_ContingencyLossNumberOfFormerHealthcareProviders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingency Loss, Number Of Former Healthcare Providers</link:label>
    <link:label id="lab_mdxg_ContingencyLossNumberOfFormerHealthcareProviders_documentation_en-US" xlink:label="lab_mdxg_ContingencyLossNumberOfFormerHealthcareProviders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingency Loss, Number Of Former Healthcare Providers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ContingencyLossNumberOfFormerHealthcareProviders" xlink:href="mdxg-20210630.xsd#mdxg_ContingencyLossNumberOfFormerHealthcareProviders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_ContingencyLossNumberOfFormerHealthcareProviders" xlink:to="lab_mdxg_ContingencyLossNumberOfFormerHealthcareProviders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_efff50d5-a498-4669-98b9-23d275ae6492_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash&#160;flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_ba6e8008-34ba-41da-bf86-c3ba8004f3eb_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_0bc88c62-bd59-42bb-aa6b-35a7cb9db9b3_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_5b57cf8d-0bdd-442c-a007-c50ec2325f27_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_b1cf1bc9-db43-4cb3-8b52-d8c0575fbf6f_totalLabel_en-US" xlink:label="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total adjustments</link:label>
    <link:label id="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_32b0fe84-d75a-4f84-a052-3f010f78be3a_terseLabel_en-US" xlink:label="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends on Series B Convertible Preferred Stock</link:label>
    <link:label id="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_label_en-US" xlink:label="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile to Net Income (Loss) Available to Common Stockholders</link:label>
    <link:label id="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_documentation_en-US" xlink:label="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile to Net Income (Loss) Available to Common Stockholders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" xlink:href="mdxg-20210630.xsd#mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" xlink:to="lab_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_4877a6c9-da34-4d96-9420-48e59cd5f3be_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_db19f307-6bdb-4d03-93f9-42d70a9acd8a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, convertible preferred stock, and stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_432edae5-c92f-40af-baef-456e6807b359_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_5906bdbd-9474-49dc-9fb1-f7dc4c6af400_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal costs</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_a441ca2e-6da3-4e49-ac81-c59b435e77ed_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued GPO fees</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_70c605f8-99a5-4962-b6af-c743339ea9fa_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_807c0b92-1b45-4d33-aa07-7dbb16badb9d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_676bdaf8-ee01-4660-b2d0-e3482e1866ad_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_ef303a03-b4e3-41f5-9d89-0c28c8b48aae_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_fb702caa-a997-464d-9401-b0357f1669c4_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_79fbb155-1739-4fba-b663-521e570a22ad_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS&#8217; DEFICIT</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_ProceedsfromIssuanceofTemporaryEquity_85252b30-290a-4874-ae90-57a3c4e9d447_terseLabel_en-US" xlink:label="lab_mdxg_ProceedsfromIssuanceofTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of temporary equity</link:label>
    <link:label id="lab_mdxg_ProceedsfromIssuanceofTemporaryEquity_label_en-US" xlink:label="lab_mdxg_ProceedsfromIssuanceofTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Temporary Equity</link:label>
    <link:label id="lab_mdxg_ProceedsfromIssuanceofTemporaryEquity_documentation_en-US" xlink:label="lab_mdxg_ProceedsfromIssuanceofTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ProceedsfromIssuanceofTemporaryEquity" xlink:href="mdxg-20210630.xsd#mdxg_ProceedsfromIssuanceofTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_ProceedsfromIssuanceofTemporaryEquity" xlink:to="lab_mdxg_ProceedsfromIssuanceofTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_87e91efb-ed26-4814-96c5-1826f30a1ca9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_39305b96-c1a1-4d3c-a586-08ed03418e31_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_ab415570-85e6-49b7-a5f5-fa64bbc6b4a7_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_eb50639e-9d69-43a2-bf79-0ddb1ddf6162_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dce99127-300d-4478-b27f-6ffd60e28579_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a4c30500-adc4-4518-9449-89cbd991b5a9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_ce059eda-467c-4aab-8e91-624dee61c593_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_2f6ae8d5-5a13-41d7-b5a8-076c1ceaeb62_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_c54aac7e-8d55-40d5-9447-b4eb83930182_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Business</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_c2114441-2c17-4029-956f-8610799f4f90_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_cfbd2925-e35e-49fb-87cd-6acfd9596a28_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from term loans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Medium-term Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfMediumTermNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_f80366e2-0b35-4926-8b03-3f6774f0c21b_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_a0c24fdb-30d4-4182-adb0-c00e1d1c70af_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_9de2929f-98e3-43ed-9353-033cf2dac24d_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_cb4ca38e-8efc-4c13-a171-04a7a025179d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_b961e618-de36-44d5-94e1-98d0f133fd83_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdTradingDays_1dce1a2a-af2f-4b6e-912b-c4b78f36fc17_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of trading days within consecutive day trading period common stock must exceed trigger conversion price</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdTradingDays_label_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion, Threshold Trading Days</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdTradingDays_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdTradingDays" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityConversionThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityConversionThresholdTradingDays" xlink:to="lab_mdxg_TemporaryEquityConversionThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_47a452fd-face-454b-89b9-45cb3302e3ff_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_7902dd9b-0831-4c6c-bf41-c369c25cb18a_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_ae5cce07-3e7b-47af-abce-8f5cae6c6b20_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_7f20712a-b52a-4ba3-9585-95f4250286f4_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise_9142eb0b-cc04-47a0-8340-4d653b12ab16_terseLabel_en-US" xlink:label="lab_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of non-cash consideration received for option exercise</link:label>
    <link:label id="lab_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise_label_en-US" xlink:label="lab_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value Of Non-Cash Consideration Received For Option Exercise</link:label>
    <link:label id="lab_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise_documentation_en-US" xlink:label="lab_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value Of Non-Cash Consideration Received For Option Exercise</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise" xlink:href="mdxg-20210630.xsd#mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise" xlink:to="lab_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_AccruedRebates_daf65909-66a3-4a7a-bd02-af9eedc93636_terseLabel_en-US" xlink:label="lab_mdxg_AccruedRebates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued rebates</link:label>
    <link:label id="lab_mdxg_AccruedRebates_label_en-US" xlink:label="lab_mdxg_AccruedRebates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates</link:label>
    <link:label id="lab_mdxg_AccruedRebates_documentation_en-US" xlink:label="lab_mdxg_AccruedRebates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AccruedRebates" xlink:href="mdxg-20210630.xsd#mdxg_AccruedRebates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_AccruedRebates" xlink:to="lab_mdxg_AccruedRebates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_7cedf081-9701-477d-8262-47a59a94fb60_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_b60811bd-6014-459d-b2ed-7509b61dc16b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_c1abef56-6d24-408d-8145-6759b6828461_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_a90e79c0-7f6d-4044-b3e2-baacd48e0b7d_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_2d2adaf8-c95a-4963-97ed-2281b6cdeacc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIncomeTaxRefunds_2870275d-fd21-4e0d-92df-6080dc10fb94_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal tax refund</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIncomeTaxRefunds_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Income Tax Refunds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:to="lab_us-gaap_ProceedsFromIncomeTaxRefunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c5ba8c7f-58e3-442f-aaf9-363f91cb7d8b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_03507319-bd2d-43a0-aaa5-4f2d53b36712_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_276bba3e-d0c1-4919-8d70-4a2bc0f54a7f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_d655077d-96ce-4402-a79b-6722073e3f10_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_3dad89c8-5bb6-4cc9-ad3b-d4a7ef139119_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_30f60376-69c3-467a-8806-c23138d2bb4b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_NumberOfProducts_35c95a42-2efe-4e4f-9a3c-871c27f7b462_terseLabel_en-US" xlink:label="lab_mdxg_NumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Products</link:label>
    <link:label id="lab_mdxg_NumberOfProducts_label_en-US" xlink:label="lab_mdxg_NumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Products</link:label>
    <link:label id="lab_mdxg_NumberOfProducts_documentation_en-US" xlink:label="lab_mdxg_NumberOfProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NumberOfProducts" xlink:href="mdxg-20210630.xsd#mdxg_NumberOfProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_NumberOfProducts" xlink:to="lab_mdxg_NumberOfProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature_e9e79fc7-ee80-44c0-8373-efc7bab03dcb_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of increasing-rate dividend feature</link:label>
    <link:label id="lab_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature_49cdd356-75af-4221-993d-12d629ebfa74_verboseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed dividends on Series B Convertible Preferred Stock</link:label>
    <link:label id="lab_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature_label_en-US" xlink:label="lab_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion of Increasing-rate Dividend Feature</link:label>
    <link:label id="lab_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion of Increasing-rate Dividend Feature</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature" xlink:to="lab_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_68888543-7c7d-47d6-9a11-3ee49c744bfc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Net Sales by Products and Customer Type</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee_82d35f47-8c0b-412b-9b0e-77f2f683d379_terseLabel_en-US" xlink:label="lab_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment fee on BT Term Loan</link:label>
    <link:label id="lab_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee_label_en-US" xlink:label="lab_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash Activities, Debt Instrument, Amendment Fee</link:label>
    <link:label id="lab_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee_documentation_en-US" xlink:label="lab_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash Activities, Debt Instrument, Amendment Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee" xlink:href="mdxg-20210630.xsd#mdxg_NoncashActivitiesDebtInstrumentAmendmentFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee" xlink:to="lab_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_85ed3571-5b3f-44c2-bb1e-873ee1c65882_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock; $0.001 par value; 187,500,000 shares authorized; 112,703,926 issued and 111,881,938 outstanding at June&#160;30, 2021 and 112,703,926 issued and 110,930,243 outstanding at December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_37ec5c39-1a75-4020-b091-1faf805890b6_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, Beginning Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8f5f105f-8dd8-44ba-84c1-224cdd95ee02_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, Ending Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1586eb57-d00b-40d1-a5b0-b5a627525cbb_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_e730c784-666f-42b0-b6c4-b8be44740e37_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance stock unit awards</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_d251ac48-ac90-442c-880a-8dc42eabaa22_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 12)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_CustomerAndSupplierRelationshipsMember_32ff0251-8a7b-40ca-98bf-516be6b03a92_terseLabel_en-US" xlink:label="lab_mdxg_CustomerAndSupplierRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer and supplier relationships</link:label>
    <link:label id="lab_mdxg_CustomerAndSupplierRelationshipsMember_label_en-US" xlink:label="lab_mdxg_CustomerAndSupplierRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer And Supplier Relationships [Member]</link:label>
    <link:label id="lab_mdxg_CustomerAndSupplierRelationshipsMember_documentation_en-US" xlink:label="lab_mdxg_CustomerAndSupplierRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer And Supplier Relationships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CustomerAndSupplierRelationshipsMember" xlink:href="mdxg-20210630.xsd#mdxg_CustomerAndSupplierRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_CustomerAndSupplierRelationshipsMember" xlink:to="lab_mdxg_CustomerAndSupplierRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_f211898a-b20c-4133-8ef9-c543c0d895a7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_CreditFacilitiesMember_7cfe3b51-82ea-4bb4-801e-2f9c6c648e0e_terseLabel_en-US" xlink:label="lab_mdxg_CreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facilities</link:label>
    <link:label id="lab_mdxg_CreditFacilitiesMember_label_en-US" xlink:label="lab_mdxg_CreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facilities [Member]</link:label>
    <link:label id="lab_mdxg_CreditFacilitiesMember_documentation_en-US" xlink:label="lab_mdxg_CreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CreditFacilitiesMember" xlink:href="mdxg-20210630.xsd#mdxg_CreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_CreditFacilitiesMember" xlink:to="lab_mdxg_CreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock_e9b326f3-cf9f-463e-8ece-164fdcf8f6ec_terseLabel_en-US" xlink:label="lab_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Issuance Costs</link:label>
    <link:label id="lab_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock_label_en-US" xlink:label="lab_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Issuance Costs [Table Text Block]</link:label>
    <link:label id="lab_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock_documentation_en-US" xlink:label="lab_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Issuance Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock" xlink:href="mdxg-20210630.xsd#mdxg_ScheduleofDebtIssuanceCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock" xlink:to="lab_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_6feb79a4-42e3-4013-9f7e-2f5d3923a340_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_DebtCovenantMinimumLiquidity_50f399b8-86eb-48fc-8c30-219845579b7a_terseLabel_en-US" xlink:label="lab_mdxg_DebtCovenantMinimumLiquidity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt covenant, minimum liquidity</link:label>
    <link:label id="lab_mdxg_DebtCovenantMinimumLiquidity_label_en-US" xlink:label="lab_mdxg_DebtCovenantMinimumLiquidity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Minimum Liquidity</link:label>
    <link:label id="lab_mdxg_DebtCovenantMinimumLiquidity_documentation_en-US" xlink:label="lab_mdxg_DebtCovenantMinimumLiquidity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Minimum Liquidity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtCovenantMinimumLiquidity" xlink:href="mdxg-20210630.xsd#mdxg_DebtCovenantMinimumLiquidity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_DebtCovenantMinimumLiquidity" xlink:to="lab_mdxg_DebtCovenantMinimumLiquidity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_92e13467-395f-4961-b65c-b73ccd2850ad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing cost</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_70f3cfc7-1968-4897-8cf3-e5477a7251bf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from BT Term Loan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis_0e3e4cb8-7946-401e-9f99-d9662f9f87cb_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B preferred stock, maximum voting stock percentage on an as-converted basis (percent)</link:label>
    <link:label id="lab_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis_label_en-US" xlink:label="lab_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Maximum Voting Stock Percentage on As-converted Basis</link:label>
    <link:label id="lab_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Maximum Voting Stock Percentage on As-converted Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" xlink:to="lab_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_244be3ee-adbb-41d3-be4e-f6ed3f46ac7c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_44c96248-5e31-49a7-8bdf-6cd8cdb2be46_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_fd69a680-c783-4231-b6fb-38350505073e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_27f22e1c-35a9-4f60-95c0-b90e63c6540a_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_FinancingTransactionsMember_04e84534-fc4e-4c05-ad8b-69167dae1520_terseLabel_en-US" xlink:label="lab_mdxg_FinancingTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Transactions</link:label>
    <link:label id="lab_mdxg_FinancingTransactionsMember_label_en-US" xlink:label="lab_mdxg_FinancingTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Transactions [Member]</link:label>
    <link:label id="lab_mdxg_FinancingTransactionsMember_documentation_en-US" xlink:label="lab_mdxg_FinancingTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Transactions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FinancingTransactionsMember" xlink:href="mdxg-20210630.xsd#mdxg_FinancingTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_FinancingTransactionsMember" xlink:to="lab_mdxg_FinancingTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_408098f3-558d-464a-ac19-8f5680c71030_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_abf4654e-cf53-4f41-b57b-8f73b3dcfc26_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsDomain_d56d0c93-97ea-453b-9cfa-11368b5523f8_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Domain]</link:label>
    <link:label id="lab_us-gaap_DividendsDomain_label_en-US" xlink:label="lab_us-gaap_DividendsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsDomain" xlink:to="lab_us-gaap_DividendsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_552844d4-d488-4efd-a085-288018b6bfdf_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredClassBMember_04a82848-b395-4a7e-a617-8dc4d6d2198f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredClassBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Class B Convertible Stock</link:label>
    <link:label id="lab_us-gaap_PreferredClassBMember_label_en-US" xlink:label="lab_us-gaap_PreferredClassBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Class B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredClassBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredClassBMember" xlink:to="lab_us-gaap_PreferredClassBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_PaymentsforApplicationCostsPatent_abb36044-7c30-4c19-ace2-328ab4554580_negatedTerseLabel_en-US" xlink:label="lab_mdxg_PaymentsforApplicationCostsPatent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent application costs</link:label>
    <link:label id="lab_mdxg_PaymentsforApplicationCostsPatent_label_en-US" xlink:label="lab_mdxg_PaymentsforApplicationCostsPatent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Application Costs, Patent</link:label>
    <link:label id="lab_mdxg_PaymentsforApplicationCostsPatent_documentation_en-US" xlink:label="lab_mdxg_PaymentsforApplicationCostsPatent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Application Costs, Patent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PaymentsforApplicationCostsPatent" xlink:href="mdxg-20210630.xsd#mdxg_PaymentsforApplicationCostsPatent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_PaymentsforApplicationCostsPatent" xlink:to="lab_mdxg_PaymentsforApplicationCostsPatent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_eb04456f-8f81-433c-8472-c9265e5daeab_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock Series B; $0.001 par value; 100,000 shares authorized, issued and outstanding at June&#160;30, 2021 and December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_615602a5-0900-4ccc-b0a4-9d933eed4534_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock, outstanding, beginning</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_752b1645-c0fc-4e7f-91d4-febe53781ffa_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock, outstanding, ending</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_b08be5c8-d701-44ea-adba-98a194a93df8_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_3ec101eb-9cc1-4e3d-9a1d-50eb2c073f69_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_63818560-a323-4131-af7e-4dc297cce0e3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_186cf591-3941-4d85-80bd-aecd84067ba6_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Options, weighted average remaining contractual term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_187221d4-ac55-47eb-b31b-447137221626_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile to net (loss) income available to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_ea295d95-d60a-4587-9f87-dd76ecab675f_terseLabel_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Delayed Draw Term Loan</link:label>
    <link:label id="lab_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_label_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Delayed Draw Term Loan [Member]</link:label>
    <link:label id="lab_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_documentation_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Delayed Draw Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember" xlink:to="lab_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_a287513b-dc7b-415c-8b45-a96b6fcbc980_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage_243313ec-8768-414c-9b2a-f28925616157_terseLabel_en-US" xlink:label="lab_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional commitment fee (percent)</link:label>
    <link:label id="lab_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:label id="lab_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage_documentation_en-US" xlink:label="lab_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage" xlink:to="lab_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_84e6f015-4140-4fdd-86c5-b41685d02804_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed dividends</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_f5bcacd2-f59f-43db-bec0-3bcbd4e4b165_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deemed dividends</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_eb3fab04-94b0-4ced-8efc-966e9552139b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_8bec0f14-b7e9-46ae-adcf-b6a4bcc726a9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_0548663c-8686-4c69-ba40-81a9e3511cf6_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_96dd3d83-7745-4948-8169-d9c1f16e4adc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_beb20ed1-90b8-4cc7-96a4-74e97f94a42d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_b8fd4ab1-9926-420e-bcb5-3b50f4a6d7f4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_49b2d7f3-183d-43b3-a0cd-cd877540711a_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TotalNetLeverageRatio_864b59b8-0db8-4740-8690-e846efc6fc3e_terseLabel_en-US" xlink:label="lab_mdxg_TotalNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net leverage ratio</link:label>
    <link:label id="lab_mdxg_TotalNetLeverageRatio_label_en-US" xlink:label="lab_mdxg_TotalNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Net Leverage Ratio</link:label>
    <link:label id="lab_mdxg_TotalNetLeverageRatio_documentation_en-US" xlink:label="lab_mdxg_TotalNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Net Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TotalNetLeverageRatio" xlink:href="mdxg-20210630.xsd#mdxg_TotalNetLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TotalNetLeverageRatio" xlink:to="lab_mdxg_TotalNetLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_eb11f2cf-965e-4c94-8307-be1961bd22ea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_828637c0-21a4-472d-b027-1718b142d22d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_38568bd3-6fa5-405a-8836-8aa991e26737_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Series B Preferred Stock</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_4d0fe152-6753-441b-9d77-c65678818afd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_87f45a99-4ebb-4093-bcf9-6ce02494714f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_62bd84f9-b4ad-416c-8d68-4ce4d5aea7b1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_f047f755-4416-4b12-a991-1315264951b5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_795cc4fe-bcfc-4977-9018-8b2aa3117116_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_bc2ac55e-21f0-4db3-9d91-cf85d00c61af_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_f75b2e8c-3f68-4693-bb79-cadd8ccaa766_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_1a48b4c4-f20d-43fc-9393-05ae709f024e_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_d664aa7c-19c0-4369-b185-43b8576e78ef_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_e3e3648c-ed64-4eb7-b3a2-22278195d37d_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Customers</link:label>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:to="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_ef19e997-c0ca-45aa-8435-6c8e6bd079f6_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_173ecb14-d290-4ed8-9a2a-45113d1435e4_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_3744ff7a-b1d8-449d-9284-db5cff55a679_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_b92032e3-3395-44e6-8392-0e827b989dfb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityDividendRatePercentage_62c37324-907b-4462-b82c-d41a7809974a_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B convertible stock, cumulative dividend (percent)</link:label>
    <link:label id="lab_mdxg_TemporaryEquityDividendRatePercentage_label_en-US" xlink:label="lab_mdxg_TemporaryEquityDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Dividend Rate, Percentage</link:label>
    <link:label id="lab_mdxg_TemporaryEquityDividendRatePercentage_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Dividend Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityDividendRatePercentage" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityDividendRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityDividendRatePercentage" xlink:to="lab_mdxg_TemporaryEquityDividendRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_8d8256b7-b67a-4f71-8dab-4f95ada710b1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assessment of Revenue under ASC 606</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_d41d27dd-cc58-4cb9-b169-dd2ef27cc19f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_6bfb56f3-b5cc-4f7e-9114-c86a5dc6b5f8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the Term Loan</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_ee0aa126-5c9e-4f1a-a0b5-f561b29aa207_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_1615b8ba-cebc-4dec-8643-e560464a9a89_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_cd9dc049-a48d-498f-9acd-72a945d7f724_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_e3873394-a8a1-4598-b3b0-d9de100ef897_terseLabel_en-US" xlink:label="lab_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of primary distribution channels</link:label>
    <link:label id="lab_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_label_en-US" xlink:label="lab_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Number Of Distribution Channels</link:label>
    <link:label id="lab_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_documentation_en-US" xlink:label="lab_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Number Of Distribution Channels</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels" xlink:href="mdxg-20210630.xsd#mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels" xlink:to="lab_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_75b11d9e-fcfe-4f1a-8f37-58344ffadd0f_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_PatentsinProcessMember_9d7cbc9d-3cf7-44e9-ae9f-464aa9bd4d02_terseLabel_en-US" xlink:label="lab_mdxg_PatentsinProcessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents in process</link:label>
    <link:label id="lab_mdxg_PatentsinProcessMember_label_en-US" xlink:label="lab_mdxg_PatentsinProcessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents in Process [Member]</link:label>
    <link:label id="lab_mdxg_PatentsinProcessMember_documentation_en-US" xlink:label="lab_mdxg_PatentsinProcessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents in Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PatentsinProcessMember" xlink:href="mdxg-20210630.xsd#mdxg_PatentsinProcessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_PatentsinProcessMember" xlink:to="lab_mdxg_PatentsinProcessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_9d9e4bdc-ab2c-4934-a7cc-e9b372c2bc37_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_0afaa836-0824-463b-a2fa-0b17496d4026_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquitySharesIssueduponConversion_1983bc0b-6a57-44d9-b3d7-ac33cbf31a5b_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquitySharesIssueduponConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred convertible stock, shares issuable upon conversion (in shares)</link:label>
    <link:label id="lab_mdxg_TemporaryEquitySharesIssueduponConversion_label_en-US" xlink:label="lab_mdxg_TemporaryEquitySharesIssueduponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Issued upon Conversion</link:label>
    <link:label id="lab_mdxg_TemporaryEquitySharesIssueduponConversion_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquitySharesIssueduponConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Issued upon Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquitySharesIssueduponConversion" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquitySharesIssueduponConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquitySharesIssueduponConversion" xlink:to="lab_mdxg_TemporaryEquitySharesIssueduponConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f1ca8eb3-bfc3-4ce6-a127-627b7ebdc84a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_611a0c9f-c486-4d61-a77e-955c8b10f40e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember_1cc7d0f0-c30d-4356-ad4c-db6a9e1f1415_terseLabel_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x</link:label>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember_label_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x [Member]</link:label>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember_documentation_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember" xlink:to="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f39d728f-5ae2-4314-b6d5-914ced1d3f51_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_70461da0-1a6f-4a1b-928a-41d6061aedf5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3353e77e-f230-44f3-ad6d-df741883a2c2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested options expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_d255b4e8-7100-4984-95ce-34d9ff2e75e0_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_e79ed6f1-0f6c-4cb9-b5f7-7ccf8dd31675_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_a4825e5e-372e-41f0-a120-0c6cff29039b_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_ScheduleofInterestExpenseTableTextBlock_fa54343c-2393-47d9-a750-6c68a76f465a_terseLabel_en-US" xlink:label="lab_mdxg_ScheduleofInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Expense</link:label>
    <link:label id="lab_mdxg_ScheduleofInterestExpenseTableTextBlock_label_en-US" xlink:label="lab_mdxg_ScheduleofInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Expense [Table Text Block]</link:label>
    <link:label id="lab_mdxg_ScheduleofInterestExpenseTableTextBlock_documentation_en-US" xlink:label="lab_mdxg_ScheduleofInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ScheduleofInterestExpenseTableTextBlock" xlink:href="mdxg-20210630.xsd#mdxg_ScheduleofInterestExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_ScheduleofInterestExpenseTableTextBlock" xlink:to="lab_mdxg_ScheduleofInterestExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_9e71c262-9ec2-4ed5-9ef8-2734cb763f07_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_b18e6005-0c25-4f61-a4c9-d30ff48ebe14_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_8777f239-1d92-4c83-822e-85b5172ef1f9_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_0231b8eb-6ae4-4f44-991e-d7fed7c6e5d9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_58668900-db72-4be1-a3f2-7604da0abb26_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_ba19432d-2fdb-4403-b508-ccc21c108482_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosure of Cash Flow and Non-cash Investing and Financing Activities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d310eee1-3e79-489e-99ef-e1fbf26731a3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_134f52bd-3677-4ca5-8cd3-c5e29945a1e1_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_1e4035d6-74c7-4e78-9387-57a100ec3f3f_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_c2442891-9c78-4566-9e8c-2f7393c79eaa_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_d55280e0-4a8b-4544-a1b4-3aee1ad1b19d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_f19459b5-16a8-4fc7-bd3a-803863e873c8_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_258769f1-01d4-4d64-b391-125065157ffc_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_294b8c2b-8151-49bf-836b-87a40362e99c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal issued</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_303676e4-3533-47b5-8502-bc561dfb7609_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licenses</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger_9b0b6050-a123-4e20-882e-fa9395b211c1_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B preferred stock, minimum percentage of conversion stock price to trigger conversion (percent)</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger_label_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" xlink:to="lab_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5af4a1f4-665f-4e29-87d5-b006ba74a72c_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_3737862c-a5b7-4fc8-8040-be583f7c1bc8_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_794f0c80-1951-4bcd-9d17-e7cbee6138e0_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock unit awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_2b4343f0-49a9-4504-9705-49ec00524c32_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_85bf99fa-d694-4fb0-bee6-be0a72a8922a_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_48874eaa-79e3-4c7d-a353-aff43f809e29_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_7022a593-a9a1-4f14-81aa-b555083581c4_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_52345417-6948-472b-b6ae-729c064d7f6e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_LongTermDebtMaturityAfterYearFour_00b819ba-ef37-41e5-8739-094dc534505e_terseLabel_en-US" xlink:label="lab_mdxg_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_mdxg_LongTermDebtMaturityAfterYearFour_label_en-US" xlink:label="lab_mdxg_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Four</link:label>
    <link:label id="lab_mdxg_LongTermDebtMaturityAfterYearFour_documentation_en-US" xlink:label="lab_mdxg_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_LongTermDebtMaturityAfterYearFour" xlink:href="mdxg-20210630.xsd#mdxg_LongTermDebtMaturityAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_LongTermDebtMaturityAfterYearFour" xlink:to="lab_mdxg_LongTermDebtMaturityAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1817d647-85af-42b6-aab0-0dc6219b215b_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross carrying value, indefinite lived</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_97a4aa9f-95a2-43cb-aaa1-5c214c9dbe4f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_8fb98999-b58b-44b4-885c-3b67578aa0e8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested options forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6605e5e0-65c5-46ca-874d-2a918deff2df_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_5f2c869e-866e-4125-94ca-f417c8393c8d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_ScheduleOfDepreciationTableTextBlock_337a6843-3a29-4bd3-9703-a40ac44bfe7f_terseLabel_en-US" xlink:label="lab_mdxg_ScheduleOfDepreciationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Depreciation Expense</link:label>
    <link:label id="lab_mdxg_ScheduleOfDepreciationTableTextBlock_label_en-US" xlink:label="lab_mdxg_ScheduleOfDepreciationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Depreciation [Table Text Block]</link:label>
    <link:label id="lab_mdxg_ScheduleOfDepreciationTableTextBlock_documentation_en-US" xlink:label="lab_mdxg_ScheduleOfDepreciationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ScheduleOfDepreciationTableTextBlock" xlink:href="mdxg-20210630.xsd#mdxg_ScheduleOfDepreciationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_ScheduleOfDepreciationTableTextBlock" xlink:to="lab_mdxg_ScheduleOfDepreciationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_326abc01-3534-49ab-a8f5-6f2dddd2e304_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_5cb19a60-bb70-4168-92b5-04fa8835492e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableTable_b566b027-6bba-4430-9fe6-e420143b68d0_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableTable_label_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableTable" xlink:to="lab_us-gaap_DividendsPayableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_8f35e5fc-54a6-4813-b633-f8dae2f49386_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_f4b371f6-d6ad-4b58-ba84-bd1a76a519ad_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a92f3d55-d2af-48d1-b439-1496b162bf5a_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_49919afa-2812-4109-bc0f-6fd10a00698d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_211ef986-8af7-4aff-bfa0-94732e2ece74_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_a3cb7291-2ebc-4534-b685-bd7dc3156922_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_68cb47b1-6a10-47cc-b17f-891f970dafd9_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_5d974469-78a0-48eb-8f69-c9f9fea83ce6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:to="lab_us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_8d115e4b-a64b-4589-bfbc-5553774399c4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_85d8abb0-2aff-4d5c-a896-02f855ebd593_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested options expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_f14ee2b4-d063-4bf9-9b0f-5e1585a68356_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_4de8d542-0781-4392-9dfb-9589e239a29d_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_27c95c32-f085-4b20-9527-0d2305a52e3c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_c3a53c61-ad3b-4b9e-bf67-f7efba44ed6b_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_201a2176-5a37-424a-9319-907b0b15e007_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_0b408409-e796-4af5-873e-2404d0e8824f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_f4b058bd-0ca0-4edd-9b46-a96c9a548702_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_008e0dac-a398-4260-a6b0-d6766e5548a5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_9f1ec82f-8c02-41bb-b4af-0a026a78148f_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of original issue discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_53de800d-7cd5-481c-8a0f-f3e5b49f0ffc_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_7388f5e6-d083-4d51-95ae-621f21a53dca_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_4833adc2-e229-42cf-8cac-79ffe5ad5961_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_917a4f9d-a47e-4009-b7ab-1c5b03f16ee9_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_AdvancedWoundCareTissueAndOtherMember_4db8a8fa-f094-40c8-b4ff-df8b8d44cc33_terseLabel_en-US" xlink:label="lab_mdxg_AdvancedWoundCareTissueAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tissue/Other</link:label>
    <link:label id="lab_mdxg_AdvancedWoundCareTissueAndOtherMember_label_en-US" xlink:label="lab_mdxg_AdvancedWoundCareTissueAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Wound Care, Tissue And Other [Member]</link:label>
    <link:label id="lab_mdxg_AdvancedWoundCareTissueAndOtherMember_documentation_en-US" xlink:label="lab_mdxg_AdvancedWoundCareTissueAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Wound Care, Tissue And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdvancedWoundCareTissueAndOtherMember" xlink:href="mdxg-20210630.xsd#mdxg_AdvancedWoundCareTissueAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_AdvancedWoundCareTissueAndOtherMember" xlink:to="lab_mdxg_AdvancedWoundCareTissueAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_AccruedClinicalTrialsCurrent_d64e0dc1-c805-4d2d-8204-4fba5f1f68ee_terseLabel_en-US" xlink:label="lab_mdxg_AccruedClinicalTrialsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued clinical trials</link:label>
    <link:label id="lab_mdxg_AccruedClinicalTrialsCurrent_label_en-US" xlink:label="lab_mdxg_AccruedClinicalTrialsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Clinical Trials, Current</link:label>
    <link:label id="lab_mdxg_AccruedClinicalTrialsCurrent_documentation_en-US" xlink:label="lab_mdxg_AccruedClinicalTrialsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Clinical Trials, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AccruedClinicalTrialsCurrent" xlink:href="mdxg-20210630.xsd#mdxg_AccruedClinicalTrialsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_AccruedClinicalTrialsCurrent" xlink:to="lab_mdxg_AccruedClinicalTrialsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_876199af-8411-4c82-821c-94a26b753080_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock canceled/forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_e59315a0-1012-4c88-86a1-deb189411a62_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_label_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableLineItems" xlink:to="lab_us-gaap_DividendsPayableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0aa20b92-1ad0-42a9-bd73-dcdb0cdb839a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_c3260270-c4d2-4b9f-89ba-a91e0097f3a6_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation&#160;expense</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_1b8a6b09-63bc-4d83-8139-0ffe2b70381e_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c60aa41b-8055-4c94-81e5-c63318f7ae3d_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_4daae0a1-d6ee-4baa-aea6-fc323a9cd147_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross carrying amount</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_7412f079-465d-44e4-8232-725480edf9b2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_34bd8571-1b61-4d04-8c28-9af2edd76555_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_f1b119ce-5464-4a12-993d-1e108698fd82_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_76a95999-047a-4dee-9307-534c6185708f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_ab322d86-5582-4249-926e-b6d81bd61cdc_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on principal balance</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_904b1b8d-5504-41fe-a063-8141c388c879_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_InvestigationRestatementandRelated_a4ed39cf-5059-43dc-9a04-777a4dccc4fd_terseLabel_en-US" xlink:label="lab_mdxg_InvestigationRestatementandRelated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investigation, restatement and related</link:label>
    <link:label id="lab_mdxg_InvestigationRestatementandRelated_label_en-US" xlink:label="lab_mdxg_InvestigationRestatementandRelated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investigation, Restatement and Related</link:label>
    <link:label id="lab_mdxg_InvestigationRestatementandRelated_documentation_en-US" xlink:label="lab_mdxg_InvestigationRestatementandRelated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investigation, Restatement and Related</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_InvestigationRestatementandRelated" xlink:href="mdxg-20210630.xsd#mdxg_InvestigationRestatementandRelated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_InvestigationRestatementandRelated" xlink:to="lab_mdxg_InvestigationRestatementandRelated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_0fd04c9a-8966-4289-b4e4-7f53cb252715_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_f9434167-0156-49d9-a967-b8715cd430a8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_2ba262ae-1db6-4cb4-b2a7-d4b4b362ffde_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_8c54f67a-9081-4997-942b-a1bca655ecb9_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_e1f3d33a-4925-418b-839e-c3be131daff1_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_223326b1-cccb-48d2-8e23-ab6090e440a1_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_1afd95f9-8b60-497b-beed-c6e472ced177_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityConversionRatio_a0a5b38b-b352-42df-9841-69c36430366d_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion ratio of Series B preferred stock to common stock</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionRatio_label_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion Ratio</link:label>
    <link:label id="lab_mdxg_TemporaryEquityConversionRatio_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionRatio" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityConversionRatio" xlink:to="lab_mdxg_TemporaryEquityConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_2c581dcb-8f66-48db-b787-56e0e8904fc9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareMember_9fe40d33-6961-45c2-9f50-0e470dcf0c4a_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Wound Care</link:label>
    <link:label id="lab_us-gaap_HealthCareMember_label_en-US" xlink:label="lab_us-gaap_HealthCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareMember" xlink:to="lab_us-gaap_HealthCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e3f68bef-638e-49c1-825f-c6350cb32cc9_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss available to common stockholders (Note 8)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2e5bd68b-751e-4deb-a186-776117b7744c_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss available to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9c2d9db5-ebdc-4a8a-91fa-ec63ad7a7f7c_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss available to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_b29d5cb0-185b-4d2b-8c2e-9dcc5fe44ccc_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_3245e263-60ac-4960-b320-0e10769c0d9a_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_31314bc1-bbb6-47b0-bb40-37fd81ac6a33_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent_c80093fa-529e-4559-871a-30b8fe706b6a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated returns</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Refund Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_a657bf27-6891-4d49-98e0-4d66781d0340_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_556fe697-8af3-4cc8-97d8-983e91ff5195_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_27234918-995d-4c03-8114-e7f62341427c_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_8aae0146-0375-41ef-bdf4-ecce0e2beb37_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_0a207111-4543-4a12-8f20-66c8d6de9d09_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_35e5ddcf-c71d-45e1-a8dc-3eb02646e533_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_feefcc34-8056-4357-8c09-b9409d68d3c0_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_62f755ad-2c52-4a4c-bd87-120639624903_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9600a4a3-bccd-4381-b51a-7a64ee6de266_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_8219c41d-962e-47da-bb10-78f8bedd454a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share - diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_30490bc3-8e9a-44d4-b35e-2109077d09c7_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net (loss) income per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_bcc56918-40f9-4a7c-ac02-c1997949ca89_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred financing costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_af46a363-c0b5-4d34-8446-de7dfb35e18e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_cf09dd9b-5c13-4b1b-9c60-5b03158dddba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_732d0fb8-af3a-48f5-8cc1-e6cabb890acb_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B convertible preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:to="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_967c7d6a-5f9e-4844-8ed3-296f092d3af7_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_3886c9a9-1beb-49c2-868e-ff6c46c73411_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net carrying amount</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_AmendedTermLoanAgreementMember_47dfff7e-d30d-43af-947c-94fe795613b0_terseLabel_en-US" xlink:label="lab_mdxg_AmendedTermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Term Loan Agreement</link:label>
    <link:label id="lab_mdxg_AmendedTermLoanAgreementMember_label_en-US" xlink:label="lab_mdxg_AmendedTermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Term Loan Agreement [Member]</link:label>
    <link:label id="lab_mdxg_AmendedTermLoanAgreementMember_documentation_en-US" xlink:label="lab_mdxg_AmendedTermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Term Loan Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AmendedTermLoanAgreementMember" xlink:href="mdxg-20210630.xsd#mdxg_AmendedTermLoanAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_AmendedTermLoanAgreementMember" xlink:to="lab_mdxg_AmendedTermLoanAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_63d3f462-59ea-4607-bf1c-2f02d0a5a8da_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_7a4ec1f3-5121-47f7-9db0-9ac7a1472199_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock at cost; 821,988 shares at June&#160;30, 2021 and 1,773,683 shares at December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent_fa583b3b-652b-4a7b-8c2d-dafdba994aae_terseLabel_en-US" xlink:label="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, prepayment make-whole premium as percent of prepaid principal, plus accrued interest (percent)</link:label>
    <link:label id="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent_label_en-US" xlink:label="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Plus Accrued Interest, Percent</link:label>
    <link:label id="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent_documentation_en-US" xlink:label="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Plus Accrued Interest, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent" xlink:to="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_d8b63d75-b374-4624-b0d2-b87324068ba3_terseLabel_en-US" xlink:label="lab_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:label id="lab_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="mdxg-20210630.xsd#mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_4077fe81-e901-494c-af13-8c8b95d130c5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restricted Stock Awards by Award Type</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_40fb4019-3f3e-4f3d-934b-29915f7d70d4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock canceled/forfeited</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_773a1b38-5530-4d33-842f-c658bf0b4252_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_72f3b9e5-236a-4547-8c08-4ea0cbda32b7_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:to="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_1eb002ae-efc3-4e55-a156-39022ea4b433_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c0e49d09-5ea2-4990-a0af-5208fa92f512_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 (excluding the six months ended June 30, 2021)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_b12c2c03-ef67-4718-a276-8a2f9a824ce5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ff710c79-4c05-43b0-8fa0-bf0da88b3246_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_b4a1ba75-52bd-4fa8-9236-d33bba9303ee_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_8fba7e4f-6f66-43fb-84cb-b6c2b668e993_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_e4f4d739-4fff-48b3-9fb7-203528db75a7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_138d8865-4de0-449e-bbaa-102236d5f9e9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_4b620aaf-0176-4480-b19d-3e0bfa22f43e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_c2323eeb-de92-4756-adef-e5eb41bc98f3_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_366ef2ce-1d70-426a-b04b-2d711cd027fa_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_DebtInstrumentInterestRateFloorPercentage_f59f23f6-b326-44e3-887a-216615a67548_terseLabel_en-US" xlink:label="lab_mdxg_DebtInstrumentInterestRateFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate, floor (percent)</link:label>
    <link:label id="lab_mdxg_DebtInstrumentInterestRateFloorPercentage_label_en-US" xlink:label="lab_mdxg_DebtInstrumentInterestRateFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Floor Percentage</link:label>
    <link:label id="lab_mdxg_DebtInstrumentInterestRateFloorPercentage_documentation_en-US" xlink:label="lab_mdxg_DebtInstrumentInterestRateFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Floor Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentInterestRateFloorPercentage" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentInterestRateFloorPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_DebtInstrumentInterestRateFloorPercentage" xlink:to="lab_mdxg_DebtInstrumentInterestRateFloorPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_2b2d8898-66aa-451d-b89e-e61f0b77e0b8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_18576567-a04f-4473-8b8a-c586a5f2cc4a_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1ae3dbff-4d84-49d4-b56e-2963ef3334da_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_0444e153-3462-4faf-b091-34bb612a8bb4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_fefe7613-c2f8-4fea-9da7-2ee0e1ffab18_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_a2315f4c-de81-4d34-8d5e-9d63b5517837_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B convertible preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_3aedaa5a-61b5-47fa-8f70-8591957c0d88_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_dc8afd1b-f4c8-4691-bfd8-517df7ef12c2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_e3262070-c281-4c01-8e18-538b06fe3706_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Future Amortization Expense for Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_50812d1f-1a38-4f3d-abd5-52b881a875fd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_25250bf5-e7aa-4a62-9e8d-fb6605256af9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_a7f8ef72-e320-435a-a024-00dcf922ce26_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts, Premiums and Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_4f375ae4-7b61-4e90-888a-1149f3149704_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_97188782-d2d0-4d9d-84de-f8f5d622d589_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_e7abd125-791c-47ea-99a6-8d7cdf55508e_terseLabel_en-US" xlink:label="lab_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of basic and diluted net loss per share [Abstract]</link:label>
    <link:label id="lab_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_label_en-US" xlink:label="lab_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of basic and diluted net loss per share [Abstract]</link:label>
    <link:label id="lab_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_documentation_en-US" xlink:label="lab_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract" xlink:href="mdxg-20210630.xsd#mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract" xlink:to="lab_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_a9f63363-2bd6-4a04-92d2-d0532a78bf90_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d22f6f28-f7d5-42e1-ad20-b2a3d1a7a441_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_662d84cd-3f57-4598-8241-ef647f97569d_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory and clean room equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_ContingencyLossNumberOfSecuritiesClassActions_1a5af2bd-3789-4655-b220-c796ba3ca015_terseLabel_en-US" xlink:label="lab_mdxg_ContingencyLossNumberOfSecuritiesClassActions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of securities class actions</link:label>
    <link:label id="lab_mdxg_ContingencyLossNumberOfSecuritiesClassActions_label_en-US" xlink:label="lab_mdxg_ContingencyLossNumberOfSecuritiesClassActions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingency Loss, Number Of Securities Class Actions</link:label>
    <link:label id="lab_mdxg_ContingencyLossNumberOfSecuritiesClassActions_documentation_en-US" xlink:label="lab_mdxg_ContingencyLossNumberOfSecuritiesClassActions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingency Loss, Number Of Securities Class Actions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ContingencyLossNumberOfSecuritiesClassActions" xlink:href="mdxg-20210630.xsd#mdxg_ContingencyLossNumberOfSecuritiesClassActions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_ContingencyLossNumberOfSecuritiesClassActions" xlink:to="lab_mdxg_ContingencyLossNumberOfSecuritiesClassActions" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_OperatingLeaseRightofuseAssetAmortization_5ce237a7-a6f1-48b5-b83d-d0db6c36104c_terseLabel_en-US" xlink:label="lab_mdxg_OperatingLeaseRightofuseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expenses</link:label>
    <link:label id="lab_mdxg_OperatingLeaseRightofuseAssetAmortization_label_en-US" xlink:label="lab_mdxg_OperatingLeaseRightofuseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-use Asset, Amortization</link:label>
    <link:label id="lab_mdxg_OperatingLeaseRightofuseAssetAmortization_documentation_en-US" xlink:label="lab_mdxg_OperatingLeaseRightofuseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_OperatingLeaseRightofuseAssetAmortization" xlink:href="mdxg-20210630.xsd#mdxg_OperatingLeaseRightofuseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_OperatingLeaseRightofuseAssetAmortization" xlink:to="lab_mdxg_OperatingLeaseRightofuseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_d6c7f296-9129-486c-afa0-4052773df990_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_89951430-6e42-4030-bcf0-af408a3dd27f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b3f3c295-0417-4815-9fe1-a15fd83ae8b7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_09700d58-a36b-4505-92c0-9a6d2006f91d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_79715086-d34b-413d-b321-66e36a9f7e61_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfMediumTermNotes_6f58b65c-4554-4dfa-8f07-95fdb51634af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfMediumTermNotes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of term loans</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfMediumTermNotes_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfMediumTermNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Medium-term Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfMediumTermNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfMediumTermNotes" xlink:to="lab_us-gaap_RepaymentsOfMediumTermNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredCompensation_f52d90aa-3925-4dd2-ad4e-24bb48be6880_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredCompensation_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_c21d81ea-bb2e-45d4-b08e-f17995a5425c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_f91bbd56-1fd9-4ffb-83f3-8c0cd385501e_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and know how</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member_b9cc1d89-831f-4fed-8b35-2765b16bd145_terseLabel_en-US" xlink:label="lab_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounted Dividend Rate prior to Quarterly Dividend Payment ending on June 30,2021</link:label>
    <link:label id="lab_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member_label_en-US" xlink:label="lab_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounted Dividend Rate prior to Quarterly Dividend Payment ending on June 30,2021 [Member]</link:label>
    <link:label id="lab_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member_documentation_en-US" xlink:label="lab_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounted Dividend Rate prior to Quarterly Dividend Payment ending on June 30,2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member" xlink:href="mdxg-20210630.xsd#mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member" xlink:to="lab_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_b9e57a00-cf2b-40b9-9855-be10dd05879d_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_b313cadf-57bf-4d6a-88ce-5c8d430f9df4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemTable_99f2dd95-2dcb-4292-9594-b1596f6e994f_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Table]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemTable_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable" xlink:to="lab_us-gaap_UnusualOrInfrequentItemTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f38730cf-b928-4631-bd2f-2ce725c2059d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_e33679fe-c095-4b76-99b4-17e5b4ed1169_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c4a8398a-acc0-4b97-bbf7-9caf8ff4beae_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_72078b46-814f-4234-af13-9ba51cd3386f_verboseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated dividend on Series B Convertible Preferred Stock</link:label>
    <link:label id="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_270a0788-9f46-4873-bed1-4d7fddaa1353_terseLabel_en-US" xlink:label="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred convertible Stock, dividends accrued but not recorded for the period</link:label>
    <link:label id="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_label_en-US" xlink:label="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accreted but Unrecorded Dividends</link:label>
    <link:label id="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_documentation_en-US" xlink:label="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accreted but Unrecorded Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityAccretedbutUnrecordedDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends" xlink:to="lab_mdxg_TemporaryEquityAccretedbutUnrecordedDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_f27855a4-3635-43a3-9bda-2c94a2b9e84f_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred financing costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_e6b65423-8175-447d-930a-34b3f291cda6_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_ce083173-a319-4b39-8de6-e954bd2f722c_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_4a636369-987e-4ebf-b7b1-67e7cfd01f9c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on fixed asset disposal</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_8a581843-a17a-4056-b122-11c3ded801ba_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred cost of sales</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_21769d7d-6404-4903-bca9-c96ac9088a7d_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5a618e46-15c3-4f48-a4a7-3928218fb281_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_effd2827-ef52-417a-8108-76d325165123_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_LeaseRightOfUseAssetAndLiability_a9f7ec04-4073-4e3a-8025-e0b7b23de2a6_terseLabel_en-US" xlink:label="lab_mdxg_LeaseRightOfUseAssetAndLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease right of use asset and liability</link:label>
    <link:label id="lab_mdxg_LeaseRightOfUseAssetAndLiability_label_en-US" xlink:label="lab_mdxg_LeaseRightOfUseAssetAndLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right Of Use Asset And Liability</link:label>
    <link:label id="lab_mdxg_LeaseRightOfUseAssetAndLiability_documentation_en-US" xlink:label="lab_mdxg_LeaseRightOfUseAssetAndLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right Of Use Asset And Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_LeaseRightOfUseAssetAndLiability" xlink:href="mdxg-20210630.xsd#mdxg_LeaseRightOfUseAssetAndLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_LeaseRightOfUseAssetAndLiability" xlink:to="lab_mdxg_LeaseRightOfUseAssetAndLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_e689c615-931e-416d-854f-fc9485c7c584_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_8264644c-2272-468b-9b90-31f20ffe6d1b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_f21a30af-555d-4720-96b1-ea82b9bf029f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c5ab57b7-8f07-410d-90bd-1f6c97b0b7ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Activity Summary - Finite-lived</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_93b2660a-ea91-4920-99d7-e80ba0a6ea4b_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_147b4027-d266-40a3-889e-bc2a11b79360_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_a05a1cea-5be8-4976-85f2-40c66a1736ec_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments from note receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Held-to-maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_8dcec16f-8db1-47f6-ae8a-023922b6715f_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_e74bbe6b-dbca-42fd-926e-cbf4dce8d14d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6d264afe-6ed1-4d67-9b79-ddaf6ab51321_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7f93b62c-62d5-4230-8b8b-562445f2e0e7_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceSettlementsReceivable_95caac1b-0c2c-4069-aef6-80b235f24552_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceSettlementsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements indemnified by insurance</link:label>
    <link:label id="lab_us-gaap_InsuranceSettlementsReceivable_label_en-US" xlink:label="lab_us-gaap_InsuranceSettlementsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Settlements Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceSettlementsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceSettlementsReceivable" xlink:to="lab_us-gaap_InsuranceSettlementsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember_ee3a9383-20dc-457f-8d6a-dff97ef71113_terseLabel_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 1.0x</link:label>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember_label_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 1.0x [Member]</link:label>
    <link:label id="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember_documentation_en-US" xlink:label="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 1.0x [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember" xlink:to="lab_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ed10ea45-4671-4749-aa77-89f609abe1ab_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1f51955d-f74a-4231-a4c9-48abfe3d9c19_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding adjusted for potential common shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceRecoveries_aeb9b930-8567-428c-885e-900fae0c9dd5_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceRecoveries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance recoveries</link:label>
    <link:label id="lab_us-gaap_InsuranceRecoveries_label_en-US" xlink:label="lab_us-gaap_InsuranceRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Recoveries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceRecoveries" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceRecoveries" xlink:to="lab_us-gaap_InsuranceRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_ff99675b-8881-4902-a551-b7753ec0fd79_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_45e95570-d856-4607-b02b-558d756b5cbd_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_8bb3e932-93e2-434a-a18d-642ef0924d7e_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_54c13169-54af-415a-952d-86c55fef7c7c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock Options Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d6cc10f2-7d16-4d7c-a350-33b24872b448_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemLineItems_701d5095-8693-49ba-bc0d-0bb86ca46d3e_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Line Items]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemLineItems_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems" xlink:to="lab_us-gaap_UnusualOrInfrequentItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_2820b547-aa52-47e2-b56e-c2c385a810f8_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_35add68e-c76f-4976-b0cd-f7c6605e4a97_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_ec6ac951-ab8b-46f5-ad32-4cd4c4471d6d_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_140b22e5-fa7e-424c-83a7-389a19604d54_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_aab392aa-fdb5-4b9a-ac20-a2f6e7decdd7_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b2f28808-bcaf-4245-b586-d02d3da679dc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_77e65d88-a5a3-48bf-bf5d-44cf1d8959aa_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaid_7619fb9e-dd34-4697-9f15-97e60a2b63d3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaid_label_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9f83a31f-7d0d-4480-ba0e-7d8600541570_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in cash resulting from changes in:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fbe8894b-41f9-410c-9b08-84c3c92d47b5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a2e31f74-aa0a-4384-97ff-42b42363d0cc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_0a841911-7c72-46b7-9822-17b23fa02e62_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate at issuance (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_04297f0d-ba4e-4da3-94d9-566a125823b5_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders_a7d8d51f-89a8-4311-b58d-bef605956c30_terseLabel_en-US" xlink:label="lab_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of board seats elected by Series B preferred stockholders</link:label>
    <link:label id="lab_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders_label_en-US" xlink:label="lab_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Board Seats Elected by Temporary Equity Holders</link:label>
    <link:label id="lab_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders_documentation_en-US" xlink:label="lab_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Board Seats Elected by Temporary Equity Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders" xlink:href="mdxg-20210630.xsd#mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders" xlink:to="lab_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward_0ea1cedf-fcb1-48b0-8b2e-ebf5edd20195_terseLabel_en-US" xlink:label="lab_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit recognized with respect to net operating loss</link:label>
    <link:label id="lab_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward_label_en-US" xlink:label="lab_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Net Operating Loss Carryforward</link:label>
    <link:label id="lab_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward_documentation_en-US" xlink:label="lab_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Net Operating Loss Carryforward</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" xlink:href="mdxg-20210630.xsd#mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" xlink:to="lab_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_052ccc97-b341-431c-ab12-eefa7cb782a3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_78e6e751-8c58-4636-a5c7-1282a4b9e7a5_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_248707cd-354c-4f0c-9c32-7fb6b76adad6_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_931f24c9-e3b6-4e90-95bb-66f7e12f187a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased for tax withholdings on vesting of restricted stock</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_24b605a9-632f-4499-ac9e-bcce9b9ea220_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_61b3f29a-a9c1-4034-b655-d8636192841d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_7c5bdb66-30f9-4455-b40c-00181c377573_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commissions to sales agents</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_DebtInstrumentCommitmentFees_8b0fda32-73a1-49f4-80a1-a2eb790a6752_terseLabel_en-US" xlink:label="lab_mdxg_DebtInstrumentCommitmentFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee</link:label>
    <link:label id="lab_mdxg_DebtInstrumentCommitmentFees_label_en-US" xlink:label="lab_mdxg_DebtInstrumentCommitmentFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Commitment Fees</link:label>
    <link:label id="lab_mdxg_DebtInstrumentCommitmentFees_documentation_en-US" xlink:label="lab_mdxg_DebtInstrumentCommitmentFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Commitment Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentCommitmentFees" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentCommitmentFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_DebtInstrumentCommitmentFees" xlink:to="lab_mdxg_DebtInstrumentCommitmentFees" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_DebtInstrumentDefaultInterestRate_a89b1b20-7a15-4c72-a3be-3912e64dfb87_terseLabel_en-US" xlink:label="lab_mdxg_DebtInstrumentDefaultInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Default interest rate (percent)</link:label>
    <link:label id="lab_mdxg_DebtInstrumentDefaultInterestRate_label_en-US" xlink:label="lab_mdxg_DebtInstrumentDefaultInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Default Interest Rate</link:label>
    <link:label id="lab_mdxg_DebtInstrumentDefaultInterestRate_documentation_en-US" xlink:label="lab_mdxg_DebtInstrumentDefaultInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Default Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentDefaultInterestRate" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentDefaultInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_DebtInstrumentDefaultInterestRate" xlink:to="lab_mdxg_DebtInstrumentDefaultInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_AccruedSettlementCostsCurrent_67c11f97-26b5-478e-902c-424ab932b0bf_terseLabel_en-US" xlink:label="lab_mdxg_AccruedSettlementCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement costs</link:label>
    <link:label id="lab_mdxg_AccruedSettlementCostsCurrent_label_en-US" xlink:label="lab_mdxg_AccruedSettlementCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Settlement Costs, Current</link:label>
    <link:label id="lab_mdxg_AccruedSettlementCostsCurrent_documentation_en-US" xlink:label="lab_mdxg_AccruedSettlementCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Settlement Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AccruedSettlementCostsCurrent" xlink:href="mdxg-20210630.xsd#mdxg_AccruedSettlementCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_AccruedSettlementCostsCurrent" xlink:to="lab_mdxg_AccruedSettlementCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_cf8752eb-ee6d-468d-8d4c-41acbccc6a11_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for legal settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_bed9b8a3-c735-4c72-b3be-d9c008c1a683_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_cf5f07d1-4b09-44ee-9641-d45c602a39a6_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_2107f4f1-c741-483c-98d2-6d2f44f75b73_terseLabel_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_label_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:to="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_8ec36b15-6d74-479a-bd26-6a204765a472_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_43384b74-f7ae-4017-903f-7535ad83299f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent_dea5d415-9082-438c-8c97-97390e8f2809_terseLabel_en-US" xlink:label="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, prepayment make-whole premium as percent of prepaid principal (percent)</link:label>
    <link:label id="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent_label_en-US" xlink:label="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Percent</link:label>
    <link:label id="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent_documentation_en-US" xlink:label="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" xlink:to="lab_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_995572ee-0225-4d3c-857a-130751615510_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued and Adopted Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_312f80c8-7fe3-45dd-ba16-4a1a65ad2694_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_36d6b8ed-7e80-40a3-a994-511ecdb5639a_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_a1352f10-7096-4db4-a6c2-b57cb5cb8626_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Correction of out-of-period error (Note 1)</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_515cd89e-0a53-4716-9197-4317c6b86071_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Correction of error</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_6c76a319-9b25-4b8d-a943-72b23cad03ba_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_6593a9e0-7983-40f1-b62f-9b14774d1f23_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMachineryAndEquipment_a2a02e8f-bb48-4d6b-9505-f95f609c8b22_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMachineryAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Machinery and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_6350c4e3-0aa1-4bee-b1bd-43ac83d72552_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_86207270-58b0-493a-9153-81b939eaf9e8_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_mdxg_LegalProceedingsMember_8a7201ab-8b44-4dab-bdc4-9f1b554d2c24_terseLabel_en-US" xlink:label="lab_mdxg_LegalProceedingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings</link:label>
    <link:label id="lab_mdxg_LegalProceedingsMember_label_en-US" xlink:label="lab_mdxg_LegalProceedingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings [Member]</link:label>
    <link:label id="lab_mdxg_LegalProceedingsMember_documentation_en-US" xlink:label="lab_mdxg_LegalProceedingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_LegalProceedingsMember" xlink:href="mdxg-20210630.xsd#mdxg_LegalProceedingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdxg_LegalProceedingsMember" xlink:to="lab_mdxg_LegalProceedingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_6da5c6f3-7150-4585-8fe6-3b135364f5d7_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b0602ca2-25f5-4728-accb-88225d8396ff_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash flows used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_0943df7a-77cc-4e7f-a006-a81334d0c2a8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_4bb2f245-6a03-4f42-ba8e-96f8a5bfec15_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, before Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingenciesTable_3f2a0a8b-9d52-4870-a4d3-bbef7c4d3e5f_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_GainContingenciesTable_label_en-US" xlink:label="lab_us-gaap_GainContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingenciesTable" xlink:to="lab_us-gaap_GainContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_dccaaa51-aee7-4818-af31-43d7cc205f2b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_b630eaac-63c2-4bc8-b631-6fbb8e6c5521_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original issue discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_986d6577-fec4-44a0-bad0-6ecd9be4b20a_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original issue discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLineItems_f68377f3-65e2-462a-a03c-39839f0a967d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:label id="lab_us-gaap_InventoryLineItems_label_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLineItems" xlink:to="lab_us-gaap_InventoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_6047a61c-4fe3-47ff-8b8a-5987e657e2f4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in litigation settlement</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a59e7b62-105d-4608-8aa9-1bc84ab82741_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_9e7a1862-80a6-43aa-992a-2abf21d474da_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly installments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>mdxg-20210630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:2348d07d-1fe7-4f85-b08a-d7c74be22bf0,g:fbe44d2f-ecde-4c93-87d4-07ca0cdbb039-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mimedx.com/role/Cover" xlink:type="simple" xlink:href="mdxg-20210630.xsd#Cover"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_761c579d-d14d-4f05-a09e-4644565a5446" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_DocumentType_761c579d-d14d-4f05-a09e-4644565a5446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_d8054169-71f9-4531-8b4f-73b4bf9f58fc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_DocumentQuarterlyReport_d8054169-71f9-4531-8b4f-73b4bf9f58fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b1a9c8f7-f369-4f37-9937-b44c41577fb0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_DocumentPeriodEndDate_b1a9c8f7-f369-4f37-9937-b44c41577fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_77a3a483-821f-47e4-801f-701bebdd708c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_DocumentTransitionReport_77a3a483-821f-47e4-801f-701bebdd708c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_72c5238a-0dcb-4833-a15f-206812bcc086" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_EntityFileNumber_72c5238a-0dcb-4833-a15f-206812bcc086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_bd5f46c3-332d-4b2d-a4a9-0c5ac7c80561" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_EntityRegistrantName_bd5f46c3-332d-4b2d-a4a9-0c5ac7c80561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_55d9496d-5978-4573-aa89-2661192d12d0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_55d9496d-5978-4573-aa89-2661192d12d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b104f3dd-d47e-43d0-9bbc-c840fe303c57" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_EntityTaxIdentificationNumber_b104f3dd-d47e-43d0-9bbc-c840fe303c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_86ae41fe-2b80-45f6-8bbf-338836ac42d4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_EntityAddressAddressLine1_86ae41fe-2b80-45f6-8bbf-338836ac42d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1f09e31f-f8a1-4dfa-b961-cf5580275d12" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_EntityAddressCityOrTown_1f09e31f-f8a1-4dfa-b961-cf5580275d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_452671e7-7dac-477b-875d-b6a3e825236d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_EntityAddressStateOrProvince_452671e7-7dac-477b-875d-b6a3e825236d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_0fa47f2e-b412-4d9c-bf1c-5cea11ad2d99" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_EntityAddressPostalZipCode_0fa47f2e-b412-4d9c-bf1c-5cea11ad2d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b20a7838-d2e1-4ec0-9919-9e7f52901590" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_CityAreaCode_b20a7838-d2e1-4ec0-9919-9e7f52901590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_679f027f-069b-4809-b19b-043530e0b116" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_LocalPhoneNumber_679f027f-069b-4809-b19b-043530e0b116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9819d812-1c95-4a45-b613-5421731ed443" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_Security12bTitle_9819d812-1c95-4a45-b613-5421731ed443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_6b3d46e6-ef84-4a51-b3b4-ae769894c857" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_TradingSymbol_6b3d46e6-ef84-4a51-b3b4-ae769894c857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_61dc27d3-af32-4a14-a028-8bd79f911428" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_SecurityExchangeName_61dc27d3-af32-4a14-a028-8bd79f911428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_4e94da23-bbad-48ce-8f83-89d39cb8d1fe" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_EntityCurrentReportingStatus_4e94da23-bbad-48ce-8f83-89d39cb8d1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_2b15e56f-89ec-4994-979b-0cfd421da190" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_EntityInteractiveDataCurrent_2b15e56f-89ec-4994-979b-0cfd421da190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_53845158-068a-4a79-8ab9-2077ee8c7cb2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_EntityFilerCategory_53845158-068a-4a79-8ab9-2077ee8c7cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_725da3af-d39f-45c3-874b-3e6ca62d5283" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_EntitySmallBusiness_725da3af-d39f-45c3-874b-3e6ca62d5283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_fdbb5750-1e71-4064-bbe0-b95be7c51f25" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_EntityEmergingGrowthCompany_fdbb5750-1e71-4064-bbe0-b95be7c51f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_d285db28-fde6-4bcf-915c-eb89297639c5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_EntityShellCompany_d285db28-fde6-4bcf-915c-eb89297639c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_de052744-3202-4baf-a0fa-0e8ca3864eb8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_de052744-3202-4baf-a0fa-0e8ca3864eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_b0cfcee9-e056-4267-85d7-fbbe5dd5c593" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_EntityCentralIndexKey_b0cfcee9-e056-4267-85d7-fbbe5dd5c593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c3341e0e-f715-4be6-86e3-74fc26d1d6d9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_CurrentFiscalYearEndDate_c3341e0e-f715-4be6-86e3-74fc26d1d6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_762f640d-618e-420a-a0de-e9388e751ddc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_DocumentFiscalYearFocus_762f640d-618e-420a-a0de-e9388e751ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_f3304b82-9959-47f3-8c04-88d3e70bad60" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_f3304b82-9959-47f3-8c04-88d3e70bad60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_8a43b5da-ad31-475d-a46c-75e8d34fb7b4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a909c38-7922-42f4-8a30-44c172fd761e" xlink:to="loc_dei_AmendmentFlag_8a43b5da-ad31-475d-a46c-75e8d34fb7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mdxg-20210630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_07748f3f-7051-446f-a9de-d2678c1abae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_a7e356e8-6d40-46ff-81d7-cdb44834cbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_07748f3f-7051-446f-a9de-d2678c1abae4" xlink:to="loc_us-gaap_AssetsAbstract_a7e356e8-6d40-46ff-81d7-cdb44834cbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_27685957-3f62-4ff1-b891-60ce46a131b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a7e356e8-6d40-46ff-81d7-cdb44834cbb4" xlink:to="loc_us-gaap_AssetsCurrentAbstract_27685957-3f62-4ff1-b891-60ce46a131b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ca0de06c-210f-4652-91ad-a122baa4d1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_27685957-3f62-4ff1-b891-60ce46a131b1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ca0de06c-210f-4652-91ad-a122baa4d1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_56be734c-bd90-4994-86cd-9652c2062954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_27685957-3f62-4ff1-b891-60ce46a131b1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_56be734c-bd90-4994-86cd-9652c2062954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3ef0004a-bbc3-462f-9c38-88079f9de943" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_27685957-3f62-4ff1-b891-60ce46a131b1" xlink:to="loc_us-gaap_InventoryNet_3ef0004a-bbc3-462f-9c38-88079f9de943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1deb2163-f45a-4b03-a4f9-95a92bd05002" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_27685957-3f62-4ff1-b891-60ce46a131b1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1deb2163-f45a-4b03-a4f9-95a92bd05002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_94d58525-e64a-4283-bf75-426694e397ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_27685957-3f62-4ff1-b891-60ce46a131b1" xlink:to="loc_us-gaap_IncomeTaxesReceivable_94d58525-e64a-4283-bf75-426694e397ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_32b3160e-e977-4cd5-9218-93b91525a99f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_27685957-3f62-4ff1-b891-60ce46a131b1" xlink:to="loc_us-gaap_OtherAssetsCurrent_32b3160e-e977-4cd5-9218-93b91525a99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_20bcb7fe-4c43-405c-aae5-410c25fbbf99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_27685957-3f62-4ff1-b891-60ce46a131b1" xlink:to="loc_us-gaap_AssetsCurrent_20bcb7fe-4c43-405c-aae5-410c25fbbf99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_77797e7d-3412-4720-a89f-d4b753514f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a7e356e8-6d40-46ff-81d7-cdb44834cbb4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_77797e7d-3412-4720-a89f-d4b753514f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset_52e45299-614a-4be7-8ec4-3d0b78b0ac5c" xlink:href="mdxg-20210630.xsd#mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a7e356e8-6d40-46ff-81d7-cdb44834cbb4" xlink:to="loc_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset_52e45299-614a-4be7-8ec4-3d0b78b0ac5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7d93be42-e876-4d81-95ee-0a0032ded8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a7e356e8-6d40-46ff-81d7-cdb44834cbb4" xlink:to="loc_us-gaap_Goodwill_7d93be42-e876-4d81-95ee-0a0032ded8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_63f1d497-50f3-4bdb-a63b-c41e57bbe03b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a7e356e8-6d40-46ff-81d7-cdb44834cbb4" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_63f1d497-50f3-4bdb-a63b-c41e57bbe03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5d1d0b5f-3de2-4553-91dc-bb3a1182e23d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a7e356e8-6d40-46ff-81d7-cdb44834cbb4" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5d1d0b5f-3de2-4553-91dc-bb3a1182e23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3beec936-2896-4ed8-8705-44a5e62f2d29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a7e356e8-6d40-46ff-81d7-cdb44834cbb4" xlink:to="loc_us-gaap_Assets_3beec936-2896-4ed8-8705-44a5e62f2d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_418ff1ea-7a94-426d-a055-45f24754b464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_07748f3f-7051-446f-a9de-d2678c1abae4" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_418ff1ea-7a94-426d-a055-45f24754b464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_d2a74129-84ac-445a-abf3-a163b325a235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_418ff1ea-7a94-426d-a055-45f24754b464" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_d2a74129-84ac-445a-abf3-a163b325a235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_c3f411b4-adc0-4363-8ba0-70d1b11bbf81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d2a74129-84ac-445a-abf3-a163b325a235" xlink:to="loc_us-gaap_AccountsPayableCurrent_c3f411b4-adc0-4363-8ba0-70d1b11bbf81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_523c594a-2a07-4aa6-9623-7e5b0f0f0d43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d2a74129-84ac-445a-abf3-a163b325a235" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_523c594a-2a07-4aa6-9623-7e5b0f0f0d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_2e2bf981-4771-4e64-97ec-6e23e7ffed31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d2a74129-84ac-445a-abf3-a163b325a235" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_2e2bf981-4771-4e64-97ec-6e23e7ffed31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_5056815f-58d3-43ab-a240-1b0f6f61d15d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d2a74129-84ac-445a-abf3-a163b325a235" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_5056815f-58d3-43ab-a240-1b0f6f61d15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1c24b288-50aa-46d1-995a-6fe027da1776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d2a74129-84ac-445a-abf3-a163b325a235" xlink:to="loc_us-gaap_LiabilitiesCurrent_1c24b288-50aa-46d1-995a-6fe027da1776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4cb86f70-7aef-48a4-9367-222053bb8254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_418ff1ea-7a94-426d-a055-45f24754b464" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_4cb86f70-7aef-48a4-9367-222053bb8254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2101b38b-e16d-431e-af19-d6dd6862b5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_418ff1ea-7a94-426d-a055-45f24754b464" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2101b38b-e16d-431e-af19-d6dd6862b5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8234698c-d302-44ca-9f12-03a2d03099fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_418ff1ea-7a94-426d-a055-45f24754b464" xlink:to="loc_us-gaap_Liabilities_8234698c-d302-44ca-9f12-03a2d03099fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b09e867b-f80e-4af8-bc09-856e2cf72780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_418ff1ea-7a94-426d-a055-45f24754b464" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b09e867b-f80e-4af8-bc09-856e2cf72780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_bf51762c-1da3-47c7-bb3d-3fbe56f5afe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_418ff1ea-7a94-426d-a055-45f24754b464" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_bf51762c-1da3-47c7-bb3d-3fbe56f5afe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_44433644-00ab-4b9b-99d8-40fdcd1e37be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_418ff1ea-7a94-426d-a055-45f24754b464" xlink:to="loc_us-gaap_StockholdersEquityAbstract_44433644-00ab-4b9b-99d8-40fdcd1e37be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_113deb75-4972-4c1f-8a97-18602b429edf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_44433644-00ab-4b9b-99d8-40fdcd1e37be" xlink:to="loc_us-gaap_PreferredStockValue_113deb75-4972-4c1f-8a97-18602b429edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_bee5a713-da26-4ece-907d-b38bb79c5118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_44433644-00ab-4b9b-99d8-40fdcd1e37be" xlink:to="loc_us-gaap_CommonStockValue_bee5a713-da26-4ece-907d-b38bb79c5118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_074007c0-a886-43b5-861e-37ee1ac9081c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_44433644-00ab-4b9b-99d8-40fdcd1e37be" xlink:to="loc_us-gaap_AdditionalPaidInCapital_074007c0-a886-43b5-861e-37ee1ac9081c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_bbfb3b52-66be-40fc-b1cb-8d4d781431d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_44433644-00ab-4b9b-99d8-40fdcd1e37be" xlink:to="loc_us-gaap_TreasuryStockValue_bbfb3b52-66be-40fc-b1cb-8d4d781431d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_45ebfa06-032a-4329-835f-d7b59206a35e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_44433644-00ab-4b9b-99d8-40fdcd1e37be" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_45ebfa06-032a-4329-835f-d7b59206a35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5f4206fd-9a1a-42ac-afae-be7eaaad06a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_44433644-00ab-4b9b-99d8-40fdcd1e37be" xlink:to="loc_us-gaap_StockholdersEquity_5f4206fd-9a1a-42ac-afae-be7eaaad06a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4ccd9614-cd05-4d98-9af6-2e11a6143b47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_418ff1ea-7a94-426d-a055-45f24754b464" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_4ccd9614-cd05-4d98-9af6-2e11a6143b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mdxg-20210630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_bfeec240-10e1-415a-b944-287aa4c9d32c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e91b586f-3ad9-43a9-a43e-39853cb53ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bfeec240-10e1-415a-b944-287aa4c9d32c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e91b586f-3ad9-43a9-a43e-39853cb53ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_5910ef8d-454d-446a-92a3-a8f225a9f930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e91b586f-3ad9-43a9-a43e-39853cb53ecd" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_5910ef8d-454d-446a-92a3-a8f225a9f930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_fef377ec-ae3f-4449-9798-a811875faba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e91b586f-3ad9-43a9-a43e-39853cb53ecd" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_fef377ec-ae3f-4449-9798-a811875faba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_de1becec-98d9-415e-9297-1ae86e0071e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e91b586f-3ad9-43a9-a43e-39853cb53ecd" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_de1becec-98d9-415e-9297-1ae86e0071e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_68673052-e131-435f-a3e8-e4ce37bc472b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e91b586f-3ad9-43a9-a43e-39853cb53ecd" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_68673052-e131-435f-a3e8-e4ce37bc472b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_aa6d6cbe-65f8-4514-af33-c7b575aafdb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e91b586f-3ad9-43a9-a43e-39853cb53ecd" xlink:to="loc_us-gaap_StockholdersEquityAbstract_aa6d6cbe-65f8-4514-af33-c7b575aafdb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_2b61a5db-6d35-478b-ac15-83d521893f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aa6d6cbe-65f8-4514-af33-c7b575aafdb0" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_2b61a5db-6d35-478b-ac15-83d521893f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_e53be674-51d5-44c9-810a-6364fab87b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aa6d6cbe-65f8-4514-af33-c7b575aafdb0" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_e53be674-51d5-44c9-810a-6364fab87b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_37c36420-ee23-4340-b150-ed157ab887ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aa6d6cbe-65f8-4514-af33-c7b575aafdb0" xlink:to="loc_us-gaap_PreferredStockSharesIssued_37c36420-ee23-4340-b150-ed157ab887ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_c3348a2f-e4e1-45bd-ad50-f04bc5981a81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aa6d6cbe-65f8-4514-af33-c7b575aafdb0" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_c3348a2f-e4e1-45bd-ad50-f04bc5981a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_64b90fc5-d679-4d13-8636-d7c8bcded5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aa6d6cbe-65f8-4514-af33-c7b575aafdb0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_64b90fc5-d679-4d13-8636-d7c8bcded5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_5177d3d0-3601-4b09-9826-efe355468fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aa6d6cbe-65f8-4514-af33-c7b575aafdb0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_5177d3d0-3601-4b09-9826-efe355468fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_43bcd4db-3973-4f1b-bd43-34558f3f0572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aa6d6cbe-65f8-4514-af33-c7b575aafdb0" xlink:to="loc_us-gaap_CommonStockSharesIssued_43bcd4db-3973-4f1b-bd43-34558f3f0572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_bca05f95-de15-4854-bef7-fd1e6e9b0503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aa6d6cbe-65f8-4514-af33-c7b575aafdb0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_bca05f95-de15-4854-bef7-fd1e6e9b0503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_76f5fc5e-d73a-4639-8470-34e8d709dd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aa6d6cbe-65f8-4514-af33-c7b575aafdb0" xlink:to="loc_us-gaap_TreasuryStockShares_76f5fc5e-d73a-4639-8470-34e8d709dd4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mdxg-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_1c9f850b-0fe1-4373-9c53-2c602908509f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b5659e0d-a221-4b5d-b692-c27d2db2aeac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1c9f850b-0fe1-4373-9c53-2c602908509f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b5659e0d-a221-4b5d-b692-c27d2db2aeac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_7a79bdf9-e309-427d-868f-1696296c98d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1c9f850b-0fe1-4373-9c53-2c602908509f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_7a79bdf9-e309-427d-868f-1696296c98d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_6727d1a6-bdd8-4dec-a8e2-20721bc7b33b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1c9f850b-0fe1-4373-9c53-2c602908509f" xlink:to="loc_us-gaap_GrossProfit_6727d1a6-bdd8-4dec-a8e2-20721bc7b33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_65e8e580-cfad-4401-9fd0-1e149c5ac6da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1c9f850b-0fe1-4373-9c53-2c602908509f" xlink:to="loc_us-gaap_OperatingExpensesAbstract_65e8e580-cfad-4401-9fd0-1e149c5ac6da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_91cde838-cfbe-4779-bbc9-d3ff57ddb0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_65e8e580-cfad-4401-9fd0-1e149c5ac6da" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_91cde838-cfbe-4779-bbc9-d3ff57ddb0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_InvestigationRestatementandRelated_ba72ea9a-ac49-425a-a2a6-d360a81bf260" xlink:href="mdxg-20210630.xsd#mdxg_InvestigationRestatementandRelated"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_65e8e580-cfad-4401-9fd0-1e149c5ac6da" xlink:to="loc_mdxg_InvestigationRestatementandRelated_ba72ea9a-ac49-425a-a2a6-d360a81bf260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_9f18b6e6-0470-4a9e-832b-f4b3cd766b27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_65e8e580-cfad-4401-9fd0-1e149c5ac6da" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_9f18b6e6-0470-4a9e-832b-f4b3cd766b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_177ef569-ee53-4699-8f17-86f7773b7954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_65e8e580-cfad-4401-9fd0-1e149c5ac6da" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_177ef569-ee53-4699-8f17-86f7773b7954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3617a9c9-d7eb-430c-be3a-2b153d216cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1c9f850b-0fe1-4373-9c53-2c602908509f" xlink:to="loc_us-gaap_OperatingIncomeLoss_3617a9c9-d7eb-430c-be3a-2b153d216cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_410a52a6-186d-4fb5-b5a1-8cd75df78536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1c9f850b-0fe1-4373-9c53-2c602908509f" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_410a52a6-186d-4fb5-b5a1-8cd75df78536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_eba4e39b-4ad3-463f-b8e4-3c92be468782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_410a52a6-186d-4fb5-b5a1-8cd75df78536" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_eba4e39b-4ad3-463f-b8e4-3c92be468782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1c12e112-2225-4943-86cd-86fa0d9f4c10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_410a52a6-186d-4fb5-b5a1-8cd75df78536" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1c12e112-2225-4943-86cd-86fa0d9f4c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_91114edc-dea3-46ba-b4bc-08f64fef448e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1c9f850b-0fe1-4373-9c53-2c602908509f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_91114edc-dea3-46ba-b4bc-08f64fef448e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fbcfec63-db4a-4df4-bcb8-98a5e7af2028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1c9f850b-0fe1-4373-9c53-2c602908509f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fbcfec63-db4a-4df4-bcb8-98a5e7af2028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4611c076-3274-44f6-8a52-b35d8045f7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1c9f850b-0fe1-4373-9c53-2c602908509f" xlink:to="loc_us-gaap_NetIncomeLoss_4611c076-3274-44f6-8a52-b35d8045f7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_ee4be894-a01d-4521-b6ac-5c0b21133e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1c9f850b-0fe1-4373-9c53-2c602908509f" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_ee4be894-a01d-4521-b6ac-5c0b21133e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_cf290ffa-449c-4377-ba75-e965cb9ed90a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1c9f850b-0fe1-4373-9c53-2c602908509f" xlink:to="loc_us-gaap_EarningsPerShareBasic_cf290ffa-449c-4377-ba75-e965cb9ed90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e10e57d0-ce64-43b0-8ef3-3e934745b459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1c9f850b-0fe1-4373-9c53-2c602908509f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e10e57d0-ce64-43b0-8ef3-3e934745b459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ede8a7b3-2a7e-483c-b52f-0fabe869c9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1c9f850b-0fe1-4373-9c53-2c602908509f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ede8a7b3-2a7e-483c-b52f-0fabe869c9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c52b0756-362c-4cda-aab2-4a6414bbe120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1c9f850b-0fe1-4373-9c53-2c602908509f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c52b0756-362c-4cda-aab2-4a6414bbe120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT" xlink:type="simple" xlink:href="mdxg-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_ddff5b72-6c6a-4e55-be7e-27d46ff03793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2f839a37-0f97-4f00-a89c-4e73b975f9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_ddff5b72-6c6a-4e55-be7e-27d46ff03793" xlink:to="loc_us-gaap_StatementTable_2f839a37-0f97-4f00-a89c-4e73b975f9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b8edef6f-757b-451e-9c67-ecb7087d4b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2f839a37-0f97-4f00-a89c-4e73b975f9fb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b8edef6f-757b-451e-9c67-ecb7087d4b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c9fd8a7c-1ce9-4c98-bd9e-791d8abdc5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b8edef6f-757b-451e-9c67-ecb7087d4b7b" xlink:to="loc_us-gaap_EquityComponentDomain_c9fd8a7c-1ce9-4c98-bd9e-791d8abdc5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_acd9d397-553e-49de-ae9f-280b4a68e979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c9fd8a7c-1ce9-4c98-bd9e-791d8abdc5d8" xlink:to="loc_us-gaap_CommonStockMember_acd9d397-553e-49de-ae9f-280b4a68e979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b3f653e4-1ffc-4798-9112-ed1f11b163fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c9fd8a7c-1ce9-4c98-bd9e-791d8abdc5d8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b3f653e4-1ffc-4798-9112-ed1f11b163fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_dbf6a193-6a0f-49f1-81d9-9509419c99c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c9fd8a7c-1ce9-4c98-bd9e-791d8abdc5d8" xlink:to="loc_us-gaap_TreasuryStockMember_dbf6a193-6a0f-49f1-81d9-9509419c99c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e44e75d4-67c0-4ed3-8864-a54f296367a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c9fd8a7c-1ce9-4c98-bd9e-791d8abdc5d8" xlink:to="loc_us-gaap_RetainedEarningsMember_e44e75d4-67c0-4ed3-8864-a54f296367a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_6f32a795-55c8-4581-b598-c77cb37f4c6f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2f839a37-0f97-4f00-a89c-4e73b975f9fb" xlink:to="loc_srt_RestatementAxis_6f32a795-55c8-4581-b598-c77cb37f4c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_5b8459f2-1c42-4216-a328-8d4033259a9b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_6f32a795-55c8-4581-b598-c77cb37f4c6f" xlink:to="loc_srt_RestatementDomain_5b8459f2-1c42-4216-a328-8d4033259a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_b785d40d-4e3a-44e9-85bd-bb9d95e62ebc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_5b8459f2-1c42-4216-a328-8d4033259a9b" xlink:to="loc_srt_RestatementAdjustmentMember_b785d40d-4e3a-44e9-85bd-bb9d95e62ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_4d7f80d2-c2b7-4514-8fbd-35904fcfde99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2f839a37-0f97-4f00-a89c-4e73b975f9fb" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_4d7f80d2-c2b7-4514-8fbd-35904fcfde99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_b25f43c5-432e-4f1c-9129-8cd3b45d2a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_4d7f80d2-c2b7-4514-8fbd-35904fcfde99" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_b25f43c5-432e-4f1c-9129-8cd3b45d2a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_StockAwardMisstatementsMember_25abda69-9fa5-4c5c-922c-97f92e9e0065" xlink:href="mdxg-20210630.xsd#mdxg_StockAwardMisstatementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_b25f43c5-432e-4f1c-9129-8cd3b45d2a74" xlink:to="loc_mdxg_StockAwardMisstatementsMember_25abda69-9fa5-4c5c-922c-97f92e9e0065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a093f003-9684-4c0f-a677-8d2bfdf96f96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2f839a37-0f97-4f00-a89c-4e73b975f9fb" xlink:to="loc_us-gaap_StatementLineItems_a093f003-9684-4c0f-a677-8d2bfdf96f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a093f003-9684-4c0f-a677-8d2bfdf96f96" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_85f97108-66a6-41fe-b014-ba24a595fa33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_CommonStockSharesIssued_85f97108-66a6-41fe-b014-ba24a595fa33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bac0d799-9cfe-43ec-ba2e-9494955e0d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_StockholdersEquity_bac0d799-9cfe-43ec-ba2e-9494955e0d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_f819d2c0-97a7-4485-97ca-01bd4e02d8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_f819d2c0-97a7-4485-97ca-01bd4e02d8ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TreasuryStockSharesAdjustment_48b974d2-4a9b-434b-8966-d821825ca161" xlink:href="mdxg-20210630.xsd#mdxg_TreasuryStockSharesAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_mdxg_TreasuryStockSharesAdjustment_48b974d2-4a9b-434b-8966-d821825ca161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_72b6e693-fb02-4bdb-8361-1e1add373f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_72b6e693-fb02-4bdb-8361-1e1add373f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_056a214a-9748-4328-8262-f61ff815d4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_056a214a-9748-4328-8262-f61ff815d4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_476cdd9e-f354-4662-86e7-9583c59157d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_476cdd9e-f354-4662-86e7-9583c59157d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2d419015-9950-41f9-a2bb-052f47192b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2d419015-9950-41f9-a2bb-052f47192b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_ae61b80c-e0c8-46c0-8002-41b0175be587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_ae61b80c-e0c8-46c0-8002-41b0175be587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_7b88de65-0362-4687-830e-7bcbd7de62c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_7b88de65-0362-4687-830e-7bcbd7de62c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_b4760961-416a-4368-befe-88f8b8cd5e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_b4760961-416a-4368-befe-88f8b8cd5e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_a6221a88-a734-4b34-b6a3-c34cf2c72e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_a6221a88-a734-4b34-b6a3-c34cf2c72e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_0e53fb1e-c4e1-4aac-a646-5d472bb1f393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_0e53fb1e-c4e1-4aac-a646-5d472bb1f393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_d0b2263d-a819-4f53-b5c0-0875a8e6dd9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_d0b2263d-a819-4f53-b5c0-0875a8e6dd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_034eaf4e-ab3f-4747-b01e-5879b9645f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_NetIncomeLoss_034eaf4e-ab3f-4747-b01e-5879b9645f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_6d957369-4062-4659-8861-8cca53476f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_CommonStockSharesIssued_6d957369-4062-4659-8861-8cca53476f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9f80f4ee-937a-4e34-a4c4-fda833133b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8659aab8-7715-450d-820c-adb2b8471d2f" xlink:to="loc_us-gaap_StockholdersEquity_9f80f4ee-937a-4e34-a4c4-fda833133b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mdxg-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_aa8d8a4a-6c43-44e2-820c-f9c889e86bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1545a7aa-bfe4-4fb7-b3f1-44b5e1240d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_aa8d8a4a-6c43-44e2-820c-f9c889e86bb6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1545a7aa-bfe4-4fb7-b3f1-44b5e1240d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_09a744c0-53df-4759-8041-2918f8d049d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1545a7aa-bfe4-4fb7-b3f1-44b5e1240d1a" xlink:to="loc_us-gaap_NetIncomeLoss_09a744c0-53df-4759-8041-2918f8d049d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5e9aee79-63b8-4fa3-9546-a767c9a54c64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1545a7aa-bfe4-4fb7-b3f1-44b5e1240d1a" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5e9aee79-63b8-4fa3-9546-a767c9a54c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a8df274a-fb2b-4c70-843c-6b047d987713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5e9aee79-63b8-4fa3-9546-a767c9a54c64" xlink:to="loc_us-gaap_ShareBasedCompensation_a8df274a-fb2b-4c70-843c-6b047d987713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_a03a4735-cd99-488e-a10e-01363f23e00b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5e9aee79-63b8-4fa3-9546-a767c9a54c64" xlink:to="loc_us-gaap_Depreciation_a03a4735-cd99-488e-a10e-01363f23e00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_93817e1a-1ffb-4a91-903b-5e64130cd6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5e9aee79-63b8-4fa3-9546-a767c9a54c64" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_93817e1a-1ffb-4a91-903b-5e64130cd6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_6e1ce392-4c9b-42e9-998f-c40a175a6c93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5e9aee79-63b8-4fa3-9546-a767c9a54c64" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_6e1ce392-4c9b-42e9-998f-c40a175a6c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_OperatingLeaseRightofuseAssetAmortization_fd89b6cf-6dd4-4ff1-9137-3b038f4a2f20" xlink:href="mdxg-20210630.xsd#mdxg_OperatingLeaseRightofuseAssetAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5e9aee79-63b8-4fa3-9546-a767c9a54c64" xlink:to="loc_mdxg_OperatingLeaseRightofuseAssetAmortization_fd89b6cf-6dd4-4ff1-9137-3b038f4a2f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationAccretionExpense_32584aad-95f8-4294-afd4-d036a2d63bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetRetirementObligationAccretionExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5e9aee79-63b8-4fa3-9546-a767c9a54c64" xlink:to="loc_us-gaap_AssetRetirementObligationAccretionExpense_32584aad-95f8-4294-afd4-d036a2d63bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_42159dc9-0630-4939-b2bb-702c5651f08c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5e9aee79-63b8-4fa3-9546-a767c9a54c64" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_42159dc9-0630-4939-b2bb-702c5651f08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_de4768ed-7967-4c36-8cbd-2ae19e053d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5e9aee79-63b8-4fa3-9546-a767c9a54c64" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_de4768ed-7967-4c36-8cbd-2ae19e053d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0b96b276-de1b-426a-91bf-44da1aba209d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_de4768ed-7967-4c36-8cbd-2ae19e053d3e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0b96b276-de1b-426a-91bf-44da1aba209d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_15c94f33-a5bc-40d4-b4d3-3add0ed8055b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_de4768ed-7967-4c36-8cbd-2ae19e053d3e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_15c94f33-a5bc-40d4-b4d3-3add0ed8055b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_ff2ae556-e6b4-4a60-8b31-6cbc77b5865b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_de4768ed-7967-4c36-8cbd-2ae19e053d3e" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_ff2ae556-e6b4-4a60-8b31-6cbc77b5865b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_16213465-1130-473e-a12d-b50a6ba77c73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_de4768ed-7967-4c36-8cbd-2ae19e053d3e" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_16213465-1130-473e-a12d-b50a6ba77c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_be58a82f-c448-4a5e-9797-ebedb9765a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_de4768ed-7967-4c36-8cbd-2ae19e053d3e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_be58a82f-c448-4a5e-9797-ebedb9765a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5c2cffd8-76ff-4304-b46c-dc6e52185d07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_de4768ed-7967-4c36-8cbd-2ae19e053d3e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5c2cffd8-76ff-4304-b46c-dc6e52185d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_aa0af3ce-1f5e-429b-a17b-2396a26ccf8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_de4768ed-7967-4c36-8cbd-2ae19e053d3e" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_aa0af3ce-1f5e-429b-a17b-2396a26ccf8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_cae26a82-233f-4a3c-a2f8-4c10234cd13b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_de4768ed-7967-4c36-8cbd-2ae19e053d3e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_cae26a82-233f-4a3c-a2f8-4c10234cd13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_575d615c-aa9b-47c7-b1f7-ed5a0dcdd71f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_de4768ed-7967-4c36-8cbd-2ae19e053d3e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_575d615c-aa9b-47c7-b1f7-ed5a0dcdd71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aae65857-739b-4e80-8bfe-68ac7abab4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1545a7aa-bfe4-4fb7-b3f1-44b5e1240d1a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aae65857-739b-4e80-8bfe-68ac7abab4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f923d333-cbfb-454a-9868-348b24c0b816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_aa8d8a4a-6c43-44e2-820c-f9c889e86bb6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f923d333-cbfb-454a-9868-348b24c0b816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment_5f94fc8d-3466-4724-a4a2-6413699fcd57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f923d333-cbfb-454a-9868-348b24c0b816" xlink:to="loc_us-gaap_PaymentsToAcquireMachineryAndEquipment_5f94fc8d-3466-4724-a4a2-6413699fcd57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_eba9da4c-a9f2-43a0-8724-cd63b7249d66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f923d333-cbfb-454a-9868-348b24c0b816" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_eba9da4c-a9f2-43a0-8724-cd63b7249d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PaymentsforApplicationCostsPatent_6d8d4273-fc1f-4c44-b245-9b414b501472" xlink:href="mdxg-20210630.xsd#mdxg_PaymentsforApplicationCostsPatent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f923d333-cbfb-454a-9868-348b24c0b816" xlink:to="loc_mdxg_PaymentsforApplicationCostsPatent_6d8d4273-fc1f-4c44-b245-9b414b501472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d90108ce-24c7-4943-8b6f-9765ecaa89f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f923d333-cbfb-454a-9868-348b24c0b816" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d90108ce-24c7-4943-8b6f-9765ecaa89f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f01aa4-89d9-4c49-bdff-c13278c49829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_aa8d8a4a-6c43-44e2-820c-f9c889e86bb6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f01aa4-89d9-4c49-bdff-c13278c49829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_e2afa48f-6678-472a-9d6b-a15e5b8fdcd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f01aa4-89d9-4c49-bdff-c13278c49829" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_e2afa48f-6678-472a-9d6b-a15e5b8fdcd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b887c5a8-01c9-4829-8344-2a13fa55fe66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f01aa4-89d9-4c49-bdff-c13278c49829" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b887c5a8-01c9-4829-8344-2a13fa55fe66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_39dcb2ca-1cc7-4110-a6a1-03851120ae4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f01aa4-89d9-4c49-bdff-c13278c49829" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_39dcb2ca-1cc7-4110-a6a1-03851120ae4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_68fbfaf3-9990-4b99-8ba0-9d1dc13d4033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f01aa4-89d9-4c49-bdff-c13278c49829" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_68fbfaf3-9990-4b99-8ba0-9d1dc13d4033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes_848b41ef-23df-4f65-a40a-099e94766ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfMediumTermNotes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f01aa4-89d9-4c49-bdff-c13278c49829" xlink:to="loc_us-gaap_RepaymentsOfMediumTermNotes_848b41ef-23df-4f65-a40a-099e94766ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_3468fab4-7a9c-410c-932a-a306baf377c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfMediumTermNotes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f01aa4-89d9-4c49-bdff-c13278c49829" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_3468fab4-7a9c-410c-932a-a306baf377c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d417dd7-f7f2-4e79-86f3-2696f85e8135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_44f01aa4-89d9-4c49-bdff-c13278c49829" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d417dd7-f7f2-4e79-86f3-2696f85e8135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bee4138d-a5e9-41e1-8bde-6180febea2db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_aa8d8a4a-6c43-44e2-820c-f9c889e86bb6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bee4138d-a5e9-41e1-8bde-6180febea2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7d4bb637-f7b8-48be-ba18-c9b5ea6325dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_aa8d8a4a-6c43-44e2-820c-f9c889e86bb6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7d4bb637-f7b8-48be-ba18-c9b5ea6325dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2e779a5b-0f43-4b00-b0e4-766b681a1db4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_aa8d8a4a-6c43-44e2-820c-f9c889e86bb6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2e779a5b-0f43-4b00-b0e4-766b681a1db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/NatureofBusiness" xlink:type="simple" xlink:href="mdxg-20210630.xsd#NatureofBusiness"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/NatureofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9cf16e0f-2e80-47c7-9d75-82331c73c2e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_0ddd2568-1ceb-43ad-af5b-e280bf0e3ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9cf16e0f-2e80-47c7-9d75-82331c73c2e4" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_0ddd2568-1ceb-43ad-af5b-e280bf0e3ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/NatureofBusinessDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#NatureofBusinessDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/NatureofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cb864b89-4da1-4239-8cca-d9051fcbf487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable_8da82bae-1920-448a-8c6c-4d47d5250273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cb864b89-4da1-4239-8cca-d9051fcbf487" xlink:to="loc_us-gaap_UnusualOrInfrequentItemTable_8da82bae-1920-448a-8c6c-4d47d5250273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_15219b8b-db54-418e-933d-57369fc35035" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_8da82bae-1920-448a-8c6c-4d47d5250273" xlink:to="loc_srt_ProductOrServiceAxis_15219b8b-db54-418e-933d-57369fc35035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c4ac2f80-2089-44b8-9008-27bc3aa45fd0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_15219b8b-db54-418e-933d-57369fc35035" xlink:to="loc_srt_ProductsAndServicesDomain_c4ac2f80-2089-44b8-9008-27bc3aa45fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_Section351Member_cfec40c8-ba60-4fbc-8f51-8230fc66997b" xlink:href="mdxg-20210630.xsd#mdxg_Section351Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c4ac2f80-2089-44b8-9008-27bc3aa45fd0" xlink:to="loc_mdxg_Section351Member_cfec40c8-ba60-4fbc-8f51-8230fc66997b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_04f82b3d-913a-4400-b22b-be08978429ae" xlink:href="mdxg-20210630.xsd#mdxg_AdvancedWoundCareUmbilicalCordDerivedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c4ac2f80-2089-44b8-9008-27bc3aa45fd0" xlink:to="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_04f82b3d-913a-4400-b22b-be08978429ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_873700d7-a5ff-4868-800f-e38a721e7a85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_8da82bae-1920-448a-8c6c-4d47d5250273" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_873700d7-a5ff-4868-800f-e38a721e7a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_42c34d54-ae1d-4fc0-a2c1-399019b3e4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_873700d7-a5ff-4868-800f-e38a721e7a85" xlink:to="loc_us-gaap_EquityComponentDomain_42c34d54-ae1d-4fc0-a2c1-399019b3e4d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ee44fce0-a44b-4883-8279-71199502e3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_42c34d54-ae1d-4fc0-a2c1-399019b3e4d4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ee44fce0-a44b-4883-8279-71199502e3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_c7eb9570-1ce0-4769-9de8-7c136719a51b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_42c34d54-ae1d-4fc0-a2c1-399019b3e4d4" xlink:to="loc_us-gaap_TreasuryStockMember_c7eb9570-1ce0-4769-9de8-7c136719a51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8c80f958-65f7-4674-bdf8-cf82c85aab00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_42c34d54-ae1d-4fc0-a2c1-399019b3e4d4" xlink:to="loc_us-gaap_CommonStockMember_8c80f958-65f7-4674-bdf8-cf82c85aab00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_349f96f6-0ab5-4211-8a1a-fc8fbd3b94f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_8da82bae-1920-448a-8c6c-4d47d5250273" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_349f96f6-0ab5-4211-8a1a-fc8fbd3b94f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_b7766283-ea1a-4eff-9dc2-b616cf8c6221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_349f96f6-0ab5-4211-8a1a-fc8fbd3b94f5" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_b7766283-ea1a-4eff-9dc2-b616cf8c6221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_StockAwardMisstatementsMember_06211fdc-98eb-41ff-acfc-4879aa5eb8a8" xlink:href="mdxg-20210630.xsd#mdxg_StockAwardMisstatementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_b7766283-ea1a-4eff-9dc2-b616cf8c6221" xlink:to="loc_mdxg_StockAwardMisstatementsMember_06211fdc-98eb-41ff-acfc-4879aa5eb8a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_f27e324c-e09b-4177-b88b-caf076cd3b58" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_8da82bae-1920-448a-8c6c-4d47d5250273" xlink:to="loc_srt_RestatementAxis_f27e324c-e09b-4177-b88b-caf076cd3b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_0cb1e380-374b-46ad-af4c-57ab850d8071" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_f27e324c-e09b-4177-b88b-caf076cd3b58" xlink:to="loc_srt_RestatementDomain_0cb1e380-374b-46ad-af4c-57ab850d8071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_1767bf4c-646f-4044-85d6-f71d208b1834" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_0cb1e380-374b-46ad-af4c-57ab850d8071" xlink:to="loc_srt_RestatementAdjustmentMember_1767bf4c-646f-4044-85d6-f71d208b1834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_8da82bae-1920-448a-8c6c-4d47d5250273" xlink:to="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5724dc78-9faa-46e8-90e9-b0add3490aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5724dc78-9faa-46e8-90e9-b0add3490aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_13a29793-98c0-4852-98a2-407078977642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:to="loc_us-gaap_InventoryNet_13a29793-98c0-4852-98a2-407078977642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_af97017e-2d0f-45cd-8d8e-62b31fd557ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_af97017e-2d0f-45cd-8d8e-62b31fd557ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_9ef6af8d-6ccb-4265-b6fe-559368c6a55f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_9ef6af8d-6ccb-4265-b6fe-559368c6a55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_218e979b-8f73-462c-bb73-cb2c9c5cbe2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_218e979b-8f73-462c-bb73-cb2c9c5cbe2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_8d08eb5b-1a30-486f-a599-ffe9c66bcdd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_8d08eb5b-1a30-486f-a599-ffe9c66bcdd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TreasuryStockSharesAdjustment_3f7bb73d-532b-432e-b9b5-f4c499ffeabf" xlink:href="mdxg-20210630.xsd#mdxg_TreasuryStockSharesAdjustment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_55effd00-51b6-44fe-a34f-d98986214b17" xlink:to="loc_mdxg_TreasuryStockSharesAdjustment_3f7bb73d-532b-432e-b9b5-f4c499ffeabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="mdxg-20210630.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_616e0a77-9e81-44c1-b0bc-cb64809d8269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_e0759baa-05fa-46c6-9513-8f6e3965088e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_616e0a77-9e81-44c1-b0bc-cb64809d8269" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_e0759baa-05fa-46c6-9513-8f6e3965088e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mdxg-20210630.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_236cddb2-d7a7-4ff9-97cb-fce32c053678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_25ba1166-c367-4499-a5f9-8c9ed2ed1c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_236cddb2-d7a7-4ff9-97cb-fce32c053678" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_25ba1166-c367-4499-a5f9-8c9ed2ed1c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_fab77d82-8a84-4594-8722-3c3f40e8178a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_236cddb2-d7a7-4ff9-97cb-fce32c053678" xlink:to="loc_us-gaap_UseOfEstimates_fab77d82-8a84-4594-8722-3c3f40e8178a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_a435763f-8a72-4d4b-ac04-5a9d36b9f014" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_236cddb2-d7a7-4ff9-97cb-fce32c053678" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_a435763f-8a72-4d4b-ac04-5a9d36b9f014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_1d73c8be-e47f-4baa-a502-16aef0bfb7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_236cddb2-d7a7-4ff9-97cb-fce32c053678" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_1d73c8be-e47f-4baa-a502-16aef0bfb7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_3cb692bf-7466-4e64-b702-aaff8c0fc7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_236cddb2-d7a7-4ff9-97cb-fce32c053678" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_3cb692bf-7466-4e64-b702-aaff8c0fc7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7b41e05f-3600-4d8d-8ec6-4a7a483445dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_236cddb2-d7a7-4ff9-97cb-fce32c053678" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7b41e05f-3600-4d8d-8ec6-4a7a483445dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_450ac5da-1f3a-488d-92e3-9a2446ce76b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_236cddb2-d7a7-4ff9-97cb-fce32c053678" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_450ac5da-1f3a-488d-92e3-9a2446ce76b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_efd412f0-d77f-474c-b1ff-6827f2a3bd41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_236cddb2-d7a7-4ff9-97cb-fce32c053678" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_efd412f0-d77f-474c-b1ff-6827f2a3bd41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="mdxg-20210630.xsd#SignificantAccountingPoliciesSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b1dbf4ba-65b1-4622-b989-ba069ea84647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_b2116717-07b6-4a19-90b0-1929b2d9baae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b1dbf4ba-65b1-4622-b989-ba069ea84647" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_b2116717-07b6-4a19-90b0-1929b2d9baae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_40efcce8-6db5-4f2b-a857-c349e30f1536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a33a8f94-99f7-4053-a0b5-875b705a8452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_40efcce8-6db5-4f2b-a857-c349e30f1536" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a33a8f94-99f7-4053-a0b5-875b705a8452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6e6b1e74-f6ef-43ee-8982-6f7c80b32fde" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a33a8f94-99f7-4053-a0b5-875b705a8452" xlink:to="loc_srt_RangeAxis_6e6b1e74-f6ef-43ee-8982-6f7c80b32fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c701ee43-e534-4200-a7a9-43e3b66b3250" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6e6b1e74-f6ef-43ee-8982-6f7c80b32fde" xlink:to="loc_srt_RangeMember_c701ee43-e534-4200-a7a9-43e3b66b3250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7ca8c80e-e624-44ab-96a8-64d4ebb1b14a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c701ee43-e534-4200-a7a9-43e3b66b3250" xlink:to="loc_srt_MinimumMember_7ca8c80e-e624-44ab-96a8-64d4ebb1b14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_469e6574-73df-4f50-9ae7-82cd750897e2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c701ee43-e534-4200-a7a9-43e3b66b3250" xlink:to="loc_srt_MaximumMember_469e6574-73df-4f50-9ae7-82cd750897e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_91d42b76-911b-436c-b2ce-cd166bed85fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a33a8f94-99f7-4053-a0b5-875b705a8452" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_91d42b76-911b-436c-b2ce-cd166bed85fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_a2fa230b-6abf-4ca1-889b-a88e582a6e55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_91d42b76-911b-436c-b2ce-cd166bed85fc" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_a2fa230b-6abf-4ca1-889b-a88e582a6e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_c17ce856-d71c-412c-87b1-cb246dd530e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_91d42b76-911b-436c-b2ce-cd166bed85fc" xlink:to="loc_us-gaap_NumberOfReportingUnits_c17ce856-d71c-412c-87b1-cb246dd530e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_814fede4-97af-446c-b7ce-bbb4ea717c38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_91d42b76-911b-436c-b2ce-cd166bed85fc" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_814fede4-97af-446c-b7ce-bbb4ea717c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_RevenueFromContractWithCustomerPaymentTerms_73225d74-f951-4c16-adfc-b3fc1fcad8ad" xlink:href="mdxg-20210630.xsd#mdxg_RevenueFromContractWithCustomerPaymentTerms"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_91d42b76-911b-436c-b2ce-cd166bed85fc" xlink:to="loc_mdxg_RevenueFromContractWithCustomerPaymentTerms_73225d74-f951-4c16-adfc-b3fc1fcad8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_ce079d51-20af-4bbf-a120-e188cb35ed0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_91d42b76-911b-436c-b2ce-cd166bed85fc" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_ce079d51-20af-4bbf-a120-e188cb35ed0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details" xlink:type="simple" xlink:href="mdxg-20210630.xsd#SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e08f170b-579b-4102-bbf4-7a9f94551ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_4d31f02d-588f-4eaf-a62b-c64978086d75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e08f170b-579b-4102-bbf4-7a9f94551ab5" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_4d31f02d-588f-4eaf-a62b-c64978086d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_81154c77-571f-4cda-b3ff-847a6e592903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_4d31f02d-588f-4eaf-a62b-c64978086d75" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_81154c77-571f-4cda-b3ff-847a6e592903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_9348f1f7-f71e-4bca-a7fd-60d364b2695c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_81154c77-571f-4cda-b3ff-847a6e592903" xlink:to="loc_us-gaap_TypeOfAdoptionMember_9348f1f7-f71e-4bca-a7fd-60d364b2695c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_060941a7-532c-46c0-b239-c0443941786a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_9348f1f7-f71e-4bca-a7fd-60d364b2695c" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_060941a7-532c-46c0-b239-c0443941786a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_f0811232-74d9-482e-a098-8178ac56e842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable_4d31f02d-588f-4eaf-a62b-c64978086d75" xlink:to="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_f0811232-74d9-482e-a098-8178ac56e842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c3ddb18a-89b3-4320-9d25-3eaaa11cb590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_f0811232-74d9-482e-a098-8178ac56e842" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c3ddb18a-89b3-4320-9d25-3eaaa11cb590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_40fb5eec-5457-4638-b543-bfa17b774631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_f0811232-74d9-482e-a098-8178ac56e842" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_40fb5eec-5457-4638-b543-bfa17b774631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_b851d1a0-3b2c-4246-87e6-725316e0ce7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems_f0811232-74d9-482e-a098-8178ac56e842" xlink:to="loc_us-gaap_GrossProfit_b851d1a0-3b2c-4246-87e6-725316e0ce7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/Inventory" xlink:type="simple" xlink:href="mdxg-20210630.xsd#Inventory"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/Inventory" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_1fce2e5a-144e-4972-8ef9-bda44e96409c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_96c8341c-ffa0-4870-987a-5c72c86a8008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_1fce2e5a-144e-4972-8ef9-bda44e96409c" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_96c8341c-ffa0-4870-987a-5c72c86a8008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/InventoryTables" xlink:type="simple" xlink:href="mdxg-20210630.xsd#InventoryTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/InventoryTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_168d2988-d577-4e86-917d-1cd4d3d635bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_091b5dfa-c128-42a3-ac3f-278ec18c32fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_168d2988-d577-4e86-917d-1cd4d3d635bd" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_091b5dfa-c128-42a3-ac3f-278ec18c32fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/InventoryDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#InventoryDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/InventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_0957f116-6aa5-45d1-aec4-e0d0797b9844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_f30c4a88-2ff1-4fea-ae14-0008a3166ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0957f116-6aa5-45d1-aec4-e0d0797b9844" xlink:to="loc_us-gaap_InventoryRawMaterials_f30c4a88-2ff1-4fea-ae14-0008a3166ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_5715499e-1292-475e-8688-9d47c96756ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0957f116-6aa5-45d1-aec4-e0d0797b9844" xlink:to="loc_us-gaap_InventoryWorkInProcess_5715499e-1292-475e-8688-9d47c96756ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_6f67920c-99b1-4eab-8883-64efec68f72f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0957f116-6aa5-45d1-aec4-e0d0797b9844" xlink:to="loc_us-gaap_InventoryFinishedGoods_6f67920c-99b1-4eab-8883-64efec68f72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_859b60df-c659-4fa7-b3ae-88c382cb9be8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0957f116-6aa5-45d1-aec4-e0d0797b9844" xlink:to="loc_us-gaap_InventoryNet_859b60df-c659-4fa7-b3ae-88c382cb9be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_e12692a1-46e0-4abf-a528-c8521cac4f69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0957f116-6aa5-45d1-aec4-e0d0797b9844" xlink:to="loc_us-gaap_InventoryCurrentTable_e12692a1-46e0-4abf-a528-c8521cac4f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ed3ba8bc-c574-4637-b46b-54739c5bf3ca" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_e12692a1-46e0-4abf-a528-c8521cac4f69" xlink:to="loc_srt_ProductOrServiceAxis_ed3ba8bc-c574-4637-b46b-54739c5bf3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fd6f2220-b5c0-4869-9a7b-243ce7a1f8a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_ed3ba8bc-c574-4637-b46b-54739c5bf3ca" xlink:to="loc_srt_ProductsAndServicesDomain_fd6f2220-b5c0-4869-9a7b-243ce7a1f8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_Section351Member_849e986a-4674-417d-bec8-86171121c57c" xlink:href="mdxg-20210630.xsd#mdxg_Section351Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_fd6f2220-b5c0-4869-9a7b-243ce7a1f8a1" xlink:to="loc_mdxg_Section351Member_849e986a-4674-417d-bec8-86171121c57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_fe1bb5a6-bccb-4c5e-9860-789de76138da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_e12692a1-46e0-4abf-a528-c8521cac4f69" xlink:to="loc_us-gaap_InventoryLineItems_fe1bb5a6-bccb-4c5e-9860-789de76138da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_010b7884-e9aa-4e5a-ab78-d4159a1798fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_fe1bb5a6-bccb-4c5e-9860-789de76138da" xlink:to="loc_us-gaap_InventoryWriteDown_010b7884-e9aa-4e5a-ab78-d4159a1798fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="mdxg-20210630.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_69c297fc-d62a-4d55-810d-93a07ab26a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_74d28818-fc50-4245-95aa-7d113834f956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_69c297fc-d62a-4d55-810d-93a07ab26a63" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_74d28818-fc50-4245-95aa-7d113834f956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="mdxg-20210630.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_02c9ee76-0225-4efc-8b91-0ed6db9f094b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_706bf22d-ec7e-4729-9c2d-8ec9759d7de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_02c9ee76-0225-4efc-8b91-0ed6db9f094b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_706bf22d-ec7e-4729-9c2d-8ec9759d7de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ScheduleOfDepreciationTableTextBlock_48c5728e-93dc-4876-99eb-7c791e5f3b46" xlink:href="mdxg-20210630.xsd#mdxg_ScheduleOfDepreciationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_02c9ee76-0225-4efc-8b91-0ed6db9f094b" xlink:to="loc_mdxg_ScheduleOfDepreciationTableTextBlock_48c5728e-93dc-4876-99eb-7c791e5f3b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#PropertyandEquipmentSummaryofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_dd0bf2a3-df18-47dd-85b1-5c55975d901e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7de5d3f9-0bed-404d-a935-9840648dc89f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_dd0bf2a3-df18-47dd-85b1-5c55975d901e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7de5d3f9-0bed-404d-a935-9840648dc89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c18101a1-f675-4b6c-8279-3a381f5c8d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7de5d3f9-0bed-404d-a935-9840648dc89f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c18101a1-f675-4b6c-8279-3a381f5c8d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24862c5f-609c-43ea-b411-9bf166133e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c18101a1-f675-4b6c-8279-3a381f5c8d99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24862c5f-609c-43ea-b411-9bf166133e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_ff5084d0-734d-433a-87c1-b3179cb85209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24862c5f-609c-43ea-b411-9bf166133e80" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_ff5084d0-734d-433a-87c1-b3179cb85209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_4d4beb4a-8597-4d32-a5d4-95e978e541aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24862c5f-609c-43ea-b411-9bf166133e80" xlink:to="loc_us-gaap_EquipmentMember_4d4beb4a-8597-4d32-a5d4-95e978e541aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_d74804c8-2fc6-4554-8b75-844f9bc97fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24862c5f-609c-43ea-b411-9bf166133e80" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_d74804c8-2fc6-4554-8b75-844f9bc97fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_eaa01dbc-e548-43ca-9c1f-25a1418134da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24862c5f-609c-43ea-b411-9bf166133e80" xlink:to="loc_us-gaap_ConstructionInProgressMember_eaa01dbc-e548-43ca-9c1f-25a1418134da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AssetRetirementCostMember_03d09a85-3daa-41ce-aceb-e7883e06d0f2" xlink:href="mdxg-20210630.xsd#mdxg_AssetRetirementCostMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24862c5f-609c-43ea-b411-9bf166133e80" xlink:to="loc_mdxg_AssetRetirementCostMember_03d09a85-3daa-41ce-aceb-e7883e06d0f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FinanceLeaseAssetsMember_4b140b64-6237-47fb-bc52-097bcb43271d" xlink:href="mdxg-20210630.xsd#mdxg_FinanceLeaseAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24862c5f-609c-43ea-b411-9bf166133e80" xlink:to="loc_mdxg_FinanceLeaseAssetsMember_4b140b64-6237-47fb-bc52-097bcb43271d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c7dc779-c4ff-49c0-84fb-155edf567e99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7de5d3f9-0bed-404d-a935-9840648dc89f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c7dc779-c4ff-49c0-84fb-155edf567e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e1518ba0-c008-4f36-8f65-6b94d6a44b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c7dc779-c4ff-49c0-84fb-155edf567e99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e1518ba0-c008-4f36-8f65-6b94d6a44b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_bcb74694-8949-488a-8766-18bec2351e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c7dc779-c4ff-49c0-84fb-155edf567e99" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_bcb74694-8949-488a-8766-18bec2351e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_8274a1d5-8d6e-4891-8818-fc51d90f4a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c7dc779-c4ff-49c0-84fb-155edf567e99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_8274a1d5-8d6e-4891-8818-fc51d90f4a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_657bef09-c150-4657-827d-c7f834a00e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c7dc779-c4ff-49c0-84fb-155edf567e99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_657bef09-c150-4657-827d-c7f834a00e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_73d8b67c-8765-46be-a4f9-5a8b90e9bdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c7dc779-c4ff-49c0-84fb-155edf567e99" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_73d8b67c-8765-46be-a4f9-5a8b90e9bdbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/PropertyandEquipmentDepreciationExpenseDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#PropertyandEquipmentDepreciationExpenseDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/PropertyandEquipmentDepreciationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_aa836b8d-1922-40d5-94de-e656f43fed98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_d62d01d2-e992-4593-9e05-12b4a0060b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_aa836b8d-1922-40d5-94de-e656f43fed98" xlink:to="loc_us-gaap_Depreciation_d62d01d2-e992-4593-9e05-12b4a0060b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/IntangibleAssets" xlink:type="simple" xlink:href="mdxg-20210630.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e4948c23-304f-4e2b-9d52-507a2bc38ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_1e34eec4-87cb-4107-bac6-c810728fdbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e4948c23-304f-4e2b-9d52-507a2bc38ad6" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_1e34eec4-87cb-4107-bac6-c810728fdbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="mdxg-20210630.xsd#IntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/IntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7d42598b-2c66-4d42-b0e4-a9b12dc5a0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_67d0c1fa-fbc0-4bf7-ac10-0fe7e9b2a1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7d42598b-2c66-4d42-b0e4-a9b12dc5a0b2" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_67d0c1fa-fbc0-4bf7-ac10-0fe7e9b2a1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2307827e-107b-4723-a2c0-d82cc771b6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7d42598b-2c66-4d42-b0e4-a9b12dc5a0b2" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2307827e-107b-4723-a2c0-d82cc771b6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_da5aae33-cb82-47b2-bf7c-c00b605d2761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7d42598b-2c66-4d42-b0e4-a9b12dc5a0b2" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_da5aae33-cb82-47b2-bf7c-c00b605d2761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#IntangibleAssetsActivitySummaryDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fb7caf8a-5691-4b10-a50c-a5fee46e8f36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_12870b76-0fa7-492e-a593-76f29dbf9039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fb7caf8a-5691-4b10-a50c-a5fee46e8f36" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_12870b76-0fa7-492e-a593-76f29dbf9039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a049feaf-783c-4966-9a9d-8f8582707015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_12870b76-0fa7-492e-a593-76f29dbf9039" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a049feaf-783c-4966-9a9d-8f8582707015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fbb9c883-a7dc-401d-9ecb-17c6b07d691b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a049feaf-783c-4966-9a9d-8f8582707015" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fbb9c883-a7dc-401d-9ecb-17c6b07d691b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_46611be8-1f16-45ad-be77-3f121cd11085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fbb9c883-a7dc-401d-9ecb-17c6b07d691b" xlink:to="loc_us-gaap_PatentsMember_46611be8-1f16-45ad-be77-3f121cd11085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_d0ec3881-623c-461b-b371-364872019bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fbb9c883-a7dc-401d-9ecb-17c6b07d691b" xlink:to="loc_us-gaap_LicensingAgreementsMember_d0ec3881-623c-461b-b371-364872019bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CustomerAndSupplierRelationshipsMember_085ce558-46dd-4929-9e3a-96b1385fd0db" xlink:href="mdxg-20210630.xsd#mdxg_CustomerAndSupplierRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fbb9c883-a7dc-401d-9ecb-17c6b07d691b" xlink:to="loc_mdxg_CustomerAndSupplierRelationshipsMember_085ce558-46dd-4929-9e3a-96b1385fd0db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_d70d16ae-c15d-4d92-a622-ed3031d62b58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fbb9c883-a7dc-401d-9ecb-17c6b07d691b" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_d70d16ae-c15d-4d92-a622-ed3031d62b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_32d9740d-7ece-4565-9b90-d0a9d89ed826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_12870b76-0fa7-492e-a593-76f29dbf9039" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_32d9740d-7ece-4565-9b90-d0a9d89ed826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d75f0bec-70ba-46c0-8f18-d2cccf7dc367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_32d9740d-7ece-4565-9b90-d0a9d89ed826" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d75f0bec-70ba-46c0-8f18-d2cccf7dc367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3b1924ab-064c-4297-85a2-efd4986c4f33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_32d9740d-7ece-4565-9b90-d0a9d89ed826" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3b1924ab-064c-4297-85a2-efd4986c4f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f5f0869c-7023-4b94-98f7-52ae2f856bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_32d9740d-7ece-4565-9b90-d0a9d89ed826" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f5f0869c-7023-4b94-98f7-52ae2f856bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2fa9156c-cb13-4a6f-a44c-c3ba7a7c47b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fb7caf8a-5691-4b10-a50c-a5fee46e8f36" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2fa9156c-cb13-4a6f-a44c-c3ba7a7c47b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8e58536a-0c75-497e-86af-6989980b1cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2fa9156c-cb13-4a6f-a44c-c3ba7a7c47b0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8e58536a-0c75-497e-86af-6989980b1cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f3f00af8-c3f0-4166-a31d-8c6374f1eeaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8e58536a-0c75-497e-86af-6989980b1cd6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f3f00af8-c3f0-4166-a31d-8c6374f1eeaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_fb656c4c-9609-4755-934a-d71d9adca251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f3f00af8-c3f0-4166-a31d-8c6374f1eeaa" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_fb656c4c-9609-4755-934a-d71d9adca251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PatentsinProcessMember_fdafef45-1cae-43b9-ba96-ce2a3d76aab3" xlink:href="mdxg-20210630.xsd#mdxg_PatentsinProcessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f3f00af8-c3f0-4166-a31d-8c6374f1eeaa" xlink:to="loc_mdxg_PatentsinProcessMember_fdafef45-1cae-43b9-ba96-ce2a3d76aab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_e9209217-36f2-47b1-a185-f9ff27e1a797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2fa9156c-cb13-4a6f-a44c-c3ba7a7c47b0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_e9209217-36f2-47b1-a185-f9ff27e1a797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a60dfbac-01fa-4c64-9d3f-ca5b7f47331e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_e9209217-36f2-47b1-a185-f9ff27e1a797" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a60dfbac-01fa-4c64-9d3f-ca5b7f47331e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_acd04292-64de-41ae-be8c-2dcaeb7ab942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fb7caf8a-5691-4b10-a50c-a5fee46e8f36" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_acd04292-64de-41ae-be8c-2dcaeb7ab942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_be3b7072-fcaf-4811-a4ac-4907ed7f81fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fb7caf8a-5691-4b10-a50c-a5fee46e8f36" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_be3b7072-fcaf-4811-a4ac-4907ed7f81fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/IntangibleAssetsAmortizationExpenseDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#IntangibleAssetsAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/IntangibleAssetsAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_76589930-1527-4e14-a84c-25ebb82e9558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_57652d42-7630-48cf-85c1-1b7c9950a851" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_76589930-1527-4e14-a84c-25ebb82e9558" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_57652d42-7630-48cf-85c1-1b7c9950a851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_faaad48e-b8b2-4da3-8310-7a7705f4fbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8ba36899-106c-4cb7-8ecb-eea3f6036128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_faaad48e-b8b2-4da3-8310-7a7705f4fbc0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8ba36899-106c-4cb7-8ecb-eea3f6036128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c52bb804-93fc-431d-aac9-3f78adffde5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8ba36899-106c-4cb7-8ecb-eea3f6036128" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c52bb804-93fc-431d-aac9-3f78adffde5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_90fa0b25-4a6c-4df1-8719-5a3d51b4a52f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8ba36899-106c-4cb7-8ecb-eea3f6036128" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_90fa0b25-4a6c-4df1-8719-5a3d51b4a52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6327a77d-9e69-4389-be4a-f2b3700b1aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8ba36899-106c-4cb7-8ecb-eea3f6036128" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6327a77d-9e69-4389-be4a-f2b3700b1aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_79ae9d1b-98ec-4f14-8290-057b419eafe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8ba36899-106c-4cb7-8ecb-eea3f6036128" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_79ae9d1b-98ec-4f14-8290-057b419eafe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1beceec6-3acb-446b-8b05-d9b756bd7bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8ba36899-106c-4cb7-8ecb-eea3f6036128" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1beceec6-3acb-446b-8b05-d9b756bd7bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_5566ae1a-6a71-48ea-898a-8b8a4c863064" xlink:href="mdxg-20210630.xsd#mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8ba36899-106c-4cb7-8ecb-eea3f6036128" xlink:to="loc_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_5566ae1a-6a71-48ea-898a-8b8a4c863064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d4399ebf-9fd2-4f4b-b138-49597acf9d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8ba36899-106c-4cb7-8ecb-eea3f6036128" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d4399ebf-9fd2-4f4b-b138-49597acf9d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/AccruedExpenses" xlink:type="simple" xlink:href="mdxg-20210630.xsd#AccruedExpenses"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/AccruedExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_65702199-a533-4aac-af2d-d1f2624f0abe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_bf4a2ee5-7fa9-4145-a7a7-e1b54fd403e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_65702199-a533-4aac-af2d-d1f2624f0abe" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_bf4a2ee5-7fa9-4145-a7a7-e1b54fd403e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="mdxg-20210630.xsd#AccruedExpensesTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/AccruedExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_a2367089-801e-45b0-bfab-6a59a2bd3b04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_7bdf0571-2008-40a3-aa8f-7cd7425729ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_a2367089-801e-45b0-bfab-6a59a2bd3b04" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_7bdf0571-2008-40a3-aa8f-7cd7425729ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#AccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_7ec8c33d-7e46-4576-b101-248ef40fce83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_b9f08812-5c84-4e90-862d-f120658e830c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7ec8c33d-7e46-4576-b101-248ef40fce83" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_b9f08812-5c84-4e90-862d-f120658e830c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AccruedSettlementCostsCurrent_65ad8923-77f3-40f3-95f3-bd8397ad7798" xlink:href="mdxg-20210630.xsd#mdxg_AccruedSettlementCostsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7ec8c33d-7e46-4576-b101-248ef40fce83" xlink:to="loc_mdxg_AccruedSettlementCostsCurrent_65ad8923-77f3-40f3-95f3-bd8397ad7798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_3c53d527-2a3d-4c3a-8d28-c2ea51120bea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7ec8c33d-7e46-4576-b101-248ef40fce83" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_3c53d527-2a3d-4c3a-8d28-c2ea51120bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_d3fcf714-5f98-4c18-90a7-55de9adad749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7ec8c33d-7e46-4576-b101-248ef40fce83" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_d3fcf714-5f98-4c18-90a7-55de9adad749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AccruedClinicalTrialsCurrent_a29d4df8-9906-4251-ac77-c717b7a472a8" xlink:href="mdxg-20210630.xsd#mdxg_AccruedClinicalTrialsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7ec8c33d-7e46-4576-b101-248ef40fce83" xlink:to="loc_mdxg_AccruedClinicalTrialsCurrent_a29d4df8-9906-4251-ac77-c717b7a472a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7b3b1735-4ba8-4f2e-b82d-81a65efb74be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7ec8c33d-7e46-4576-b101-248ef40fce83" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7b3b1735-4ba8-4f2e-b82d-81a65efb74be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AccruedRebates_25c2fc87-b966-49ce-bf3a-64974a2fee02" xlink:href="mdxg-20210630.xsd#mdxg_AccruedRebates"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7ec8c33d-7e46-4576-b101-248ef40fce83" xlink:to="loc_mdxg_AccruedRebates_25c2fc87-b966-49ce-bf3a-64974a2fee02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_8162723a-4682-4637-8e62-0fb6d490d8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7ec8c33d-7e46-4576-b101-248ef40fce83" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_8162723a-4682-4637-8e62-0fb6d490d8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_910c778b-148e-4a4a-ad67-afc818eb1d71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7ec8c33d-7e46-4576-b101-248ef40fce83" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_910c778b-148e-4a4a-ad67-afc818eb1d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebt" xlink:type="simple" xlink:href="mdxg-20210630.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4a7e8cb7-2d9c-4325-b074-83958d26efb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_0839c45b-9034-4008-9161-d2e0086f41c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4a7e8cb7-2d9c-4325-b074-83958d26efb6" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_0839c45b-9034-4008-9161-d2e0086f41c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="mdxg-20210630.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_65b2dee8-e051-4540-840d-0d4eec1fc023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock_2a9b5fcc-7826-4b1e-b3a1-6d4b3148b4f7" xlink:href="mdxg-20210630.xsd#mdxg_ScheduleofDebtIssuanceCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_65b2dee8-e051-4540-840d-0d4eec1fc023" xlink:to="loc_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock_2a9b5fcc-7826-4b1e-b3a1-6d4b3148b4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_5a009bd4-4878-43b4-bfbc-0931f3151f96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_65b2dee8-e051-4540-840d-0d4eec1fc023" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_5a009bd4-4878-43b4-bfbc-0931f3151f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ScheduleofInterestExpenseTableTextBlock_60df7574-08d2-4beb-9431-6668b1670366" xlink:href="mdxg-20210630.xsd#mdxg_ScheduleofInterestExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_65b2dee8-e051-4540-840d-0d4eec1fc023" xlink:to="loc_mdxg_ScheduleofInterestExpenseTableTextBlock_60df7574-08d2-4beb-9431-6668b1670366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8609885e-694a-4bc5-b4f0-f40b73e2e125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_65b2dee8-e051-4540-840d-0d4eec1fc023" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8609885e-694a-4bc5-b4f0-f40b73e2e125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#LongTermDebtTermLoanDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_077756ed-0c4f-4a75-a747-81ef97c78d64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_16753035-bf55-4b33-9a75-712ffbb8d16f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_077756ed-0c4f-4a75-a747-81ef97c78d64" xlink:to="loc_us-gaap_DebtInstrumentTable_16753035-bf55-4b33-9a75-712ffbb8d16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ea0721eb-84ef-4b6b-b380-fd01da67591f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_16753035-bf55-4b33-9a75-712ffbb8d16f" xlink:to="loc_srt_RangeAxis_ea0721eb-84ef-4b6b-b380-fd01da67591f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e9f3a0a9-7dcf-4300-afd2-08bf9a241fae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ea0721eb-84ef-4b6b-b380-fd01da67591f" xlink:to="loc_srt_RangeMember_e9f3a0a9-7dcf-4300-afd2-08bf9a241fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_42949a58-ab46-4f03-88f2-5e872caa35d6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e9f3a0a9-7dcf-4300-afd2-08bf9a241fae" xlink:to="loc_srt_MinimumMember_42949a58-ab46-4f03-88f2-5e872caa35d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bd81aa91-1869-4aab-998a-bd573e75d926" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e9f3a0a9-7dcf-4300-afd2-08bf9a241fae" xlink:to="loc_srt_MaximumMember_bd81aa91-1869-4aab-998a-bd573e75d926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4abaf3a9-31bb-43c8-af8d-a87d9a89f93c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_16753035-bf55-4b33-9a75-712ffbb8d16f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4abaf3a9-31bb-43c8-af8d-a87d9a89f93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c7e433a8-9e8c-4c27-a28a-e1a38db2b52d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4abaf3a9-31bb-43c8-af8d-a87d9a89f93c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c7e433a8-9e8c-4c27-a28a-e1a38db2b52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e6def081-6b56-40e2-a547-ec3c81bc27b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c7e433a8-9e8c-4c27-a28a-e1a38db2b52d" xlink:to="loc_us-gaap_SubsequentEventMember_e6def081-6b56-40e2-a547-ec3c81bc27b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7c5b0421-3196-4d85-807a-a9bd0a5efbfd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_16753035-bf55-4b33-9a75-712ffbb8d16f" xlink:to="loc_srt_StatementScenarioAxis_7c5b0421-3196-4d85-807a-a9bd0a5efbfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_64216635-fdac-4d09-b6a6-d1bd9e51427f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_7c5b0421-3196-4d85-807a-a9bd0a5efbfd" xlink:to="loc_srt_ScenarioUnspecifiedDomain_64216635-fdac-4d09-b6a6-d1bd9e51427f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_270bd868-756d-457a-b39c-8eb29dbd832a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_64216635-fdac-4d09-b6a6-d1bd9e51427f" xlink:to="loc_srt_ScenarioForecastMember_270bd868-756d-457a-b39c-8eb29dbd832a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_139db035-8289-4533-9d50-8306e338ade4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_16753035-bf55-4b33-9a75-712ffbb8d16f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_139db035-8289-4533-9d50-8306e338ade4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_925dea43-8252-4f94-aed8-43fed57c1411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_139db035-8289-4533-9d50-8306e338ade4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_925dea43-8252-4f94-aed8-43fed57c1411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_63515ee4-5ffd-4474-95f6-9c70f561ddfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_925dea43-8252-4f94-aed8-43fed57c1411" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_63515ee4-5ffd-4474-95f6-9c70f561ddfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f845f71a-8b40-4f2d-8fe3-b7a9cb4b15e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_16753035-bf55-4b33-9a75-712ffbb8d16f" xlink:to="loc_us-gaap_DebtInstrumentAxis_f845f71a-8b40-4f2d-8fe3-b7a9cb4b15e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f845f71a-8b40-4f2d-8fe3-b7a9cb4b15e9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember_b7d4c2a8-0410-4542-a308-61e91df06653" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanMember_b7d4c2a8-0410-4542-a308-61e91df06653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FinancingTransactionsMember_aa6411b1-2012-40ec-8067-17b650571721" xlink:href="mdxg-20210630.xsd#mdxg_FinancingTransactionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:to="loc_mdxg_FinancingTransactionsMember_aa6411b1-2012-40ec-8067-17b650571721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember_e175dfe3-369a-4a73-a050-6f8579074e93" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember_e175dfe3-369a-4a73-a050-6f8579074e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember_ad54c73a-e613-4d0e-9579-04470e628bfe" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember_ad54c73a-e613-4d0e-9579-04470e628bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CreditFacilitiesMember_fe7a1053-ba62-4b8c-ac32-c6026869cb24" xlink:href="mdxg-20210630.xsd#mdxg_CreditFacilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:to="loc_mdxg_CreditFacilitiesMember_fe7a1053-ba62-4b8c-ac32-c6026869cb24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_6e25cb3f-5b8b-4499-9948-7350c7e2cce2" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:to="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_6e25cb3f-5b8b-4499-9948-7350c7e2cce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TermLoanAgreementMember_62f9cbba-2ce0-4336-87c7-58453fd9a496" xlink:href="mdxg-20210630.xsd#mdxg_TermLoanAgreementMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:to="loc_mdxg_TermLoanAgreementMember_62f9cbba-2ce0-4336-87c7-58453fd9a496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AmendedTermLoanAgreementMember_998c82fc-9670-48eb-bbe0-c11f88b82a37" xlink:href="mdxg-20210630.xsd#mdxg_AmendedTermLoanAgreementMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e2403515-373d-498d-8795-a3f307bf9f4b" xlink:to="loc_mdxg_AmendedTermLoanAgreementMember_998c82fc-9670-48eb-bbe0-c11f88b82a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_5cb42898-5305-4364-abef-8d95a4092216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_16753035-bf55-4b33-9a75-712ffbb8d16f" xlink:to="loc_us-gaap_VariableRateAxis_5cb42898-5305-4364-abef-8d95a4092216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_5aee25f0-d8b2-43b9-bb35-0d7c2355bea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_5cb42898-5305-4364-abef-8d95a4092216" xlink:to="loc_us-gaap_VariableRateDomain_5aee25f0-d8b2-43b9-bb35-0d7c2355bea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_51a49cfc-3172-4e85-9e7e-e0f400262553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_5aee25f0-d8b2-43b9-bb35-0d7c2355bea5" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_51a49cfc-3172-4e85-9e7e-e0f400262553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_5c959235-bbc7-484e-8028-1382fcf35abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_5aee25f0-d8b2-43b9-bb35-0d7c2355bea5" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_5c959235-bbc7-484e-8028-1382fcf35abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_4f373c31-213b-4530-818e-ac0c32c6b3af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_5aee25f0-d8b2-43b9-bb35-0d7c2355bea5" xlink:to="loc_us-gaap_PrimeRateMember_4f373c31-213b-4530-818e-ac0c32c6b3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_16753035-bf55-4b33-9a75-712ffbb8d16f" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_0d489200-7c6b-401f-87fa-3361c61a342a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_0d489200-7c6b-401f-87fa-3361c61a342a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentInterestRateFloorPercentage_e06ec100-55d9-4bd9-8a9f-3eb3703cf89a" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentInterestRateFloorPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_mdxg_DebtInstrumentInterestRateFloorPercentage_e06ec100-55d9-4bd9-8a9f-3eb3703cf89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d691848b-574f-4d3e-b2dd-515bca5b6f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d691848b-574f-4d3e-b2dd-515bca5b6f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TotalNetLeverageRatio_b2f4dde3-ae35-4eea-a398-342068ae8ebe" xlink:href="mdxg-20210630.xsd#mdxg_TotalNetLeverageRatio"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_mdxg_TotalNetLeverageRatio_b2f4dde3-ae35-4eea-a398-342068ae8ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentDefaultInterestRate_e52b568b-4d30-4d5e-a7e9-db3f77b99076" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentDefaultInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_mdxg_DebtInstrumentDefaultInterestRate_e52b568b-4d30-4d5e-a7e9-db3f77b99076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_aaa9779b-0693-472d-97dc-a0676a720266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_aaa9779b-0693-472d-97dc-a0676a720266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtCovenantMinimumLiquidity_475bf6ae-d1cd-402f-a190-2e7373eece85" xlink:href="mdxg-20210630.xsd#mdxg_DebtCovenantMinimumLiquidity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_mdxg_DebtCovenantMinimumLiquidity_475bf6ae-d1cd-402f-a190-2e7373eece85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent_a133a541-712d-4b2d-b8fa-1be15c41cd5f" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent_a133a541-712d-4b2d-b8fa-1be15c41cd5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent_5ce52d92-4018-43f3-86ba-93d01f041a73" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent_5ce52d92-4018-43f3-86ba-93d01f041a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage_ee6c6398-b9a9-4e8d-85ed-eb620bee2b42" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage_ee6c6398-b9a9-4e8d-85ed-eb620bee2b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_6fc06db0-c33a-4e7a-8b55-0ca7943d4a69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_us-gaap_LongTermDebtFairValue_6fc06db0-c33a-4e7a-8b55-0ca7943d4a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_e64472ea-772a-4d1c-8835-dcd70ceaa0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_e64472ea-772a-4d1c-8835-dcd70ceaa0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_321647fc-6960-4680-916f-fc54c72c947c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_321647fc-6960-4680-916f-fc54c72c947c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_f1d70418-df2d-4a05-a4e7-5b82b7c82549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_f1d70418-df2d-4a05-a4e7-5b82b7c82549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_219088e6-7646-4289-9f4b-92e9cc2c2349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d1d6db31-2e36-43b2-a8b9-f85a684aea8a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_219088e6-7646-4289-9f4b-92e9cc2c2349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#LongTermDebtTermLoanDebtIssuanceCostsDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_049dae28-18cf-465d-8f10-198e435a06d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_21e4efd5-d887-44df-b476-c8bf92a29078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_049dae28-18cf-465d-8f10-198e435a06d3" xlink:to="loc_us-gaap_DebtInstrumentTable_21e4efd5-d887-44df-b476-c8bf92a29078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f876d2d3-eba4-444f-8d57-ec65449f443a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_21e4efd5-d887-44df-b476-c8bf92a29078" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f876d2d3-eba4-444f-8d57-ec65449f443a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9bd0cfe8-cdae-4cc9-b821-fcdf4dd88b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f876d2d3-eba4-444f-8d57-ec65449f443a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9bd0cfe8-cdae-4cc9-b821-fcdf4dd88b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_c9139218-673d-4064-830f-26b6fb4efd03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9bd0cfe8-cdae-4cc9-b821-fcdf4dd88b30" xlink:to="loc_us-gaap_LongTermDebtMember_c9139218-673d-4064-830f-26b6fb4efd03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_eaa67e6f-2411-48de-bf48-f53bd35846c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9bd0cfe8-cdae-4cc9-b821-fcdf4dd88b30" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_eaa67e6f-2411-48de-bf48-f53bd35846c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e4f0dd3c-df9b-49ec-8ea9-790b97cd2f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_21e4efd5-d887-44df-b476-c8bf92a29078" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e4f0dd3c-df9b-49ec-8ea9-790b97cd2f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4a139d97-5a25-4c81-a148-87079e36da3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e4f0dd3c-df9b-49ec-8ea9-790b97cd2f4c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4a139d97-5a25-4c81-a148-87079e36da3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_e9e6989b-a0d2-4bfc-be5c-b5f34349a03e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4a139d97-5a25-4c81-a148-87079e36da3e" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_e9e6989b-a0d2-4bfc-be5c-b5f34349a03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_403979dd-d076-4f1f-a589-e8d021aa98bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_21e4efd5-d887-44df-b476-c8bf92a29078" xlink:to="loc_us-gaap_DebtInstrumentAxis_403979dd-d076-4f1f-a589-e8d021aa98bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_917bbc11-d2e7-4cd7-8a8c-6008d106a8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_403979dd-d076-4f1f-a589-e8d021aa98bf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_917bbc11-d2e7-4cd7-8a8c-6008d106a8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CreditFacilitiesMember_35e075fb-ef2c-46fc-b757-7a3e2d55c336" xlink:href="mdxg-20210630.xsd#mdxg_CreditFacilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_917bbc11-d2e7-4cd7-8a8c-6008d106a8a7" xlink:to="loc_mdxg_CreditFacilitiesMember_35e075fb-ef2c-46fc-b757-7a3e2d55c336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember_0ce1bf12-3e7c-4ebf-8fd8-7563a0bd4320" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdxg_CreditFacilitiesMember_35e075fb-ef2c-46fc-b757-7a3e2d55c336" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanMember_0ce1bf12-3e7c-4ebf-8fd8-7563a0bd4320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_a7a0a7c8-ca8a-429e-ac9f-e3c9ec0fcfa6" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdxg_CreditFacilitiesMember_35e075fb-ef2c-46fc-b757-7a3e2d55c336" xlink:to="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_a7a0a7c8-ca8a-429e-ac9f-e3c9ec0fcfa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_420c27b5-e96e-46fe-a7dd-d158f220fd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_21e4efd5-d887-44df-b476-c8bf92a29078" xlink:to="loc_us-gaap_DebtInstrumentLineItems_420c27b5-e96e-46fe-a7dd-d158f220fd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_a3cbbd7f-e383-4377-a752-131b82c1da6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_420c27b5-e96e-46fe-a7dd-d158f220fd7e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_a3cbbd7f-e383-4377-a752-131b82c1da6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_2f33c99d-df30-4dba-9c23-184b654c1284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_420c27b5-e96e-46fe-a7dd-d158f220fd7e" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_2f33c99d-df30-4dba-9c23-184b654c1284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#LongTermDebtTermLoanBalancesDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2502cc49-c694-4273-b24a-f06e77e06010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7f1f7aa5-f0d1-49c2-80ad-742f7ce1c766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2502cc49-c694-4273-b24a-f06e77e06010" xlink:to="loc_us-gaap_DebtInstrumentTable_7f1f7aa5-f0d1-49c2-80ad-742f7ce1c766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0a185dc4-f33e-4055-bd72-9554366980bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7f1f7aa5-f0d1-49c2-80ad-742f7ce1c766" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0a185dc4-f33e-4055-bd72-9554366980bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d4a9ec13-e128-46b1-9897-5fedb3965995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0a185dc4-f33e-4055-bd72-9554366980bf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d4a9ec13-e128-46b1-9897-5fedb3965995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_ce85f8ac-dd30-4a15-9218-51ac4e3888c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d4a9ec13-e128-46b1-9897-5fedb3965995" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_ce85f8ac-dd30-4a15-9218-51ac4e3888c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c4f6b96b-89a7-4450-95bb-5400f41aaa01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7f1f7aa5-f0d1-49c2-80ad-742f7ce1c766" xlink:to="loc_us-gaap_DebtInstrumentAxis_c4f6b96b-89a7-4450-95bb-5400f41aaa01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d9c2d33a-e07c-4ab4-84b2-98fe56a4fe77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c4f6b96b-89a7-4450-95bb-5400f41aaa01" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d9c2d33a-e07c-4ab4-84b2-98fe56a4fe77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember_b08fa160-f54d-4fe4-b1a7-88bd521aadd3" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d9c2d33a-e07c-4ab4-84b2-98fe56a4fe77" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanMember_b08fa160-f54d-4fe4-b1a7-88bd521aadd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_91ee6e8b-b961-480d-a32a-718845289e46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7f1f7aa5-f0d1-49c2-80ad-742f7ce1c766" xlink:to="loc_us-gaap_DebtInstrumentLineItems_91ee6e8b-b961-480d-a32a-718845289e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f446a6c1-1193-4cb8-b4de-c7a894df1a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_91ee6e8b-b961-480d-a32a-718845289e46" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f446a6c1-1193-4cb8-b4de-c7a894df1a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_2abec197-56dc-4e77-bb4a-3605907be2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_91ee6e8b-b961-480d-a32a-718845289e46" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_2abec197-56dc-4e77-bb4a-3605907be2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2accb0b4-62ad-444d-9ad8-86c2d62ad8ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_91ee6e8b-b961-480d-a32a-718845289e46" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_2accb0b4-62ad-444d-9ad8-86c2d62ad8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_53853efb-ab65-4d9e-ad8d-60d966e20799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_91ee6e8b-b961-480d-a32a-718845289e46" xlink:to="loc_us-gaap_LongTermDebt_53853efb-ab65-4d9e-ad8d-60d966e20799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#LongTermDebtTermLoanInterestExpenseDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_518e654a-e372-49aa-9b15-b3b394fd7843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_745ddef4-d6af-4a33-a38a-71e75867b66d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_518e654a-e372-49aa-9b15-b3b394fd7843" xlink:to="loc_us-gaap_DebtInstrumentTable_745ddef4-d6af-4a33-a38a-71e75867b66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_02dacd96-271b-43eb-8b4f-0fcb0b2c1459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_745ddef4-d6af-4a33-a38a-71e75867b66d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_02dacd96-271b-43eb-8b4f-0fcb0b2c1459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b1b09665-b072-4b6f-a7a5-b8c748ed3ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_02dacd96-271b-43eb-8b4f-0fcb0b2c1459" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b1b09665-b072-4b6f-a7a5-b8c748ed3ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_a3686ef8-0acb-4729-89d8-892cf999e88a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b1b09665-b072-4b6f-a7a5-b8c748ed3ab8" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_a3686ef8-0acb-4729-89d8-892cf999e88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b4722757-0a3a-4588-8a23-2f69aa8e271c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_745ddef4-d6af-4a33-a38a-71e75867b66d" xlink:to="loc_us-gaap_DebtInstrumentAxis_b4722757-0a3a-4588-8a23-2f69aa8e271c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1f155b9d-feef-43c6-97b0-c7e3b2dc3a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b4722757-0a3a-4588-8a23-2f69aa8e271c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1f155b9d-feef-43c6-97b0-c7e3b2dc3a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementTermLoanMember_e431a150-a643-40cf-b9bd-ff898b66b845" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1f155b9d-feef-43c6-97b0-c7e3b2dc3a8f" xlink:to="loc_mdxg_HayfinLoanAgreementTermLoanMember_e431a150-a643-40cf-b9bd-ff898b66b845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_48862669-15fe-4603-9fd6-2eb7fb23c32b" xlink:href="mdxg-20210630.xsd#mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1f155b9d-feef-43c6-97b0-c7e3b2dc3a8f" xlink:to="loc_mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember_48862669-15fe-4603-9fd6-2eb7fb23c32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TermLoanAgreementMember_87abf62f-f198-4051-a4d6-28957acedf1e" xlink:href="mdxg-20210630.xsd#mdxg_TermLoanAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1f155b9d-feef-43c6-97b0-c7e3b2dc3a8f" xlink:to="loc_mdxg_TermLoanAgreementMember_87abf62f-f198-4051-a4d6-28957acedf1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d39bb340-a127-4b21-9dd3-28b7ef003484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_745ddef4-d6af-4a33-a38a-71e75867b66d" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d39bb340-a127-4b21-9dd3-28b7ef003484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DebtInstrumentCommitmentFees_9ee2acc3-ec7a-42d2-9ee7-5b32fbf91d7b" xlink:href="mdxg-20210630.xsd#mdxg_DebtInstrumentCommitmentFees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d39bb340-a127-4b21-9dd3-28b7ef003484" xlink:to="loc_mdxg_DebtInstrumentCommitmentFees_9ee2acc3-ec7a-42d2-9ee7-5b32fbf91d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_db210b59-2512-40ca-a742-c96ae2d177af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d39bb340-a127-4b21-9dd3-28b7ef003484" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_db210b59-2512-40ca-a742-c96ae2d177af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_51854d14-4087-4086-b26f-72af2bea1511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d39bb340-a127-4b21-9dd3-28b7ef003484" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_51854d14-4087-4086-b26f-72af2bea1511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet_f7ce4ee8-6bd0-4270-b1a2-89a568e9cb71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredLoanOriginationFeesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d39bb340-a127-4b21-9dd3-28b7ef003484" xlink:to="loc_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet_f7ce4ee8-6bd0-4270-b1a2-89a568e9cb71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_403add06-0b71-40e0-bf71-4fb512e10ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d39bb340-a127-4b21-9dd3-28b7ef003484" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_403add06-0b71-40e0-bf71-4fb512e10ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_e89c0ea8-081c-46f9-aebe-ee156a99b711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d39bb340-a127-4b21-9dd3-28b7ef003484" xlink:to="loc_us-gaap_InterestExpenseDebt_e89c0ea8-081c-46f9-aebe-ee156a99b711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#LongTermDebtTermLoanMaturityDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_adba147b-6dfc-4964-9d43-e49920385558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_ec430dcf-97ed-4cf2-a9a7-da7bb4bb2d21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_adba147b-6dfc-4964-9d43-e49920385558" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_ec430dcf-97ed-4cf2-a9a7-da7bb4bb2d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_7e9de580-b363-4a22-a08d-77ce6dc47525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_adba147b-6dfc-4964-9d43-e49920385558" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_7e9de580-b363-4a22-a08d-77ce6dc47525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_86675d46-1227-4a2b-8239-0712a4558613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_adba147b-6dfc-4964-9d43-e49920385558" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_86675d46-1227-4a2b-8239-0712a4558613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_6412637a-31f1-47bd-8a51-aaab3010cd9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_adba147b-6dfc-4964-9d43-e49920385558" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_6412637a-31f1-47bd-8a51-aaab3010cd9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_49e40e2c-e3d6-48ce-8f7e-f47c19aeb934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_adba147b-6dfc-4964-9d43-e49920385558" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_49e40e2c-e3d6-48ce-8f7e-f47c19aeb934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_LongTermDebtMaturityAfterYearFour_e558f20f-a98d-4e3c-9502-42964eea07f9" xlink:href="mdxg-20210630.xsd#mdxg_LongTermDebtMaturityAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_adba147b-6dfc-4964-9d43-e49920385558" xlink:to="loc_mdxg_LongTermDebtMaturityAfterYearFour_e558f20f-a98d-4e3c-9502-42964eea07f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d31f3eaf-b083-4c28-b8c7-c927db59dd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_adba147b-6dfc-4964-9d43-e49920385558" xlink:to="loc_us-gaap_LongTermDebt_d31f3eaf-b083-4c28-b8c7-c927db59dd2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#LongTermDebtPaycheckProtectionProgramLoanDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e5b33a20-0661-4fa5-aa95-363e8ee6806c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_837fae1d-faa8-4fde-9e06-3fad45e53ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e5b33a20-0661-4fa5-aa95-363e8ee6806c" xlink:to="loc_us-gaap_DebtInstrumentTable_837fae1d-faa8-4fde-9e06-3fad45e53ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6c71de6c-02b7-41c3-929a-8399e5d4d3df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_837fae1d-faa8-4fde-9e06-3fad45e53ab9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6c71de6c-02b7-41c3-929a-8399e5d4d3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fb2a4eab-4f4d-44da-8b81-11da2b42199a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6c71de6c-02b7-41c3-929a-8399e5d4d3df" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fb2a4eab-4f4d-44da-8b81-11da2b42199a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_461ea97d-4634-4ce7-b35a-4ca7167552e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fb2a4eab-4f4d-44da-8b81-11da2b42199a" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_461ea97d-4634-4ce7-b35a-4ca7167552e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d9f55382-c2ef-4731-a5e1-68bfc9e2fa70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_837fae1d-faa8-4fde-9e06-3fad45e53ab9" xlink:to="loc_us-gaap_DebtInstrumentAxis_d9f55382-c2ef-4731-a5e1-68bfc9e2fa70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_45ee9fea-c4c2-46ac-ab33-599d72d4d710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d9f55382-c2ef-4731-a5e1-68bfc9e2fa70" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_45ee9fea-c4c2-46ac-ab33-599d72d4d710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PaycheckProtectionProgramLoanMember_cd2bd25e-e911-4144-afa8-3bfa5902f5d1" xlink:href="mdxg-20210630.xsd#mdxg_PaycheckProtectionProgramLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_45ee9fea-c4c2-46ac-ab33-599d72d4d710" xlink:to="loc_mdxg_PaycheckProtectionProgramLoanMember_cd2bd25e-e911-4144-afa8-3bfa5902f5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_beba51d7-d8a5-4e3b-bcb0-77f3d9f99ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_837fae1d-faa8-4fde-9e06-3fad45e53ab9" xlink:to="loc_us-gaap_VariableRateAxis_beba51d7-d8a5-4e3b-bcb0-77f3d9f99ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6ac568ae-c9ad-4357-bc24-e9fd58f4cbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_beba51d7-d8a5-4e3b-bcb0-77f3d9f99ba9" xlink:to="loc_us-gaap_VariableRateDomain_6ac568ae-c9ad-4357-bc24-e9fd58f4cbc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_1c3b444f-80e5-4d24-92be-464e12d62aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_837fae1d-faa8-4fde-9e06-3fad45e53ab9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_1c3b444f-80e5-4d24-92be-464e12d62aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_38f9e555-b9e8-4892-8a36-187737a0632f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_1c3b444f-80e5-4d24-92be-464e12d62aaf" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_38f9e555-b9e8-4892-8a36-187737a0632f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9e4bd0fd-01b6-4810-9de8-0166a468c16e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_837fae1d-faa8-4fde-9e06-3fad45e53ab9" xlink:to="loc_srt_RangeAxis_9e4bd0fd-01b6-4810-9de8-0166a468c16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b4f26ebd-4379-4623-bd01-8e044f128f45" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9e4bd0fd-01b6-4810-9de8-0166a468c16e" xlink:to="loc_srt_RangeMember_b4f26ebd-4379-4623-bd01-8e044f128f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_60a49d30-f95f-4dfb-8417-d1a7f8d451a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_837fae1d-faa8-4fde-9e06-3fad45e53ab9" xlink:to="loc_us-gaap_DebtInstrumentLineItems_60a49d30-f95f-4dfb-8417-d1a7f8d451a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_38744359-bd14-4c44-8ee3-9976e71147d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_60a49d30-f95f-4dfb-8417-d1a7f8d451a1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_38744359-bd14-4c44-8ee3-9976e71147d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/NetLossPerCommonShare" xlink:type="simple" xlink:href="mdxg-20210630.xsd#NetLossPerCommonShare"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/NetLossPerCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f2374776-8738-4417-83e9-b56403b2c622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_ff6b58c2-4a38-4ea1-9b3b-6188d9472d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f2374776-8738-4417-83e9-b56403b2c622" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_ff6b58c2-4a38-4ea1-9b3b-6188d9472d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/NetLossPerCommonShareTables" xlink:type="simple" xlink:href="mdxg-20210630.xsd#NetLossPerCommonShareTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/NetLossPerCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ccccc1ff-e67a-405c-a686-f2f74a1d7b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_a67e49a9-e8d3-426d-bb05-09ee0e4efb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ccccc1ff-e67a-405c-a686-f2f74a1d7b53" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_a67e49a9-e8d3-426d-bb05-09ee0e4efb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_57334010-28b0-409d-98a6-4ff33663e445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ccccc1ff-e67a-405c-a686-f2f74a1d7b53" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_57334010-28b0-409d-98a6-4ff33663e445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#NetLossPerCommonShareBasicNetLossPerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_af8dbef3-064b-4cab-8bb7-ccd9bf79f415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1e25e278-34ba-4fcf-a48c-6736f688c7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_af8dbef3-064b-4cab-8bb7-ccd9bf79f415" xlink:to="loc_us-gaap_NetIncomeLoss_1e25e278-34ba-4fcf-a48c-6736f688c7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_9808aacb-f5e8-41a8-bf73-2bd23f2f3c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_af8dbef3-064b-4cab-8bb7-ccd9bf79f415" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_9808aacb-f5e8-41a8-bf73-2bd23f2f3c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_18a50102-fa33-490a-aea3-dc7b924b74bf" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityAccretedbutUnrecordedDividends"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_9808aacb-f5e8-41a8-bf73-2bd23f2f3c6d" xlink:to="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_18a50102-fa33-490a-aea3-dc7b924b74bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature_20bc316d-4a12-4f5a-b7df-2ef8be056143" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_9808aacb-f5e8-41a8-bf73-2bd23f2f3c6d" xlink:to="loc_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature_20bc316d-4a12-4f5a-b7df-2ef8be056143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_f9f7fee4-d8dc-47bf-8a91-584a5d46225c" xlink:href="mdxg-20210630.xsd#mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_af8dbef3-064b-4cab-8bb7-ccd9bf79f415" xlink:to="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_f9f7fee4-d8dc-47bf-8a91-584a5d46225c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_08d1e362-b4eb-430e-acec-dc450f254d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_af8dbef3-064b-4cab-8bb7-ccd9bf79f415" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_08d1e362-b4eb-430e-acec-dc450f254d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3cbcc79c-d9f3-4133-a809-7a75a5e5379b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_af8dbef3-064b-4cab-8bb7-ccd9bf79f415" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3cbcc79c-d9f3-4133-a809-7a75a5e5379b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_49d057d8-0199-48bf-89c5-01fe25691c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_af8dbef3-064b-4cab-8bb7-ccd9bf79f415" xlink:to="loc_us-gaap_EarningsPerShareBasic_49d057d8-0199-48bf-89c5-01fe25691c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c67c3a2f-5d9c-4542-bca4-b876062fc467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_9de1bcc2-4cba-456f-be4b-213d2965d795" xlink:href="mdxg-20210630.xsd#mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c67c3a2f-5d9c-4542-bca4-b876062fc467" xlink:to="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_9de1bcc2-4cba-456f-be4b-213d2965d795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7510065b-9019-4d44-ab7a-a9fa25988ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_9de1bcc2-4cba-456f-be4b-213d2965d795" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7510065b-9019-4d44-ab7a-a9fa25988ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_d22bd3d5-d90a-4d60-b915-ddf86cd70716" xlink:href="mdxg-20210630.xsd#mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_9de1bcc2-4cba-456f-be4b-213d2965d795" xlink:to="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_d22bd3d5-d90a-4d60-b915-ddf86cd70716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_ee7ad24c-7194-40c9-b8d1-08e81f1f4bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2ccc1520-4f7c-4a3a-9013-0eaa80030e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_9de1bcc2-4cba-456f-be4b-213d2965d795" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2ccc1520-4f7c-4a3a-9013-0eaa80030e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2cddac6b-2562-4bed-ad93-c7766c752e78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_9de1bcc2-4cba-456f-be4b-213d2965d795" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2cddac6b-2562-4bed-ad93-c7766c752e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d9e90e17-74e2-4970-a5cc-bcde5bfb0efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract_9de1bcc2-4cba-456f-be4b-213d2965d795" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d9e90e17-74e2-4970-a5cc-bcde5bfb0efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0bf80ec0-c1a9-4644-bbef-13408ba92526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c67c3a2f-5d9c-4542-bca4-b876062fc467" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0bf80ec0-c1a9-4644-bbef-13408ba92526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_76d28b72-2d8f-4a3f-ac4c-8818e9d60469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0bf80ec0-c1a9-4644-bbef-13408ba92526" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_76d28b72-2d8f-4a3f-ac4c-8818e9d60469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ca9e0e8-43de-4965-aee9-6f135606a916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_76d28b72-2d8f-4a3f-ac4c-8818e9d60469" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ca9e0e8-43de-4965-aee9-6f135606a916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_bb4ac544-bdfe-4e15-b433-d0732a1b6f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ca9e0e8-43de-4965-aee9-6f135606a916" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_bb4ac544-bdfe-4e15-b433-d0732a1b6f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_4fb70bf4-affe-43cc-8c7b-b0c5bc15de2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ca9e0e8-43de-4965-aee9-6f135606a916" xlink:to="loc_us-gaap_RestrictedStockMember_4fb70bf4-affe-43cc-8c7b-b0c5bc15de2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0e2c1662-39ad-4135-86d0-37dc94589f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ca9e0e8-43de-4965-aee9-6f135606a916" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0e2c1662-39ad-4135-86d0-37dc94589f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_46eb4c1b-d628-4202-82b8-7e194ceb5348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ca9e0e8-43de-4965-aee9-6f135606a916" xlink:to="loc_us-gaap_EmployeeStockOptionMember_46eb4c1b-d628-4202-82b8-7e194ceb5348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_6674df51-5429-4bae-adff-98ce2fa4532d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_4ca9e0e8-43de-4965-aee9-6f135606a916" xlink:to="loc_us-gaap_PerformanceSharesMember_6674df51-5429-4bae-adff-98ce2fa4532d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13688ad4-698e-45e6-9549-94b2bb96d394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0bf80ec0-c1a9-4644-bbef-13408ba92526" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13688ad4-698e-45e6-9549-94b2bb96d394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_054de175-058f-42f1-894a-35ce5723bdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13688ad4-698e-45e6-9549-94b2bb96d394" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_054de175-058f-42f1-894a-35ce5723bdfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_fdc67cdb-040b-4a85-a1c1-e427950264d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13688ad4-698e-45e6-9549-94b2bb96d394" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_fdc67cdb-040b-4a85-a1c1-e427950264d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_e0a6039b-7eac-4ea9-bfa9-61b7ec8a8b45" xlink:href="mdxg-20210630.xsd#mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13688ad4-698e-45e6-9549-94b2bb96d394" xlink:to="loc_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders_e0a6039b-7eac-4ea9-bfa9-61b7ec8a8b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_708b99d9-4371-466c-8a7b-f3d963f05879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13688ad4-698e-45e6-9549-94b2bb96d394" xlink:to="loc_us-gaap_EarningsPerShareDiluted_708b99d9-4371-466c-8a7b-f3d963f05879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e8729280-4f9f-46f9-ac8d-6c3f8e810d00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13688ad4-698e-45e6-9549-94b2bb96d394" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e8729280-4f9f-46f9-ac8d-6c3f8e810d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a9928586-e20a-43c3-99e5-b38c1572793d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_13688ad4-698e-45e6-9549-94b2bb96d394" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a9928586-e20a-43c3-99e5-b38c1572793d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/Equity" xlink:type="simple" xlink:href="mdxg-20210630.xsd#Equity"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/Equity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d0e0eb8f-7faa-4852-863a-f330dfef704b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b69ea359-ffa0-4404-a58b-292e35a80a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d0e0eb8f-7faa-4852-863a-f330dfef704b" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b69ea359-ffa0-4404-a58b-292e35a80a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/EquityEquityTables" xlink:type="simple" xlink:href="mdxg-20210630.xsd#EquityEquityTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/EquityEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_572894ca-e6b8-4698-9beb-e1fa18fe9899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_df2174b7-d7a6-4a75-aae9-9454f23e1bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_572894ca-e6b8-4698-9beb-e1fa18fe9899" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_df2174b7-d7a6-4a75-aae9-9454f23e1bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_cf04aac1-a94a-45d6-a1ff-ea06e7dd75b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_572894ca-e6b8-4698-9beb-e1fa18fe9899" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_cf04aac1-a94a-45d6-a1ff-ea06e7dd75b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_d5ce5b01-2086-43ae-b8d2-e52ebee93003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_572894ca-e6b8-4698-9beb-e1fa18fe9899" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_d5ce5b01-2086-43ae-b8d2-e52ebee93003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/EquityNarrativeDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#EquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/EquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e758ef0a-1363-425a-82c4-30bfd7dbe2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_d214da80-ee28-4c9f-a9e0-d5557d91ff6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e758ef0a-1363-425a-82c4-30bfd7dbe2e9" xlink:to="loc_us-gaap_DividendsPayableTable_d214da80-ee28-4c9f-a9e0-d5557d91ff6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_74a5d6ea-884e-4a0b-8765-66790b6eb884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_d214da80-ee28-4c9f-a9e0-d5557d91ff6e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_74a5d6ea-884e-4a0b-8765-66790b6eb884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3a665876-63be-4198-9f55-5ded4442a6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_74a5d6ea-884e-4a0b-8765-66790b6eb884" xlink:to="loc_us-gaap_ClassOfStockDomain_3a665876-63be-4198-9f55-5ded4442a6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredClassBMember_fd448eca-516b-4174-b629-43c8241807a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredClassBMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3a665876-63be-4198-9f55-5ded4442a6fc" xlink:to="loc_us-gaap_PreferredClassBMember_fd448eca-516b-4174-b629-43c8241807a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_9ba63b0d-ddfb-4e6c-ae1e-12d318a41b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3a665876-63be-4198-9f55-5ded4442a6fc" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_9ba63b0d-ddfb-4e6c-ae1e-12d318a41b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsAxis_4a4b3a7e-aa03-4714-aa3b-a8ca45b783d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_d214da80-ee28-4c9f-a9e0-d5557d91ff6e" xlink:to="loc_us-gaap_DividendsAxis_4a4b3a7e-aa03-4714-aa3b-a8ca45b783d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsDomain_c3f835ae-4005-4826-b2ae-6606db19673b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsAxis_4a4b3a7e-aa03-4714-aa3b-a8ca45b783d5" xlink:to="loc_us-gaap_DividendsDomain_c3f835ae-4005-4826-b2ae-6606db19673b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member_334cfdab-00cb-48a3-b6c1-2dcb56dcd42b" xlink:href="mdxg-20210630.xsd#mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsDomain_c3f835ae-4005-4826-b2ae-6606db19673b" xlink:to="loc_mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member_334cfdab-00cb-48a3-b6c1-2dcb56dcd42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member_0edeead7-931a-4785-8ca3-c99723b004ff" xlink:href="mdxg-20210630.xsd#mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsDomain_c3f835ae-4005-4826-b2ae-6606db19673b" xlink:to="loc_mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member_0edeead7-931a-4785-8ca3-c99723b004ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_d214da80-ee28-4c9f-a9e0-d5557d91ff6e" xlink:to="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_4106afc6-9fe9-401c-af91-de46ec40f73b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_4106afc6-9fe9-401c-af91-de46ec40f73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_ef60b93e-9949-41d5-806c-b7786ff483a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_ef60b93e-9949-41d5-806c-b7786ff483a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ProceedsfromIssuanceofTemporaryEquity_a60cbc8d-439b-4172-bad0-f7b9dc014429" xlink:href="mdxg-20210630.xsd#mdxg_ProceedsfromIssuanceofTemporaryEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_ProceedsfromIssuanceofTemporaryEquity_a60cbc8d-439b-4172-bad0-f7b9dc014429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityDividendRatePercentage_871e9942-e08d-4299-b45c-ce8f13b20b88" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityDividendRatePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityDividendRatePercentage_871e9942-e08d-4299-b45c-ce8f13b20b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionPricePerShare_8327b5b1-b19e-47af-9f7d-797df91fd109" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityConversionPricePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityConversionPricePerShare_8327b5b1-b19e-47af-9f7d-797df91fd109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionRatio_44015f64-92a9-4808-83fd-860cab80376e" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityConversionRatio"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityConversionRatio_44015f64-92a9-4808-83fd-860cab80376e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger_c53d96ec-c76e-4dc9-9157-73781d95d44c" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger_c53d96ec-c76e-4dc9-9157-73781d95d44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdTradingDays_88721f5c-5de2-48e2-995e-3911367c06a8" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityConversionThresholdTradingDays"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityConversionThresholdTradingDays_88721f5c-5de2-48e2-995e-3911367c06a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityThresholdConsecutiveTradingDays_c69562be-c32f-4744-9a04-a9afa0f9dcf8" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityThresholdConsecutiveTradingDays"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityThresholdConsecutiveTradingDays_c69562be-c32f-4744-9a04-a9afa0f9dcf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion_00a1a44e-0cb8-412a-a7b1-6ee058afda64" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion_00a1a44e-0cb8-412a-a7b1-6ee058afda64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders_d1619ace-f00e-4fa0-92eb-f844c7970407" xlink:href="mdxg-20210630.xsd#mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders_d1619ace-f00e-4fa0-92eb-f844c7970407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis_0c1a3079-0c58-4e88-afd5-4f0e1f55e434" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis_0c1a3079-0c58-4e88-afd5-4f0e1f55e434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityIncreasingrateDividendFeature_234e8a82-ec39-4337-a5f2-048591a0c125" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityIncreasingrateDividendFeature"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityIncreasingrateDividendFeature_234e8a82-ec39-4337-a5f2-048591a0c125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_b9a124f3-6bc9-4d0e-96f8-da5f45db9a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_b9a124f3-6bc9-4d0e-96f8-da5f45db9a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_f3c34112-9993-40b7-aa28-da080503d5ae" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityAccretedbutUnrecordedDividends"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquityAccretedbutUnrecordedDividends_f3c34112-9993-40b7-aa28-da080503d5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquitySharesIssueduponConversion_9b84021a-ab64-4945-bd3b-9d6e4b576a14" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquitySharesIssueduponConversion"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_13818850-1c5f-41cd-9b0b-8567175ac645" xlink:to="loc_mdxg_TemporaryEquitySharesIssueduponConversion_9b84021a-ab64-4945-bd3b-9d6e4b576a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ad352263-255d-46d2-8bbd-8e016cd9b574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e758ef0a-1363-425a-82c4-30bfd7dbe2e9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ad352263-255d-46d2-8bbd-8e016cd9b574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_5d692edb-77f2-44d9-9406-b552b6f56627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e758ef0a-1363-425a-82c4-30bfd7dbe2e9" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_5d692edb-77f2-44d9-9406-b552b6f56627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#EquityChangesinSeriesBPreferredStockDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_892ed150-667e-49e2-8e80-2bc4bc952718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_d0b7bb13-39eb-490b-9f46-3ff60e0ee857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_892ed150-667e-49e2-8e80-2bc4bc952718" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_d0b7bb13-39eb-490b-9f46-3ff60e0ee857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e3a104dc-6a29-46cf-9e7f-8b0578e8b716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d0b7bb13-39eb-490b-9f46-3ff60e0ee857" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e3a104dc-6a29-46cf-9e7f-8b0578e8b716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2df8a31c-d336-4e81-a940-08316bc48080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e3a104dc-6a29-46cf-9e7f-8b0578e8b716" xlink:to="loc_us-gaap_ClassOfStockDomain_2df8a31c-d336-4e81-a940-08316bc48080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_aab5fbbf-630e-40d1-a310-1d9e85439b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2df8a31c-d336-4e81-a940-08316bc48080" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_aab5fbbf-630e-40d1-a310-1d9e85439b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_53c8aaa0-f1b2-4e27-94b2-9f555b6104e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d0b7bb13-39eb-490b-9f46-3ff60e0ee857" xlink:to="loc_us-gaap_ClassOfStockLineItems_53c8aaa0-f1b2-4e27-94b2-9f555b6104e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_14efa84c-3efc-4289-a449-d592f3ac37df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_53c8aaa0-f1b2-4e27-94b2-9f555b6104e4" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_14efa84c-3efc-4289-a449-d592f3ac37df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_46881800-7061-4391-9f7a-9ec618e3403e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_14efa84c-3efc-4289-a449-d592f3ac37df" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_46881800-7061-4391-9f7a-9ec618e3403e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_23d10769-a269-4140-b68d-8eaca5206595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_14efa84c-3efc-4289-a449-d592f3ac37df" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_23d10769-a269-4140-b68d-8eaca5206595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_31966ef1-ca16-4978-8923-7c71d3d84186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_14efa84c-3efc-4289-a449-d592f3ac37df" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_31966ef1-ca16-4978-8923-7c71d3d84186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_82a5f5c5-aa83-4809-9199-6984ac236c84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_14efa84c-3efc-4289-a449-d592f3ac37df" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_82a5f5c5-aa83-4809-9199-6984ac236c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d1f50fb1-ff51-4069-8207-d0502dd71e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_14efa84c-3efc-4289-a449-d592f3ac37df" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d1f50fb1-ff51-4069-8207-d0502dd71e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/EquityRestrictedStockAwardsDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#EquityRestrictedStockAwardsDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/EquityRestrictedStockAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_63f8c42c-6eae-4688-91f8-068135184b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_99b938aa-817c-49ba-abd9-5d4c507fde82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_63f8c42c-6eae-4688-91f8-068135184b7a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_99b938aa-817c-49ba-abd9-5d4c507fde82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_51b36b16-8c79-4a6d-be82-df47c952a6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_99b938aa-817c-49ba-abd9-5d4c507fde82" xlink:to="loc_us-gaap_AwardTypeAxis_51b36b16-8c79-4a6d-be82-df47c952a6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b29af66-a951-48dd-8ac3-32a946d303e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_51b36b16-8c79-4a6d-be82-df47c952a6c6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b29af66-a951-48dd-8ac3-32a946d303e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_376b59bb-057b-487e-8ac2-8a3c5c70552c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b29af66-a951-48dd-8ac3-32a946d303e0" xlink:to="loc_us-gaap_RestrictedStockMember_376b59bb-057b-487e-8ac2-8a3c5c70552c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_377e8964-0fbe-49ac-8f98-c0184c49e8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b29af66-a951-48dd-8ac3-32a946d303e0" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_377e8964-0fbe-49ac-8f98-c0184c49e8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_cd89a2a4-9588-46ac-8687-206b31f14806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b29af66-a951-48dd-8ac3-32a946d303e0" xlink:to="loc_us-gaap_PerformanceSharesMember_cd89a2a4-9588-46ac-8687-206b31f14806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_350b9450-8a1b-4334-a117-a9a29995e649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_99b938aa-817c-49ba-abd9-5d4c507fde82" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_350b9450-8a1b-4334-a117-a9a29995e649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88203f74-2a4a-4032-8755-a0580e03a502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_350b9450-8a1b-4334-a117-a9a29995e649" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88203f74-2a4a-4032-8755-a0580e03a502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4e1b8f8b-e4d5-426f-81f8-caef23700b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88203f74-2a4a-4032-8755-a0580e03a502" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4e1b8f8b-e4d5-426f-81f8-caef23700b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_59d67c6d-3c56-461c-a31e-fcea7857b8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88203f74-2a4a-4032-8755-a0580e03a502" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_59d67c6d-3c56-461c-a31e-fcea7857b8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ad6bb3fb-83a5-49f2-8ff3-e92a12b7d8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88203f74-2a4a-4032-8755-a0580e03a502" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ad6bb3fb-83a5-49f2-8ff3-e92a12b7d8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1b11c216-5db2-4943-a970-80bd2c8acdd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88203f74-2a4a-4032-8755-a0580e03a502" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1b11c216-5db2-4943-a970-80bd2c8acdd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c74095f9-ed25-4db9-a98e-c66bbfec15bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_88203f74-2a4a-4032-8755-a0580e03a502" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c74095f9-ed25-4db9-a98e-c66bbfec15bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d36a9dc4-19d7-44d1-a496-d4ce6175dae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_350b9450-8a1b-4334-a117-a9a29995e649" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d36a9dc4-19d7-44d1-a496-d4ce6175dae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_00fc1ef7-1c16-4f4c-bbc9-30fa005e093d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d36a9dc4-19d7-44d1-a496-d4ce6175dae1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_00fc1ef7-1c16-4f4c-bbc9-30fa005e093d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9c149a95-2aa0-4455-93b9-ce3ecfadcf52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d36a9dc4-19d7-44d1-a496-d4ce6175dae1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9c149a95-2aa0-4455-93b9-ce3ecfadcf52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_96693a8a-a9ee-455f-ad90-87bdc850b070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d36a9dc4-19d7-44d1-a496-d4ce6175dae1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_96693a8a-a9ee-455f-ad90-87bdc850b070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_b3461288-20ee-4299-a562-bcf9758f5c64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d36a9dc4-19d7-44d1-a496-d4ce6175dae1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_b3461288-20ee-4299-a562-bcf9758f5c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_cf2e72e7-445a-4b21-86ac-54dd34f326eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d36a9dc4-19d7-44d1-a496-d4ce6175dae1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_cf2e72e7-445a-4b21-86ac-54dd34f326eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/EquityStockIncentivePlansDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#EquityStockIncentivePlansDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/EquityStockIncentivePlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1ddbc755-b0c6-4ec0-888b-d6038d0d5cda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a27cdef2-1799-4dcd-8aca-6b23f8afb5df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1ddbc755-b0c6-4ec0-888b-d6038d0d5cda" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a27cdef2-1799-4dcd-8aca-6b23f8afb5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_95b061ed-2884-4c6d-a1d3-03f2a2e6b73f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a27cdef2-1799-4dcd-8aca-6b23f8afb5df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_95b061ed-2884-4c6d-a1d3-03f2a2e6b73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1add9f45-4dd2-4c50-84a6-89a2e95003f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a27cdef2-1799-4dcd-8aca-6b23f8afb5df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1add9f45-4dd2-4c50-84a6-89a2e95003f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0846a79a-9390-4609-af06-419ae23860f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a27cdef2-1799-4dcd-8aca-6b23f8afb5df" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0846a79a-9390-4609-af06-419ae23860f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_a3127d81-de7e-4627-847d-f281b7e55990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a27cdef2-1799-4dcd-8aca-6b23f8afb5df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_a3127d81-de7e-4627-847d-f281b7e55990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d60fab72-2774-4522-bafa-b1df59eaa4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a27cdef2-1799-4dcd-8aca-6b23f8afb5df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_d60fab72-2774-4522-bafa-b1df59eaa4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7cd92fb8-9b4d-446e-8a32-12591067cdb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a27cdef2-1799-4dcd-8aca-6b23f8afb5df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7cd92fb8-9b4d-446e-8a32-12591067cdb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_15f6fc3c-f3f4-4794-a128-29014957198e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a27cdef2-1799-4dcd-8aca-6b23f8afb5df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_15f6fc3c-f3f4-4794-a128-29014957198e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd1eb0f5-309e-4507-b3f3-638be99cf21f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1ddbc755-b0c6-4ec0-888b-d6038d0d5cda" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd1eb0f5-309e-4507-b3f3-638be99cf21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e2407f2b-d490-4618-badb-72cc28200f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd1eb0f5-309e-4507-b3f3-638be99cf21f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e2407f2b-d490-4618-badb-72cc28200f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_38af7e95-95d4-4fb0-9292-0f467e170815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd1eb0f5-309e-4507-b3f3-638be99cf21f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_38af7e95-95d4-4fb0-9292-0f467e170815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b0d0a96f-4fe1-49c8-bff7-e683f48f233a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd1eb0f5-309e-4507-b3f3-638be99cf21f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b0d0a96f-4fe1-49c8-bff7-e683f48f233a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_70d151e8-c5a1-4e73-a96c-a255eec05d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd1eb0f5-309e-4507-b3f3-638be99cf21f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_70d151e8-c5a1-4e73-a96c-a255eec05d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3bad3f8f-9ff2-429b-82c5-103d7d3767c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd1eb0f5-309e-4507-b3f3-638be99cf21f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3bad3f8f-9ff2-429b-82c5-103d7d3767c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_bbbd799d-1b2d-4300-a86a-c76e0b516eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd1eb0f5-309e-4507-b3f3-638be99cf21f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_bbbd799d-1b2d-4300-a86a-c76e0b516eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_15252ee6-99ca-489b-87ce-4878bd9f177b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_bd1eb0f5-309e-4507-b3f3-638be99cf21f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_15252ee6-99ca-489b-87ce-4878bd9f177b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_e92a56f3-2083-4c29-97a6-06125aa9b49a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1ddbc755-b0c6-4ec0-888b-d6038d0d5cda" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_e92a56f3-2083-4c29-97a6-06125aa9b49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_cf03987a-131e-4f1d-9a0b-2808e3a82a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_e92a56f3-2083-4c29-97a6-06125aa9b49a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_cf03987a-131e-4f1d-9a0b-2808e3a82a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c634dd6e-a9db-4cfb-83d5-2cfdb2b7a690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_e92a56f3-2083-4c29-97a6-06125aa9b49a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c634dd6e-a9db-4cfb-83d5-2cfdb2b7a690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1e7beb8d-1497-46f1-88e1-7ec3ec50da5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1ddbc755-b0c6-4ec0-888b-d6038d0d5cda" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1e7beb8d-1497-46f1-88e1-7ec3ec50da5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_512cfe5c-6268-45d3-854d-1d31d7da1aec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1e7beb8d-1497-46f1-88e1-7ec3ec50da5b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_512cfe5c-6268-45d3-854d-1d31d7da1aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_713bb3cf-e92d-4bb7-af9c-c48762a35ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1e7beb8d-1497-46f1-88e1-7ec3ec50da5b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_713bb3cf-e92d-4bb7-af9c-c48762a35ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/Incometaxes" xlink:type="simple" xlink:href="mdxg-20210630.xsd#Incometaxes"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/Incometaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_956884f7-579c-415f-8352-de7ff4657eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_07536c8d-efbe-4042-9afa-bee3e072b137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_956884f7-579c-415f-8352-de7ff4657eb8" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_07536c8d-efbe-4042-9afa-bee3e072b137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/IncometaxesDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#IncometaxesDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/IncometaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a0a6405b-93a5-4e17-b454-1e3cae618943" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_35f8044b-b858-4cde-a7b8-bb50f84ea038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a0a6405b-93a5-4e17-b454-1e3cae618943" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_35f8044b-b858-4cde-a7b8-bb50f84ea038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems_6d4cb039-5b34-4fe2-8ca7-3830bc4c739b" xlink:href="mdxg-20210630.xsd#mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a0a6405b-93a5-4e17-b454-1e3cae618943" xlink:to="loc_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems_6d4cb039-5b34-4fe2-8ca7-3830bc4c739b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable_29fe22c6-647b-4acc-8905-7b8e627d2aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a0a6405b-93a5-4e17-b454-1e3cae618943" xlink:to="loc_us-gaap_UnusualOrInfrequentItemTable_29fe22c6-647b-4acc-8905-7b8e627d2aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_430c6cc0-1c6f-4a76-b944-20e3fc0de427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_29fe22c6-647b-4acc-8905-7b8e627d2aed" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_430c6cc0-1c6f-4a76-b944-20e3fc0de427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_fc2a5b68-3d6e-44d9-9757-442b2952d25c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_430c6cc0-1c6f-4a76-b944-20e3fc0de427" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_fc2a5b68-3d6e-44d9-9757-442b2952d25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_CARESActMember_f2d1aa5e-7d3e-4c97-8e57-aaae55d50f1a" xlink:href="mdxg-20210630.xsd#mdxg_CARESActMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_fc2a5b68-3d6e-44d9-9757-442b2952d25c" xlink:to="loc_mdxg_CARESActMember_f2d1aa5e-7d3e-4c97-8e57-aaae55d50f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems_151617ff-f6bc-4f7f-90e5-f333a16a86fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_29fe22c6-647b-4acc-8905-7b8e627d2aed" xlink:to="loc_us-gaap_UnusualOrInfrequentItemLineItems_151617ff-f6bc-4f7f-90e5-f333a16a86fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d2cce165-80be-4a38-923d-ad023e2774bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_151617ff-f6bc-4f7f-90e5-f333a16a86fc" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d2cce165-80be-4a38-923d-ad023e2774bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIncomeTaxRefunds_e0859313-72e9-4139-a0bd-70c27b47345f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIncomeTaxRefunds"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_151617ff-f6bc-4f7f-90e5-f333a16a86fc" xlink:to="loc_us-gaap_ProceedsFromIncomeTaxRefunds_e0859313-72e9-4139-a0bd-70c27b47345f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward_2751155b-2cb9-4856-a50a-7263874ea81e" xlink:href="mdxg-20210630.xsd#mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a0a6405b-93a5-4e17-b454-1e3cae618943" xlink:to="loc_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward_2751155b-2cb9-4856-a50a-7263874ea81e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities" xlink:type="simple" xlink:href="mdxg-20210630.xsd#SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_60ffe5b3-b630-4453-b103-91f13056916a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_c2092101-2de5-4075-813c-3e4f098c613e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_60ffe5b3-b630-4453-b103-91f13056916a" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_c2092101-2de5-4075-813c-3e4f098c613e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables" xlink:type="simple" xlink:href="mdxg-20210630.xsd#SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_0268564b-68cf-48e2-9d63-ad1d04f88bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_8fea5f98-1fc4-433a-8772-997dcd97bff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_0268564b-68cf-48e2-9d63-ad1d04f88bf6" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_8fea5f98-1fc4-433a-8772-997dcd97bff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_03b97d2f-6fe3-469a-9a0a-b0144ff57199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_c5096371-20cc-4ed8-b824-d062c440a06e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_03b97d2f-6fe3-469a-9a0a-b0144ff57199" xlink:to="loc_us-gaap_InterestPaid_c5096371-20cc-4ed8-b824-d062c440a06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_bbdda6c0-c913-4da1-bed9-1cb349a7acd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_03b97d2f-6fe3-469a-9a0a-b0144ff57199" xlink:to="loc_us-gaap_IncomeTaxesPaid_bbdda6c0-c913-4da1-bed9-1cb349a7acd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f295258e-727a-46c2-8658-8a1662eef6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_03b97d2f-6fe3-469a-9a0a-b0144ff57199" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f295258e-727a-46c2-8658-8a1662eef6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_LeaseRightOfUseAssetAndLiability_a500f20a-6fed-4082-901f-6364321a41df" xlink:href="mdxg-20210630.xsd#mdxg_LeaseRightOfUseAssetAndLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f295258e-727a-46c2-8658-8a1662eef6ca" xlink:to="loc_mdxg_LeaseRightOfUseAssetAndLiability_a500f20a-6fed-4082-901f-6364321a41df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NotesReceivableForSaleOfPropertyAndEquipment_642d0951-9dd3-49ce-9d28-6d146acbfe73" xlink:href="mdxg-20210630.xsd#mdxg_NotesReceivableForSaleOfPropertyAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f295258e-727a-46c2-8658-8a1662eef6ca" xlink:to="loc_mdxg_NotesReceivableForSaleOfPropertyAndEquipment_642d0951-9dd3-49ce-9d28-6d146acbfe73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_04a23d17-27c1-4029-b5c2-9660ac9c7e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f295258e-727a-46c2-8658-8a1662eef6ca" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_04a23d17-27c1-4029-b5c2-9660ac9c7e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise_5810ba77-1cab-441c-b6b9-b1fe6cf4242e" xlink:href="mdxg-20210630.xsd#mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f295258e-727a-46c2-8658-8a1662eef6ca" xlink:to="loc_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise_5810ba77-1cab-441c-b6b9-b1fe6cf4242e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature_cd4dfe56-e7dd-4b0f-9a70-229b3ad5214b" xlink:href="mdxg-20210630.xsd#mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f295258e-727a-46c2-8658-8a1662eef6ca" xlink:to="loc_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature_cd4dfe56-e7dd-4b0f-9a70-229b3ad5214b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NoncashActivitiesDeferredFinancingCosts_0a9d79b9-4653-411c-9596-8a407e849687" xlink:href="mdxg-20210630.xsd#mdxg_NoncashActivitiesDeferredFinancingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f295258e-727a-46c2-8658-8a1662eef6ca" xlink:to="loc_mdxg_NoncashActivitiesDeferredFinancingCosts_0a9d79b9-4653-411c-9596-8a407e849687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee_d6201561-9aef-4bc2-9cb8-0f358b1e8c65" xlink:href="mdxg-20210630.xsd#mdxg_NoncashActivitiesDebtInstrumentAmendmentFee"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f295258e-727a-46c2-8658-8a1662eef6ca" xlink:to="loc_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee_d6201561-9aef-4bc2-9cb8-0f358b1e8c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/ContractualCommitmentsandContingencies" xlink:type="simple" xlink:href="mdxg-20210630.xsd#ContractualCommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/ContractualCommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_dc0232a8-a630-4a9a-9722-ef7301870829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4f7f9723-0cbd-4d53-817e-ccbbb54ab582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_dc0232a8-a630-4a9a-9722-ef7301870829" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4f7f9723-0cbd-4d53-817e-ccbbb54ab582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#ContractualCommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8b39dc42-7e01-4e31-b465-f51490bea182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable_36fc051d-c010-437a-8628-7c6bb203f92f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8b39dc42-7e01-4e31-b465-f51490bea182" xlink:to="loc_us-gaap_GainContingenciesTable_36fc051d-c010-437a-8628-7c6bb203f92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_00dd4897-9efc-4fa8-bcba-9fa2e38c5a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_36fc051d-c010-437a-8628-7c6bb203f92f" xlink:to="loc_us-gaap_LitigationStatusAxis_00dd4897-9efc-4fa8-bcba-9fa2e38c5a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_bb2b95cf-32c0-49f5-8124-d3a8b869cd37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_00dd4897-9efc-4fa8-bcba-9fa2e38c5a9b" xlink:to="loc_us-gaap_LitigationStatusDomain_bb2b95cf-32c0-49f5-8124-d3a8b869cd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_LegalProceedingsMember_9adcea6d-3ebd-49a7-91c7-cf041874a23a" xlink:href="mdxg-20210630.xsd#mdxg_LegalProceedingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_bb2b95cf-32c0-49f5-8124-d3a8b869cd37" xlink:to="loc_mdxg_LegalProceedingsMember_9adcea6d-3ebd-49a7-91c7-cf041874a23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_36fc051d-c010-437a-8628-7c6bb203f92f" xlink:to="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_7ab0743b-3a4b-4961-81c3-13e8af671f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_7ab0743b-3a4b-4961-81c3-13e8af671f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivable_5b769bab-3086-4892-b46a-31347b1149ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceSettlementsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:to="loc_us-gaap_InsuranceSettlementsReceivable_5b769bab-3086-4892-b46a-31347b1149ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_34eeefe0-6c08-466d-ab36-fe4ae5e8985c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_34eeefe0-6c08-466d-ab36-fe4ae5e8985c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceRecoveries_eedfc612-18a6-458f-840f-6bacc8fc34c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceRecoveries"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:to="loc_us-gaap_InsuranceRecoveries_eedfc612-18a6-458f-840f-6bacc8fc34c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ContingencyLossNumberOfSecuritiesClassActions_51a6a7a1-429c-4d2d-8b9c-f05097d1ef77" xlink:href="mdxg-20210630.xsd#mdxg_ContingencyLossNumberOfSecuritiesClassActions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:to="loc_mdxg_ContingencyLossNumberOfSecuritiesClassActions_51a6a7a1-429c-4d2d-8b9c-f05097d1ef77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_ContingencyLossNumberOfFormerHealthcareProviders_f4554218-5466-4a9d-8b1b-da8838aaa24c" xlink:href="mdxg-20210630.xsd#mdxg_ContingencyLossNumberOfFormerHealthcareProviders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:to="loc_mdxg_ContingencyLossNumberOfFormerHealthcareProviders_f4554218-5466-4a9d-8b1b-da8838aaa24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_c4dbc2b5-ee50-4f44-9bdf-290544778f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_5bd1e240-a1c5-41fd-96df-339341b863f9" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_c4dbc2b5-ee50-4f44-9bdf-290544778f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/Revenue" xlink:type="simple" xlink:href="mdxg-20210630.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1523a665-1403-4ae0-809c-69255de7158c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_aeec0af4-b996-4bf1-9b96-729ed01606f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1523a665-1403-4ae0-809c-69255de7158c" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_aeec0af4-b996-4bf1-9b96-729ed01606f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/RevenueTables" xlink:type="simple" xlink:href="mdxg-20210630.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bf272db6-2eb1-4eb7-97df-7d4cf4c8a528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_6ae26470-40a0-4f4e-b49e-a92f2f7c124b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bf272db6-2eb1-4eb7-97df-7d4cf4c8a528" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_6ae26470-40a0-4f4e-b49e-a92f2f7c124b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#RevenueSummaryofRevenuebyProductTypeDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fe579281-b504-4902-8e2b-b4ccf005ae5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_NumberOfProducts_e5198bd3-8ba6-43d6-848d-e3db84774c7e" xlink:href="mdxg-20210630.xsd#mdxg_NumberOfProducts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fe579281-b504-4902-8e2b-b4ccf005ae5d" xlink:to="loc_mdxg_NumberOfProducts_e5198bd3-8ba6-43d6-848d-e3db84774c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c9c80746-e4ee-4470-8a6c-1ef25cd3a4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fe579281-b504-4902-8e2b-b4ccf005ae5d" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c9c80746-e4ee-4470-8a6c-1ef25cd3a4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3f762526-96a2-4017-8418-3708f1d66e82" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c9c80746-e4ee-4470-8a6c-1ef25cd3a4c5" xlink:to="loc_srt_ProductOrServiceAxis_3f762526-96a2-4017-8418-3708f1d66e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_eed88720-a27e-46ec-b964-46f9368f0cce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_3f762526-96a2-4017-8418-3708f1d66e82" xlink:to="loc_srt_ProductsAndServicesDomain_eed88720-a27e-46ec-b964-46f9368f0cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareMember_24755b10-0c4c-4404-8972-ee0f38a0686e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_eed88720-a27e-46ec-b964-46f9368f0cce" xlink:to="loc_us-gaap_HealthCareMember_24755b10-0c4c-4404-8972-ee0f38a0686e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdvancedWoundCareTissueAndOtherMember_5ecea1cf-b7ad-4520-a811-c85c85312ae7" xlink:href="mdxg-20210630.xsd#mdxg_AdvancedWoundCareTissueAndOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareMember_24755b10-0c4c-4404-8972-ee0f38a0686e" xlink:to="loc_mdxg_AdvancedWoundCareTissueAndOtherMember_5ecea1cf-b7ad-4520-a811-c85c85312ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_7e651f86-b2a3-4db5-9955-5da073b41883" xlink:href="mdxg-20210630.xsd#mdxg_AdvancedWoundCareUmbilicalCordDerivedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareMember_24755b10-0c4c-4404-8972-ee0f38a0686e" xlink:to="loc_mdxg_AdvancedWoundCareUmbilicalCordDerivedMember_7e651f86-b2a3-4db5-9955-5da073b41883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_Section351Member_e33d2b41-414d-4fe6-923a-a5630bbee9b3" xlink:href="mdxg-20210630.xsd#mdxg_Section351Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_eed88720-a27e-46ec-b964-46f9368f0cce" xlink:to="loc_mdxg_Section351Member_e33d2b41-414d-4fe6-923a-a5630bbee9b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_2009800c-8376-48b3-8844-b7600e828276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_eed88720-a27e-46ec-b964-46f9368f0cce" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_2009800c-8376-48b3-8844-b7600e828276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_64bfb32d-0196-47d2-a14c-82fd4d2cb5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_c9c80746-e4ee-4470-8a6c-1ef25cd3a4c5" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_64bfb32d-0196-47d2-a14c-82fd4d2cb5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3096050e-911d-430a-ade7-9cc814a9c67f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_64bfb32d-0196-47d2-a14c-82fd4d2cb5a9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3096050e-911d-430a-ade7-9cc814a9c67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails" xlink:type="simple" xlink:href="mdxg-20210630.xsd#RevenueSummaryofRevenuebyCustomerTypeDetails"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_84b41354-460b-45b4-bd92-b6b33617fc69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_45c8c4c4-a3af-4441-8853-911b1d27e539" xlink:href="mdxg-20210630.xsd#mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_84b41354-460b-45b4-bd92-b6b33617fc69" xlink:to="loc_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_45c8c4c4-a3af-4441-8853-911b1d27e539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_e9329c41-4587-4268-9630-30fd4576e669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_84b41354-460b-45b4-bd92-b6b33617fc69" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_e9329c41-4587-4268-9630-30fd4576e669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_319ae5fa-c386-4a51-bd7f-518cb7ba2ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_e9329c41-4587-4268-9630-30fd4576e669" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_319ae5fa-c386-4a51-bd7f-518cb7ba2ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ebac7410-b579-4485-bb77-3b9ec699a6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_319ae5fa-c386-4a51-bd7f-518cb7ba2ffb" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ebac7410-b579-4485-bb77-3b9ec699a6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_ec7720c9-ab22-42c3-8d0b-42da7a642235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ebac7410-b579-4485-bb77-3b9ec699a6aa" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_ec7720c9-ab22-42c3-8d0b-42da7a642235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_91c0f30f-27ff-45b0-80dd-d655dea3b234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_ebac7410-b579-4485-bb77-3b9ec699a6aa" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_91c0f30f-27ff-45b0-80dd-d655dea3b234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1197d-737e-4b47-bf8d-27fc7810e748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_e9329c41-4587-4268-9630-30fd4576e669" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1197d-737e-4b47-bf8d-27fc7810e748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5f7f0228-62a9-474e-b5a0-13cd03a7e4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1197d-737e-4b47-bf8d-27fc7810e748" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5f7f0228-62a9-474e-b5a0-13cd03a7e4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_fd043407-fea5-4530-b7e8-121ceb7ac7ad" xlink:href="mdxg-20210630.xsd#mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1197d-737e-4b47-bf8d-27fc7810e748" xlink:to="loc_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels_fd043407-fea5-4530-b7e8-121ceb7ac7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mimedx.com/role/SubsequentEvents" xlink:type="simple" xlink:href="mdxg-20210630.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://mimedx.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_d8ed08d7-c4fa-417e-8aa3-a4a8eb8a3a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_3d5dfb96-7389-4a29-8fc9-ec68f2287de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_d8ed08d7-c4fa-417e-8aa3-a4a8eb8a3a4c" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_3d5dfb96-7389-4a29-8fc9-ec68f2287de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>a1029carlsonpetearoff_imag.jpg
<TEXT>
begin 644 a1029carlsonpetearoff_imag.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" !M 98# 2(  A$! Q$!_\0
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M7LK[MI;(Y\7B\/@</*O7=H1W=F_+979]/45^3O\ Q$P^(_\ HSRQ_P#"X?\
M^0Z/^(F'Q'_T9Y8_^%P__P AU]1_Q#WBW_H'_P#)X?\ R1\__KIPW_S_ /\
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M+U9PW_!-<:]_PUEHW]C^9]G_ +/OO[5\O./L_P!G?&[V\WR>O?%)_P '*?\
MR1[X7_\ 8RWW_I.E?7'[&/PW_93^%]O>Z)\#OBSX?\7^(+BW636-1L=<M;JY
M\H$# 2%V\F'>>G<D;F8A<?)'_!RI_P D>^&'_8RWW_I.E?4\%QJ4^+L,IIIW
M>ZM]F1X'%$HRX<Q#B[Z+\T?D-6CX@\*>(?"T>GSZ]I4UO'JVFI?Z;)(N%N;=
MF9!(A[C?'(A]&1AU!K.K]!_VB_V2A\3_ /@B_P#!K]I_PII6_6O .GW5OK+1
M1_//I,^I7 ).!EO)F*L!D!5FG8U_0>99I3RVMAXU-JL^2_9N,FOO:2^9^*X#
M+ZF84Z[AO3ASV[I-)_<FW\CX4^&GQ%\5_"+XB:'\4_ U]]FUCP[JUOJ.FS$9
M"S12!UW#^)21@KT()!ZU_2M^SE\<?"G[2GP-\+_'3P3*IT[Q+I$=VD0E#M;2
MGY9K=BO&^*59(FQT:-A7\QM?JG_P;J?M<$#Q)^QEXPU?^]KW@L3R_1;VU3<_
M_7.=(T7_ )^G8U\5XE9+]>RE8VFO?H[^<'O]SL_)7/JN \U^JYB\)-^[5V_Q
M+;[U=>;L?JK1117X ?L@5A_$KXA>%_A-\/M:^)_C?4!:Z/X?TN?4-2N.I2&*
M,NV!W; P!W. .M;E?G#_ ,'#G[60\"?!O0_V4/"VI[=3\93+J/B%8I!NCTN"
M3]VC#.0);A00>A%M(#UKU\ARJIG6;4L''[3U?:*UD_DKV\SS<VS"GE>75,3+
M[*T7=O1+YL_*G]HOXX>*OVD_CGXH^.?C-V^W>)=8ENVA:0L+>(G$4"D_PQQ!
M(U_V4%8OA_P!XH\3>%M?\9Z5I[-IOAJUMYM5NV1MD?G7"011[@"/,9G+!21E
M8Y",[2*Q:_13Q1^R:G[.'_!!_4/'6OZ:L/B;XD^(M%US4G8+OCL3,/L$&5)R
M!"QFP0&5KJ13]VOZ7S#,,/DM/#4()+GG"G%>5TG\E%/YV[GX3@<%6S:I7K3?
MP0G.3\[-K[Y?A<_.NOU4_P"#9?\ YK9_W+?_ +E*_*NOU4_X-E_^:V?]RW_[
ME*\?Q _Y)'$_]N?^G('H<%_\E+0_[>_](D?JI115?4]5TO1-/FU;6=2M[.UM
MXR]Q=74RQQQJ.K,S$ #W)K^:5=Z(_>"Q17SK\2_^"L?_  3Q^%-R;+Q'^U#H
M-Y,"1Y7AU)]5^8=BUG'*J_B17"R?\%W/^"<*.43XI:TX_O+X3O<'\XP?TKV*
M7#N?5X\U/"U&N_)*WY'F5,ZR>C+EGB()]N:-_P S[$HKYE^'W_!8K_@G+\1]
M072M,_:3T_3;AOX?$&FW>GQC_MK<1)$/^^Z^BO#/BOPMXUT2W\2^#?$FGZMI
MMTF^UU#3+Q+B"9?570E6'N#7'B\NS# .V)HRA_BBU^:1U8?&X/&*]"I&?^%I
M_DS0HHHKC.D**,UX_P#';]OS]CG]FJ[FTKXR_M!^']+U"WP)M'AN&O+Z//3=
M;6RR2KGU*@5OA\+B<94]G0@YR[13;^Y&5:O1P]/GJR45W;27WL]@H(###"OC
MU_\ @NS_ ,$X4G\I?BMK#+G_ %B^$[[;^L8/Z5Z5\%/^"F_["G[0&I1:%\.?
MVC]";49Y!'!INL>;IMQ-(>B1I=I&96]DW5Z%;A_/,-3=2KA:D8K=N$K+U=M#
MBHYQE.(GR4\1!OLI*_YGE_\ P48_9'^$7A'X/>*/VE?"=LVAW.@61O\ 5M/L
M8 ;>]C4@.5CR!%)R#E?E.#E<L7'P7X:\2Z#XLTJ+7?#>JPWEI,N8YH6S^!'5
M2.ZD @]0*_4+_@J&?^-?/Q:_[$^X_FM?SX_#KXG>+?A?K']K>%[_ &K)C[5:
M29:&=1V9?7T(P1DX/)KZ?AKA%\19+5KT9\M6$[)/X6N5.SZI]G\FNJ\+/.)8
MY'F=.E5C>G.-VUNG=J_FNZ^[L_OKX:?$7QM\+/%47C'P!XBN-,U"W(V3V[?>
M7.2CJ?E=#@95@0>XK]"OV3OV]_!GQW$/@OQVEOH/BKY5BA,F+;4B>/W#,<J^
M?^63$GD;2_S;?RU^!_Q-L?C+X6O/$^B:3=1?V:\$6L1M$S):2RAS&ID VD/Y
M4FWH3L;@8KKMS(=ZL01R".U?'X[!XC XJ6'Q$7&<79I]/ZW3V:U1]+A<51Q>
M'C6HR4HRV:_K_AF?M!FBOA_]D#_@HY=Z6]K\-?VB-3DGM>(K#Q5-EI(NP6Z[
MNO;S?O#^/.2P^W+2\M;^UCO;&YCFAFC5X9H7#*ZD9# C@@CH17$URG42444$
MXZT@"BL+5_BC\,_#^HR:1KWQ$T*QNX<":UO-6ACD3(R,JS C@@\CH:K?\+J^
M#G_16?#/_@^M_P#XN@#IJ*H^'_%'AKQ99MJ'A;Q%8ZE;I)Y;SZ?=I,BO@':2
MA(S@@X]Q10!_++7Z ?\ !N-_R>YXJ_[)7??^G+3*_/\ K] /^#<7_D]WQ5_V
M2N^_].6F5_47&7_)+XK_  /\T?S[PO\ \E!A_P#%_F>G?\'%7[);17'AO]LG
MPEI7RR;-!\7F&/\ B&YK.Y; ]-\+,3V@45^6-?TY?M(? SPK^TM\#/%'P*\:
M1K_9_B729+1IO+#-;2_>BG4'^..54D7_ &D%?S3_ !)^'WBKX3?$+7/A?XXL
M/LNL>']5GT_4K?DA9HI"C8/=<C(/<$'O7SGAKG7U[*7@JC]^CMYP>WW.Z\E8
M][CS*OJF9+%P7NU=_*2W^]6?K<_8;_@WV_:W_P"%J?L]ZE^S+XMU82:Y\/YO
M-T<339DN-'G<E0-SEG\B;?&2 %2.6W45^A%?S@_\$^/VJ]2_8W_:P\+_ !G6
MZF71TNOL'BJUA9O])TN<A9P55E\PI\LR*3M\V",GI7]'-C?6>I6<6HZ==1SV
M]Q&LD$\,@9)$89#*1P00<@CJ*_/O$3)?[+SQUX+W*UY+RE]I??K\S[3@K-?[
M0RA4IOWZ7NOT^R_NT^1+7YD_\'%G[5[>'/ GAO\ 8\\,7[+=>(RFN^*@A(_T
M&*1EM83\NUA)<(\AP0RFT3(P]?I/XJ\3Z!X)\,:EXR\5:I%8Z7I-A->ZE>SG
M"6]O$A>21O954D^PK^:_]K_]HK6_VL/VE/%WQ^UR%H?^$@U5GL+1MN;6RC41
M6T)V@ E($C4M@;F!8\DUMX;Y+_:.=?6ZB]RCKZS?P_=K+R:7<QXYS7ZCE7U>
M#]ZKI_VZOB^_1>C9YMT%?OS_ ,$;OV33^RW^QGHUQX@TSR/$WC;;KVO>8N)(
MEE0?9K<\9&R#82I^[)))ZU^1W_!+;]E%OVO?VR/#7@/5],^T>'-'D_MKQ4'7
M,;6-NRGR6]1+(8X3WQ*3VK^A]%"+M KZ+Q2SKEC3RRF]_?G^45^;:\DSQ/#W
M*M:F837]V/\ [<_R7WG\UW[=_P#R?!\9/^RJ>(/_ $Y3UB_LK_\ )SWPX_['
MS1__ $MBK:_;O_Y/@^,G_95/$'_IRGK%_97_ .3GOAQ_V/FC_P#I;%7Z91_Y
M$<?^O:_])/@Y_P#(Y?\ U\_]N/Z(/VTO^3.?BS_V3/7O_3?/7\T?3I7]+G[:
M/_)G7Q9_[)GKW_IOGK^:.OSWPG_W#$_XH_D?:^(W^]X?_"_S1^BG_!MU_P G
M3>.C_P!4_/\ Z76U>R_\'*G_ "1[X8?]C+??^DZ5XU_P;=?\G3>.O^R?G_TN
MMJ]E_P"#E3_DCWPP_P"QEOO_ $G2N?'?\G4H^B_]-LZ,%_R;VK\__2T?D-7]
M '_!+/P?X=^(7_!*SP#X#\7Z7'?:3K7AG4;'4[.3[L]O+>722(?8JQ%?S_U_
M0I_P1^_Y1N?"W_L$W?\ Z7W->GXIRE'):$HNS55?^DR/-\/4I9M53_Y]O_TJ
M)^%_[67[/?B/]E7]HOQ9\!/$OF/)X?U1XK.ZD7'VNT8"2WG]/GA9&P.A)'45
MG_L[?&_Q9^S;\<O"_P =/!,C?VAX9U>*\6'S61;F('$MNY7G9+$7C;'57:OT
MZ_X.)OV2'U[P;X?_ &QO".E%KC0V31?%K0QDYLY')M;AL# "3,T18G)-Q$.B
MU^2-?4\.YI1XDX?A5J)-R3C->=K27S6OHT?/YYE]7(<ZE"GI9J4'Y7NON>GJ
MC^HOX8_$;PK\7_AWH?Q2\#:A]JT?Q#I<&H:;/T+0RH'7</X6 ."O4$$'D5NU
M^;/_  ;N?M8MXT^%.O?LD>*M2W:AX1=M5\-+(QW/IL\G[^,<=(KAPW)_Y>P!
MPO'Z35_.>?934R3-JN#E]EZ/O%ZQ?W;^=T?N&3YC3S7+:>*C]I:KLUHU]_X%
M;6-7TS0-*N==UK4(;2SL[=Y[RZN) D<,2*69V8\!0H))/0"OYO/VZOVG-3_:
M]_:F\6?'"YDF&GZAJ!@\/VTV0;;38?W=NFTD[6* .X''F.Y[U^M7_!>7]JZ3
MX#_LC+\(/#6H-#K_ ,3KB335V;@T>EQ!6O7!VE?F#PVY4D$K<N5SL./PYK]6
M\+LE]CA:F9U%K/W8_P"%/WG\Y:?]NL_.O$'-?:5H8"#TC[TO5K1?):_-'N7_
M  3E_96G_;$_:Y\+?"*[LFET..X_M+Q6RL0$TRW*M*I((9?,)2 ,O*M,IZ U
M^M'_  7AABMO^"<>N6]O&J1QZ_I*HBC 4"X7 'M7%_\ !OS^R;_PJC]G'4/V
MD?%.E^7K7Q"N-NE^8OSPZ3 S+'U&5\V7S)#V9%A:NW_X+T?\HZ=>_P"QATK_
M -*17EYUG7]J>(&%HP=X4:D8K_%S+F?WZ?\ ;IZ.4Y7_ &?P9B*DU[]6$I/T
MY7RK[M?F?A%7ZJ?\&R__ #6S_N6__<I7Y5U^JG_!LO\ \UL_[EO_ -RE?>>(
M'_)(XG_MS_TY ^-X+_Y*6A_V]_Z1(^XOV]_VZ_AA^P;\&F^(OC5%U'6-19[;
MPMX:AN DVJ7(7)YY*0IE3)+@A RC!9T5OPG_ &K?VZ?VE?VR_$\NO?&CX@W,
MUAYQ>Q\-6,C0Z;8CL(X 2"0./,<M(>[&O3/^"R_[1^K?M!_MW>+-.^VS'1O
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M):.ZVOIK;??K<_/\^HYE@\4L'C)<SIJT7WB]59]ORVZ'Z@?\&WGAO0?%MO\
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M2JH?:,E&=1UK^?\ A7.I9%G=+$M^X_=G_A>_W:2]4?M'$.5K-\IJ4%\6\?\
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M  -;6ON^QMA<CS*GP?/ 2C^]=[*ZZR3WO;8_G?K^A3_@C]_RC<^%O_8)N_\
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M."0?RD_X*#_\$2/AK^S3X.NOB]\*OC=K']E>:1'X?UK2H[B6,]<"Y22/Y1T
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GYOV\"?'2XN+34HP+C3=0T-7@\P$8E 68$. "N0>0><X7!67H6?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>mdxg-20210630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mdxg="http://mimedx.com/20210630"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mdxg-20210630.xsd" xlink:type="simple"/>
    <context id="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia1567ea2920241da83b0cf184d8203c1_I20210715">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <instant>2021-07-15</instant>
        </period>
    </context>
    <context id="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8ef27cfe3bed49c7847029a654380438_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i820448fd1936408287034ea0448702c2_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i863500d35994474dbb64036911295267_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i94e12588009a4ccfb7ad506dde230474_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idaaed7e418d64295a2fdef9e72420feb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4d42da3fca664e9196260b0048b8c7a3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i248ea4052a6f4c4a9e79289b81e5d3c5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibb5f8c6fa26a4473999a549b0860daa7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i57d5766bcb174f22a384db94fb1662dc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0f6cf3288aaf451eb539d95c21c0d3f7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i625a8149caf145fb9f6ec49640947103_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7ded271c9e984021b5cc96dfb866079c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i40f91b34ec1c4894992f703f06575098_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id9609d1f974a4ffab0a6a9d68d904674_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia753205aa5374672ad737a15eeaecfcb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3712fe3086a74c9281904d0dc624c0c7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib6653e360f5f4cbd89a180be4fef12f6_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib89406b6d1ed4e27bb530f0566c3e7f4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if3d2f62cbcc2471997607a0f531eddcf_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib3340cbdc0854f9c82647d193a0bb6c7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic5176913ab4841a18870be0accaff0da_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8489118c314c410d9e4ecd5e688a6296_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7c6adf93efd64417b653d94ea5764037_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iecbaa13b22fc4a349dac5a5be52a1ece_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib743ddf65e0546dc8061175cd5b6f187_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0bfff166fb7a47dbade947a596cfe795_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ifa78efde51724943b11905098dacfc15_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9986cdbe1a3a4875971e5c4896a4f876_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2d1e691baee849e4b5421dd9318cfdaa_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9dbf6fb74aec470fbddc41840209cdca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6959021b92d74cf7bd68800c7edb8e59_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9814d3643edd40fe8a5543aa058929ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8ea175868cc44c02963e1fa0d02e98cc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieac267072afd40b5973cebef23f08bc7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4c45415d8d674cdcb88b2754e8ca0f7a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie2c14fb9c8534a52af40933de71d470e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i61f3769f86034f0caba9e0a5c93826f0_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i65c1178147214476b81d7b7b0c807490_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6b69bb9ce62747dba42e6f35f7d6bea8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i893ba49ad5c3430a8b5ce9861abc1c91_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7835fe481e7a474d88cb9bc9fc4b4e9d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1f7fefe2fb0e4c148fd6ecd8635f790a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2560068f9115460db66d530c87ec76d1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3e24f6442afe457aa2166e8538c1e212_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0a967865ec2b404e982f0925ee8083a6_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i67915ef0633745a1bee624f657dfd70d_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i32d60e88dd1c4b5dad71c5e90be4b433_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:Section351Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2f69b69d3f9a4ac2b110d37dcc110405_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:Section351Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i90e644d3bd014f92ba1bb40b0b78d305_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:Section351Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4c9b39d7c36e4c6f960af71b46e8ca65_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:Section351Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib148d38e25b94492bf90c7d639339309_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4419ab9cc84f446692df129d313037a1_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i66be1c10c07c47af8bcae86ad35148ae_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3cbcb788b0524138bc71b680f77362cc_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i54f3fa70af5b41b893e305ac0470f535_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareUmbilicalCordDerivedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaca0961cc5c74e099acc7bc6fe95a9ef_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">mdxg:StockAwardMisstatementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iab79a42abcfc49bf821585364d7300c9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9da3db9cb0b24a25ada54ecbe079f087_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i28d0157a57fe4b55ac3580147766d8d8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie18163f5013a4be0b9bd02bf40e60571_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i326a81676c33465b89855dd27ba292da_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i39f649d4d661481e8d6a6d250cdba5f7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2cccbdf946f0459cb7d8cd1a05b4cd5c_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0ffcb532f3f045a79f3f2a726bce2285_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i45a35085d43841c29afd03db8ea30feb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic0cec0ff165d410fb950f0fe592b80e5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia7887f65880b416a9a1b7b135b38514d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8a82046d4b9b4effaec4f006f2703487_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i804fe80afd1c4483a92cd48a806655ec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0fa1ee6b8d8d4beeabdc8444cf7a0a97_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iec2d038f80894231a4c3c16bcb971517_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i76c421a22e8847a89a5ee26247adacac_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mdxg:AssetRetirementCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i87db49da4123419b8897eb063c0b4c9c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mdxg:AssetRetirementCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if5140cbcb67b477eae5103576b9d79ec_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mdxg:FinanceLeaseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i455d7d410196418eba05ebd95eca8809_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mdxg:FinanceLeaseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5af507b3d6eb4a15b70f0d9de1dfba91_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if023d360bddb4609ba7c01984189031c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia2bff240b04449a29fba2137bf43f2a5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id528f8cf639346baa0d5733e68b0a62f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d57cdcc92e54b889ac2aebd6d6a1bd5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdxg:CustomerAndSupplierRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idb2b2d4264234ed0a37f95b5dd66ce05_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mdxg:CustomerAndSupplierRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb88a22bf81946bb95ccd3c5b11de65f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i730a400496914c0995bd54501e4e7e6f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id51bf5d57c5e4be793cdd487a6614d13_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6cf6e76c76f74939bf341b622ea02bbc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee3d4e93e5e14202a11a01a6f5173801_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mdxg:PatentsinProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i900de095b8b74867bd9ff846daf9e193_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">mdxg:PatentsinProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6d8cb358a527440ca633e34b0e64c145_I20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-02</instant>
        </period>
    </context>
    <context id="i36fba5a1c02d4b94be2074d914f99d5f_I20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:FinancingTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-02</instant>
        </period>
    </context>
    <context id="i988d17ea85c647989e6243f2f3379dbe_D20200702-20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-02</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="i3a655ae7f78948dc884c2536cdf9fd11_D20200702-20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-02</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="iafe464ecd0c245028772137cfcf6b7a0_D20200702-20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-02</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="i973342a619924d6ab0a08e0c4e94b963_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ida1580ac0a56414d8129f9f379f10f0b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5f29d38c99bd445aa0e38a3711d8885e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib9bfddcbaf8f4b90bb405439470f7519_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8cfe91ee3d3e4b3d9edcd8c90d48aad2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2aaba77a0a5f47b5a0450a1a8b2b3ea4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i37aa6fed4311472bb500b5fe0dc149d2_D20210701-20250702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2025-07-02</endDate>
        </period>
    </context>
    <context id="ie28e9a5ef3004dc196ad8be7ab8d8836_D20200702-20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-02</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="i2750d4e108d4450589ec176ea4bc1a68_D20200703-20210702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-03</startDate>
            <endDate>2021-07-02</endDate>
        </period>
    </context>
    <context id="i1cc550f11ce34dab8a1ee5533fd2f5d8_D20210703-20220702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-03</startDate>
            <endDate>2022-07-02</endDate>
        </period>
    </context>
    <context id="i3c88e9fdfe1944b3a4fb9430459677f4_D20220703-20230702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-03</startDate>
            <endDate>2023-07-02</endDate>
        </period>
    </context>
    <context id="ieb2ea45a6256434aa77aa52d97c892eb_D20230703-20250702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-03</startDate>
            <endDate>2025-07-02</endDate>
        </period>
    </context>
    <context id="ibfaa87d5ef5044f39cfb5c90c4cea4d3_I20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-02</instant>
        </period>
    </context>
    <context id="i2f958b3caaef429182bf8441abc2cad2_I20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-02</instant>
        </period>
    </context>
    <context id="i4a0a54ed1a52415a881e9947529ad09f_I20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:CreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-02</instant>
        </period>
    </context>
    <context id="ia4f4a7fffef64fbfb835915c94681b34_D20200702-20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-02</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="if47b0734d0cf4bd2a2b9d44595fbacaf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i24e573531fad49c7b4a1c7704442ac21_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if5df4f4bf6ea45a98669bcf3e1a28aef_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0796339395b546c6950867927cd6139b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i942e6e118deb4bf993725d0b8307938d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib5ea19804b864811aa3bd0894d4736be_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:HayfinLoanAgreementDelayedDrawTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia1e47a6e2d7b4dc0872d79087da38fa4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i127934462af147b1b7b36883a1681b77_I20190610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-10</instant>
        </period>
    </context>
    <context id="i202be97ddd3241418491fe12bce8c12f_D20190610-20190610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-10</startDate>
            <endDate>2019-06-10</endDate>
        </period>
    </context>
    <context id="iea093603b31a44c6b009a07438c52b17_I20200422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:AmendedTermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-22</instant>
        </period>
    </context>
    <context id="i42392901e13144e0b50ffcaa3b266c87_D20200422-20200422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:AmendedTermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-22</startDate>
            <endDate>2020-04-22</endDate>
        </period>
    </context>
    <context id="ib8de3a02e7144468ba0178c4374d8f4a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6299c3dc628d43df867e4bad14106f97_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i065ebf02aa6941e1bdf67379b756096e_D20200424-20200424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mdxg:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-24</startDate>
            <endDate>2020-04-24</endDate>
        </period>
    </context>
    <context id="ib5d9cce6f74d4093affc241694089467_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8bce3a37af914ed9bc5f8c6c3bc59d45_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic4f8987ea15d4408a2035650b2c87f80_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7ed571a8257d42d0a215125b4da04164_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1e66c91f80be4fd983fd0e3efb808448_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8010a62ee3794b6c895396a9baf80f0b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id7c826330d9d41ec9b4befdcda0afa9b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0d26eec9d61c46dc81a087e6461dcb69_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ida46e7ad09274073ab420623ea4c37dd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i47d7bba684bf44828fe6f1b9f07feeff_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4a894936a837468783a21f9dfa898b71_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9fd65f6db4c84b2584ef68fc69fd6b76_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3bc25263e6e64af3b15df41c8754ccca_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9c4217efe8eb4763aa03a1421b865da2_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if97f9edcdca840aa946e43c3245c6e72_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie877a21137404e27bf43f4596c236a0b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i559662d3c9bb44b2ac2b0a2d023a981b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5e6cb875ef234a24a387547a3a122428_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i89c45fca675442c183fc2fb72b865f09_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i21cedcbc67b9433fb42883dc4ec104eb_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-02</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="i7a8becc5cd6748029d491e754d21f558_I20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-02</instant>
        </period>
    </context>
    <context id="i921b8b2918b843b0957acbb1acd7cb40_D20200702-20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">mdxg:DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-02</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="ib585d269397a4280a16c10b8e637430b_D20200702-20200702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">mdxg:PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-02</startDate>
            <endDate>2020-07-02</endDate>
        </period>
    </context>
    <context id="i6be9faea4b8c45d299d9f176ac10cfcd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3cb990ced5454e60b46fb9974649db9f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i16cc01f782b84ac9b6f4b691a457573d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i737e0eaa5bad434fa72a35230884fc03_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaddd4342ea2443bb9b81a46e5ee973a5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4546c782bd4c4b0d9660d32d5de807aa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7ff6f3016254469984a003f5d14d5292_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia78110d12796433b9330985e2b4ef783_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i31a08061cd074967ac410fd896f93157_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i00bd0e49ae8e4e4293bd95e2e845969d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i94b5714cc2e94fc681505d6f23aecd98_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic8dea383f42948e8b56cf4145aeb42f1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie805768234ab4942a5d4fb8ca1a8f3d8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia78947d6c8ca4e8ba3edb9ac39391648_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia54e27be716048c4b4d253e772d6aca1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mdxg:CARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i41bb6f1393b14bd2b5dfaa6483ec1fd7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mdxg:CARESActMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i65bb668e9dae4047a84b02a215986f46_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mdxg:LegalProceedingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3cb4c6f5e91944bc98bf3dad39781578_D20190116-20190116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <startDate>2019-01-16</startDate>
            <endDate>2019-01-16</endDate>
        </period>
    </context>
    <context id="ib237d9ecb84f4d6ab8dfb6cb01b37609_D20200603-20200603">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <startDate>2020-06-03</startDate>
            <endDate>2020-06-03</endDate>
        </period>
    </context>
    <context id="ia6a7a1b394c249888a94eef3b4a3a19f_D20210415-20210415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
        </entity>
        <period>
            <startDate>2021-04-15</startDate>
            <endDate>2021-04-15</endDate>
        </period>
    </context>
    <context id="ic4efd76f6ada46ba8946b7513a22f04a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareTissueAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if46c195635a441178204ec28dde34b01_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareTissueAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i89a37b3906b04310b236e33525aaa95c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareTissueAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1f2bacc597854374bcc516e82f0c5eed_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mdxg:AdvancedWoundCareTissueAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibbf94484fb9640fc95e9891697e411dd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie638d9289b64407d97b93fe9e2db87ff_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i609c12eea03c4236afb3906bceaa436a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idad418953507466e82cdd357b1a16e0b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iaf8f1fdd25a54565b673685695a81bfa_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2dac69150d044c06bb537de5bc9ec0e2_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iab79f8b8ff3646738e954901d9a7200a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4687e4322dec454fa997eabfa8d90145_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i03a9f6a871fa4fed9fca89e62057ca76_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i45054bede241426187915c74a28a6005_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i279daae437cf44a19a94bd273c1d1703_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6bf9f8f4f2bb4f39ba8d91db9fb20a2a_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibf429a45cf5f420a848a9ed4775b39e4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4b2c8606605244ffa5589d29bede8a28_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i00c73051b417433f810f88637d373bcf_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4c204e277321442bbfb6659be2a31d13_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001376339</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="reportingunit">
        <measure>mdxg:reportingUnit</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="day">
        <measure>mdxg:day</measure>
    </unit>
    <unit id="director">
        <measure>mdxg:director</measure>
    </unit>
    <unit id="securityclassaction">
        <measure>mdxg:securityClassAction</measure>
    </unit>
    <unit id="healthcareprovider">
        <measure>mdxg:healthcareProvider</measure>
    </unit>
    <unit id="product">
        <measure>mdxg:product</measure>
    </unit>
    <unit id="distributionchannel">
        <measure>mdxg:distributionChannel</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80L2ZyYWc6ODlhZWYxZWExOTIzNDMxZjgwMDVjZmJhZTEyMjc4NWMvdGFibGU6YTkwNDc5MTVjNjczNDEyMThiMTE4ZjY4NzEzY2NlODEvdGFibGVyYW5nZTphOTA0NzkxNWM2NzM0MTIxOGIxMThmNjg3MTNjY2U4MV8zLTEtMS0xLTA_f8e0ff81-ea4e-4a40-a604-9d1cacd68df7">0001376339</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80L2ZyYWc6ODlhZWYxZWExOTIzNDMxZjgwMDVjZmJhZTEyMjc4NWMvdGFibGU6YTkwNDc5MTVjNjczNDEyMThiMTE4ZjY4NzEzY2NlODEvdGFibGVyYW5nZTphOTA0NzkxNWM2NzM0MTIxOGIxMThmNjg3MTNjY2U4MV80LTEtMS0xLTA_c6bcdbbb-45ea-40ae-8b6d-1105c270267b">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80L2ZyYWc6ODlhZWYxZWExOTIzNDMxZjgwMDVjZmJhZTEyMjc4NWMvdGFibGU6YTkwNDc5MTVjNjczNDEyMThiMTE4ZjY4NzEzY2NlODEvdGFibGVyYW5nZTphOTA0NzkxNWM2NzM0MTIxOGIxMThmNjg3MTNjY2U4MV83LTEtMS0xLTA_eb8a52ec-d8ae-4c27-acae-d384f39afb19">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80L2ZyYWc6ODlhZWYxZWExOTIzNDMxZjgwMDVjZmJhZTEyMjc4NWMvdGFibGU6YTkwNDc5MTVjNjczNDEyMThiMTE4ZjY4NzEzY2NlODEvdGFibGVyYW5nZTphOTA0NzkxNWM2NzM0MTIxOGIxMThmNjg3MTNjY2U4MV84LTEtMS0xLTA_a93cc69b-5659-4ec3-8d7e-ea6680009215">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80L2ZyYWc6ODlhZWYxZWExOTIzNDMxZjgwMDVjZmJhZTEyMjc4NWMvdGFibGU6YTkwNDc5MTVjNjczNDEyMThiMTE4ZjY4NzEzY2NlODEvdGFibGVyYW5nZTphOTA0NzkxNWM2NzM0MTIxOGIxMThmNjg3MTNjY2U4MV8xMC0xLTEtMS0w_dc530f74-06d8-490e-9877-4f62195c18d9">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8xNzkz_0341999e-cab6-4cb4-b421-92340f16e3d0">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6NWQwN2EzMGVlOTY0NDk3ZmEyNWU4NDkzNjBmOTZlNWEvdGFibGVyYW5nZTo1ZDA3YTMwZWU5NjQ0OTdmYTI1ZTg0OTM2MGY5NmU1YV8wLTAtMS0xLTA_c63bcde8-c004-43d2-ae6e-bf8f51ef14a5">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8zODQ4MjkwNjk5MDI5_6860b3e7-86ea-44e3-9304-0997fc040a38">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6NGFlZTI2YWVjYzVkNGJmNzhhOGQwYjI3ZjFmMDQxYTEvdGFibGVyYW5nZTo0YWVlMjZhZWNjNWQ0YmY3OGE4ZDBiMjdmMWYwNDFhMV8wLTAtMS0xLTA_3ff48d0f-636f-4513-9bbc-aef6ff2d1917">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8xNzk0_fc11d4fe-dc16-4a25-8d5c-13d5b4835254">001-35887</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8xNzk4_22285eaf-2bce-4c0c-9e67-ab2f893bb6ba">MIMEDX GROUP, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6YWYxYzQ2MzAzNTdiNDEyNThlMzkwYmUzN2VjMzkyNGUvdGFibGVyYW5nZTphZjFjNDYzMDM1N2I0MTI1OGUzOTBiZTM3ZWMzOTI0ZV8wLTAtMS0xLTA_394c531d-a130-4f3b-a50e-4c0f766a1f51">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6YWYxYzQ2MzAzNTdiNDEyNThlMzkwYmUzN2VjMzkyNGUvdGFibGVyYW5nZTphZjFjNDYzMDM1N2I0MTI1OGUzOTBiZTM3ZWMzOTI0ZV8wLTItMS0xLTA_7accae96-1a0a-4767-91d6-5b0f628b2fdb">26-2792552</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6MzVkNWUyNzlmOTBlNGVkZTkwMjA0NDI5NWNkMGFjZWUvdGFibGVyYW5nZTozNWQ1ZTI3OWY5MGU0ZWRlOTAyMDQ0Mjk1Y2QwYWNlZV8wLTAtMS0xLTAvdGV4dHJlZ2lvbjoyZjVhNzZlMTllYjA0NTQyYTdhNmI4ZmZlY2I1MDViNV80_283dd2d2-b99c-422d-8515-65eccef50323">1775 West Oak Commons Ct NE</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6MzVkNWUyNzlmOTBlNGVkZTkwMjA0NDI5NWNkMGFjZWUvdGFibGVyYW5nZTozNWQ1ZTI3OWY5MGU0ZWRlOTAyMDQ0Mjk1Y2QwYWNlZV8wLTAtMS0xLTAvdGV4dHJlZ2lvbjoyZjVhNzZlMTllYjA0NTQyYTdhNmI4ZmZlY2I1MDViNV83_fe6844eb-3769-46e0-afa2-277ae898b034">Marietta</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6MzVkNWUyNzlmOTBlNGVkZTkwMjA0NDI5NWNkMGFjZWUvdGFibGVyYW5nZTozNWQ1ZTI3OWY5MGU0ZWRlOTAyMDQ0Mjk1Y2QwYWNlZV8wLTAtMS0xLTAvdGV4dHJlZ2lvbjoyZjVhNzZlMTllYjA0NTQyYTdhNmI4ZmZlY2I1MDViNV8xMQ_084d5359-aa2a-451e-9580-c1a48d11be2c">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6MzVkNWUyNzlmOTBlNGVkZTkwMjA0NDI5NWNkMGFjZWUvdGFibGVyYW5nZTozNWQ1ZTI3OWY5MGU0ZWRlOTAyMDQ0Mjk1Y2QwYWNlZV8wLTItMS0xLTA_ed68c031-28d6-468b-a0d3-e002e9fed08d">30062</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8xNzk1_baa24748-daab-48c5-8589-bde8c5fbc786">770</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8xNzk2_5e513754-60ce-4ec8-8acd-8f40002fc1c4">651-9100</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6OTMzNTUzYWY1ODIwNDhjOGJmMTYzZTAwNDA3ODUxNjQvdGFibGVyYW5nZTo5MzM1NTNhZjU4MjA0OGM4YmYxNjNlMDA0MDc4NTE2NF8xLTAtMS0xLTA_3ad7115a-645e-492f-a158-fcb7a6cc97eb">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6OTMzNTUzYWY1ODIwNDhjOGJmMTYzZTAwNDA3ODUxNjQvdGFibGVyYW5nZTo5MzM1NTNhZjU4MjA0OGM4YmYxNjNlMDA0MDc4NTE2NF8xLTEtMS0xLTA_827bdd6e-b1d1-4051-ac58-b9e0421df3bf">MDXG</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6OTMzNTUzYWY1ODIwNDhjOGJmMTYzZTAwNDA3ODUxNjQvdGFibGVyYW5nZTo5MzM1NTNhZjU4MjA0OGM4YmYxNjNlMDA0MDc4NTE2NF8xLTItMS0xLTA_c997e442-76b2-4394-8ca6-fdea69228331">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8xNzk5_afa14667-1d70-4910-a184-589eb246ae30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8xODAw_5b8b1ab0-844d-4217-a56f-acbd808de683">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6ZWFjYWUzM2YwNGNiNGIxNTg2YzcxOWQwOWQ4NGUyNjcvdGFibGVyYW5nZTplYWNhZTMzZjA0Y2I0YjE1ODZjNzE5ZDA5ZDg0ZTI2N18wLTAtMS0xLTM0NjQvdGV4dHJlZ2lvbjo0MDUzYmQzYTRhMTM0OGE5YmM4NjU3MjRmZjZmMjBkMV8zODQ4MjkwNjk3Mjcz_36ec1726-98d2-43e0-a8bd-b5455e014225">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6ZWFjYWUzM2YwNGNiNGIxNTg2YzcxOWQwOWQ4NGUyNjcvdGFibGVyYW5nZTplYWNhZTMzZjA0Y2I0YjE1ODZjNzE5ZDA5ZDg0ZTI2N18wLTMtMS0xLTAvdGV4dHJlZ2lvbjphMTM0ODk0NGQ2Yzg0NWM0YmNjMDY3MTgyYzQ2ZDQ5Zl8zMA_c9b19649-d952-4f90-9c25-52d9ebd94171">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGFibGU6ZWFjYWUzM2YwNGNiNGIxNTg2YzcxOWQwOWQ4NGUyNjcvdGFibGVyYW5nZTplYWNhZTMzZjA0Y2I0YjE1ODZjNzE5ZDA5ZDg0ZTI2N18wLTQtMS0xLTAvdGV4dHJlZ2lvbjpiMjQxZWQ2M2FiMzc0OWU2YjY1MjczNjVhNzJmN2RiNV8yOA_944a1d09-4d61-474d-8311-fcdee00fb3fd">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF8xODAx_4444b2bc-a4d7-493a-8013-bf66f05c0d28">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ia1567ea2920241da83b0cf184d8203c1_I20210715"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xL2ZyYWc6ZWMxNzcxOWE2ZWFlNDcyYzg1MDc5YjkzN2VmMzAxZGQvdGV4dHJlZ2lvbjplYzE3NzE5YTZlYWU0NzJjODUwNzliOTM3ZWYzMDFkZF84MjQ2MzM3MjEwMTM5_0f3a2cfc-a692-4c01-8500-333ebee3f320"
      unitRef="shares">111946829</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMy0xLTEtMS0w_06dfd352-f0c9-4484-999c-157b38a4b20a"
      unitRef="usd">85007000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMy0zLTEtMS0w_ca146b3b-9610-4fe2-93b8-44870040c93d"
      unitRef="usd">95812000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNC0xLTEtMS0w_e0fd737b-39cc-45d8-8d31-6debfa6441e0"
      unitRef="usd">37243000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNC0zLTEtMS0w_cbf4de75-8aaf-44ec-98f6-b4f94174bce1"
      unitRef="usd">35423000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNS0xLTEtMS0w_03ea0220-a35e-439c-bfff-c9ce6e2005e0"
      unitRef="usd">10137000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNS0zLTEtMS0w_f9386052-5d65-4e5a-9b7f-2152ec7c4c94"
      unitRef="usd">10361000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNi0xLTEtMS0w_f1d59884-4e0a-4324-bee7-f578a036c270"
      unitRef="usd">3350000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNi0zLTEtMS0w_8db41e26-2eee-4440-ad63-6e5c789dfbca"
      unitRef="usd">5605000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNy0xLTEtMS0w_2029d0b1-96ab-49f1-976f-689cafed1e2f"
      unitRef="usd">10138000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNy0zLTEtMS0w_140c7719-3ace-4534-bee1-daa329e60128"
      unitRef="usd">10045000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherAssetsCurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfOC0xLTEtMS0w_337c6191-547d-42e2-b386-fd8ae15ce2d5"
      unitRef="usd">1816000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfOC0zLTEtMS0w_2094961f-7879-467f-bd91-b88091d4e1f5"
      unitRef="usd">3371000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfOS0xLTEtMS0w_275588ca-db9d-4a4f-aa23-d9d8bfeb8e66"
      unitRef="usd">147691000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfOS0zLTEtMS0w_846320cb-d856-4e3c-9a6e-a3503faab6b1"
      unitRef="usd">160617000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTEtMS0xLTEtMA_f2dff5bd-434e-46aa-9305-fd2bf906977d"
      unitRef="usd">10273000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTEtMy0xLTEtMA_c3cec02f-1c72-404f-807e-9e85cb6fb90f"
      unitRef="usd">11437000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <mdxg:OperatingLeaseAndFinancingLeaseRightOfUseAsset
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTItMS0xLTEtMA_4133e93a-fa9f-4c59-bda1-ce95780ba4aa"
      unitRef="usd">3144000</mdxg:OperatingLeaseAndFinancingLeaseRightOfUseAsset>
    <mdxg:OperatingLeaseAndFinancingLeaseRightOfUseAsset
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTItMy0xLTEtMA_93734104-0556-4750-be53-fe5890e4bf75"
      unitRef="usd">3623000</mdxg:OperatingLeaseAndFinancingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTMtMS0xLTEtMA_af9a3709-0294-4bf2-8045-694020d02d5d"
      unitRef="usd">19976000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTMtMy0xLTEtMA_43673bd9-2dab-4ee1-a84a-30a496f9e418"
      unitRef="usd">19976000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTQtMS0xLTEtMA_95b1fbc3-e83c-49ea-8f37-3c44d753b0d7"
      unitRef="usd">5750000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTQtMy0xLTEtMA_2c0593e4-5c65-407f-8faf-35760d746673"
      unitRef="usd">6004000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTYtMS0xLTEtMA_07ef5909-38bb-4ccb-a34a-361328057ffc"
      unitRef="usd">313000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTYtMy0xLTEtMA_adf25e49-e728-4f5c-ba4c-de8431dff7f9"
      unitRef="usd">375000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTctMS0xLTEtMA_103bc85a-d459-4fb1-9830-472e8b894425"
      unitRef="usd">187147000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMTctMy0xLTEtMA_45f719df-c17c-44ca-bbba-3dc942e8b5d6"
      unitRef="usd">202032000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjAtMS0xLTEtMA_ae69098b-0c50-4655-b037-827724265abe"
      unitRef="usd">10563000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjAtMy0xLTEtMA_6bdbeba4-6e4a-41cf-8166-aa84533b5eee"
      unitRef="usd">8765000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjEtMS0xLTEtMA_1c9f6aae-f76a-4e20-98b3-cc91170115d7"
      unitRef="usd">21257000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjEtMy0xLTEtMA_2896c875-46a1-44bc-9dfb-b755ab4e1939"
      unitRef="usd">18467000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjItMS0xLTEtMA_796f7484-21d1-4341-9612-b8268c49bebc"
      unitRef="usd">17073000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjItMy0xLTEtMA_91a872b9-90a1-4e4e-8664-3d87589d4676"
      unitRef="usd">30460000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjctMS0xLTEtMA_90aa13ba-35cf-48f2-830f-ac817e49f60a"
      unitRef="usd">1678000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjctMy0xLTEtMA_0a9c3668-abf6-4749-9d0b-fb51b72b8035"
      unitRef="usd">1470000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjgtMS0xLTEtMA_7ca1a368-86eb-4740-84b3-741723139da3"
      unitRef="usd">50571000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjgtMy0xLTEtMA_c6eab480-1d3b-403b-9a99-70665387894c"
      unitRef="usd">59162000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjktMS0xLTEtMA_68fc75cd-a8c6-4432-999d-62e84ed8a573"
      unitRef="usd">47905000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMjktMy0xLTEtMA_85f9a73a-21e7-49fe-a35c-5654d12846e5"
      unitRef="usd">47697000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzAtMS0xLTEtMA_24f30cce-9df5-4a4b-b1de-219c04dfba4a"
      unitRef="usd">3314000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzAtMy0xLTEtMA_6d5cedd7-2088-4630-9caa-b8906adb0017"
      unitRef="usd">3755000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzEtMS0xLTEtMA_d8cc5354-da40-489c-bc99-0d344be29e1d"
      unitRef="usd">101790000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzEtMy0xLTEtMA_7d2196c7-3559-4285-abf4-9c8e08b2d081"
      unitRef="usd">110614000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzItMS0xLTEtMA_0d7fcad6-ddbb-4d33-9a23-4562ffd87d31"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzItMy0xLTEtMA_5d8b0036-0697-4b95-accd-08a595c7da79"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NDhhM2ZjYjNkYzRhZjQ4MzZiMzA1ZmNkYTJiZmE3XzQy_9a01a77f-9775-4c62-899a-3f45ed531807"
      unitRef="usdPerShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NDhhM2ZjYjNkYzRhZjQ4MzZiMzA1ZmNkYTJiZmE3XzQy_b2055115-db41-4b2e-b1df-d491af7ae2c6"
      unitRef="usdPerShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NDhhM2ZjYjNkYzRhZjQ4MzZiMzA1ZmNkYTJiZmE3XzU2_4b6815a9-0fd0-4312-b5d0-477f2500337b"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NDhhM2ZjYjNkYzRhZjQ4MzZiMzA1ZmNkYTJiZmE3XzU2_64bbddda-86ec-4297-b919-63f6816a0efd"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NDhhM2ZjYjNkYzRhZjQ4MzZiMzA1ZmNkYTJiZmE3XzU2_bafa57be-45a2-4658-864e-c6ec0b7cdda5"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NDhhM2ZjYjNkYzRhZjQ4MzZiMzA1ZmNkYTJiZmE3XzU2_c28eb13b-4c3a-4159-a891-0993af076811"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NDhhM2ZjYjNkYzRhZjQ4MzZiMzA1ZmNkYTJiZmE3XzU2_d1b6ffb2-20b5-4b99-b6e5-05d19d4ee17a"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NDhhM2ZjYjNkYzRhZjQ4MzZiMzA1ZmNkYTJiZmE3XzU2_eff992c5-8f4d-4c43-bc60-675023b11008"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMS0xLTEtMA_92941733-f757-4cc3-9635-203d6073ac74"
      unitRef="usd">92494000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzMtMy0xLTEtMA_e8642eab-47a6-4ca2-9004-eee19f056eaf"
      unitRef="usd">91568000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNGEyNjU4YzBjZjRiZWY4MTY3NDdmNmQ3YmE4YTE1XzMw_1a6499d8-e8a4-41eb-a108-aee5ee21e301"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNGEyNjU4YzBjZjRiZWY4MTY3NDdmNmQ3YmE4YTE1XzMw_98047f93-6b8d-4f75-b6ef-105a1693344c"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNGEyNjU4YzBjZjRiZWY4MTY3NDdmNmQ3YmE4YTE1XzQ0_4587dc86-a7b7-4d58-b640-bcb64e94377b"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNGEyNjU4YzBjZjRiZWY4MTY3NDdmNmQ3YmE4YTE1XzQ0_67d93f59-b58f-439b-bd7e-ba42ba9e1a9f"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNGEyNjU4YzBjZjRiZWY4MTY3NDdmNmQ3YmE4YTE1XzY2_092bfcc2-038d-47f4-8f0e-9fc578154e72"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNGEyNjU4YzBjZjRiZWY4MTY3NDdmNmQ3YmE4YTE1XzY2_260ff8a5-2bd0-4060-b0d4-3e01d403107f"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNGEyNjU4YzBjZjRiZWY4MTY3NDdmNmQ3YmE4YTE1XzY2_55e90c2f-d653-4ee0-a15b-63bdda5e9d9a"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOmYzNGEyNjU4YzBjZjRiZWY4MTY3NDdmNmQ3YmE4YTE1XzY2_e8b06079-4ffa-49e3-a0aa-e43854a0c9d1"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMS0xLTEtMA_c49d0074-24c3-4fc9-b043-ea6bbe14c93f"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzUtMy0xLTEtMA_7e621a03-f7f8-4ae0-ba9e-f359c9142f9c"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzE4_9c2299e8-78a3-414b-b43a-2bf24b8af087"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzE4_bb526472-9b8d-44b8-8893-690797324ee2"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzMy_43b29d4a-c000-43fa-83d6-f7b2a3a24ca8"
      unitRef="shares">187500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzU0_1715b260-71d2-4e7f-b3d5-e6c02b3b13b3"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzU0_b389c198-4e30-4f9e-a69d-2d500bb7492d"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzY4_864964a0-9723-4d6e-b6c0-c614e1444e94"
      unitRef="shares">111881938</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzkz_1715b260-71d2-4e7f-b3d5-e6c02b3b13b3"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzkz_b389c198-4e30-4f9e-a69d-2d500bb7492d"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMC0xLTEtMC90ZXh0cmVnaW9uOjM3ZTZjMzc5Y2VkMTQwNjViZGFhZjkyYzM5MDk5MWExXzEwNw_fe4f5f14-2ce6-4f1b-83a1-759dbea06fc5"
      unitRef="shares">110930243</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMS0xLTEtMA_d63d1cf3-2287-4d7a-b1f4-d7fe2d8debbb"
      unitRef="usd">113000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzYtMy0xLTEtMA_caaf693e-4727-4be5-9a9d-9ace5f162e8a"
      unitRef="usd">113000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzctMS0xLTEtMA_ba63e36d-2657-42cd-8ce0-98ae6c2902ff"
      unitRef="usd">158720000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzctMy0xLTEtMA_486d7554-910d-46fe-a613-66d3d4f275f0"
      unitRef="usd">158610000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NmZjZTg5OTBjMjRmZjdhNzQ2MDg5YmIzZTdhOTNmXzI4_c035eee0-5a7d-46a1-a523-6eb487f6727c"
      unitRef="shares">821988</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmI5NmZjZTg5OTBjMjRmZjdhNzQ2MDg5YmIzZTdhOTNmXzQ4_3c1b67f5-4a42-42f1-bd8d-6b08f2b243ff"
      unitRef="shares">1773683</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzgtMS0xLTEtMA_30365bd1-5f82-4ece-9fb6-cbaa5e8e5147"
      unitRef="usd">4385000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzgtMy0xLTEtMA_fd0da5b6-2af5-4886-b75a-19fcf4bf4ce9"
      unitRef="usd">7449000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzktMS0xLTEtMA_62fcb764-d204-49fa-a5f2-1450a6f1a2dc"
      unitRef="usd">-161585000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfMzktMy0xLTEtMA_c2380b26-f5b7-45b1-acc0-61891fc708a0"
      unitRef="usd">-151424000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNDAtMS0xLTEtMA_2f34fd08-f66c-48af-9d9f-9bee084bfe00"
      unitRef="usd">-7137000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNDAtMy0xLTEtMA_67858fbd-b405-4529-bb68-dc47de798ebf"
      unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNDEtMS0xLTEtMA_52d754b9-3613-4153-a0bc-fb5af1287e90"
      unitRef="usd">187147000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8xOS9mcmFnOmUwYTExMDExNDhjZjQ4ZGE5YmE2M2RmYzY1NmM2MzIwL3RhYmxlOjEzYzMwOTQ5ODBjZjRhZDNiY2QzOWIwMzBlYjBhZjc2L3RhYmxlcmFuZ2U6MTNjMzA5NDk4MGNmNGFkM2JjZDM5YjAzMGViMGFmNzZfNDEtMy0xLTEtMA_dff4ea2c-e1b5-4967-857c-f631fb7e4cbd"
      unitRef="usd">202032000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMy0xLTEtMS0w_0a28639e-f68d-4b0a-9c4e-ba582f880a87"
      unitRef="usd">68165000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMy0zLTEtMS0w_644402db-716b-43bb-bd0b-50bcf88dde2e"
      unitRef="usd">53647000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMy0zLTEtMS0w_ed84a725-0c55-49d4-bdda-0713b11f5294"
      unitRef="usd">53647000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMy01LTEtMS0w_f42413ab-3f2d-4462-8d71-13d789ff15e7"
      unitRef="usd">128132000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMy03LTEtMS0w_0daecd0c-7c26-4332-b148-8aea72146eb1"
      unitRef="usd">115383000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNC0xLTEtMS0w_14954cc5-cc18-4cc0-8a71-740d628492bf"
      unitRef="usd">12760000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNC0zLTEtMS0w_1f6d74c3-954d-4d45-a655-bef145693154"
      unitRef="usd">8198000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNC0zLTEtMS0w_a57dc3d6-a8f3-4e86-b3ba-289b663d6537"
      unitRef="usd">8198000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNC01LTEtMS0w_5af623b8-df7c-4453-84a1-17be3d299f9d"
      unitRef="usd">22401000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNC03LTEtMS0w_b17f6201-650c-4357-b991-0935385633ef"
      unitRef="usd">18223000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNS0xLTEtMS0w_bfab3700-f51e-423b-aa12-4da223397e76"
      unitRef="usd">55405000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNS0zLTEtMS0w_cc05611c-92e4-4879-ae94-f8166672297a"
      unitRef="usd">45449000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNS01LTEtMS0w_e196a72c-5a8a-4fca-920e-fc593ab9dde6"
      unitRef="usd">105731000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfNS03LTEtMS0w_d4f9fe06-b936-4d5b-8571-0dad90613763"
      unitRef="usd">97160000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOC0xLTEtMS0w_c9c3c27d-fd75-4831-81fc-b7caf4399ed6"
      unitRef="usd">53599000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOC0zLTEtMS0w_90c66060-9791-4892-9e77-afdf3b9bf1b1"
      unitRef="usd">37329000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOC0zLTEtMS0w_b15ffd2f-ef2a-44ae-9249-acdd05bae856"
      unitRef="usd">37329000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOC01LTEtMS0w_567f9498-c763-4fb3-9939-69617d552a26"
      unitRef="usd">99003000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOC03LTEtMS0w_c24c3c42-b493-4feb-a165-bc0d55eb3794"
      unitRef="usd">84270000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <mdxg:InvestigationRestatementandRelated
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOS0xLTEtMS0w_f39a52e9-61b5-45e1-88df-f6a963f5486a"
      unitRef="usd">-2062000</mdxg:InvestigationRestatementandRelated>
    <mdxg:InvestigationRestatementandRelated
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOS0zLTEtMS0w_22ee44c5-99b3-431a-8405-0c9211d7dbf5"
      unitRef="usd">11446000</mdxg:InvestigationRestatementandRelated>
    <mdxg:InvestigationRestatementandRelated
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOS0zLTEtMS0w_c5ebc1cf-77a2-4796-ad99-a61934e31e5b"
      unitRef="usd">11446000</mdxg:InvestigationRestatementandRelated>
    <mdxg:InvestigationRestatementandRelated
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOS01LTEtMS0w_0590bd9c-3be2-47b2-baa1-5f36a6cbebcd"
      unitRef="usd">5134000</mdxg:InvestigationRestatementandRelated>
    <mdxg:InvestigationRestatementandRelated
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfOS03LTEtMS0w_5ce4796f-f712-430a-9024-fc84143cdfd3"
      unitRef="usd">27038000</mdxg:InvestigationRestatementandRelated>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTAtMS0xLTEtMA_2701b9fd-47a1-4fcb-9e6e-b3c67e31dbdc"
      unitRef="usd">4063000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTAtMy0xLTEtMA_0157be7d-56d2-4887-bc22-3af6d17fa044"
      unitRef="usd">2259000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTAtMy0xLTEtMA_23aec459-f16f-4f70-a371-2ce3e6c8e533"
      unitRef="usd">2259000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTAtNS0xLTEtMA_68cf3e43-a3e1-4c2c-851c-43511c40da19"
      unitRef="usd">8402000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTAtNy0xLTEtMA_aad949ac-f547-4572-86d2-4f547e6aace0"
      unitRef="usd">4910000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTEtMS0xLTEtMA_9837a77c-853f-4c68-8b4a-39d7bcf2807e"
      unitRef="usd">215000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTEtMy0xLTEtMA_45cec807-3333-4a4a-b636-37362d523ad7"
      unitRef="usd">271000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTEtMy0xLTEtMA_f0eccecb-d312-45c6-bcbc-4fca1e52709f"
      unitRef="usd">271000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTEtNS0xLTEtMA_e47c3bd9-ba85-4a4a-8eab-4f2a3df06640"
      unitRef="usd">454000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTEtNy0xLTEtMA_ddbb4f15-1ba1-43ce-98d5-f799b65ce609"
      unitRef="usd">542000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTMtMS0xLTEtMA_5c4396ff-db70-45cf-a94f-926e519480a0"
      unitRef="usd">-410000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTMtMy0xLTEtMA_677afc05-21e0-4a17-80bb-379d2101eeca"
      unitRef="usd">-5856000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTMtNS0xLTEtMA_962e3c27-05be-4b78-a005-c9aa80375f24"
      unitRef="usd">-7262000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTMtNy0xLTEtMA_bac9d132-509e-4eab-b792-e93eb2849066"
      unitRef="usd">-19600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTctMS0xLTEtMA_a90d6011-dc8c-4d9f-82d7-feca8f97c0c9"
      unitRef="usd">-1371000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTctMy0xLTEtMA_11c64273-f643-4586-96cd-a9ace6f2692c"
      unitRef="usd">-2574000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTctMy0xLTEtMA_b12535c6-1c81-4287-ba70-9ad15d3aa674"
      unitRef="usd">-2574000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTctNS0xLTEtMA_79802d19-158a-4af1-8f81-04adf57894ff"
      unitRef="usd">-2844000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTctNy0xLTEtMA_8bea0642-3797-4729-8bdf-ea9a044a07a0"
      unitRef="usd">-4961000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTgtMS0xLTEtMA_46be04cf-8eaf-4a9a-9888-23f95aa4f5b7"
      unitRef="usd">-3000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTgtMy0xLTEtMA_5a539606-85a1-476f-b7c0-0a203a7f20b3"
      unitRef="usd">-9000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTgtMy0xLTEtMA_6b083207-c7ea-4206-aac2-400ee281a255"
      unitRef="usd">-9000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTgtNS0xLTEtMA_513a7f6c-9198-4f87-a5f8-f358201b7b4d"
      unitRef="usd">-2000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTgtNy0xLTEtMA_eee2b0da-806d-48db-948c-84f600e53e77"
      unitRef="usd">-3000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTktMS0xLTEtMA_dd886a49-f8c7-4a01-aaeb-0aede56449dd"
      unitRef="usd">-1784000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTktMy0xLTEtMA_b09d7bd9-5108-499a-9dce-b0d91119046c"
      unitRef="usd">-8439000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTktNS0xLTEtMA_ca1e9bc8-5b6c-449a-ab2b-3cff6855b017"
      unitRef="usd">-10108000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMTktNy0xLTEtMA_d9c99111-f499-45dd-b67c-94c3c4c70317"
      unitRef="usd">-24564000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjAtMS0xLTEtMA_f203c5eb-e530-48d6-b7b4-dc37da589bc2"
      unitRef="usd">-5000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjAtMy0xLTEtMA_05d0e05f-892c-4a3c-a43c-18a89398035b"
      unitRef="usd">27000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjAtMy0xLTEtMA_0cf661af-b723-4122-83f8-5e2f00d84eb4"
      unitRef="usd">27000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjAtNS0xLTEtMA_76f48639-f0c6-4683-8770-16e977265aa6"
      unitRef="usd">53000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjAtNy0xLTEtMA_c8cabf98-c56c-4918-9edd-be1b315eaa5c"
      unitRef="usd">-11277000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjEtMS0xLTEtMA_3015aa33-03c8-4e86-a767-9573750c2e34"
      unitRef="usd">-1779000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjEtMy0xLTEtMA_a45056cc-2bb4-4cc2-894c-f9aa5bb1065c"
      unitRef="usd">-8466000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjEtNS0xLTEtMA_9ded7a20-518c-4710-8cee-08ecc0dddfd2"
      unitRef="usd">-10161000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjEtNy0xLTEtMA_6c5e3672-ee8f-44cd-abb1-93512d7edae1"
      unitRef="usd">-13287000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjMtMS0xLTEtMA_bb374a97-310d-4583-941c-9f83bc2db120"
      unitRef="usd">-3276000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjMtMy0xLTEtMA_4547fee4-c0b4-44d3-a533-11b0a81faa9c"
      unitRef="usd">-8466000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLoss
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjMtMy0xLTEtMA_e8f00e35-0717-4ffd-81e3-85d89639053e"
      unitRef="usd">-8466000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjMtNS0xLTEtMA_d0e520ae-0fef-4854-bd43-2944c39defd8"
      unitRef="usd">-13126000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjMtNy0xLTEtMA_5c665667-7ee8-423a-8f97-63a4e93558e8"
      unitRef="usd">-13287000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjUtMS0xLTEtMA_1e57976a-ef46-4b65-96b8-b5b7e0562278"
      unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjUtMy0xLTEtMA_f8dc2ad9-f5ff-4cd3-8d77-afe2faf7171e"
      unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjUtNS0xLTEtMA_2407323b-e351-462c-b2fc-9387aed5d8b8"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjUtNy0xLTEtMA_c8207d3a-7224-44b9-a179-6b6a2cca6fd1"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjYtMS0xLTEtMA_ef409bc1-6ef7-4149-891a-2b68b37d47d5"
      unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjYtMy0xLTEtMA_931f4728-3463-4403-98c0-987e95cd8ccb"
      unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjYtNS0xLTEtMA_68db7d49-46f2-4557-954c-3e459fe7b459"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjYtNy0xLTEtMA_316d7c76-3467-4813-afa2-d2af512706ab"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtMS0xLTEtMA_f5bddecb-6180-49ff-933c-8243b2dc142e"
      unitRef="shares">110276636</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtMS0xLTEtMA_f5d937dc-14be-442a-b8e5-3e6a6198a841"
      unitRef="shares">110276636</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtMS0xLTEtMA_fbd3bfce-59f9-48dc-a53c-9125d0d868dc"
      unitRef="shares">110276636</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtMy0xLTEtMA_92be8069-f672-4e66-9d39-ad763174062f"
      unitRef="shares">108119461</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtMy0xLTEtMA_bdf4c466-4d49-47d3-a19c-e4e697bcdccd"
      unitRef="shares">108119461</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtMy0xLTEtMA_e64fc3c8-39f3-4eb3-a698-006835fccebd"
      unitRef="shares">108119461</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtNS0xLTEtMA_2feaace4-e7f0-4d44-9c05-edc84b830e0a"
      unitRef="shares">109841428</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtNS0xLTEtMA_67d93b88-69c1-46ae-909b-55f8467630f5"
      unitRef="shares">109841428</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtNS0xLTEtMA_6cb305a7-3ddc-4fa4-b92f-3ef94b359694"
      unitRef="shares">109841428</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtNy0xLTEtMA_4b150d1b-43d9-4e6e-be3b-614efc84e099"
      unitRef="shares">108081625</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtNy0xLTEtMA_a8e4888c-ef3c-4225-a2e2-e3232b652f41"
      unitRef="shares">108081625</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjgtNy0xLTEtMA_eeed6b3f-e9d5-45a1-905b-41dc7ab36bde"
      unitRef="shares">108081625</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktMS0xLTEtMA_f5bddecb-6180-49ff-933c-8243b2dc142e"
      unitRef="shares">110276636</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktMS0xLTEtMA_f5d937dc-14be-442a-b8e5-3e6a6198a841"
      unitRef="shares">110276636</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktMS0xLTEtMA_fbd3bfce-59f9-48dc-a53c-9125d0d868dc"
      unitRef="shares">110276636</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktMy0xLTEtMA_92be8069-f672-4e66-9d39-ad763174062f"
      unitRef="shares">108119461</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktMy0xLTEtMA_bdf4c466-4d49-47d3-a19c-e4e697bcdccd"
      unitRef="shares">108119461</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktMy0xLTEtMA_e64fc3c8-39f3-4eb3-a698-006835fccebd"
      unitRef="shares">108119461</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktNS0xLTEtMA_2feaace4-e7f0-4d44-9c05-edc84b830e0a"
      unitRef="shares">109841428</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktNS0xLTEtMA_67d93b88-69c1-46ae-909b-55f8467630f5"
      unitRef="shares">109841428</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktNS0xLTEtMA_6cb305a7-3ddc-4fa4-b92f-3ef94b359694"
      unitRef="shares">109841428</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktNy0xLTEtMA_4b150d1b-43d9-4e6e-be3b-614efc84e099"
      unitRef="shares">108081625</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktNy0xLTEtMA_a8e4888c-ef3c-4225-a2e2-e3232b652f41"
      unitRef="shares">108081625</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yMi9mcmFnOmUwYWQzMTI0YjNmNDRkZGU4YTY0YTMwYzliZTYyZmIzL3RhYmxlOjIzYjZkNGRjNWY3YjRjNjc4ZWU0YjY4NDlmYzEyMDc4L3RhYmxlcmFuZ2U6MjNiNmQ0ZGM1ZjdiNGM2NzhlZTRiNjg0OWZjMTIwNzhfMjktNy0xLTEtMA_eeed6b3f-e9d5-45a1-905b-41dc7ab36bde"
      unitRef="shares">108081625</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i863500d35994474dbb64036911295267_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMi0xLTEtMS0w_553e8600-b627-437f-8864-d253b5633bf2"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i863500d35994474dbb64036911295267_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMi0yLTEtMS0w_02f860d4-0698-45a7-b62d-61247334e4cf"
      unitRef="usd">113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i94e12588009a4ccfb7ad506dde230474_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMi0zLTEtMS0w_267fa732-0dc2-41a1-b45d-7521fb23498e"
      unitRef="usd">156733000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="idaaed7e418d64295a2fdef9e72420feb_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMi00LTEtMS0w_6ac7f16c-5ec7-4eb9-83c0-aedff83ce4bb"
      unitRef="shares">1083297</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="idaaed7e418d64295a2fdef9e72420feb_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMi01LTEtMS0w_36a2c977-4b92-4d2f-9779-a8e36994022b"
      unitRef="usd">-5091000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4d42da3fca664e9196260b0048b8c7a3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMi02LTEtMS0w_1132a0fa-d45c-446b-b097-5df70f3dff8d"
      unitRef="usd">-159806000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i248ea4052a6f4c4a9e79289b81e5d3c5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMi03LTEtMS0w_488794fc-57ec-4cdd-b025-a7b105842254"
      unitRef="usd">-8051000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ibb5f8c6fa26a4473999a549b0860daa7_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMy0zLTEtMS02Mjg5_56fc6203-32c6-4ce4-87d0-2e2e1c8bc326"
      unitRef="usd">-928000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <mdxg:TreasuryStockSharesAdjustment
      contextRef="i57d5766bcb174f22a384db94fb1662dc_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMy00LTEtMS02Mjg5_a87e072d-3d91-41be-91d2-15a327630a0e"
      unitRef="shares">-239502</mdxg:TreasuryStockSharesAdjustment>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i57d5766bcb174f22a384db94fb1662dc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMy01LTEtMS02Mjg5_790106a4-943d-4378-9fa9-c375fe545f6b"
      unitRef="usd">928000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i0f6cf3288aaf451eb539d95c21c0d3f7_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMy03LTEtMS02NDAx_aaace679-dece-4444-8e4a-a4ff85911be6"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i625a8149caf145fb9f6ec49640947103_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMy0zLTEtMS0w_893b4a4a-a7a9-4a52-abce-ff637240c4c5"
      unitRef="usd">464000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMy03LTEtMS0w_c69f6257-aa92-4a12-b03d-d00f6833e585"
      unitRef="usd">464000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i625a8149caf145fb9f6ec49640947103_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfNC0zLTEtMS0w_882a6608-288a-4345-add5-c93702214bf5"
      unitRef="usd">4060000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfNC03LTEtMS0w_f7f7b2c7-3431-49eb-8bab-bfdb05c34a20"
      unitRef="usd">4060000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i625a8149caf145fb9f6ec49640947103_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfNi0zLTEtMS0w_9dddec9b-5ef9-4a2b-978e-02912c7a808a"
      unitRef="usd">-668000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfNi00LTEtMS0w_fd44f37e-ebfa-4cb0-9643-f2e44837f57f"
      unitRef="shares">141516</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfNi01LTEtMS0w_7f2522c8-0f35-4aa3-85e0-0ac240250b63"
      unitRef="usd">1112000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfNi03LTEtMS0w_abd2a9ec-37b3-43f6-88b5-6bfd87773224"
      unitRef="usd">444000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i625a8149caf145fb9f6ec49640947103_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfOC0zLTEtMS0w_0261712d-1e20-4a1f-9a40-5ee4d93b8a97"
      unitRef="usd">-116000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfOC00LTEtMS0w_8d4b38b1-7bf8-4d01-a025-0d58d399e88b"
      unitRef="shares">19774</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfOC01LTEtMS0w_dfb38339-5bf0-4396-8e11-185da38dbd99"
      unitRef="usd">116000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfOC03LTEtMS0w_993a8918-337c-4692-b907-24aa1fa05536"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i625a8149caf145fb9f6ec49640947103_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfOS0zLTEtMS0w_b371b183-01dc-4046-98b4-fc771b1fe2d0"
      unitRef="usd">-103000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfOS00LTEtMS0w_c7ec9cbf-d158-4fee-83a3-3ac18b13caec"
      unitRef="shares">12437</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfOS01LTEtMS0w_fa6a73fd-b11c-4f53-9863-44d5e960ed3d"
      unitRef="usd">103000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfOS03LTEtMS0w_21f86661-9b0b-4ea1-aee4-3dba9eccf0cc"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTItNC0xLTEtMA_60df0f5e-2360-4657-a059-352722a64bdd"
      unitRef="shares">127046</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ie1ce84f8461b46e6abbdaec16acb85fa_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTItNS0xLTEtMA_742bc20f-b879-4ed9-a55a-9b6596a263f3"
      unitRef="usd">1347000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTItNy0xLTEtMA_5024012e-460c-4ee8-8622-7fefc79e83c4"
      unitRef="usd">1347000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="i7ded271c9e984021b5cc96dfb866079c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTMtNi0xLTEtMA_cc76c49a-e832-488c-b96b-6833657c2be8"
      unitRef="usd">-1779000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTMtNy0xLTEtMA_0cdc7e6c-f75f-437d-988b-cd1321e5fe69"
      unitRef="usd">-1779000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="i40f91b34ec1c4894992f703f06575098_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTQtMS0xLTEtMA_c0b88894-fc18-40b3-8b4d-945af5617e5d"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i40f91b34ec1c4894992f703f06575098_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTQtMi0xLTEtMA_2e8e5f25-a908-4863-96cb-9cd989fccf24"
      unitRef="usd">113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id9609d1f974a4ffab0a6a9d68d904674_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTQtMy0xLTEtMA_e49b24b3-5b76-4dcc-9541-fb94fe24ce61"
      unitRef="usd">158720000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia753205aa5374672ad737a15eeaecfcb_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTQtNC0xLTEtMA_10e9b95c-6b44-4bad-8d1f-807e2a8b2ef9"
      unitRef="shares">821988</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ia753205aa5374672ad737a15eeaecfcb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTQtNS0xLTEtMA_7ce6edc7-650e-4ab7-bb64-bfae0d942edd"
      unitRef="usd">-4385000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3712fe3086a74c9281904d0dc624c0c7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTQtNi0xLTEtMA_58cb4c6c-c720-4e47-832f-4cc732c99c09"
      unitRef="usd">-161585000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg4M2JjYjZlZDk4ZjQ4ODg4ZmRiMGVmZWIzNWI3ZjQ2L3RhYmxlcmFuZ2U6ODgzYmNiNmVkOThmNDg4ODhmZGIwZWZlYjM1YjdmNDZfMTQtNy0xLTEtMA_41d7747b-dd88-4415-800d-2405d1740121"
      unitRef="usd">-7137000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib6653e360f5f4cbd89a180be4fef12f6_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMi0xLTEtMS0w_3fba35b2-d7bc-4b23-a58f-b5bf8fb5c0d6"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ib6653e360f5f4cbd89a180be4fef12f6_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMi0yLTEtMS0w_e7a8c758-b12a-4058-9e65-40394dbce5f8"
      unitRef="usd">113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib89406b6d1ed4e27bb530f0566c3e7f4_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMi0zLTEtMS0w_3d530dce-c870-43eb-a297-d6221d760195"
      unitRef="usd">149765000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="if3d2f62cbcc2471997607a0f531eddcf_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMi00LTEtMS0w_ea48ae55-2abe-4fde-8dce-75b0f2794698"
      unitRef="shares">2163066</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="if3d2f62cbcc2471997607a0f531eddcf_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMi01LTEtMS0w_58952fd7-72c0-441c-8c21-f11572413436"
      unitRef="usd">-12578000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib3340cbdc0854f9c82647d193a0bb6c7_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMi02LTEtMS0w_a481e439-9a37-4f05-a7ad-1996dc6c68e4"
      unitRef="usd">-106961000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic5176913ab4841a18870be0accaff0da_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMi03LTEtMS0w_26196305-eb9b-48e6-9c9b-91e6b2d8817d"
      unitRef="usd">30339000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8489118c314c410d9e4ecd5e688a6296_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMy0zLTEtMS0w_abcccfd3-204e-4c87-a3b0-32a7b39be9d4"
      unitRef="usd">1866000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMy03LTEtMS0w_988a1fde-2402-443d-968c-771e99d2d5c6"
      unitRef="usd">1866000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8489118c314c410d9e4ecd5e688a6296_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfNC0zLTEtMS0w_c0686b15-203d-4190-accf-c26d48c67e7e"
      unitRef="usd">-444000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i7c6adf93efd64417b653d94ea5764037_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfNC00LTEtMS0w_f03f0ee7-33da-44a6-8dc3-d7ef235a6c9c"
      unitRef="shares">50000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7c6adf93efd64417b653d94ea5764037_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfNC01LTEtMS0w_2602886d-f158-4d8d-aad1-7f5567b62738"
      unitRef="usd">444000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfNC03LTEtMS0w_affcb8fe-d91e-4c51-b528-a45107255497"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i8489118c314c410d9e4ecd5e688a6296_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfNi0zLTEtMS0w_efd52344-a124-4cd5-83c8-967d3cd4e9c7"
      unitRef="usd">-378000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="i7c6adf93efd64417b653d94ea5764037_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfNi00LTEtMS0w_1c7bb4af-b2f8-4a09-8473-ad3aba6c84f7"
      unitRef="shares">42613</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i7c6adf93efd64417b653d94ea5764037_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfNi01LTEtMS0w_a3896925-0dc2-4898-82d9-5240f3f3c1af"
      unitRef="usd">378000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfNi03LTEtMS0w_700354f0-9961-4fdb-9175-30b064beb16d"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8489118c314c410d9e4ecd5e688a6296_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfOS0zLTEtMS0w_a3537083-c0db-44d1-971a-5d2913fcafd9"
      unitRef="usd">-60000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i7c6adf93efd64417b653d94ea5764037_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfOS00LTEtMS0w_fd809c7f-e4c6-40f6-bb73-afa1e88f29a3"
      unitRef="shares">256843</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i7c6adf93efd64417b653d94ea5764037_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfOS01LTEtMS0w_b29f2eab-c3f6-4d34-ba9b-af5d02108699"
      unitRef="usd">939000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfOS03LTEtMS0w_c8046ee9-024f-4647-8fa0-829729bd9d6a"
      unitRef="usd">879000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="iecbaa13b22fc4a349dac5a5be52a1ece_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTAtNi0xLTEtMA_0a0dac74-a256-4575-ad76-f89ed1493d32"
      unitRef="usd">-8466000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTAtNy0xLTEtMA_cbd11c98-ef63-43b4-85a2-5c80928ad580"
      unitRef="usd">-8466000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib743ddf65e0546dc8061175cd5b6f187_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTEtMS0xLTEtMA_5c1706fc-93b3-4e9d-9d89-0a94e6c00e71"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ib743ddf65e0546dc8061175cd5b6f187_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTEtMi0xLTEtMA_660ca123-080b-4180-9934-80823c2467a7"
      unitRef="usd">113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0bfff166fb7a47dbade947a596cfe795_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTEtMy0xLTEtMA_1755f305-2891-4d6d-a1cd-ba2f0f461b69"
      unitRef="usd">151625000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="ifa78efde51724943b11905098dacfc15_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTEtNC0xLTEtMA_23652316-d4b3-4faf-a404-4ec4b8b5fd6c"
      unitRef="shares">2412522</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ifa78efde51724943b11905098dacfc15_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTEtNS0xLTEtMA_c0e925d1-ca53-47d5-810a-d053d3dab502"
      unitRef="usd">-13451000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9986cdbe1a3a4875971e5c4896a4f876_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTEtNi0xLTEtMA_4a690d68-4abc-47c5-921f-d04e32605223"
      unitRef="usd">-115427000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2d1e691baee849e4b5421dd9318cfdaa_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjg1NmM0YThjODVkZjQ2ZjRiZmMwZmZmOWQ4NGZkMTQ1L3RhYmxlcmFuZ2U6ODU2YzRhOGM4NWRmNDZmNGJmYzBmZmY5ZDg0ZmQxNDVfMTEtNy0xLTEtMA_7b2bad9b-38cc-4fba-9366-230ccf15a6e2"
      unitRef="usd">22860000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9dbf6fb74aec470fbddc41840209cdca_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMi0xLTEtMS0yMDM0_05af9e44-7bb7-4daf-b269-282ea72815c5"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i9dbf6fb74aec470fbddc41840209cdca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMi0yLTEtMS0yMDM0_7a891ea2-5564-45c7-ac50-646366ef991b"
      unitRef="usd">113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6959021b92d74cf7bd68800c7edb8e59_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMi0zLTEtMS0yMDM0_1d2328c5-69bf-4ed2-a601-4bbf16e3f16d"
      unitRef="usd">158610000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9814d3643edd40fe8a5543aa058929ab_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMi00LTEtMS0yMDM0_cadc4146-54b0-428a-8410-a98eaeaebdc4"
      unitRef="shares">1773683</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i9814d3643edd40fe8a5543aa058929ab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMi01LTEtMS0yMDM0_e2c75666-4d54-40ea-96b2-5268b8c21cbf"
      unitRef="usd">-7449000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8ea175868cc44c02963e1fa0d02e98cc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMi02LTEtMS0yMDM0_b729d053-0903-4c05-a3f5-4c69b2104e37"
      unitRef="usd">-151424000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMi03LTEtMS0yMDM0_2e2cfff8-f850-42a1-ad93-4c900acf6626"
      unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ieac267072afd40b5973cebef23f08bc7_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMy0zLTEtMS02MzAy_15964957-a801-4217-95db-7a212be7e314"
      unitRef="usd">-2009000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <mdxg:TreasuryStockSharesAdjustment
      contextRef="i4c45415d8d674cdcb88b2754e8ca0f7a_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMy00LTEtMS02MzAy_d604c8b2-39b8-46f0-9465-3c644b02c0e3"
      unitRef="shares">-239502</mdxg:TreasuryStockSharesAdjustment>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i4c45415d8d674cdcb88b2754e8ca0f7a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMy01LTEtMS02MzAy_953a6564-4c9e-4baf-8acd-2d6ef622fc7f"
      unitRef="usd">2009000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ie2c14fb9c8534a52af40933de71d470e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMy03LTEtMS02MzAy_70c91d0a-3281-4c9d-821d-ea759716abd3"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i61f3769f86034f0caba9e0a5c93826f0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMy0zLTEtMS0yMDM5_a6a32fb7-7eb0-4bd0-8dce-00b5de0071cd"
      unitRef="usd">926000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMy03LTEtMS0yMDM5_544d5719-b348-4ed6-aa31-b328f11f8627"
      unitRef="usd">926000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i61f3769f86034f0caba9e0a5c93826f0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNC0zLTEtMS0yMDQ5_a2d726e6-3474-4352-8ded-b25707f56b4b"
      unitRef="usd">7304000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNC03LTEtMS0yMDQ5_ff28bea5-7582-4c48-b488-68cf9d769d07"
      unitRef="usd">7304000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i61f3769f86034f0caba9e0a5c93826f0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNS0zLTEtMS0yMDQ5_c0067907-a79a-4277-8112-947a8a20f503"
      unitRef="usd">-934000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i65c1178147214476b81d7b7b0c807490_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNS00LTEtMS0yMDQ5_73470896-4a2c-44b5-9bad-db8db9eca7da"
      unitRef="shares">452329</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i65c1178147214476b81d7b7b0c807490_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNS01LTEtMS0yMDQ5_127ac5dc-eee6-4808-b2c3-89ceb7c2313f"
      unitRef="usd">2293000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNS03LTEtMS0yMDQ5_e9b78d2a-5417-4d23-a099-a6b96d92653a"
      unitRef="usd">1359000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i61f3769f86034f0caba9e0a5c93826f0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNi0zLTEtMS0yMDQ5_3d3767f2-1d82-4489-8ec4-f6ac5ddd9ac3"
      unitRef="usd">-3576000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i65c1178147214476b81d7b7b0c807490_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNi00LTEtMS0yMDQ5_7d57f362-b30a-45e6-9c32-16adb9da7e80"
      unitRef="shares">761775</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i65c1178147214476b81d7b7b0c807490_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNi01LTEtMS0yMDQ5_13063502-7c73-4fd3-835e-e79733a50a91"
      unitRef="usd">3576000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNi03LTEtMS0yMDQ5_676a3529-54b9-44b3-bca7-3eb18d13bfcf"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i61f3769f86034f0caba9e0a5c93826f0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNy0zLTEtMS0yMDQ5_89ea58f1-efe0-4a35-95a0-489efd8dfe93"
      unitRef="usd">-251000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="i65c1178147214476b81d7b7b0c807490_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNy00LTEtMS0yMDQ5_d58d0911-4d36-4e4e-a0bb-875d616e5189"
      unitRef="shares">48026</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i65c1178147214476b81d7b7b0c807490_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNy01LTEtMS0yMDQ5_96cf3100-e14a-40db-9265-061acccb50ce"
      unitRef="usd">251000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfNy03LTEtMS0yMDQ5_b8295d50-2a00-4036-ba5d-42e9f3425575"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i65c1178147214476b81d7b7b0c807490_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfOS00LTEtMS0yMDUy_7f112f71-a609-411a-b573-4ccd3a5b1141"
      unitRef="shares">453885</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i65c1178147214476b81d7b7b0c807490_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfOS01LTEtMS0yMDUy_17342e81-9ed3-42ee-885b-d56fb9df0e09"
      unitRef="usd">4563000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfOS03LTEtMS0yMDUy_45b93081-6829-4fae-bc5b-609c4186a93b"
      unitRef="usd">4563000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="i6b69bb9ce62747dba42e6f35f7d6bea8_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtNi0xLTEtMjA1Mg_c9e069d2-26e8-4eaf-99ee-b89d5a6a31b7"
      unitRef="usd">-10161000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtNy0xLTEtMjA1Mg_8320e32b-27c6-40c7-9fef-fb1f05b96e54"
      unitRef="usd">-10161000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="i40f91b34ec1c4894992f703f06575098_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtMS0xLTEtMjgxMA_fff573a0-13d8-47b0-91fc-fbcc31909e58"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i40f91b34ec1c4894992f703f06575098_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtMi0xLTEtMjgxMA_b93cd66f-2b7a-4ca2-9fcc-907ac7f36e3d"
      unitRef="usd">113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id9609d1f974a4ffab0a6a9d68d904674_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtMy0xLTEtMjgxMA_6faa7a94-e6d3-45a6-8d3e-45d982b16567"
      unitRef="usd">158720000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia753205aa5374672ad737a15eeaecfcb_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtNC0xLTEtMjgxMA_a7d8db6a-15f5-4956-bf23-8d5e38ac1448"
      unitRef="shares">821988</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ia753205aa5374672ad737a15eeaecfcb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtNS0xLTEtMjgxMA_302dc773-6bef-4183-9be8-df9b04802e4c"
      unitRef="usd">-4385000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3712fe3086a74c9281904d0dc624c0c7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtNi0xLTEtMjgxMA_21b76f74-772a-4b20-a6dc-78df77f753f2"
      unitRef="usd">-161585000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjQxZWY1NjE2NWVjNTQ0M2E5NTY1ZmQ0ZmQ5OTI4YWMyL3RhYmxlcmFuZ2U6NDFlZjU2MTY1ZWM1NDQzYTk1NjVmZDRmZDk5MjhhYzJfMTAtNy0xLTEtMjgxMA_ba524851-7b17-429e-8f34-91b59cbf88fd"
      unitRef="usd">-7137000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i893ba49ad5c3430a8b5ce9861abc1c91_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMi0xLTEtMS0yMDgw_9dcd576c-2c94-4e0e-b8e0-1a98cec17ab9"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i893ba49ad5c3430a8b5ce9861abc1c91_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMi0yLTEtMS0yMDgw_eadf0637-1e7a-4679-88bc-d19539c197bf"
      unitRef="usd">113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7835fe481e7a474d88cb9bc9fc4b4e9d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMi0zLTEtMS0yMDgw_f94d4600-0edf-4d44-a7b8-792473500c47"
      unitRef="usd">147231000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1f7fefe2fb0e4c148fd6ecd8635f790a_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMi00LTEtMS0yMDgw_ebf65904-f7a7-47af-9507-3553a737be02"
      unitRef="shares">1885277</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i1f7fefe2fb0e4c148fd6ecd8635f790a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMi01LTEtMS0yMDgw_d4848430-fbd6-49c3-8422-9d5b803cf90b"
      unitRef="usd">-10806000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2560068f9115460db66d530c87ec76d1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMi02LTEtMS0yMDgw_aba098b9-c92d-483b-b068-6ee55372d707"
      unitRef="usd">-102140000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3e24f6442afe457aa2166e8538c1e212_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMi03LTEtMS0yMDgw_268b3f42-90ad-4a71-8e4d-b15950a79a0a"
      unitRef="usd">34398000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0a967865ec2b404e982f0925ee8083a6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNC0zLTEtMS0yMDg2_35d82759-1b5e-4bc1-8a49-6b293743b670"
      unitRef="usd">3781000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNC03LTEtMS0yMDg2_0e9f13ca-809c-4e4c-a259-d8c249f9c210"
      unitRef="usd">3781000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0a967865ec2b404e982f0925ee8083a6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNS0zLTEtMS0yMDg2_c56fac85-9021-4518-8c68-b2336b7d8cc6"
      unitRef="usd">-1658000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNS00LTEtMS0yMDg2_7bab8f98-4fda-485a-baca-764bedb76e4d"
      unitRef="shares">220300</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNS01LTEtMS0yMDg2_8c13597e-678b-416f-abaa-3bee18496bf2"
      unitRef="usd">1956000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNS03LTEtMS0yMDg2_7569c969-07bf-4cd6-919c-3cec43c720d8"
      unitRef="usd">298000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i0a967865ec2b404e982f0925ee8083a6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNi0zLTEtMS0yMDg2_b69a46ab-3de6-42e8-b216-addb5be3308a"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNi00LTEtMS0yMDg2_a4729e4d-1d44-4af2-aa81-c2871ca35c9c"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNi01LTEtMS0yMDg2_4e8caab9-16f7-47d0-9a2e-8b571b0a63df"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNi03LTEtMS0yMDg2_b514bb78-87e1-43e2-bc15-dcbfa0ac8a50"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i0a967865ec2b404e982f0925ee8083a6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNy0zLTEtMS0yMDg2_ba7be457-dbfe-462f-81af-67a69396a223"
      unitRef="usd">-2124000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNy00LTEtMS0yMDg2_9282c55f-eb9e-4cd4-b948-b1fe5fcdfc5e"
      unitRef="shares">285611</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNy01LTEtMS0yMDg2_c4c42e05-2af3-499b-943e-c365db00883a"
      unitRef="usd">2124000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfNy03LTEtMS0yMDg2_22ded607-f07d-4e60-aec9-a97651f23aff"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i0a967865ec2b404e982f0925ee8083a6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfOC0zLTEtMS0yMDg5_7ffa4b65-57e5-4e8e-be19-498d9c11c8bd"
      unitRef="usd">-147000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfOC00LTEtMS0yMDg5_7bc460aa-4b21-4a95-9596-900c632b35af"
      unitRef="shares">461934</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i7a6b5641a1ef4d7a8433bf23dca161a9_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfOC01LTEtMS0yMDg5_92a89ccd-e20c-4bb2-b235-3b9c4d809495"
      unitRef="usd">2477000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfOC03LTEtMS0yMDg5_104fb29a-79e2-4dfd-8ba2-2ac50e3aa907"
      unitRef="usd">2330000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="i67915ef0633745a1bee624f657dfd70d_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfOS02LTEtMS0yMDg5_957b0a80-9943-4320-b56e-76074d74bd4a"
      unitRef="usd">-13287000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfOS03LTEtMS0yMDg5_da793cb1-f872-4c4e-850d-833202c6d4ed"
      unitRef="usd">-13287000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib743ddf65e0546dc8061175cd5b6f187_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMTAtMS0xLTEtMjgwNA_c3144939-012c-4af2-8d65-8cca31aed4a5"
      unitRef="shares">112703926</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ib743ddf65e0546dc8061175cd5b6f187_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMTAtMi0xLTEtMjgwNA_7f9c3b24-4621-4fc0-9e64-a008a5e3f3f1"
      unitRef="usd">113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0bfff166fb7a47dbade947a596cfe795_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMTAtMy0xLTEtMjgwNA_aa9e5f7c-dc7f-4ec9-a01d-d15e5c8981b2"
      unitRef="usd">151625000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="ifa78efde51724943b11905098dacfc15_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMTAtNC0xLTEtMjgwNA_adf2dc08-5e80-43a4-9449-194a58ff0a08"
      unitRef="shares">2412522</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ifa78efde51724943b11905098dacfc15_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMTAtNS0xLTEtMjgwNA_15073882-7d15-45c1-89df-a7db62b91008"
      unitRef="usd">-13451000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9986cdbe1a3a4875971e5c4896a4f876_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMTAtNi0xLTEtMjgwNA_d6eebadd-906f-4610-8727-a5d3e18d4191"
      unitRef="usd">-115427000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2d1e691baee849e4b5421dd9318cfdaa_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yNS9mcmFnOjhkYmUyMWU2M2RjYzQ0NTg4ODFkMjUyZDk4NmI4MjM0L3RhYmxlOjViMzg5ZDFlYTgxMjRiMGZhYzJiYWE1NGE1NjBhNGZhL3RhYmxlcmFuZ2U6NWIzODlkMWVhODEyNGIwZmFjMmJhYTU0YTU2MGE0ZmFfMTAtNy0xLTEtMjgwNA_4a1b019d-8a2a-4f72-8559-9c53b91db072"
      unitRef="usd">22860000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMy0xLTEtMS0w_920bf0f0-9ec4-4ca7-80a3-d3402eec878b"
      unitRef="usd">-10161000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMy0zLTEtMS0w_c47a817c-ed97-4271-a7f7-1ce1c1572c87"
      unitRef="usd">-13287000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNS0xLTEtMS0w_eb6bac43-d113-4110-98d4-f7eb02d8450b"
      unitRef="usd">7304000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNS0zLTEtMS0w_6575dcfe-9da1-4cc2-ae6c-8b9174936dc9"
      unitRef="usd">7783000</us-gaap:ShareBasedCompensation>
    <us-gaap:Depreciation
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNy0xLTEtMS0w_bf4babf2-b66e-4af8-9170-a285c445e955"
      unitRef="usd">2467000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNy0zLTEtMS0w_1043a2cc-7b81-4197-8c5f-e62168460919"
      unitRef="usd">2928000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfOC0xLTEtMS0w_73134702-df5e-471d-a1cf-4a09fb0a77bd"
      unitRef="usd">454000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfOC0zLTEtMS0w_2e596522-6b7e-40eb-94bf-18bad846dd22"
      unitRef="usd">542000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTAtMS0xLTEtMA_b76bf98c-d0a4-4a6f-871a-c7c0c2aae468"
      unitRef="usd">833000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTAtMy0xLTEtMA_02ecd1bd-f611-46a2-9227-6d6956e22d33"
      unitRef="usd">1441000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <mdxg:OperatingLeaseRightofuseAssetAmortization
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTItMS0xLTEtMA_f25fd5f8-f05a-4035-a4db-1e7568fc565f"
      unitRef="usd">480000</mdxg:OperatingLeaseRightofuseAssetAmortization>
    <mdxg:OperatingLeaseRightofuseAssetAmortization
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTItMy0xLTEtMA_42368239-14ab-4fa2-b294-951dd220d17a"
      unitRef="usd">486000</mdxg:OperatingLeaseRightofuseAssetAmortization>
    <us-gaap:AssetRetirementObligationAccretionExpense
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTMtMS0xLTEtMA_31871d1f-8e70-41bc-9986-b8f509f5e97d"
      unitRef="usd">37000</us-gaap:AssetRetirementObligationAccretionExpense>
    <us-gaap:AssetRetirementObligationAccretionExpense
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTMtMy0xLTEtMA_c592d5cd-1853-4547-a817-bc546b6e6d84"
      unitRef="usd">0</us-gaap:AssetRetirementObligationAccretionExpense>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTUtMS0xLTEtMA_f0e62e34-dda3-4068-bfef-d1e29d537641"
      unitRef="usd">-236000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTUtMy0xLTEtMA_1203e983-fd7b-436e-8729-53dcc2d20707"
      unitRef="usd">-1000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTktMS0xLTEtMA_3fef4857-7a80-451b-8a45-bcc07e0de2d4"
      unitRef="usd">1820000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMTktMy0xLTEtMA_7ff17a04-8700-46b5-b891-8f4be1546d05"
      unitRef="usd">-2230000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjAtMS0xLTEtMA_c2ae6818-7ed8-4f73-9e2f-142e1a239681"
      unitRef="usd">-224000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjAtMy0xLTEtMA_9fb4083d-04c3-4fe3-92bb-f54692dfdbf6"
      unitRef="usd">1460000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjEtMS0xLTEtMA_5c8a0544-2a73-4024-86b6-e063968bfa38"
      unitRef="usd">-2254000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjEtMy0xLTEtMA_a0fb745a-60af-440f-85a9-18ce46cc746d"
      unitRef="usd">-3819000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjItMS0xLTEtMA_c3e1383a-ec6a-4bc4-bc42-029b5a416812"
      unitRef="usd">93000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjItMy0xLTEtMA_619cbf49-5fda-4106-a044-97334b17bf22"
      unitRef="usd">10682000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjMtMS0xLTEtMA_76de417e-0fe6-4b74-846b-946fbf22758d"
      unitRef="usd">-1387000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjMtMy0xLTEtMA_df781ada-fa0c-4573-922b-217541e552c9"
      unitRef="usd">-821000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjQtMS0xLTEtMA_ac9fb6ea-700c-4890-b802-fb964fadd1e7"
      unitRef="usd">2794000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjQtMy0xLTEtMA_9a4ecf13-bb5d-423c-9951-132840896ab8"
      unitRef="usd">3236000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjUtMS0xLTEtMA_cf6a22c6-992f-45c0-86da-22415e8f14d1"
      unitRef="usd">2790000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjUtMy0xLTEtMA_c937c565-2fa5-4544-8eab-c263eb850afe"
      unitRef="usd">-518000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjYtMS0xLTEtMA_a9debd03-b3f7-40d3-94fd-ba4dbab3b8c5"
      unitRef="usd">-13752000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjYtMy0xLTEtMA_e782c0c4-e005-42d7-bdce-fa44c4b9de69"
      unitRef="usd">-12109000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjctMS0xLTEtMA_5f8576a8-6073-4990-b242-bcf84e42c942"
      unitRef="usd">-514000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjctMy0xLTEtMA_7dd01708-4e6e-4a8a-b2dd-81f49fcc29ac"
      unitRef="usd">-609000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjgtMS0xLTEtMA_f3b75286-ab19-458f-9150-ff32d51e3cd9"
      unitRef="usd">-5080000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMjgtMy0xLTEtMA_75e45d9a-c271-4af4-a7d9-754cb0ddb904"
      unitRef="usd">-15378000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMachineryAndEquipment
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzEtMS0xLTEtMA_376147f9-b6ee-455e-a078-4253d49f1d4a"
      unitRef="usd">2346000</us-gaap:PaymentsToAcquireMachineryAndEquipment>
    <us-gaap:PaymentsToAcquireMachineryAndEquipment
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzEtMy0xLTEtMA_33da77e3-78a7-4cc3-badf-0d5abb1ba333"
      unitRef="usd">1421000</us-gaap:PaymentsToAcquireMachineryAndEquipment>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzItMS0xLTEtMA_8cf08a43-25e8-4f51-bf29-cdfd04af6e93"
      unitRef="usd">45000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzItMy0xLTEtMA_5ac80fe1-5c8d-4ae0-bc9f-d368c5033ce9"
      unitRef="usd">0</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <mdxg:PaymentsforApplicationCostsPatent
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzQtMS0xLTEtMA_12e6aec2-e784-41b8-b14e-8a2b7ca2b8eb"
      unitRef="usd">200000</mdxg:PaymentsforApplicationCostsPatent>
    <mdxg:PaymentsforApplicationCostsPatent
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzQtMy0xLTEtMA_1e98bdf1-0e8d-4c76-ae5a-d6e0a60bfdba"
      unitRef="usd">151000</mdxg:PaymentsforApplicationCostsPatent>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzUtMS0xLTEtMA_b0c3094a-5040-4ede-9efc-fe4399818c82"
      unitRef="usd">-2501000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzUtMy0xLTEtMA_846de24f-f161-499a-b6eb-01887e69dad3"
      unitRef="usd">-1572000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzgtMS0xLTEtMA_8d9bd251-e830-45f4-9215-31450b508524"
      unitRef="usd">1359000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzgtMy0xLTEtMA_5425171c-6ea2-4371-93bf-61cca6694ddf"
      unitRef="usd">298000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzktMS0xLTEtMA_5297812f-f34f-47cc-8394-e2f59b13aefd"
      unitRef="usd">4563000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfMzktMy0xLTEtMA_50f3ebb2-db20-4abf-b150-333e01ea8cff"
      unitRef="usd">2330000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDAtMS0xLTEtMA_5b461fd4-38a0-4ce4-b894-38bf27efa7ed"
      unitRef="usd">20000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDAtMy0xLTEtMA_a8ca337a-dc18-48cd-b1c2-d7c8203435a0"
      unitRef="usd">0</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDEtMS0xLTEtMA_5ee5ac7a-44f0-40a7-82ab-ffdec667734f"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDEtMy0xLTEtMA_99375558-0669-413c-b1fb-e8a280a0f1f6"
      unitRef="usd">23000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:RepaymentsOfMediumTermNotes
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDItMS0xLTEtMA_2c2f291e-fff1-432c-a443-ee40d67b3fca"
      unitRef="usd">0</us-gaap:RepaymentsOfMediumTermNotes>
    <us-gaap:RepaymentsOfMediumTermNotes
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDItMy0xLTEtMA_8ed00fca-3843-44f5-9cb1-11547f439b9b"
      unitRef="usd">11875000</us-gaap:RepaymentsOfMediumTermNotes>
    <us-gaap:ProceedsFromIssuanceOfMediumTermNotes
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDMtMS0xLTEtMjM3MQ_68b51bfd-1c39-496b-a303-b75417400a51"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfMediumTermNotes>
    <us-gaap:ProceedsFromIssuanceOfMediumTermNotes
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDMtMy0xLTEtMjM3NQ_6dd6a27f-04be-467d-aea0-7c23f65c989b"
      unitRef="usd">10000000</us-gaap:ProceedsFromIssuanceOfMediumTermNotes>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDMtMS0xLTEtMA_ca1aac8c-e685-4408-8695-d861ec6a9211"
      unitRef="usd">-3224000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDMtMy0xLTEtMA_ad943fb3-fa0e-4d9a-b395-9f3714b04bd7"
      unitRef="usd">-3930000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDUtMS0xLTEtMA_cf930e92-fb93-4e3f-9243-eff93a1eacc2"
      unitRef="usd">-10805000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDUtMy0xLTEtMA_da6191dc-3004-41db-8bba-9abc8c1cf89a"
      unitRef="usd">-20880000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDctMS0xLTEtMA_73e85413-6b20-4275-a176-f193d6495da4"
      unitRef="usd">95812000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3e24f6442afe457aa2166e8538c1e212_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDctMy0xLTEtMA_3a581076-5fd8-4a07-b86e-eafe87346b5d"
      unitRef="usd">69069000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDgtMS0xLTEtMA_0ae4f6ae-e1a9-4801-ad7b-ba0608c83a9a"
      unitRef="usd">85007000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2d1e691baee849e4b5421dd9318cfdaa_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8yOC9mcmFnOjIyNjE1NDUxYjg1NzRmYjY5MGE3OWU2ZjE5Nzg2MzM3L3RhYmxlOjZkYmEwMWE1Nzc3YTQzOGNiYzQ3M2ZmYjI2NjFhNzhkL3RhYmxlcmFuZ2U6NmRiYTAxYTU3NzdhNDM4Y2JjNDczZmZiMjY2MWE3OGRfNDgtMy0xLTEtMA_cf96e7d7-09a6-4158-a90c-1a5f7431780d"
      unitRef="usd">48189000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMzg2Mw_c7c90929-594e-4e02-9208-197931046777">Nature of Business&lt;div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;MiMedx Group, Inc. (together with its subsidiaries, except where the context otherwise requires, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;MiMedx&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#x201d; or the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, MiMedx has both a base business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-state pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. The Company derives its products from human placental tissues and processes these tissues using its proprietary methods, including the PURION&#xae; process. MiMedx employs Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce its allografts. MiMedx provides products primarily in the wound care, burn, and surgical sectors of healthcare. All of its products are regulated by the United State Food and Drug Administration (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;FDA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s business model is focused primarily on the United States of America but the Company is pursuing opportunities for international expansion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Enforcement Discretion&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2017, the FDA published a series of guidances that established an updated framework for the regulation of cellular and tissue-based products. These guidances clarified the FDA&#x2019;s views about the criteria that differentiate those products subject to regulation under Section 361 of the Public Health Service Act from those considered to be drugs, devices, and/or biological products subject to licensure under Section 351 of the Public Health Service Act and related regulations. The Company identified its micronized and particulate products as being subject to regulation under Section 351, requiring pre-market approval from the FDA for a specified indication with demonstrated clinical efficacy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The FDA exercised enforcement discretion with respect to Investigative New Drug (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;IND&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) applications and pre-market approval requirements through May 31, 2021. As of May 31, 2021, the Company stopped marketing its Section 351 products and will be precluded from marketing its Section 351 products in the United States until a Biologics License Application (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;BLA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) is granted. If and when the FDA approves a BLA, we expect to be allowed to market the Section 351 products again, but only for specific indications as permitted by the FDA. Sales of the Company&#x2019;s Section 351 products were $8.6 million and $6.2 million for the three months ended June&#160;30, 2021 and 2020, respectively, and $16.7 million and $14.9 million for the six months ended June&#160;30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company currently markets EPICORD and AMNIOCORD tissue products derived from human umbilical cord, as providing a protective environment or as a barrier. If the FDA were to determine that EPICORD and AMNIOCORD do not meet the requirements for regulation solely under Section 361, then pre-market clearance or approval would be required. The loss of the Company&#x2019;s ability to market and sell its umbilical cord-derived products would have an adverse effect on the Company&#x2019;s revenue, business, financial condition, and results of operations. Net sales of the Company&#x2019;s umbilical cord-derived products were $5.9 million and $3.3 million for the three months ended June&#160;30, 2021 and 2020, respectively, and $10.8 million and $7.2 million for the six months ended June&#160;30, 2021 and 2020, respectively. Cord inventory, which would be at risk for write-down as a result of this determination, was $0.8 million as of June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Out-of-Period Adjustment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended June&#160;30, 2021, the Company identified certain Restricted Stock Unit and Performance Stock Unit awards which were not appropriately reflected in the Company&#x2019;s balance of common stock outstanding beginning in 2019. The effects of these errors caused misstatements in the Company&#x2019;s balance of treasury stock, additional paid-in capital, and common stock outstanding on each of the Company&#x2019;s reported consolidated balance sheets and consolidated statements of stockholders&#x2019; (deficit) equity for interim and annual periods beginning with those statements as of and for the year ended December 31, 2019. The identified errors did not affect total stockholders&#x2019; (deficit) equity or earnings per share in any period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded an out-of-period adjustment during the three and six months ended June&#160;30, 2021, which resulted in decreases of $0.9 million and $2.0 million to the balance of additional paid-in capital for the three and six months ended June&#160;30, 2021, respectively, and increases of $0.9&#160;million and $2.0&#160;million to the balance of treasury stock during those same periods. The balance of common shares outstanding at June&#160;30, 2021 of 111,881,938 reflects a cumulative increase of 239,502 shares relating to the adjustment.&lt;/span&gt;&lt;/div&gt;The Company concluded the effect of the misstatement was not material, qualitatively or quantitatively, to any interim or annual period.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32d60e88dd1c4b5dad71c5e90be4b433_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTYzOTY2NQ_41f1cc6b-469a-4ac3-9c6f-79fbc0527c5f"
      unitRef="usd">8600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f69b69d3f9a4ac2b110d37dcc110405_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTYzOTY4Ng_921911b6-7c20-4d07-b83e-0dc8ada2081c"
      unitRef="usd">6200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i90e644d3bd014f92ba1bb40b0b78d305_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTYzOTc1OA_f7892a55-556f-49b4-818b-22b1cc400b91"
      unitRef="usd">16700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c9b39d7c36e4c6f960af71b46e8ca65_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTYzOTc4Mg_36b037bc-7ef7-49a7-bbf6-17cca4d65f81"
      unitRef="usd">14900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib148d38e25b94492bf90c7d639339309_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTYzOTg1OQ_3b47ba9b-3c74-4944-beb4-cdf58aa8d1e3"
      unitRef="usd">5900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4419ab9cc84f446692df129d313037a1_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTYzOTg3Mw_736cab4b-39cf-4c6e-85b9-71d8c4ac17a4"
      unitRef="usd">3300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66be1c10c07c47af8bcae86ad35148ae_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTYzOTgwNg_d06da6c6-59b2-4693-83fb-8e7142d67e9f"
      unitRef="usd">10800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3cbcb788b0524138bc71b680f77362cc_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTYzOTgyOQ_c5927482-8b19-41a2-b055-82920fb984d3"
      unitRef="usd">7200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InventoryNet
      contextRef="i54f3fa70af5b41b893e305ac0470f535_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMTA5OTUxMTY0MDY2Ng_f487cc50-e2b0-4fac-b378-bcfb33e29136"
      unitRef="usd">800000</us-gaap:InventoryNet>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ibb5f8c6fa26a4473999a549b0860daa7_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMjc0ODc3OTA4Njk5NA_47864e48-3dbf-4b91-957e-fd8f1e50f006"
      unitRef="usd">-900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ieac267072afd40b5973cebef23f08bc7_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMjc0ODc3OTA4NzAwMg_ab9e4575-2e23-4fe1-b224-43b8d76b65b5"
      unitRef="usd">-2000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i57d5766bcb174f22a384db94fb1662dc_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMjE5OTAyMzI3Mzk1NQ_34de3cd5-2e9f-4796-b578-ae3efd163a01"
      unitRef="usd">900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i4c45415d8d674cdcb88b2754e8ca0f7a_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMjE5OTAyMzI3Mzk2OQ_66134a31-d740-444b-ab5a-d3250977fda0"
      unitRef="usd">2000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMjc0ODc3OTA4NzIzNQ_864964a0-9723-4d6e-b6c0-c614e1444e94"
      unitRef="shares">111881938</us-gaap:CommonStockSharesOutstanding>
    <mdxg:TreasuryStockSharesAdjustment
      contextRef="iaca0961cc5c74e099acc7bc6fe95a9ef_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNC9mcmFnOmUyYWY4M2RhOTU3ZjRjZmE4ZWVmNTUxZjc4OTc3MDljL3RleHRyZWdpb246ZTJhZjgzZGE5NTdmNGNmYThlZWY1NTFmNzg5NzcwOWNfMjc0ODc3OTA4NzI3Mw_958c486f-5977-4291-b0e9-ccdc60c21791"
      unitRef="shares">239502</mdxg:TreasuryStockSharesAdjustment>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2Mzg_a836a185-e8a8-40ad-988a-68515ae7a4af">Significant Accounting Policies&lt;div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Please see Note 2 to the Company&#x2019;s Consolidated Financial Statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the Securities and Exchange Commission (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;SEC&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) on March 8, 2021 (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2020 Form 10-K&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) for a description of all significant accounting policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;GAAP&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) from interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the results of operations for the periods presented have been included.&#160;The operating results for the three and six months ended June&#160;30, 2021 and 2020 are not necessarily indicative of the results that may be expected for the fiscal year.&#160;The balance sheet as of December&#160;31, 2020 was derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited condensed consolidated financial statements should be read in conjunction with the historical consolidated financial statements of the Company included in the 2020 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements have been prepared in accordance with GAAP. Conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported unaudited condensed consolidated statements of operations during the reporting period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment and intangible assets, estimates regarding asset retirement obligations, estimates for contingent liabilities, the measurement of right-of-use assets and lease liabilities, management&#x2019;s assessment of the Company&#x2019;s ability to continue as a going concern, estimates of fair value of share-based payments, and valuation of deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the above, the Company has considered the potential effects of the Covid-19 Pandemic and potential negative impacts resulting from the end of the FDA&#x2019;s period of Enforcement Discretion with respect to its determinations surrounding impairments, increases in allowances for credit losses, increases in the Company&#x2019;s returns reserve, other expenses, and changes in accounting judgments that have or are reasonably likely to have a material impact on the unaudited condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of MiMedx Group, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable represent amounts due from customers for which revenue has been recognized. Generally, the Company does not require collateral or any other security to support its receivables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Bad debt expense and the allowance for doubtful accounts are based on historical trends and current expectations for credit losses and reasonable and supportable forecasts. The Company&#x2019;s policy to reserve for potential bad debts is based on the aging of the individual receivables as well as customer-specific qualitative factors, such as bankruptcy proceedings. The Company manages credit risk by routinely performing credit checks on customers prior to sales. The individual receivables are written-off after all reasonable efforts to collect the funds have been made. Actual write-offs may differ from the amounts reserved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s allowance for doubtful accounts was $0.8 million and $0.7 million as of June&#160;30, 2021 and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of purchase price over the fair value of net assets of acquired businesses. The Company assesses  goodwill for impairment at least annually on October 1 and whenever events or substantive changes in circumstances indicate that the asset may be impaired. The Company may first choose to assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then the Company performs a quantitative analysis. The Company may also choose to bypass the qualitative assessment and proceed directly to the quantitative analysis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, the Company concluded it operates as one reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the quantitative analysis, if the carrying value of the reporting unit exceeds its fair value, goodwill impairment is recognized for the amount that the carrying value exceeds fair value, not to exceed the total amount of goodwill allocated to the reporting unit. The Company determines fair value using income and market approaches. Under the income approach, the fair value of the Company is the present value of its future economic benefits. These benefits can include revenue, cost savings, tax deductions, and proceeds from its disposition. Value indications are developed by discounting expected cash flows to their present value at a rate of return that incorporates the risk-free rate for the use of funds, industry trends, and entity-specific risks as of the goodwill impairment testing date. Under the market approach, the Company derives the fair value of the reporting unit using observed fair values of a set of companies with comparable business models to the reporting unit under evaluation. These amounts are reconciled to the Company&#x2019;s market capitalization as of the test date for reasonableness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Change in Annual Goodwill Impairment Testing Date &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to change its annual goodwill and indefinite-lived intangible asset impairment testing date from September 30 to October 1. The change in the annual impairment testing date provides the Company with more time in identifying and calculating any impairments and to maximize the use of the Company&#x2019;s available resources. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because GAAP does not permit more than 12 months to pass between annual goodwill impairment tests, the Company performed quantitative tests on September 30 and October 1, 2020. As a result of each of these tests, the Company concluded that the fair value of the reporting unit exceeded the carrying value and recorded no impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sells its products primarily to individual customers and independent distributors (collectively referred to as &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). Customers obtain and use products either through ship and bill arrangements or consignment arrangements. Under ship and bill arrangements, the customer submits an order. Upon approval of the sales order, the Company ships product to the customer and invoices them for the product sold. Under consignment arrangements, the customer takes possession of the product, but the Company retains title until the implantation, or application of the Company&#x2019;s product to the patient.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue as performance obligations are fulfilled; which generally occurs upon the shipment of product to the customers for ship and bill orders or upon implantation for consignment sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized based on consideration the Company expects to be entitled to from the sale. This consists of the gross selling price of the product, less any discounts or rebates (collectively, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;deductions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; or &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;sales deductions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). Gross selling price is a standard set by the Company for all customers unless a contract governing the sale provides for a specified price. Sales deductions are specified in individual contracts with customers and are generally achieved based on total sales during a specified period. The Company estimates the total sales deductions that a specific customer will achieve over the relevant term and applies the reduction to sales as they are made throughout the period. Rebates owed to customers are accrued and recorded in accrued expenses on the unaudited condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company acts as principal in all of its customer arrangements and records revenue on a gross basis. Shipping is considered immaterial in the context of the overall customer arrangement, and damages or loss of goods in transit are rare. Therefore, shipping is not deemed a separately-recognized performance obligation and the Company has elected to treat shipping costs as activities to fulfill the promise to transfer the product. The Company maintains a returns policy that allows its customers to return product that is consigned, damaged, or non-conforming, ordered in error, or due to a recall. The estimate of the provision for returns is based on historical experience with actual returns. The Company&#x2019;s payment terms for customers are typically 30 to 60 days from receipt of title of the goods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the above revenue recognition policy, the Company recognizes revenue from customers with balances outstanding as of September 30, 2019 for which all of the criteria necessary for revenue recognition were not met at the time of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;shipment and that such criteria would not be met until collection of such sales (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Remaining Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). This was in accordance with the change in the Company&#x2019;s revenue recognition pattern beginning September 30, 2019 (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company defers the recognition of cost of sales associated with the Remaining Contracts until revenue is recognized and cash is collected. Deferred cost of sales, included as part of other current assets on the unaudited condensed consolidated balance sheets, were $0.1&#160;million and $0.2&#160;million as of June&#160;30, 2021 and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the effects of cash collections on the Remaining Contracts on the unaudited condensed consolidated statements of operations for each of the three and six months ended June&#160;30, 2021 and 2020 are as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-right:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is, or contains, a lease at inception.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Lease assets and liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The lease term used in the calculation includes options to extend or terminate the lease when the exercise of such options are reasonably certain. The determination of whether the Company is reasonably certain to exercise a renewal or termination option is reassessed as new information arises and is accounted for prospectively as of the point in time the determination is made regarding the modification of the lease term. The Company uses its incremental borrowing rate in determining the present value of lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets resulting from operating leases are included in right of use asset on the unaudited condensed consolidated balance sheets as of June&#160;30, 2021 and December&#160;31, 2020. Right-of-use assets resulting from the Company&#x2019;s finance leases are included in property and equipment, net on the unaudited condensed consolidated balance sheet as of June&#160;30, 2021. Associated liabilities from both operating and finance leases are included on the unaudited condensed consolidated balance sheet as part of other current liabilities, to the extent that principal payments on such obligations will be paid in the next 12 months, and other liabilities, to the extent that principal payments on such obligations will be paid more than one year in the future. As of June&#160;30, 2021, the Company has both finance and operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable components of the lease payments such as fair market value adjustments, utilities, and maintenance costs are expensed as incurred and not included in determining the present value of lease liabilities. As an accounting policy election, the Company excludes short-term leases having initial terms of 12 months or fewer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For operating leases, lease expense is recognized on a straight-line basis over the lease term through selling, general and administrative expense on the unaudited condensed consolidated statements of operations. For finance leases, the right of use asset is amortized, straight-line, over the life of the lease as depreciation expense, which is included as a component of selling, general and administrative expense on the unaudited condensed consolidated statements of operations. The Company recognizes interest expense on finance lease liabilities based on the incremental borrowing rate at lease inception applied to the outstanding lease liability. The Company does not recognize interest expense on operating lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payments on operating leases are considered cash flows from operating activities. Payments on finance leases, to the extent that the payment relates to the reduction of the principal balance of the liability, are considered cash flows from financing activities. Payments toward the interest portion of finance lease liabilities are classified as cash flows from operating activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#x201d; which simplifies and clarifies certain calculation and presentation matters related to convertible equity and debt instruments. Specifically, ASU simplifies the accounting for such instruments by removing requirements to separately account for conversion features as a derivative under ASC Topic 815 and removing the requirement to account for beneficial conversion &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;features on such instruments. Accounting Standards Update 2020-06 also provides clearer guidance surrounding disclosure of such instruments and provides specific guidance for how such instruments are to be incorporated in the calculation of Diluted EPS. The guidance under ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company adopted this standard on January 1, 2021 on a modified retrospective basis. There was no impact upon adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-right:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued Accounting Standards Update (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ASU&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) 2020-04, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;, which provides temporary, optional expedients and exceptions to accounting guidance for certain contract modifications and hedging arrangements to ease financial reporting burdens as a result of market transitions from the London Interbank Offered Rate (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;LIBOR&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) to alternative reference rates. The guidance is available for prospective application upon its issuance and can generally be applied to contract modifications and hedging relationships entered into beginning March 12, 2020 through December 31, 2022. As of June&#160;30, 2021, the Company has long-term debt outstanding which carries an interest rate tied to LIBOR, the agreement for which contemplates an interest rate alternative in the event that LIBOR is unavailable. The Company is evaluating the possibility of adoption and the related impact on its financial statements. If adopted, the Company does not expect the provisions of this ASU to have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All other ASUs issued and not yet effective for the six months ended June 30, 2021, and through the date of this report, were assessed and determined to be either not applicable or are expected to have minimal impact on the Company&#x2019;s financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2Mzk_1ec351ff-2733-44b2-89c4-f62ead8a9fbf">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;GAAP&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) from interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the results of operations for the periods presented have been included.&#160;The operating results for the three and six months ended June&#160;30, 2021 and 2020 are not necessarily indicative of the results that may be expected for the fiscal year.&#160;The balance sheet as of December&#160;31, 2020 was derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited condensed consolidated financial statements should be read in conjunction with the historical consolidated financial statements of the Company included in the 2020 Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2MDc_b59a6a33-0488-4294-9230-98241bda3349">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements have been prepared in accordance with GAAP. Conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported unaudited condensed consolidated statements of operations during the reporting period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment and intangible assets, estimates regarding asset retirement obligations, estimates for contingent liabilities, the measurement of right-of-use assets and lease liabilities, management&#x2019;s assessment of the Company&#x2019;s ability to continue as a going concern, estimates of fair value of share-based payments, and valuation of deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the above, the Company has considered the potential effects of the Covid-19 Pandemic and potential negative impacts resulting from the end of the FDA&#x2019;s period of Enforcement Discretion with respect to its determinations surrounding impairments, increases in allowances for credit losses, increases in the Company&#x2019;s returns reserve, other expenses, and changes in accounting judgments that have or are reasonably likely to have a material impact on the unaudited condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2MjQ_04be9a82-607e-432d-a01f-f7d78b34167b">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of MiMedx Group, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2MjE_cbd257a0-b7f9-4c69-b925-a4b12e77bf02">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable represent amounts due from customers for which revenue has been recognized. Generally, the Company does not require collateral or any other security to support its receivables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Bad debt expense and the allowance for doubtful accounts are based on historical trends and current expectations for credit losses and reasonable and supportable forecasts. The Company&#x2019;s policy to reserve for potential bad debts is based on the aging of the individual receivables as well as customer-specific qualitative factors, such as bankruptcy proceedings. The Company manages credit risk by routinely performing credit checks on customers prior to sales. The individual receivables are written-off after all reasonable efforts to collect the funds have been made. Actual write-offs may differ from the amounts reserved.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
      contextRef="i2d1e691baee849e4b5421dd9318cfdaa_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTA5OTUxMTY2MjQ1MQ_1a947ad3-bc36-4482-9410-45e47e1ed4e8"
      unitRef="usd">800000</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTA5OTUxMTY0OTI3OQ_01483d8f-32f5-4ead-9077-5e9d64c57f38"
      unitRef="usd">700000</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2Mzc_2be2a4b2-fcc0-41ef-a162-9545a450e119">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of purchase price over the fair value of net assets of acquired businesses. The Company assesses  goodwill for impairment at least annually on October 1 and whenever events or substantive changes in circumstances indicate that the asset may be impaired. The Company may first choose to assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then the Company performs a quantitative analysis. The Company may also choose to bypass the qualitative assessment and proceed directly to the quantitative analysis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, the Company concluded it operates as one reporting unit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the quantitative analysis, if the carrying value of the reporting unit exceeds its fair value, goodwill impairment is recognized for the amount that the carrying value exceeds fair value, not to exceed the total amount of goodwill allocated to the reporting unit. The Company determines fair value using income and market approaches. Under the income approach, the fair value of the Company is the present value of its future economic benefits. These benefits can include revenue, cost savings, tax deductions, and proceeds from its disposition. Value indications are developed by discounting expected cash flows to their present value at a rate of return that incorporates the risk-free rate for the use of funds, industry trends, and entity-specific risks as of the goodwill impairment testing date. Under the market approach, the Company derives the fair value of the reporting unit using observed fair values of a set of companies with comparable business models to the reporting unit under evaluation. These amounts are reconciled to the Company&#x2019;s market capitalization as of the test date for reasonableness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Change in Annual Goodwill Impairment Testing Date &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to change its annual goodwill and indefinite-lived intangible asset impairment testing date from September 30 to October 1. The change in the annual impairment testing date provides the Company with more time in identifying and calculating any impairments and to maximize the use of the Company&#x2019;s available resources. &lt;/span&gt;&lt;/div&gt;Because GAAP does not permit more than 12 months to pass between annual goodwill impairment tests, the Company performed quantitative tests on September 30 and October 1, 2020.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:NumberOfReportingUnits
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfNTk4Mw_d3d4e67a-6320-4976-b813-27b972724a19"
      unitRef="reportingunit">1</us-gaap:NumberOfReportingUnits>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="iab79a42abcfc49bf821585364d7300c9_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfNzg0Ng_436a95ab-ecd2-4eca-bd19-a55749fe0a92"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2NTY_2acdd062-f004-4bee-9d2a-a30c644e24c2">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sells its products primarily to individual customers and independent distributors (collectively referred to as &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). Customers obtain and use products either through ship and bill arrangements or consignment arrangements. Under ship and bill arrangements, the customer submits an order. Upon approval of the sales order, the Company ships product to the customer and invoices them for the product sold. Under consignment arrangements, the customer takes possession of the product, but the Company retains title until the implantation, or application of the Company&#x2019;s product to the patient.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue as performance obligations are fulfilled; which generally occurs upon the shipment of product to the customers for ship and bill orders or upon implantation for consignment sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized based on consideration the Company expects to be entitled to from the sale. This consists of the gross selling price of the product, less any discounts or rebates (collectively, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;deductions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; or &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;sales deductions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). Gross selling price is a standard set by the Company for all customers unless a contract governing the sale provides for a specified price. Sales deductions are specified in individual contracts with customers and are generally achieved based on total sales during a specified period. The Company estimates the total sales deductions that a specific customer will achieve over the relevant term and applies the reduction to sales as they are made throughout the period. Rebates owed to customers are accrued and recorded in accrued expenses on the unaudited condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company acts as principal in all of its customer arrangements and records revenue on a gross basis. Shipping is considered immaterial in the context of the overall customer arrangement, and damages or loss of goods in transit are rare. Therefore, shipping is not deemed a separately-recognized performance obligation and the Company has elected to treat shipping costs as activities to fulfill the promise to transfer the product. The Company maintains a returns policy that allows its customers to return product that is consigned, damaged, or non-conforming, ordered in error, or due to a recall. The estimate of the provision for returns is based on historical experience with actual returns. The Company&#x2019;s payment terms for customers are typically 30 to 60 days from receipt of title of the goods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the above revenue recognition policy, the Company recognizes revenue from customers with balances outstanding as of September 30, 2019 for which all of the criteria necessary for revenue recognition were not met at the time of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;shipment and that such criteria would not be met until collection of such sales (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Remaining Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). This was in accordance with the change in the Company&#x2019;s revenue recognition pattern beginning September 30, 2019 (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company defers the recognition of cost of sales associated with the Remaining Contracts until revenue is recognized and cash is collected. Deferred cost of sales, included as part of other current assets on the unaudited condensed consolidated balance sheets, were $0.1&#160;million and $0.2&#160;million as of June&#160;30, 2021 and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the effects of cash collections on the Remaining Contracts on the unaudited condensed consolidated statements of operations for each of the three and six months ended June&#160;30, 2021 and 2020 are as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <mdxg:RevenueFromContractWithCustomerPaymentTerms
      contextRef="i9da3db9cb0b24a25ada54ecbe079f087_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMzg0ODI5MDczNTg2Nw_4a8009ab-c034-448b-9637-18f5c04f32eb">P30D</mdxg:RevenueFromContractWithCustomerPaymentTerms>
    <mdxg:RevenueFromContractWithCustomerPaymentTerms
      contextRef="i28d0157a57fe4b55ac3580147766d8d8_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMzg0ODI5MDczNTg4MQ_d3ab85c7-dad5-4e36-b574-0e5265839134">P60D</mdxg:RevenueFromContractWithCustomerPaymentTerms>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTA5OTUxMTY1MjgxMg_7852d12c-4543-4c4b-a64e-6c9c5246b036"
      unitRef="usd">100000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTA5OTUxMTY1MjgyMA_5960ed17-d5cc-4b07-9fbd-40e5587dd1c3"
      unitRef="usd">200000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2MDk_82ef6c63-5ae2-4b33-9683-bd25c2f18a75">&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the effects of cash collections on the Remaining Contracts on the unaudited condensed consolidated statements of operations for each of the three and six months ended June&#160;30, 2021 and 2020 are as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:13.2pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie18163f5013a4be0b9bd02bf40e60571_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfMi0xLTEtMS0w_3d969d1d-305a-41ee-af8c-445a19f14e38"
      unitRef="usd">313000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i326a81676c33465b89855dd27ba292da_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfMi0zLTEtMS0w_91b557f4-c1f0-4136-b9f8-49bd8389ba7e"
      unitRef="usd">1706000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i39f649d4d661481e8d6a6d250cdba5f7_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfMi01LTEtMS0xNjI1_90bc6220-f26c-406c-beed-c9a6b49936fb"
      unitRef="usd">611000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cccbdf946f0459cb7d8cd1a05b4cd5c_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfMi03LTEtMS0xNjM0_0f7197a1-8167-4b86-978d-b4db1496f94e"
      unitRef="usd">6201000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie18163f5013a4be0b9bd02bf40e60571_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfMy0xLTEtMS0w_f2ffd051-5af8-4f02-8e49-7e74270bb9d4"
      unitRef="usd">44000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i326a81676c33465b89855dd27ba292da_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfMy0zLTEtMS0w_12ffe8c0-a859-42b9-a12e-a8340a1ffb27"
      unitRef="usd">239000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i39f649d4d661481e8d6a6d250cdba5f7_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfMy01LTEtMS0yODUx_3a875de8-84a6-45be-ae71-62c4438517c5"
      unitRef="usd">86000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2cccbdf946f0459cb7d8cd1a05b4cd5c_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfMy03LTEtMS0yODUx_c3b3cfaf-4ac6-4cfc-9e4d-380330d7da24"
      unitRef="usd">868000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="ie18163f5013a4be0b9bd02bf40e60571_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfNC0xLTEtMS0w_947fd24f-9d3f-4653-8205-fd972ab36009"
      unitRef="usd">269000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i326a81676c33465b89855dd27ba292da_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfNC0zLTEtMS0w_077fce08-c6a8-4bc5-a9fd-efc486787c24"
      unitRef="usd">1467000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i39f649d4d661481e8d6a6d250cdba5f7_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfNC01LTEtMS0yODUx_e7c21684-cb21-4def-a6e0-9acb3b3c46c0"
      unitRef="usd">525000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i2cccbdf946f0459cb7d8cd1a05b4cd5c_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RhYmxlOmVlNzdlNGMyZWQ3YTQwZDA5ZWFlMWFjZmM5YWYyOTg1L3RhYmxlcmFuZ2U6ZWU3N2U0YzJlZDdhNDBkMDllYWUxYWNmYzlhZjI5ODVfNC03LTEtMS0yODUx_54bc6a71-b260-4b8f-a6b8-c593052cf49a"
      unitRef="usd">5333000</us-gaap:GrossProfit>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2NTA_eb019fe4-1b68-443a-b97b-71331149216f">&lt;div style="margin-bottom:10pt;padding-right:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is, or contains, a lease at inception.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Lease assets and liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The lease term used in the calculation includes options to extend or terminate the lease when the exercise of such options are reasonably certain. The determination of whether the Company is reasonably certain to exercise a renewal or termination option is reassessed as new information arises and is accounted for prospectively as of the point in time the determination is made regarding the modification of the lease term. The Company uses its incremental borrowing rate in determining the present value of lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets resulting from operating leases are included in right of use asset on the unaudited condensed consolidated balance sheets as of June&#160;30, 2021 and December&#160;31, 2020. Right-of-use assets resulting from the Company&#x2019;s finance leases are included in property and equipment, net on the unaudited condensed consolidated balance sheet as of June&#160;30, 2021. Associated liabilities from both operating and finance leases are included on the unaudited condensed consolidated balance sheet as part of other current liabilities, to the extent that principal payments on such obligations will be paid in the next 12 months, and other liabilities, to the extent that principal payments on such obligations will be paid more than one year in the future. As of June&#160;30, 2021, the Company has both finance and operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable components of the lease payments such as fair market value adjustments, utilities, and maintenance costs are expensed as incurred and not included in determining the present value of lease liabilities. As an accounting policy election, the Company excludes short-term leases having initial terms of 12 months or fewer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For operating leases, lease expense is recognized on a straight-line basis over the lease term through selling, general and administrative expense on the unaudited condensed consolidated statements of operations. For finance leases, the right of use asset is amortized, straight-line, over the life of the lease as depreciation expense, which is included as a component of selling, general and administrative expense on the unaudited condensed consolidated statements of operations. The Company recognizes interest expense on finance lease liabilities based on the incremental borrowing rate at lease inception applied to the outstanding lease liability. The Company does not recognize interest expense on operating lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payments on operating leases are considered cash flows from operating activities. Payments on finance leases, to the extent that the payment relates to the reduction of the principal balance of the liability, are considered cash flows from financing activities. Payments toward the interest portion of finance lease liabilities are classified as cash flows from operating activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#x201d; which simplifies and clarifies certain calculation and presentation matters related to convertible equity and debt instruments. Specifically, ASU simplifies the accounting for such instruments by removing requirements to separately account for conversion features as a derivative under ASC Topic 815 and removing the requirement to account for beneficial conversion &lt;/span&gt;&lt;/div&gt;features on such instruments. Accounting Standards Update 2020-06 also provides clearer guidance surrounding disclosure of such instruments and provides specific guidance for how such instruments are to be incorporated in the calculation of Diluted EPS. The guidance under ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company adopted this standard on January 1, 2021 on a modified retrospective basis. There was no impact upon adoption.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV8zNy9mcmFnOmE5MmJmZTI1YWYzMDQ3YWNiNzA1YzNiMTMwNzJiNzFhL3RleHRyZWdpb246YTkyYmZlMjVhZjMwNDdhY2I3MDVjM2IxMzA3MmI3MWFfMTg2MTU_accd0fef-a6da-40ec-8b0d-a8ef4d9beff7">&lt;div style="margin-bottom:10pt;padding-right:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued Accounting Standards Update (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ASU&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) 2020-04, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;, which provides temporary, optional expedients and exceptions to accounting guidance for certain contract modifications and hedging arrangements to ease financial reporting burdens as a result of market transitions from the London Interbank Offered Rate (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;LIBOR&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) to alternative reference rates. The guidance is available for prospective application upon its issuance and can generally be applied to contract modifications and hedging relationships entered into beginning March 12, 2020 through December 31, 2022. As of June&#160;30, 2021, the Company has long-term debt outstanding which carries an interest rate tied to LIBOR, the agreement for which contemplates an interest rate alternative in the event that LIBOR is unavailable. The Company is evaluating the possibility of adoption and the related impact on its financial statements. If adopted, the Company does not expect the provisions of this ASU to have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All other ASUs issued and not yet effective for the six months ended June 30, 2021, and through the date of this report, were assessed and determined to be either not applicable or are expected to have minimal impact on the Company&#x2019;s financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RleHRyZWdpb246YTU4NmM2ZmFjN2U1NGM3ZThlMTQ0ZjAwMDdjOTI4MDlfNzc_659c5c04-a834-456c-a77b-c79f6cdcbddf">Inventory&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consisted of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.228%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the conclusion of the FDA&#x2019;s period of Enforcement Discretion on May 31, 2021, the Company fully reserved $1.0 million of its Section 351 product inventory during the three and six months ended June&#160;30, 2021. This amount is included as part of cost of sales on the unaudited condensed consolidated statements of operations for those periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RleHRyZWdpb246YTU4NmM2ZmFjN2U1NGM3ZThlMTQ0ZjAwMDdjOTI4MDlfODI_664604dd-690d-45f8-9a07-d8f5d8aa0110">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consisted of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.228%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RhYmxlOjE0NmUyZjM3MDRlYzQ1MWJiZWZmMDkwYWM0NDFiOTNjL3RhYmxlcmFuZ2U6MTQ2ZTJmMzcwNGVjNDUxYmJlZmYwOTBhYzQ0MWI5M2NfMS0xLTEtMS0w_1f65f3a8-a4ff-49db-8b46-334b219f3122"
      unitRef="usd">396000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RhYmxlOjE0NmUyZjM3MDRlYzQ1MWJiZWZmMDkwYWM0NDFiOTNjL3RhYmxlcmFuZ2U6MTQ2ZTJmMzcwNGVjNDUxYmJlZmYwOTBhYzQ0MWI5M2NfMS0zLTEtMS0w_f2a00cff-c8ec-4f40-be48-a3e86635b1a8"
      unitRef="usd">314000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RhYmxlOjE0NmUyZjM3MDRlYzQ1MWJiZWZmMDkwYWM0NDFiOTNjL3RhYmxlcmFuZ2U6MTQ2ZTJmMzcwNGVjNDUxYmJlZmYwOTBhYzQ0MWI5M2NfMi0xLTEtMS0w_ac5023be-d13b-44e9-92b9-f1121b63457e"
      unitRef="usd">6099000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RhYmxlOjE0NmUyZjM3MDRlYzQ1MWJiZWZmMDkwYWM0NDFiOTNjL3RhYmxlcmFuZ2U6MTQ2ZTJmMzcwNGVjNDUxYmJlZmYwOTBhYzQ0MWI5M2NfMi0zLTEtMS0w_99a8ba3a-6a13-4e0b-ba46-9c3a3a4c787e"
      unitRef="usd">4316000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RhYmxlOjE0NmUyZjM3MDRlYzQ1MWJiZWZmMDkwYWM0NDFiOTNjL3RhYmxlcmFuZ2U6MTQ2ZTJmMzcwNGVjNDUxYmJlZmYwOTBhYzQ0MWI5M2NfMy0xLTEtMS0w_6980fd4e-2974-4111-8056-bcbd15ebebe0"
      unitRef="usd">3642000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RhYmxlOjE0NmUyZjM3MDRlYzQ1MWJiZWZmMDkwYWM0NDFiOTNjL3RhYmxlcmFuZ2U6MTQ2ZTJmMzcwNGVjNDUxYmJlZmYwOTBhYzQ0MWI5M2NfMy0zLTEtMS0w_b0e98d3c-d1a1-48c6-a48b-3b62be7d22a2"
      unitRef="usd">5731000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RhYmxlOjE0NmUyZjM3MDRlYzQ1MWJiZWZmMDkwYWM0NDFiOTNjL3RhYmxlcmFuZ2U6MTQ2ZTJmMzcwNGVjNDUxYmJlZmYwOTBhYzQ0MWI5M2NfNi0xLTEtMS0w_c249429b-aca2-4e7f-a73a-b04058c10d67"
      unitRef="usd">10137000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RhYmxlOjE0NmUyZjM3MDRlYzQ1MWJiZWZmMDkwYWM0NDFiOTNjL3RhYmxlcmFuZ2U6MTQ2ZTJmMzcwNGVjNDUxYmJlZmYwOTBhYzQ0MWI5M2NfNi0zLTEtMS0w_1b8c0bdd-a876-4bb6-beab-54949f3f18d0"
      unitRef="usd">10361000</us-gaap:InventoryNet>
    <us-gaap:InventoryWriteDown
      contextRef="i90e644d3bd014f92ba1bb40b0b78d305_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RleHRyZWdpb246YTU4NmM2ZmFjN2U1NGM3ZThlMTQ0ZjAwMDdjOTI4MDlfMTA5OTUxMTYyODc4NQ_dba8553d-cff2-48b7-85ad-819f19c8ce3f"
      unitRef="usd">1000000.0</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i32d60e88dd1c4b5dad71c5e90be4b433_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80My9mcmFnOmE1ODZjNmZhYzdlNTRjN2U4ZTE0NGYwMDA3YzkyODA5L3RleHRyZWdpb246YTU4NmM2ZmFjN2U1NGM3ZThlMTQ0ZjAwMDdjOTI4MDlfMTA5OTUxMTYyODc4NQ_dbe06e54-b53d-4f02-b6ab-fc04317a1282"
      unitRef="usd">1000000.0</us-gaap:InventoryWriteDown>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RleHRyZWdpb246ZjM3ZTI0MTE5NDkzNGViYWIyNWYxYmNmMTE3NmI1Y2NfNDMw_10373f9f-ae3b-4f76-aa08-0b1b5da07dc3">Property and Equipment&#160;&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory and clean room equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset retirement cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense for each of the three and six months ended June&#160;30, 2021 and 2020 is summarized in the table below (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense is allocated amongst cost of sales, research and development, and selling, general, and administrative expense on the unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RleHRyZWdpb246ZjM3ZTI0MTE5NDkzNGViYWIyNWYxYmNmMTE3NmI1Y2NfNDIx_09978434-c4d7-404f-88de-df392677d072">&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory and clean room equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset retirement cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0ffcb532f3f045a79f3f2a726bce2285_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfMS0xLTEtMS0w_3205ff5d-efef-4dcc-866e-f94747cfd91c"
      unitRef="usd">8039000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i45a35085d43841c29afd03db8ea30feb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfMS0zLTEtMS0w_429b5b31-3720-4184-b984-34e91e62247c"
      unitRef="usd">6010000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic0cec0ff165d410fb950f0fe592b80e5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfMi0xLTEtMS0w_1d27fe49-3792-451c-8e7e-271753f6b2e8"
      unitRef="usd">15424000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia7887f65880b416a9a1b7b135b38514d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfMi0zLTEtMS0w_72380a30-e9d1-47df-9b11-5ee795bc62b2"
      unitRef="usd">15524000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8a82046d4b9b4effaec4f006f2703487_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfMy0xLTEtMS0w_3d219a82-0183-4a7c-92ab-09bca7483ea6"
      unitRef="usd">15062000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i804fe80afd1c4483a92cd48a806655ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfMy0zLTEtMS0w_d5c35057-1c55-47b1-b05d-f5a5a9f7e542"
      unitRef="usd">15295000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0fa1ee6b8d8d4beeabdc8444cf7a0a97_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNC0xLTEtMS0w_78f70ac6-b541-4d7d-b738-78e487ce2b7e"
      unitRef="usd">1972000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iec2d038f80894231a4c3c16bcb971517_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNC0zLTEtMS0w_142c8678-0129-4e25-bae4-a18e17b73fce"
      unitRef="usd">3321000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i76c421a22e8847a89a5ee26247adacac_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNS0xLTEtMS0w_009929fa-a540-497f-a02e-1a476f486e6f"
      unitRef="usd">860000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i87db49da4123419b8897eb063c0b4c9c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNS0zLTEtMS0w_0a51326c-fb8d-4930-a7b6-551e120e97f4"
      unitRef="usd">785000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="if5140cbcb67b477eae5103576b9d79ec_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNi0xLTEtMS0xMzE3_42ab2d60-12ad-4f1c-9463-e34a2933c523"
      unitRef="usd">189000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="i455d7d410196418eba05ebd95eca8809_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNi0zLTEtMS0xMzI3_9e9e493d-ef5f-4e4d-8050-633bbb0de768"
      unitRef="usd">0</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNi0xLTEtMS0w_ee783636-a96a-49df-af60-51430811eb56"
      unitRef="usd">41546000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNi0zLTEtMS0w_ae3a345c-bbb4-437e-8a7b-8a7fc6eba481"
      unitRef="usd">40935000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNy0xLTEtMS0w_ca9776ef-c738-435b-98a9-43a2d4638942"
      unitRef="usd">31273000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfNy0zLTEtMS0w_130cd5bb-204f-48ec-8a7b-dc1d6621645d"
      unitRef="usd">29498000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfOC0xLTEtMS0w_5aa6968f-64bf-41f2-a667-0d46edbdfc34"
      unitRef="usd">10273000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjIxM2JlZDIxMTcxNjRiMDk5ODA3ZDA4MTkwYzlhMzU3L3RhYmxlcmFuZ2U6MjEzYmVkMjExNzE2NGIwOTk4MDdkMDgxOTBjOWEzNTdfOC0zLTEtMS0w_2c2e539c-3302-4302-878c-8e5ab584fd3a"
      unitRef="usd">11437000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <mdxg:ScheduleOfDepreciationTableTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RleHRyZWdpb246ZjM3ZTI0MTE5NDkzNGViYWIyNWYxYmNmMTE3NmI1Y2NfNDI3_0b025348-f298-4bfd-a8c2-b85597f4bb9b">Depreciation expense for each of the three and six months ended June&#160;30, 2021 and 2020 is summarized in the table below (amounts in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</mdxg:ScheduleOfDepreciationTableTextBlock>
    <us-gaap:Depreciation
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjMwMzg3ODVkYTViNTQxODM4Yjk3NTIxMTVkZWY0ZjNlL3RhYmxlcmFuZ2U6MzAzODc4NWRhNWI1NDE4MzhiOTc1MjExNWRlZjRmM2VfMi0xLTEtMS0xMzMy_d3b35a30-e1d9-4ae3-930b-fecab6f955fa"
      unitRef="usd">1306000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjMwMzg3ODVkYTViNTQxODM4Yjk3NTIxMTVkZWY0ZjNlL3RhYmxlcmFuZ2U6MzAzODc4NWRhNWI1NDE4MzhiOTc1MjExNWRlZjRmM2VfMi0zLTEtMS0yODY3_bde35fca-b24f-492b-8cfd-82b0f7f7c04a"
      unitRef="usd">1422000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjMwMzg3ODVkYTViNTQxODM4Yjk3NTIxMTVkZWY0ZjNlL3RhYmxlcmFuZ2U6MzAzODc4NWRhNWI1NDE4MzhiOTc1MjExNWRlZjRmM2VfMi0yLTEtMS0w_7980fdc2-db0b-41b7-bdb2-5d828a2f2ddf"
      unitRef="usd">2467000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV80Ni9mcmFnOmYzN2UyNDExOTQ5MzRlYmFiMjVmMWJjZjExNzZiNWNjL3RhYmxlOjMwMzg3ODVkYTViNTQxODM4Yjk3NTIxMTVkZWY0ZjNlL3RhYmxlcmFuZ2U6MzAzODc4NWRhNWI1NDE4MzhiOTc1MjExNWRlZjRmM2VfMi00LTEtMS0w_b4e5c78e-3c49-45f3-ae59-4a49ba7f014a"
      unitRef="usd">2928000</us-gaap:Depreciation>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RleHRyZWdpb246YjM4YzY3ZGRkM2FlNGFkMDgyNjJiZjlmM2RjOGVjMmVfMzAy_0d86eeff-ffca-4a6c-b600-1ae5b1f694fa">Intangible Assets&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and know how&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,069)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer and supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,766)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names and trademarks&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense for the three and six months ended June 30, 2021 and 2020 is summarized in the table below (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.963%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected future amortization of intangible assets as of June&#160;30, 2021, is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated&lt;br/&gt;Amortization &lt;br/&gt;Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (excluding the six months ended June 30, 2021)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RleHRyZWdpb246YjM4YzY3ZGRkM2FlNGFkMDgyNjJiZjlmM2RjOGVjMmVfMjg3_04e1b79b-764b-467d-8020-2c75d1a9cc97">&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and know how&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,069)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer and supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,766)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names and trademarks&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense for the three and six months ended June 30, 2021 and 2020 is summarized in the table below (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.963%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RleHRyZWdpb246YjM4YzY3ZGRkM2FlNGFkMDgyNjJiZjlmM2RjOGVjMmVfMjk0_82174884-33e7-457a-8bea-10654bf9fd9c">&lt;div style="margin-bottom:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and know how&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,069)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer and supplier relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,766)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names and trademarks&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5af507b3d6eb4a15b70f0d9de1dfba91_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMy0xLTEtMS0w_00c3f5e8-b936-49c1-be43-8319c8bff8bb"
      unitRef="usd">9546000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5af507b3d6eb4a15b70f0d9de1dfba91_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMy0yLTEtMS0w_d159bd3f-5e57-4177-9329-98195c5403b7"
      unitRef="usd">6069000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5af507b3d6eb4a15b70f0d9de1dfba91_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMy0zLTEtMS0w_1b4ccab7-68ff-44bc-a028-8a6652cb20e4"
      unitRef="usd">3477000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if023d360bddb4609ba7c01984189031c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMy01LTEtMS0w_3f26abfb-8c8d-44c7-ae19-b0c9f10c5bd4"
      unitRef="usd">9510000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if023d360bddb4609ba7c01984189031c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMy02LTEtMS0w_ea65ac7d-90a2-4195-813c-4ed19351aeeb"
      unitRef="usd">5730000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if023d360bddb4609ba7c01984189031c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMy03LTEtMS0w_487ee2e3-f507-45fc-94d9-2b7b660f7007"
      unitRef="usd">3780000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia2bff240b04449a29fba2137bf43f2a5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNC0xLTEtMS0w_714b44ec-91bc-4839-bd33-360fcfa17e43"
      unitRef="usd">1414000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia2bff240b04449a29fba2137bf43f2a5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNC0yLTEtMS0w_8a1f1f9d-123d-4edc-bd16-387865fca4e3"
      unitRef="usd">1403000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia2bff240b04449a29fba2137bf43f2a5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNC0zLTEtMS0w_271c2de0-1a36-4948-936e-d14868c96670"
      unitRef="usd">11000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id528f8cf639346baa0d5733e68b0a62f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNC01LTEtMS0w_4ec75862-4eeb-439e-9293-802a75a28125"
      unitRef="usd">1414000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id528f8cf639346baa0d5733e68b0a62f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNC02LTEtMS0w_16d1c7a3-3889-4e9c-b97c-ef78ccee795d"
      unitRef="usd">1334000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id528f8cf639346baa0d5733e68b0a62f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNC03LTEtMS0w_1be41044-3d16-41ce-8ca8-653d742359e7"
      unitRef="usd">80000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0d57cdcc92e54b889ac2aebd6d6a1bd5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNS0xLTEtMS0w_267ca163-2048-4f14-83f2-ee50525eda47"
      unitRef="usd">241000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0d57cdcc92e54b889ac2aebd6d6a1bd5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNS0yLTEtMS0w_6ea54099-c311-44db-81eb-9447b4baa072"
      unitRef="usd">181000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0d57cdcc92e54b889ac2aebd6d6a1bd5_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNS0zLTEtMS0w_5d308645-8920-4a7d-be57-6d169c243c29"
      unitRef="usd">60000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idb2b2d4264234ed0a37f95b5dd66ce05_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNS01LTEtMS0w_b1bf9900-5d1c-4f57-9eac-3fcaff68afa2"
      unitRef="usd">241000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idb2b2d4264234ed0a37f95b5dd66ce05_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNS02LTEtMS0w_9c579b0d-d7c0-4262-8ae9-1113a9426bb2"
      unitRef="usd">172000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idb2b2d4264234ed0a37f95b5dd66ce05_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNS03LTEtMS0w_97d16ac6-1435-43ec-9fc2-1fd45319e30f"
      unitRef="usd">69000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ifb88a22bf81946bb95ccd3c5b11de65f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNi0xLTEtMS0w_da999768-da0d-4e07-bb20-a4c67d923422"
      unitRef="usd">120000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifb88a22bf81946bb95ccd3c5b11de65f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNi0yLTEtMS0w_d45338b9-414f-4b09-a720-a05f0996edcf"
      unitRef="usd">113000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ifb88a22bf81946bb95ccd3c5b11de65f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNi0zLTEtMS0w_ca4bdbd9-7841-4265-a4e2-3fb2b536bdaa"
      unitRef="usd">7000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i730a400496914c0995bd54501e4e7e6f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNi01LTEtMS0w_3ae0cac7-8c16-48bd-962e-867971514848"
      unitRef="usd">120000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i730a400496914c0995bd54501e4e7e6f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNi02LTEtMS0w_ebd41e29-2d05-464e-9a62-80d05bda70fe"
      unitRef="usd">98000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i730a400496914c0995bd54501e4e7e6f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNi03LTEtMS0w_11aea2dd-4be1-4fb5-80bf-68e5ddf4f614"
      unitRef="usd">22000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNy0xLTEtMS0w_f482f34b-44da-4ac9-bd98-d2496c2ddc04"
      unitRef="usd">11321000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNy0yLTEtMS0w_4d4b606b-3be2-4414-804d-f5ccd586bdec"
      unitRef="usd">7766000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNy0zLTEtMS0w_96ebb119-bc33-4f1d-9ee9-39749bf833d0"
      unitRef="usd">3555000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNy01LTEtMS0w_19e8b657-b576-45c6-a7ba-783562d7f811"
      unitRef="usd">11285000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNy02LTEtMS0w_2477c753-eb26-4043-8587-b3596689f14e"
      unitRef="usd">7334000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfNy03LTEtMS0w_776d0454-e893-4236-9bed-792f1a08bde4"
      unitRef="usd">3951000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="id51bf5d57c5e4be793cdd487a6614d13_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTAtMS0xLTEtMA_4c6a2ee7-e06a-47bd-9913-db2c44f45f01"
      unitRef="usd">1008000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="id51bf5d57c5e4be793cdd487a6614d13_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTAtMy0xLTEtMA_b59d96d8-f61b-44bf-8286-2609b845f51f"
      unitRef="usd">1008000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i6cf6e76c76f74939bf341b622ea02bbc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTAtNS0xLTEtMA_f7321177-5fa8-436e-a709-6a97a854895d"
      unitRef="usd">1008000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i6cf6e76c76f74939bf341b622ea02bbc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTAtNy0xLTEtMA_eed7aeb7-274c-42c6-8096-db109db6d02d"
      unitRef="usd">1008000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iee3d4e93e5e14202a11a01a6f5173801_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTEtMS0xLTEtMA_d7c04e65-5928-4e76-8484-a1b7bdfa87db"
      unitRef="usd">1187000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iee3d4e93e5e14202a11a01a6f5173801_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTEtMy0xLTEtMA_9e7c102b-43b0-49ef-8f4b-8a469697a033"
      unitRef="usd">1187000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i900de095b8b74867bd9ff846daf9e193_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTEtNS0xLTEtMA_7c1c4130-9c63-4cf6-944c-814da2b045d9"
      unitRef="usd">1045000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i900de095b8b74867bd9ff846daf9e193_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTEtNy0xLTEtMA_1f900053-5872-4e43-a85e-5bd300d8c0c2"
      unitRef="usd">1045000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTItMS0xLTEtMA_4182ced7-f8f2-478e-9e1f-fffb40d1c189"
      unitRef="usd">13516000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTItMy0xLTEtMA_7644564e-0d85-4313-8848-847ed4d638ef"
      unitRef="usd">5750000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTItNS0xLTEtMA_0d5ba2e8-128e-40a6-9172-62cda3fd980d"
      unitRef="usd">13338000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOjk0YjM4N2E2MjdlZDQyNWY5MTI0ODJlYjU5ZGMxNGM1L3RhYmxlcmFuZ2U6OTRiMzg3YTYyN2VkNDI1ZjkxMjQ4MmViNTlkYzE0YzVfMTItNy0xLTEtMA_ddd605cb-f58e-43df-a806-e3e6bd79f9c0"
      unitRef="usd">6004000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmIzZDUwYzc1YjZiZDRhYzc5MDMzZDk4ZjRjYzg5NDYzL3RhYmxlcmFuZ2U6YjNkNTBjNzViNmJkNGFjNzkwMzNkOThmNGNjODk0NjNfMi0xLTEtMS0w_9837a77c-853f-4c68-8b4a-39d7bcf2807e"
      unitRef="usd">215000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmIzZDUwYzc1YjZiZDRhYzc5MDMzZDk4ZjRjYzg5NDYzL3RhYmxlcmFuZ2U6YjNkNTBjNzViNmJkNGFjNzkwMzNkOThmNGNjODk0NjNfMi0zLTEtMS0w_45cec807-3333-4a4a-b636-37362d523ad7"
      unitRef="usd">271000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmIzZDUwYzc1YjZiZDRhYzc5MDMzZDk4ZjRjYzg5NDYzL3RhYmxlcmFuZ2U6YjNkNTBjNzViNmJkNGFjNzkwMzNkOThmNGNjODk0NjNfMi0zLTEtMS0w_f0eccecb-d312-45c6-bcbc-4fca1e52709f"
      unitRef="usd">271000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmIzZDUwYzc1YjZiZDRhYzc5MDMzZDk4ZjRjYzg5NDYzL3RhYmxlcmFuZ2U6YjNkNTBjNzViNmJkNGFjNzkwMzNkOThmNGNjODk0NjNfMi01LTEtMS0yMTM3_e47c3bd9-ba85-4a4a-8eab-4f2a3df06640"
      unitRef="usd">454000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmIzZDUwYzc1YjZiZDRhYzc5MDMzZDk4ZjRjYzg5NDYzL3RhYmxlcmFuZ2U6YjNkNTBjNzViNmJkNGFjNzkwMzNkOThmNGNjODk0NjNfMi03LTEtMS0yMTM3_ddbb4f15-1ba1-43ce-98d5-f799b65ce609"
      unitRef="usd">542000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RleHRyZWdpb246YjM4YzY3ZGRkM2FlNGFkMDgyNjJiZjlmM2RjOGVjMmVfMjg0_f80893b3-5b13-4fc4-bc12-64429e92cac2">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected future amortization of intangible assets as of June&#160;30, 2021, is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated&lt;br/&gt;Amortization &lt;br/&gt;Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (excluding the six months ended June 30, 2021)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmRhYzUwZTAyM2Y2ODQ3OGQ5OTE5NTgyODBkODQ5YjM4L3RhYmxlcmFuZ2U6ZGFjNTBlMDIzZjY4NDc4ZDk5MTk1ODI4MGQ4NDliMzhfMS0xLTEtMS0w_245bfbac-1997-43aa-8ee7-a9c71e4ccd37"
      unitRef="usd">366000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmRhYzUwZTAyM2Y2ODQ3OGQ5OTE5NTgyODBkODQ5YjM4L3RhYmxlcmFuZ2U6ZGFjNTBlMDIzZjY4NDc4ZDk5MTk1ODI4MGQ4NDliMzhfMi0xLTEtMS0w_01d46a04-0026-4d72-bf35-047ca1447370"
      unitRef="usd">694000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmRhYzUwZTAyM2Y2ODQ3OGQ5OTE5NTgyODBkODQ5YjM4L3RhYmxlcmFuZ2U6ZGFjNTBlMDIzZjY4NDc4ZDk5MTk1ODI4MGQ4NDliMzhfMy0xLTEtMS0w_d47428e1-9d02-4bee-ac38-36d3bb014b58"
      unitRef="usd">694000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmRhYzUwZTAyM2Y2ODQ3OGQ5OTE5NTgyODBkODQ5YjM4L3RhYmxlcmFuZ2U6ZGFjNTBlMDIzZjY4NDc4ZDk5MTk1ODI4MGQ4NDliMzhfNC0xLTEtMS0w_fb44c19a-bce9-4d26-9352-18f3920d9429"
      unitRef="usd">694000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmRhYzUwZTAyM2Y2ODQ3OGQ5OTE5NTgyODBkODQ5YjM4L3RhYmxlcmFuZ2U6ZGFjNTBlMDIzZjY4NDc4ZDk5MTk1ODI4MGQ4NDliMzhfNS0xLTEtMS0w_dd4106c1-53c6-4a8a-a693-6a4ec2ed84cc"
      unitRef="usd">282000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <mdxg:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmRhYzUwZTAyM2Y2ODQ3OGQ5OTE5NTgyODBkODQ5YjM4L3RhYmxlcmFuZ2U6ZGFjNTBlMDIzZjY4NDc4ZDk5MTk1ODI4MGQ4NDliMzhfNi0xLTEtMS0w_9168465c-c5fc-491b-8be9-8d81bec71320"
      unitRef="usd">825000</mdxg:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81Mi9mcmFnOmIzOGM2N2RkZDNhZTRhZDA4MjYyYmY5ZjNkYzhlYzJlL3RhYmxlOmRhYzUwZTAyM2Y2ODQ3OGQ5OTE5NTgyODBkODQ5YjM4L3RhYmxlcmFuZ2U6ZGFjNTBlMDIzZjY4NDc4ZDk5MTk1ODI4MGQ4NDliMzhfNy0xLTEtMS0w_670590ae-2ae3-467f-a95c-033c6f77ecde"
      unitRef="usd">3555000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RleHRyZWdpb246ZjBmMTdiMDE5NDYxNDY3ZWE3ZGFmMzYyNTM3ZmI5YWVfODg_c88d4865-dace-4bfe-9a24-7925b5797c15">Accrued Expenses&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses&#160;consisted of the following&#160;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.485%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.743%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commissions to sales agents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued clinical trials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued GPO fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RleHRyZWdpb246ZjBmMTdiMDE5NDYxNDY3ZWE3ZGFmMzYyNTM3ZmI5YWVfODY_14051c49-d825-414a-b1dc-1127e3c3963a">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses&#160;consisted of the following&#160;(in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.485%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.743%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commissions to sales agents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated returns&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued clinical trials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued GPO fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfMS0xLTEtMS0w_9ffbc6ce-1a21-4e20-80eb-fe9ce7a5bbb1"
      unitRef="usd">7161000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfMS0zLTEtMS0w_68d1dc6c-28fe-496b-8910-ede829794921"
      unitRef="usd">14822000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <mdxg:AccruedSettlementCostsCurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfMi0xLTEtMS0w_3e101743-b423-43ff-a2b3-0544c66f73e7"
      unitRef="usd">4495000</mdxg:AccruedSettlementCostsCurrent>
    <mdxg:AccruedSettlementCostsCurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfMi0zLTEtMS0w_a08fdb77-3f7d-4a0b-838d-8137d9442ac6"
      unitRef="usd">9975000</mdxg:AccruedSettlementCostsCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfMy0xLTEtMS00MDgz_6782c380-3c84-4142-8b7d-e743fa908bdd"
      unitRef="usd">1823000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfMy0zLTEtMS00MDgz_c7b00668-7243-4274-b246-bafce3421028"
      unitRef="usd">2141000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfMy0xLTEtMS0w_d9534b21-f3e7-4b20-97a7-a5aedcf23c88"
      unitRef="usd">777000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfMy0zLTEtMS0w_58281596-d840-4bd0-b1bc-0741abf319a9"
      unitRef="usd">688000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <mdxg:AccruedClinicalTrialsCurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfNS0xLTEtMS0w_6cb50cc4-7a0c-43f6-bca2-c93bcd0bde83"
      unitRef="usd">686000</mdxg:AccruedClinicalTrialsCurrent>
    <mdxg:AccruedClinicalTrialsCurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfNS0zLTEtMS0w_be653b76-7c73-4eb6-a7a1-c21ee56153f8"
      unitRef="usd">651000</mdxg:AccruedClinicalTrialsCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfNi0xLTEtMS00MDkx_a15dd123-7bca-4688-a6a4-8e61e905c2f6"
      unitRef="usd">520000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfNi0zLTEtMS00MDkx_d24899bc-18b0-4f26-b80c-f4981484dedd"
      unitRef="usd">554000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <mdxg:AccruedRebates
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfNi0xLTEtMS0w_51b4b7a2-f9f7-4054-8059-409aa6b10845"
      unitRef="usd">372000</mdxg:AccruedRebates>
    <mdxg:AccruedRebates
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfNi0zLTEtMS0w_5b7d311c-1716-4065-8d43-d5f49a08eb22"
      unitRef="usd">886000</mdxg:AccruedRebates>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfOC0xLTEtMS0zNDEx_f4f81504-5536-4e77-a93c-c14e8efec443"
      unitRef="usd">1239000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfOC0zLTEtMS0zNDEz_e3354676-941b-40e0-bdd7-661a06ac0feb"
      unitRef="usd">743000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfOC0xLTEtMS0w_fe999a4d-26c9-4f4e-b64b-413b3b7ff27c"
      unitRef="usd">17073000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81NS9mcmFnOmYwZjE3YjAxOTQ2MTQ2N2VhN2RhZjM2MjUzN2ZiOWFlL3RhYmxlOjg5ODY5MmE5ZDlkMjQxNTE5NzAxYWU4YzRhMzg5NDA4L3RhYmxlcmFuZ2U6ODk4NjkyYTlkOWQyNDE1MTk3MDFhZThjNGEzODk0MDhfOC0zLTEtMS0w_e3a387e2-f8e2-41b0-8706-195a42d0aa21"
      unitRef="usd">30460000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTAxNTY_0236b48c-6bab-42a1-8de1-05cb1b08a614">Long Term Debt&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Hayfin Term Loan Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 30, 2020, the Company entered into a Loan Agreement with, among others, Hayfin Services, LLP, (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Hayfin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) an affiliate of Hayfin Capital Management LLP (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Hayfin Loan Agreement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;), which Hayfin funded (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Hayfin Loan Transaction&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) on July 2, 2020 (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Closing Date&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) and provided the Company with a senior secured term loan in an aggregate amount of $50 million (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Term Loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). The Term Loan matures on June 30, 2025 (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Maturity Date&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). Interest is payable on the Term Loan for the balance outstanding quarterly through the Maturity Date. No principal payments on the Term Loan are due and payable until the Maturity Date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Hayfin Loan Agreement also provided for an additional delayed draw term loan (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DD TL&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#x201d; collectively with the Term Loan, the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Facilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) in the form of a committed but undrawn facility. The Company had the option to borrow on the DD TL through June 30, 2021. The Company did not borrow on the DD TL prior to June 30, 2021 and the Company&#x2019;s option to draw upon these funds has expired.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Facilities, which are senior secured obligations, were entered into together with the sale of the Company&#x2019;s Series B Convertible Preferred Stock (as defined and described in Note 9, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) in an aggregate amount of up to $100 million (collectively, the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financing Transactions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) in order to:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;refinance the outstanding indebtedness (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Refinancing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) under the Loan Agreement, dated as of June 10, 2019 (as amended and restated, the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;BT Term Loan Agreement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;), among the Company, the lenders and Blue Torch Finance LLC as administrative agent and collateral agent for such lenders,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) &#160;&#160;&#160;&#160;pay fees and expenses incurred with certain financing transactions, and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) &#160;&#160;&#160;&#160;finance the working capital, capital expenditures, and other general corporate purposes of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interest rate applicable to any borrowings under the Term Loan accrues at a rate equal to LIBOR (subject to a floor of 1.5%) plus a margin of 6.75% per annum (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Margin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). If LIBOR is unavailable, the loan will carry interest at the Margin plus the greatest of the Prime Rate, the Federal Funds Rate plus 0.5% per annum, and 2.5%. The Margin is eligible for a reduction depending on the Total Net Leverage Ratio for the quarter; as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;6.5% per annum if the Total Net Leverage Ratio (as defined in the Hayfin Loan Agreement) is less than 2.0x but greater than or equal to 1.0x, or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;6.0% per annum if the Total Net Leverage Ratio is less than 1.0x.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An additional 3.0% margin is applied to the interest rate in the event of default as defined by the Hayfin Loan Agreement. At issuance and as of June&#160;30, 2021, the Term Loan carried an interest rate of 8.3%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Facilities contain financial covenants requiring the Company, on a consolidated basis, to maintain the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Maximum Total Net Leverage Ratio of 4.5x through June 30, 2021, further reduced to 4.0x thereafter for the life of the loans, required to be calculated on a quarterly basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Minimum Liquidity (as defined in the Hayfin Loan Agreement) of $10 million, an at-all-times financial covenant tested monthly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, the Company is in compliance with all financial covenants required under the Hayfin Loan Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Facilities also specify that any prepayment of the Term Loan, voluntary or mandatory, as defined in the Term Loan Agreement, will subject MiMedx to a prepayment premium applicable as of the date of the prepayment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;On or before the first anniversary of the Closing Date:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25e6;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;A make-whole premium, equal to the greater of:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;5% of the principal balance repaid, and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;102% of the principal balance plus interest that would have been accrued from the repayment date to 12 months following the Closing Date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;After the first anniversary of the Closing Date but on or before the second anniversary of the Closing Date: 2% of the principal balance repaid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;After the second anniversary of the Closing Date: 1% of the principal balance repaid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;After the third anniversary of the Closing Date: 0% of the principal balance repaid.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Loan Agreement also includes events of default customary for facilities of this type, and upon the occurrence of such events of default, subject to customary cure rights, all outstanding loans under the Credit Facilities may be accelerated or the lenders&#x2019; commitments terminated. The mandatory prepayments are also required in the event of a change in control, incurring other indebtedness, certain proceeds from disposal of assets and insured casualty event. Annually, beginning with the fiscal year ending December 31, 2021, the Company is required to prepay the outstanding loans based on the percentage of the Excess Cash Flow (as defined in the Hayfin Loan Agreement), if such is generated, with the percentage determined based on the Total Net Leverage thresholds. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Hayfin maintains a first-priority security interest in substantially all of the Company&#x2019;s assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Original issue discount and deferred financing costs incurred as part of the Financing Transactions were allocated between the sale of the Series B Convertible Preferred Stock and the Hayfin Term Loan on the basis of the relative fair values of the transactions. The costs allocated to the Hayfin Term Loan were further allocated between the Term Loan and the DD TL on the basis of the maximum potential principal outstanding between the Credit Facilities. A summary of the allocation of the deferred financing costs and original issue discount between the Term Loan and the DD TL on July 2, 2020 was as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.263%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 2, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD TL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Long term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred financing costs and original issue discount associated with the Term Loan are amortized using the effective interest method through the Maturity Date. The amortization of such amounts are presented as part of interest expense, net on the unaudited condensed consolidated statement of operations for the three and six months ended June&#160;30, 2021. Unamortized deferred financing costs and original issue discount associated with the Term Loan are presented as a reduction to the principal balance on the Term Loan as part of long term debt, net on the unaudited condensed consolidated balance sheet as of June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred financing costs and original issue discount associated with the DD TL were amortized using the straight line method through the expiration of the DD TL commitment term on June 30, 2021. Amortization of these amounts are presented as part of interest expense, net on the unaudited condensed consolidated statement of operations for the three and six months ended June&#160;30, 2021. Unamortized deferred financing costs and original issue discount associated with the DD TL are presented as other current assets on the unaudited condensed consolidated balance sheet as of December&#160;31, 2020. There were no such amounts outstanding as of June&#160;30, 2021. In addition, the DD TL was subject to an additional commitment fee of 1% per annum of the amount undrawn, which is recognized as interest expense. The DD TL was not drawn upon as of June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The balances of the Term Loan as of June&#160;30, 2021 and December&#160;31, 2020 were as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.941%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.339%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.340%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,816)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense related to the Term Loan, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stated interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense related to the DD TL, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitment fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Principal payments on the Term Loan as of June&#160;30, 2021 are as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (excluding the six months ended June&#160;30, 2021)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, the fair value of the Term Loan was $52.0&#160;million. This valuation was calculated based on a series of Level 2 and Level 3 inputs, including a discount rate based on the credit risk spread of debt instruments of similar risk character in reference to U.S. Treasury instruments with similar maturities, with an incremental risk premium for risk factors specific to the Company. To derive the fair value of the Term Loan, the remaining cash flows associated with the Term Loan were discounted to June&#160;30, 2021 using this discount rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;BT Term Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 10, 2019, the Company entered into a loan agreement (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;BT Term Loan Agreement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) with the subsidiaries of the Company as guarantors and party thereto from time to time, the lenders party thereto from time to time and Blue Torch Finance LLC (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Blue Torch&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;), as administrative agent and collateral agent, pursuant to which the full amount of $75 million was borrowed and funded (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;BT Term Loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). The proceeds from the BT Term Loan were used (i) for working capital and general corporate purposes and (ii) to pay transaction fees, costs and expenses incurred in connection with the BT Term Loan and the related transactions. The BT Term Loan would have matured on June 20, 2022 and was repayable in quarterly installments of $0.9 million; the balance was due on June 20, 2022. Blue Torch maintained a first-priority security interest in substantially all the Company&#x2019;s assets. The BT Term Loan was issued net of the original issue discount of $2.3 million. The Company also incurred $6.7 million of deferred financing costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 22, 2020, the Company amended its BT Loan Agreement with Blue Torch. The amendment provided for an increase in the maximum Total Leverage Ratio, which was a quarterly test, for the remainder of 2020, and also provided for a reduction in the minimum Liquidity requirement from&#160;April 2020&#160;through and including&#160;November 2020. In connection with the amendment, the Company agreed to pay a one-time fee of $0.7 million, added to the principal balance, and a 1 percentage point increase in the interest rate to LIBOR plus 9%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 2, 2020, a portion of the proceeds from each of the sales of the Company&#x2019;s Series B Convertible Preferred Stock and the borrowings from the Hayfin Loan Transaction were used to repay the outstanding balance of principal, accrued but unpaid interest, and prepayment premium under the BT Loan Agreement. In connection with the repayment of the BT Term Loan, the Company terminated the BT Loan Agreement. The Company has no continuing obligations related to the BT Term Loan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense related to the BT Term Loan, included in interest expense, net in the unaudited condensed consolidated statements of operations was as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on principal balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of amendment fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total BT Term Loan interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Paycheck Protection Program Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applied for and on April 24, 2020 received proceeds of $10&#160;million in the form of a loan under the Paycheck Protection Program (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PPP Loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 11, 2020, the Company repaid the PPP Loan in full. There are no continuing obligations under the PPP Loan as of June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6d8cb358a527440ca633e34b0e64c145_I20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfNDA3_d77e59f6-5a9e-49c0-b838-838d73fc11f1"
      unitRef="usd">50000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i36fba5a1c02d4b94be2074d914f99d5f_I20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTEwNQ_caca2384-2561-48b4-b36f-95cbe48ac479"
      unitRef="usd">100000000</us-gaap:DebtInstrumentFaceAmount>
    <mdxg:DebtInstrumentInterestRateFloorPercentage
      contextRef="i988d17ea85c647989e6243f2f3379dbe_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTc2OQ_986ffa28-cb5d-40a8-bd29-069a0dbb88a3"
      unitRef="number">0.015</mdxg:DebtInstrumentInterestRateFloorPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i988d17ea85c647989e6243f2f3379dbe_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTc5MA_1a639345-797a-4e14-9f95-5f307d0ab8e2"
      unitRef="number">0.0675</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i3a655ae7f78948dc884c2536cdf9fd11_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTk1Mg_ced0803c-a116-4964-bfed-c379c65c1d0c"
      unitRef="number">0.005</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iafe464ecd0c245028772137cfcf6b7a0_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTk3MA_e8097392-9d0a-4415-bd4f-59309b543679"
      unitRef="number">0.025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i973342a619924d6ab0a08e0c4e94b963_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjA4NQ_66d414be-4df4-429e-8edb-016d9d3025e4"
      unitRef="number">0.065</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <mdxg:TotalNetLeverageRatio
      contextRef="ida1580ac0a56414d8129f9f379f10f0b_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjE4NQ_7caad0f9-c217-4c6f-aef8-210bf3609c15"
      unitRef="number">2.0</mdxg:TotalNetLeverageRatio>
    <mdxg:TotalNetLeverageRatio
      contextRef="i5f29d38c99bd445aa0e38a3711d8885e_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjIxOA_c6f3bfdc-45a2-4f91-907d-6015d239e9bd"
      unitRef="number">1.0</mdxg:TotalNetLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ib9bfddcbaf8f4b90bb405439470f7519_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjIyNg_1c9d60f9-27e7-4a9a-89e1-c9ac6388cf7b"
      unitRef="number">0.060</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <mdxg:TotalNetLeverageRatio
      contextRef="ib9bfddcbaf8f4b90bb405439470f7519_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjI4NA_a4c69cc0-583b-4960-b1b9-6d32ed96a2f2"
      unitRef="number">1.0</mdxg:TotalNetLeverageRatio>
    <mdxg:DebtInstrumentDefaultInterestRate
      contextRef="i988d17ea85c647989e6243f2f3379dbe_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjMwMw_b020fcb3-1711-4a75-94b4-307adb2d6d0c"
      unitRef="number">0.030</mdxg:DebtInstrumentDefaultInterestRate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i8cfe91ee3d3e4b3d9edcd8c90d48aad2_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjQ3OA_fd7ff1af-e919-435a-9320-cf061e54d60e"
      unitRef="number">0.083</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <mdxg:TotalNetLeverageRatio
      contextRef="i2aaba77a0a5f47b5a0450a1a8b2b3ea4_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjY0NA_7ad48c7b-b869-49a1-8e1a-e141372e9f67"
      unitRef="number">4.5</mdxg:TotalNetLeverageRatio>
    <mdxg:TotalNetLeverageRatio
      contextRef="i37aa6fed4311472bb500b5fe0dc149d2_D20210701-20250702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjY5MA_73a0c306-389e-44eb-a63d-27a9ff29618c"
      unitRef="number">4.0</mdxg:TotalNetLeverageRatio>
    <mdxg:DebtCovenantMinimumLiquidity
      contextRef="ie28e9a5ef3004dc196ad8be7ab8d8836_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMjg0Mw_d94c5233-2883-4829-bac5-bfde22b225e6"
      unitRef="usd">10000000</mdxg:DebtCovenantMinimumLiquidity>
    <mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent
      contextRef="i2750d4e108d4450589ec176ea4bc1a68_D20200703-20210702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMzIzMA_a8a5ce88-303d-409f-838e-2e29eb00ffd4"
      unitRef="number">0.05</mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent>
    <mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent
      contextRef="i2750d4e108d4450589ec176ea4bc1a68_D20200703-20210702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMzI3MA_afbd7d43-e91c-4ff6-8969-0258f9116ccc"
      unitRef="number">1.02</mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent>
    <mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent
      contextRef="i1cc550f11ce34dab8a1ee5533fd2f5d8_D20210703-20220702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMzUxNQ_9ee37509-5a5a-4c2e-8d3a-d5d195e864b3"
      unitRef="number">0.02</mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent>
    <mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent
      contextRef="i3c88e9fdfe1944b3a4fb9430459677f4_D20220703-20230702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMzYwMQ_d46e9456-d73c-4189-87d5-d3e57874b3b4"
      unitRef="number">0.01</mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent>
    <mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent
      contextRef="ieb2ea45a6256434aa77aa52d97c892eb_D20230703-20250702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMzY4Ng_d50d76e0-fbc1-4877-8678-6baa5cf0fa09"
      unitRef="number">0</mdxg:DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent>
    <mdxg:ScheduleofDebtIssuanceCostsTableTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTAxNjQ_f1558f6f-92bc-4c79-9e18-343303290b32">A summary of the allocation of the deferred financing costs and original issue discount between the Term Loan and the DD TL on July 2, 2020 was as follows (amounts in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.263%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 2, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD TL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Long term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</mdxg:ScheduleofDebtIssuanceCostsTableTextBlock>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ibfaa87d5ef5044f39cfb5c90c4cea4d3_I20200702"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjFkYWI5MjVmOWUxNDRkMGU4MTE0ODUxY2QzMmNhOTA2L3RhYmxlcmFuZ2U6MWRhYjkyNWY5ZTE0NGQwZTgxMTQ4NTFjZDMyY2E5MDZfMy0xLTEtMS0w_6b706c7d-6649-42a8-ac80-23b638652bcc"
      unitRef="usd">333000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i2f958b3caaef429182bf8441abc2cad2_I20200702"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjFkYWI5MjVmOWUxNDRkMGU4MTE0ODUxY2QzMmNhOTA2L3RhYmxlcmFuZ2U6MWRhYjkyNWY5ZTE0NGQwZTgxMTQ4NTFjZDMyY2E5MDZfMy0zLTEtMS0w_40d3ab8d-be4d-4ebf-8e40-c48cf1df2fbc"
      unitRef="usd">167000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i4a0a54ed1a52415a881e9947529ad09f_I20200702"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjFkYWI5MjVmOWUxNDRkMGU4MTE0ODUxY2QzMmNhOTA2L3RhYmxlcmFuZ2U6MWRhYjkyNWY5ZTE0NGQwZTgxMTQ4NTFjZDMyY2E5MDZfMy01LTEtMS0w_3d87c4da-0c26-4f96-94c0-9091c634fd1f"
      unitRef="usd">500000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="ibfaa87d5ef5044f39cfb5c90c4cea4d3_I20200702"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjFkYWI5MjVmOWUxNDRkMGU4MTE0ODUxY2QzMmNhOTA2L3RhYmxlcmFuZ2U6MWRhYjkyNWY5ZTE0NGQwZTgxMTQ4NTFjZDMyY2E5MDZfNC0xLTEtMS0w_82cab07c-efa4-44a1-bdab-417be2b04e3b"
      unitRef="usd">2169000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i2f958b3caaef429182bf8441abc2cad2_I20200702"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjFkYWI5MjVmOWUxNDRkMGU4MTE0ODUxY2QzMmNhOTA2L3RhYmxlcmFuZ2U6MWRhYjkyNWY5ZTE0NGQwZTgxMTQ4NTFjZDMyY2E5MDZfNC0zLTEtMS0w_4424c9ed-b4c4-4d2a-bb6e-c4a36e4ff251"
      unitRef="usd">1084000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i4a0a54ed1a52415a881e9947529ad09f_I20200702"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjFkYWI5MjVmOWUxNDRkMGU4MTE0ODUxY2QzMmNhOTA2L3RhYmxlcmFuZ2U6MWRhYjkyNWY5ZTE0NGQwZTgxMTQ4NTFjZDMyY2E5MDZfNC01LTEtMS0w_21de1c9c-6d48-4597-99ce-28bf7e2cdf58"
      unitRef="usd">3253000</us-gaap:DeferredFinanceCostsGross>
    <mdxg:DebtInstrumentUnusedCapacityCommitmentFeePercentage
      contextRef="ia4f4a7fffef64fbfb835915c94681b34_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfNjcxNQ_9d44496a-3c89-49c4-8e2e-ce4a8779630e"
      unitRef="number">0.01</mdxg:DebtInstrumentUnusedCapacityCommitmentFeePercentage>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTAxNTc_6919e69c-f9d7-4153-ae20-6b3f3af450d5">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The balances of the Term Loan as of June&#160;30, 2021 and December&#160;31, 2020 were as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.941%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.339%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.340%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding principal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,816)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if47b0734d0cf4bd2a2b9d44595fbacaf_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjNjYTI1MDdiN2MxMzRiYjJiNGNmZjg2ZjdmOTUyMmMyL3RhYmxlcmFuZ2U6M2NhMjUwN2I3YzEzNGJiMmI0Y2ZmODZmN2Y5NTIyYzJfMS0xLTEtMS0w_b33218b4-67ca-418a-9d6e-cd0a985384dc"
      unitRef="usd">50000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i24e573531fad49c7b4a1c7704442ac21_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjNjYTI1MDdiN2MxMzRiYjJiNGNmZjg2ZjdmOTUyMmMyL3RhYmxlcmFuZ2U6M2NhMjUwN2I3YzEzNGJiMmI0Y2ZmODZmN2Y5NTIyYzJfMS0zLTEtMS0w_e8bff143-2d08-44df-9fc9-38677a2d2d8c"
      unitRef="usd">50000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="if47b0734d0cf4bd2a2b9d44595fbacaf_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjNjYTI1MDdiN2MxMzRiYjJiNGNmZjg2ZjdmOTUyMmMyL3RhYmxlcmFuZ2U6M2NhMjUwN2I3YzEzNGJiMmI0Y2ZmODZmN2Y5NTIyYzJfMi0xLTEtMS0w_8895e9b7-ed98-4b04-98e6-8d91f5f99e58"
      unitRef="usd">1816000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i24e573531fad49c7b4a1c7704442ac21_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjNjYTI1MDdiN2MxMzRiYjJiNGNmZjg2ZjdmOTUyMmMyL3RhYmxlcmFuZ2U6M2NhMjUwN2I3YzEzNGJiMmI0Y2ZmODZmN2Y5NTIyYzJfMi0zLTEtMS0w_2f1cadd0-0e47-4559-af89-6b461b029ad7"
      unitRef="usd">1996000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="if47b0734d0cf4bd2a2b9d44595fbacaf_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjNjYTI1MDdiN2MxMzRiYjJiNGNmZjg2ZjdmOTUyMmMyL3RhYmxlcmFuZ2U6M2NhMjUwN2I3YzEzNGJiMmI0Y2ZmODZmN2Y5NTIyYzJfMy0xLTEtMS0w_c5d8b029-9392-411d-a521-45a2ca61cad9"
      unitRef="usd">279000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i24e573531fad49c7b4a1c7704442ac21_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjNjYTI1MDdiN2MxMzRiYjJiNGNmZjg2ZjdmOTUyMmMyL3RhYmxlcmFuZ2U6M2NhMjUwN2I3YzEzNGJiMmI0Y2ZmODZmN2Y5NTIyYzJfMy0zLTEtMS0w_51aaeba8-0f6b-44be-864a-596df667e510"
      unitRef="usd">307000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="if47b0734d0cf4bd2a2b9d44595fbacaf_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjNjYTI1MDdiN2MxMzRiYjJiNGNmZjg2ZjdmOTUyMmMyL3RhYmxlcmFuZ2U6M2NhMjUwN2I3YzEzNGJiMmI0Y2ZmODZmN2Y5NTIyYzJfNC0xLTEtMS0w_7f482edf-1d11-4985-8ef5-9fa37ab3ba44"
      unitRef="usd">47905000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i24e573531fad49c7b4a1c7704442ac21_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjNjYTI1MDdiN2MxMzRiYjJiNGNmZjg2ZjdmOTUyMmMyL3RhYmxlcmFuZ2U6M2NhMjUwN2I3YzEzNGJiMmI0Y2ZmODZmN2Y5NTIyYzJfNC0zLTEtMS0w_44be6e4c-1345-43a7-b8b9-d71eb9366eb8"
      unitRef="usd">47697000</us-gaap:LongTermDebt>
    <mdxg:ScheduleofInterestExpenseTableTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTAxNjU_9dc76566-1d4b-4c52-a377-80eb007098ce">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense related to the Term Loan, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stated interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense related to the DD TL, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitment fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense related to the BT Term Loan, included in interest expense, net in the unaudited condensed consolidated statements of operations was as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on principal balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of original issue discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of amendment fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total BT Term Loan interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mdxg:ScheduleofInterestExpenseTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="if5df4f4bf6ea45a98669bcf3e1a28aef_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjdlZTc4NGY1YjBmNjQ0NGVhN2VmY2EzMTg4MTE1MmVjL3RhYmxlcmFuZ2U6N2VlNzg0ZjViMGY2NDQ0ZWE3ZWZjYTMxODgxMTUyZWNfMi0xLTEtMS0w_883d70f9-94d0-431d-bd07-1741c2f1b3b7"
      unitRef="usd">1031000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i0796339395b546c6950867927cd6139b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjdlZTc4NGY1YjBmNjQ0NGVhN2VmY2EzMTg4MTE1MmVjL3RhYmxlcmFuZ2U6N2VlNzg0ZjViMGY2NDQ0ZWE3ZWZjYTMxODgxMTUyZWNfMi0zLTEtMS03MTA_20a595fe-fec3-4bdf-946e-423e638d1686"
      unitRef="usd">2062000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="if5df4f4bf6ea45a98669bcf3e1a28aef_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjdlZTc4NGY1YjBmNjQ0NGVhN2VmY2EzMTg4MTE1MmVjL3RhYmxlcmFuZ2U6N2VlNzg0ZjViMGY2NDQ0ZWE3ZWZjYTMxODgxMTUyZWNfMy0xLTEtMS0w_74cd8be9-7141-4685-b5bc-41f420dc5e21"
      unitRef="usd">92000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i0796339395b546c6950867927cd6139b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjdlZTc4NGY1YjBmNjQ0NGVhN2VmY2EzMTg4MTE1MmVjL3RhYmxlcmFuZ2U6N2VlNzg0ZjViMGY2NDQ0ZWE3ZWZjYTMxODgxMTUyZWNfMy0zLTEtMS03MTk_74e1d98f-5b10-42e6-a3c3-69ed2519a802"
      unitRef="usd">181000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="if5df4f4bf6ea45a98669bcf3e1a28aef_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjdlZTc4NGY1YjBmNjQ0NGVhN2VmY2EzMTg4MTE1MmVjL3RhYmxlcmFuZ2U6N2VlNzg0ZjViMGY2NDQ0ZWE3ZWZjYTMxODgxMTUyZWNfNC0xLTEtMS0w_51f68060-14b6-4427-9c6d-4d10cb5a6467"
      unitRef="usd">14000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i0796339395b546c6950867927cd6139b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjdlZTc4NGY1YjBmNjQ0NGVhN2VmY2EzMTg4MTE1MmVjL3RhYmxlcmFuZ2U6N2VlNzg0ZjViMGY2NDQ0ZWE3ZWZjYTMxODgxMTUyZWNfNC0zLTEtMS03MzY_0e4a13ec-8802-4d10-bb2c-afd0e922906e"
      unitRef="usd">27000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestExpenseDebt
      contextRef="if5df4f4bf6ea45a98669bcf3e1a28aef_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjdlZTc4NGY1YjBmNjQ0NGVhN2VmY2EzMTg4MTE1MmVjL3RhYmxlcmFuZ2U6N2VlNzg0ZjViMGY2NDQ0ZWE3ZWZjYTMxODgxMTUyZWNfNS0xLTEtMS0w_ca6a295a-48b8-4c14-b455-4ae5036ae5d2"
      unitRef="usd">1137000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i0796339395b546c6950867927cd6139b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjdlZTc4NGY1YjBmNjQ0NGVhN2VmY2EzMTg4MTE1MmVjL3RhYmxlcmFuZ2U6N2VlNzg0ZjViMGY2NDQ0ZWE3ZWZjYTMxODgxMTUyZWNfNS0zLTEtMS0yOTAz_c2e488cd-0f29-4c55-a76c-3c121cf4f4cc"
      unitRef="usd">2270000</us-gaap:InterestExpenseDebt>
    <mdxg:DebtInstrumentCommitmentFees
      contextRef="i942e6e118deb4bf993725d0b8307938d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjZjNjhmNTQ2MWZmYzQ0YWI4OGQ2OGFhNGY0NDhiYzJiL3RhYmxlcmFuZ2U6NmM2OGY1NDYxZmZjNDRhYjg4ZDY4YWE0ZjQ0OGJjMmJfMi0xLTEtMS0w_62952cc5-bd77-43d2-b5b7-e6ab3de033d8"
      unitRef="usd">63000</mdxg:DebtInstrumentCommitmentFees>
    <mdxg:DebtInstrumentCommitmentFees
      contextRef="ib5ea19804b864811aa3bd0894d4736be_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjZjNjhmNTQ2MWZmYzQ0YWI4OGQ2OGFhNGY0NDhiYzJiL3RhYmxlcmFuZ2U6NmM2OGY1NDYxZmZjNDRhYjg4ZDY4YWE0ZjQ0OGJjMmJfMi0zLTEtMS03NjU_023f2ee8-ba8e-4036-8f58-8c10903c067d"
      unitRef="usd">126000</mdxg:DebtInstrumentCommitmentFees>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i942e6e118deb4bf993725d0b8307938d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjZjNjhmNTQ2MWZmYzQ0YWI4OGQ2OGFhNGY0NDhiYzJiL3RhYmxlcmFuZ2U6NmM2OGY1NDYxZmZjNDRhYjg4ZDY4YWE0ZjQ0OGJjMmJfMy0xLTEtMS0w_431a1bb5-643d-4e08-962a-f0d2877c356d"
      unitRef="usd">271000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ib5ea19804b864811aa3bd0894d4736be_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjZjNjhmNTQ2MWZmYzQ0YWI4OGQ2OGFhNGY0NDhiYzJiL3RhYmxlcmFuZ2U6NmM2OGY1NDYxZmZjNDRhYjg4ZDY4YWE0ZjQ0OGJjMmJfMy0zLTEtMS03NzI_b3e3c30e-bf9d-49af-a101-057e8eb3b5ac"
      unitRef="usd">542000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i942e6e118deb4bf993725d0b8307938d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjZjNjhmNTQ2MWZmYzQ0YWI4OGQ2OGFhNGY0NDhiYzJiL3RhYmxlcmFuZ2U6NmM2OGY1NDYxZmZjNDRhYjg4ZDY4YWE0ZjQ0OGJjMmJfNC0xLTEtMS0w_35b2f630-217a-491e-a8e2-1a4ad16d7910"
      unitRef="usd">42000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ib5ea19804b864811aa3bd0894d4736be_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjZjNjhmNTQ2MWZmYzQ0YWI4OGQ2OGFhNGY0NDhiYzJiL3RhYmxlcmFuZ2U6NmM2OGY1NDYxZmZjNDRhYjg4ZDY4YWE0ZjQ0OGJjMmJfNC0zLTEtMS03Nzg_08424f0a-2f77-43ba-b790-c836551e2cd7"
      unitRef="usd">83000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestExpenseDebt
      contextRef="i942e6e118deb4bf993725d0b8307938d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjZjNjhmNTQ2MWZmYzQ0YWI4OGQ2OGFhNGY0NDhiYzJiL3RhYmxlcmFuZ2U6NmM2OGY1NDYxZmZjNDRhYjg4ZDY4YWE0ZjQ0OGJjMmJfNS0xLTEtMS0w_6173fa88-306e-41c0-8aac-a11ab0af6940"
      unitRef="usd">376000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ib5ea19804b864811aa3bd0894d4736be_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjZjNjhmNTQ2MWZmYzQ0YWI4OGQ2OGFhNGY0NDhiYzJiL3RhYmxlcmFuZ2U6NmM2OGY1NDYxZmZjNDRhYjg4ZDY4YWE0ZjQ0OGJjMmJfNS0zLTEtMS0yOTA1_7ce27ca8-5bf7-48ff-969b-b359253666ab"
      unitRef="usd">751000</us-gaap:InterestExpenseDebt>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTAxNjY_c913d81b-d36e-4ed2-a496-6c62c3532882">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Principal payments on the Term Loan as of June&#160;30, 2021 are as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (excluding the six months ended June&#160;30, 2021)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOmM3NzM1YTk3ZGU0MzQwNzQ5NDJkODRkN2UxYTJjMWE4L3RhYmxlcmFuZ2U6Yzc3MzVhOTdkZTQzNDA3NDk0MmQ4NGQ3ZTFhMmMxYThfMS0xLTEtMS0w_30fabc69-bcd2-4fbb-b51c-ae991782e063"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOmM3NzM1YTk3ZGU0MzQwNzQ5NDJkODRkN2UxYTJjMWE4L3RhYmxlcmFuZ2U6Yzc3MzVhOTdkZTQzNDA3NDk0MmQ4NGQ3ZTFhMmMxYThfMi0xLTEtMS0w_7bc8c802-cf2d-45d8-8eab-14e1ac2ca29a"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOmM3NzM1YTk3ZGU0MzQwNzQ5NDJkODRkN2UxYTJjMWE4L3RhYmxlcmFuZ2U6Yzc3MzVhOTdkZTQzNDA3NDk0MmQ4NGQ3ZTFhMmMxYThfMy0xLTEtMS0w_de964046-2dc8-43da-b389-8ebfc4653211"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOmM3NzM1YTk3ZGU0MzQwNzQ5NDJkODRkN2UxYTJjMWE4L3RhYmxlcmFuZ2U6Yzc3MzVhOTdkZTQzNDA3NDk0MmQ4NGQ3ZTFhMmMxYThfNC0xLTEtMS0w_707fcfc7-36e1-446a-bfe9-f49183065aa2"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOmM3NzM1YTk3ZGU0MzQwNzQ5NDJkODRkN2UxYTJjMWE4L3RhYmxlcmFuZ2U6Yzc3MzVhOTdkZTQzNDA3NDk0MmQ4NGQ3ZTFhMmMxYThfNS0xLTEtMS0w_c9b50fe6-5be2-4be6-8005-26a0600d504c"
      unitRef="usd">50000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <mdxg:LongTermDebtMaturityAfterYearFour
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOmM3NzM1YTk3ZGU0MzQwNzQ5NDJkODRkN2UxYTJjMWE4L3RhYmxlcmFuZ2U6Yzc3MzVhOTdkZTQzNDA3NDk0MmQ4NGQ3ZTFhMmMxYThfNi0xLTEtMS0w_dace6d5f-33f3-4ec4-940f-05a945362724"
      unitRef="usd">0</mdxg:LongTermDebtMaturityAfterYearFour>
    <us-gaap:LongTermDebt
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOmM3NzM1YTk3ZGU0MzQwNzQ5NDJkODRkN2UxYTJjMWE4L3RhYmxlcmFuZ2U6Yzc3MzVhOTdkZTQzNDA3NDk0MmQ4NGQ3ZTFhMmMxYThfNy0xLTEtMS0w_5448df09-9346-40a2-9b5e-ba5cd6d40eb5"
      unitRef="usd">50000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtFairValue
      contextRef="ia1e47a6e2d7b4dc0872d79087da38fa4_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMTA5OTUxMTYzOTMxMw_0ee1892b-c6da-4f89-b70c-0cecba7c62a3"
      unitRef="usd">52000000.0</us-gaap:LongTermDebtFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i127934462af147b1b7b36883a1681b77_I20190610"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfODMyMg_a2699a72-cad8-4c70-8714-c01a27bc3aa3"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="i202be97ddd3241418491fe12bce8c12f_D20190610-20190610"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfODY5OQ_4e37756d-28b4-4f41-9acd-fcd482ac63fa"
      unitRef="usd">900000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i127934462af147b1b7b36883a1681b77_I20190610"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfODkwNw_e6a30025-3fa7-4c09-b05c-c2982309b98a"
      unitRef="usd">2300000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i127934462af147b1b7b36883a1681b77_I20190610"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfODkzNw_f7c22622-6ab9-46d1-950e-0cd6a0007dce"
      unitRef="usd">6700000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="iea093603b31a44c6b009a07438c52b17_I20200422"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfOTM4MA_dd45b3b3-cde9-48d6-9149-a4af87ae862f"
      unitRef="usd">700000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease
      contextRef="i42392901e13144e0b50ffcaa3b266c87_D20200422-20200422"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfOTQyMg_29ca6587-530e-4006-99b9-cb4df192eafb"
      unitRef="number">0.01</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i42392901e13144e0b50ffcaa3b266c87_D20200422-20200422"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfOTQ4Ng_0fbaefda-c8ef-4991-8411-d2bcce8c9ec3"
      unitRef="number">0.09</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="ib8de3a02e7144468ba0178c4374d8f4a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfMi0zLTEtMS0w_2fc8335b-432d-4a22-aeaf-cef0d43e5888"
      unitRef="usd">1891000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i6299c3dc628d43df867e4bad14106f97_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfMi01LTEtMS0yOTA3_fdb0e722-2bde-49f3-b487-6946440ef04d"
      unitRef="usd">3731000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ib8de3a02e7144468ba0178c4374d8f4a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfMy0zLTEtMS0w_6ee612e0-9428-4e71-acb0-8f2d753bbb2e"
      unitRef="usd">183000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i6299c3dc628d43df867e4bad14106f97_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfMy01LTEtMS0yOTA3_a4efe6f6-90ad-44d2-8e29-d510d038599c"
      unitRef="usd">350000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDeferredLoanOriginationFeesNet
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfNC0zLTEtMS0yOTk1_d7abc584-b65e-449d-b10e-8e3d9b2d97fd"
      unitRef="usd">51000</us-gaap:AmortizationOfDeferredLoanOriginationFeesNet>
    <us-gaap:AmortizationOfDeferredLoanOriginationFeesNet
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfNC01LTEtMS0yOTk3_dbf915b5-d44e-4b0e-8ecf-fd3454ac5786"
      unitRef="usd">51000</us-gaap:AmortizationOfDeferredLoanOriginationFeesNet>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ib8de3a02e7144468ba0178c4374d8f4a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfNC0zLTEtMS0w_10236cf1-0b96-4b3c-be96-fd25daa00565"
      unitRef="usd">542000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i6299c3dc628d43df867e4bad14106f97_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfNS01LTEtMS0yOTA3_75dba1a5-2834-4b79-89ab-95efa7ecd60f"
      unitRef="usd">1040000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:InterestExpenseDebt
      contextRef="ib8de3a02e7144468ba0178c4374d8f4a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfNS0zLTEtMS0w_76f14a7e-fbcc-4cad-a176-4be88da63c93"
      unitRef="usd">2667000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i6299c3dc628d43df867e4bad14106f97_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RhYmxlOjVlNmRhMDdhYTA4MTRhY2ZiNDNiY2EzMzY4NDI4ZjVkL3RhYmxlcmFuZ2U6NWU2ZGEwN2FhMDgxNGFjZmI0M2JjYTMzNjg0MjhmNWRfNi01LTEtMS0yOTA3_58877636-e0cb-4462-8095-144c49d8db63"
      unitRef="usd">5172000</us-gaap:InterestExpenseDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i065ebf02aa6941e1bdf67379b756096e_D20200424-20200424"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV81OC9mcmFnOjc4ZDk3OGRjODMwYzRhMTZhZjhmYTRhZTM1NGYwMDI5L3RleHRyZWdpb246NzhkOTc4ZGM4MzBjNGExNmFmOGZhNGFlMzU0ZjAwMjlfMzg0ODI5MDcwOTU5Nw_2efe261e-5f45-4bec-a14d-0d2314d2b692"
      unitRef="usd">10000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RleHRyZWdpb246ZjRlMmJkMzA0NzkxNDI5NTkzYWJlZjg1ZTZkNzc2NjhfMjQ5Mg_d5f7c10d-c63d-4c7f-af52-97902cbf2d4b">Net Loss Per Common Share&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss per common share is calculated using two methods: basic and diluted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basic Net Loss Per Common Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per common share is calculated as net loss available to common stockholders divided by weighted average common shares outstanding. Net loss available to common stockholders is calculated as net loss less (i) dividends accumulated on the Company&#x2019;s Series B Convertible Preferred Stock during the period, and (ii) periodic accretion of the increasing-rate dividend feature.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of net loss to net loss available to common stockholders and calculation of basic net loss per common share for each of the three and six months ended June&#160;30, 2021 and 2020 (amounts in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,779)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile to net (loss) income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated dividend on Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of increasing-rate dividend feature&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,276,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,119,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,841,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,081,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Diluted Net Loss Per Common Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted net loss per common share is calculated as net loss available to common stockholders, adjusted for dividends on convertible preferred stock (to the extent such conversions would be dilutive), divided by weighted average common shares outstanding plus potential common shares. The calculation of potential common shares considers incremental shares resulting from certain transactions, including the exercise of stock options and the issuance of restricted stock using the treasury stock method, as well as the hypothetical conversion of the Company&#x2019;s Series B Convertible Preferred Stock using the if-converted method. The treasury stock method assumes that proceeds from the transaction are used to purchase common stock at the average market price throughout the period. The if-converted method adds back dividends accrued or deemed on the Company&#x2019;s Series B Convertible Preferred Stock and assumes conversion as of the later of the beginning of the period or the original transaction date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each individual transaction is assessed for its dilutive effect on net loss per common share. To the extent that the transaction is antidilutive, or does not reduce net loss per common share, the effect is excluded from the calculation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of diluted net loss per common share (in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.579%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends on Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,276,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,119,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,841,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,081,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Potential common shares (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,373,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,232,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,117,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding adjusted for potential common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,276,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,119,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,841,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,081,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Potential common shares reflects hypothetical transactions involving convertible securities and share-based payment awards using the if-converted and treasury stock methods, respectively. The effect of each of these adjustments on the calculation is presented in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,758,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,497,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,450,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,386,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock unit awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance stock unit awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Potential common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,373,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,232,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,117,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RleHRyZWdpb246ZjRlMmJkMzA0NzkxNDI5NTkzYWJlZjg1ZTZkNzc2NjhfMjQ4OQ_9c6d5b8d-affd-4338-82ba-13a3f27e0fbe">The following table provides a reconciliation of net loss to net loss available to common stockholders and calculation of basic net loss per common share for each of the three and six months ended June&#160;30, 2021 and 2020 (amounts in thousands, except share and per share amounts):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,779)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to reconcile to net (loss) income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated dividend on Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion of increasing-rate dividend feature&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,276,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,119,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,841,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,081,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMi0xLTEtMS0w_6a272aff-9408-4377-82b4-48731bd02157"
      unitRef="usd">-1779000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMi0zLTEtMS0w_4547fee4-c0b4-44d3-a533-11b0a81faa9c"
      unitRef="usd">-8466000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLoss
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMi0zLTEtMS0w_e8f00e35-0717-4ffd-81e3-85d89639053e"
      unitRef="usd">-8466000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMi01LTEtMS0w_9ded7a20-518c-4710-8cee-08ecc0dddfd2"
      unitRef="usd">-10161000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMi03LTEtMS0w_b2ea3acb-bc5c-4ab5-8287-90be469a9b2e"
      unitRef="usd">-13287000</us-gaap:NetIncomeLoss>
    <mdxg:TemporaryEquityAccretedbutUnrecordedDividends
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNC0xLTEtMS0w_6f258700-3786-4203-8450-46bb5145d8d4"
      unitRef="usd">1033000</mdxg:TemporaryEquityAccretedbutUnrecordedDividends>
    <mdxg:TemporaryEquityAccretedbutUnrecordedDividends
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNC0zLTEtMS0w_27941400-519e-40f3-a75f-57dc2326af88"
      unitRef="usd">0</mdxg:TemporaryEquityAccretedbutUnrecordedDividends>
    <mdxg:TemporaryEquityAccretedbutUnrecordedDividends
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNC01LTEtMS0w_92d900b9-6922-4d66-a487-3b776d97b326"
      unitRef="usd">2039000</mdxg:TemporaryEquityAccretedbutUnrecordedDividends>
    <mdxg:TemporaryEquityAccretedbutUnrecordedDividends
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNC03LTEtMS0w_22fc3e69-5a6a-4d9a-9666-c55e5bbaed86"
      unitRef="usd">0</mdxg:TemporaryEquityAccretedbutUnrecordedDividends>
    <mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNi0xLTEtMS0w_25ceb438-a8bf-41a1-bc90-bc86931a5272"
      unitRef="usd">464000</mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature>
    <mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNi0zLTEtMS0w_187c3661-30cd-4559-aeb2-1d2ad94fdbe6"
      unitRef="usd">0</mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature>
    <mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNi01LTEtMS0w_1b3433e5-cf33-4a4c-98b0-aa2addc4f54b"
      unitRef="usd">926000</mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature>
    <mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNi03LTEtMS0w_797b5f36-993e-4bf7-bf67-fee3ccb962bb"
      unitRef="usd">0</mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature>
    <mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNy0xLTEtMS0w_0f2dc312-982f-4212-a394-77bec933cef8"
      unitRef="usd">1497000</mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders>
    <mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNy0zLTEtMS0w_3756f58a-5051-4b36-9b20-47949fd652b1"
      unitRef="usd">0</mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders>
    <mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNy01LTEtMS0w_899b3f52-1663-4bc6-b756-05e8512cd6ef"
      unitRef="usd">2965000</mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders>
    <mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfNy03LTEtMS0w_346a8480-0bb1-4b52-b494-029a40c2d319"
      unitRef="usd">0</mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOC0xLTEtMS0w_85c8ac5d-bc90-465d-b397-defc416ce8ff"
      unitRef="usd">-3276000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOC0zLTEtMS0w_58ba38b2-1548-4d5b-8bbe-daebcfde358f"
      unitRef="usd">-8466000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOC01LTEtMS0w_d0e520ae-0fef-4854-bd43-2944c39defd8"
      unitRef="usd">-13126000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOC03LTEtMS0w_5c665667-7ee8-423a-8f97-63a4e93558e8"
      unitRef="usd">-13287000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS0xLTEtMS0w_f5bddecb-6180-49ff-933c-8243b2dc142e"
      unitRef="shares">110276636</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS0xLTEtMS0w_f5d937dc-14be-442a-b8e5-3e6a6198a841"
      unitRef="shares">110276636</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS0xLTEtMS0w_fbd3bfce-59f9-48dc-a53c-9125d0d868dc"
      unitRef="shares">110276636</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS0zLTEtMS0w_92be8069-f672-4e66-9d39-ad763174062f"
      unitRef="shares">108119461</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS0zLTEtMS0w_bdf4c466-4d49-47d3-a19c-e4e697bcdccd"
      unitRef="shares">108119461</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS0zLTEtMS0w_e64fc3c8-39f3-4eb3-a698-006835fccebd"
      unitRef="shares">108119461</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS01LTEtMS0w_2feaace4-e7f0-4d44-9c05-edc84b830e0a"
      unitRef="shares">109841428</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS01LTEtMS0w_67d93b88-69c1-46ae-909b-55f8467630f5"
      unitRef="shares">109841428</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS01LTEtMS0w_6cb305a7-3ddc-4fa4-b92f-3ef94b359694"
      unitRef="shares">109841428</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS03LTEtMS0w_4b150d1b-43d9-4e6e-be3b-614efc84e099"
      unitRef="shares">108081625</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS03LTEtMS0w_a8e4888c-ef3c-4225-a2e2-e3232b652f41"
      unitRef="shares">108081625</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfOS03LTEtMS0w_eeed6b3f-e9d5-45a1-905b-41dc7ab36bde"
      unitRef="shares">108081625</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMTAtMS0xLTEtMA_b57c1f02-c55d-4a4c-a1a7-c8c7194e4eed"
      unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMTAtMy0xLTEtMA_13f9916d-6d6a-4ce9-a0f3-fe2ae116d756"
      unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMTAtNS0xLTEtMA_cd497db7-210b-4529-9fbb-51e543dcde31"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjIyNDQ0MTExZDMwZjQ0ZGJiZDY1MjM4ZjZhMjIyNGE4L3RhYmxlcmFuZ2U6MjI0NDQxMTFkMzBmNDRkYmJkNjUyMzhmNmEyMjI0YThfMTAtNy0xLTEtMA_5bd643b3-cffa-41ee-a20e-18a0e6274d5a"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RleHRyZWdpb246ZjRlMmJkMzA0NzkxNDI5NTkzYWJlZjg1ZTZkNzc2NjhfMjQ5Ng_f19f0595-5925-44af-aa8f-ff3c2fd413e6">&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of diluted net loss per common share (in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.579%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends on Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,276,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,119,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,841,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,081,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Potential common shares (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,373,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,232,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,117,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding adjusted for potential common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,276,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,119,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,841,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,081,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Potential common shares reflects hypothetical transactions involving convertible securities and share-based payment awards using the if-converted and treasury stock methods, respectively. The effect of each of these adjustments on the calculation is presented in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,758,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,497,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,450,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,386,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock unit awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance stock unit awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Potential common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,373,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,232,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,117,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfMi0xLTEtMS0w_2c24b7d7-66db-497d-84be-71ab5ef62735"
      unitRef="usd">-3276000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfMi0zLTEtMS0w_58ba38b2-1548-4d5b-8bbe-daebcfde358f"
      unitRef="usd">-8466000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfMi01LTEtMS0w_d0e520ae-0fef-4854-bd43-2944c39defd8"
      unitRef="usd">-13126000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfMi03LTEtMS0w_5c665667-7ee8-423a-8f97-63a4e93558e8"
      unitRef="usd">-13287000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfMy0xLTEtMS0w_e5a670d9-4e27-4175-bfd5-7d95a2c65fa8"
      unitRef="usd">1497000</mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders>
    <mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfMy0zLTEtMS0w_2726a856-a693-4841-acd7-0cafeecc1c51"
      unitRef="usd">0</mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders>
    <mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfMy01LTEtMS0w_899b3f52-1663-4bc6-b756-05e8512cd6ef"
      unitRef="usd">2965000</mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders>
    <mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfMy03LTEtMS0w_346a8480-0bb1-4b52-b494-029a40c2d319"
      unitRef="usd">0</mdxg:AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNC0xLTEtMS0w_73a57c05-d02e-4843-98de-15d0eeabf0d7"
      unitRef="usd">-3276000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNC0zLTEtMS0w_c2b8a1e7-5021-4c13-968c-e0d55a4ef71a"
      unitRef="usd">-8466000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNC01LTEtMS0w_69e0cc54-600e-49ff-9526-eb2035523679"
      unitRef="usd">-13126000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNC03LTEtMS0w_0cdf7616-09b0-4333-a430-2a11d83cd86b"
      unitRef="usd">-13287000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNS0xLTEtMS0w_b3e3bcd5-3134-486c-963d-a23f933f82bf"
      unitRef="shares">110276636</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNS0zLTEtMS0w_c029577b-d376-4123-984e-b61f9b0d3310"
      unitRef="shares">108119461</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNS01LTEtMS0w_bdd816bf-4b56-47f5-84c9-ed7ee1197e65"
      unitRef="shares">109841428</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNS03LTEtMS0w_7d090e18-575f-4e15-babc-16d0ccdafd84"
      unitRef="shares">108081625</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNi0xLTEtMS0w_54964c21-897a-4080-b80d-17e034b85abc"
      unitRef="shares">30373856</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNi0zLTEtMS0w_8657672c-828b-49f4-bef2-d21b31216d42"
      unitRef="shares">1635618</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNi01LTEtMS0w_7b14e897-7d5b-46a2-8b71-a176adc90904"
      unitRef="shares">30232150</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNi03LTEtMS0w_05bbc296-f6f3-4f88-b6fc-aa47a22f9ca2"
      unitRef="shares">2117833</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNy0xLTEtMS0w_dcfababc-52ff-4d38-9566-090fa3c8e8b2"
      unitRef="shares">110276636</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNy0zLTEtMS0w_b97b7418-58df-47b3-9681-94181124983f"
      unitRef="shares">108119461</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNy01LTEtMS0w_62b93e99-f432-48f8-8b55-51e3687b5f60"
      unitRef="shares">109841428</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfNy03LTEtMS0w_044485c1-e240-4772-84bb-722fbe376dbe"
      unitRef="shares">108081625</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfOC0xLTEtMS0w_b833012b-448c-48d8-986c-7a0b952e94c7"
      unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfOC0zLTEtMS0w_b5de18ae-b6bd-49a7-9cab-bfb6acae66f2"
      unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfOC01LTEtMS0w_08c6326e-c3fb-498b-b418-4800101faaa0"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjNjZTc0NmNlYjRiNzRiMTRiYWZmZDBhZWM5M2RkM2M5L3RhYmxlcmFuZ2U6M2NlNzQ2Y2ViNGI3NGIxNGJhZmZkMGFlYzkzZGQzYzlfOC03LTEtMS0w_5186db26-b495-40b6-a4ae-ecae3bbe43c6"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib5d9cce6f74d4093affc241694089467_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfMi0xLTEtMS0w_f823db86-198b-4fad-879b-11cdf3b1a4a9"
      unitRef="shares">26758916</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8bce3a37af914ed9bc5f8c6c3bc59d45_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfMi0zLTEtMS0w_8215d524-66fc-4df1-aa54-aadbd6cb51eb"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic4f8987ea15d4408a2035650b2c87f80_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfMi01LTEtMS0w_5cfd973d-68e8-46ec-97a4-8cfac40de93a"
      unitRef="shares">26497570</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7ed571a8257d42d0a215125b4da04164_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfMi03LTEtMS0w_1b880bbb-c2df-492a-94a1-e73afeb32523"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1e66c91f80be4fd983fd0e3efb808448_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfMy0xLTEtMS0w_5ebb876a-f7d5-4b45-9a68-a64f2fc2dc61"
      unitRef="shares">1271626</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8010a62ee3794b6c895396a9baf80f0b_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfMy0zLTEtMS0w_e2767f34-74d5-4d7d-932b-0a077ebb171a"
      unitRef="shares">1044479</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id7c826330d9d41ec9b4befdcda0afa9b_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfMy01LTEtMS0w_c5bb0b08-9781-4974-a9ef-cc29cd0a184f"
      unitRef="shares">1450671</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0d26eec9d61c46dc81a087e6461dcb69_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfMy03LTEtMS0w_144e7e07-72eb-4e95-8d0b-77d458d0ac9d"
      unitRef="shares">1386674</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ida46e7ad09274073ab420623ea4c37dd_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNC0xLTEtMS0w_1bc98383-0dc4-4c21-85e7-0cc43ff61d8c"
      unitRef="shares">1471412</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i47d7bba684bf44828fe6f1b9f07feeff_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNC0zLTEtMS0w_1db7792b-2855-4006-a379-f1b763bc1bee"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4a894936a837468783a21f9dfa898b71_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNC01LTEtMS0w_e6b22e11-89c9-4a38-af48-1596387a9246"
      unitRef="shares">1345953</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9fd65f6db4c84b2584ef68fc69fd6b76_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNC03LTEtMS0w_a92db18c-e066-4194-b96c-7950f29453b8"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3bc25263e6e64af3b15df41c8754ccca_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNS0xLTEtMS0w_50c7f009-6769-417a-9aaa-f019fb8caef9"
      unitRef="shares">838644</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9c4217efe8eb4763aa03a1421b865da2_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNS0zLTEtMS0w_c70a4e5f-c25b-417b-919a-2b2afb6b1b93"
      unitRef="shares">562513</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if97f9edcdca840aa946e43c3245c6e72_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNS01LTEtMS0w_16bab86e-f72a-48be-b3bd-a7d489d8b571"
      unitRef="shares">906811</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie877a21137404e27bf43f4596c236a0b_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNS03LTEtMS0w_63e75377-170a-4bd3-b5a3-22efc0049c37"
      unitRef="shares">714600</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i559662d3c9bb44b2ac2b0a2d023a981b_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNi0xLTEtMS0w_7587ee16-1d8b-4c85-ad10-012f0299134e"
      unitRef="shares">33258</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5e6cb875ef234a24a387547a3a122428_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNi0zLTEtMS0w_a0ed03a5-f0e9-461e-ac2f-2940a636e475"
      unitRef="shares">28626</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i89c45fca675442c183fc2fb72b865f09_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNi01LTEtMS0w_5fba5a51-31e4-461d-a750-8503895fa98a"
      unitRef="shares">31145</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i21cedcbc67b9433fb42883dc4ec104eb_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNi03LTEtMS0w_f1a3c2f0-880e-4ee7-945a-ab4ab1d5d5e2"
      unitRef="shares">16559</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNy0xLTEtMS0w_54964c21-897a-4080-b80d-17e034b85abc"
      unitRef="shares">30373856</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNy0zLTEtMS0w_2c135671-f825-45a1-95ad-fc3d2b965ba1"
      unitRef="shares">1635618</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNy01LTEtMS0w_1d8a67f3-17dd-4fb4-92cb-3ccc28e21b9f"
      unitRef="shares">30232150</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82MS9mcmFnOmY0ZTJiZDMwNDc5MTQyOTU5M2FiZWY4NWU2ZDc3NjY4L3RhYmxlOjM5ZGQ3MGYyYWQwMzQwZDA4NTM0ZjE5MzkzNDFkYmViL3RhYmxlcmFuZ2U6MzlkZDcwZjJhZDAzNDBkMDg1MzRmMTkzOTM0MWRiZWJfNy03LTEtMS0w_25fa6f95-547b-4069-b258-6d5eea58e2e1"
      unitRef="shares">2117833</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfNTE2MQ_45708137-de3d-4260-a1d8-ee07d95eb933">Equity&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Series B Convertible Preferred Stock &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 2, 2020, the Company issued $100 million of the Company&#x2019;s Series B Convertible Preferred Stock, par value $0.001 per share (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;), to an affiliate of EW Healthcare Partners and to certain funds managed by Hayfin Capital Management LLP (individually, the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Holder&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#x201d; collectively the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Holders&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;) pursuant to a Securities Purchase Agreement with Falcon Fund 2 Holding Company, L.P., an affiliate of EW Healthcare Partners, and certain funds managed by Hayfin, dated as of June 30, 2020 (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Securities Purchase Agreement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;), for an aggregate purchase price of $100 million (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred Stock Transaction&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series B Preferred Stock paid a 4.0% cumulative dividend per annum prior to the quarterly dividend payment ending on June 30, 2021, and pays a 6.0% cumulative dividend per annum thereafter. Dividends are declared at the sole discretion of the Company&#x2019;s board of directors. Dividends are paid at the end of each quarter based for dividend amounts that accumulate beginning on the last payment date through the day prior to the end of each quarter. In lieu of paying a dividend, the Company may elect to accrue the dividend owed to shareholders. Accrued dividend balances accumulate dividends at the prevailing dividend rate for each dividend period for which they are outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of Series B Preferred Stock, including any accumulated and unpaid dividends, is convertible into Company&#x2019;s common stock at any time at the option of the Holder at a conversion price of $3.85 per common share, or 259.74 common shares for each share of Series B Preferred Stock prior to any accumulated and unpaid dividends. The Series B Preferred Stock, including any accumulated and unpaid dividends, automatically converts into common stock at any time after the third anniversary of the issuance date, provided that the common stock has traded at 200% or more of the conversion price for 20 out of 30 consecutive trading days and on such date of conversion the common stock has traded at 200% or more of the conversion price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the Series B Preferred Stock, voting as a class, generally are entitled to elect two members to the board of directors. Holders of the Series B Preferred Stock are entitled to vote on all matters to be voted on by the Company&#x2019;s shareholders on an as-converted basis as a single class with the common stock not to exceed 19.9% of the total voting stock of the Company. Holders of the Series B Preferred Stock are also entitled to a liquidation preference in an amount equal to the original issue price plus all accumulated and unpaid dividends in the event of a liquidation, dissolution, or winding-up of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series B Preferred Stock instrument contains an increasing-rate cumulative dividend feature. The Company determined the present value of the difference between the (1) dividends that will be payable, in the period preceding commencement of the perpetual dividend; and (2) the perpetual dividend amount for a corresponding number of periods to ascribe a fair value to this feature. The present value is calculated using a market rate for dividend yield. The Company calculated the amount of the increasing-rate dividend feature as $1.8 million. This amount is amortized as a deemed dividend to preferred shareholders using the effective interest method through the commencement date of the Perpetual Dividend Rate. During the three and six months ended June&#160;30, 2021, the Company recognized $0.5 million and $0.9 million of deemed dividends related to the amortization of the increasing rate dividend feature.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company undergoes a change of control, the Company will have the option to repurchase some or all of the then-outstanding shares of Series B Preferred Stock for cash in an amount equal to the liquidation preference, subject to the rights of the holders of the Series B Preferred Stock in connection with such change in control. If the Company does not exercise such repurchase right, holders of the Series B Preferred Stock will have the option to (1) require the Company to repurchase any or &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;all of their then-outstanding shares of Series B Preferred Stock for cash in an amount equal to the liquidation preference or (2) convert the Series B Preferred Stock, including accumulated and unpaid dividends into common stock and receive their pro rata consideration thereunder. Because the contingent redemption of the Series B Preferred Stock by the holders in the event of change in control is outside the Company&#x2019;s control, the Series B Preferred Stock is classified as temporary equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table illustrates changes in the Company&#x2019;s balance of Series B Preferred Stock for the three months ended June&#160;30, 2021 (in thousands, except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table illustrates changes in the Company&#x2019;s balance of Series B Preferred Stock for the six months ended June&#160;30, 2021 (in thousands, except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has not declared or paid any dividends on the Series B Convertible Preferred Stock since issuance. Dividends in accumulated but not paid as of June&#160;30, 2021 was $4.1 million. As this amount has not been declared, the Company has not recorded this amount on its unaudited condensed consolidated balance sheet as of June&#160;30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on accumulated dividends as of June&#160;30, 2021, the Series B Convertible Preferred Stock was convertible into an aggregate of 27,027,252 shares of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has issued several classes of restricted stock awards to employees: restricted stock (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RSAs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;), restricted stock unit awards (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;RSUs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;), and performance stock unit awards (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;PSUs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;). The following is summary information for restricted stock awards for the six months ended June 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, there was $33.0&#160;million of unrecognized share-based compensation expense related to restricted stock awards. That expense is expected to be recognized over a weighted-average period of 2.41 years, which approximates the remaining vesting period of these grants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table summarizes activity of unvested restricted stock awards by award type from January 1, 2021 through June&#160;30, 2021. Unvested RSA awards noted below are included in issued and outstanding common stock as of June&#160;30, 2021, while unvested RSUs and PSUs are not included in issued or outstanding common stock as of June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Grant Date&lt;br/&gt;&#160;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Grant Date&lt;br/&gt;&#160;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Grant Date&lt;br/&gt;&#160;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at January 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,325,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,957,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(862,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(761,775)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at June&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,405,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of stock option activity for the three months ended June 30, 2021 is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.015%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.731%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(494,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested options forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested options expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at June&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,481,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,974,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at June&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,481,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,974,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTA1_6a1a79e5-7146-4f9a-be4e-11a90eb26a47"
      unitRef="usd">100000000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i7a8becc5cd6748029d491e754d21f558_I20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTcz_bb0d098e-e001-4943-8c12-eaee952893c2"
      unitRef="usdPerShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <mdxg:ProceedsfromIssuanceofTemporaryEquity
      contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfNjQ0_a2b07691-08eb-4d82-bab0-0cd4f3d2c39f"
      unitRef="usd">100000000</mdxg:ProceedsfromIssuanceofTemporaryEquity>
    <mdxg:TemporaryEquityDividendRatePercentage
      contextRef="i921b8b2918b843b0957acbb1acd7cb40_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfNzIx_63838622-c1c4-4bc9-961f-2a4e0e90e144"
      unitRef="number">0.040</mdxg:TemporaryEquityDividendRatePercentage>
    <mdxg:TemporaryEquityDividendRatePercentage
      contextRef="ib585d269397a4280a16c10b8e637430b_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfODI1_1dbe6b48-5c43-4f13-96fb-449a77059182"
      unitRef="number">0.060</mdxg:TemporaryEquityDividendRatePercentage>
    <mdxg:TemporaryEquityConversionPricePerShare
      contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTU1Ng_626d585a-2d96-4c24-bb40-16bc4070f94f"
      unitRef="usdPerShare">3.85</mdxg:TemporaryEquityConversionPricePerShare>
    <mdxg:TemporaryEquityConversionRatio
      contextRef="i7a8becc5cd6748029d491e754d21f558_I20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTU4MA_c88e7956-ad24-479f-804c-d478de80cbc1"
      unitRef="number">259.74</mdxg:TemporaryEquityConversionRatio>
    <mdxg:TemporaryEquityConversionThresholdPercentageofStockPriceTrigger
      contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTkxMw_28f9d561-59bc-4061-aa4e-0c3a1c2a51b2"
      unitRef="number">2</mdxg:TemporaryEquityConversionThresholdPercentageofStockPriceTrigger>
    <mdxg:TemporaryEquityConversionThresholdTradingDays
      contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTk1Mg_d4e72038-5e6c-4428-bf60-8a2643190b54"
      unitRef="day">20</mdxg:TemporaryEquityConversionThresholdTradingDays>
    <mdxg:TemporaryEquityThresholdConsecutiveTradingDays
      contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTk2Mg_92287373-f502-4715-98d8-9d55cf419467"
      unitRef="day">30</mdxg:TemporaryEquityThresholdConsecutiveTradingDays>
    <mdxg:TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion
      contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMjA1Mg_0cda5e43-a372-4aae-9563-793bb41ae100"
      unitRef="number">2</mdxg:TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion>
    <mdxg:NumberofBoardSeatsElectedbyTemporaryEquityHolders
      contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMjE3MA_0f973d01-4336-4849-b03a-396cf4e34785"
      unitRef="director">2</mdxg:NumberofBoardSeatsElectedbyTemporaryEquityHolders>
    <mdxg:TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis
      contextRef="ida254e317ad2466f921f0ca9b8fc9395_D20200702-20200702"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMjQwOA_5407f6d1-4079-4cbe-8609-88d3fd94384d"
      unitRef="number">0.199</mdxg:TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis>
    <mdxg:TemporaryEquityIncreasingrateDividendFeature
      contextRef="i7a8becc5cd6748029d491e754d21f558_I20200702"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMzIzNg_b9594578-b9ed-47db-94b5-c083c688ad14"
      unitRef="usd">1800000</mdxg:TemporaryEquityIncreasingrateDividendFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i6be9faea4b8c45d299d9f176ac10cfcd_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMzQ2NA_313c9239-4ae5-43f9-b0d8-9325ee5367f2"
      unitRef="usd">500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i3cb990ced5454e60b46fb9974649db9f_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTA5OTUxMTYzMzkxOA_91d94b62-fb04-4c06-b1e6-d0af26e1cd2b"
      unitRef="usd">900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:TemporaryEquityTableTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfNTE2Mg_0d2a957e-b5ab-4f35-8ae6-c1f5140a4821">&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table illustrates changes in the Company&#x2019;s balance of Series B Preferred Stock for the three months ended June&#160;30, 2021 (in thousands, except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table illustrates changes in the Company&#x2019;s balance of Series B Preferred Stock for the six months ended June&#160;30, 2021 (in thousands, except share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.610%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i16cc01f782b84ac9b6f4b691a457573d_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk2ZDc4ZmY1NjMzNjRlYzk4NjYzZDRhMDljNDY2OWYxL3RhYmxlcmFuZ2U6OTZkNzhmZjU2MzM2NGVjOTg2NjNkNGEwOWM0NjY5ZjFfMi0xLTEtMS0w_808e04a1-d0da-424d-951e-c4957435dba4"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i16cc01f782b84ac9b6f4b691a457573d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk2ZDc4ZmY1NjMzNjRlYzk4NjYzZDRhMDljNDY2OWYxL3RhYmxlcmFuZ2U6OTZkNzhmZjU2MzM2NGVjOTg2NjNkNGEwOWM0NjY5ZjFfMi0zLTEtMS0w_e62a83a3-c5d4-401e-9782-8e8976eafb8f"
      unitRef="usd">92030000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i6be9faea4b8c45d299d9f176ac10cfcd_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk2ZDc4ZmY1NjMzNjRlYzk4NjYzZDRhMDljNDY2OWYxL3RhYmxlcmFuZ2U6OTZkNzhmZjU2MzM2NGVjOTg2NjNkNGEwOWM0NjY5ZjFfMy0zLTEtMS0w_151eb878-f121-4bc1-8f13-bf6f60d76336"
      unitRef="usd">464000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i737e0eaa5bad434fa72a35230884fc03_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk2ZDc4ZmY1NjMzNjRlYzk4NjYzZDRhMDljNDY2OWYxL3RhYmxlcmFuZ2U6OTZkNzhmZjU2MzM2NGVjOTg2NjNkNGEwOWM0NjY5ZjFfNC0xLTEtMS0w_9b8350ca-8700-4acc-b3d6-74b51cb223f4"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i737e0eaa5bad434fa72a35230884fc03_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk2ZDc4ZmY1NjMzNjRlYzk4NjYzZDRhMDljNDY2OWYxL3RhYmxlcmFuZ2U6OTZkNzhmZjU2MzM2NGVjOTg2NjNkNGEwOWM0NjY5ZjFfNC0zLTEtMS0w_52f1fe41-6f52-4807-86f4-dcd1371f4ff3"
      unitRef="usd">92494000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="iaddd4342ea2443bb9b81a46e5ee973a5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk5OTg3N2ZiNjY4ODRmYWM5MDcyYWZhNjNlZmY5MDc1L3RhYmxlcmFuZ2U6OTk5ODc3ZmI2Njg4NGZhYzkwNzJhZmE2M2VmZjkwNzVfMi0xLTEtMS0yODYy_3495f2cc-8d2a-400e-99f5-74552c96757a"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="iaddd4342ea2443bb9b81a46e5ee973a5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk5OTg3N2ZiNjY4ODRmYWM5MDcyYWZhNjNlZmY5MDc1L3RhYmxlcmFuZ2U6OTk5ODc3ZmI2Njg4NGZhYzkwNzJhZmE2M2VmZjkwNzVfMi0zLTEtMS0yODYy_147d5e94-7d16-4c13-bcf3-8bf5e517179f"
      unitRef="usd">91568000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i3cb990ced5454e60b46fb9974649db9f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk5OTg3N2ZiNjY4ODRmYWM5MDcyYWZhNjNlZmY5MDc1L3RhYmxlcmFuZ2U6OTk5ODc3ZmI2Njg4NGZhYzkwNzJhZmE2M2VmZjkwNzVfMy0zLTEtMS0yODYy_5f5f03ff-f967-46ad-83bf-441a8a90df6f"
      unitRef="usd">926000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i737e0eaa5bad434fa72a35230884fc03_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk5OTg3N2ZiNjY4ODRmYWM5MDcyYWZhNjNlZmY5MDc1L3RhYmxlcmFuZ2U6OTk5ODc3ZmI2Njg4NGZhYzkwNzJhZmE2M2VmZjkwNzVfNC0xLTEtMS0yOTE3_5d1610e7-f221-41eb-a274-3e9eee8d325d"
      unitRef="shares">100000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i737e0eaa5bad434fa72a35230884fc03_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjk5OTg3N2ZiNjY4ODRmYWM5MDcyYWZhNjNlZmY5MDc1L3RhYmxlcmFuZ2U6OTk5ODc3ZmI2Njg4NGZhYzkwNzJhZmE2M2VmZjkwNzVfNC0zLTEtMS0yOTIx_78cf613d-7d92-4d7d-86d3-36200257f135"
      unitRef="usd">92494000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <mdxg:TemporaryEquityAccretedbutUnrecordedDividends
      contextRef="i3cb990ced5454e60b46fb9974649db9f_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTA5OTUxMTYzNDIxNg_0159d1f7-0c09-49cf-a011-aafe9642b85f"
      unitRef="usd">4100000</mdxg:TemporaryEquityAccretedbutUnrecordedDividends>
    <mdxg:TemporaryEquitySharesIssueduponConversion
      contextRef="i737e0eaa5bad434fa72a35230884fc03_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTA5OTUxMTYzNDI1MA_7b429fe1-231b-4db2-8dde-1ee33e5861b0"
      unitRef="shares">27027252</mdxg:TemporaryEquitySharesIssueduponConversion>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTA5OTUxMTYzMzI2MA_30afeed0-93fa-4192-940d-bb2e631cd4c0"
      unitRef="usd">33000000.0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfMTA5OTUxMTYzMzQyMg_bca773bd-b0bc-46b3-b0ea-0161f95e8e17">P2Y4M28D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfNDk0NzgwMjMzMTEwMw_03356514-207b-4f8b-bffa-0a4a5c6b0e31">&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The below table summarizes activity of unvested restricted stock awards by award type from January 1, 2021 through June&#160;30, 2021. Unvested RSA awards noted below are included in issued and outstanding common stock as of June&#160;30, 2021, while unvested RSUs and PSUs are not included in issued or outstanding common stock as of June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Grant Date&lt;br/&gt;&#160;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Grant Date&lt;br/&gt;&#160;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Grant Date&lt;br/&gt;&#160;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at January 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,325,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,957,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(862,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(761,775)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(116,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at June&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,265,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,405,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i4546c782bd4c4b0d9660d32d5de807aa_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMi0xLTEtMS0yNQ_72cce751-e693-4ad3-a282-2f361e343fb9"
      unitRef="shares">2175859</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i4546c782bd4c4b0d9660d32d5de807aa_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMi0yLTEtMS0yNQ_e55a42a5-1484-4d2c-90c0-96c414ff2822"
      unitRef="usdPerShare">4.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i7ff6f3016254469984a003f5d14d5292_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMi00LTEtMS0yNQ_aa945404-7af2-420c-80df-27e9760b23f3"
      unitRef="shares">2325273</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i7ff6f3016254469984a003f5d14d5292_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMi01LTEtMS0yNQ_c1dd7cec-ccec-418d-be6c-9181007389c9"
      unitRef="usdPerShare">5.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia78110d12796433b9330985e2b4ef783_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMi03LTEtMS0yNQ_abbfcfff-4d09-4274-b679-a29c4c1d4fc8"
      unitRef="shares">35212</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia78110d12796433b9330985e2b4ef783_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMi04LTEtMS0yNQ_62e69f0f-151f-4ba5-9aad-64fa490a1cb0"
      unitRef="usdPerShare">7.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i31a08061cd074967ac410fd896f93157_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMy0xLTEtMS0yNQ_8bf31d3e-bcd5-4f3d-91c8-004288a33006"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i31a08061cd074967ac410fd896f93157_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMy0yLTEtMS0yNQ_188f52e8-eebd-4bf3-9146-bd70980291ec"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i00bd0e49ae8e4e4293bd95e2e845969d_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMy00LTEtMS0yNQ_24138a66-976d-42f6-b839-ea6879cf2f1c"
      unitRef="shares">2957900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i00bd0e49ae8e4e4293bd95e2e845969d_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMy01LTEtMS0yNQ_8c9a9e4d-53ab-4625-8482-9a4e70344eaf"
      unitRef="usdPerShare">10.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i94b5714cc2e94fc681505d6f23aecd98_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMy03LTEtMS0yNQ_78d4144a-1f6e-4003-8728-75944b66f8d6"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i94b5714cc2e94fc681505d6f23aecd98_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfMy04LTEtMS0yNQ_d5ea4d73-b321-43cf-bd42-c6a6bf0479b8"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i31a08061cd074967ac410fd896f93157_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNC0xLTEtMS0yNQ_51d57be7-a57d-4b87-ae71-a5e98053cb76"
      unitRef="shares">862790</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i31a08061cd074967ac410fd896f93157_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNC0yLTEtMS0yNQ_38dd8492-29c4-41a0-a5fe-882b6fda7bf5"
      unitRef="usdPerShare">4.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i00bd0e49ae8e4e4293bd95e2e845969d_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNC00LTEtMS0yNQ_f1ffb9e1-3b25-464d-92df-5ca37f4f975f"
      unitRef="shares">761775</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i00bd0e49ae8e4e4293bd95e2e845969d_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNC01LTEtMS0yNQ_680744e1-19f0-44c4-be06-78113209c56f"
      unitRef="usdPerShare">5.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i94b5714cc2e94fc681505d6f23aecd98_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNC03LTEtMS0yNQ_8402849f-80f8-4999-bee7-f83ebb63eb13"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i94b5714cc2e94fc681505d6f23aecd98_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNC04LTEtMS0yNQ_92b7757a-f08a-4cf8-bef6-625fd1df4df6"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i31a08061cd074967ac410fd896f93157_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNS0xLTEtMS0yNQ_4e3e513d-13eb-441b-a8c3-d7b997399cfd"
      unitRef="shares">48026</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i31a08061cd074967ac410fd896f93157_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNS0yLTEtMS0yNQ_c045c75e-4d56-4aa0-a87a-78497b055a96"
      unitRef="usdPerShare">3.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i00bd0e49ae8e4e4293bd95e2e845969d_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNS00LTEtMS0yNQ_df03f67b-a7fe-4386-ad36-70587aec15ff"
      unitRef="shares">116019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i00bd0e49ae8e4e4293bd95e2e845969d_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNS01LTEtMS0yNQ_80e4b0d5-d4c6-481c-b190-4151ba400a03"
      unitRef="usdPerShare">8.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i94b5714cc2e94fc681505d6f23aecd98_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNS03LTEtMS0yNQ_d09c67a1-04ae-47ee-8d05-53ee4b0b6406"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i94b5714cc2e94fc681505d6f23aecd98_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNS04LTEtMS0yNQ_48bb3b1e-d93c-41ec-a1e9-7f4e30ed2757"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ic8dea383f42948e8b56cf4145aeb42f1_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNi0xLTEtMS0yNQ_1c7271b2-2897-4067-a550-562e8e2a7317"
      unitRef="shares">1265043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ic8dea383f42948e8b56cf4145aeb42f1_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNi0yLTEtMS0yNQ_7a14d9e1-f74b-4efc-ad15-82e604761b2d"
      unitRef="usdPerShare">4.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie805768234ab4942a5d4fb8ca1a8f3d8_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNi00LTEtMS0yNQ_e46f28d8-09cf-4d96-b991-e076b4bd32ae"
      unitRef="shares">4405379</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ie805768234ab4942a5d4fb8ca1a8f3d8_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNi01LTEtMS0yNQ_41cb25b4-f877-441d-aa0f-24ffe359dc37"
      unitRef="usdPerShare">8.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia78947d6c8ca4e8ba3edb9ac39391648_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNi03LTEtMS0yNQ_04d41f4f-ccae-40a9-b5ad-b37486db7964"
      unitRef="shares">35212</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia78947d6c8ca4e8ba3edb9ac39391648_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjdmM2ZkYWYxOWY5MDRkYzE5NzQ1MjU2YzkyOTVkOTI3L3RhYmxlcmFuZ2U6N2YzZmRhZjE5ZjkwNGRjMTk3NDUyNTZjOTI5NWQ5MjdfNi04LTEtMS0yNQ_1941dd46-9240-434e-a2fc-3bc7be0f7919"
      unitRef="usdPerShare">7.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RleHRyZWdpb246MTI3ZGRlYWM3MzNmNDY2OGE2NDE2NTNiZTE5N2E3OTlfNDk0NzgwMjMzMTEwNA_727c1e46-81c9-48a6-a182-4203aa464520">&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of stock option activity for the three months ended June 30, 2021 is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.015%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.731%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at January 1, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(494,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested options forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested options expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at June&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,481,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,974,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at June&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,481,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,974,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfMS0xLTEtMS0yNQ_61ed9b0c-80e9-45b4-8d4d-c5f5e304ae9b"
      unitRef="shares">2025683</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i8ef27cfe3bed49c7847029a654380438_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfMS0zLTEtMS0yNQ_bf6d2b33-a32c-4e43-ac03-1aa219f0d405"
      unitRef="usdPerShare">4.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfMi0xLTEtMS0yNQ_f76cdb56-ebfc-466f-acb1-622f68a39be3"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfMi0zLTEtMS0yNQ_282f4a25-744a-4634-a848-cb06f409869b"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfMy0xLTEtMS0yNQ_dce30f7a-1a86-4ae4-a875-2895da5182ba"
      unitRef="shares">494139</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfMy0zLTEtMS0yNQ_b90e82fc-c9e0-4b4e-b7f1-2ae22d839f74"
      unitRef="usdPerShare">3.52</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNC0xLTEtMS0yNQ_324ada67-b785-49c0-8640-018c5f4d9d65"
      unitRef="shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNC0zLTEtMS0yNQ_0c2124c2-202d-4ca2-a519-15359c196b6f"
      unitRef="usdPerShare">1.23</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNS0xLTEtMS0yNQ_92ea29ac-67b1-47d5-990e-4fc1fe5bfd23"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNS0zLTEtMS0yNQ_72338cd1-0c99-4583-a22a-9b09b044f8e5"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNi0xLTEtMS0yNQ_5b580d9a-b231-4163-8cb1-47d0e958418b"
      unitRef="shares">1481544</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNi0zLTEtMS0yNQ_02145e51-106e-49fa-83d0-a17e3a8d3e87"
      unitRef="usdPerShare">5.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNi01LTEtMS0yNQ_7136924e-688d-43c1-b4fb-9485911bce84">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNi03LTEtMS0yNQ_e657f5a5-c6d4-4f6e-88e9-09c1573c1ddf"
      unitRef="usd">10974672</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNy0xLTEtMS0yNQ_09ba5359-e5d3-4d65-8747-fb5ffa910f37"
      unitRef="shares">1481544</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNy0zLTEtMS0yNQ_73fbbcbb-8458-4f11-87af-1059f6250ded"
      unitRef="usdPerShare">5.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNy01LTEtMS0yNQ_6850fbca-1f3d-405a-ac45-96d622102e7c">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82NC9mcmFnOjEyN2RkZWFjNzMzZjQ2NjhhNjQxNjUzYmUxOTdhNzk5L3RhYmxlOjNlMDAzYjY0YjRmZjRlMjI4MDhhZTFjMmI5ZDFkMjgyL3RhYmxlcmFuZ2U6M2UwMDNiNjRiNGZmNGUyMjgwOGFlMWMyYjlkMWQyODJfNy03LTEtMS0yNQ_a7fac14b-bf38-41fa-9897-dedb71a30d21"
      unitRef="usd">10974672</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfODE4_5b7bda02-413c-4790-be67-c64cc18e2ee4">Income Taxes&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rates for the Company were 0.3% and (0.3)% for the three months ended June&#160;30, 2021 and June&#160;30, 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rates for the Company were (0.5)% and 45.9%, for the six months ended June&#160;30, 2021 and June&#160;30, 2020, respectively. These effective tax rates include the impact of discrete items of $0 and $11.4 million for the three months ended June&#160;30, 2021 and June&#160;30, 2020, respectively. The discrete items recorded for the six months ended June&#160;30, 2020 were primarily related to modifications to the tax rules for carryback of net operating losses as a result of the CARES Act which resulted in a federal tax refund of $11.3 million and an income tax benefit of the same amount. Of this amount, the Company has collected $1.2 million as of June&#160;30, 2021. No benefit had been recognized with respect to the net operating losses due to a previously-recorded valuation allowance.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfNjQ_7ee16064-04a5-404e-ae60-003ffdd6665f"
      unitRef="number">0.003</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfNzE_13066b22-dc6f-456b-89f9-413b87b3de61"
      unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfMjc0ODc3OTA3MzMwMA_8dbaf5e5-fd3b-4c37-94cf-5b7628acca5e"
      unitRef="number">-0.005</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfMTA5OTUxMTYyOTQ1OA_e067597d-7ffc-4469-9de4-7041ddab2a0e"
      unitRef="number">0.459</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <mdxg:EffectiveIncomeTaxRateReconciliationDiscreteItems
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfMTky_3f89c10f-17cf-4e74-91fa-7fe613bddfd6"
      unitRef="usd">0</mdxg:EffectiveIncomeTaxRateReconciliationDiscreteItems>
    <mdxg:EffectiveIncomeTaxRateReconciliationDiscreteItems
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfMTk5_c9c22462-c747-46f3-81b8-bc2c3b70d627"
      unitRef="usd">11400000</mdxg:EffectiveIncomeTaxRateReconciliationDiscreteItems>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia54e27be716048c4b4d253e772d6aca1_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfNjQ5_0221a84b-e35e-41aa-a8cf-4059cbf57624"
      unitRef="usd">-11300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProceedsFromIncomeTaxRefunds
      contextRef="i41bb6f1393b14bd2b5dfaa6483ec1fd7_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfMTA5OTUxMTYzMDQ5Mw_0ca5e6fc-5682-4272-a814-478b5ee33342"
      unitRef="usd">1200000</us-gaap:ProceedsFromIncomeTaxRefunds>
    <mdxg:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV82Ny9mcmFnOjBkYzZmMjY2OTJiMDQ4Njc4MmU3NzM4ZmI4MWY0YjlkL3RleHRyZWdpb246MGRjNmYyNjY5MmIwNDg2NzgyZTc3MzhmYjgxZjRiOWRfNjk4_dfef0e52-a62f-4ad1-ae4d-430cfde81d64"
      unitRef="usd">0</mdxg:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RleHRyZWdpb246OGNlMDNhOGUwNjBmNGIyMDkyZjQwZWUzZWE3NjY3MGVfMTgw_05b7faef-a26e-4d9b-8eb0-f08463d0b4a0">Supplemental Disclosure of Cash Flow and Non-cash Investing and Financing Activities&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected cash payments, receipts, and non-cash activities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right of use asset and liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note receivable for sale of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases of equipment in accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of non-cash consideration received for option exercise&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividends on Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amendment fee on BT Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RleHRyZWdpb246OGNlMDNhOGUwNjBmNGIyMDkyZjQwZWUzZWE3NjY3MGVfMTkw_396e9568-67c4-4313-999e-24685f6bd71e">&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected cash payments, receipts, and non-cash activities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.045%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right of use asset and liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note receivable for sale of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases of equipment in accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of non-cash consideration received for option exercise&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deemed dividends on Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amendment fee on BT Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:InterestPaid
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfMi0xLTEtMS0w_09a76893-f95f-42c9-9c06-42ce93078b13"
      unitRef="usd">2207000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfMi0zLTEtMS0w_e821b004-4880-410f-858c-4cda486f3b5b"
      unitRef="usd">3731000</us-gaap:InterestPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfMy0xLTEtMS0w_10161582-ab05-4be3-863c-64603bf30a3d"
      unitRef="usd">157000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfMy0zLTEtMS0w_03955c8a-82cb-493e-a3ce-648c90d2d591"
      unitRef="usd">13000</us-gaap:IncomeTaxesPaid>
    <mdxg:LeaseRightOfUseAssetAndLiability
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfNS0xLTEtMS0w_a0ed9c03-32c5-4715-9749-a1aa20cea777"
      unitRef="usd">189000</mdxg:LeaseRightOfUseAssetAndLiability>
    <mdxg:LeaseRightOfUseAssetAndLiability
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfNS0zLTEtMS0w_e3c9c297-021a-419e-83ea-3b89d294796f"
      unitRef="usd">0</mdxg:LeaseRightOfUseAssetAndLiability>
    <mdxg:NotesReceivableForSaleOfPropertyAndEquipment
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfNi0xLTEtMS0w_b4323d6c-18a7-42d0-aa1b-8e8ae349e7e8"
      unitRef="usd">75000</mdxg:NotesReceivableForSaleOfPropertyAndEquipment>
    <mdxg:NotesReceivableForSaleOfPropertyAndEquipment
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfNi0zLTEtMS0w_a7de694c-62ba-47c2-8fef-eb5a4c512529"
      unitRef="usd">0</mdxg:NotesReceivableForSaleOfPropertyAndEquipment>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfNy0xLTEtMS0w_ccfac8dc-3607-4872-b846-92828fcf5a29"
      unitRef="usd">67000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfNy0zLTEtMS0w_72293ddf-d565-4556-b205-f96b1263d610"
      unitRef="usd">0</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <mdxg:FairValueOfNonCashConsiderationReceivedForOptionExercise
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfOC0xLTEtMS0w_27b2ff0a-4082-4fd3-be60-918613dac25d"
      unitRef="usd">380000</mdxg:FairValueOfNonCashConsiderationReceivedForOptionExercise>
    <mdxg:FairValueOfNonCashConsiderationReceivedForOptionExercise
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfOC0zLTEtMS0w_5c9d01b9-4462-4a63-a529-1115bd53cc40"
      unitRef="usd">0</mdxg:FairValueOfNonCashConsiderationReceivedForOptionExercise>
    <mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfOS0xLTEtMS0w_1b3433e5-cf33-4a4c-98b0-aa2addc4f54b"
      unitRef="usd">926000</mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature>
    <mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfOS0zLTEtMS0w_ec23178a-5ee4-4adc-9a1d-2125f6477ec1"
      unitRef="usd">0</mdxg:TemporaryEquityAccretionofIncreasingrateDividendFeature>
    <mdxg:NoncashActivitiesDeferredFinancingCosts
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfMTAtMS0xLTEtNTE5Nw_3fb2be4f-a9a8-4753-9bed-759bf28eab42"
      unitRef="usd">0</mdxg:NoncashActivitiesDeferredFinancingCosts>
    <mdxg:NoncashActivitiesDeferredFinancingCosts
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfMTAtMy0xLTEtNTE5Nw_f1abce08-313f-44ad-8631-59daec5f3ca0"
      unitRef="usd">1715000</mdxg:NoncashActivitiesDeferredFinancingCosts>
    <mdxg:NoncashActivitiesDebtInstrumentAmendmentFee
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfMTEtMS0xLTEtNTE5Nw_0a8a6d5c-f54e-4950-9d72-8c143b5614ed"
      unitRef="usd">0</mdxg:NoncashActivitiesDebtInstrumentAmendmentFee>
    <mdxg:NoncashActivitiesDebtInstrumentAmendmentFee
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83MC9mcmFnOjhjZTAzYThlMDYwZjRiMjA5MmY0MGVlM2VhNzY2NzBlL3RhYmxlOjRlMTAyZTJkZmVlYjQ0ZTNiNTcxZjc2YWNmODM2MGU2L3RhYmxlcmFuZ2U6NGUxMDJlMmRmZWViNDRlM2I1NzFmNzZhY2Y4MzYwZTZfMTEtMy0xLTEtNTE5Nw_f128090a-1b58-4592-82d2-d4d143b0450d"
      unitRef="usd">722000</mdxg:NoncashActivitiesDebtInstrumentAmendmentFee>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83My9mcmFnOmEzZjcxZjRmZDBiZTQwMTdhMzJiNzQ3ZGU3ODI5OTY5L3RleHRyZWdpb246YTNmNzFmNGZkMGJlNDAxN2EzMmI3NDdkZTc4Mjk5NjlfMTMxMjQ_d2e7f3b5-1485-488f-9d00-e25f88b0b346">Contractual Commitments and Contingencies&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation and Regulatory Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, the Company and its subsidiaries are parties to numerous civil claims and lawsuits and subject to regulatory examinations, investigations, and requests for information. Some of these matters involve claims for substantial amounts. The Company&#x2019;s experience has shown that the damages alleged by plaintiffs or claimants are often overstated, based on unsubstantiated legal theories, unsupported by facts, and/or bear no relation to the ultimate award that a court might grant. Additionally, the outcome of litigation and regulatory matters and the timing of ultimate resolution are inherently difficult to predict. These factors make it difficult for the Company to provide a meaningful estimate of the range of reasonably possible outcomes of claims in the aggregate or by individual claim. However, on a case-by-case basis, reserves are established for those legal claims in which it is probable that a loss will be incurred and the amount of such loss can be reasonably estimated. The Company's unaudited condensed consolidated financial statements as of June&#160;30, 2021&#160;reflect the Company's current best estimate of probable losses associated with these matters, including costs to comply with various settlement agreements, where applicable. The actual costs of resolving these claims, as well as the cost to resolve claims that are either not probable or not estimable at this time, may be substantially higher or lower than the amounts reserved. For more information regarding the Company&#x2019;s legal proceedings, refer to Note 14, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; in the 2020 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, the Company has accrued $4.5 million related to the legal proceedings. The Company is entitled to indemnification from insurance companies in connection with legal proceedings of $0.4 million. This indemnification receivable is recorded as part of other current assets in the unaudited condensed consolidated balance sheet as of June&#160;30, 2021. The Company paid $6.5 million toward the resolution of legal matters involving the Company during the six months ended June&#160;30, 2021. In addition, $0.7 million was paid on the Company&#x2019;s behalf through insurance providers during the six months ended June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company received funds from certain director and officer insurance policies for previously-incurred legal expenses under the Company&#x2019;s indemnification agreements. These funds were recognized as a reduction to investigation, restatement, and related expense during each of the three and six months ended June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a description of certain litigation and regulatory matters:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Securities Class Action&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On January 16, 2019, the United States District Court for the Northern District of Georgia entered an order consolidating two purported securities class actions (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;MacPhee v. MiMedx Group, Inc., et al.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; filed February 23, 2018 and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Kline v. MiMedx Group, Inc., et al.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; filed February 26, 2018). The order also appointed Carpenters Pension Fund of Illinois (&#x201c;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;CPFI&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x201d;) as lead plaintiff. On May 1, 2019, CPFI filed a consolidated amended complaint, naming as defendants the Company, Michael J. Senken, Parker H. &#x201c;Pete&#x201d; Petit, William C. Taylor, Christopher M. Cashman and Cherry Bekaert &amp;amp; Holland LLP. The amended complaint (the &#x201c;Securities Class Action Complaint&#x201d;) alleged violations of Section 10(b) of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;), Rule 10b-5 promulgated thereunder, and Section 20(a) of the Exchange Act. It asserted a class period of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;March 7, 2013 through June 29, 2018. Following the filing of motions to dismiss by the various defendants, CPFI was granted leave to file an amended complaint. CPFI filed its amended complaint against the Company, Michael J. Senken, Parker H. Petit, William C. Taylor, and Cherry Bekaert &amp;amp; Holland (Christopher Cashman was dropped as a defendant) on March 30, 2020; defendants filed motions to dismiss on May 29, 2020. On March 25, 2021, the Court granted defendants&#x2019; respective motions to dismiss, finding that CPFI lacked standing to bring the underlying claims and also could not establish loss causation because it sold all of its shares in MiMedx prior to any corrective disclosures, and dismissed the case. On April 22, 2021, CPFI filed a motion for reconsideration of the dismissal and for leave to amend to add a new plaintiff to attempt to cure the standing and loss causation issues. The Company has opposed CPFI&#x2019;s motions and the hearing on the same scheduled for July 28, 2021 has been postponed; no new date has yet been set.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Investigations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Department of Veterans&#x2019; Affairs Office of Inspector General (&#x201c;VA-OIG&#x201d;) and Civil Division of the Department of Justice (&#x201c;DOJ-Civil&#x201d;) Subpoenas and/or Investigations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;VA-OIG has issued subpoenas to the Company seeking, among other things, information concerning the Company&#x2019;s financial relationships with VA clinicians. DOJ-Civil has requested similar information. The Company has cooperated fully and produced responsive information to VA-OIG and DOJ-Civil. Periodically, VA-OIG has requested additional documents and information regarding payments to individual VA clinicians. Most recently, on June 3, 2020, the Company received a subpoena from the VA-OIG requesting information regarding the Company&#x2019;s financial relationships and interactions with two healthcare providers at the VA Long Beach Healthcare System. The Company has continued to cooperate and respond to these requests. At this time the Company is unable to predict the outcome of the investigation, including whether the investigation will result in any action or proceeding against us. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Department of Defense Office of Inspector General Investigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 8, 2021, the Company received a subpoena issued by the Department of Defense Office of Inspector General seeking records regarding the sales of the Company&#x2019;s micronized and other products to federal medical facilities and federal contracting offices, including those operated by the Department of Veterans Affairs or the Department of Defense. The subpoena also seeks information regarding the Company&#x2019;s communications with the FDA regarding its products. The Company understands that the Office of the United States Attorney for the Western District of Washington Civil Division is overseeing the investigation, which is being conducted principally by agents employed by the Department of the Army Criminal Investigation Command. The Company is cooperating with the government&#x2019;s investigation and at this time the Company is unable to predict the outcome of the investigation, including whether the investigation will result in any action or proceeding against us. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Former Employee Litigation and Related Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 19, 2018, the Company&#x2019;s former Chief Financial Officer filed a complaint in the Superior Court for Cobb County, Georgia (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Michael J. Senken v. MiMedx Group, Inc.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) in which he claims that the Company has breached its obligations under the Company&#x2019;s charter and bylaws to advance to him, and indemnify him for, his legal fees and costs that he incurred in connection with certain Company internal investigations and litigation. The Company filed its answer denying the plaintiff&#x2019;s claims on April 19, 2019. To date, no deadlines have been established by the court. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On January 12, 2021, the Company filed suit in the Circuit Court of the Eleventh Judicial District in and for Miami-Dade County, Florida (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;MiMedx Group, Inc. v. Petit, et. al.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;) against its former CEO, Parker H. &#x201c;Pete&#x201d; Petit, and its former COO, William C. Taylor, seeking a determination of its rights and obligations under indemnification agreements with Petit and Taylor following a federal jury&#x2019;s guilty verdict against Petit for securities fraud and Taylor for conspiracy to commit securities fraud. The Company is seeking a declaratory judgment that it is not obligated to indemnify or advance expenses to Petit and Taylor in connection with certain cases to which Petit and Taylor are parties and also seeking to recoup amounts previously paid on behalf of Petit and Taylor in connection with such cases.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On April 22, 2021, Petit and Taylor filed an answer and asserted counterclaims against the Company alleging breach of their indemnification agreements, breach of the covenant of good faith and fair dealing with respect to their indemnification agreements, and seeking a declaration that the Company remains obligated to indemnify and advance fees in connection with certain cases.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Petit and Taylor simultaneously also filed a motion seeking to compel the Company to advance and reinstate its payments of Petit and Taylor&#x2019;s legal expenses. The Company opposed Petit and Taylor&#x2019;s motion and a hearing was set for June 23, 2021. At the joint request of the parties, the hearing was cancelled to allow the parties to attend a mediation to attempt a resolution of this matter; such mediation is currently scheduled for August 11, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On April 15, 2021, Quinn Emanuel Urquhart &amp;amp; Sullivan, LLP, Freshfields Bruckhaus Deringer US LLP, and Kobre Kim, LLP, law firms who have represented Mr. Petit and Mr. Taylor in various legal actions, including their criminal trial, filed suit in the Supreme Court of the State of New York County of New York against the Company (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Quinn Emanuel Urquhart &amp;amp; Sullivan, LLP, et al. v. MiMedx Group, Inc.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;) for breach of contract, breach of implied-in-fact contract, quasi-contract/unjust enrichment, promissory estoppel, equitable estoppel, and account stated seeking to enforce the Company&#x2019;s alleged obligation to pay the firms for the legal fees and expenses incurred during their representations of Mr. Petit and Mr. Taylor. The parties have settled this matter and the case has been dismissed. The settlement reduced the Company&#x2019;s liability to the plaintiffs, with respect to their representations of Messrs. Petit and Taylor, by $2.4 million. This reduction was included in investigation, restatement, and related expense on the unaudited condensed consolidated statements of operations for each of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;three and six months ended June&#160;30, 2021. The Company has paid the settlement amount and has no continuing obligations to the plaintiffs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defamation Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 4, 2018, Sparrow Fund Management, LP (&#x201c;Sparrow&#x201d;) filed a complaint against the Company and Mr. Petit, including claims for defamation and civil conspiracy in the United States District Court for the Southern District of New York (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sparrow Fund Management, L.P. v. MiMedx Group, Inc. et. al.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;). The complaint seeks monetary damages and injunctive relief and alleges the defendants commenced a campaign to publicly discredit Sparrow by falsely claiming it was a short seller who engaged in illegal and criminal behavior by spreading false information in an attempt to manipulate the price of our common stock. On March 31, 2019, a judge granted defendants&#x2019; motions to dismiss in full, but allowed Sparrow the ability to file an amended complaint. The Magistrate has recommended Sparrow&#x2019;s motion for leave to amend be granted in part and denied in part and the Judge adopted the Magistrate&#x2019;s recommendation. Sparrow filed its amended complaint against MiMedx (Mr. Petit has been dropped from the lawsuit) on April 3, 2020 and the Company filed its answer. This case is in discovery. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On June 17, 2019, the principals of Viceroy Research (&#x201c;Viceroy&#x201d;), filed suit in the Circuit Court for the Seventeenth Judicial Circuit in Broward County, Florida (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Fraser John Perring et. al. v. MiMedx Group, Inc. et. al.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;) against the Company and Mr. Petit, alleging defamation and malicious prosecution based on the defendants&#x2019; alleged campaign to publicly discredit Viceroy and the lawsuit the Company previously filed against the plaintiffs, but which the Company subsequently dismissed without prejudice. On November 1, 2019, the Court granted Mr. Petit&#x2019;s motion to dismiss on jurisdictional grounds, denied the Company&#x2019;s motion to dismiss, and granted plaintiffs leave to file an amended complaint to address the deficiencies in its claims against Mr. Petit, which they did on November 21, 2019. The parties have settled this matter and the case has been dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Florida Business Corporation Act and agreements with its current and former officers and directors, the Company is obligated to indemnify its current and former officers and directors who are made party to a proceeding, including a proceeding brought by or in the right of the corporation, with certain exceptions, and to advance expenses to defend such matters. The Company has already borne substantial costs to satisfy these indemnification and expense advance obligations and may continue to do so in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the matters described above, the Company is a party to a variety of other legal matters that arise in the ordinary course of the Company&#x2019;s business, none of which is deemed to be individually material at this time. Due to the inherent uncertainty of litigation, there can be no assurance that the resolution of any particular claim or proceeding would not have a material adverse effect on the Company&#x2019;s business, results of operations, financial position or liquidity.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83My9mcmFnOmEzZjcxZjRmZDBiZTQwMTdhMzJiNzQ3ZGU3ODI5OTY5L3RleHRyZWdpb246YTNmNzFmNGZkMGJlNDAxN2EzMmI3NDdkZTc4Mjk5NjlfMTA5OTUxMTY2NTA1NQ_5477d5b7-347b-4935-b1e9-078e569bb24c"
      unitRef="usd">4500000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:InsuranceSettlementsReceivable
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83My9mcmFnOmEzZjcxZjRmZDBiZTQwMTdhMzJiNzQ3ZGU3ODI5OTY5L3RleHRyZWdpb246YTNmNzFmNGZkMGJlNDAxN2EzMmI3NDdkZTc4Mjk5NjlfMTA5OTUxMTY0MzA0Mw_98c79362-d152-423c-bce5-f75f0e2393e7"
      unitRef="usd">400000</us-gaap:InsuranceSettlementsReceivable>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83My9mcmFnOmEzZjcxZjRmZDBiZTQwMTdhMzJiNzQ3ZGU3ODI5OTY5L3RleHRyZWdpb246YTNmNzFmNGZkMGJlNDAxN2EzMmI3NDdkZTc4Mjk5NjlfMTA5OTUxMTY0MzIyMQ_99f91b10-3dcc-4739-a303-f843142bdfb6"
      unitRef="usd">6500000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:InsuranceRecoveries
      contextRef="i65bb668e9dae4047a84b02a215986f46_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83My9mcmFnOmEzZjcxZjRmZDBiZTQwMTdhMzJiNzQ3ZGU3ODI5OTY5L3RleHRyZWdpb246YTNmNzFmNGZkMGJlNDAxN2EzMmI3NDdkZTc4Mjk5NjlfMTA5OTUxMTY0MzI4MQ_a10078df-c62b-4dbe-8a45-75d166df79df"
      unitRef="usd">700000</us-gaap:InsuranceRecoveries>
    <mdxg:ContingencyLossNumberOfSecuritiesClassActions
      contextRef="i3cb4c6f5e91944bc98bf3dad39781578_D20190116-20190116"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83My9mcmFnOmEzZjcxZjRmZDBiZTQwMTdhMzJiNzQ3ZGU3ODI5OTY5L3RleHRyZWdpb246YTNmNzFmNGZkMGJlNDAxN2EzMmI3NDdkZTc4Mjk5NjlfMjU2Mg_a9e4ebfd-e7b3-4df9-b855-cae4b86027bf"
      unitRef="securityclassaction">2</mdxg:ContingencyLossNumberOfSecuritiesClassActions>
    <mdxg:ContingencyLossNumberOfFormerHealthcareProviders
      contextRef="ib237d9ecb84f4d6ab8dfb6cb01b37609_D20200603-20200603"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83My9mcmFnOmEzZjcxZjRmZDBiZTQwMTdhMzJiNzQ3ZGU3ODI5OTY5L3RleHRyZWdpb246YTNmNzFmNGZkMGJlNDAxN2EzMmI3NDdkZTc4Mjk5NjlfNDk0OQ_fd763d68-5312-45ce-bb81-3feb1943ba85"
      unitRef="healthcareprovider">2</mdxg:ContingencyLossNumberOfFormerHealthcareProviders>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="ia6a7a1b394c249888a94eef3b4a3a19f_D20210415-20210415"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83My9mcmFnOmEzZjcxZjRmZDBiZTQwMTdhMzJiNzQ3ZGU3ODI5OTY5L3RleHRyZWdpb246YTNmNzFmNGZkMGJlNDAxN2EzMmI3NDdkZTc4Mjk5NjlfMTA5OTUxMTY2Mzc2OQ_6e9e530b-9024-494f-8397-cd8295544ad6"
      unitRef="usd">-2400000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RleHRyZWdpb246NDlhY2UyMzM5OTNkNGFkNzg3OWJjYzVkOTI3ZjRiZmNfNDY3_6ece1418-1e62-4cca-9935-b5de7b083854">Revenue&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue by Product&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;MiMedx has two primary classes of products: (1) Advanced Wound Care, or Section 361, products, consisting of its sheet allograft products, and (2) Section 351 products, consisting of the Company&#x2019;s micronized and particulate products. Advanced Wound Care is further disaggregated between the Company&#x2019;s Tissue/Other and Cord products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of net sales by each class of product (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advanced Wound Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Tissue/Other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Cord&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Advanced Wound Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 351&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;(1) &#x201c;Other&#x201d; represents cash collections on the Remaining Contracts. Remaining Contracts are those contracts for which performance obligations have been satisfied as of September 30, 2019, but for which the criteria required for revenue recognition had not been met and would not be met until the ultimate collection of cash. For all practicable purposes, the Company is not able to allocate these revenues to different product groups.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue by Customer&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;MiMedx has two primary distribution channels: (1) direct to customers (healthcare professionals and/or facilities) (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Direct Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;), and (2) sales through distributors (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Distributors&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of net sales by each customer type (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.233%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct Customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not have significant foreign operations or a single external customer from which 10% or more of revenues were derived during the three or six months ended June&#160;30, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <mdxg:NumberOfProducts
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RleHRyZWdpb246NDlhY2UyMzM5OTNkNGFkNzg3OWJjYzVkOTI3ZjRiZmNfNDc_6fa6a162-74c8-4009-b8a0-6ad2bc9fc0a5"
      unitRef="product">2</mdxg:NumberOfProducts>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RleHRyZWdpb246NDlhY2UyMzM5OTNkNGFkNzg3OWJjYzVkOTI3ZjRiZmNfNDY5_b896a8cf-9753-4f65-b804-ce0e5c31a62d">&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of net sales by each class of product (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advanced Wound Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Tissue/Other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Cord&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Advanced Wound Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 351&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;(1) &#x201c;Other&#x201d; represents cash collections on the Remaining Contracts. Remaining Contracts are those contracts for which performance obligations have been satisfied as of September 30, 2019, but for which the criteria required for revenue recognition had not been met and would not be met until the ultimate collection of cash. For all practicable purposes, the Company is not able to allocate these revenues to different product groups.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of net sales by each customer type (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.233%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct Customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4efd76f6ada46ba8946b7513a22f04a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfMy0xLTEtMS00OTc1_3ad73893-08d6-4de8-973b-540e9423daeb"
      unitRef="usd">53408000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if46c195635a441178204ec28dde34b01_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfMy0zLTEtMS00OTc1_922cd654-102a-48d5-b009-7c12a81ebf29"
      unitRef="usd">42528000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i89a37b3906b04310b236e33525aaa95c_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfMy01LTEtMS00OTc1_20304783-79c3-4276-88ac-d636b25a9821"
      unitRef="usd">99977000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f2bacc597854374bcc516e82f0c5eed_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfMy03LTEtMS00OTc1_bd60ca49-d265-4cd7-9fb4-1a7158748172"
      unitRef="usd">87134000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib148d38e25b94492bf90c7d639339309_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNC0xLTEtMS00NjYz_5216eb6c-5dc2-4c25-b8e1-95acd1b8fa70"
      unitRef="usd">5886000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4419ab9cc84f446692df129d313037a1_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNC0zLTEtMS00Njc0_7b263a5e-4fef-480d-9b09-935d32b5b555"
      unitRef="usd">3263000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66be1c10c07c47af8bcae86ad35148ae_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNC01LTEtMS00Njk3_7071b74c-43d1-48ea-8ea6-169ad692bdd9"
      unitRef="usd">10846000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3cbcb788b0524138bc71b680f77362cc_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNC03LTEtMS00NzA0_6c8f7765-a9b2-4acc-abbb-9e820f50a700"
      unitRef="usd">7160000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbf94484fb9640fc95e9891697e411dd_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNS0xLTEtMS00OTgx_07020c0d-77ed-4ad2-aa2a-d209829b98fd"
      unitRef="usd">59294000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie638d9289b64407d97b93fe9e2db87ff_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNS0zLTEtMS00OTgx_fd827746-c5c2-4397-9639-3c7b9289162c"
      unitRef="usd">45791000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i609c12eea03c4236afb3906bceaa436a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNS01LTEtMS00OTgx_042bd221-1fb7-498f-b513-5e1779959346"
      unitRef="usd">110823000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idad418953507466e82cdd357b1a16e0b_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNS03LTEtMS00OTgx_c33a8025-202d-4f55-b72e-a6128aef9a0d"
      unitRef="usd">94294000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32d60e88dd1c4b5dad71c5e90be4b433_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfMy0xLTEtMS0w_812dbe95-c9a9-4166-88f9-fb1400f9198a"
      unitRef="usd">8558000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f69b69d3f9a4ac2b110d37dcc110405_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfMy0zLTEtMS0w_90e74fbc-600b-4126-8935-4856acc95e46"
      unitRef="usd">6150000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i90e644d3bd014f92ba1bb40b0b78d305_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfMy01LTEtMS0w_44717802-8086-451c-aafe-6d08eb829607"
      unitRef="usd">16698000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c9b39d7c36e4c6f960af71b46e8ca65_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfMy03LTEtMS0w_b43477b4-1adb-4054-9f56-5f1dd7565379"
      unitRef="usd">14888000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf8f1fdd25a54565b673685695a81bfa_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNC0xLTEtMS00MzM_d6b945a8-805c-474a-ade5-d606740f666d"
      unitRef="usd">313000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2dac69150d044c06bb537de5bc9ec0e2_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNC0zLTEtMS00MzM_f25d8647-09d8-4fd1-bbe5-9e4fd6f3734a"
      unitRef="usd">1706000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab79f8b8ff3646738e954901d9a7200a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNC01LTEtMS00MzM_f91577bb-6f7a-4ad1-beaa-a1b4cabc5ac8"
      unitRef="usd">611000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4687e4322dec454fa997eabfa8d90145_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNC03LTEtMS00MzM_fedfbe9a-4abf-49b5-8b9e-60caa296c1b0"
      unitRef="usd">6201000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNS0xLTEtMS0w_3faf3582-213c-410b-a306-2bd7b192a6f1"
      unitRef="usd">68165000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNS0zLTEtMS0w_891bf166-3f74-41ed-ae38-09252f6da0de"
      unitRef="usd">53647000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNS01LTEtMS0w_3a56dd20-4cfb-4a6a-b6fb-66f68aa06b34"
      unitRef="usd">128132000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjlhMTBkODg5MmMzMjQ0ZTRiNGQ3YjYxM2RjZjQ1YTI2L3RhYmxlcmFuZ2U6OWExMGQ4ODkyYzMyNDRlNGI0ZDdiNjEzZGNmNDVhMjZfNS03LTEtMS0w_f4008690-8f08-45ba-b3e5-11b411769bff"
      unitRef="usd">115383000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <mdxg:RevenueFromContractWithCustomerNumberOfDistributionChannels
      contextRef="i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RleHRyZWdpb246NDlhY2UyMzM5OTNkNGFkNzg3OWJjYzVkOTI3ZjRiZmNfMzg0ODI5MDcwNjExOQ_80732b1f-ad12-4a65-b2a7-a59165973a46"
      unitRef="distributionchannel">2</mdxg:RevenueFromContractWithCustomerNumberOfDistributionChannels>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03a9f6a871fa4fed9fca89e62057ca76_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfMi0xLTEtMS0yOTU2_1ecf2a67-2843-4a91-89aa-a67544e636f2"
      unitRef="usd">66061000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45054bede241426187915c74a28a6005_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfMi0zLTEtMS0yOTU4_eba5fd37-b5f1-445c-aa5c-824d83600dbf"
      unitRef="usd">52755000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i279daae437cf44a19a94bd273c1d1703_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfMi01LTEtMS0yOTYw_9e456407-6b3e-4084-829e-a942627f0890"
      unitRef="usd">123619000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6bf9f8f4f2bb4f39ba8d91db9fb20a2a_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfMi03LTEtMS0yOTYy_9dadb43c-27d1-49ef-9678-c5d9d220aef0"
      unitRef="usd">112651000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf429a45cf5f420a848a9ed4775b39e4_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfMy0xLTEtMS0yOTU2_007fcf55-6dbb-4edf-9451-fbd150d31bf3"
      unitRef="usd">2104000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b2c8606605244ffa5589d29bede8a28_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfMy0zLTEtMS0yOTU4_68e6d628-4f43-4db1-a0d2-98465d491a46"
      unitRef="usd">892000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00c73051b417433f810f88637d373bcf_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfMy01LTEtMS0yOTYw_553015a7-9614-4ea0-97b2-bf886be5d37f"
      unitRef="usd">4513000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c204e277321442bbfb6659be2a31d13_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfMy03LTEtMS0yOTYy_469607a9-9d5a-450a-a520-d9c10e029701"
      unitRef="usd">2732000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfNC0xLTEtMS0yOTU2_5a0c55c6-62f2-4b3d-82e0-3e79ea068078"
      unitRef="usd">68165000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfNC0zLTEtMS0yOTU4_9cee922c-e688-4611-959a-0ea9a874c009"
      unitRef="usd">53647000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfNC01LTEtMS0yOTYw_a0679eb3-0e63-4ff3-977b-8d0bcdf14596"
      unitRef="usd">128132000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i820448fd1936408287034ea0448702c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV83Ni9mcmFnOjQ5YWNlMjMzOTkzZDRhZDc4NzliY2M1ZDkyN2Y0YmZjL3RhYmxlOjMzOGRmY2ViMGViMzQzYzRiNWE5NjYyZGY3OTg2ZWQ0L3RhYmxlcmFuZ2U6MzM4ZGZjZWIwZWIzNDNjNGI1YTk2NjJkZjc5ODZlZDRfNC03LTEtMS0yOTYy_80bebb8a-56b4-4480-96f8-d490050b366d"
      unitRef="usd">115383000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjU4NmY0ZDQ4ZTQzMjRiNDE4MjBhYWYzZjI4YzBiOTY5L3NlYzo1ODZmNGQ0OGU0MzI0YjQxODIwYWFmM2YyOGMwYjk2OV84Mi9mcmFnOmU2N2E0Yzc4YTEyMTRlZDRhNWRlYjNjYThhNjEyNTkxL3RleHRyZWdpb246ZTY3YTRjNzhhMTIxNGVkNGE1ZGViM2NhOGE2MTI1OTFfMjgx_d9adc532-11a1-45ec-b4e2-874e0e17575d">Subsequent EventsNone noted.</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869233205784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jul. 15, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MIMEDX GROUP, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-2792552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1775 West Oak Commons Ct NE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marietta<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">30062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">651-9100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MDXG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,946,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001376339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869233150296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 85,007<span></span>
</td>
<td class="nump">$ 95,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">37,243<span></span>
</td>
<td class="nump">35,423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">10,137<span></span>
</td>
<td class="nump">10,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses</a></td>
<td class="nump">3,350<span></span>
</td>
<td class="nump">5,605<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">10,138<span></span>
</td>
<td class="nump">10,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">1,816<span></span>
</td>
<td class="nump">3,371<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">147,691<span></span>
</td>
<td class="nump">160,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">10,273<span></span>
</td>
<td class="nump">11,437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset', window );">Right of use asset</a></td>
<td class="nump">3,144<span></span>
</td>
<td class="nump">3,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">19,976<span></span>
</td>
<td class="nump">19,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">5,750<span></span>
</td>
<td class="nump">6,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">187,147<span></span>
</td>
<td class="nump">202,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">10,563<span></span>
</td>
<td class="nump">8,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">21,257<span></span>
</td>
<td class="nump">18,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">17,073<span></span>
</td>
<td class="nump">30,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">1,678<span></span>
</td>
<td class="nump">1,470<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">50,571<span></span>
</td>
<td class="nump">59,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long term debt, net</a></td>
<td class="nump">47,905<span></span>
</td>
<td class="nump">47,697<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">3,314<span></span>
</td>
<td class="nump">3,755<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">101,790<span></span>
</td>
<td class="nump">110,614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock Series B; $0.001 par value; 100,000 shares authorized, issued and outstanding at June&#160;30, 2021 and December&#160;31, 2020</a></td>
<td class="nump">92,494<span></span>
</td>
<td class="nump">91,568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock Series A; $0.001 par value; 5,000,000 shares authorized, 0 issued and outstanding at June&#160;30, 2021 and December&#160;31, 2020</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock; $0.001 par value; 187,500,000 shares authorized; 112,703,926 issued and 111,881,938 outstanding at June&#160;30, 2021 and 112,703,926 issued and 110,930,243 outstanding at December&#160;31, 2020</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">158,720<span></span>
</td>
<td class="nump">158,610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock at cost; 821,988 shares at June&#160;30, 2021 and 1,773,683 shares at December&#160;31, 2020</a></td>
<td class="num">(4,385)<span></span>
</td>
<td class="num">(7,449)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(161,585)<span></span>
</td>
<td class="num">(151,424)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' deficit</a></td>
<td class="num">(7,137)<span></span>
</td>
<td class="num">(150)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, convertible preferred stock, and stockholders&#8217; deficit</a></td>
<td class="nump">$ 187,147<span></span>
</td>
<td class="nump">$ 202,032<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease And Financing Lease, Right-Of-Use-Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869323699304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS&#8217; DEFICIT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Series B convertible preferred stock par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Series B convertible preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Series B convertible preferred stock, shares issued (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Series B convertible preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">187,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">112,703,926<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">111,881,938<span></span>
</td>
<td class="nump">110,930,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">821,988<span></span>
</td>
<td class="nump">1,773,683<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869232790056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 68,165<span></span>
</td>
<td class="nump">$ 53,647<span></span>
</td>
<td class="nump">$ 128,132<span></span>
</td>
<td class="nump">$ 115,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">12,760<span></span>
</td>
<td class="nump">8,198<span></span>
</td>
<td class="nump">22,401<span></span>
</td>
<td class="nump">18,223<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">55,405<span></span>
</td>
<td class="nump">45,449<span></span>
</td>
<td class="nump">105,731<span></span>
</td>
<td class="nump">97,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">53,599<span></span>
</td>
<td class="nump">37,329<span></span>
</td>
<td class="nump">99,003<span></span>
</td>
<td class="nump">84,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_InvestigationRestatementandRelated', window );">Investigation, restatement and related</a></td>
<td class="num">(2,062)<span></span>
</td>
<td class="nump">11,446<span></span>
</td>
<td class="nump">5,134<span></span>
</td>
<td class="nump">27,038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">4,063<span></span>
</td>
<td class="nump">2,259<span></span>
</td>
<td class="nump">8,402<span></span>
</td>
<td class="nump">4,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">215<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="nump">454<span></span>
</td>
<td class="nump">542<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(410)<span></span>
</td>
<td class="num">(5,856)<span></span>
</td>
<td class="num">(7,262)<span></span>
</td>
<td class="num">(19,600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expense, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="num">(1,371)<span></span>
</td>
<td class="num">(2,574)<span></span>
</td>
<td class="num">(2,844)<span></span>
</td>
<td class="num">(4,961)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income tax provision</a></td>
<td class="num">(1,784)<span></span>
</td>
<td class="num">(8,439)<span></span>
</td>
<td class="num">(10,108)<span></span>
</td>
<td class="num">(24,564)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision benefit (expense)</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="nump">11,277<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(1,779)<span></span>
</td>
<td class="num">(8,466)<span></span>
</td>
<td class="num">(10,161)<span></span>
</td>
<td class="num">(13,287)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss available to common stockholders (Note 8)</a></td>
<td class="num">$ (3,276)<span></span>
</td>
<td class="num">$ (8,466)<span></span>
</td>
<td class="num">$ (13,126)<span></span>
</td>
<td class="num">$ (13,287)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share - basic (in dollars per share)</a></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (in dollars per share)</a></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">110,276,636<span></span>
</td>
<td class="nump">108,119,461<span></span>
</td>
<td class="nump">109,841,428<span></span>
</td>
<td class="nump">108,081,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">110,276,636<span></span>
</td>
<td class="nump">108,119,461<span></span>
</td>
<td class="nump">109,841,428<span></span>
</td>
<td class="nump">108,081,625<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_InvestigationRestatementandRelated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investigation, Restatement and Related</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_InvestigationRestatementandRelated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869232247928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Revision of Prior Period, Adjustment</div></th>
<th class="th"><div>Common Stock Issued</div></th>
<th class="th">
<div>Common Stock Issued </div>
<div>Revision of Prior Period, Adjustment</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Revision of Prior Period, Adjustment</div>
</th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th">
<div>Treasury Stock </div>
<div>Revision of Prior Period, Adjustment</div>
</th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance beginning of period (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,885,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Dec. 31, 2019</a></td>
<td class="nump">$ 34,398,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147,231,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,806,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (102,140,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation&#160;expense</a></td>
<td class="nump">3,781,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,781,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">298,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,658,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,956,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(220,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Restricted stock canceled/forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,124,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,124,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Restricted stock canceled/forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">285,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">461,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding</a></td>
<td class="num">(2,330,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,477,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(13,287,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,287,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance end of period (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,412,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Jun. 30, 2020</a></td>
<td class="nump">22,860,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13,451,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(115,427,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance beginning of period (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,163,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Mar. 31, 2020</a></td>
<td class="nump">30,339,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,765,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12,578,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(106,961,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation&#160;expense</a></td>
<td class="nump">1,866,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,866,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(444,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 444,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Restricted stock canceled/forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">378,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (378,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Restricted stock canceled/forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding</a></td>
<td class="num">(879,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (939,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(8,466,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,466,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance end of period (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,412,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Jun. 30, 2020</a></td>
<td class="nump">$ 22,860,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13,451,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(115,427,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,773,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Dec. 31, 2020</a></td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,610,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,449,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(151,424,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Correction of out-of-period error (Note 1) | Stock Award Misstatements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,009,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,009,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TreasuryStockSharesAdjustment', window );">Correction of out-of-period error (Note 1) (in shares) | Stock Award Misstatements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(239,502)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Deemed dividends</a></td>
<td class="num">(926,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(926,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation&#160;expense</a></td>
<td class="nump">7,304,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,304,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 1,359,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(934,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,293,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="num">(494,139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(452,329)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,576,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,576,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(761,775)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Restricted stock canceled/forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (251,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Restricted stock canceled/forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">453,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding</a></td>
<td class="num">(4,563,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,563,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (10,161,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,161,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance end of period (in shares) at Jun. 30, 2021</a></td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">821,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Jun. 30, 2021</a></td>
<td class="num">$ (7,137,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,720,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,385,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(161,585,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance beginning of period (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,083,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, beginning of period at Mar. 31, 2021</a></td>
<td class="num">(8,051,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,733,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,091,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(159,806,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Correction of out-of-period error (Note 1) | Stock Award Misstatements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (928,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 928,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TreasuryStockSharesAdjustment', window );">Correction of out-of-period error (Note 1) (in shares) | Stock Award Misstatements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(239,502)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Deemed dividends</a></td>
<td class="num">(464,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(464,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation&#160;expense</a></td>
<td class="nump">4,060,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,060,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">444,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(668,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,112,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(141,516)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(116,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,774)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Restricted stock canceled/forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (103,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Restricted stock canceled/forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding</a></td>
<td class="num">(1,347,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,347,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,779,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,779,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance end of period (in shares) at Jun. 30, 2021</a></td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">821,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, end of period at Jun. 30, 2021</a></td>
<td class="num">$ (7,137,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 158,720,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,385,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (161,585,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TreasuryStockSharesAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TreasuryStockSharesAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares related to Restricted Stock Award forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=mdxg_StockAwardMisstatementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=mdxg_StockAwardMisstatementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869233762648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (10,161)<span></span>
</td>
<td class="num">$ (13,287)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash flows used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">7,304<span></span>
</td>
<td class="nump">7,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">2,467<span></span>
</td>
<td class="nump">2,928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">454<span></span>
</td>
<td class="nump">542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of deferred financing costs</a></td>
<td class="nump">833<span></span>
</td>
<td class="nump">1,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_OperatingLeaseRightofuseAssetAmortization', window );">Non-cash lease expenses</a></td>
<td class="nump">480<span></span>
</td>
<td class="nump">486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationAccretionExpense', window );">Accretion of asset retirement obligation</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on fixed asset disposal</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Increase (decrease) in cash resulting from changes in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(1,820)<span></span>
</td>
<td class="nump">2,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">224<span></span>
</td>
<td class="num">(1,460)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="nump">2,254<span></span>
</td>
<td class="nump">3,819<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable', window );">Income taxes</a></td>
<td class="num">(93)<span></span>
</td>
<td class="num">(10,682)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">1,387<span></span>
</td>
<td class="nump">821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">2,794<span></span>
</td>
<td class="nump">3,236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCompensation', window );">Accrued compensation</a></td>
<td class="nump">2,790<span></span>
</td>
<td class="num">(518)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="num">(13,752)<span></span>
</td>
<td class="num">(12,109)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(514)<span></span>
</td>
<td class="num">(609)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash flows used in operating activities</a></td>
<td class="num">(5,080)<span></span>
</td>
<td class="num">(15,378)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash&#160;flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMachineryAndEquipment', window );">Purchases of equipment</a></td>
<td class="num">(2,346)<span></span>
</td>
<td class="num">(1,421)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities', window );">Principal payments from note receivable</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_PaymentsforApplicationCostsPatent', window );">Patent application costs</a></td>
<td class="num">(200)<span></span>
</td>
<td class="num">(151)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash flows used in investing activities</a></td>
<td class="num">(2,501)<span></span>
</td>
<td class="num">(1,572)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">1,359<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Stock repurchased for tax withholdings on vesting of restricted stock</a></td>
<td class="num">(4,563)<span></span>
</td>
<td class="num">(2,330)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Principal payments on finance lease</a></td>
<td class="num">(20)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Deferred financing cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfMediumTermNotes', window );">Repayment of term loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(11,875)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfMediumTermNotes', window );">Proceeds from term loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash flows used in financing activities</a></td>
<td class="num">(3,224)<span></span>
</td>
<td class="num">(3,930)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash</a></td>
<td class="num">(10,805)<span></span>
</td>
<td class="num">(20,880)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">95,812<span></span>
</td>
<td class="nump">69,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">$ 85,007<span></span>
</td>
<td class="nump">$ 48,189<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_OperatingLeaseRightofuseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-of-use Asset, Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_OperatingLeaseRightofuseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_PaymentsforApplicationCostsPatent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Application Costs, Patent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_PaymentsforApplicationCostsPatent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationAccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6392676&amp;loc=d3e7480-110848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationAccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMachineryAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of machinery and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMachineryAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfMediumTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt funding received on a regular basis with maturities ranging from 5-10 years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfMediumTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfMediumTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfMediumTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869348419640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Nature of Business</a></td>
<td class="text">Nature of Business<div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MiMedx Group, Inc. (together with its subsidiaries, except where the context otherwise requires, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MiMedx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; or the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, MiMedx has both a base business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-state pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. The Company derives its products from human placental tissues and processes these tissues using its proprietary methods, including the PURION&#174; process. MiMedx employs Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce its allografts. MiMedx provides products primarily in the wound care, burn, and surgical sectors of healthcare. All of its products are regulated by the United State Food and Drug Administration (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business model is focused primarily on the United States of America but the Company is pursuing opportunities for international expansion.</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Enforcement Discretion</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, the FDA published a series of guidances that established an updated framework for the regulation of cellular and tissue-based products. These guidances clarified the FDA&#8217;s views about the criteria that differentiate those products subject to regulation under Section 361 of the Public Health Service Act from those considered to be drugs, devices, and/or biological products subject to licensure under Section 351 of the Public Health Service Act and related regulations. The Company identified its micronized and particulate products as being subject to regulation under Section 351, requiring pre-market approval from the FDA for a specified indication with demonstrated clinical efficacy.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA exercised enforcement discretion with respect to Investigative New Drug (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IND</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) applications and pre-market approval requirements through May 31, 2021. As of May 31, 2021, the Company stopped marketing its Section 351 products and will be precluded from marketing its Section 351 products in the United States until a Biologics License Application (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BLA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is granted. If and when the FDA approves a BLA, we expect to be allowed to market the Section 351 products again, but only for specific indications as permitted by the FDA. Sales of the Company&#8217;s Section 351 products were $8.6 million and $6.2 million for the three months ended June&#160;30, 2021 and 2020, respectively, and $16.7 million and $14.9 million for the six months ended June&#160;30, 2021 and 2020, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently markets EPICORD and AMNIOCORD tissue products derived from human umbilical cord, as providing a protective environment or as a barrier. If the FDA were to determine that EPICORD and AMNIOCORD do not meet the requirements for regulation solely under Section 361, then pre-market clearance or approval would be required. The loss of the Company&#8217;s ability to market and sell its umbilical cord-derived products would have an adverse effect on the Company&#8217;s revenue, business, financial condition, and results of operations. Net sales of the Company&#8217;s umbilical cord-derived products were $5.9 million and $3.3 million for the three months ended June&#160;30, 2021 and 2020, respectively, and $10.8 million and $7.2 million for the six months ended June&#160;30, 2021 and 2020, respectively. Cord inventory, which would be at risk for write-down as a result of this determination, was $0.8 million as of June&#160;30, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Out-of-Period Adjustment</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2021, the Company identified certain Restricted Stock Unit and Performance Stock Unit awards which were not appropriately reflected in the Company&#8217;s balance of common stock outstanding beginning in 2019. The effects of these errors caused misstatements in the Company&#8217;s balance of treasury stock, additional paid-in capital, and common stock outstanding on each of the Company&#8217;s reported consolidated balance sheets and consolidated statements of stockholders&#8217; (deficit) equity for interim and annual periods beginning with those statements as of and for the year ended December 31, 2019. The identified errors did not affect total stockholders&#8217; (deficit) equity or earnings per share in any period.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded an out-of-period adjustment during the three and six months ended June&#160;30, 2021, which resulted in decreases of $0.9 million and $2.0 million to the balance of additional paid-in capital for the three and six months ended June&#160;30, 2021, respectively, and increases of $0.9&#160;million and $2.0&#160;million to the balance of treasury stock during those same periods. The balance of common shares outstanding at June&#160;30, 2021 of 111,881,938 reflects a cumulative increase of 239,502 shares relating to the adjustment.</span></div>The Company concluded the effect of the misstatement was not material, qualitatively or quantitatively, to any interim or annual period.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869231585416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see Note 2 to the Company&#8217;s Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, filed with the Securities and Exchange Commission (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SEC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) on March 8, 2021 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Form 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for a description of all significant accounting policies.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GAAP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) from interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the results of operations for the periods presented have been included.&#160;The operating results for the three and six months ended June&#160;30, 2021 and 2020 are not necessarily indicative of the results that may be expected for the fiscal year.&#160;The balance sheet as of December&#160;31, 2020 was derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements should be read in conjunction with the historical consolidated financial statements of the Company included in the 2020 Form 10-K.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared in accordance with GAAP. Conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported unaudited condensed consolidated statements of operations during the reporting period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment and intangible assets, estimates regarding asset retirement obligations, estimates for contingent liabilities, the measurement of right-of-use assets and lease liabilities, management&#8217;s assessment of the Company&#8217;s ability to continue as a going concern, estimates of fair value of share-based payments, and valuation of deferred tax assets.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above, the Company has considered the potential effects of the Covid-19 Pandemic and potential negative impacts resulting from the end of the FDA&#8217;s period of Enforcement Discretion with respect to its determinations surrounding impairments, increases in allowances for credit losses, increases in the Company&#8217;s returns reserve, other expenses, and changes in accounting judgments that have or are reasonably likely to have a material impact on the unaudited condensed consolidated financial statements.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of MiMedx Group, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable represent amounts due from customers for which revenue has been recognized. Generally, the Company does not require collateral or any other security to support its receivables.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bad debt expense and the allowance for doubtful accounts are based on historical trends and current expectations for credit losses and reasonable and supportable forecasts. The Company&#8217;s policy to reserve for potential bad debts is based on the aging of the individual receivables as well as customer-specific qualitative factors, such as bankruptcy proceedings. The Company manages credit risk by routinely performing credit checks on customers prior to sales. The individual receivables are written-off after all reasonable efforts to collect the funds have been made. Actual write-offs may differ from the amounts reserved.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for doubtful accounts was $0.8 million and $0.7 million as of June&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of purchase price over the fair value of net assets of acquired businesses. The Company assesses  goodwill for impairment at least annually on October 1 and whenever events or substantive changes in circumstances indicate that the asset may be impaired. The Company may first choose to assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then the Company performs a quantitative analysis. The Company may also choose to bypass the qualitative assessment and proceed directly to the quantitative analysis.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company concluded it operates as one reporting unit.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the quantitative analysis, if the carrying value of the reporting unit exceeds its fair value, goodwill impairment is recognized for the amount that the carrying value exceeds fair value, not to exceed the total amount of goodwill allocated to the reporting unit. The Company determines fair value using income and market approaches. Under the income approach, the fair value of the Company is the present value of its future economic benefits. These benefits can include revenue, cost savings, tax deductions, and proceeds from its disposition. Value indications are developed by discounting expected cash flows to their present value at a rate of return that incorporates the risk-free rate for the use of funds, industry trends, and entity-specific risks as of the goodwill impairment testing date. Under the market approach, the Company derives the fair value of the reporting unit using observed fair values of a set of companies with comparable business models to the reporting unit under evaluation. These amounts are reconciled to the Company&#8217;s market capitalization as of the test date for reasonableness.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Annual Goodwill Impairment Testing Date </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to change its annual goodwill and indefinite-lived intangible asset impairment testing date from September 30 to October 1. The change in the annual impairment testing date provides the Company with more time in identifying and calculating any impairments and to maximize the use of the Company&#8217;s available resources. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because GAAP does not permit more than 12 months to pass between annual goodwill impairment tests, the Company performed quantitative tests on September 30 and October 1, 2020. As a result of each of these tests, the Company concluded that the fair value of the reporting unit exceeded the carrying value and recorded no impairment.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells its products primarily to individual customers and independent distributors (collectively referred to as &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Customers obtain and use products either through ship and bill arrangements or consignment arrangements. Under ship and bill arrangements, the customer submits an order. Upon approval of the sales order, the Company ships product to the customer and invoices them for the product sold. Under consignment arrangements, the customer takes possession of the product, but the Company retains title until the implantation, or application of the Company&#8217;s product to the patient.</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue as performance obligations are fulfilled; which generally occurs upon the shipment of product to the customers for ship and bill orders or upon implantation for consignment sales.</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized based on consideration the Company expects to be entitled to from the sale. This consists of the gross selling price of the product, less any discounts or rebates (collectively, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">deductions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">sales deductions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Gross selling price is a standard set by the Company for all customers unless a contract governing the sale provides for a specified price. Sales deductions are specified in individual contracts with customers and are generally achieved based on total sales during a specified period. The Company estimates the total sales deductions that a specific customer will achieve over the relevant term and applies the reduction to sales as they are made throughout the period. Rebates owed to customers are accrued and recorded in accrued expenses on the unaudited condensed consolidated balance sheets.</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company acts as principal in all of its customer arrangements and records revenue on a gross basis. Shipping is considered immaterial in the context of the overall customer arrangement, and damages or loss of goods in transit are rare. Therefore, shipping is not deemed a separately-recognized performance obligation and the Company has elected to treat shipping costs as activities to fulfill the promise to transfer the product. The Company maintains a returns policy that allows its customers to return product that is consigned, damaged, or non-conforming, ordered in error, or due to a recall. The estimate of the provision for returns is based on historical experience with actual returns. The Company&#8217;s payment terms for customers are typically 30 to 60 days from receipt of title of the goods.</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above revenue recognition policy, the Company recognizes revenue from customers with balances outstanding as of September 30, 2019 for which all of the criteria necessary for revenue recognition were not met at the time of </span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shipment and that such criteria would not be met until collection of such sales (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). This was in accordance with the change in the Company&#8217;s revenue recognition pattern beginning September 30, 2019 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company defers the recognition of cost of sales associated with the Remaining Contracts until revenue is recognized and cash is collected. Deferred cost of sales, included as part of other current assets on the unaudited condensed consolidated balance sheets, were $0.1&#160;million and $0.2&#160;million as of June&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the effects of cash collections on the Remaining Contracts on the unaudited condensed consolidated statements of operations for each of the three and six months ended June&#160;30, 2021 and 2020 are as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.554%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is, or contains, a lease at inception.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Lease assets and liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The lease term used in the calculation includes options to extend or terminate the lease when the exercise of such options are reasonably certain. The determination of whether the Company is reasonably certain to exercise a renewal or termination option is reassessed as new information arises and is accounted for prospectively as of the point in time the determination is made regarding the modification of the lease term. The Company uses its incremental borrowing rate in determining the present value of lease payments.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets resulting from operating leases are included in right of use asset on the unaudited condensed consolidated balance sheets as of June&#160;30, 2021 and December&#160;31, 2020. Right-of-use assets resulting from the Company&#8217;s finance leases are included in property and equipment, net on the unaudited condensed consolidated balance sheet as of June&#160;30, 2021. Associated liabilities from both operating and finance leases are included on the unaudited condensed consolidated balance sheet as part of other current liabilities, to the extent that principal payments on such obligations will be paid in the next 12 months, and other liabilities, to the extent that principal payments on such obligations will be paid more than one year in the future. As of June&#160;30, 2021, the Company has both finance and operating leases.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable components of the lease payments such as fair market value adjustments, utilities, and maintenance costs are expensed as incurred and not included in determining the present value of lease liabilities. As an accounting policy election, the Company excludes short-term leases having initial terms of 12 months or fewer. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases, lease expense is recognized on a straight-line basis over the lease term through selling, general and administrative expense on the unaudited condensed consolidated statements of operations. For finance leases, the right of use asset is amortized, straight-line, over the life of the lease as depreciation expense, which is included as a component of selling, general and administrative expense on the unaudited condensed consolidated statements of operations. The Company recognizes interest expense on finance lease liabilities based on the incremental borrowing rate at lease inception applied to the outstanding lease liability. The Company does not recognize interest expense on operating lease liabilities.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments on operating leases are considered cash flows from operating activities. Payments on finance leases, to the extent that the payment relates to the reduction of the principal balance of the liability, are considered cash flows from financing activities. Payments toward the interest portion of finance lease liabilities are classified as cash flows from operating activities.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; which simplifies and clarifies certain calculation and presentation matters related to convertible equity and debt instruments. Specifically, ASU simplifies the accounting for such instruments by removing requirements to separately account for conversion features as a derivative under ASC Topic 815 and removing the requirement to account for beneficial conversion </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">features on such instruments. Accounting Standards Update 2020-06 also provides clearer guidance surrounding disclosure of such instruments and provides specific guidance for how such instruments are to be incorporated in the calculation of Diluted EPS. The guidance under ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company adopted this standard on January 1, 2021 on a modified retrospective basis. There was no impact upon adoption.</span></div><div style="margin-bottom:10pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standards Update (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) 2020-04, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, which provides temporary, optional expedients and exceptions to accounting guidance for certain contract modifications and hedging arrangements to ease financial reporting burdens as a result of market transitions from the London Interbank Offered Rate (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LIBOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to alternative reference rates. The guidance is available for prospective application upon its issuance and can generally be applied to contract modifications and hedging relationships entered into beginning March 12, 2020 through December 31, 2022. As of June&#160;30, 2021, the Company has long-term debt outstanding which carries an interest rate tied to LIBOR, the agreement for which contemplates an interest rate alternative in the event that LIBOR is unavailable. The Company is evaluating the possibility of adoption and the related impact on its financial statements. If adopted, the Company does not expect the provisions of this ASU to have a material impact on its consolidated financial statements.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other ASUs issued and not yet effective for the six months ended June 30, 2021, and through the date of this report, were assessed and determined to be either not applicable or are expected to have minimal impact on the Company&#8217;s financial position or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869233747576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td>
<td class="text">Inventory<div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.228%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,137&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,361&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the conclusion of the FDA&#8217;s period of Enforcement Discretion on May 31, 2021, the Company fully reserved $1.0 million of its Section 351 product inventory during the three and six months ended June&#160;30, 2021. This amount is included as part of cost of sales on the unaudited condensed consolidated statements of operations for those periods.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869231556680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and Equipment&#160;<div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:61.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and clean room equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset retirement cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Property and equipment, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,273)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,498)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,273&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,437&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for each of the three and six months ended June&#160;30, 2021 and 2020 is summarized in the table below (amounts in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"/><td style="width:24.580%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.056%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.056%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,422&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense is allocated amongst cost of sales, research and development, and selling, general, and administrative expense on the unaudited condensed consolidated statements of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869230083160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text">Intangible Assets<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are summarized as follows (in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:38.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.768%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and know how</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,069)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,730)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,403)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer and supplier relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,321&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,766)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,334)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,951&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names and trademarks</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,516&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,750&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,338&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for the three and six months ended June 30, 2021 and 2020 is summarized in the table below (amounts in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:28.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected future amortization of intangible assets as of June&#160;30, 2021, is as follows (in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated<br/>Amortization <br/>Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (excluding the six months ended June 30, 2021)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869232164808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text">Accrued Expenses<div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses&#160;consisted of the following&#160;(in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.485%"><tr><td style="width:1.0%"/><td style="width:53.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.743%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal costs</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,161&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commissions to sales agents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued clinical trials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued GPO fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,073&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,460&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869231431288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long Term Debt</a></td>
<td class="text">Long Term Debt<div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin Term Loan Agreement</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020, the Company entered into a Loan Agreement with, among others, Hayfin Services, LLP, (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) an affiliate of Hayfin Capital Management LLP (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin Loan Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), which Hayfin funded (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hayfin Loan Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) on July 2, 2020 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Closing Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and provided the Company with a senior secured term loan in an aggregate amount of $50 million (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Term Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The Term Loan matures on June 30, 2025 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maturity Date</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Interest is payable on the Term Loan for the balance outstanding quarterly through the Maturity Date. No principal payments on the Term Loan are due and payable until the Maturity Date.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Hayfin Loan Agreement also provided for an additional delayed draw term loan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DD TL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; collectively with the Term Loan, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in the form of a committed but undrawn facility. The Company had the option to borrow on the DD TL through June 30, 2021. The Company did not borrow on the DD TL prior to June 30, 2021 and the Company&#8217;s option to draw upon these funds has expired.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facilities, which are senior secured obligations, were entered into together with the sale of the Company&#8217;s Series B Convertible Preferred Stock (as defined and described in Note 9, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in an aggregate amount of up to $100 million (collectively, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Transactions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in order to:</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;refinance the outstanding indebtedness (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Refinancing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) under the Loan Agreement, dated as of June 10, 2019 (as amended and restated, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BT Term Loan Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), among the Company, the lenders and Blue Torch Finance LLC as administrative agent and collateral agent for such lenders,</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) &#160;&#160;&#160;&#160;pay fees and expenses incurred with certain financing transactions, and</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) &#160;&#160;&#160;&#160;finance the working capital, capital expenditures, and other general corporate purposes of the Company.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate applicable to any borrowings under the Term Loan accrues at a rate equal to LIBOR (subject to a floor of 1.5%) plus a margin of 6.75% per annum (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). If LIBOR is unavailable, the loan will carry interest at the Margin plus the greatest of the Prime Rate, the Federal Funds Rate plus 0.5% per annum, and 2.5%. The Margin is eligible for a reduction depending on the Total Net Leverage Ratio for the quarter; as follows:</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">6.5% per annum if the Total Net Leverage Ratio (as defined in the Hayfin Loan Agreement) is less than 2.0x but greater than or equal to 1.0x, or</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">6.0% per annum if the Total Net Leverage Ratio is less than 1.0x.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional 3.0% margin is applied to the interest rate in the event of default as defined by the Hayfin Loan Agreement. At issuance and as of June&#160;30, 2021, the Term Loan carried an interest rate of 8.3%.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facilities contain financial covenants requiring the Company, on a consolidated basis, to maintain the following:</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Maximum Total Net Leverage Ratio of 4.5x through June 30, 2021, further reduced to 4.0x thereafter for the life of the loans, required to be calculated on a quarterly basis.</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Minimum Liquidity (as defined in the Hayfin Loan Agreement) of $10 million, an at-all-times financial covenant tested monthly.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company is in compliance with all financial covenants required under the Hayfin Loan Agreement.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facilities also specify that any prepayment of the Term Loan, voluntary or mandatory, as defined in the Term Loan Agreement, will subject MiMedx to a prepayment premium applicable as of the date of the prepayment:</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On or before the first anniversary of the Closing Date:</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">A make-whole premium, equal to the greater of:</span></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">5% of the principal balance repaid, and</span></div><div style="margin-bottom:10pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">102% of the principal balance plus interest that would have been accrued from the repayment date to 12 months following the Closing Date.</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After the first anniversary of the Closing Date but on or before the second anniversary of the Closing Date: 2% of the principal balance repaid.</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After the second anniversary of the Closing Date: 1% of the principal balance repaid.</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After the third anniversary of the Closing Date: 0% of the principal balance repaid.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan Agreement also includes events of default customary for facilities of this type, and upon the occurrence of such events of default, subject to customary cure rights, all outstanding loans under the Credit Facilities may be accelerated or the lenders&#8217; commitments terminated. The mandatory prepayments are also required in the event of a change in control, incurring other indebtedness, certain proceeds from disposal of assets and insured casualty event. Annually, beginning with the fiscal year ending December 31, 2021, the Company is required to prepay the outstanding loans based on the percentage of the Excess Cash Flow (as defined in the Hayfin Loan Agreement), if such is generated, with the percentage determined based on the Total Net Leverage thresholds. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hayfin maintains a first-priority security interest in substantially all of the Company&#8217;s assets.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Original issue discount and deferred financing costs incurred as part of the Financing Transactions were allocated between the sale of the Series B Convertible Preferred Stock and the Hayfin Term Loan on the basis of the relative fair values of the transactions. The costs allocated to the Hayfin Term Loan were further allocated between the Term Loan and the DD TL on the basis of the maximum potential principal outstanding between the Credit Facilities. A summary of the allocation of the deferred financing costs and original issue discount between the Term Loan and the DD TL on July 2, 2020 was as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.263%"><tr><td style="width:1.0%"/><td style="width:24.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.125%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.125%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD TL</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Long term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Original issue discount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred financing costs and original issue discount associated with the Term Loan are amortized using the effective interest method through the Maturity Date. The amortization of such amounts are presented as part of interest expense, net on the unaudited condensed consolidated statement of operations for the three and six months ended June&#160;30, 2021. Unamortized deferred financing costs and original issue discount associated with the Term Loan are presented as a reduction to the principal balance on the Term Loan as part of long term debt, net on the unaudited condensed consolidated balance sheet as of June&#160;30, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred financing costs and original issue discount associated with the DD TL were amortized using the straight line method through the expiration of the DD TL commitment term on June 30, 2021. Amortization of these amounts are presented as part of interest expense, net on the unaudited condensed consolidated statement of operations for the three and six months ended June&#160;30, 2021. Unamortized deferred financing costs and original issue discount associated with the DD TL are presented as other current assets on the unaudited condensed consolidated balance sheet as of December&#160;31, 2020. There were no such amounts outstanding as of June&#160;30, 2021. In addition, the DD TL was subject to an additional commitment fee of 1% per annum of the amount undrawn, which is recognized as interest expense. The DD TL was not drawn upon as of June&#160;30, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balances of the Term Loan as of June&#160;30, 2021 and December&#160;31, 2020 were as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.941%"><tr><td style="width:1.0%"/><td style="width:33.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.339%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.340%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,816)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,905&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,697&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the Term Loan, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"><tr><td style="width:1.0%"/><td style="width:40.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.499%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stated interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,062&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,270&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the DD TL, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"><tr><td style="width:1.0%"/><td style="width:40.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.499%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment fee</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on the Term Loan as of June&#160;30, 2021 are as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (excluding the six months ended June&#160;30, 2021)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the fair value of the Term Loan was $52.0&#160;million. This valuation was calculated based on a series of Level 2 and Level 3 inputs, including a discount rate based on the credit risk spread of debt instruments of similar risk character in reference to U.S. Treasury instruments with similar maturities, with an incremental risk premium for risk factors specific to the Company. To derive the fair value of the Term Loan, the remaining cash flows associated with the Term Loan were discounted to June&#160;30, 2021 using this discount rate.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BT Term Loan</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2019, the Company entered into a loan agreement (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BT Term Loan Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) with the subsidiaries of the Company as guarantors and party thereto from time to time, the lenders party thereto from time to time and Blue Torch Finance LLC (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Blue Torch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), as administrative agent and collateral agent, pursuant to which the full amount of $75 million was borrowed and funded (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BT Term Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The proceeds from the BT Term Loan were used (i) for working capital and general corporate purposes and (ii) to pay transaction fees, costs and expenses incurred in connection with the BT Term Loan and the related transactions. The BT Term Loan would have matured on June 20, 2022 and was repayable in quarterly installments of $0.9 million; the balance was due on June 20, 2022. Blue Torch maintained a first-priority security interest in substantially all the Company&#8217;s assets. The BT Term Loan was issued net of the original issue discount of $2.3 million. The Company also incurred $6.7 million of deferred financing costs.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2020, the Company amended its BT Loan Agreement with Blue Torch. The amendment provided for an increase in the maximum Total Leverage Ratio, which was a quarterly test, for the remainder of 2020, and also provided for a reduction in the minimum Liquidity requirement from&#160;April 2020&#160;through and including&#160;November 2020. In connection with the amendment, the Company agreed to pay a one-time fee of $0.7 million, added to the principal balance, and a 1 percentage point increase in the interest rate to LIBOR plus 9%.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 2, 2020, a portion of the proceeds from each of the sales of the Company&#8217;s Series B Convertible Preferred Stock and the borrowings from the Hayfin Loan Transaction were used to repay the outstanding balance of principal, accrued but unpaid interest, and prepayment premium under the BT Loan Agreement. In connection with the repayment of the BT Term Loan, the Company terminated the BT Loan Agreement. The Company has no continuing obligations related to the BT Term Loan. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the BT Term Loan, included in interest expense, net in the unaudited condensed consolidated statements of operations was as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"><tr><td style="width:1.0%"/><td style="width:41.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:27.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.183%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on principal balance</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,891&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,731&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of original issue discount</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of amendment fee</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,040&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total BT Term Loan interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,667&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Paycheck Protection Program Loan</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applied for and on April 24, 2020 received proceeds of $10&#160;million in the form of a loan under the Paycheck Protection Program (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PPP Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 11, 2020, the Company repaid the PPP Loan in full. There are no continuing obligations under the PPP Loan as of June&#160;30, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869231414584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Common Share</a></td>
<td class="text">Net Loss Per Common Share<div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per common share is calculated using two methods: basic and diluted.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basic Net Loss Per Common Share</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per common share is calculated as net loss available to common stockholders divided by weighted average common shares outstanding. Net loss available to common stockholders is calculated as net loss less (i) dividends accumulated on the Company&#8217;s Series B Convertible Preferred Stock during the period, and (ii) periodic accretion of the increasing-rate dividend feature.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of net loss to net loss available to common stockholders and calculation of basic net loss per common share for each of the three and six months ended June&#160;30, 2021 and 2020 (amounts in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:41.275%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.832%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,779)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,466)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,161)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,287)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile to net (loss) income available to common stockholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated dividend on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of increasing-rate dividend feature</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total adjustments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,965&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss available to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,276)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,466)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,126)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,287)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,276,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,119,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,841,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,081,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net loss per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diluted Net Loss Per Common Share</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted net loss per common share is calculated as net loss available to common stockholders, adjusted for dividends on convertible preferred stock (to the extent such conversions would be dilutive), divided by weighted average common shares outstanding plus potential common shares. The calculation of potential common shares considers incremental shares resulting from certain transactions, including the exercise of stock options and the issuance of restricted stock using the treasury stock method, as well as the hypothetical conversion of the Company&#8217;s Series B Convertible Preferred Stock using the if-converted method. The treasury stock method assumes that proceeds from the transaction are used to purchase common stock at the average market price throughout the period. The if-converted method adds back dividends accrued or deemed on the Company&#8217;s Series B Convertible Preferred Stock and assumes conversion as of the later of the beginning of the period or the original transaction date.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each individual transaction is assessed for its dilutive effect on net loss per common share. To the extent that the transaction is antidilutive, or does not reduce net loss per common share, the effect is excluded from the calculation.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of diluted net loss per common share (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,276)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,466)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,126)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,287)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,276)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,466)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,126)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,287)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,276,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,119,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,841,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,081,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,373,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,232,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding adjusted for potential common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,276,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,119,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,841,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,081,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net loss per common share</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Potential common shares reflects hypothetical transactions involving convertible securities and share-based payment awards using the if-converted and treasury stock methods, respectively. The effect of each of these adjustments on the calculation is presented in the table below:</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.116%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,758,916&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,497,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,450,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock unit awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock unit awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,373,856&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635,618&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,232,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117,833&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869231959112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Equity</a></td>
<td class="text">Equity<div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series B Convertible Preferred Stock </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 2, 2020, the Company issued $100 million of the Company&#8217;s Series B Convertible Preferred Stock, par value $0.001 per share (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series B Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), to an affiliate of EW Healthcare Partners and to certain funds managed by Hayfin Capital Management LLP (individually, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; collectively the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) pursuant to a Securities Purchase Agreement with Falcon Fund 2 Holding Company, L.P., an affiliate of EW Healthcare Partners, and certain funds managed by Hayfin, dated as of June 30, 2020 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Purchase Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), for an aggregate purchase price of $100 million (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Preferred Stock paid a 4.0% cumulative dividend per annum prior to the quarterly dividend payment ending on June 30, 2021, and pays a 6.0% cumulative dividend per annum thereafter. Dividends are declared at the sole discretion of the Company&#8217;s board of directors. Dividends are paid at the end of each quarter based for dividend amounts that accumulate beginning on the last payment date through the day prior to the end of each quarter. In lieu of paying a dividend, the Company may elect to accrue the dividend owed to shareholders. Accrued dividend balances accumulate dividends at the prevailing dividend rate for each dividend period for which they are outstanding.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of Series B Preferred Stock, including any accumulated and unpaid dividends, is convertible into Company&#8217;s common stock at any time at the option of the Holder at a conversion price of $3.85 per common share, or 259.74 common shares for each share of Series B Preferred Stock prior to any accumulated and unpaid dividends. The Series B Preferred Stock, including any accumulated and unpaid dividends, automatically converts into common stock at any time after the third anniversary of the issuance date, provided that the common stock has traded at 200% or more of the conversion price for 20 out of 30 consecutive trading days and on such date of conversion the common stock has traded at 200% or more of the conversion price.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Series B Preferred Stock, voting as a class, generally are entitled to elect two members to the board of directors. Holders of the Series B Preferred Stock are entitled to vote on all matters to be voted on by the Company&#8217;s shareholders on an as-converted basis as a single class with the common stock not to exceed 19.9% of the total voting stock of the Company. Holders of the Series B Preferred Stock are also entitled to a liquidation preference in an amount equal to the original issue price plus all accumulated and unpaid dividends in the event of a liquidation, dissolution, or winding-up of the Company.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Preferred Stock instrument contains an increasing-rate cumulative dividend feature. The Company determined the present value of the difference between the (1) dividends that will be payable, in the period preceding commencement of the perpetual dividend; and (2) the perpetual dividend amount for a corresponding number of periods to ascribe a fair value to this feature. The present value is calculated using a market rate for dividend yield. The Company calculated the amount of the increasing-rate dividend feature as $1.8 million. This amount is amortized as a deemed dividend to preferred shareholders using the effective interest method through the commencement date of the Perpetual Dividend Rate. During the three and six months ended June&#160;30, 2021, the Company recognized $0.5 million and $0.9 million of deemed dividends related to the amortization of the increasing rate dividend feature.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company undergoes a change of control, the Company will have the option to repurchase some or all of the then-outstanding shares of Series B Preferred Stock for cash in an amount equal to the liquidation preference, subject to the rights of the holders of the Series B Preferred Stock in connection with such change in control. If the Company does not exercise such repurchase right, holders of the Series B Preferred Stock will have the option to (1) require the Company to repurchase any or </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">all of their then-outstanding shares of Series B Preferred Stock for cash in an amount equal to the liquidation preference or (2) convert the Series B Preferred Stock, including accumulated and unpaid dividends into common stock and receive their pro rata consideration thereunder. Because the contingent redemption of the Series B Preferred Stock by the holders in the event of change in control is outside the Company&#8217;s control, the Series B Preferred Stock is classified as temporary equity.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the three months ended June&#160;30, 2021 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"><tr><td style="width:1.0%"/><td style="width:42.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.608%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,030&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the six months ended June&#160;30, 2021 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"><tr><td style="width:1.0%"/><td style="width:42.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.608%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not declared or paid any dividends on the Series B Convertible Preferred Stock since issuance. Dividends in accumulated but not paid as of June&#160;30, 2021 was $4.1 million. As this amount has not been declared, the Company has not recorded this amount on its unaudited condensed consolidated balance sheet as of June&#160;30, 2021. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on accumulated dividends as of June&#160;30, 2021, the Series B Convertible Preferred Stock was convertible into an aggregate of 27,027,252 shares of the Company&#8217;s common stock.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued several classes of restricted stock awards to employees: restricted stock (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSAs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), restricted stock unit awards (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and performance stock unit awards (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). The following is summary information for restricted stock awards for the six months ended June 30, 2021.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, there was $33.0&#160;million of unrecognized share-based compensation expense related to restricted stock awards. That expense is expected to be recognized over a weighted-average period of 2.41 years, which approximates the remaining vesting period of these grants.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table summarizes activity of unvested restricted stock awards by award type from January 1, 2021 through June&#160;30, 2021. Unvested RSA awards noted below are included in issued and outstanding common stock as of June&#160;30, 2021, while unvested RSUs and PSUs are not included in issued or outstanding common stock as of June&#160;30, 2021.</span></div><div style="margin-bottom:10pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"><tr><td style="width:1.0%"/><td style="width:31.817%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.580%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.580%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.291%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at January 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175,859&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.78&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,325,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,957,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(862,790)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(761,775)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,026)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at June&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265,043&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,405,379&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity for the three months ended June 30, 2021 is presented below:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:48.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.731%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(494,139)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested options forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested options expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481,544&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,974,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at June&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481,544&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,974,672&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869231448280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the Company were 0.3% and (0.3)% for the three months ended June&#160;30, 2021 and June&#160;30, 2020, respectively. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the Company were (0.5)% and 45.9%, for the six months ended June&#160;30, 2021 and June&#160;30, 2020, respectively. These effective tax rates include the impact of discrete items of $0 and $11.4 million for the three months ended June&#160;30, 2021 and June&#160;30, 2020, respectively. The discrete items recorded for the six months ended June&#160;30, 2020 were primarily related to modifications to the tax rules for carryback of net operating losses as a result of the CARES Act which resulted in a federal tax refund of $11.3 million and an income tax benefit of the same amount. Of this amount, the Company has collected $1.2 million as of June&#160;30, 2021. No benefit had been recognized with respect to the net operating losses due to a previously-recorded valuation allowance.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869232125080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities</a></td>
<td class="text">Supplemental Disclosure of Cash Flow and Non-cash Investing and Financing Activities<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected cash payments, receipts, and non-cash activities are as follows (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:72.045%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.365%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,731&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right of use asset and liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note receivable for sale of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of equipment in accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of non-cash consideration received for option exercise</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment fee on BT Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869233735320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contractual Commitments and Contingencies</a></td>
<td class="text">Contractual Commitments and Contingencies<div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Matters</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company and its subsidiaries are parties to numerous civil claims and lawsuits and subject to regulatory examinations, investigations, and requests for information. Some of these matters involve claims for substantial amounts. The Company&#8217;s experience has shown that the damages alleged by plaintiffs or claimants are often overstated, based on unsubstantiated legal theories, unsupported by facts, and/or bear no relation to the ultimate award that a court might grant. Additionally, the outcome of litigation and regulatory matters and the timing of ultimate resolution are inherently difficult to predict. These factors make it difficult for the Company to provide a meaningful estimate of the range of reasonably possible outcomes of claims in the aggregate or by individual claim. However, on a case-by-case basis, reserves are established for those legal claims in which it is probable that a loss will be incurred and the amount of such loss can be reasonably estimated. The Company's unaudited condensed consolidated financial statements as of June&#160;30, 2021&#160;reflect the Company's current best estimate of probable losses associated with these matters, including costs to comply with various settlement agreements, where applicable. The actual costs of resolving these claims, as well as the cost to resolve claims that are either not probable or not estimable at this time, may be substantially higher or lower than the amounts reserved. For more information regarding the Company&#8217;s legal proceedings, refer to Note 14, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in the 2020 Form 10-K.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company has accrued $4.5 million related to the legal proceedings. The Company is entitled to indemnification from insurance companies in connection with legal proceedings of $0.4 million. This indemnification receivable is recorded as part of other current assets in the unaudited condensed consolidated balance sheet as of June&#160;30, 2021. The Company paid $6.5 million toward the resolution of legal matters involving the Company during the six months ended June&#160;30, 2021. In addition, $0.7 million was paid on the Company&#8217;s behalf through insurance providers during the six months ended June&#160;30, 2021.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company received funds from certain director and officer insurance policies for previously-incurred legal expenses under the Company&#8217;s indemnification agreements. These funds were recognized as a reduction to investigation, restatement, and related expense during each of the three and six months ended June&#160;30, 2021.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of certain litigation and regulatory matters:</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Securities Class Action</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 16, 2019, the United States District Court for the Northern District of Georgia entered an order consolidating two purported securities class actions (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">MacPhee v. MiMedx Group, Inc., et al.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> filed February 23, 2018 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Kline v. MiMedx Group, Inc., et al.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> filed February 26, 2018). The order also appointed Carpenters Pension Fund of Illinois (&#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">CPFI</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) as lead plaintiff. On May 1, 2019, CPFI filed a consolidated amended complaint, naming as defendants the Company, Michael J. Senken, Parker H. &#8220;Pete&#8221; Petit, William C. Taylor, Christopher M. Cashman and Cherry Bekaert &amp; Holland LLP. The amended complaint (the &#8220;Securities Class Action Complaint&#8221;) alleged violations of Section 10(b) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), Rule 10b-5 promulgated thereunder, and Section 20(a) of the Exchange Act. It asserted a class period of </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">March 7, 2013 through June 29, 2018. Following the filing of motions to dismiss by the various defendants, CPFI was granted leave to file an amended complaint. CPFI filed its amended complaint against the Company, Michael J. Senken, Parker H. Petit, William C. Taylor, and Cherry Bekaert &amp; Holland (Christopher Cashman was dropped as a defendant) on March 30, 2020; defendants filed motions to dismiss on May 29, 2020. On March 25, 2021, the Court granted defendants&#8217; respective motions to dismiss, finding that CPFI lacked standing to bring the underlying claims and also could not establish loss causation because it sold all of its shares in MiMedx prior to any corrective disclosures, and dismissed the case. On April 22, 2021, CPFI filed a motion for reconsideration of the dismissal and for leave to amend to add a new plaintiff to attempt to cure the standing and loss causation issues. The Company has opposed CPFI&#8217;s motions and the hearing on the same scheduled for July 28, 2021 has been postponed; no new date has yet been set.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Investigations</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Department of Veterans&#8217; Affairs Office of Inspector General (&#8220;VA-OIG&#8221;) and Civil Division of the Department of Justice (&#8220;DOJ-Civil&#8221;) Subpoenas and/or Investigations</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VA-OIG has issued subpoenas to the Company seeking, among other things, information concerning the Company&#8217;s financial relationships with VA clinicians. DOJ-Civil has requested similar information. The Company has cooperated fully and produced responsive information to VA-OIG and DOJ-Civil. Periodically, VA-OIG has requested additional documents and information regarding payments to individual VA clinicians. Most recently, on June 3, 2020, the Company received a subpoena from the VA-OIG requesting information regarding the Company&#8217;s financial relationships and interactions with two healthcare providers at the VA Long Beach Healthcare System. The Company has continued to cooperate and respond to these requests. At this time the Company is unable to predict the outcome of the investigation, including whether the investigation will result in any action or proceeding against us. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Department of Defense Office of Inspector General Investigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 8, 2021, the Company received a subpoena issued by the Department of Defense Office of Inspector General seeking records regarding the sales of the Company&#8217;s micronized and other products to federal medical facilities and federal contracting offices, including those operated by the Department of Veterans Affairs or the Department of Defense. The subpoena also seeks information regarding the Company&#8217;s communications with the FDA regarding its products. The Company understands that the Office of the United States Attorney for the Western District of Washington Civil Division is overseeing the investigation, which is being conducted principally by agents employed by the Department of the Army Criminal Investigation Command. The Company is cooperating with the government&#8217;s investigation and at this time the Company is unable to predict the outcome of the investigation, including whether the investigation will result in any action or proceeding against us. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Former Employee Litigation and Related Matters</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2018, the Company&#8217;s former Chief Financial Officer filed a complaint in the Superior Court for Cobb County, Georgia (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Michael J. Senken v. MiMedx Group, Inc.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) in which he claims that the Company has breached its obligations under the Company&#8217;s charter and bylaws to advance to him, and indemnify him for, his legal fees and costs that he incurred in connection with certain Company internal investigations and litigation. The Company filed its answer denying the plaintiff&#8217;s claims on April 19, 2019. To date, no deadlines have been established by the court. </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 12, 2021, the Company filed suit in the Circuit Court of the Eleventh Judicial District in and for Miami-Dade County, Florida (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">MiMedx Group, Inc. v. Petit, et. al.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) against its former CEO, Parker H. &#8220;Pete&#8221; Petit, and its former COO, William C. Taylor, seeking a determination of its rights and obligations under indemnification agreements with Petit and Taylor following a federal jury&#8217;s guilty verdict against Petit for securities fraud and Taylor for conspiracy to commit securities fraud. The Company is seeking a declaratory judgment that it is not obligated to indemnify or advance expenses to Petit and Taylor in connection with certain cases to which Petit and Taylor are parties and also seeking to recoup amounts previously paid on behalf of Petit and Taylor in connection with such cases.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 22, 2021, Petit and Taylor filed an answer and asserted counterclaims against the Company alleging breach of their indemnification agreements, breach of the covenant of good faith and fair dealing with respect to their indemnification agreements, and seeking a declaration that the Company remains obligated to indemnify and advance fees in connection with certain cases.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Petit and Taylor simultaneously also filed a motion seeking to compel the Company to advance and reinstate its payments of Petit and Taylor&#8217;s legal expenses. The Company opposed Petit and Taylor&#8217;s motion and a hearing was set for June 23, 2021. At the joint request of the parties, the hearing was cancelled to allow the parties to attend a mediation to attempt a resolution of this matter; such mediation is currently scheduled for August 11, 2021.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 15, 2021, Quinn Emanuel Urquhart &amp; Sullivan, LLP, Freshfields Bruckhaus Deringer US LLP, and Kobre Kim, LLP, law firms who have represented Mr. Petit and Mr. Taylor in various legal actions, including their criminal trial, filed suit in the Supreme Court of the State of New York County of New York against the Company (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Quinn Emanuel Urquhart &amp; Sullivan, LLP, et al. v. MiMedx Group, Inc.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) for breach of contract, breach of implied-in-fact contract, quasi-contract/unjust enrichment, promissory estoppel, equitable estoppel, and account stated seeking to enforce the Company&#8217;s alleged obligation to pay the firms for the legal fees and expenses incurred during their representations of Mr. Petit and Mr. Taylor. The parties have settled this matter and the case has been dismissed. The settlement reduced the Company&#8217;s liability to the plaintiffs, with respect to their representations of Messrs. Petit and Taylor, by $2.4 million. This reduction was included in investigation, restatement, and related expense on the unaudited condensed consolidated statements of operations for each of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">three and six months ended June&#160;30, 2021. The Company has paid the settlement amount and has no continuing obligations to the plaintiffs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defamation Claims</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 4, 2018, Sparrow Fund Management, LP (&#8220;Sparrow&#8221;) filed a complaint against the Company and Mr. Petit, including claims for defamation and civil conspiracy in the United States District Court for the Southern District of New York (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sparrow Fund Management, L.P. v. MiMedx Group, Inc. et. al.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The complaint seeks monetary damages and injunctive relief and alleges the defendants commenced a campaign to publicly discredit Sparrow by falsely claiming it was a short seller who engaged in illegal and criminal behavior by spreading false information in an attempt to manipulate the price of our common stock. On March 31, 2019, a judge granted defendants&#8217; motions to dismiss in full, but allowed Sparrow the ability to file an amended complaint. The Magistrate has recommended Sparrow&#8217;s motion for leave to amend be granted in part and denied in part and the Judge adopted the Magistrate&#8217;s recommendation. Sparrow filed its amended complaint against MiMedx (Mr. Petit has been dropped from the lawsuit) on April 3, 2020 and the Company filed its answer. This case is in discovery. </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 17, 2019, the principals of Viceroy Research (&#8220;Viceroy&#8221;), filed suit in the Circuit Court for the Seventeenth Judicial Circuit in Broward County, Florida (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Fraser John Perring et. al. v. MiMedx Group, Inc. et. al.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) against the Company and Mr. Petit, alleging defamation and malicious prosecution based on the defendants&#8217; alleged campaign to publicly discredit Viceroy and the lawsuit the Company previously filed against the plaintiffs, but which the Company subsequently dismissed without prejudice. On November 1, 2019, the Court granted Mr. Petit&#8217;s motion to dismiss on jurisdictional grounds, denied the Company&#8217;s motion to dismiss, and granted plaintiffs leave to file an amended complaint to address the deficiencies in its claims against Mr. Petit, which they did on November 21, 2019. The parties have settled this matter and the case has been dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Matters</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Florida Business Corporation Act and agreements with its current and former officers and directors, the Company is obligated to indemnify its current and former officers and directors who are made party to a proceeding, including a proceeding brought by or in the right of the corporation, with certain exceptions, and to advance expenses to defend such matters. The Company has already borne substantial costs to satisfy these indemnification and expense advance obligations and may continue to do so in the future. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the matters described above, the Company is a party to a variety of other legal matters that arise in the ordinary course of the Company&#8217;s business, none of which is deemed to be individually material at this time. Due to the inherent uncertainty of litigation, there can be no assurance that the resolution of any particular claim or proceeding would not have a material adverse effect on the Company&#8217;s business, results of operations, financial position or liquidity.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869232043688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue by Product</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MiMedx has two primary classes of products: (1) Advanced Wound Care, or Section 361, products, consisting of its sheet allograft products, and (2) Section 351 products, consisting of the Company&#8217;s micronized and particulate products. Advanced Wound Care is further disaggregated between the Company&#8217;s Tissue/Other and Cord products.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of net sales by each class of product (in thousands): </span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"><tr><td style="width:1.0%"/><td style="width:29.632%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Wound Care</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Tissue/Other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cord</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Advanced Wound Care</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,791&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,823&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 351</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,165&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,647&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,132&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,383&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1) &#8220;Other&#8221; represents cash collections on the Remaining Contracts. Remaining Contracts are those contracts for which performance obligations have been satisfied as of September 30, 2019, but for which the criteria required for revenue recognition had not been met and would not be met until the ultimate collection of cash. For all practicable purposes, the Company is not able to allocate these revenues to different product groups.</span></div><div style="margin-bottom:10pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue by Customer</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MiMedx has two primary distribution channels: (1) direct to customers (healthcare professionals and/or facilities) (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Direct Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and (2) sales through distributors (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distributors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of net sales by each customer type (in thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.233%"><tr><td style="width:1.0%"/><td style="width:24.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct Customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,755&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,165&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,647&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,132&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,383&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have significant foreign operations or a single external customer from which 10% or more of revenues were derived during the three or six months ended June&#160;30, 2021 or 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869229991224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent EventsNone noted.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869233179752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GAAP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) from interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the results of operations for the periods presented have been included.&#160;The operating results for the three and six months ended June&#160;30, 2021 and 2020 are not necessarily indicative of the results that may be expected for the fiscal year.&#160;The balance sheet as of December&#160;31, 2020 was derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements should be read in conjunction with the historical consolidated financial statements of the Company included in the 2020 Form 10-K.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared in accordance with GAAP. Conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported unaudited condensed consolidated statements of operations during the reporting period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment and intangible assets, estimates regarding asset retirement obligations, estimates for contingent liabilities, the measurement of right-of-use assets and lease liabilities, management&#8217;s assessment of the Company&#8217;s ability to continue as a going concern, estimates of fair value of share-based payments, and valuation of deferred tax assets.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above, the Company has considered the potential effects of the Covid-19 Pandemic and potential negative impacts resulting from the end of the FDA&#8217;s period of Enforcement Discretion with respect to its determinations surrounding impairments, increases in allowances for credit losses, increases in the Company&#8217;s returns reserve, other expenses, and changes in accounting judgments that have or are reasonably likely to have a material impact on the unaudited condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of MiMedx Group, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable represent amounts due from customers for which revenue has been recognized. Generally, the Company does not require collateral or any other security to support its receivables.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bad debt expense and the allowance for doubtful accounts are based on historical trends and current expectations for credit losses and reasonable and supportable forecasts. The Company&#8217;s policy to reserve for potential bad debts is based on the aging of the individual receivables as well as customer-specific qualitative factors, such as bankruptcy proceedings. The Company manages credit risk by routinely performing credit checks on customers prior to sales. The individual receivables are written-off after all reasonable efforts to collect the funds have been made. Actual write-offs may differ from the amounts reserved.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of purchase price over the fair value of net assets of acquired businesses. The Company assesses  goodwill for impairment at least annually on October 1 and whenever events or substantive changes in circumstances indicate that the asset may be impaired. The Company may first choose to assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then the Company performs a quantitative analysis. The Company may also choose to bypass the qualitative assessment and proceed directly to the quantitative analysis.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company concluded it operates as one reporting unit.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the quantitative analysis, if the carrying value of the reporting unit exceeds its fair value, goodwill impairment is recognized for the amount that the carrying value exceeds fair value, not to exceed the total amount of goodwill allocated to the reporting unit. The Company determines fair value using income and market approaches. Under the income approach, the fair value of the Company is the present value of its future economic benefits. These benefits can include revenue, cost savings, tax deductions, and proceeds from its disposition. Value indications are developed by discounting expected cash flows to their present value at a rate of return that incorporates the risk-free rate for the use of funds, industry trends, and entity-specific risks as of the goodwill impairment testing date. Under the market approach, the Company derives the fair value of the reporting unit using observed fair values of a set of companies with comparable business models to the reporting unit under evaluation. These amounts are reconciled to the Company&#8217;s market capitalization as of the test date for reasonableness.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Annual Goodwill Impairment Testing Date </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to change its annual goodwill and indefinite-lived intangible asset impairment testing date from September 30 to October 1. The change in the annual impairment testing date provides the Company with more time in identifying and calculating any impairments and to maximize the use of the Company&#8217;s available resources. </span></div>Because GAAP does not permit more than 12 months to pass between annual goodwill impairment tests, the Company performed quantitative tests on September 30 and October 1, 2020.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells its products primarily to individual customers and independent distributors (collectively referred to as &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Customers obtain and use products either through ship and bill arrangements or consignment arrangements. Under ship and bill arrangements, the customer submits an order. Upon approval of the sales order, the Company ships product to the customer and invoices them for the product sold. Under consignment arrangements, the customer takes possession of the product, but the Company retains title until the implantation, or application of the Company&#8217;s product to the patient.</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue as performance obligations are fulfilled; which generally occurs upon the shipment of product to the customers for ship and bill orders or upon implantation for consignment sales.</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized based on consideration the Company expects to be entitled to from the sale. This consists of the gross selling price of the product, less any discounts or rebates (collectively, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">deductions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">sales deductions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Gross selling price is a standard set by the Company for all customers unless a contract governing the sale provides for a specified price. Sales deductions are specified in individual contracts with customers and are generally achieved based on total sales during a specified period. The Company estimates the total sales deductions that a specific customer will achieve over the relevant term and applies the reduction to sales as they are made throughout the period. Rebates owed to customers are accrued and recorded in accrued expenses on the unaudited condensed consolidated balance sheets.</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company acts as principal in all of its customer arrangements and records revenue on a gross basis. Shipping is considered immaterial in the context of the overall customer arrangement, and damages or loss of goods in transit are rare. Therefore, shipping is not deemed a separately-recognized performance obligation and the Company has elected to treat shipping costs as activities to fulfill the promise to transfer the product. The Company maintains a returns policy that allows its customers to return product that is consigned, damaged, or non-conforming, ordered in error, or due to a recall. The estimate of the provision for returns is based on historical experience with actual returns. The Company&#8217;s payment terms for customers are typically 30 to 60 days from receipt of title of the goods.</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above revenue recognition policy, the Company recognizes revenue from customers with balances outstanding as of September 30, 2019 for which all of the criteria necessary for revenue recognition were not met at the time of </span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shipment and that such criteria would not be met until collection of such sales (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). This was in accordance with the change in the Company&#8217;s revenue recognition pattern beginning September 30, 2019 (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company defers the recognition of cost of sales associated with the Remaining Contracts until revenue is recognized and cash is collected. Deferred cost of sales, included as part of other current assets on the unaudited condensed consolidated balance sheets, were $0.1&#160;million and $0.2&#160;million as of June&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the effects of cash collections on the Remaining Contracts on the unaudited condensed consolidated statements of operations for each of the three and six months ended June&#160;30, 2021 and 2020 are as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.554%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:10pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is, or contains, a lease at inception.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Lease assets and liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The lease term used in the calculation includes options to extend or terminate the lease when the exercise of such options are reasonably certain. The determination of whether the Company is reasonably certain to exercise a renewal or termination option is reassessed as new information arises and is accounted for prospectively as of the point in time the determination is made regarding the modification of the lease term. The Company uses its incremental borrowing rate in determining the present value of lease payments.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets resulting from operating leases are included in right of use asset on the unaudited condensed consolidated balance sheets as of June&#160;30, 2021 and December&#160;31, 2020. Right-of-use assets resulting from the Company&#8217;s finance leases are included in property and equipment, net on the unaudited condensed consolidated balance sheet as of June&#160;30, 2021. Associated liabilities from both operating and finance leases are included on the unaudited condensed consolidated balance sheet as part of other current liabilities, to the extent that principal payments on such obligations will be paid in the next 12 months, and other liabilities, to the extent that principal payments on such obligations will be paid more than one year in the future. As of June&#160;30, 2021, the Company has both finance and operating leases.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable components of the lease payments such as fair market value adjustments, utilities, and maintenance costs are expensed as incurred and not included in determining the present value of lease liabilities. As an accounting policy election, the Company excludes short-term leases having initial terms of 12 months or fewer. </span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases, lease expense is recognized on a straight-line basis over the lease term through selling, general and administrative expense on the unaudited condensed consolidated statements of operations. For finance leases, the right of use asset is amortized, straight-line, over the life of the lease as depreciation expense, which is included as a component of selling, general and administrative expense on the unaudited condensed consolidated statements of operations. The Company recognizes interest expense on finance lease liabilities based on the incremental borrowing rate at lease inception applied to the outstanding lease liability. The Company does not recognize interest expense on operating lease liabilities.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments on operating leases are considered cash flows from operating activities. Payments on finance leases, to the extent that the payment relates to the reduction of the principal balance of the liability, are considered cash flows from financing activities. Payments toward the interest portion of finance lease liabilities are classified as cash flows from operating activities.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; which simplifies and clarifies certain calculation and presentation matters related to convertible equity and debt instruments. Specifically, ASU simplifies the accounting for such instruments by removing requirements to separately account for conversion features as a derivative under ASC Topic 815 and removing the requirement to account for beneficial conversion </span></div>features on such instruments. Accounting Standards Update 2020-06 also provides clearer guidance surrounding disclosure of such instruments and provides specific guidance for how such instruments are to be incorporated in the calculation of Diluted EPS. The guidance under ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company adopted this standard on January 1, 2021 on a modified retrospective basis. There was no impact upon adoption.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued and Adopted Accounting Standards</a></td>
<td class="text"><div style="margin-bottom:10pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standards Update (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) 2020-04, &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, which provides temporary, optional expedients and exceptions to accounting guidance for certain contract modifications and hedging arrangements to ease financial reporting burdens as a result of market transitions from the London Interbank Offered Rate (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LIBOR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to alternative reference rates. The guidance is available for prospective application upon its issuance and can generally be applied to contract modifications and hedging relationships entered into beginning March 12, 2020 through December 31, 2022. As of June&#160;30, 2021, the Company has long-term debt outstanding which carries an interest rate tied to LIBOR, the agreement for which contemplates an interest rate alternative in the event that LIBOR is unavailable. The Company is evaluating the possibility of adoption and the related impact on its financial statements. If adopted, the Company does not expect the provisions of this ASU to have a material impact on its consolidated financial statements.</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other ASUs issued and not yet effective for the six months ended June 30, 2021, and through the date of this report, were assessed and determined to be either not applicable or are expected to have minimal impact on the Company&#8217;s financial position or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869228923176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Assessment of Revenue under ASC 606</a></td>
<td class="text"><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the effects of cash collections on the Remaining Contracts on the unaudited condensed consolidated statements of operations for each of the three and six months ended June&#160;30, 2021 and 2020 are as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:13.2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.554%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e725-108305<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869232183624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventory</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.228%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,137&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,361&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869231651928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of Property and Equipment</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:61.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and clean room equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset retirement cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Property and equipment, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,273)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,498)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,273&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,437&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ScheduleOfDepreciationTableTextBlock', window );">Schedule of Depreciation Expense</a></td>
<td class="text">Depreciation expense for each of the three and six months ended June&#160;30, 2021 and 2020 is summarized in the table below (amounts in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"/><td style="width:24.580%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.056%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.056%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,422&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_ScheduleOfDepreciationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Depreciation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_ScheduleOfDepreciationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869231516424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Intangible Assets Activity Summary - Indefinite-lived</a></td>
<td class="text"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are summarized as follows (in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:38.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.768%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and know how</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,069)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,730)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,403)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer and supplier relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,321&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,766)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,334)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,951&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names and trademarks</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,516&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,750&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,338&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Intangible Assets Activity Summary - Finite-lived</a></td>
<td class="text"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are summarized as follows (in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:38.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.762%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.768%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortized intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and know how</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,069)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,730)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,403)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer and supplier relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,321&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,766)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,334)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,951&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names and trademarks</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,516&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,750&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,338&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for the three and six months ended June 30, 2021 and 2020 is summarized in the table below (amounts in thousands):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:28.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Estimated Future Amortization Expense for Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected future amortization of intangible assets as of June&#160;30, 2021, is as follows (in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated<br/>Amortization <br/>Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (excluding the six months ended June 30, 2021)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,555&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869230046472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses&#160;consisted of the following&#160;(in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.485%"><tr><td style="width:1.0%"/><td style="width:53.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.541%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.743%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal costs</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,161&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commissions to sales agents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated returns</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued clinical trials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued GPO fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,073&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,460&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869229858712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock', window );">Schedule of Debt Issuance Costs</a></td>
<td class="text">A summary of the allocation of the deferred financing costs and original issue discount between the Term Loan and the DD TL on July 2, 2020 was as follows (amounts in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.263%"><tr><td style="width:1.0%"/><td style="width:24.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.125%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.125%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.130%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD TL</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Long term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Original issue discount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balances of the Term Loan as of June&#160;30, 2021 and December&#160;31, 2020 were as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.941%"><tr><td style="width:1.0%"/><td style="width:33.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.339%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.775%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.340%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding principal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,816)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,905&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,697&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ScheduleofInterestExpenseTableTextBlock', window );">Schedule of Interest Expense</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the Term Loan, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"><tr><td style="width:1.0%"/><td style="width:40.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.499%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stated interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,062&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,270&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the DD TL, included in interest expense, net in the unaudited condensed consolidated statements of operations, was as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.216%"><tr><td style="width:1.0%"/><td style="width:40.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.499%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment fee</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of original issue discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the BT Term Loan, included in interest expense, net in the unaudited condensed consolidated statements of operations was as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"><tr><td style="width:1.0%"/><td style="width:41.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:27.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.183%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on principal balance</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,891&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,731&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of original issue discount</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of amendment fee</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,040&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total BT Term Loan interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,667&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Future Principal Payments for the Term Loan</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on the Term Loan as of June&#160;30, 2021 are as follows (amounts in thousands):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (excluding the six months ended June&#160;30, 2021)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_ScheduleofDebtIssuanceCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Debt Issuance Costs [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_ScheduleofDebtIssuanceCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_ScheduleofInterestExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Interest Expense [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_ScheduleofInterestExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869231349352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock', window );">Schedule of Earnings Per Share, Basic</a></td>
<td class="text">The following table provides a reconciliation of net loss to net loss available to common stockholders and calculation of basic net loss per common share for each of the three and six months ended June&#160;30, 2021 and 2020 (amounts in thousands, except share and per share amounts):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:41.275%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.832%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,779)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,466)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,161)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,287)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile to net (loss) income available to common stockholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated dividend on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of increasing-rate dividend feature</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total adjustments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,965&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss available to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,276)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,466)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,126)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,287)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,276,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,119,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,841,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,081,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net loss per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock', window );">Schedule of Earnings Per Share, Diluted</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of diluted net loss per common share (in thousands, except share and per share amounts):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss available to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,276)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,466)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,126)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,287)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,276)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,466)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,126)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,287)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,276,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,119,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,841,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,081,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,373,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,232,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding adjusted for potential common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,276,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,119,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,841,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,081,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net loss per common share</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Potential common shares reflects hypothetical transactions involving convertible securities and share-based payment awards using the if-converted and treasury stock methods, respectively. The effect of each of these adjustments on the calculation is presented in the table below:</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.116%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,758,916&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,497,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,450,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock unit awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock unit awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential common shares</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,373,856&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635,618&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,232,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117,833&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effect of income (loss) on basic earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869228406776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Schedule of Series B Preferred Stock</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the three months ended June&#160;30, 2021 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"><tr><td style="width:1.0%"/><td style="width:42.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.608%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,030&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table illustrates changes in the Company&#8217;s balance of Series B Preferred Stock for the six months ended June&#160;30, 2021 (in thousands, except share amounts):</span></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.175%"><tr><td style="width:1.0%"/><td style="width:42.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.608%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred Stock</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Restricted Stock Awards by Award Type</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below table summarizes activity of unvested restricted stock awards by award type from January 1, 2021 through June&#160;30, 2021. Unvested RSA awards noted below are included in issued and outstanding common stock as of June&#160;30, 2021, while unvested RSUs and PSUs are not included in issued or outstanding common stock as of June&#160;30, 2021.</span></div><div style="margin-bottom:10pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.713%"><tr><td style="width:1.0%"/><td style="width:31.817%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.580%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.580%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.291%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Grant Date<br/>&#160;Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at January 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175,859&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.78&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,325,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,212&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,957,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(862,790)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(761,775)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,026)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at June&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265,043&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,405,379&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,212&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Options Activity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity for the three months ended June 30, 2021 is presented below:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:48.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.731%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at January 1, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(494,139)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested options forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested options expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at June&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481,544&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,974,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at June&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481,544&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,974,672&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869231352536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Disclosure of Cash Flow and Non-cash Investing and Financing Activities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected cash payments, receipts, and non-cash activities are as follows (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:72.045%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.365%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,731&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right of use asset and liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note receivable for sale of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of equipment in accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of non-cash consideration received for option exercise</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deemed dividends on Series B Convertible Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment fee on BT Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869231562232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Summary of Net Sales by Products and Customer Type</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of net sales by each class of product (in thousands): </span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.812%"><tr><td style="width:1.0%"/><td style="width:29.632%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Wound Care</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Tissue/Other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cord</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Advanced Wound Care</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,791&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,823&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 351</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,165&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,647&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,132&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,383&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(1) &#8220;Other&#8221; represents cash collections on the Remaining Contracts. Remaining Contracts are those contracts for which performance obligations have been satisfied as of September 30, 2019, but for which the criteria required for revenue recognition had not been met and would not be met until the ultimate collection of cash. For all practicable purposes, the Company is not able to allocate these revenues to different product groups.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of net sales by each customer type (in thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.233%"><tr><td style="width:1.0%"/><td style="width:24.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct Customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,755&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,165&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,647&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,132&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,383&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869236318568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 68,165<span></span>
</td>
<td class="nump">$ 53,647<span></span>
</td>
<td class="nump">$ 128,132<span></span>
</td>
<td class="nump">$ 115,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">10,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding</a></td>
<td class="num">(1,347)<span></span>
</td>
<td class="num">(879)<span></span>
</td>
<td class="num">(4,563)<span></span>
</td>
<td class="num">(2,330)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Restricted stock canceled/forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=mdxg_StockAwardMisstatementsMember', window );">Stock Award Misstatements | Revision of Prior Period, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Correction of error</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Restricted stock canceled/forfeited</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">378<span></span>
</td>
<td class="nump">251<span></span>
</td>
<td class="nump">2,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital | Stock Award Misstatements | Revision of Prior Period, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Correction of error</a></td>
<td class="num">(928)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,009)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares repurchased for tax withholding</a></td>
<td class="num">(1,347)<span></span>
</td>
<td class="num">(939)<span></span>
</td>
<td class="num">(4,563)<span></span>
</td>
<td class="num">(2,477)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Restricted stock canceled/forfeited</a></td>
<td class="num">$ (103)<span></span>
</td>
<td class="num">$ (378)<span></span>
</td>
<td class="num">$ (251)<span></span>
</td>
<td class="num">$ (2,124)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Restricted stock canceled/forfeited (in shares)</a></td>
<td class="nump">12,437<span></span>
</td>
<td class="nump">42,613<span></span>
</td>
<td class="nump">48,026<span></span>
</td>
<td class="nump">285,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock | Stock Award Misstatements | Revision of Prior Period, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Correction of error</a></td>
<td class="nump">$ 928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TreasuryStockSharesAdjustment', window );">Treasury stock adjustment (in shares)</a></td>
<td class="num">(239,502)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(239,502)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock Issued | Stock Award Misstatements | Revision of Prior Period, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TreasuryStockSharesAdjustment', window );">Treasury stock adjustment (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mdxg_Section351Member', window );">Section 351</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 8,558<span></span>
</td>
<td class="nump">$ 6,150<span></span>
</td>
<td class="nump">$ 16,698<span></span>
</td>
<td class="nump">$ 14,888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareUmbilicalCordDerivedMember', window );">Cord</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">5,886<span></span>
</td>
<td class="nump">$ 3,263<span></span>
</td>
<td class="nump">10,846<span></span>
</td>
<td class="nump">$ 7,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TreasuryStockSharesAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TreasuryStockSharesAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares related to Restricted Stock Award forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=mdxg_StockAwardMisstatementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=mdxg_StockAwardMisstatementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mdxg_Section351Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mdxg_Section351Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareUmbilicalCordDerivedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareUmbilicalCordDerivedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869236338520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>reportingUnit</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reportingUnit</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Deferred cost of sales</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_RevenueFromContractWithCustomerPaymentTerms', window );">Customer payment terms</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_RevenueFromContractWithCustomerPaymentTerms', window );">Customer payment terms</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_RevenueFromContractWithCustomerPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Payment Terms</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_RevenueFromContractWithCustomerPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869232655144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Assessment of Revenue under ASC 606 (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 68,165<span></span>
</td>
<td class="nump">$ 53,647<span></span>
</td>
<td class="nump">$ 128,132<span></span>
</td>
<td class="nump">$ 115,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">12,760<span></span>
</td>
<td class="nump">8,198<span></span>
</td>
<td class="nump">22,401<span></span>
</td>
<td class="nump">18,223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">55,405<span></span>
</td>
<td class="nump">45,449<span></span>
</td>
<td class="nump">105,731<span></span>
</td>
<td class="nump">97,160<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member', window );">Accounting Standards Update 2014-09</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems', window );"><strong>Revenue, Initial Application Period Cumulative Effect Transition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">1,706<span></span>
</td>
<td class="nump">611<span></span>
</td>
<td class="nump">6,201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">239<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">$ 1,467<span></span>
</td>
<td class="nump">$ 525<span></span>
</td>
<td class="nump">$ 5,333<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869313414856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 396<span></span>
</td>
<td class="nump">$ 396<span></span>
</td>
<td class="nump">$ 314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">6,099<span></span>
</td>
<td class="nump">6,099<span></span>
</td>
<td class="nump">4,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">3,642<span></span>
</td>
<td class="nump">3,642<span></span>
</td>
<td class="nump">5,731<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">10,137<span></span>
</td>
<td class="nump">10,137<span></span>
</td>
<td class="nump">$ 10,361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mdxg_Section351Member', window );">Section 351</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mdxg_Section351Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mdxg_Section351Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869233906920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Summary of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property and equipment, gross</a></td>
<td class="nump">$ 41,546<span></span>
</td>
<td class="nump">$ 40,935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Less accumulated depreciation</a></td>
<td class="num">(31,273)<span></span>
</td>
<td class="num">(29,498)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">10,273<span></span>
</td>
<td class="nump">11,437<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">8,039<span></span>
</td>
<td class="nump">6,010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory and clean room equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">15,424<span></span>
</td>
<td class="nump">15,524<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">15,062<span></span>
</td>
<td class="nump">15,295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,972<span></span>
</td>
<td class="nump">3,321<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mdxg_AssetRetirementCostMember', window );">Asset retirement cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">860<span></span>
</td>
<td class="nump">785<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mdxg_FinanceLeaseAssetsMember', window );">Finance lease assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization', window );">Finance lease assets</a></td>
<td class="nump">$ 189<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mdxg_AssetRetirementCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mdxg_AssetRetirementCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mdxg_FinanceLeaseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mdxg_FinanceLeaseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869229884888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Depreciation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 1,306<span></span>
</td>
<td class="nump">$ 1,422<span></span>
</td>
<td class="nump">$ 2,467<span></span>
</td>
<td class="nump">$ 2,928<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869236314360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Activity Summary (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 11,321<span></span>
</td>
<td class="nump">$ 11,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(7,766)<span></span>
</td>
<td class="num">(7,334)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">3,555<span></span>
</td>
<td class="nump">3,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross carrying amount</a></td>
<td class="nump">13,516<span></span>
</td>
<td class="nump">13,338<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net carrying amount</a></td>
<td class="nump">5,750<span></span>
</td>
<td class="nump">6,004<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trade names and trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Gross carrying value, indefinite lived</a></td>
<td class="nump">1,008<span></span>
</td>
<td class="nump">1,008<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=mdxg_PatentsinProcessMember', window );">Patents in process</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Gross carrying value, indefinite lived</a></td>
<td class="nump">1,187<span></span>
</td>
<td class="nump">1,045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents and know how</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">9,546<span></span>
</td>
<td class="nump">9,510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(6,069)<span></span>
</td>
<td class="num">(5,730)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">3,477<span></span>
</td>
<td class="nump">3,780<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1,403)<span></span>
</td>
<td class="num">(1,334)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mdxg_CustomerAndSupplierRelationshipsMember', window );">Customer and supplier relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">241<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(181)<span></span>
</td>
<td class="num">(172)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(113)<span></span>
</td>
<td class="num">(98)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=mdxg_PatentsinProcessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=mdxg_PatentsinProcessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mdxg_CustomerAndSupplierRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mdxg_CustomerAndSupplierRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869230145896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Amortization Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 215<span></span>
</td>
<td class="nump">$ 271<span></span>
</td>
<td class="nump">$ 454<span></span>
</td>
<td class="nump">$ 542<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869232064552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Estimated future amortization expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2021 (excluding the six months ended June 30, 2021)</a></td>
<td class="nump">$ 366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 3,555<span></span>
</td>
<td class="nump">$ 3,951<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869228125480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Legal costs</a></td>
<td class="nump">$ 7,161<span></span>
</td>
<td class="nump">$ 14,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_AccruedSettlementCostsCurrent', window );">Settlement costs</a></td>
<td class="nump">4,495<span></span>
</td>
<td class="nump">9,975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Commissions to sales agents</a></td>
<td class="nump">1,823<span></span>
</td>
<td class="nump">2,141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent', window );">Estimated returns</a></td>
<td class="nump">777<span></span>
</td>
<td class="nump">688<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_AccruedClinicalTrialsCurrent', window );">Accrued clinical trials</a></td>
<td class="nump">686<span></span>
</td>
<td class="nump">651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Accrued GPO fees</a></td>
<td class="nump">520<span></span>
</td>
<td class="nump">554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_AccruedRebates', window );">Accrued rebates</a></td>
<td class="nump">372<span></span>
</td>
<td class="nump">886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,239<span></span>
</td>
<td class="nump">743<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 17,073<span></span>
</td>
<td class="nump">$ 30,460<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_AccruedClinicalTrialsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Clinical Trials, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_AccruedClinicalTrialsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_AccruedRebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Rebates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_AccruedRebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_AccruedSettlementCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Settlement Costs, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_AccruedSettlementCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=123410239&amp;loc=SL49130611-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerRefundLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869222792232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt - Term Loan (Details) - Term loan<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
<th class="th" colspan="1">48 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 02, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 22, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 10, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jul. 02, 2023</div></th>
<th class="th"><div>Jul. 02, 2022</div></th>
<th class="th"><div>Jul. 02, 2021</div></th>
<th class="th"><div>Jul. 02, 2025</div></th>
<th class="th"><div>Jul. 02, 2025</div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Hayfin Loan Agreement Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal issued</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 279,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 307,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Hayfin Loan Agreement Term Loan | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtInstrumentInterestRateFloorPercentage', window );">Debt instrument, interest rate, floor (percent)</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtInstrumentDefaultInterestRate', window );">Default interest rate (percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate at issuance (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Financing Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal issued</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TotalNetLeverageRatio', window );">Total net leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtCovenantMinimumLiquidity', window );">Debt covenant, minimum liquidity</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Deferred financing costs</a></td>
<td class="nump">$ 3,253,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Hayfin Loan Agreement Delayed Draw Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage', window );">Additional commitment fee (percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">BT Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of the Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Quarterly installments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Amended Term Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Amended Term Loan Agreement | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease', window );">Increase in interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast | Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast | Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 1.0x | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TotalNetLeverageRatio', window );">Total net leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast | Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TotalNetLeverageRatio', window );">Total net leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent', window );">Debt instrument, prepayment make-whole premium as percent of prepaid principal (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent', window );">Debt instrument, prepayment make-whole premium as percent of prepaid principal (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent', window );">Debt instrument, prepayment make-whole premium as percent of prepaid principal, plus accrued interest (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Hayfin Loan Agreement Term Loan | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Forecast | Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TotalNetLeverageRatio', window );">Total net leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Hayfin Loan Agreement Term Loan | Fed Funds Effective Rate Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Forecast | Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TotalNetLeverageRatio', window );">Total net leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_DebtCovenantMinimumLiquidity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Covenant, Minimum Liquidity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_DebtCovenantMinimumLiquidity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_DebtInstrumentDefaultInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Default Interest Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_DebtInstrumentDefaultInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_DebtInstrumentInterestRateFloorPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Interest Rate, Floor Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_DebtInstrumentInterestRateFloorPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Plus Accrued Interest, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Unused Capacity, Commitment Fee Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TotalNetLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Net Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TotalNetLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental percentage increase (decrease) in the stated rate on a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_FinancingTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_FinancingTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_CreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_CreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_TermLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_TermLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_AmendedTermLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_AmendedTermLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869236320344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long Term Debt - Term Loan Debt Issuance Costs (Details) - Term loan - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jul. 02, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Hayfin Loan Agreement Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="nump">$ 279<span></span>
</td>
<td class="nump">$ 307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember', window );">Long term debt | Hayfin Loan Agreement Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,169<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember', window );">Other current assets | Hayfin Loan Agreement Delayed Draw Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,084<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_CreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_CreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869233737240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long Term Debt - Term Loan Balances (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Term loan | Hayfin Loan Agreement Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs</a></td>
<td class="num">(1,816)<span></span>
</td>
<td class="num">(1,996)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="num">(279)<span></span>
</td>
<td class="num">(307)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="nump">$ 47,905<span></span>
</td>
<td class="nump">$ 47,697<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869233945752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt - Term Loan Interest Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet', window );">Accretion of amendment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Term loan | Hayfin Loan Agreement Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Interest on principal balance</a></td>
<td class="nump">$ 1,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Accretion of original issue discount</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing costs</a></td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total BT Term Loan interest expense</a></td>
<td class="nump">1,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Term loan | Hayfin Loan Agreement Delayed Draw Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_DebtInstrumentCommitmentFees', window );">Commitment fee</a></td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Accretion of original issue discount</a></td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing costs</a></td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total BT Term Loan interest expense</a></td>
<td class="nump">$ 376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Term loan | BT Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Interest on principal balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Accretion of original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,040<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total BT Term Loan interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,172<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_DebtInstrumentCommitmentFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Commitment Fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_DebtInstrumentCommitmentFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredLoanOriginationFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net increase(decrease) in interest income during the period representing the allocation of deferred loan origination fees less deferred loan origination costs using the effective interest method over the term of the debt arrangement to which they pertain taking into account the effect of prepayments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124402152&amp;loc=d3e8622-111531<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredLoanOriginationFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_TermLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_TermLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869230049256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long Term Debt - Term Loan Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2021 (excluding the six months ended June&#160;30, 2021)</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term debt</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_LongTermDebtMaturityAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Maturity, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_LongTermDebtMaturityAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869230133176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long Term Debt - Paycheck Protection Program Loan (Details)<br></strong></div></th>
<th class="th">
<div>Apr. 24, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Term loan | PPP Loan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from BT Term Loan</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mdxg_PaycheckProtectionProgramLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mdxg_PaycheckProtectionProgramLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869236826632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share - Basic Net Loss Per Common Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,779)<span></span>
</td>
<td class="num">$ (8,466)<span></span>
</td>
<td class="num">$ (10,161)<span></span>
</td>
<td class="num">$ (13,287)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Adjustments to reconcile to net (loss) income available to common stockholders</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityAccretedbutUnrecordedDividends', window );">Accumulated dividend on Series B Convertible Preferred Stock</a></td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,039<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature', window );">Accretion of increasing-rate dividend feature</a></td>
<td class="nump">464<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders', window );">Total adjustments</a></td>
<td class="nump">1,497<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,965<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss available to common stockholders</a></td>
<td class="num">$ (3,276)<span></span>
</td>
<td class="num">$ (8,466)<span></span>
</td>
<td class="num">$ (13,126)<span></span>
</td>
<td class="num">$ (13,287)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">110,276,636<span></span>
</td>
<td class="nump">108,119,461<span></span>
</td>
<td class="nump">109,841,428<span></span>
</td>
<td class="nump">108,081,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share (in dollars per share)</a></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Reconcile to Net Income (Loss) Available to Common Stockholders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityAccretedbutUnrecordedDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Accreted but Unrecorded Dividends</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityAccretedbutUnrecordedDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Accretion of Increasing-rate Dividend Feature</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869236250040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share - Diluted Net Loss Per Common Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract', window );"><strong>Computation of basic and diluted net loss per share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss available to common stockholders</a></td>
<td class="num">$ (3,276)<span></span>
</td>
<td class="num">$ (8,466)<span></span>
</td>
<td class="num">$ (13,126)<span></span>
</td>
<td class="num">$ (13,287)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders', window );">Dividends on Series B Convertible Preferred Stock</a></td>
<td class="nump">$ 1,497<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,965<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding (in shares)</a></td>
<td class="nump">110,276,636<span></span>
</td>
<td class="nump">108,119,461<span></span>
</td>
<td class="nump">109,841,428<span></span>
</td>
<td class="nump">108,081,625<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding adjusted for potential common shares</a></td>
<td class="nump">110,276,636<span></span>
</td>
<td class="nump">108,119,461<span></span>
</td>
<td class="nump">109,841,428<span></span>
</td>
<td class="nump">108,081,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net (loss) income per common share (in dollars per share)</a></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">30,373,856<span></span>
</td>
<td class="nump">1,635,618<span></span>
</td>
<td class="nump">30,232,150<span></span>
</td>
<td class="nump">2,117,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss available to common stockholders</a></td>
<td class="num">$ (3,276)<span></span>
</td>
<td class="num">$ (8,466)<span></span>
</td>
<td class="num">$ (13,126)<span></span>
</td>
<td class="num">$ (13,287)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders', window );">Dividends on Series B Convertible Preferred Stock</a></td>
<td class="nump">$ 1,497<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,965<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share - diluted (in dollars per share)</a></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">110,276,636<span></span>
</td>
<td class="nump">108,119,461<span></span>
</td>
<td class="nump">109,841,428<span></span>
</td>
<td class="nump">108,081,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">110,276,636<span></span>
</td>
<td class="nump">108,119,461<span></span>
</td>
<td class="nump">109,841,428<span></span>
</td>
<td class="nump">108,081,625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">26,758,916<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">26,497,570<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">1,271,626<span></span>
</td>
<td class="nump">1,044,479<span></span>
</td>
<td class="nump">1,450,671<span></span>
</td>
<td class="nump">1,386,674<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock unit awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">1,471,412<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,345,953<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Outstanding stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">838,644<span></span>
</td>
<td class="nump">562,513<span></span>
</td>
<td class="nump">906,811<span></span>
</td>
<td class="nump">714,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember', window );">Performance stock unit awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">33,258<span></span>
</td>
<td class="nump">28,626<span></span>
</td>
<td class="nump">31,145<span></span>
</td>
<td class="nump">16,559<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Reconcile to Net Income (Loss) Available to Common Stockholders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869324680552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 02, 2020 </div>
<div>USD ($) </div>
<div>day </div>
<div>director </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Series B convertible preferred stock par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Deemed dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (464,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (926,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityAccretedbutUnrecordedDividends', window );">Series B Preferred convertible Stock, dividends accrued but not recorded for the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,033,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,039,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Total unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Outstanding Options, weighted average remaining contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 4 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassBMember', window );">Preferred Class B Convertible Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series B Preferred Stock</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Series B convertible preferred stock par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ProceedsfromIssuanceofTemporaryEquity', window );">Proceeds from issuance of temporary equity</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityConversionPricePerShare', window );">Series B preferred stock, conversion price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityConversionRatio', window );">Conversion ratio of Series B preferred stock to common stock</a></td>
<td class="nump">259.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger', window );">Series B preferred stock, minimum percentage of conversion stock price to trigger conversion (percent)</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityConversionThresholdTradingDays', window );">Number of trading days within consecutive day trading period common stock must exceed trigger conversion price | day</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityThresholdConsecutiveTradingDays', window );">Series B preferred stock, threshold number of consecutive trading days | day</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion', window );">Series B preferred stock, minimum percentage of conversion stock price on conversion date (percent)</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders', window );">Number of board seats elected by Series B preferred stockholders | director</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis', window );">Series B preferred stock, maximum voting stock percentage on an as-converted basis (percent)</a></td>
<td class="nump">19.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityIncreasingrateDividendFeature', window );">Series B preferred stock, increasing-rate dividend feature</a></td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassBMember', window );">Preferred Class B Convertible Stock | Discounted Dividend Rate prior to Quarterly Dividend Payment ending on June 30,2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityDividendRatePercentage', window );">Series B convertible stock, cumulative dividend (percent)</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassBMember', window );">Preferred Class B Convertible Stock | Perpetual Dividend Rate after Quarterly Dividend Payment ending on June 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityDividendRatePercentage', window );">Series B convertible stock, cumulative dividend (percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Deemed dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (464,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (926,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityAccretedbutUnrecordedDividends', window );">Series B Preferred convertible Stock, dividends accrued but not recorded for the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquitySharesIssueduponConversion', window );">Series B Preferred convertible stock, shares issuable upon conversion (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,027,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,027,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Board Seats Elected by Temporary Equity Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_ProceedsfromIssuanceofTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Issuance of Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_ProceedsfromIssuanceofTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityAccretedbutUnrecordedDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Accreted but Unrecorded Dividends</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityAccretedbutUnrecordedDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityConversionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Conversion Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityConversionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger on Date of Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityConversionThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Conversion, Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityConversionThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Dividend Rate, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityIncreasingrateDividendFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Increasing-rate Dividend Feature</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityIncreasingrateDividendFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Maximum Voting Stock Percentage on As-converted Basis</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquitySharesIssueduponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Shares Issued upon Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquitySharesIssueduponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Threshold Consecutive Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869233749016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Changes in Series B Preferred Stock (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Series B Preferred Stock, outstanding, beginning (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Series B Preferred Stock, outstanding, beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Deemed dividends</a></td>
<td class="nump">$ 464<span></span>
</td>
<td class="nump">$ 926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Series B Preferred Stock, outstanding, ending (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Series B Preferred Stock, outstanding, ending</a></td>
<td class="nump">$ 92,494<span></span>
</td>
<td class="nump">$ 92,494<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Series B Preferred Stock, outstanding, beginning (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Series B Preferred Stock, outstanding, beginning</a></td>
<td class="nump">$ 92,030<span></span>
</td>
<td class="nump">$ 91,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Deemed dividends</a></td>
<td class="nump">$ 464<span></span>
</td>
<td class="nump">$ 926<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Series B Preferred Stock, outstanding, ending (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Series B Preferred Stock, outstanding, ending</a></td>
<td class="nump">$ 92,494<span></span>
</td>
<td class="nump">$ 92,494<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869236716696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Restricted Stock Awards (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, Beginning Balance (in shares) | shares</a></td>
<td class="nump">2,175,859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(862,790)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(48,026)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, Ending Balance (in shares) | shares</a></td>
<td class="nump">1,265,043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Beginning Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 4.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">4.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">3.60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Ending Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 4.79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock unit awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, Beginning Balance (in shares) | shares</a></td>
<td class="nump">2,325,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">2,957,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(761,775)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(116,019)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, Ending Balance (in shares) | shares</a></td>
<td class="nump">4,405,379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Beginning Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 5.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">10.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">5.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">8.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Ending Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 8.65<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance stock unit awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, Beginning Balance (in shares) | shares</a></td>
<td class="nump">35,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, Ending Balance (in shares) | shares</a></td>
<td class="nump">35,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Beginning Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 7.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Ending Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 7.10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869236098600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Stock Incentive Plans (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning of period (in shares)</a></td>
<td class="nump">2,025,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(494,139)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Unvested options forfeited (in shares)</a></td>
<td class="num">(50,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Vested options expired (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, end of period (in shares)</a></td>
<td class="nump">1,481,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable options, vested and expected to vest (in shares)</a></td>
<td class="nump">1,481,544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning of period (in dollars per share)</a></td>
<td class="nump">$ 4.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">3.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Unvested options forfeited (in dollars per share)</a></td>
<td class="nump">1.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Vested options expired (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, end of period (in dollars per share)</a></td>
<td class="nump">5.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (in dollars per share)</a></td>
<td class="nump">$ 5.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted- Average Remaining Contractual Term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding (in years)</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable (in years)</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding</a></td>
<td class="nump">$ 10,974,672<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable</a></td>
<td class="nump">$ 10,974,672<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869233659096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
<td class="nump">45.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems', window );">Effective income tax rate impact of discrete items</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 11,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision benefit (expense)</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="num">$ (27,000)<span></span>
</td>
<td class="num">$ (53,000)<span></span>
</td>
<td class="nump">$ 11,277,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward', window );">Tax benefit recognized with respect to net operating loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=mdxg_CARESActMember', window );">CARES Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision benefit (expense)</a></td>
<td class="nump">$ 11,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIncomeTaxRefunds', window );">Federal tax refund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Discrete Items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Net Operating Loss Carryforward</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIncomeTaxRefunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash received during the period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIncomeTaxRefunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=mdxg_CARESActMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=mdxg_CARESActMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869232783704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash paid for interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,207<span></span>
</td>
<td class="nump">$ 3,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_LeaseRightOfUseAssetAndLiability', window );">Lease right of use asset and liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_NotesReceivableForSaleOfPropertyAndEquipment', window );">Note receivable for sale of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of equipment in accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise', window );">Fair value of non-cash consideration received for option exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature', window );">Deemed dividends on Series B Convertible Preferred Stock</a></td>
<td class="nump">$ 464<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_NoncashActivitiesDeferredFinancingCosts', window );">Deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee', window );">Amendment fee on BT Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 722<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value Of Non-Cash Consideration Received For Option Exercise</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_LeaseRightOfUseAssetAndLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Right Of Use Asset And Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_LeaseRightOfUseAssetAndLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_NoncashActivitiesDebtInstrumentAmendmentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash Activities, Debt Instrument, Amendment Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_NoncashActivitiesDebtInstrumentAmendmentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_NoncashActivitiesDeferredFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash Activities, Deferred Financing Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_NoncashActivitiesDeferredFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_NotesReceivableForSaleOfPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable For Sale Of Property And Equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_NotesReceivableForSaleOfPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Accretion of Increasing-rate Dividend Feature</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869236551384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contractual Commitments and Contingencies - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 15, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 03, 2020 </div>
<div>healthcareProvider</div>
</th>
<th class="th">
<div>Jan. 16, 2019 </div>
<div>securityClassAction</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceSettlementsReceivable', window );">Settlements indemnified by insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for legal settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ContingencyLossNumberOfSecuritiesClassActions', window );">Number of securities class actions | securityClassAction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_ContingencyLossNumberOfFormerHealthcareProviders', window );">Number of healthcare providers | healthcareProvider</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Decrease in litigation settlement</a></td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mdxg_LegalProceedingsMember', window );">Legal Proceedings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceRecoveries', window );">Insurance recoveries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_ContingencyLossNumberOfFormerHealthcareProviders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingency Loss, Number Of Former Healthcare Providers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_ContingencyLossNumberOfFormerHealthcareProviders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_ContingencyLossNumberOfSecuritiesClassActions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingency Loss, Number Of Securities Class Actions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_ContingencyLossNumberOfSecuritiesClassActions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recovered from insurance. These recoveries reduce costs and losses that are reported as a separate line item under operating expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceSettlementsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceSettlementsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mdxg_LegalProceedingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mdxg_LegalProceedingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869236611784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Summary of Revenue by Product Type (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>product</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>product</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_NumberOfProducts', window );">Number Of Products | product</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 68,165<span></span>
</td>
<td class="nump">$ 53,647<span></span>
</td>
<td class="nump">$ 128,132<span></span>
</td>
<td class="nump">$ 115,383<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCareMember', window );">Advanced Wound Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">59,294<span></span>
</td>
<td class="nump">45,791<span></span>
</td>
<td class="nump">110,823<span></span>
</td>
<td class="nump">94,294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareTissueAndOtherMember', window );">Tissue/Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">53,408<span></span>
</td>
<td class="nump">42,528<span></span>
</td>
<td class="nump">99,977<span></span>
</td>
<td class="nump">87,134<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareUmbilicalCordDerivedMember', window );">Cord</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">5,886<span></span>
</td>
<td class="nump">3,263<span></span>
</td>
<td class="nump">10,846<span></span>
</td>
<td class="nump">7,160<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mdxg_Section351Member', window );">Section 351</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">8,558<span></span>
</td>
<td class="nump">6,150<span></span>
</td>
<td class="nump">16,698<span></span>
</td>
<td class="nump">14,888<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 313<span></span>
</td>
<td class="nump">$ 1,706<span></span>
</td>
<td class="nump">$ 611<span></span>
</td>
<td class="nump">$ 6,201<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_NumberOfProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_NumberOfProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareTissueAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareTissueAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareUmbilicalCordDerivedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mdxg_AdvancedWoundCareUmbilicalCordDerivedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mdxg_Section351Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mdxg_Section351Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139869232781704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Summary of Revenue by Customer Type (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>distributionChannel</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>distributionChannel</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels', window );">Number of primary distribution channels | distributionChannel</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 68,165<span></span>
</td>
<td class="nump">$ 53,647<span></span>
</td>
<td class="nump">$ 128,132<span></span>
</td>
<td class="nump">$ 115,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels', window );">Number of primary distribution channels | distributionChannel</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember', window );">Direct Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 66,061<span></span>
</td>
<td class="nump">52,755<span></span>
</td>
<td class="nump">$ 123,619<span></span>
</td>
<td class="nump">112,651<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember', window );">Distributors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 2,104<span></span>
</td>
<td class="nump">$ 892<span></span>
</td>
<td class="nump">$ 4,513<span></span>
</td>
<td class="nump">$ 2,732<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Number Of Distribution Channels</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdxg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>75
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M \4<$4-H2C?@!JWTFP4F!L0 XSXUA:>T +9K@?8"$P,4ZWOZE#\$@(!@&&&
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MFPTE9KY<EDW[B1XVV&B$\G6C9;49# PJ47??['%CB)T!,(][ -D,(,,!L6<
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M]H7,K=1:5NWEDK."*P. WQ<2*K[-C5E@^T[O^']02P,$%     @ QHD#4QK
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M3ACC!V]Z^H,?"^.]:>G7M9(0K?$&^!Y?>(X?<(/T%V!>_1]02P,$%     @
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M["GC;I$XPO8:237@7/<X[!6<*7S2RC46/J@:ZZ?V"7$:B;$CL6OV)N"OG;J
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ML"1H<)&E'JA^3_07(W=.FUMI2.GN6--J164#R%]*:8X7FV!8ULM?4$L#!!0
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M%5E=\ YX3UUJR!L:=5P#K(GK2XWY.<70YQLR)<N3-HPF''&K'V51_%C!Y=V
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MTG,:/TSCA^/XX23@SG7710Y?^S2\V,209L+.SFQ7<&WC+IG4_DDZ:IO"!-3
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MF5BR^*XJHS6H0-RL2N64V"1V+3[(- +X'Z"["%E>DJ\:)WCB9__.]YZ(A\>
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M(?($^QFX8*50M1A^BA302F)3E]1UYF^TR%2V(/DUJQRCP">J<+ (-%*$#S0
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MCB_<7K:YL;K@'R,LM+4ZX\NUDM@4T0"\7VHP6WU#"[2_3GGS/U!+ P04
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M:J=:UL+AA5$?9>&K1?0J@@)+T2I_8[H_<*CGC./E1KGP#5WO.YU&D+?.FWH
M$X-:ZOY7; <=#@"OTJ\ L@&0!=Y]HL#R4GBQG%O3@65OBL:+4&I $SFIN2FW
MWM*I))Q?OM&YJ1&\V**;)YXBLCW)!_1YC\Z^@GX);XWVE8,K76#Q&)\0DY%.
MMJ=SGCT;\,]6QS!-3R%+L\DS\:9C>=,0;_I\>7=B"Y?2Y<JXUB)\6JV=MW0A
M_GXFQ6Q,,0LI9C^HX#>A[Q@-=Q4"EB6&F\H1P0I/=OKO@:>S"U,W0N^@0RHB
MC:?'('0!O]#JY'AT\I5%A+KO"W)?@%3%4=6 .;30MT77]%G5+OX^&I3][*0G
M,CN+?SL^'=V<W/XL#?<T$:ESU188LDCBDGLP)1348(N>3!YKQY:C-&0YFDSB
M&?UYE.(Y\/_J])^D%G-C.=0WB9#V$C96TD"4:D=P1046X V!"EG*7/#L<FP(
MG%F"5@V]R(6UN[7([[E630.<1C4))/4&Z*([\A+T8=(THM@G-&]U<W4+*Y*L
MJV1>#:>44]*(A!(+"J'Z1%BV) 'K2 ).1P%9%Z&Y"<.]AS5J+.68P@FRB]JT
MVL?PGFW2#?O31Q>H(GXTP'A"([<ISKXD"0U\U) 8WIDQ524*6J,.BF^T_)<"
M=-)7^Q;M%7M2EJ)%/A>D/#Y(TSJU>S%V[D&H5O0OAJ(G2^@<XZ?&1'(P=&NT
MF_"T<#U49C]_1^OX>JWZH?W%O7_ZW@J[D=1EA25!T_C7LPAL_YST&V^:,,+7
MQM.#$)85O<!HV8'.2V/\?L,)QC=]^1E02P,$%     @ QHD#4S;T4IE3 P
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MW@C42G%^=OR?M.S:>ETU"A[@T3=J.30,X_;XOT](M&T-5VDV,P2V$;41G?$
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M@D;'IR<!Z&$"!\.JSG?]2EF:(;]MZ-%"[0+HO%+*;@V78'P&%V]02P,$%
M  @ QHD#4UMX%YU^ P  !@@  !D   !X;"]W;W)K<VAE971S+W-H965T,C0N
M>&ULA55M;^,V#/XKA'<84L"H;=E.G"X)T%?<ACL@N-YM'X9]4&PF%LZ6<I+<
M]/;K1\F)FQ9I]L649/+A0XHB9SNEOYL:T<)SVT@S#VIKMU=19,H:6VXNU18E
M_5DKW7)+6[V)S%8CK[Q1VT0LCL=1RX4,%C-_MM2+F>IL(R0N-9BN;;G^>8.-
MVLV#)#@<?!&;VKJ#:#';\@T^HOVV76K:10-*)5J41B@)&M?SX#JYNLF=OE?X
M4^#.'*W!1;)2ZKO;_%[-@]@1P@9+ZQ XB2>\Q:9Q0$3CQQXS&%PZP^/U ?W!
MQTZQK+C!6]7\)2I;SX,B@ K7O&OL%[7[B/MX/,%2-<9_8=?K9N2Q[(Q5[=Z8
M]JV0O>3/^SP<&13Q.P9L;\ \[]Z19WG'+5_,M-J!=MJ$YA8^5&]-Y(1TE_)H
M-?T59&<72TWWJ^U/X+*"^Q^=V%+&+8R^\E6#YF(667+B5*-R#WC3 [)W ,?P
M64E;&[B7%5:O[2,B-S!D!X8W["S@'YV\A#0.@<4L.8.7#A&G'B_]GXA#6#:<
M0GT=^-_7*V,UU<H_9UQE@ZO,N\K><?785SJH-9S.\ZGTGH5T;_3*;'F)\X >
MH4']A,'K2\0AEE+1VS$6*T? U@AKU= C%'(#(R'I1'6&+,S%%5"2<4@RW&&)
M[0HUI(D_B>$34N77JJE M%NMGM Y,/ !BC!.IR3'89R0&E\IS:W2/96R04Y/
M5ZGVB%62AQG+G,A)/'1:"MMI?,.=?L=CY@2;YG!+D5C=]0^9J!.%#45O( FG
M$P9IF!+K:V.HB6FT0N,^?F.A&,<P*7)X$)++$J%QD0!WNF1>3.'77PJ6L-_@
M=!)#V&A%CK(DS+,Q9'$X37-*!QWQLNS:KN$NP172;92">X(C2AN;I!<P8M,P
MFQ87[V)+(OP!DMBINT429ND$SE1>/E1>?K[RJ'E778/NYN^.N=T_4SLW>*KP
MSB*>+KQ7T-A#4Y5I0%[6AZJSM<;^>HUXAK;O#NBZPYNR<RJ^VH39#PGQ+RGY
M4B48UY%@Y<8(C'BK.E> ;\KXJW=UW(!>7#R2\]-_O'/O^&5U,C*ZH3"-QUYF
MC)%D83:>>#EEQ<F+BXYZ<XMZXR>0H=HD_GV;'DZ'(7?=]_87]7Y"?N9Z(Z2A
M$EZ3:7PYH1O3_=3I-U9M?:=?*4MSPR]K&M2HG0+]7RME#QOG8!C]B_\ 4$L#
M!!0    ( ,:) U,H"MH\5P0  "$.   9    >&PO=V]R:W-H965T<R]S:&5E
M=#(U+GAM;.U766_C-A#^*P,A#S;@Q+KM!+8!Y]KNHKL(-MD61=$'6AK;1"11
M):EULK^^0])6G,11%V@?\V#QFGOF&Y.3C9#W:HVHX:$L*C7UUEK79\.ARM98
M,G4B:JSH9"EDR30MY6JH:HDLMTQE,0Q]/QV6C%?>;&+W;N1L(AI=\ IO)*BF
M+)E\/,=";*9>X.TVOO+56IN-X6Q2LQ7>HOY6WTA:#5LI.2^Q4EQ4('$Y]>;!
MV7EJZ"W!;QPW:F\.QI.%$/=F\3&?>KXQ" O,M)' :/B.%U@41A"9\?=6IM>J
M-(S[\YWT:^L[^;)@"B]$\3O/]7KJC3W(<<F:0G\5FU]PZT]BY&6B4/8+&T>;
M^AYDC=*BW#*3!26OW,@>MG'88QB_Q1!N&4)KMU-DK;QDFLTF4FQ &FJ29B;6
M5<M-QO'*).562SKEQ*=G'RO-JA5?% ASI5 KZ-TQ6JG^9*A)OJ$:9EM9YTY6
M^(:L%#Z+2J\57%4YYL_YAV17:URX,^X\[!3XJ:E.(/('$/IAT"$O:IV-K+SH
M#7D?A,@WO"B 53F\]OR2JZP0JI$(?\X72DLJF;\ZU,:MVMBJC7\ZQG-3BUP_
MPJW# AR3.51+O.(:CPNJT_Q0^#O5&/B>J9IE./4(GPKE=_3V=3.GFY%[#H+\
M!^:T"TM1$#8I\[P"O1:-HO"H_AE0^+$-/UQBAN4")42!W?'A@Q1*P063\I%7
M*YB7HJDT^98U95,P3<)I2VK^@UD ?J$6\Y+X?Q"Q)2!2_LK7&Q)1&9\IW_<5
M96U-OR,X'21Q2F,O'?CI:9]FT2 >C=Q)X)N39#"*?'<R&OOP*\^H$:&"8! '
M,?1H\*,^!,'31A3%?2#2"PM:BI-1JIJZ+C@M)!;6!;7FM8(P#HAE'/0A];>+
M44B+4_@BJN-,E#5J<F(E$4OK0$#A[@4!J1RY^>FX#V$(=T(S*N>.$!R1D8.(
M\D=.C0:C-'5.)4GBCL)QXHZL_>;H- G@6]4E\TZR'(%(T(56FS45U+U5-_#]
M\9OC+B-4:K44&2H3TF \:K]^G&R_SK>#'I']@4D@92GQW484&2644#^&#LPF
M+6:3_X[9ZW_!:Z>*=[R^X_4=KQ:OSVH&'VJ3.JIR2=6-]*.HNN3P!RC=#0/-
M#>-%P1L26^=<[0/&@H3$F%L-+,PM%'K,EJ*"%P"ZLZKV+S%/*FY)^>$3J]PJ
M?IH=].@(PL D+QR9[,9);"(2AUWM*FW;5=K9KJZ4YJ7%WW6CS07FF0%7>R%]
MU=@.-:Y.98<;E]&1&0.6S@"V;X!8'J@+ZF2T_RR, Y.[C@[W!S)I<F_:R;/^
M]N2_S4$/'[*BL60F]]V%8U&4IF8>$J1C,XEVDW@W22 <$W[72$^?I2:UXS#Y
M*3@[[![*\7#OVDX-:&4?)PHR4YON!M_NMN^?N;OV/Y&[Q]-G)E>\4E#@DEC]
MDQ']]4CW('$++6K["%@(3=W.3M?TAD-I".A\*83>+8R"]E4X^P=02P,$%
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M+NDBBLH*T/NYE&8[L0::J^WX+U!+ P04    " #&B0-3Q.[^SDT%  "B#@
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M,LL_E*HJA,:"IB YK_*N&H#FSN$M1(M0-IH^>V@.1/"\=&LMO+2E%L(#&?E
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M-_<__Y3Z7O)2D6BKO"E.D@2J;FNK2XD(=7>4:(X2Z"!P. @XLTY$J_)FJ1S
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M>H4K,F5N0M>![+KP;J+%QG:^"Z&IC[;#DOZXH#0;Z/U*T&=W-S$.AK]"TW\
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M7MH_%HMV1I[5VY?FD[ [J1THW))I<C$>16W=3QMOZC Q-\;3_ W+DAX\M*Q
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M=Q0(,C"UE/-!D@]F\@%YU4#5<F/<43]Z!!="@FW48,@S<WD-CXU&_*:*0#5
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M7EG=3*J)%H4[JY="F[C<<&UN<RBM@7F?":$?)]9!<S^<_ 502P,$%     @
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MKX-+6Q/=#WC]M+@C8D&91#G,-16?#?5JB[I:UQW%E[9^O7"EJZ%M9OJ% \(
M]/R<<[7N& ?MFVGZ%U!+ P04    " #&B0-3%"[O9)P#  #$#@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970S-BYX;6R]5UUOTS 4_2M6Q -(8[&=KP:UE:!C
M @12Q?AX0#QXJ=M:)'&QG17^/==)EJ1-F@':]M+&R;GW'A_;Q_9T+]4/O>7<
MH%]9FNN9LS5F]\)U=;+E&=/G<L=S^+*6*F,&FFKCZIWB;%4&9:E+,0[=C(G<
MF4_+=TLUG\K"I"+G2X5TD65,_7[%4[F?.<2Y??%1;+;&OG#GTQW;\"MN/N^6
M"EINDV4E,IYK(7.D^'KFO"0O%M2S 27BB^![W7E&MBO74OZPC;>KF8,M(Y[R
MQ-@4#/YN^(*GJ<T$/'[629VFI@WL/M]FORP[#YVY9IHO9/I5K,QVYDP<M.)K
M5J3FH]R_X76' ILOD:DN?]&^QF(')84V,JN#@4$F\NJ?_:J%Z 00_T0 K0/H
MWP9X=4"IG%LQ*[MUP0R;3Y7<(V71D,T^E-J4T= ;D=MAO#(*O@J(,_.E@AFA
MS&_$\A5Z_;,0.Q@C@YZCJVI<D5RC$YBG%]PPD>IG@/Y\=8&>/GF&GB"1HT];
M66C ZJEK@*(MY"8UG5<5'7J"SKLB/T<>/D,44S(0OA@/O^ )A),R'!^&NR!,
MHPYMU*%E/N\.=<[0,F70Y4,!OKT'.'IK>*:_CQ3SFF)>6<S_FZ'@MU7.T$9)
M/2AEE2XLT]GE>C/W2>"'4_>FJ]@ "L=>T* .N/H-5W^4ZWNN-2S!I,B*E!F^
M@I4#+I((9M?F$-<J7=!A\=PC-/*.R [ :.S'DV&V0<,V^"]E<VZ&N 8]$@3W
MJ0Z@B.]%PTS#AFEXAZY@25N9KI#(=DK><$M4CTRNJ$D</?Q,GC3%)O<[DR<]
M+2?8BX\$[X-"3/"PWG'#-![7FUU+Q8Q4%=<DY0QV)RFSEO:('@2W+HL?7G[2
M,75ROP-0YSN8S8%/_:,A&(0%'=@AW]9F"1WE>UFH7)A"\4/"8UJTKDJ\1Y"^
M-48R[HS_+GW?\TB 0WHL_1",QB=\G+362,:]<2%S;511':I@\P;7V2A^3/4P
M>>MF)'P$[5N/(]$]:Q_U18VCGO1]E.?9X\F@\JU)DG&7?*DU'-,5-T*5-H\2
MJ4>G?&MJ)'YXV6EK;A3?K^QUO@._#_&1Z@.@:')BNM/6&>FX,UZ*G.4)1ZG=
M:!&S0S VU6GGI/@(1T7:NAH=/RS>W8]:ZO[QCTR.=]8!T/&^ZG:N&/9^]X&I
MC<@UU%]###Z/8)Q4=66J&D;NREO'M31PARD?MW#-Y,H"X/M:2G/;L!>9YN(Z
M_P-02P,$%     @ QHD#4]):CWIW @  KP8  !D   !X;"]W;W)K<VAE971S
M+W-H965T,S<N>&ULI55=;YLP%/TK%NI#*W6% $N[BB U(=,VJ5+4KMO#M <'
M;H)58U/;-.V_W[4A+.EH5FTO8%^?<^X'UY=D(]6]+@$,>:JXT!.O-*:^]'V=
MEU!1?29K$'BRDJJB!K=J[>M: 2T<J>)^& 1COZ),>&GB; N5)K(QG E8***;
MJJ+J>0I<;B;>R-L:;MBZ--;@ITE-UW +YJY>*-SYO4K!*A":24$4K";>U>AR
M'EN\ WQCL-$[:V(S64IY;S>?BXD7V(" 0VZL L77(\R <RN$83QTFE[OTA)W
MUUOUCRYWS&5)-<PD_\X*4TZ\"X\4L*(--S=R\PFZ?-Y;O5QR[9YDTV$#C^2-
M-K+JR!A!Q43[ID]='78(J#-,"#M"^)(0OT*(.D+T5@]Q1XC?ZN%]1W"I^VWN
MKG 9-31-E-P09=&H9A>N^HZ-]6+"]LFM47C*D&?2A<*64^:94%&0^4/#:FP"
M0]Z1#+#O<D;=YYP_85]J(,<9&,JX/D' W6U&CH].R!%A@GPM9:-10B>^P:BL
MMI]W$4S;",)7(HC(M12FU&0N"B@&^-EA_O@ W\=J]"4)MR69A@<%OS3BC$3!
M*0F#<#00S^SM]& HG?_S/O]G[WO%B/K^B)Q>])?^."4+3K$Q]MODQ]52&X67
M_><!5W'O*G:NXE=<[74<M!TWU$ZMRMBIV#'XF(ZB8)SXC[O?:  4A^$^*/L3
M%,;C\WW0? #T(;SH06VJ_LX-K$"MW>C3))>-,&VQ>VL_7:_<4'EAGXXN9Z,!
M>X;3N!V>O^7;47Y-U9H)33BLT%5P=HX#0K7CL=T86;O[OY0&IXE;EOA' 64!
M>+Z2TFPWUD'_CTI_ 5!+ P04    " #&B0-3G'>"[)@$  ";%0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970S."YX;6R]F%%OHS@0Q[^*%>W#KM06;$-(5DFD
M;JJ]ZZJWJK:[=P^G>W")FZ""S=FFV=ZG/YL0(&#<5!OU)<$P,_Y[//QL/-MR
M\2@WE"KP,TN9G(\V2N4?/4_&&YH1><%SRO23!RXRHG13K#V9"TI6I5.6>LCW
MQUY&$C9:S,I[MV(QXX5*$T9O!9!%EA'Q_(FF?#L?P='^QK=DO5'FAK>8Y61-
M[ZCZD=\*W?+J**LDHTPFG %!'^:C2_AQB0/C4%K\F="M;%T#,Y1[SA]-XWHU
M'_E&$4UIK$P(HO^>Z)*FJ8FD=?Q;!1W5?1K']O4^^N=R\'HP]T32)4__2E9J
M,Q]-1F!%'TB1JF]\^SNM!A2:>#%/9?D+MCO;"(U 7$C%L\I9*\@2MOLG/ZM$
MM!Q@,." *@=TK .N'' YT)VR<EA71)'%3/ M$,9:1S,796Y*;SV:A)EIO%-"
M/TVTGUI<,T78.KE/*;B4DBH)SL&E26VBGL'=;F[!^RNJ2)+*#_KAC[LK\/[=
M!_ .) Q\W_!"$K:2,T]I,2:D%U<=?]IUC 8Z_E*P"X#],X!\!"WN2[?[%8VU
M.RS=_4-W3Z>@S@.J\X#*>'@@WN>$)8J>W^B:6H%^4OZ^T?;@6M%,_N/H#=>]
MX;*W8*"WWP27$BR)$,\)6X/+C!=,V7*X"S,NPY@W\FD!(3;Y>FJGRF:%)F%M
M=: QJ#4&3HV7<5QD14J43H@6*%3R'S%OGDWF+E+8$G >1>-Q1Z;-"N/ +C.L
M989.F5\UZHY(9-CK&X=AV!%H,9J&T*YO7.L;.POKFFFH[(HK_;7BBNH>(V=&
M6AV0LH,SL"[K+=ZGB0RF*>IE .(0=B?29H7QQ)ZH22U[\EK93,_M$:(G/3EA
M%/H=S7VCL>\/U-ZTECQU2OXNR(H"1C(J@:8@4*:MB?DH'=,(_0;-_AN5#FPM
M!_ (,M5)?R)I0<\TZO=*0*G$BGO8KPK?GW2FX26K0]D-O2%RRK[5F&(Z'WI-
MR@6/J73.0(-IB-]J!AKL0C=W?V$&^H"%<!)U9\!BY0<#BP5L, S='-[/@'D/
M'IGVWO"M*Q\-/Z$;H*=9F6%#3^C&Y]%K,^QC<!H&759:K: _D.X&EM!-R]>L
MSK#/OO.Q/YYVE5K,P@@/26T@"=V4/'*%KJ(<K+Y!U*M>BU4T&="(&M0BWZGQ
M)HGUIPEU40,U#$7P#2H6M;:N;O@=7;%5G(-7/X!!)\4O61VJ;%B*W'O>UU1L
M%>J@%&'@XZY2F]G@CA(U"$9N!!]9L<C&VZ[$OLU@M3:L16[6+LOO0BI*V,HB
MS]-$-P1-RX3*39(["[E!+WH+]*(&O>A$Z$5]J**@EWJWT:'&!KSH=.!%%J+"
M24^GS2I" T(;[**38!?U@3KN[IUM-E.[/MP@%[N1^Y6S\YAG.=5;&K(6E&9F
M_^#ZN&X C-\"P+@!,#X1@+$%K:B;[1>,#C6V3AQ.AU]LXRKLTM=F-1W8R>.&
MO?@D[*VBM,\\NEL%BPGJOE5>Z^3,'%O^0<0Z81*D]$$[^1>1'IW8G03N&HKG
MY6':/5<:P>7EANJO/F$,]/,'SM6^8<[GZO/8Q?]02P,$%     @ QHD#4SE/
MS@]Z @  L@8  !D   !X;"]W;W)K<VAE971S+W-H965T,SDN>&ULI55;;YLP
M%/XK%NI#*VTUMZ1319"2D&VM5*EJU^UAVH,#)\&JL3/;E&Z_?K8A+&E)5&TO
MX,MW\3D^'))&R$=5 FCT7#&N)EZI]>828Y674!%U+C; S<Y*R(IH,Y5KK#82
M2.%(%<.A[X]Q12CWTL2MW<HT$;5FE,.M1*JN*B)_S8")9N(%WG;ACJY+;1=P
MFFS(&NY!/VQNI9GA7J6@%7!%!4<25A-O&EPN8HMW@*\4&K4S1C:2I1"/=G)5
M3#S?'@@8Y-HJ$/-Z@CDP9H7,,7YVFEYO:8F[XZWZ1Q>[B65)%,P%^T8+74Z\
M#QXJ8$5JIN]$\QFZ>$96+Q=,N2=J6NS%V$-YK;2H.K(Y045Y^R;/71YV"$9G
MF!!VA/ E(3Y B#I"]%:'N"/$;W48=007.FYC=XG+B"9I(D6#I$4;-3MPV7=L
MDR_*;9W<:VEVJ>'I](IKPM=TR0!-E0*MT'LTK834]#=Q-[EX-B6I )UFH EE
MZLP 'NXS='IRADX0Y>A+*6I%>*$2K,V!K"S.._-9:QX>,(_0C>"Z5&C!"R@&
M^-EQ_O@('YM$]-D(M]F8A4<%KVM^CB+_'0K],!@XS_SM='\HG/]S7_RS^UXR
MHKXT(J<7'=#[)$314,:0N5STNDXRJG(F5"T!?9\NE9;FF_]QQ#;N;6-G&Q^P
MW:L^:*MOJ+1:E;%3L=WP*0V#48*?=J]K ',1[&.RUYAX%.]C%J\QHSCL,6V8
M>.<CK$"N7?=3*!<UUVW2^]6^P4Y=7WFQ/@LNY\' >F8:<ML__\JWW?R&R#7E
M"C%8&2O__,+T"-EVR':BQ<:U@*70IJ&X86E^*B MP.ROA-#;B37H?U/I'U!+
M P04    " #&B0-3&6:]VZP"  !I!P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970T,"YX;6R-E6]OVC 0QK^*%>U%*VU-2$B "I!::+5.VE3US_9BV@M##F(U
ML9E]*72??F<G3=D(T#?$COW<[[G#.0_72C^9# #9ILBE&7D9XNK<]\T\@X*;
M,[4"22L+I0N.--5+WZPT\-2)BMP/@R#Q"RZD-QZZ=[=Z/%0EYD+"K6:F+ JN
M7RXA5^N1U_%>7]R)98;VA3\>KO@2[@$?5[>:9GX3)14%2".49!H6(^^B<SX9
MV/UNPW<!:[,U9C:3F5)/=G*3CKS &H(<YF@C<'H\PP3RW 8B&[_KF%Z#M,+M
M\6OT:Y<[Y3+C!B8J_R%2S$9>WV,I+'B9XYU:?X8ZG]C&FZO<N%^VKO<&'IN7
M!E51B\E!(63UY)NZ#EN"3G>/(*P%X7L%42V(7**5,Y?6E",?#[5:,VUW4S0[
M<+5Q:LI&2/LOWJ.F54$Z'-](Y'(I9CFP"V, #?O$K@P**A"D[+K$4M-*H32*
M/]P5_FI#)\@ HQ/$=M4G4T N<G-*<1[OI^SDPRG[P(1D#YDJ#9>I&?I(OBW=
MG]<>+RN/X1Z/7TIYQJ+@(PN#L-,BGQR63V%.\HZ3!__*?:I64[*P*5GHXD5[
MXKV59U&5AV^7!^KR_+R8&=1T2G\=0$8-,G+([AZD39R=P&:>EZF02X89,",V
MK% 2,\- IN2&R@1-F4[;REQ!$@>QG_?S.$J2H?_<XJS;..L><Q:VH2I5O(5*
M!MUV5-R@XF.HJ T5OQ^5-*CD&*K;ADK>C^HUJ-XQ5-R&ZNV@PG[8CNHWJ/Y!
MU$,&U.@7"+H-V-\!]JVS-N"@ 0X. K_1+33A6K_8,TM-I)381A[L'LLX?D-7
MWWC+ID'<^<^?O]4([27TE>NED(;EL"!9<-:C]'35V*L)JI7KC3.%U&G=,*.[
M$+3=0.L+I?!U8MMM<[N._P)02P,$%     @ QHD#4Z:YEU$# P  0@D  !D
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MT,EVC\@ZZQ.F,RYUI8#\OIUK5.:!_WE'O-N(=YUX[XBXM4HN89OQ*F=FL[
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MM;M:]M3@@^(_6&F;9?0Y@A(K>N3V475?<:CGUO,5BIOPAJZ/7<01%$=CE1C
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M:#SY=!N![D>U=ZQJPWCLE77#%LS&W6[4/L#M5\K-P>#XB1O_%]E?4$L#!!0
M   ( ,:) U.#4\W_%@0  (H-   9    >&PO=V]R:W-H965T<R]S:&5E=#0X
M+GAM;*57;8_B-A#^*U9T'W:EV\TK(:P :7FIVJI7H>.V]Z'J!Y,8<#>QJ>W
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M5.86E*4"65!^Z'=";(7=K$"^]]8*>+T\?#5=%1QB# <;NL2&@NH^AS93*KC
M(?'APM^8YN".GI?OK=>ZU\T+WP-ZXK#-D WJ);X_BMH5>&&%CI+(CX*D195=
M*^B-@\$-NBXZ)[^7KJH]8N?D.<#M=TF8X2;C>8Y%M6AF[315&R67$?4>O79U
MO %+VO1887[0IN9[L(H6]Z*W+(C8F:9>@J<E4U6/T,PV#X=GTRZWYF?^T]RW
MS"_T0\/TLF_JJU?*)RQVE$F4DRULY3T.(8RB:ORK@>('T]ENN((^V7SNX;%$
MA ; ^I9S=1[H#9KGU_0?4$L#!!0    ( ,:) U-+**DL_04  ,(=   9
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M@@$DB=&D>3SE2IW"I@'NCC?:/UOGM3,3(F' DQ\T4G'7:3DH@AE9)NJ>K[]
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;+U676_;.@S]*X*Q"W3
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ML2ATRCBL)%%%EE'Y,H=4'">=H/.Z\9WM]MIL>--Q3G>P!OTC7TE<>;65A&7
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MX[<&2". [[<"BV2U, [JKY?IOU!+ P04    " #&B0-3OZ"6OBX#  !U"0
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M'G>J Z<\!ZCW&\;D:9 [J'OZR;]02P,$%     @ QHD#4],&M#U? P  "PP
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MP<7(:$E6G6<UT:)PK=5::%,Q-TQ-MTZE-3#?MT+HP\0&:/K_V?]02P,$%
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MO251E"1^!#"_@BC"$'@;<013 !HP)(JJ?7!O/PJ;?2K<_/\U_@U02P,$%
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ,:) U.8%URB.@4  &85   8
M          " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " #&B0-3' AKAGH&  !M&@  &               @(%^#0  >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ QHD#4^RJMOVM P  +@X
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M965T-RYX;6Q02P$"% ,4    " #&B0-3<4R<HPP7   -1@  &
M    @(%C.0  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
MQHD#4_"7< (0 P  9P8  !@              ("!I5   'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( ,:) U,PJT_9H ,   \(   9
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M970Q-"YX;6Q02P$"% ,4    " #&B0-3+>,G3+X+  "I(@  &0
M    @(%Q=@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M ,:) U-.%V_(/P,  -\'   9              " @6:"  !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ QHD#4S;T4IE3 P  F@<  !D
M             ("!W(4  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    " #&B0-32:W*OR(4  "H.0  &0              @(%FB0  >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( ,:) U.'Y'(Y+04
M .0+   9              " @;^=  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ QHD#4_J6/6C= 0  6P0  !D              ("!
M(Z,  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " #&B0-3
MDD_A7@D6  !#1   &0              @($WI0  >&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+ 0(4 Q0    ( ,:) U/FC]7QW0(  $8&   9
M      " @7>[  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%
M  @ QHD#4T(6?)YF @  $@4  !D              ("!B[X  'AL+W=O<FMS
M:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " #&B0-36W@7G7X#   &"
M&0              @($HP0  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+
M 0(4 Q0    ( ,:) U,H"MH\5P0  "$.   9              " @=W$  !X
M;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ QHD#4Q[?5IW1
M @  OP4  !D              ("!:\D  'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6Q02P$"% ,4    " #&B0-3\!80_L0$  #F#@  &0
M@(%SS   >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( ,:)
M U/$[O[.304  *(.   9              " @6[1  !X;"]W;W)K<VAE971S
M+W-H965T,C@N>&UL4$L! A0#%     @ QHD#4VZM>AJ^!   %@T  !D
M         ("!\M8  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
M    " #&B0-3EA:^M5H#  !.!P  &0              @('GVP  >&PO=V]R
M:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( ,:) U-'"Q\.'P0  .8(
M   9              " @7C?  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL
M4$L! A0#%     @ QHD#4P;KNPR'!0  7QL  !D              ("!SN,
M 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " #&B0-33#**
M@R<#   K"@  &0              @(&,Z0  >&PO=V]R:W-H965T<R]S:&5E
M=#,S+GAM;%!+ 0(4 Q0    ( ,:) U-7=V-EG0,  %8,   9
M  " @>KL  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @
MQHD#4TV_SBKG @  /PD  !D              ("!OO   'AL+W=O<FMS:&5E
M=',O<VAE970S-2YX;6Q02P$"% ,4    " #&B0-3%"[O9)P#  #$#@  &0
M            @('<\P  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4
M Q0    ( ,:) U/26H]Z=P(  *\&   9              " @:_W  !X;"]W
M;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ QHD#4YQW@NR8!
MFQ4  !D              ("!7?H  'AL+W=O<FMS:&5E=',O<VAE970S."YX
M;6Q02P$"% ,4    " #&B0-3.4_.#WH"  "R!@  &0              @($L
M_P  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( ,:) U,9
M9KW;K (  &D'   9              " @=T! 0!X;"]W;W)K<VAE971S+W-H
M965T-# N>&UL4$L! A0#%     @ QHD#4Z:YEU$# P  0@D  !D
M     ("!P 0! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,:) U/R\ *G; (  (@&   9              "
M@?49 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ QHD#
M4PJ#NAL+ @  .P0  !D              ("!F!P! 'AL+W=O<FMS:&5E=',O
M<VAE970T-RYX;6Q02P$"% ,4    " #&B0-3@U/-_Q8$  "*#0  &0
M        @(':'@$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0
M   ( ,:) U-+**DL_04  ,(=   9              " @2<C 0!X;"]W;W)K
M<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ QHD#4_\%+^HZ!@  LQH
M !D              ("!6RD! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q0
M2P$"% ,4    " #&B0-39Q ?9CP#  #%#   &0              @(',+P$
M>&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( ,:) U.:54A?
MF 0  &@8   9              " @3\S 0!X;"]W;W)K<VAE971S+W-H965T
M-3(N>&UL4$L! A0#%     @ QHD#4Q?J<ZC> P  &P\  !D
M ("!#C@! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " #&
MB0-3Z1?(!&P#  !O"P  &0              @($C/ $ >&PO=V]R:W-H965T
M<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( ,:) U-Q$P1C#00  ,D,   9
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M;',O+G)E;'-02P$"% ,4    " #&B0-3GI JH\D$   W)@  #P
M    @ %P4P$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ QHD#4Q,G[+KO
M 0  I2(  !H              ( !9E@! 'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ QHD#4V(CYQC8 0  2"(  !,
M ( !C5H! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     $( 0@ %$@  EEP!
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>193</ContextCount>
  <ElementCount>365</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>59</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Nature of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/NatureofBusiness</Role>
      <ShortName>Nature of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2111104 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2115105 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2120106 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2123107 - Disclosure - Long Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/LongTermDebt</Role>
      <ShortName>Long Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2131108 - Disclosure - Net Loss Per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/NetLossPerCommonShare</Role>
      <ShortName>Net Loss Per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2135109 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2141110 - Disclosure - Income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/Incometaxes</Role>
      <ShortName>Income taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2143111 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities</Role>
      <ShortName>Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2146112 - Disclosure - Contractual Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/ContractualCommitmentsandContingencies</Role>
      <ShortName>Contractual Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2148113 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2152114 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://mimedx.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mimedx.com/role/Inventory</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2312303 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mimedx.com/role/PropertyandEquipment</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2316304 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mimedx.com/role/IntangibleAssets</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2321305 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/AccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mimedx.com/role/AccruedExpenses</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2324306 - Disclosure - Long Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/LongTermDebtTables</Role>
      <ShortName>Long Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mimedx.com/role/LongTermDebt</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2332307 - Disclosure - Net Loss Per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/NetLossPerCommonShareTables</Role>
      <ShortName>Net Loss Per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mimedx.com/role/NetLossPerCommonShare</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2336308 - Disclosure - Equity Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/EquityEquityTables</Role>
      <ShortName>Equity Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2344309 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables</Role>
      <ShortName>Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2349310 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mimedx.com/role/Revenue</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Nature of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/NatureofBusinessDetails</Role>
      <ShortName>Nature of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mimedx.com/role/NatureofBusiness</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Significant Accounting Policies - Assessment of Revenue under ASC 606 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details</Role>
      <ShortName>Significant Accounting Policies - Assessment of Revenue under ASC 606 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/InventoryDetails</Role>
      <ShortName>Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mimedx.com/role/InventoryTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2413405 - Disclosure - Property and Equipment - Summary of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment - Summary of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - Property and Equipment - Depreciation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/PropertyandEquipmentDepreciationExpenseDetails</Role>
      <ShortName>Property and Equipment - Depreciation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2417407 - Disclosure - Intangible Assets - Activity Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails</Role>
      <ShortName>Intangible Assets - Activity Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2418408 - Disclosure - Intangible Assets - Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/IntangibleAssetsAmortizationExpenseDetails</Role>
      <ShortName>Intangible Assets - Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2419409 - Disclosure - Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2422410 - Disclosure - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/AccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mimedx.com/role/AccruedExpensesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2425411 - Disclosure - Long Term Debt - Term Loan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/LongTermDebtTermLoanDetails</Role>
      <ShortName>Long Term Debt - Term Loan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2426412 - Disclosure - Long Term Debt - Term Loan Debt Issuance Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails</Role>
      <ShortName>Long Term Debt - Term Loan Debt Issuance Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2427413 - Disclosure - Long Term Debt - Term Loan Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails</Role>
      <ShortName>Long Term Debt - Term Loan Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2428414 - Disclosure - Long Term Debt - Term Loan Interest Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails</Role>
      <ShortName>Long Term Debt - Term Loan Interest Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2429415 - Disclosure - Long Term Debt - Term Loan Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails</Role>
      <ShortName>Long Term Debt - Term Loan Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2430416 - Disclosure - Long Term Debt - Paycheck Protection Program Loan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails</Role>
      <ShortName>Long Term Debt - Paycheck Protection Program Loan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2433417 - Disclosure - Net Loss Per Common Share - Basic Net Loss Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails</Role>
      <ShortName>Net Loss Per Common Share - Basic Net Loss Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2434418 - Disclosure - Net Loss Per Common Share - Diluted Net Loss Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails</Role>
      <ShortName>Net Loss Per Common Share - Diluted Net Loss Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2437419 - Disclosure - Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/EquityNarrativeDetails</Role>
      <ShortName>Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2438420 - Disclosure - Equity - Changes in Series B Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails</Role>
      <ShortName>Equity - Changes in Series B Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2439421 - Disclosure - Equity - Restricted Stock Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/EquityRestrictedStockAwardsDetails</Role>
      <ShortName>Equity - Restricted Stock Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2440422 - Disclosure - Equity - Stock Incentive Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/EquityStockIncentivePlansDetails</Role>
      <ShortName>Equity - Stock Incentive Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2442423 - Disclosure - Income taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/IncometaxesDetails</Role>
      <ShortName>Income taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mimedx.com/role/Incometaxes</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2445424 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails</Role>
      <ShortName>Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2447425 - Disclosure - Contractual Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Contractual Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2450426 - Disclosure - Revenue - Summary of Revenue by Product Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails</Role>
      <ShortName>Revenue - Summary of Revenue by Product Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="mdxg-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2451427 - Disclosure - Revenue - Summary of Revenue by Customer Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails</Role>
      <ShortName>Revenue - Summary of Revenue by Customer Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="mdxg-20210630.htm">mdxg-20210630.htm</File>
    <File>ex101carlsonarofferletter.htm</File>
    <File>ex102formofdirectorrsaawar.htm</File>
    <File>ex103formofdirectorrsaawar.htm</File>
    <File>ex104formofdirectorrsaawar.htm</File>
    <File>exhibit311-20210630.htm</File>
    <File>exhibit312-20210630.htm</File>
    <File>exhibit321-20210630.htm</File>
    <File>exhibit322-20210630.htm</File>
    <File>mdxg-20210630.xsd</File>
    <File>mdxg-20210630_cal.xml</File>
    <File>mdxg-20210630_def.xml</File>
    <File>mdxg-20210630_lab.xml</File>
    <File>mdxg-20210630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>80
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mdxg-20210630.htm": {
   "axisCustom": 0,
   "axisStandard": 22,
   "contextCount": 193,
   "dts": {
    "calculationLink": {
     "local": [
      "mdxg-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mdxg-20210630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mdxg-20210630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mdxg-20210630_lab.xml"
     ],
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mdxg-20210630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "mdxg-20210630.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd"
     ]
    }
   },
   "elementCount": 470,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 5
   },
   "keyCustom": 48,
   "keyStandard": 317,
   "memberCustom": 21,
   "memberStandard": 34,
   "nsprefix": "mdxg",
   "nsuri": "http://mimedx.com/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://mimedx.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111104 - Disclosure - Property and Equipment",
     "role": "http://mimedx.com/role/PropertyandEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115105 - Disclosure - Intangible Assets",
     "role": "http://mimedx.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120106 - Disclosure - Accrued Expenses",
     "role": "http://mimedx.com/role/AccruedExpenses",
     "shortName": "Accrued Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123107 - Disclosure - Long Term Debt",
     "role": "http://mimedx.com/role/LongTermDebt",
     "shortName": "Long Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131108 - Disclosure - Net Loss Per Common Share",
     "role": "http://mimedx.com/role/NetLossPerCommonShare",
     "shortName": "Net Loss Per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135109 - Disclosure - Equity",
     "role": "http://mimedx.com/role/Equity",
     "shortName": "Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141110 - Disclosure - Income taxes",
     "role": "http://mimedx.com/role/Incometaxes",
     "shortName": "Income taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143111 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities",
     "role": "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities",
     "shortName": "Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146112 - Disclosure - Contractual Commitments and Contingencies",
     "role": "http://mimedx.com/role/ContractualCommitmentsandContingencies",
     "shortName": "Contractual Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148113 - Disclosure - Revenue",
     "role": "http://mimedx.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152114 - Disclosure - Subsequent Events",
     "role": "http://mimedx.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://mimedx.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Significant Accounting Policies Significant Accounting Policies (Tables)",
     "role": "http://mimedx.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Inventory (Tables)",
     "role": "http://mimedx.com/role/InventoryTables",
     "shortName": "Inventory (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312303 - Disclosure - Property and Equipment (Tables)",
     "role": "http://mimedx.com/role/PropertyandEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316304 - Disclosure - Intangible Assets (Tables)",
     "role": "http://mimedx.com/role/IntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321305 - Disclosure - Accrued Expenses (Tables)",
     "role": "http://mimedx.com/role/AccruedExpensesTables",
     "shortName": "Accrued Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mdxg:ScheduleofDebtIssuanceCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324306 - Disclosure - Long Term Debt (Tables)",
     "role": "http://mimedx.com/role/LongTermDebtTables",
     "shortName": "Long Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mdxg:ScheduleofDebtIssuanceCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2332307 - Disclosure - Net Loss Per Common Share (Tables)",
     "role": "http://mimedx.com/role/NetLossPerCommonShareTables",
     "shortName": "Net Loss Per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336308 - Disclosure - Equity Equity (Tables)",
     "role": "http://mimedx.com/role/EquityEquityTables",
     "shortName": "Equity Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:TemporaryEquitySharesOutstanding",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344309 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Tables)",
     "role": "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables",
     "shortName": "Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2349310 - Disclosure - Revenue (Tables)",
     "role": "http://mimedx.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Nature of Business (Details)",
     "role": "http://mimedx.com/role/NatureofBusinessDetails",
     "shortName": "Nature of Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i8ef27cfe3bed49c7847029a654380438_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Significant Accounting Policies - Narrative (Details)",
     "role": "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i8ef27cfe3bed49c7847029a654380438_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Significant Accounting Policies - Assessment of Revenue under ASC 606 (Details)",
     "role": "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details",
     "shortName": "Significant Accounting Policies - Assessment of Revenue under ASC 606 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "ie18163f5013a4be0b9bd02bf40e60571_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Inventory (Details)",
     "role": "http://mimedx.com/role/InventoryDetails",
     "shortName": "Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i8ef27cfe3bed49c7847029a654380438_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413405 - Disclosure - Property and Equipment - Summary of Property and Equipment (Details)",
     "role": "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails",
     "shortName": "Property and Equipment - Summary of Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - Property and Equipment - Depreciation Expense (Details)",
     "role": "http://mimedx.com/role/PropertyandEquipmentDepreciationExpenseDetails",
     "shortName": "Property and Equipment - Depreciation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417407 - Disclosure - Intangible Assets - Activity Summary (Details)",
     "role": "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails",
     "shortName": "Intangible Assets - Activity Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418408 - Disclosure - Intangible Assets - Amortization Expense (Details)",
     "role": "http://mimedx.com/role/IntangibleAssetsAmortizationExpenseDetails",
     "shortName": "Intangible Assets - Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419409 - Disclosure - Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details)",
     "role": "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails",
     "shortName": "Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422410 - Disclosure - Accrued Expenses (Details)",
     "role": "http://mimedx.com/role/AccruedExpensesDetails",
     "shortName": "Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i6d8cb358a527440ca633e34b0e64c145_I20200702",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425411 - Disclosure - Long Term Debt - Term Loan (Details)",
     "role": "http://mimedx.com/role/LongTermDebtTermLoanDetails",
     "shortName": "Long Term Debt - Term Loan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i6d8cb358a527440ca633e34b0e64c145_I20200702",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i4a0a54ed1a52415a881e9947529ad09f_I20200702",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426412 - Disclosure - Long Term Debt - Term Loan Debt Issuance Costs (Details)",
     "role": "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
     "shortName": "Long Term Debt - Term Loan Debt Issuance Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "ibfaa87d5ef5044f39cfb5c90c4cea4d3_I20200702",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427413 - Disclosure - Long Term Debt - Term Loan Balances (Details)",
     "role": "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
     "shortName": "Long Term Debt - Term Loan Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "if47b0734d0cf4bd2a2b9d44595fbacaf_I20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfDeferredLoanOriginationFeesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428414 - Disclosure - Long Term Debt - Term Loan Interest Expense (Details)",
     "role": "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails",
     "shortName": "Long Term Debt - Term Loan Interest Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "ie4b424bee50745d7b3a4cc9fffbc5295_D20200401-20200630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfDeferredLoanOriginationFeesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429415 - Disclosure - Long Term Debt - Term Loan Maturity (Details)",
     "role": "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails",
     "shortName": "Long Term Debt - Term Loan Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i065ebf02aa6941e1bdf67379b756096e_D20200424-20200424",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430416 - Disclosure - Long Term Debt - Paycheck Protection Program Loan (Details)",
     "role": "http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails",
     "shortName": "Long Term Debt - Paycheck Protection Program Loan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i065ebf02aa6941e1bdf67379b756096e_D20200424-20200424",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433417 - Disclosure - Net Loss Per Common Share - Basic Net Loss Per Common Share (Details)",
     "role": "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails",
     "shortName": "Net Loss Per Common Share - Basic Net Loss Per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434418 - Disclosure - Net Loss Per Common Share - Diluted Net Loss Per Common Share (Details)",
     "role": "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails",
     "shortName": "Net Loss Per Common Share - Diluted Net Loss Per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i893ba49ad5c3430a8b5ce9861abc1c91_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT",
     "role": "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i893ba49ad5c3430a8b5ce9861abc1c91_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437419 - Disclosure - Equity - Narrative (Details)",
     "role": "http://mimedx.com/role/EquityNarrativeDetails",
     "shortName": "Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i8ef27cfe3bed49c7847029a654380438_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438420 - Disclosure - Equity - Changes in Series B Preferred Stock (Details)",
     "role": "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails",
     "shortName": "Equity - Changes in Series B Preferred Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i16cc01f782b84ac9b6f4b691a457573d_I20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i4546c782bd4c4b0d9660d32d5de807aa_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439421 - Disclosure - Equity - Restricted Stock Awards (Details)",
     "role": "http://mimedx.com/role/EquityRestrictedStockAwardsDetails",
     "shortName": "Equity - Restricted Stock Awards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i4546c782bd4c4b0d9660d32d5de807aa_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i8ef27cfe3bed49c7847029a654380438_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440422 - Disclosure - Equity - Stock Incentive Plans (Details)",
     "role": "http://mimedx.com/role/EquityStockIncentivePlansDetails",
     "shortName": "Equity - Stock Incentive Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i8ef27cfe3bed49c7847029a654380438_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442423 - Disclosure - Income taxes (Details)",
     "role": "http://mimedx.com/role/IncometaxesDetails",
     "shortName": "Income taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "ib92760da2e214acb91d4b50aa6073cbc_D20210401-20210630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445424 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Details)",
     "role": "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails",
     "shortName": "Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447425 - Disclosure - Contractual Commitments and Contingencies - Narrative (Details)",
     "role": "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails",
     "shortName": "Contractual Commitments and Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mdxg:NumberOfProducts",
      "reportCount": 1,
      "unitRef": "product",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450426 - Disclosure - Revenue - Summary of Revenue by Product Type (Details)",
     "role": "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails",
     "shortName": "Revenue - Summary of Revenue by Product Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "ibbf94484fb9640fc95e9891697e411dd_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i1a251f34b9af45a6bb9ed5a8c1ede1b2_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mdxg:RevenueFromContractWithCustomerNumberOfDistributionChannels",
      "reportCount": 1,
      "unitRef": "distributionchannel",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451427 - Disclosure - Revenue - Summary of Revenue by Customer Type (Details)",
     "role": "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails",
     "shortName": "Revenue - Summary of Revenue by Customer Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i03a9f6a871fa4fed9fca89e62057ca76_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Nature of Business",
     "role": "http://mimedx.com/role/NatureofBusiness",
     "shortName": "Nature of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Significant Accounting Policies",
     "role": "http://mimedx.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Inventory",
     "role": "http://mimedx.com/role/Inventory",
     "shortName": "Inventory",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mdxg-20210630.htm",
      "contextRef": "i10c87a190477420bb8fa2aa6f207ed90_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 59,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mimedx.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mdxg_AccruedClinicalTrialsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/AccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Clinical Trials, Current",
        "label": "Accrued Clinical Trials, Current",
        "terseLabel": "Accrued clinical trials"
       }
      }
     },
     "localname": "AccruedClinicalTrialsCurrent",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_AccruedRebates": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/AccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Rebates",
        "label": "Accrued Rebates",
        "terseLabel": "Accrued rebates"
       }
      }
     },
     "localname": "AccruedRebates",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_AccruedSettlementCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/AccruedExpensesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Settlement Costs, Current",
        "label": "Accrued Settlement Costs, Current",
        "terseLabel": "Settlement costs"
       }
      }
     },
     "localname": "AccruedSettlementCostsCurrent",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Reconcile to Net Income (Loss) Available to Common Stockholders",
        "label": "Adjustments to Reconcile to Net Income (Loss) Available to Common Stockholders",
        "terseLabel": "Dividends on Series B Convertible Preferred Stock",
        "totalLabel": "Total adjustments"
       }
      }
     },
     "localname": "AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_AdvancedWoundCareTissueAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advanced Wound Care, Tissue And Other",
        "label": "Advanced Wound Care, Tissue And Other [Member]",
        "terseLabel": "Tissue/Other"
       }
      }
     },
     "localname": "AdvancedWoundCareTissueAndOtherMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_AdvancedWoundCareUmbilicalCordDerivedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advanced Wound Care, Umbilical Cord-Derived",
        "label": "Advanced Wound Care, Umbilical Cord-Derived [Member]",
        "terseLabel": "Cord"
       }
      }
     },
     "localname": "AdvancedWoundCareUmbilicalCordDerivedMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/NatureofBusinessDetails",
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_AmendedTermLoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended Term Loan Agreement [Member]",
        "label": "Amended Term Loan Agreement [Member]",
        "terseLabel": "Amended Term Loan Agreement"
       }
      }
     },
     "localname": "AmendedTermLoanAgreementMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_AssetRetirementCostMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Retirement Cost [Member]",
        "label": "Asset Retirement Cost [Member]",
        "terseLabel": "Asset retirement cost"
       }
      }
     },
     "localname": "AssetRetirementCostMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_CARESActMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CARES Act",
        "label": "CARES Act [Member]",
        "terseLabel": "CARES Act"
       }
      }
     },
     "localname": "CARESActMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_ComputationOfBasicAndDilutedNetLossPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Computation of basic and diluted net loss per share [Abstract]",
        "terseLabel": "Computation of basic and diluted net loss per share [Abstract]"
       }
      }
     },
     "localname": "ComputationOfBasicAndDilutedNetLossPerShareAbstract",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mdxg_ContingencyLossNumberOfFormerHealthcareProviders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingency Loss, Number Of Former Healthcare Providers",
        "label": "Contingency Loss, Number Of Former Healthcare Providers",
        "terseLabel": "Number of healthcare providers"
       }
      }
     },
     "localname": "ContingencyLossNumberOfFormerHealthcareProviders",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdxg_ContingencyLossNumberOfSecuritiesClassActions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingency Loss, Number Of Securities Class Actions",
        "label": "Contingency Loss, Number Of Securities Class Actions",
        "terseLabel": "Number of securities class actions"
       }
      }
     },
     "localname": "ContingencyLossNumberOfSecuritiesClassActions",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdxg_CreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Facilities [Member]",
        "label": "Credit Facilities [Member]",
        "terseLabel": "Credit Facilities"
       }
      }
     },
     "localname": "CreditFacilitiesMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_CustomerAndSupplierRelationshipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer And Supplier Relationships",
        "label": "Customer And Supplier Relationships [Member]",
        "terseLabel": "Customer and supplier relationships"
       }
      }
     },
     "localname": "CustomerAndSupplierRelationshipsMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_DebtCovenantMinimumLiquidity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant, Minimum Liquidity",
        "label": "Debt Covenant, Minimum Liquidity",
        "terseLabel": "Debt covenant, minimum liquidity"
       }
      }
     },
     "localname": "DebtCovenantMinimumLiquidity",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_DebtInstrumentCommitmentFees": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Commitment Fees",
        "label": "Debt Instrument, Commitment Fees",
        "terseLabel": "Commitment fee"
       }
      }
     },
     "localname": "DebtInstrumentCommitmentFees",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_DebtInstrumentDefaultInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Default Interest Rate",
        "label": "Debt Instrument, Default Interest Rate",
        "terseLabel": "Default interest rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentDefaultInterestRate",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mdxg_DebtInstrumentInterestRateFloorPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Interest Rate, Floor Percentage",
        "label": "Debt Instrument, Interest Rate, Floor Percentage",
        "terseLabel": "Debt instrument, interest rate, floor (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateFloorPercentage",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Percent",
        "label": "Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Percent",
        "terseLabel": "Debt instrument, prepayment make-whole premium as percent of prepaid principal (percent)"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPercent",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mdxg_DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Plus Accrued Interest, Percent",
        "label": "Debt Instrument, Prepayment Penalty as Percent of Prepaid Principal, Plus Accrued Interest, Percent",
        "terseLabel": "Debt instrument, prepayment make-whole premium as percent of prepaid principal, plus accrued interest (percent)"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentPenaltyasPercentofPrepaidPrincipalPlusAccruedInterestPercent",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mdxg_DebtInstrumentUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Unused Capacity, Commitment Fee Percentage",
        "label": "Debt Instrument, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Additional commitment fee (percent)"
       }
      }
     },
     "localname": "DebtInstrumentUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mdxg_DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discounted Dividend Rate prior to Quarterly Dividend Payment ending on June 30,2021 [Member]",
        "label": "Discounted Dividend Rate prior to Quarterly Dividend Payment ending on June 30,2021 [Member]",
        "terseLabel": "Discounted Dividend Rate prior to Quarterly Dividend Payment ending on June 30,2021"
       }
      }
     },
     "localname": "DiscountedDividendRatepriortoQuarterlyDividendPaymentendingonJune302021Member",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_EffectiveIncomeTaxRateReconciliationDiscreteItems": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Discrete Items",
        "label": "Effective Income Tax Rate Reconciliation, Discrete Items",
        "terseLabel": "Effective income tax rate impact of discrete items"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDiscreteItems",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Net Operating Loss Carryforward",
        "label": "Effective Income Tax Rate Reconciliation, Net Operating Loss Carryforward",
        "terseLabel": "Tax benefit recognized with respect to net operating loss"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_FairValueOfNonCashConsiderationReceivedForOptionExercise": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value Of Non-Cash Consideration Received For Option Exercise",
        "label": "Fair value Of Non-Cash Consideration Received For Option Exercise",
        "terseLabel": "Fair value of non-cash consideration received for option exercise"
       }
      }
     },
     "localname": "FairValueOfNonCashConsiderationReceivedForOptionExercise",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_FinanceLeaseAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Assets",
        "label": "Finance Lease Assets [Member]",
        "terseLabel": "Finance lease assets"
       }
      }
     },
     "localname": "FinanceLeaseAssetsMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_FinancingTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Transactions [Member]",
        "label": "Financing Transactions [Member]",
        "terseLabel": "Financing Transactions"
       }
      }
     },
     "localname": "FinancingTransactionsMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_HayfinLoanAgreementDelayedDrawTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hayfin Loan Agreement Delayed Draw Term Loan [Member]",
        "label": "Hayfin Loan Agreement Delayed Draw Term Loan [Member]",
        "terseLabel": "Hayfin Loan Agreement Delayed Draw Term Loan"
       }
      }
     },
     "localname": "HayfinLoanAgreementDelayedDrawTermLoanMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_HayfinLoanAgreementTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hayfin Loan Agreement Term Loan [Member]",
        "label": "Hayfin Loan Agreement Term Loan [Member]",
        "terseLabel": "Hayfin Loan Agreement Term Loan"
       }
      }
     },
     "localname": "HayfinLoanAgreementTermLoanMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 1.0x [Member]",
        "label": "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 1.0x [Member]",
        "terseLabel": "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 1.0x"
       }
      }
     },
     "localname": "HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan1.0xMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x [Member]",
        "label": "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x [Member]",
        "terseLabel": "Hayfin Loan Agreement Term Loan, Total Net Leverage Ratio Less than 2.0x but Greater than or Equal to 1.0x"
       }
      }
     },
     "localname": "HayfinLoanAgreementTermLoanTotalNetLeverageRatioLessthan2.0xbutGreaterthanorEqualto1.0xMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_InvestigationRestatementandRelated": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investigation, Restatement and Related",
        "label": "Investigation, Restatement and Related",
        "terseLabel": "Investigation, restatement and related"
       }
      }
     },
     "localname": "InvestigationRestatementandRelated",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_LeaseRightOfUseAssetAndLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Right Of Use Asset And Liability",
        "label": "Lease, Right Of Use Asset And Liability",
        "terseLabel": "Lease right of use asset and liability"
       }
      }
     },
     "localname": "LeaseRightOfUseAssetAndLiability",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_LegalProceedingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal Proceedings",
        "label": "Legal Proceedings [Member]",
        "terseLabel": "Legal Proceedings"
       }
      }
     },
     "localname": "LegalProceedingsMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_LongTermDebtMaturityAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Maturity, after Year Four",
        "label": "Long-Term Debt, Maturity, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturityAfterYearFour",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_NoncashActivitiesDebtInstrumentAmendmentFee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash Activities, Debt Instrument, Amendment Fee",
        "label": "Non-cash Activities, Debt Instrument, Amendment Fee",
        "terseLabel": "Amendment fee on BT Term Loan"
       }
      }
     },
     "localname": "NoncashActivitiesDebtInstrumentAmendmentFee",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_NoncashActivitiesDeferredFinancingCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash Activities, Deferred Financing Costs",
        "label": "Non-cash Activities, Deferred Financing Costs",
        "terseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "NoncashActivitiesDeferredFinancingCosts",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_NotesReceivableForSaleOfPropertyAndEquipment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Receivable For Sale Of Property And Equipment",
        "label": "Notes Receivable For Sale Of Property And Equipment",
        "terseLabel": "Note receivable for sale of property and equipment"
       }
      }
     },
     "localname": "NotesReceivableForSaleOfPropertyAndEquipment",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_NumberOfProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Products",
        "label": "Number Of Products",
        "terseLabel": "Number Of Products"
       }
      }
     },
     "localname": "NumberOfProducts",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdxg_NumberofBoardSeatsElectedbyTemporaryEquityHolders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Board Seats Elected by Temporary Equity Holders",
        "label": "Number of Board Seats Elected by Temporary Equity Holders",
        "terseLabel": "Number of board seats elected by Series B preferred stockholders"
       }
      }
     },
     "localname": "NumberofBoardSeatsElectedbyTemporaryEquityHolders",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdxg_OperatingLeaseAndFinancingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease And Financing Lease, Right-Of-Use-Asset",
        "label": "Operating Lease And Financing Lease, Right-Of-Use-Asset",
        "terseLabel": "Right of use asset"
       }
      }
     },
     "localname": "OperatingLeaseAndFinancingLeaseRightOfUseAsset",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_OperatingLeaseRightofuseAssetAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-of-use Asset, Amortization",
        "label": "Operating Lease, Right-of-use Asset, Amortization",
        "terseLabel": "Non-cash lease expenses"
       }
      }
     },
     "localname": "OperatingLeaseRightofuseAssetAmortization",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_PatentsinProcessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patents in Process",
        "label": "Patents in Process [Member]",
        "terseLabel": "Patents in process"
       }
      }
     },
     "localname": "PatentsinProcessMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_PaycheckProtectionProgramLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Paycheck Protection Program Loan",
        "label": "Paycheck Protection Program Loan [Member]",
        "terseLabel": "PPP Loan"
       }
      }
     },
     "localname": "PaycheckProtectionProgramLoanMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_PaymentsforApplicationCostsPatent": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Application Costs, Patent",
        "label": "Payments for Application Costs, Patent",
        "negatedTerseLabel": "Patent application costs"
       }
      }
     },
     "localname": "PaymentsforApplicationCostsPatent",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Perpetual Dividend Rate after Quarterly Dividend Payment ending on June 30, 2021 [Member]",
        "label": "Perpetual Dividend Rate after Quarterly Dividend Payment ending on June 30, 2021 [Member]",
        "terseLabel": "Perpetual Dividend Rate after Quarterly Dividend Payment ending on June 30, 2021"
       }
      }
     },
     "localname": "PerpetualDividendRateafterQuarterlyDividendPaymentendingonJune302021Member",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_ProceedsfromIssuanceofTemporaryEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Issuance of Temporary Equity",
        "label": "Proceeds from Issuance of Temporary Equity",
        "terseLabel": "Proceeds from issuance of temporary equity"
       }
      }
     },
     "localname": "ProceedsfromIssuanceofTemporaryEquity",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_RevenueFromContractWithCustomerNumberOfDistributionChannels": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer, Number Of Distribution Channels",
        "label": "Revenue From Contract With Customer, Number Of Distribution Channels",
        "terseLabel": "Number of primary distribution channels"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerNumberOfDistributionChannels",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdxg_RevenueFromContractWithCustomerPaymentTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer, Payment Terms",
        "label": "Revenue From Contract With Customer, Payment Terms",
        "terseLabel": "Customer payment terms"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPaymentTerms",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mdxg_ScheduleOfDepreciationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Depreciation",
        "label": "Schedule Of Depreciation [Table Text Block]",
        "terseLabel": "Schedule of Depreciation Expense"
       }
      }
     },
     "localname": "ScheduleOfDepreciationTableTextBlock",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mdxg_ScheduleofDebtIssuanceCostsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Debt Issuance Costs [Table Text Block]",
        "label": "Schedule of Debt Issuance Costs [Table Text Block]",
        "terseLabel": "Schedule of Debt Issuance Costs"
       }
      }
     },
     "localname": "ScheduleofDebtIssuanceCostsTableTextBlock",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mdxg_ScheduleofInterestExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Interest Expense [Table Text Block]",
        "label": "Schedule of Interest Expense [Table Text Block]",
        "terseLabel": "Schedule of Interest Expense"
       }
      }
     },
     "localname": "ScheduleofInterestExpenseTableTextBlock",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mdxg_Section351Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Section 351",
        "label": "Section 351 [Member]",
        "terseLabel": "Section 351"
       }
      }
     },
     "localname": "Section351Member",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails",
      "http://mimedx.com/role/NatureofBusinessDetails",
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_StockAwardMisstatementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Award Misstatements",
        "label": "Stock Award Misstatements [Member]",
        "terseLabel": "Stock Award Misstatements"
       }
      }
     },
     "localname": "StockAwardMisstatementsMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_TemporaryEquityAccretedbutUnrecordedDividends": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Accreted but Unrecorded Dividends",
        "label": "Temporary Equity, Accreted but Unrecorded Dividends",
        "terseLabel": "Series B Preferred convertible Stock, dividends accrued but not recorded for the period",
        "verboseLabel": "Accumulated dividend on Series B Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityAccretedbutUnrecordedDividends",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails",
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_TemporaryEquityAccretionofIncreasingrateDividendFeature": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "mdxg_AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Accretion of Increasing-rate Dividend Feature",
        "label": "Temporary Equity, Accretion of Increasing-rate Dividend Feature",
        "terseLabel": "Accretion of increasing-rate dividend feature",
        "verboseLabel": "Deemed dividends on Series B Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityAccretionofIncreasingrateDividendFeature",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails",
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_TemporaryEquityConversionPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Conversion Price Per Share",
        "label": "Temporary Equity, Conversion Price Per Share",
        "terseLabel": "Series B preferred stock, conversion price (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityConversionPricePerShare",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mdxg_TemporaryEquityConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Conversion Ratio",
        "label": "Temporary Equity, Conversion Ratio",
        "terseLabel": "Conversion ratio of Series B preferred stock to common stock"
       }
      }
     },
     "localname": "TemporaryEquityConversionRatio",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger",
        "label": "Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Series B preferred stock, minimum percentage of conversion stock price to trigger conversion (percent)"
       }
      }
     },
     "localname": "TemporaryEquityConversionThresholdPercentageofStockPriceTrigger",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mdxg_TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger on Date of Conversion",
        "label": "Temporary Equity, Conversion, Threshold Percentage of Stock Price Trigger on Date of Conversion",
        "terseLabel": "Series B preferred stock, minimum percentage of conversion stock price on conversion date (percent)"
       }
      }
     },
     "localname": "TemporaryEquityConversionThresholdPercentageofStockPriceTriggeronDateofConversion",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mdxg_TemporaryEquityConversionThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Conversion, Threshold Trading Days",
        "label": "Temporary Equity, Conversion, Threshold Trading Days",
        "terseLabel": "Number of trading days within consecutive day trading period common stock must exceed trigger conversion price"
       }
      }
     },
     "localname": "TemporaryEquityConversionThresholdTradingDays",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdxg_TemporaryEquityDividendRatePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Dividend Rate, Percentage",
        "label": "Temporary Equity, Dividend Rate, Percentage",
        "terseLabel": "Series B convertible stock, cumulative dividend (percent)"
       }
      }
     },
     "localname": "TemporaryEquityDividendRatePercentage",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mdxg_TemporaryEquityIncreasingrateDividendFeature": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Increasing-rate Dividend Feature",
        "label": "Temporary Equity, Increasing-rate Dividend Feature",
        "terseLabel": "Series B preferred stock, increasing-rate dividend feature"
       }
      }
     },
     "localname": "TemporaryEquityIncreasingrateDividendFeature",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mdxg_TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Maximum Voting Stock Percentage on As-converted Basis",
        "label": "Temporary Equity, Maximum Voting Stock Percentage on As-converted Basis",
        "terseLabel": "Series B preferred stock, maximum voting stock percentage on an as-converted basis (percent)"
       }
      }
     },
     "localname": "TemporaryEquityMaximumVotingStockPercentageonAsconvertedBasis",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mdxg_TemporaryEquitySharesIssueduponConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Shares Issued upon Conversion",
        "label": "Temporary Equity, Shares Issued upon Conversion",
        "terseLabel": "Series B Preferred convertible stock, shares issuable upon conversion (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssueduponConversion",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mdxg_TemporaryEquityThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Threshold Consecutive Trading Days",
        "label": "Temporary Equity, Threshold Consecutive Trading Days",
        "terseLabel": "Series B preferred stock, threshold number of consecutive trading days"
       }
      }
     },
     "localname": "TemporaryEquityThresholdConsecutiveTradingDays",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mdxg_TermLoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Agreement [Member]",
        "label": "Term Loan Agreement [Member]",
        "terseLabel": "BT Term Loan"
       }
      }
     },
     "localname": "TermLoanAgreementMember",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mdxg_TotalNetLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Net Leverage Ratio",
        "label": "Total Net Leverage Ratio",
        "terseLabel": "Total net leverage ratio"
       }
      }
     },
     "localname": "TotalNetLeverageRatio",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mdxg_TreasuryStockSharesAdjustment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares, Adjustment",
        "label": "Treasury Stock, Shares, Adjustment",
        "terseLabel": "Correction of out-of-period error (Note 1) (in shares)",
        "verboseLabel": "Treasury stock adjustment (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAdjustment",
     "nsuri": "http://mimedx.com/20210630",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r256",
      "r295",
      "r341",
      "r343",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r493",
      "r495",
      "r512",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r256",
      "r295",
      "r341",
      "r343",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r493",
      "r495",
      "r512",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r179",
      "r332",
      "r335",
      "r461",
      "r492",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails",
      "http://mimedx.com/role/NatureofBusinessDetails",
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r179",
      "r332",
      "r335",
      "r461",
      "r492",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails",
      "http://mimedx.com/role/NatureofBusinessDetails",
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r256",
      "r295",
      "r340",
      "r341",
      "r343",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r493",
      "r495",
      "r512",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r256",
      "r295",
      "r340",
      "r341",
      "r343",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r493",
      "r495",
      "r512",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAdjustmentMember": {
     "auth_ref": [
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r118",
      "r119",
      "r121",
      "r123",
      "r124",
      "r126",
      "r127",
      "r143",
      "r414",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Adjustment [Member]",
        "terseLabel": "Revision of Prior Period, Adjustment"
       }
      }
     },
     "localname": "RestatementAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r3",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r118",
      "r119",
      "r120",
      "r121",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r143",
      "r201",
      "r202",
      "r374",
      "r384",
      "r410",
      "r414",
      "r415",
      "r416",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r3",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r118",
      "r119",
      "r120",
      "r121",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r143",
      "r201",
      "r202",
      "r374",
      "r384",
      "r410",
      "r414",
      "r415",
      "r416",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r122",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r122",
      "r128",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r122",
      "r128",
      "r236",
      "r342",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update 2014-09 [Member]",
        "terseLabel": "Accounting Standards Update 2014-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r41",
      "r448"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r9",
      "r26",
      "r184",
      "r185"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://mimedx.com/role/AccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesDetails",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "auth_ref": [
      "r473",
      "r487"
     ],
     "calculation": {
      "http://mimedx.com/role/AccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.",
        "label": "Accrued Professional Fees",
        "terseLabel": "Legal costs"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r44"
     ],
     "calculation": {
      "http://mimedx.com/role/AccruedExpensesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Sales Commission, Current",
        "terseLabel": "Commissions to sales agents"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r27",
      "r374",
      "r448"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r110",
      "r111",
      "r112",
      "r371",
      "r372",
      "r373",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForErrorCorrectionDomain": {
     "auth_ref": [
      "r118",
      "r119",
      "r120",
      "r123",
      "r124",
      "r126",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of error correction.",
        "label": "Error Correction, Type [Domain]",
        "terseLabel": "Error Correction, Type [Domain]"
       }
      }
     },
     "localname": "AdjustmentsForErrorCorrectionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r113",
      "r114",
      "r115",
      "r116",
      "r128",
      "r193",
      "r194",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r241",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r381",
      "r382",
      "r383",
      "r384",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r445",
      "r463",
      "r464",
      "r465",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares repurchased for tax withholding"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings": {
     "auth_ref": [
      "r309",
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.",
        "label": "Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings",
        "negatedTerseLabel": "Deemed dividends",
        "verboseLabel": "Deemed dividends"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails",
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Correction of out-of-period error (Note 1)",
        "verboseLabel": "Correction of error"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash flows used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables": {
     "auth_ref": [
      "r187"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.",
        "label": "Allowance for Doubtful Accounts, Premiums and Other Receivables",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r73",
      "r89",
      "r276",
      "r434"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Accretion of original issue discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDeferredLoanOriginationFeesNet": {
     "auth_ref": [
      "r89",
      "r189"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net increase(decrease) in interest income during the period representing the allocation of deferred loan origination fees less deferred loan origination costs using the effective interest method over the term of the debt arrangement to which they pertain taking into account the effect of prepayments.",
        "label": "Amortization of Deferred Loan Origination Fees, Net",
        "terseLabel": "Accretion of amendment fee"
       }
      }
     },
     "localname": "AmortizationOfDeferredLoanOriginationFeesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r68",
      "r89",
      "r276",
      "r436"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of deferred financing costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r89",
      "r276",
      "r286",
      "r287",
      "r436"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of deferred financing costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r89",
      "r212",
      "r219"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets",
        "verboseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/IntangibleAssetsAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetRetirementObligationAccretionExpense": {
     "auth_ref": [
      "r230",
      "r231"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability.",
        "label": "Asset Retirement Obligation, Accretion Expense",
        "terseLabel": "Accretion of asset retirement obligation"
       }
      }
     },
     "localname": "AssetRetirementObligationAccretionExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r105",
      "r165",
      "r169",
      "r175",
      "r196",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r396",
      "r399",
      "r417",
      "r446",
      "r448",
      "r468",
      "r482"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r59",
      "r105",
      "r196",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r396",
      "r399",
      "r417",
      "r446",
      "r448"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r346",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r402",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r93",
      "r94",
      "r95"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Purchases of equipment in accounts payable"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r37",
      "r91"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r84",
      "r91",
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r84",
      "r426"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Non-cash activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r102",
      "r105",
      "r132",
      "r133",
      "r134",
      "r137",
      "r139",
      "r149",
      "r150",
      "r151",
      "r196",
      "r242",
      "r246",
      "r247",
      "r248",
      "r251",
      "r252",
      "r293",
      "r294",
      "r298",
      "r302",
      "r417",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails",
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r49",
      "r235",
      "r474",
      "r486"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 12)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r232",
      "r233",
      "r234",
      "r238",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Contractual Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/ContractualCommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r110",
      "r111",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock Issued"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Balance end of period (in shares)",
        "periodStartLabel": "Balance beginning of period (in shares)",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r25",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r25",
      "r448"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock; $0.001 par value; 187,500,000 shares authorized; 112,703,926 issued and 111,881,938 outstanding at June\u00a030, 2021 and 112,703,926 issued and 110,930,243 outstanding at December\u00a031, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r99",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r320",
      "r322",
      "r333"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Deferred cost of sales"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r320",
      "r321",
      "r333"
     ],
     "calculation": {
      "http://mimedx.com/role/AccruedExpensesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Accrued GPO fees"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerRefundLiabilityCurrent": {
     "auth_ref": [
      "r334"
     ],
     "calculation": {
      "http://mimedx.com/role/AccruedExpensesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.",
        "label": "Contract with Customer, Refund Liability, Current",
        "terseLabel": "Estimated returns"
       }
      }
     },
     "localname": "ContractWithCustomerRefundLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r332",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r332",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r70",
      "r461"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r101",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r270",
      "r277",
      "r278",
      "r280",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long Term Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r19",
      "r20",
      "r21",
      "r104",
      "r108",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r260",
      "r266",
      "r267",
      "r268",
      "r269",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r284",
      "r285",
      "r286",
      "r287",
      "r437",
      "r469",
      "r470",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r21",
      "r281",
      "r470",
      "r481"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Outstanding principal"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r253",
      "r284",
      "r285",
      "r435",
      "r437",
      "r438"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal issued"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r46",
      "r273",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Interest rate at issuance (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental percentage increase (decrease) in the stated rate on a debt instrument.",
        "label": "Debt Instrument, Interest Rate, Increase (Decrease)",
        "terseLabel": "Increase in interest rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r47",
      "r104",
      "r108",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r260",
      "r266",
      "r267",
      "r268",
      "r269",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r284",
      "r285",
      "r286",
      "r287",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "auth_ref": [
      "r47",
      "r478"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments including both interest and principal payments.",
        "label": "Debt Instrument, Periodic Payment",
        "terseLabel": "Quarterly installments"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r47",
      "r104",
      "r108",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r260",
      "r266",
      "r267",
      "r268",
      "r269",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r279",
      "r284",
      "r285",
      "r286",
      "r287",
      "r310",
      "r313",
      "r314",
      "r315",
      "r434",
      "r435",
      "r437",
      "r438",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r266",
      "r434",
      "r438"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Original issue discount",
        "verboseLabel": "Original issue discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r436"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "verboseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r40",
      "r266",
      "r436"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r89",
      "r225"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation",
        "verboseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mimedx.com/role/PropertyandEquipmentDepreciationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about distribution of earnings to shareholders including, but not limited to, cash, property or capital stock.",
        "label": "Dividends [Axis]",
        "terseLabel": "Dividends [Axis]"
       }
      }
     },
     "localname": "DividendsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distributions of earnings to shareholders including but not limited to cash, property or capital stock.",
        "label": "Dividends [Domain]",
        "terseLabel": "Dividends [Domain]"
       }
      }
     },
     "localname": "DividendsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsPayableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Dividends Payable [Line Items]",
        "terseLabel": "Dividends Payable [Line Items]"
       }
      }
     },
     "localname": "DividendsPayableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsPayableTable": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table that contains information regarding dividends that have been declared but not paid as of the financial reporting date. This information may contain the amount, amount per share, declared date, and date to be paid.",
        "label": "Dividends Payable [Table]",
        "terseLabel": "Dividends Payable [Table]"
       }
      }
     },
     "localname": "DividendsPayableTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r67",
      "r118",
      "r119",
      "r121",
      "r122",
      "r123",
      "r129",
      "r132",
      "r137",
      "r138",
      "r139",
      "r143",
      "r144",
      "r415",
      "r416",
      "r476",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "netLabel": "Basic net loss per common share (in dollars per share)",
        "verboseLabel": "Net loss per common share - basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r67",
      "r118",
      "r119",
      "r121",
      "r122",
      "r123",
      "r132",
      "r137",
      "r138",
      "r139",
      "r143",
      "r144",
      "r415",
      "r416",
      "r476",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per common share - diluted (in dollars per share)",
        "verboseLabel": "Diluted net (loss) income per common share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Net Loss Per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "verboseLabel": "Outstanding stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideRevenueMajorCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Major Customer [Line Items]",
        "terseLabel": "Revenue, Major Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideRevenueMajorCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails",
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Laboratory and clean room equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r63",
      "r64",
      "r65",
      "r110",
      "r111",
      "r112",
      "r114",
      "r124",
      "r127",
      "r148",
      "r200",
      "r309",
      "r316",
      "r371",
      "r372",
      "r373",
      "r383",
      "r384",
      "r414",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r498",
      "r499",
      "r500",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": {
     "auth_ref": [
      "r118",
      "r119",
      "r120",
      "r123",
      "r124",
      "r126",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of error correction.",
        "label": "Error Correction, Type [Axis]",
        "terseLabel": "Error Correction, Type [Axis]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FederalFundsEffectiveSwapRateMember": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.",
        "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]",
        "terseLabel": "Fed Funds Effective Rate Overnight Index Swap Rate"
       }
      }
     },
     "localname": "FederalFundsEffectiveSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r441",
      "r444"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Principal payments on finance lease"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": {
     "auth_ref": [
      "r439"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization",
        "verboseLabel": "Finance lease assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r220"
     ],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "2021 (excluding the six months ended June 30, 2021)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r220"
     ],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r220"
     ],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r220"
     ],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r213",
      "r215",
      "r218",
      "r222",
      "r462",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Estimated future amortization expense [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r218",
      "r466"
     ],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails",
      "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r213",
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r218",
      "r462"
     ],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      },
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails",
      "http://mimedx.com/role/IntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Gain Contingencies [Line Items]",
        "terseLabel": "Gain Contingencies [Line Items]"
       }
      }
     },
     "localname": "GainContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainContingenciesTable": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sets forth the existing conditions, situations, or sets of circumstances involving uncertainties as of the balance sheet date (or before issuance of the financial statements) that might result in a gain, typically reflecting care to avoid misleading implications as to the likelihood of realization, and previously disclosed contingent gains that were recognized as income in the period.",
        "label": "Gain Contingencies [Table]",
        "terseLabel": "Gain Contingencies [Table]"
       }
      }
     },
     "localname": "GainContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Loss on fixed asset disposal"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r205",
      "r207",
      "r448",
      "r467"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r89",
      "r206",
      "r208",
      "r210"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r69",
      "r105",
      "r165",
      "r168",
      "r171",
      "r174",
      "r177",
      "r196",
      "r242",
      "r243",
      "r244",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r417"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthCareMember": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service provided for prevention, maintenance, diagnosis or treatment of physical and mental health.",
        "label": "Health Care [Member]",
        "terseLabel": "Advanced Wound Care"
       }
      }
     },
     "localname": "HealthCareMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r165",
      "r168",
      "r171",
      "r174",
      "r177"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income tax provision"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r106",
      "r378",
      "r379",
      "r380",
      "r385",
      "r387",
      "r389",
      "r390",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/Incometaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r126",
      "r127",
      "r164",
      "r376",
      "r386",
      "r388",
      "r491"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income tax provision benefit (expense)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r85",
      "r92"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r53",
      "r472",
      "r488"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredCompensation": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.",
        "label": "Increase (Decrease) in Deferred Compensation",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.",
        "label": "Increase (Decrease) in Income Taxes Receivable",
        "negatedTerseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Increase (decrease) in cash resulting from changes in:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedTerseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r214",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r221"
     ],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Gross carrying value, indefinite lived"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r214",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InsuranceRecoveries": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount recovered from insurance. These recoveries reduce costs and losses that are reported as a separate line item under operating expenses.",
        "label": "Insurance Recoveries",
        "terseLabel": "Insurance recoveries"
       }
      }
     },
     "localname": "InsuranceRecoveries",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InsuranceSettlementsReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.",
        "label": "Insurance Settlements Receivable",
        "terseLabel": "Settlements indemnified by insurance"
       }
      }
     },
     "localname": "InsuranceSettlementsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Intangible assets, gross carrying amount"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r211",
      "r216"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible assets, net carrying amount"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r73",
      "r274",
      "r283",
      "r286",
      "r287"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "totalLabel": "Total BT Term Loan interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r75",
      "r275",
      "r286",
      "r287"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Interest on principal balance"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r477"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryCurrentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Current [Table]",
        "terseLabel": "Inventory, Current [Table]"
       }
      }
     },
     "localname": "InventoryCurrentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/Inventory"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://mimedx.com/role/InventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Inventory [Line Items]",
        "terseLabel": "Inventory [Line Items]"
       }
      }
     },
     "localname": "InventoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r8",
      "r57",
      "r448"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://mimedx.com/role/InventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "totalLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mimedx.com/role/InventoryDetails",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://mimedx.com/role/InventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://mimedx.com/role/InventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r203"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r43",
      "r105",
      "r170",
      "r196",
      "r242",
      "r243",
      "r244",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r397",
      "r399",
      "r400",
      "r417",
      "r446",
      "r447"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r31",
      "r105",
      "r196",
      "r417",
      "r448",
      "r471",
      "r485"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, convertible preferred stock, and stockholders\u2019 deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS\u2019 DEFICIT"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r45",
      "r105",
      "r196",
      "r242",
      "r243",
      "r244",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r397",
      "r399",
      "r400",
      "r417",
      "r446",
      "r447",
      "r448"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Licenses"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r21",
      "r267",
      "r282",
      "r284",
      "r285",
      "r470",
      "r483"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Long term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Fair value of the Term Loan"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r108",
      "r239",
      "r272"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r108",
      "r239",
      "r272"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r108",
      "r239",
      "r272"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r108",
      "r239",
      "r272"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "2021 (excluding the six months ended June\u00a030, 2021)"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-term Debt [Member]",
        "terseLabel": "Long term debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long term debt, net"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r47",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r235"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss contingency accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in loss contingency liability.",
        "label": "Loss Contingency Accrual, Period Increase (Decrease)",
        "negatedTerseLabel": "Decrease in litigation settlement"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValuePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash flows used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash flows used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash\u00a0flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r84",
      "r87",
      "r90"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash flows used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r61",
      "r62",
      "r65",
      "r66",
      "r90",
      "r105",
      "r113",
      "r118",
      "r119",
      "r121",
      "r122",
      "r126",
      "r127",
      "r135",
      "r165",
      "r168",
      "r171",
      "r174",
      "r177",
      "r196",
      "r242",
      "r243",
      "r244",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r416",
      "r417",
      "r475",
      "r489"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "netLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r118",
      "r119",
      "r121",
      "r122",
      "r129",
      "r130",
      "r136",
      "r139",
      "r165",
      "r168",
      "r171",
      "r174",
      "r177"
     ],
     "calculation": {
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net loss available to common stockholders",
        "totalLabel": "Net loss available to common stockholders",
        "verboseLabel": "Net loss available to common stockholders (Note 8)"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Adjustments to reconcile to net (loss) income available to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued and Adopted Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Term loan"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanBalancesDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanInterestExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r165",
      "r168",
      "r171",
      "r174",
      "r177"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r6",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Nature of Business"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NatureofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r44"
     ],
     "calculation": {
      "http://mimedx.com/role/AccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r58",
      "r448"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r402",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDebtIssuanceCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r44",
      "r448"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents and know how"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Payments for legal settlements"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/ContractualCommitmentsandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Deferred financing cost"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Stock repurchased for tax withholdings on vesting of restricted stock"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMachineryAndEquipment": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for acquisition of machinery and equipment.",
        "label": "Payments to Acquire Machinery and Equipment",
        "negatedTerseLabel": "Purchases of equipment"
       }
      }
     },
     "localname": "PaymentsToAcquireMachineryAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance stock unit awards"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable preferred class B stock or outstanding preferred class B stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Preferred Class B [Member]",
        "terseLabel": "Preferred Class B Convertible Stock"
       }
      }
     },
     "localname": "PreferredClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r24",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r24",
      "r448"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock Series A; $0.001 par value; 5,000,000 shares authorized, 0 issued and outstanding at June\u00a030, 2021 and December\u00a031, 2020"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r10",
      "r35",
      "r36"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "verboseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIncomeTaxRefunds": {
     "auth_ref": [
      "r87",
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash received during the period as refunds for the overpayment of taxes.",
        "label": "Proceeds from Income Tax Refunds",
        "terseLabel": "Federal tax refund"
       }
      }
     },
     "localname": "ProceedsFromIncomeTaxRefunds",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from BT Term Loan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfMediumTermNotes": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt funding received on a regular basis with maturities ranging from 5-10 years.",
        "label": "Proceeds from Issuance of Medium-term Notes",
        "terseLabel": "Proceeds from term loans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfMediumTermNotes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": {
     "auth_ref": [
      "r77",
      "r195"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.",
        "label": "Proceeds from Sale and Maturity of Held-to-maturity Securities",
        "terseLabel": "Principal payments from note receivable"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r79",
      "r366"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r227",
      "r440",
      "r443"
     ],
     "calculation": {
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedTerseLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r60",
      "r228",
      "r443"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r18",
      "r226",
      "r439"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r39",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r229",
      "r509",
      "r510",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r38",
      "r226"
     ],
     "calculation": {
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r18",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Summary of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r18",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r186",
      "r190",
      "r191",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfMediumTermNotes": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years.",
        "label": "Repayments of Medium-term Notes",
        "negatedTerseLabel": "Repayment of term loans"
       }
      }
     },
     "localname": "RepaymentsOfMediumTermNotes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r375",
      "r460",
      "r514"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted stock awards"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock unit awards"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r316",
      "r374",
      "r448",
      "r484",
      "r502",
      "r507"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r110",
      "r111",
      "r112",
      "r114",
      "r124",
      "r127",
      "r200",
      "r371",
      "r372",
      "r373",
      "r383",
      "r384",
      "r414",
      "r498",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r162",
      "r163",
      "r167",
      "r172",
      "r173",
      "r179",
      "r180",
      "r182",
      "r331",
      "r332",
      "r461"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/NatureofBusinessDetails",
      "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails",
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails",
      "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r100",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]",
        "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]"
       }
      }
     },
     "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information when using transition method for cumulative effect in initial period of application for revenue from contract with customer.",
        "label": "Revenue, Initial Application Period Cumulative Effect Transition [Table]",
        "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Table]"
       }
      }
     },
     "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred directly to consumer.",
        "label": "Sales Channel, Directly to Consumer [Member]",
        "terseLabel": "Direct Customers"
       }
      }
     },
     "localname": "SalesChannelDirectlyToConsumerMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred through intermediary.",
        "label": "Sales Channel, Through Intermediary [Member]",
        "terseLabel": "Distributors"
       }
      }
     },
     "localname": "SalesChannelThroughIntermediaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/AccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Summary of Antidilutive Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Disclosure of Cash Flow and Non-cash Investing and Financing Activities"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SupplementalDisclosureofCashFlowandNonCashInvestingandFinancingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock": {
     "auth_ref": [
      "r133",
      "r139",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effect of income (loss) on basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock": {
     "auth_ref": [
      "r133",
      "r139",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/NetLossPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Summary of Net Sales by Products and Customer Type"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.",
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/RevenueSummaryofRevenuebyCustomerTypeDetails",
      "http://mimedx.com/role/RevenueSummaryofRevenuebyProductTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r213",
      "r217",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails",
      "http://mimedx.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r213",
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Intangible Assets Activity Summary - Finite-lived"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r221",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r221",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Intangible Assets Activity Summary - Indefinite-lived"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r16",
      "r32",
      "r33",
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/InventoryTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Future Principal Payments for the Term Loan"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r117",
      "r121",
      "r146",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Assessment of Revenue under ASC 606"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r39",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/PropertyandEquipmentSummaryofPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r346",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r348",
      "r359",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Options Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Stock Awards by Award Type"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r50",
      "r102",
      "r149",
      "r150",
      "r289",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r302",
      "r307",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Estimated Future Amortization Expense for Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r165",
      "r166",
      "r171",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r181",
      "r182",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails",
      "http://mimedx.com/role/EquityNarrativeDetails",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested, Ending Balance (in shares)",
        "periodStartLabel": "Unvested, Beginning Balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested, Ending Balance (in dollars per share)",
        "periodStartLabel": "Unvested, Beginning Balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted- Average Remaining Contractual Term (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable options, vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedTerseLabel": "Vested options expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Unvested options forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r365"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r350",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, end of period (in shares)",
        "periodStartLabel": "Outstanding, beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, end of period (in dollars per share)",
        "periodStartLabel": "Outstanding, beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r344",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityRestrictedStockAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Vested options expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Unvested options forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r365"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding Options, weighted average remaining contractual term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "terseLabel": "Shares repurchased for tax withholding (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r98",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r102",
      "r105",
      "r132",
      "r133",
      "r134",
      "r137",
      "r139",
      "r149",
      "r150",
      "r151",
      "r196",
      "r242",
      "r246",
      "r247",
      "r248",
      "r251",
      "r252",
      "r293",
      "r294",
      "r298",
      "r302",
      "r309",
      "r417",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails",
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r52",
      "r63",
      "r64",
      "r65",
      "r110",
      "r111",
      "r112",
      "r114",
      "r124",
      "r127",
      "r148",
      "r200",
      "r309",
      "r316",
      "r371",
      "r372",
      "r373",
      "r383",
      "r384",
      "r414",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r498",
      "r499",
      "r500",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r110",
      "r111",
      "r112",
      "r148",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": {
     "auth_ref": [
      "r24",
      "r25",
      "r309",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares related to Restricted Stock Award forfeited during the period.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited",
        "terseLabel": "Restricted stock canceled/forfeited (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r24",
      "r25",
      "r309",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "negatedTerseLabel": "Issuance of restricted stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r24",
      "r25",
      "r309",
      "r316",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "negatedTerseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/EquityStockIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures": {
     "auth_ref": [
      "r24",
      "r25",
      "r309",
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards forfeited during the period.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Forfeitures",
        "negatedTerseLabel": "Restricted stock canceled/forfeited"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r309",
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "verboseLabel": "Issuance of restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r24",
      "r25",
      "r316",
      "r345",
      "r360"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "verboseLabel": "Share-based compensation\u00a0expense"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r52",
      "r309",
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r25",
      "r29",
      "r30",
      "r105",
      "r188",
      "r196",
      "r417",
      "r448"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance, end of period",
        "periodStartLabel": "Balance, beginning of period",
        "totalLabel": "Total stockholders' deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity:",
        "verboseLabel": "Stockholders' deficit"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r103",
      "r294",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r308",
      "r316",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/Equity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r433",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r433",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r433",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r449",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r242",
      "r246",
      "r247",
      "r248",
      "r251",
      "r252"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Series B Preferred Stock, outstanding, ending",
        "periodStartLabel": "Series B Preferred Stock, outstanding, beginning",
        "terseLabel": "Convertible preferred stock Series B; $0.001 par value; 100,000 shares authorized, issued and outstanding at June\u00a030, 2021 and December\u00a031, 2020"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r17",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Series B convertible preferred stock par value (in dollars per share)",
        "verboseLabel": "Series B convertible preferred stock par value (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Series B convertible preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Series B convertible preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Series B Preferred Stock, outstanding, ending (in shares)",
        "periodStartLabel": "Series B Preferred Stock, outstanding, beginning (in shares)",
        "terseLabel": "Series B convertible preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mimedx.com/role/EquityChangesinSeriesBPreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of Series B Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "auth_ref": [
      "r17",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity [Table Text Block]",
        "terseLabel": "Schedule of Series B Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/EquityEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trade names and trademarks"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IntangibleAssetsActivitySummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r51",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSDEFICIT",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r51",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r51",
      "r317",
      "r318"
     ],
     "calculation": {
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock at cost; 821,988 shares at June\u00a030, 2021 and 1,773,683 shares at December\u00a031, 2020"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r113",
      "r114",
      "r115",
      "r116",
      "r128",
      "r193",
      "r194",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r241",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r381",
      "r382",
      "r383",
      "r384",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r445",
      "r463",
      "r464",
      "r465",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesAssessmentofRevenueunderASC606Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnusualOrInfrequentItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Unusual or Infrequent Item, or Both [Line Items]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Line Items]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemTable": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the nature and financial statement effect of an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Table]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Table]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/IncometaxesDetails",
      "http://mimedx.com/role/NatureofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/LongTermDebtPaycheckProtectionProgramLoanDetails",
      "http://mimedx.com/role/LongTermDebtTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r131",
      "r139"
     ],
     "calculation": {
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average common shares outstanding - diluted (in shares)",
        "totalLabel": "Weighted average shares outstanding adjusted for potential common shares"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r129",
      "r139"
     ],
     "calculation": {
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average common shares outstanding - basic (in shares)",
        "verboseLabel": "Weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mimedx.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mimedx.com/role/NetLossPerCommonShareBasicNetLossPerCommonShareDetails",
      "http://mimedx.com/role/NetLossPerCommonShareDilutedNetLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e725-108305"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e765-108305"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402152&loc=d3e8622-111531"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130611-203046-203046"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r515": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r516": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r517": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r518": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r519": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r521": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>81
<FILENAME>0001376339-21-000093-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001376339-21-000093-xbrl.zip
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M%"EJWCQV3AB1&QM7: L+(N"$P.-&"[%H2GLC-UC=C=,"+3I5ZBVG"*T@"OE
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M%KQXW;"8FX"B_^OD)Q@SLT%\#CB@;PAQ[=7"['XQ5]CHO(6P1V<K499K!%:
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MD\>;_^Q<"&2PC;P"UL>9'@-<(C>.L-FAG,9:7B#RTOM:6:%M<P%4#HTQ$EO
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MLA:+_RL>%QGTRPP7)Z:6&?1_.:/]X..,]CWWQS?HSX"\^']02P,$%     @
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MW6)Z"O\K K4?.A<"&6RCJ*H-89>/ 2Z1&T=8[5)]\7SIE[^IV_HHS;[HFFQ
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MOS[FF\@ZW37=RR.^.7D=E__CK'8*3S?UEZL+6Q/*7O*)V 3:UOD0Y?Y:\N$
M2ZXVC]YK*_>N3J\'Y[USD..#1USL6(O%_Q6/BPSZ98:+$U/+#/HEMO1C2FS_
M,K9^]]-L_3WW-S3HKWF\_"]02P,$%     @ QHD#4TR3<V,L"   4"4  !<
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M@?RL9)Z523^- OCM=-UOBW) U1 5(93&R'';5H/BCI&9NWSDO)8K&-_(>XV
M_$0U3(=WQC-RG\IIPMF0E[T3E7<=D]@QE2C"6)"*E-!T1O+4J)Q#891E5Z'A
M*4K&N%*")B2F$6XI(L>H&$9ZN36!E$=<:ZIF5F1,[[F+RF)-C7L,RF#+Q)5W
M[&$%(J%0SB&68CHT80CA="2B$=&Y_5C.GW+%BT6L 6.A$]1]VT),A1G!0)WQ
MR"EHU\V@FF0P<X)IC(2S53>\F* W/Q%T3F*1PJTV0DLWEA%QB&-8K8R+%&F$
M>*+/P_<HR6T.(50K/BLCS,(F809/6Y!8\"3)$@5% /23K0$TYAK(LI7($P@@
M]!+Q<=MIIT]$]8C$B9SJ.2X4'PIMT'T:0NU-KS>T+*^$5\^56=/VQ42X%9#!
M(W>\VD-/>WRFBQ@6-<"F@8QC@4OGJ#ZABKN0P,4B3+CC20X<A(G0(RMNQ<:@
M $L#]IH)'252YYAGR4')Q,<F4S+B#+<UV4<H&$=LO;][#]&(ID-..LB[VSR!
MA&M:#O?Y@9OJFA9[Y2^%[4I2CPF[/K')N0(5'SJKR\X;Q8\VBK'1O!ZL @@2
MMJYLKI'/$!3[](!<<HT>"?YQ//G'P2M;"H]HKG>?8KDTY A$L9-G9YDK+( $
MG CMTAI2/'7KV$9D20BKI*)X0EUD"WI>1J=<$(X=%" 'Z*)E(I@[(NH\U(()
MJH0U0/@BXF@NM2OEVA*[2P3MJH C 9Q!H1 .AVY2AK9 1'E"+7?!+*?$LD!@
MAB\WJU42WT)N!4$OF,_9BZ&3_? I<G9.RC4 [9[..^,(V)L(9N%!T>%2RUM4
M UJV.["8H8K-XP=$"1J*1)B9K1F;MK5H=J%V4?1 ?"2ZTETX>GPH#,IRE0%%
MVM6X*)**.05<GS'D*4I7 C!AA&<6I58$/90'#- L,C#4RX%,=$!Z$YKD+B.M
M/WD<H]"+"3RA-Q3L187:@6'\Y>8:[A""B6 '[3N%4.9FNP:[<"!=2'/;!L5_
MW"N2<-Y@.=!S[PGHXP)L-W@106;@!>^_]3C8,T)1@-W(QF!_!AO8*B&C*%?6
MVRN4O&'5L=0&]^T##:RE(RPT/^CM;YD2 S;(TR?2A>)H-+D[WMB33YHO]#KP
M6HVH7M0OF^$.9IPYZG/^*&AIAD/,/4^*L\X3^?)?=M&+@M;AG^U@W:, -@=E
M>9F(EA=6@;',21O:SRAH:\W(0C6*AL1(I1<UQ-W DF,<@@WGGV"]4*)*V7$F
MH)];9!_P <EH2V+X:]NB.>;Y;[F ^@[?>1JY(]'!BVI4.S@DVL(O$%O;C=N^
M/A(<P2CX?]$P3CF]MX3N"Z^C=-<RN(</\P/C9X6XZ.W\66A#[E*&B9HO4G<K
M'(I& U,04_0#95]5-$J*SL?P/YSBC"DH<^/1^D6EM>TD.R@,L4)JE.%H[K(9
MH7)/9XJ8ECVOBG0BDPFWY)K28?&0214$P,=9(F<<H].1]%E/'R$&$?XBE2=X
MM@^=G^"C0 -T-*Y'+D9# ).K"G1-:*9Y>_[E#"2:)736%JG;T4TZ6\?:Q#(Q
MBF;A"><4/UR\!#L]#4X.F_8]F%'XS^8;%Z_( O>*K&K8^MA14#MN;1VM!?6M
M8Y]:]; 9G-2^_++-H^"DT=AIV:ISA'<&W*TSFKXN-4OS"1EE]L#2;F0/I#Y/
M7^_=A,=K'O?._OK0<^\V+Y&RCPM/8?PSMZN3#Y'2I.E? _PUXPIR6,L4F7TC
MXU[MM4"![G/M!=$C4W<$:LU:7/J2L?^6OGG$I=LM*GC3LFK-OO\B[@$4F6OX
MG/#P#P;^) :>4Y"[(\%C<K5H<&[\L6D]UE57Z3_S??"3G[]DTO_^I^T?X4[X
MV@]BEFGD.HG:<@H-D4FYV3YEVV\6MOZZIOCTO_5QOSJZ^!]02P,$%     @
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M]1PYY-A;T$4D#5&U(";I$C7EJQ430M&B<EKW6PV<XX& MP7),1<2-))F/)>
M1U_R? 6.;;R%B.>:*D,_\Q!H&BJQ/Q<I+1WFV<VRN6P;63*J;33AO,A%03#*
MDF^G;V632M\FH!M(R#/EA6SK>'U(Y4=EP)SD"Y)28<RN$[J!42#5CLJ/,CC;
M\8MI3A>;VJ54-!5/Y>0/*5\G-%Q214-0UW;W$V#[0./:[G\D7V(+7' I^:KO
M(3"K-Y)G>IF14+G32&@D^UXGJYK:CJ2=/F<XW2_0YAY.F4/GJ+;TRXO?=57'
M]%K*#RK:%6BC(D$$!XCM1.7 35[D]&/!<JIF'*%@<@NZ0W($"&ZG?1@>W4#K
M-HMN,JC"E]/S6HB2WD#EUW\EY.XW&7*68E5:E>41:Z,D3*4Z%LIM/!"F2EJ6
M4Z%"WU3;)$D R5 9DB P1(98$,VJG*8D#=1[9!CJ&5W743Q5)"5R.)9 +5/<
MJ:3F7Z%!Q;X<3R59)+3>7? <"Y6!WDQ()FB__C,(F<@2LNFS5/M$$PUVD:5F
MZ2M5U *25.#1H"FWJS&[US.[;4]-VA*KE QKP=40;NHAW)+A_;VVZ?3:>W=M
MT]F[]Z=<6V:GZWUVME['Q$;S*+:6=D3I#'2WP/ ];WB-FJ!"7-_-KL'934T%
MPKL>+YW]Y7-3?SU-$,B[7:LR_CNW:U0LL0J"5XX5?\^XNI[>S12>?27CGAZT
M<.32S_NCY8ZMCT2JK4QN?,[@?TWG['P[[+>H*IRJK-HF5D(0/&$AU!I^3X#X
M'P2?"H+O*<I[/A?OQ]K2O7YKDGC,9\:=*[:,EW>,_9PF1(F[=^EVFT=ZEK!O
M2<@"4PF_1/>2[+M"V7N#5SW+^T1]LWGR!U!+ P04    " #&B0-3U.C+@PH%
M  "Z%0  %P   &5X:&EB:70S,C(M,C R,3 V,S N:'1M[5CK<]I&$/_>OV*#
MIXD]@]Y@@R">(8 ;=V+C&&72?.H<N@.N$3I5=S+0O[Y[>MA@3,;3)K$S+1\T
M2'N[MX_?/NZZ+P:C?O#I:@ASM8C@ZL.;=^=]J!F6]='K6]8@&,#;X.(=-$S;
M@2 EL>2*BYA$EC6\K$%MKE3B6]9RN327GBG2F15<6UI4PXJ$D,RDBM9.N_H+
M/AFAIS]U7Q@&#$28+5BL($P948Q")GD\@X^4R<]@&.6JODC6*9_-%;BVZ\!'
MD7[F-Z2@*ZXB=EK)Z5K%>]?*-^E.!%V?=BF_ 4Y?UWA[.FG9+B5VL^DUW!9M
MTY9W$KKMR:1!O%:+_NZ@DA8N+WBD6D?L=6W!8V/.]/Y^PS5/FHGJ+#E5<]^Q
M[9]K^=+3[E3$"O=+D;_X6XC9$:;82ADDXK/8STVJ%:P5.1212/T#._]U-,68
MD@6/UOZK@"^8A$NVA&NQ(/&KNL0P&)*E?%HLE/POACJA>OGKLE09Y40\9I4)
MCJN5?GG@'-N=2M=OJ\')@QH,5W,^X0H\UW2W??;<O?4E+4,$(4N_N9H/N[0_
MO [.S\[[O>!\=(E)?#W^T+L,(!B!TX(/YMCLFS >]G.JXS5MZ(VA-QA=!</!
ML[=MTYK*AK9]#*,S"-X.8=R[?M.['(Z-T6_OAI^@UP\TQ;7M1V'KCTPJ/ET_
M+W0]I3*[SV#.((LI2R4Z# OU%4,LP(4)?9)&4L1U4+BB/^=L"F<\)G'(202C
MZ92'N$Y,X8)?,+J"7U*1)74XCT,3#C7+RX.6Z]J=OE@D)%[G;T[GJ YS(H&M
M6)CIMJ#F7 (*PBCQD.C6 SR&4,0Q"_.W)5?S7(,ICW0'N7T?HX04FQ5ZB,04
MAJMP3N(9:BH6"RZEYD7E<MWO-'!..A+>9R1%&Z,U7+-$I IPZ9E(%^#8QGN8
MBC3G2M#-@@*+J=[VURQFA;\\NUYTJTTC"T&5C29<9:G," 99B<T4+6W2*5H'
M= .A(M%>2#:65XMT#I0&C$DZ(3&3QF@5L37T0J4I.@>*X&R&;\Y2-EE7+F6R
MKF5J)W^.Q3)B=,8T#T%=FZU'%;[M%'J@$VXV5)+.L*=.A%)BX7N(R_*+$DG^
MFA"JW6E$;*I\[QB_[.Y4?.)H4ZQ\PVDE3]4<#IVC[]-'']I^VU7'IM?0?M#1
M+D$[S2)$<(C8CG0.W.9%RO[,>,KTT"0U3.Y =TB. ,'M- _IT2VT[K+H-H-*
M?#EMKX$H:7=T?OU70NX^RY#S&*O2HBB/6!L5X3K5L5!NXH%P7=*2E$D=^KHF
MDR@"9$-EL&0C(4$LR'I93JM2C@)I/O3G=11795&!'($E,-]3WJNDYC>J&QHR
MS3SVBDPB5E$G(L7Z9F 0(I)(YE=_.I3+)")KG\>Y*W.FSC8@]4Q_HVMA2*)2
ML5S'@ER.^^VVV6IZ>N)7J*2BU<;E8<#,#P.6HKLT#-+QR5ZJ;3I[:5^2VO3,
MIN-^=;'>L8D=\%%BK=P1A3/0W1*C_KKFU2J&$JB^FZS V<YHC=W['B^<_?U3
M.C_%#1#_V\VN-/X'MZN7S3##P"NFD7]G7%6&[V>*2)[(N)<'#9S4\N?.0+IE
MZB.!:FN+:U\S]D_IFZU3Q7Z+RKJIJZIM8B$$*2).H=+P1P+[_QCXAQCXD9)^
MSQES-]96WNEW3M1?GC'N7?0EHKCI]%,6X9!SPW:N_N[2*)\D[#L6,L%,PN/K
M7I9]=RM[[Q'+9W&KF=^OGOX-4$L#!!0    ( ,:) U- 8U?)?S(" /MV&  1
M    ;61X9RTR,#(Q,#8S,"YH=&WLO6E7&\FR+OS]_@J]G/N>V[T6A7,>Z-Z^
M"P-FLX\E;,#VAB]>.4)A#>R2Q/3K;V25) 0&&V- @]6];$NJK*RLC.F)R,C(
MO__O1:M9.PM%-^^T_[&$5]!2[?^^_OO_R[)_O]E]5]OHN'XKM'NU]2*87O"U
M\[QW7/OL0_=K+1:=5NUSI_B:GYDL*^]9[YQ>%OG1<:]&$,&W+A:KA#+ED?09
MCD%F+"J>6:1,YJ63S 9";$3+1ZO1!L8\B5EP/F3,:9HIZ5F&I#/(>6L1U<M^
ME2L1F6<J,$J895@19$RDD2B'K!8Z/?:X!V\';]CNKEXT\_;7?RP=]WJGJZ]>
MG9^?KYS3E4YQ] IKK5^55Y<&3?.+WHV&%[9HEDWS-C0+:69>]0K3[L9.T3(]
MF+E7!&&>(9(1,>RDW\V.C#D==11-UY:=#"Z\2E.4(9Q1//;<K!O<C6?#]Y6C
MSMD/'ZW&^O$A'_51CGW8"5PH'SMZ8+?#")9WORQ!B+X:M!C>\,T<WFR=+EO3
M#</FZ:J_-99!8_&JNCALVO(71Z.&K;P5_,6*Z[3*X2)!T:#=_01,I!YVUBUZ
MW\X[_'C'G%]T\[OZA!'B5_^NO]MSQZ%ELKS=[9FV"]>4NF\6,!TCU?@\Y-^;
MY?'N5YNF#5,1VMG'O25@X6#\Z[];H6=JZ?XL_*>?G_UC:;W3[H%@9ON7IW";
MJ[[]8ZD7+GJORJEX]?I__:__]7<O[S7#ZS2YV7 F_WY5_?CWJZIKV_&7K__V
M^5FMV[MLAG\L^;Q[VC27J^U..\  \HO5U# 4U<?<^] N/\+U!FB'(G?5\R]Z
MNR'^8RG'R"EIL$9,2D:0M2H:8HR(!,G@-?JR40X%_L^NJ=LVK?3HD*]NMF%\
ME^OP.H5I;K=]N/B?<+E4RSUT[>FG2[O1.7M'=L\.:+WO3S;/#K?TR<[)1]9H
M':##C0_L</_#5?UD-V]L;++ZR9OC@\\'5X<GV^S@ZDV^LW_ W]%&\^"J@W<V
M#EN-K0]H9^LCJE]MHX.3#Q<[&]OG!Y_?MNKDX')GJWY^</*5['Q2Z!TYO#SX
M[,3.1O/X\//!Q>'GS8N=_>VKQD;]XO#DZ+R^\>GDL/6OX\/]S<OZB6.-S_4S
MO_4VMUL?Q<'^U_/&AN/U_4\GC1,']T";_>.\OK_)#D\.6.-J\^J -)H[&YN#
M>S[!LWC[</_T>&=_#36NOEY ?Z1Q54?U_>V+G:WM"[B_U3@YHO7]QLD!^<CJ
MG]35N_W-7GT/7;S;7_L254 Q*IP%PT"%&H8R(Q#+M,?.."^4CW+I-0(FIU)0
MJO]^=8.>3T_>2EW!W1>]50^6I 4]'GMS.4[X]7Y1 -7?YEUGF@?!%)MMOP%M
M%[3_$>W1..V=L,E(VHSQ8#*&3,B4%6!T,>*.2$2$M$NO,7E%\;.3_9JX0R1Q
M3=VW\$MW0=L?T9:.TS9893@)+O/*)&A$9&8<?/)4L4BUB1;KI==I_B=&VO?0
M?\<OB/L@XK)QXAI-G1/:9EQPG;'@ /=Z&4"'"Z% 5VN"^=+K#^0%2;L&=/4E
M;9OF:$'.'Y'SHKZ>2%F2]/R+=YRB*,%Q$5YE3*.0:263XR,(UMQAY4%8HVEV
MPS<D?743:A4A!K"-+G3O0(@)=:]V2Z *1*^5KLQJ#W#A/Y:Z>>NTF6!E^=MQ
MD7CB!AA<N>AZZ.+5S3ZJYU\_=#"&;J=?E-]*/+LZ8+2**Q[#:,..0HGXAM]R
MG[['/!2U<D#A3G]H??M_;@*8VS>_'OYTL_?34CT-OP'L+GH)8[P>>@8(#^^[
MOC8:IA]K*K($I6]>&7X?/N35C8D:]M-OY]6D=8\-3.IH&EK!=/M%>#UX?'EQ
MV,7PVO![ZN-..AC,A0R&:!@EP]XH:I&+6#$/_C%U^,MV.?TRJ9*)3W_E]_0&
M,RHSS$<=#:[\Y(SV2VZ^.64#%W;UX][&3\\F-H3C2)D%T\JX$=;JX+E1#@<?
ML"6#V9P.9KXYF^/\^7.S>6,&5(A$NABH#9YI)Q4#!*F-X(PJ!'_*&4"8@$<]
M53. ,DPRBG^=GP#/["51'+T>>,HPK/&FI=8VO4[Q2-;[YO[TXT9H=UIY^ZYN
M'ZH@;G3QZN;H?\3Y5A,ID#<D$,R,LQI[9CD"C8XD==8-]#F;;GW.7D*?WYBW
MP"PCS(; D63<2TL-<T['&*WC1/-RWM!PWM TSAMZ^+RA)YLWL$Z,J>BQIH(A
M191$E 63?@2%X\A@WO!TS]M#\<,3SIN@'"%/N=:,20:./TP?%1IC8#9P]0<6
MBCZ_?AZ\=3A*_D+UU</#+DZ;N<M[]="R\ B?P]5JK6$0!U_=ZZ5X$-RS^9]^
M"OQU6J>=-GSMKEWD (Z&S>#W5J>]U^NXKU5??[^Z\Q&C61N-Y*=-)WVTX;A!
M&LT")ER!ZZ:3#HA6&L_!%_"!4(#);&Y(L^9]GI8BP/DWN=]NKYO3O&>:,T(F
M;TP -YN!.R88"(TAT8>H@R3@Q\1@YX9,^T6)$2YG28:89\0;&IT1@@6-M2 "
M6;"?RBHG#9T;XNR&GLG;P6^:HIVWC[HS0A_"5# ,<0*>/G/,@-AHHK15.'!/
M'7\Y^DQJ!JSE43D1#1$&+##56AO.M$4JP6<C)P"4'\NJFT71*=8[11%<4N?=
MM;9_#_-05"'=-7_2[_92E]W=T!UR]9O+L2^#AFV_UNKTV[V*PU.\:;74.6OG
MIO#UO#MJ_R,NGPY#]<-1=(O>ZM@L5,^\_>-H]IY>LB?O]7#IN13".HLEBX08
MJ@"*:A8M%H+X27B+OX\0/"G[S1CHF#SKHRA<I$0IDT*$.%A.M=?<$>S +8L+
M_3\SK#^3["<(-PHS[4S$C$>KHPB.:<&09A* UPRQW[1YFY,G;L N*!85$]@R
M$82QUIO@L##.*A[-_!%W[LV%],$3B9T.6C'HV'+GM/#1*B&0U+.$E*;&LYT\
M51F*&EO*0#8=4YII3:)$-"+!)4=:O=PZX3,3\P6CL$^T@.FU0-KCJ"4S+$9C
MD1%&IQ1(C9@816%GGS03BL(^$9F,Y)0@;@RG$LA"C)=4&LQ# (,7G9T;,KUH
M%/:)B$,E)C%0I(21S&FB4IZ/1]X)PAQR<FZ(\])1V">BCQ6"TT %BCPR9[W2
M!BMD XLA N5$E:0Q!U'RES(_Z.G"PX &D+#"X^!9(-+:E!2(N!".!AG9W)!F
M$N;GZ<@4J0<Y(<XZ1\!OUEH"&C<@3Q3HYEV<&S*]G/EY0AFBE"%0:PXISJ)V
MB@@F4Z:(0=:*@?F9!^*\J/EY.OHXCJ70F!K+%,-@>I0$XX.,<R9&Y,W+T6=2
M,Z# Z<-8.8J98QAY'< 5]#P(I8P@6DP@ZVM>U/WD4].D$\9'34/T@C$L+8 M
MKUDP7*9<*SE_Q'W)*-Q$2!J<-0932TATS%"FO7'<<!LX,3BX,'\D?>$HW$2H
M:B6CWD?! ^),>*>0P%AR4,161*R&.&'VB?F";M 3>:C(QABQ$"D)$K";-3YH
M)@W7PL4@-9\;TDS(#7HB,D4C%9BY (".,,VHQ5BC%, &_1@=GA\RO:@;]$3$
MT5H)YVW AAJF)-<2!YZ6&X1A44DQ-\1Y:3?HB>A#/ [@!ED3@F+@ 5C."/9>
M4W ,HC?FY>@S,0[U-B85STQP3*)HO0=W**US(NV\,R^W66QN#/ O[&*[F2>B
MN4[+S9IXR5R4UHNT,\')X*T*7,\-:29C@)^*3%IAYJE@-'C/4 S*<,ZH,8@K
M3;2Q<T.FES3 3T4<%0RX$THHYQASB&A! XX&>42"AA_GAC@O;("?BC[!."(D
MDL1$$!X+ (FZ8$,D-")EG9Q #8+'$FKV4C$7J?C?!$%>JJ#$S50DQSC#W"LO
MP-![9Y6R1'(6E#,H2K,0@EG)1YXQDSMYU@_$81:M=HI39CB8 88TI3Y([,$=
M"0O6GQ76GTGV$S@"(^BH!*(L(F>LT0$9[C151,1)E$":%U]K"HC+'<82O#-)
M,&-26(6]M-(BIY!D$ZEO-=L>VA20U IMP5H$062Y)L%($)'R*+VPP:CY(^G+
MI^*_/%65ID!);3QWE%%DE.4.O'.!C778Z;( &M9SX*2_4 P2ZR?SSZ4"X0I,
MX9 6 9E7REEMG8Z.61:TGQO23" &^81DPE'&$ .)%@4&B%I%+X+SJ=)0E!J9
MN2'3B\4@GY XA N$A(H:8\X$\E8(SVDJOAF<%'Y^U-M+QB"?D#XT$!8%8^!\
M!L:E,00+$< A334C"28O1Y])S0 R6D@E>'#$,@1Z79&(-.$A**2H$1.HY#8O
MZOYVBM7+EYN31E@N4I)OB,Q+HQBE-A+JG<$ L?3\$?>%<R%?GJ1":LQ#!%)1
MR;C!-H!#!#J,2Q^]1'[^2/KRN9 O3U5*O$!!*>\QH&ONC9?8\:#3KC +0CL#
M^\Q3\/!]T?%]U]LI]D)QEKLP'L>L0J.4XWG<44ZBT%9H3Z,VS( IQ1AY*KUS
M.%%M$G5D9Y5^$\E%UB@ "O34>H19U,2"8@4X9)&5RM,!_:8[N#0M])O0,JJV
M5'OIJ  G6$0MD(FR+,.BG!%\!JSBM-!O(O;/8@9RI@+A5C,&\A<U<M(+JF%V
M*=*S;__6_%DZ,\Y_[O3;?MT4X6/+YM"5::YW"K\!4W46_#R:1L:P-E8[IUAD
M3 A-?,0$3"6F*-6,F'W3. VDG8C5%,(&[#!R2#HF3536F:"$\:"EF#*SL((_
M Z2=B$%-AT8 ]E$6<<(P3?EXV J%HI14$.=FWZ!. VDG8FLYBS0:"0")6X:M
MTC0 PC4.I3T G/+I+0\SG11]G@)+SB ML'/<21:0UL8Y:0'9!LV-#G$&5.LB
M.>I9\@*?=2%Y(H9G='Y3$4X[12]O'Z5?OCD9K*3XJ,E':#+L[^''K5FI#2/&
MNNB8ME$1S!6G@GE)$7*WX^%3LN[S>)-Q8Y'H5\(CWE /&-XB2Y@AW'C#67 V
M(*DC4K.0JE^*KVD?A6MIKN?MO-5OS8D4W8Q'*H\PEX;+F'8V@G6G7"',I!3"
M*S\+R5)W$<Q<S"O! E98T,AA!@T#N;+:>D1L9"@(Q"6>@0#(]?KJR**_[12-
M<+[F7++;H+0!O+7AHZO,]*UEV5$K,(1M#S:]^_'4PW2"'F9(SV-HA!)A@.Q2
M.$J9X #%%>?>$VG3B:#>S$!H9*:)/I&@"=51,.V9%P*GY#KEA1&><.2\-3S.
M@BV=::)/QAX[YZR/FHF(& <@);UR'AL$+KCS?!;"*3--](D$6E",SG)*(DU$
M-P"5:21&$F%=($1-<:!E2#0@*+QO[_)]TX#'V_;),SVM_//]R]-PD\+OP L+
MQYVFWVZ=%IVS![GBTQ)N ?)0CA3WC"J&'=$F>D13K05#1Z<*3O5>\2DGU=-M
M&W?(!8=2>2J@%D;1:HXBT(AK8A4*\R95HXLS(DE&*B6C2 >I6H:%T09;:3'E
MEBJ.F9\S27H9\CQA40R3CFX6GH&#R4*,J?1/!+P123K!6<U ;?B?(L_;?M'.
M>_TB0,.W^47Z-"LF22$6@T)@B+!C3%&CB?,,Z(>$X#S,0/F2Z:;4T\D4B@:'
M(*SRRJ>SY(WU3C&6ZC899/2\R=1Z!Z:JZ)>+.=MMN/4(2#4K4A4< 6"GHD)*
M,Y =PQQU.!V%J27F6,Z95$V 5D\G5U(X1K A)"C%I%':\!"((/#9&V?<G,A5
MM7;=[8;>;NCE10G&USO=60%\2GJ;*C(S$!J&M55*RV"!*@X H-/S8J<F0J6G
MDZ4(V!NEG!XA+9,RF, QHEP*J[W48:YDZ6W>3GD@I9-;4FQ6C!/CW,ODU&(M
M&%;!&L2#]1K0G@%_:@:J/DXMD9Y.DKB)'$E+O0B6&<RM1!%Y[0/VT9JJ8L%T
M2Q),?=X+[U(VU'8;IN$HM\T!#=Y<ULU)IUAOFNZM^.U[TYNA>%Y$A'HJD/5@
MG 32UD@'4J5 JC2B> :,TM02Z>DDR1 ;(TF[;,!9TH9HD!\"4VDC2X'R&8CD
M/8I([W*7^FD?K0$8GZDHN><$/"<7T[8,)JPQR'-):1 J'=-)XIQ*U4L3[ DC
M$T ?YYW3)'"6D+EQQ "B$%X8;/V\25@)+-;[W5ZG%0I 'WO]4^@_%+NA:<K4
MT^/\=&9DS1)+/"."@5L5/#)41LTM]UX(%Q"?,UF;/.F>T-<"23,$C)O"&M2D
MU=PY3QVW&/L@>)PSJ1O>U.BT7:=U&GIAY@R;I,@PA)@6&C.'- B:YXPC'%B0
M0<RK87MQBCV=C'F.;>3)O/' ;)":.N^9DB9E57E,IU_&MML^Q,=0;;\P/K1,
M\37MI"B_-$QK9I:U!,#'((63(DJFJ;:1,FP%(<$@8NT,>&8S1;@G+-<?J&=!
MT\ #9M"SP=@@;$3D6%*%9B#N\=.$*T')P*?.T^J)FYV%+HV0#P@,F;*2*2&M
MUS$J)KR).F!-YU#.7IY<3WC@CU?.4JX,)Y(QY S,9J#,IKHD#K/A46X2D6DE
MU[M.^Z@7BM9&L+UO%R(;G5[HOC>7!NBWTSL.Q>#SDQUDD1Z[72YVEKOSKAGB
MG^82N.A=Q[1'(&<?AIE^>&;>0#)#Y EX@XIH#3?8(9+R=@#N$"29UZE2C?8\
M+GCCL;Q1+4+D[2.PQNVNJ?:G3B]7C#9*MOMI+-_LD!ST 1^''3QX9Z16RF,9
MC.).,*F53E7E:"214JF]'1ZQ"SR633NS?3)%GMAG%RS!K4!>I^U3'@2PHC7M
MKSLQAB+XU.[=]IN=W:=BMVGE]A?5A+?3[\>Y_@?I]^--?V6CC1&<FR"C5)HI
M[Y1BCG JG(\Z>HSG@J7?%] Z_;Q@WD<_>V);@R<B%JG2L6#!>>0(XX@H*=.B
MFXO@F%MIT R)Q81Y]7ZI?!M\*$SS;;_MNYM@90!8G(6]<W/ZE)(Z+:+R(INR
M)R(J6E+*B!%8:\*\,!89I )R+  (UZ*JRDJ&N_;(-,<^%J#HYX5EO],SS4;H
MO0MG(,U':>[RSKO0[?:.39NLH O;[VT5 6:J2+]TBLW_]$VSU\%PZ2D$;500
M9L^%-M"O<RUTPU_>=HK@S'-D(=Z0/O+P[9/DR;9/>H.Y0L8ADTJ8,Z\PT8#<
MP!^)&$5D%]*WD+Z9D+[IM:H3D6L>4_5/Y;2VGC%N# I4&2HQ]DHI'A9RO9#K
M^97K%W$L)R+75MOHO;,FJ@CP&*4"ZIQ1G<I*2H[U0JZG7JY?6#Z>38T\0%?,
MI(@I%X/&:26>!F:IU\$[#Y84I8W!QI,9JAWTNXK8%$?I)U,9R1AK9-HHS2.3
MEAO$.#+8*$LL#8;-$$M/*T>M@_CDO;?&Y<V\ES]'PM'DV8A*8T0,GE&<#GVV
MEB-D>0S(.\ST2#/*BHWX(JK][&PT8R$N7$:-'\2U_,D"S(&HD':U1XH0 T[5
MPGAE@S2IEH2B8K$6,VO*;R+K%$1R0( !(Y4"*H@K'1R6 JRG==@(-6(CF@VT
MX(*-)JS\1D7?^[8;_M.'AVV>):3WS2O?:O B[$L?:+N?B'W3*0<<18Q=H,R#
M[DOE=#BG-'H2^:A8]8!]R8)])\^^TVB['\2UY.G2BYP"XQU]#%@S<,8-BU8S
MFLJ["BDC&X2[!EQ+%UR[X-IO(D@/Y5KZ=(C3$H %W C"!:/,)-?;<.*U=$J3
M4"VJTB'7+ORD!=?>XEKZ<*Y].C_)1F.4]. H<<18I-I%RYU&CCG@9D\7&?!3
MF"LV?/8;TTR5?O:.0^B]Z[AR._<W$=^C_<'D/#W[/LN>#!(U5Y8Z8T)D1&.5
MMGLSAHUUQ*5(_-1SY,^PQ$9HFLO@-PIS_M3<,6'!^#%SEH]=[Q=%FJ67*%3U
M5"S*4DR=!8]-.L*1&Z5PT)I)3K3Q2"^V#4UQ3.E9& (\%&9DC#%$ <Y*M(IR
MC<&.,J&PI6R&HHUSK;QF,@:9%N^0I,PC%YGUQ!"K4S12\VB-,S-0]&1:M<VD
M-K ^W5YTP@*7E%,<C6?:R50WT4F9RKX1XPB>_KWH"]ZX;92>KC"MCV"7;!1E
M7$(K(;1UD09LB#*C@VYGX>"[!9/<$9A]^5/UD-2)LC152V/""<V1$E(3Z;S
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M/KP@6COJG2#*,^JC$C(P:SQ@,"2B'NI%O."C6>*CASKY3\='2/!@(R+&",W
MREH?A:126\D%TB*,["L;VE>VX*.?XR-X$,R'^_J^@"&496++LU3-"Q7/!,*Q
MA]LX]A0VCGOM7$A%^CT#7&\ L8%W" R60I-"SE#(>PUZ\'FS7];@"ZY?E#D[
MFQ>NV0?$\K;HM-8[K=-^K\S]VHF;IFCG[:/N^U#L'9LBO+F\NX-;VW1@:D/W
MS?LB .X#X+?7Z[BO\QBN5M8!^*'21(U9\-HZ'I43CL('[1F?(? SMXPQ$33C
M6%1:R6 P]PRTA"&(<L&1)>#B185F:!UC;AEC(FL0,G@NL5&$2\^(1X9@C@FW
MS!L$%H7-$,R=6\:8"&[%00BG,>@&&UCT6M'H4: A6H448VJ!,6XRQFX 9)J[
MWCRC"U #1I 0P'UA5CBE.=7"Z%14;%3S<X$N)L02$\$57CI%@#CIC&WP;IVV
MS(;H'5@/$\U,I7/-(4M,!%$@3T0 3O ".R:\4]@@0)Z"">R=%7J!*":L)5X>
M2WC#1)!I7Q.1#$EJ+"-(D%1!S%'I9RE%;Q(L\;&=][J[>Q_G$5,PZ:6U1BAF
M(Z!*HF(0$5L=D8PAQ+C %-/ &A/!%LPHS3051E')A)**@G,:M8_PN[(2+[#%
M-+#&9'*^HQ<\"F^9 \5!N&(A"A6=2!>L% N,,0VL,1&L0:TC'%R2( !RFD@M
M3GN8L%.2,^><66"-FZRQV3IM=BY#*!ECYS1U-8\X0SM&L PQJ& 94,H81 V&
MWZP2W!NRP!F39HN)8(RH92SK=#NC&#)&@Z/"J*.$<0<NRRS5[)Y3MI@(O@A*
M2@";0"6&6" 2?!,:4^TX1P"/CB*="WPQ26WQ\MB" P<(XJG3UC+ G<81BPSQ
MB%"C%;8+;''K_--0Q$[1JFKXP%USN460!^$LH,L0"66&,$,3U)0&X 4AC*@%
MLI@L4TP$5RC FSPZ(X 5&'%8T>A(M)(DN!F17N"*B6N*"9RF@1U 3>N$3+5H
M:;2@'13UC@4'1B,L4,7D-<4DUD8(9X%B:3QA0D1-<$3.:*NB2V4R9JCNUZ@.
MZGK3=+L[L42#MT]$'^3-E$W>/#]!7[[6EC3*!N>X\T(RA8CV3., =L #93E7
MTU_9;QKH^"PU]G0*]]A4$-0J1BW27!IG+3;.2V?9+)VN_N0T>O"3-_*S] *^
M.Y:!OY%W7:</,^V'5]/>NE,@3-'K?.B#V(6B>3F\]MY<II'#)[ )G?:_^NU
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MX!G8?3+51)W0[A%#)6A,)"QB%",P/2)0R@DWQFCN9@ \3C51)Y--$XDUSG%
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MS&'#E,?8!N*67F^M?5^WS=92Y$L#\!&HF6<=_[[3[9GF87XZXV&ZEY/AZ_A
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M/K@<?*+N/Y:V&V]O@L1VO^4[O4&#.S*HRI3Z,H5SKQS%3K]76B(P#( K "Q
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M\55J^%C\;<S_2"&W1.?>>9I/<&='^]:ANS!,]JCJ+Z4*A3#@9DG]M!NYBG*
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M$(ET,5 ;/--.*B81T49P1A6"/Z5B0IA0O%!,TZ28KD:*R1G,A*4VTP*CC,5
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M?*_OJ95H3- 0M45 &AU82C38&$6,C$9.OA>V>X1T>]U!S=Y!)B^G2H:#=#H
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MR@B.>ZFR%Q%<\&OKV,ZKUZ"X=LU5+6&@J&+Y0; \'EE.J% NJ@!"AFQH:*W
M><: VR0#5:G8C757/+5=P;B-'H6!1+,-BDD1L%SE%?.11^EU%+R8GVTF:LG1
M4Z+\QVVJ7\$]/W#OCLTWJ7WB$7F&=,SFFV<>M*##[D24>LS6.36E9R"2F=OG
M5RPW%\N/VV^^8GF.6!XK:FN#06,])($*4"@&>FC(E9^CM-9'4EPQ0VN)T<)
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MJ91-G@A@-&;@6ZI 9[<9N#*A.,HQ>EM.7&AQ_3A5A?Z3A?X<XBP5^HN _D0
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M,%D$9U@"'I-!QX61I@P%(Z:MD;:17:^#JG;%T[(K9DSJ5Q9H# M,M!-U5)!
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M TRS:!735'CQ@,<VFI"R>>H9F:>4<+D?3SVA,Q6/1D-G5VA(66UH+*==A41
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M%I#*<0G_,8R"<07BRC(D.:5(.6$D9C8H;%+Y&(DO.V!6+A_3(52'4#\#H:@
M/;J001$B0*5VIBB<8+'VE;=EX;[A?.D0ZOX1BBX@E#8:*VD4LHHZQ"4SR,!>
MHL)[T*9*ZDJ<2LS1#<(O9PQW$/7S.?7)0M0J.2R>\E!P3G7P7)1:4U(47@H6
MH[<IH9U_9@V B2T $RVD88&#KH0U ),N"9*>.V2( &-/ETIC_>PYXQM,W3J5
M^;[ Z3OG\$V4-,S$?SLLK+MR\<JG4/0P^8^02;T6;:N71:9U_R5^X+N.BUWW
MEVZ)']@2KZ#(8*V*4A;"6VHXYEY)&K"BPGN))=-%JBB,FXK"^/;EF:YH?/RH
MV^K<C\:S]V+A1(H>,N$D+85"Q B/N+&@\6BN4&&H8B5GIB@Q:#P;I;SU>53'
MGAT"=DO<+7&WQ#\K7HUB'D]RB&(%QY+*$C/N=?RPQ-323HX_)#G.%N0X]BH0
M9C626%G$/;=(4Q#K3EK*55"6DC64XT\A1^#E%U_9_MCW1@%>'1-11Z=QV;NF
M>5V;F&Z)']H2KW)$>0=V\PW/*J\2O/&[_8P^#2RY3NZN(G??7K"?K2B"ME(@
MA2E!7!")I"TD,I2QPI0@?FT1P\(*<?G H&N6=<\LNC0BL]2%$04GFOC 7:DE
M9RP6L'56DX)H]1TN72TT\PKNS&&:WV;/+FKS6NR)%]BS--K(H"3BP6G$I= (
M2%VCLN#&.U,6GKMGSRG%&PS?0:1!QZ!WG>-P.^:\.Y.UDYRW9TVRP)K2$B94
MZ1'H2 9Q4@2DC=:(&>^)Y*HPJ4CDAA)WE2;:<6=G1*S%$M^OSZY#N7M%N46_
M7"D*956A$"Y-0-RZ BFB+&+66\YL2;&3H(#<63A1U\WS>BP8.2"5[AB%'JC>
MDZIO8_&M\3?+BSW.$X3ND*9;XH>_Q#\OGN6KKT9.CX]7D;1O9I"3KMHZTY7;
M\Y/]\&I4!=^?3).?HA.\UQ>\_0N..5,HS0MM$'.^0)SZZ),C!0+*-L)XQK#4
M,\9<HR.Q)\RI]^*>6Y%;LV=N)7;M''778M=%1YWF)54QU)[$H@A<!XJTE@19
ML'B(U4Q893MV72MV_>'>NDZPK@>G+OKMN)=6:Z,0*4(LA. P4IIZ)(TH26S8
MRESH.+6S,A[E$M^?YPYW6+B.6+CHW3."<&-*B63I">+,4V0L$<A9$S365FJ!
MUQ$+GT+<W9L+7KV>C?Z^@7>_A$S^W^@%\3B/';J3G6Z)'_X2/^0 O&42N1/&
M-Q3&YQ<]?KHTL= "<B9XQ L:D"0ZH +,4L54H2EESY[3#4+Y&AVV/6&&7?-P
MO&\P:Q>6MRJK+GK[%)74"A&0-\K'4W&.C.(2&1*\"-8%*SRPJA0;!;FK.J@=
ML]YU?/NZ!.=U4O5.6771W6>YY=1C@:@.#'&E#%)@Z"++"N$,QA(4J:ND:A<_
MVQD9#W.)?UY6[5TY^CH O#$ +OKX*'7>%;A$ 9<.<5]@I+U52*NR$ 3$G0YW
M=][11?'=H#U>K_*GT\H>IRI5P$N]B?[2.^M/CF-E/)A*%\_7'0-U2_S EO@G
MN?D6A>Z6^S@=3T[\<#)^XU-[WH/1@?[RSQQ;0,QVY2QN+73W%\M2B<,R!,U-
M(9 HO0"A*STRGBBP/Z13EA KC4N-4M;H4.T)\^0:>/+2"&(#=.#(55FT\^%=
MBT7Q(HL:RPNL->(F9KYK)9 2JD *8ULP:IC0H!?S@FPH=FN'>\>FC\"'UTG3
M>V-5LL"JBFJIK'7(4VR!7PV-]2D$8D99[B167(GHP^-+^A9=WX?7\6AG0:S3
M$J\"@_=9&J^#P7N#0;8 @P3S8*C2J%2>(NZ"0])HBJBV GNFM8IM1^@&8[<I
M!=*%Z:W$I7M^TAN,QETUO.X,IUOB;HF[)>Z6N%OB1[?$J^CB1:F(\ %T;%9R
MH8GQOHB=M$0)&EN)W0^)V@4U9&=H1R?^+]!%.C5[%37[[4)W/W&H1&FPEA@I
MQ1GBC&)D1.%16>"2NY(;Q_6SYX1M@)75A0RM'__=@2W<\=^]\M^BF>MTJ9@U
M! 59@IEKN4=28+!U&; BM87CWJT7_SV%4)7?]2#5F]*3WI_3H>\QO-&+['.;
MX)2Z=V">UZ\,5M^-IF;@9_T#;]=U=/U@;+4#2%-RYAPH#AX+7C@K<4%(*:P3
MI@A$EK$!YVW/'5^,3DY&PQ1VEX\@<XA>=[2X2AO.@ZV(7E\2BGT\.MO;.K2,
M<*Z80IA0F\N!2%<()*W5C&@/*H0 #"-T X33AJ*W+A%ZYQSU(WH)WP_;KQUT
M7K_9\-TOT /%P\M:W<W \(KZH5W+X5MA77\!Z\J@+#.4QY1%@GBP8#GY@B.-
ML=3"L\ "B5C'.HSK,*[#N&\%@AI8&5(4P92:E\YHYQ4OM5"%#;Y4XFJ,ZSJN
MWR/\G2_ G];*BU!:Y&P9$$^I%9@XY(CPPDHEB8EUX 79**AX3!#867IW9ND%
M74H?G!>DI%QQ9@A16& EG;;!DBL8O[/T?@;[[[U89'\7J+-8(N$E1IQICA28
M?H@H,/%D"%ACF6+3P-83E#XF .ATH$X'NGOW_<VP\!:U;CIMZ%9PN.CX(@*7
M3$J*2M!_$!>Q'[MR 6E09PMJ%-"#3,Y[+BX7QE@Y2*V#P0X&'RD,*B4+ZXPG
M&E0*60I5$C GN%2%YD&610>#ZP6#BSXQ5W@/YKM#"A=@%!8$(UG2$FGAF"?2
M<:*23TQL<'H'.0L=#G8X^(!P< 48I([X0A&CO9=<>6X$I\0YQ8BTP6G=N<36
M OT676)<$X.)<DAJJA$/)452"(64%0Q40&=P26/7T@U97,Y4>*@&<0H"^66B
MX:7PK^M_?OZ_\%<S\-:SK ?ZKNZ?]6BJ..)];SB:P ,G(^ [/76Q&F#D.>>'
MX_Q36IN8U],+_:$>VKX>P##A@Y3S,]N9BU,\T=51?YA66"Q"\\*,G_^OJ7YY
M?N53ZM%RNEG&IYR.QOU(%K]6,=6H_]G_=M9WD^,&2%HWUEN/Y[=H S.93JZ^
MI1YQ?:?ZQJ#O>YO4XOJT_X[C3Z D9!&XX])S1KGA1%*L=6"!2HN-*M0AE<^:
MFXZK9@:G^L@C4WG]">D $_Q5#\[T^?C9+XLK \MR82=NM(@Q4ZP?SK^Q]6O+
M*;L[NR^W_Z_WQYO]=Z\W>CM[+S9[6WO;O;?O?G^[L[VS]6;GY=LKB7A=YO!B
M'Z31WMN7VSWXZ>W^7SO;6P?PR]L#^&?WY=[!V][^J]Z+K;?_Z;WZ:_^?]9_/
MO_K#WN1X-(5GN/&_UW^X,X"=C37)ASED)9D$PQGHT['_M?GA-]<?GP[T^:_]
M87IHNNFW14:++'E!'J5IYZ]K;E5JLR2)8>OHQ/K%-2]OIJ\NB-C\75%L@M5Y
MY==XDUSYW;<>2_AFR=F-'OOM[P0M?LQ@^;4>^YT(T(<4Z+E<_YI-2EUG4IGK
MUFI:;_M?>KMPU?&X]Q)T'3>+8EV8Z=/9QU9X\@J:\9IO,MB"Y*YFC.-\EQUW
M/]:5PX^5$U[H\7$O#$9GXUZH1B>]T:FOP)88'O6BR?D9C 4__O4',LK:+<BU
MH>$>>.$A+,X=U3%(;H4R6U/KO )7E32X=5[9VLWT^B[:95-<;R?K*H=-!%M9
M:J(P+TM.L3$R:*IU$2@NO5,XI<R1)F6./.:4N?T7C<MUYWSOXTNRM_WNR_N/
M1V3OZYN3]Q_?B]T_7K+]?][1#Q]?BKVO1W3WZRZ;NUP_?'I_\O)L-[I7OUKV
M'L:W_\=>__W7O]DN_0#W[]"]CZ^.][X>?[KD<CUYTW]_L/7E_<$[MO?5'>]M
M[_+W],^/>]OVZX>3#_W=C^\I/)?M__$FS"(0W^*S0P7[%7"(0=>6(VYUB236
M##G&,?4>-E::9\\)WB#%;4[<?U"ZZ@HH>E$(=7#T6.&HR^!]:'#T=09'EI=:
MDM(BD!LEXK0D2)>A1,1Z8HDH*0#2H\S>?2C:7:M\6SP#JCRPGNT/?&]8JWWQ
MT_BSG9M-TW@RU!_>W')Z#!G0UW>H?&^VUS&G'NF*W:4I1>@F77=N2Z'VR.A\
MM#JOA/C$RL7=KRVR6M7M]:U2^1"$_RS^-PI_;PJ@6@[&!R$,<4+ *I&.HU!Z
M@ZF37&"P1<H-AM>UA>4M[)&.A7]&-=J.A>^"A>?Z>R%*X6SP2#E-$+>6(NT+
MBZ11I.2PH<ZJR,*EO'4^]YKJ\ ]!K=CVIZ"X]V^N2CS<LMAKJDJT=Z1#GU70
MI^W,-($;;0)%IBA\K)LC$< .1II*83D77HE<Z;]8U\XY=V$&/GG&O4\%HF/<
MFS/N7&T@F#--K46ED: V$%4B:6.#[(*20O("*Z(BXRHJUXAQGYHW8NMD!(/Y
MFFB]-PJ]_G"BAT?]&)*HQV,_>6I5[.]7E[C01J.U%_MA9[836VDC.B1: 8GV
M7[14B)(1QD%*(!<$J! E<4@3&T"9P"H8K,LRMM[CHO- /&)NO0,%HN/6'\>M
M<[V!>J$*02DJ3 G<BKU!BIN B#3:@=[@'*7/G@M^Z\(IG;/ASK0&YX.OJGEZ
MV/ (EF%\0^7A2=@S/UAY>-7LPXNX#5M#M]T?6UCD#IA6BV-HU_'=.C1E88*2
M%CFL.:@/14"R)!K9TF(+N^=Y(9\]E^RNZEIVGH@UY-Q[;:S7,?4/8NKS&5-C
MZJTCQJ%0$()XH2E2E):H<(42A:?4,?;L.=G@_'*P9.>GN+<(]-$0I?"C@==C
MW_-?XL&>[[P3/U[!.'%?CG[=;\*\_HK+_R8.:12FXVSLM%&J0Z*5D&BGK5X$
M*H(30:* A0;+APFDN3.(^%(4,EA1B-A_7-ZZ0D;GIUA?OKTS/T7'MS^6;^<:
M!*>LD)0I1+@VB /.(D,51TJ0Z*S CI0Z\NVM6WIT'HN;>RRLK7SCKD@G&[WX
M>Y4JV/1&!D;8A4[<L\<B[L*;V2;LS_9@ME<OLY;78=-*V+3;UBD8D25Q)"#I
M2XPX,1;%.I((=D]@%817I7OVG'6Q$X^8<^_88_'55R,'IEC'S_?&SW-=PPI%
MG; .$2D8XH*7*"97(6,%+TSA"R?YK/_O&C'U4_-7Q)3!'K!EZ'_QKE8X8@VG
MT5@/.J?%?62=+X+3'[H_C'NR/WP+T+,?7E<Q<VUR_GJ@AY-8X_,T8E:'3"LA
MT[L%[P7V!?6,(^<T(!,N)#+!!^2(I\H)5A:</'L.IM(:64&=]V+]5(V.@>^5
M@>>J!:&8>249"JXTB+/"QPKE"@GFK*4.(!C'/.TU8M_O*!5-S408K/\VQ]_7
ME8]MP(_.3;0S!%,E'C#]"T I_?3OF.6>3IXJ/YX.4JI[JAEFC_7P"-[<'W;Y
M[EV^^T_*=U=K/G\P_5. 0BPJX?N?8]7:)V;]W'/1K6N'EC1(MUWCW,ZPV:LW
MLZWJM*F5M*E/"XY7L'VX%"4J=>P"*(A!4G.!C+6PF=AYZG@,*Y'T\G'N0Z[!
M]<C9>=UK5G5L_2/8>FXDE2&0$O803",,;%T8X&BI")*!&T]B'WJ<TE$I6Z<H
MC3M5X]==Y]@9?O;#R:@Z[\YR[]_/>AE_FNWH^RY,=27@^;@0>VZI]H4D$L$&
MR=A!B2'E:4"$4T\T90J^C!V4;IW$UIWDKK&%<)_!YQTKWRDKSW4(%0SL'7,(
M<\N E3VP,C4&!5 ?%'7!F5"DB/,EO=!6;@2Y=H>WZZX^O*[\J>Z[+L1\/6N$
M7T:E>L.ZX)*; -/+MHXAK-18<(ZH+N,1+@4SIS %\K!UH%^8H)E,QDV7*O^8
M^7I-'!<=7]^.K^<*A\;!E%QH5& =$.<X("FT0D1:SPMK2U[$(- -2=0:\?43
M<UK$0O.]B?YR0XWC:=@_=QZ$OLS(B3MQ$#>B<YG>$'T6TMHL\X1)II&WA4;<
M6([@#T68*B,T)X4D]-ES=3EI_J?8.IW/XK'Y+#IVO@-VGBL3!5'6!*Z0" [8
M&3 6Q;U$JF2,&U*:$.OS$+Q1R,LE>CKWQ8_FS/W)L:^ZVGT/PW61-FN6H]M5
M#KL!-BUDNY6%\YR4'N'@"U U2HXD+V(!L2)$7"J%=-&SRI9T&NH<&(^&NW]<
M%'K'PC^&A>?JA0NE)!HTBZ"Q15S$<TY*#:*D%)QX(6CL-B#I XI#?UR>BEE(
MYZD^OW$\Y\.U?!Y<..?KO$T=)JV$27^WU0IM53"%UZC$$9.DPLA(3%$PJN !
M:)CX,IZ+E*J+OGC$_/QS'1D=/]^2GUL!&)I[&PA#Q@B'.&6Q*(8@B# J86-5
MH8V,YR%WD*S:N3%N7J]GVG5(?!":QG9=_;EKMW9C>%K(I+>AT)3: D")!C"!
M+$:R (N(4DZ$EX%P1[*ZL4XQYIT78PT/3J[MQNAX^"YXN%6G1[$R%NQ$-&@1
MZ_1P)+TVR-*">2,%UL$_>R[(Y=Y'#[[C^8/1+6X5X?EP+9Y[CK>XHQRVN&-_
M];7I#U*/^0Z;5L*F]PON#.6\<1C,'Q9*Q+%C2/'@D(G5AK5A1EKQ[#EA&Z58
MDQ/<SI6QSKI%Q]@_E;'G2H<O);78<N0Q!J6#NA(99SU0&^>6&V#[0@%CTPV"
M+P=Z=J$9]Q.:,9C3^A-S:/PLQ6.U(]P.BVZ*178AER1(419:H@+'7!(5STPH
MI\C8(+GGU"H>V[B1RR<F7?6+1\'!/R\(H^/@6W!PJ]2%<YB46"+N4^=UJ8&#
MG4.2!*Z"M51I^^QY<2M58OU<&&NM0>SY2:Y%%P:CLW%O.O8NEJ<;-93?BQOP
M^>:Z1;TD9E0Y7Z')Z/37N!OCT:#O>LWL'CEL_12/!^SK"]C6U]7H<]]Y]_OY
M.]A9@+596-EL6SM 6PG0CA8J%#-3"BH+I U1B L9D"("HQ 8=8)X9AV81V(#
M+^FPM+)U=&T>>D ^D:>,"S_%8=+APH_#A9:B(SP73FED:4E T0D<Z=(I5 IN
M#7;.@#!X]IR(#5;>YKCFOH"A5H2:@=047R2NOVLSYQK/N-9\;_."GS/(IZ!N
M1NS) 059WTQUC_O#SWY\0=GL*B!W%9!_3@7D<K-<]YKBKZ>5/=9C>. H]'S3
MJ:#S_:Y%--MK?1YW8WPPVK*P-97?U?881E^=;PU=UU;B1MK5UX6B0JPL""^#
M0J;P'JPNX9'&I42<"N:X"L1Q':/9&+\<;-NY@A\%0]]GX'S'T#^&H>?F$F-.
MEZ5GJ)2Z1-Q:AHQV 6$GM#'$:,98*E^X)$?O(7N&'XR^4?6'MG^J!S%#+_%"
M5MR'HXF_;1^&AQL<\S.+#+VN1D#-;OP*MB%VKP(DVM63:=6?G.^'__B!.Q@U
MO[_U-O[;>716A:B%DD/2!BPU9X@*'XLE"X),H I9%QSF.A1> 41QL4;9/5V(
MVWIGZUW5];;C[7OA[;GZ(;25.'B"A)4.<>TQ,E8%Y%@AK<",6:\>8 ?<1]#[
M[8&[:?0$=*6>/CT=P) 2NMC1^,D54?HIU1A/W)>CF>4&J+LUWX07<0_RWG2H
MN1)J+I0P(-07VEN*?"DYXL1(9 CW2&IJ2@M_26^>/0<QN!XF6^>#64,?3,>K
M/Y)76XUXO9+&!8*PCQJ.+0NDO=#(%1[K IO@C([GT8_+O;+6RL$5@7?+SD*[
MP+N''WBWT^QK%V!S0T!;*&A@L&58<8T$YAAQ[SQ2/E@4/&=*22*MI/$(2.#;
M0%H7>/<H<6&= N\Z7+@#7)@K.I(7SE,>4" %B3E".AX2&X2)E*4OE-,NG22)
M\@[RD']2W)WLXNZZN+L;Q-WU6B%WH3_40]N%W'4A=UW(W36/P/.A3&8?_\57
MMC_V,?YN/!G93[W1:90A3\VUNZXA>.T3M+@]^WEW7M;;YCH5:R45:R'G23IE
M'!4$><G ]!*!(T6)0(QP@8W 4E">*N*+=6K]U;E_U^\PO&/:'\RTK2-N#AQ;
M$HL*KRGBK"1(,1-00:S51:&X<^'9<ZHN9R,]CAKX#T##2#3?J_QI'=SOHKR+
M[?MZ9_W)\?%H$"<U[@%7-AYB4#XJ^+'JVXEW60]Y8B%XZYX#\,8/-.S-P>A
M?_EGOHNO1M7;8UWYW^,V=_4Q;PQQGQ;*PU!52D(#"HP'Q$MKD62*(T^#4(8P
M[8-[]IQOB*+K"_A(6?QG9 5T+/ZC6;REQ># O#$4.4/!]-"@P)A8;H$QYC'Q
M6MH04N(/NX-R"^M6C.X!J#!+\@2 8;.OT?<&L;+2$W.0_-1.Q*_RPO\5UWVV
M-0UN=3BT @[M;6\MJ!J&%R0XCIC4@$/6<V2DBK^:0$L?-.Q7#'U;CVB:SO6Q
M?JZ/Z^0!=.Q[I^P[5R- 3]",E1HY2R3BTCI0(RQH%:6%K66<"8WO+-Z_<XC<
ME".;!A*MP\H8/O_$7!P_S\-Q97Y2#4'[8=N;R<YX/(TPE2)U.U1:"946JAH(
M[X6V@$J<!U JL"Z1I-J@$&"+BJ(L&0_KF(74N3'6T(W1<>P/X]A6TS_%2B&$
M1+@H%.*$6= C@D%>:BJQQH&$ LR -7$W/C%?Q!M?^R#B,<G$5R>]P4AW 1H_
M77N8[0N@T:YW_>G) 6S.WFC2!;ZNB$4+]0E + 2JB =U(1#$&;5(<\Z0]QR[
MHC0L6+V.-DWGG%A#[>':AR =,]\A,[>BV+W#&!@6,0DL#/: 0,H:@@@1O R<
M*:/,L^>$;,CR<L&1AYRQ]U"4B\5HT%MJ%P_7J%D_[:(=1-;8.1TTW0Z:=N=Z
MQL==MOOW82&-("8X1"P#NT<5!FD6F_^5@I,22$4+TGDJG@!3WVN\1<?9/X*S
MS^><O0><[5RA:1D0YL8C7I0.:=A/5%K*0B&LDDGQP!MX25F/M2V$=%W-9ZU5
MCBOJ!2Q+Y+J-C^/*]+F'"&4/M5C JV93NZ3@V^LL6X=6$ZVMM,@74H YA262
MA1+(R8)X6VA%">@K;(/2.V@=>#T&>D#NDB>+".M4)J!#A#O4=;8.M5.<!<.
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M[^ _+WOO]K;>;>\<O-SNO=@'*;/W-O_T=O^OG>VM^/&KG;VMO1<[6W_UWA[
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M[K.79OD(W2@&T_5.?*T_+YAF]3E4XWL8CP:PJY=]-\DR&[8M/3OPNDH]"N-
M&[/O;#0=N*BZUR]QV5DR&(VO5*UU7)S)>4O)3UY^#]9<M-@6%P\URSM7PM,;
MC_7G>&34T^ZSK\!&\RGAOG'/7GQEE:%GHWU*-0LBG!WI;-0.H/%T,$FC'YWZ
MJG$!Q?(OXV]9#-\=]ZK&@R$<1+3T5!C%.8CNH+ M7<$4@_]CU1D/ZX#-1V3_
M[T-F>&FT,HC9D@,V<XZ,!_EM71!2:^F(9\^>BV]!\\J2FQ.EC;)6\L!Y42CJ
M J%@3! &8D*3SGA8"^I@NV>')2NL-ARH0UE0[&SAD02>1B5QTH+A1\J8ZLPV
M+_? ^<G&0U$83RS!%I>6ESI(8[67A79, #9IWQD/:T%C9V"@.EPX7=@""65H
M]&$P)%DP2/J2<.J*TJL0P\ WY=U!$+/&@ADI#1:4$P;4 99#(7$H@>*IM9WQ
ML!;D<0X"R@I%2RXIDH;$+ER:(M@U@215% >C)'<@H,KK^"]N83N SE3% RK8
MRLFH D Z.^[;X[D."1IMU1_GX\^S>!R)W.ALF+7BK)9EY:L_GBG".BMN9W#-
M*J0K>&!!EV#L"L.)D8IYAH6VF)<X"":NR*Y=A6)WFFF"YMB1XL%[O+O]G@)2
M!2[!8A48>6HPXD%;9%@ID;'!,.:I(JQX]OS;0)64\,MTM[:'F2L>Y^Q/)V@4
M4*XWUMMR<7S1>GN(H1+;.8ILKKPD8^_[&+)X--@Z=+>^FL1XOGGZ9._M9&0_
MI>.\]'18M\2ET59M?W6F*S=N,"=:8]%*3I;L:17#', .KGP8I##*YHSP4HR0
M'F0;. "@G)Q$"SJ]832=C"?P\CC7>74G>$@LF))MXFRB-O9CM%FK*H:S69UB
MC$[ZXWDZVS5>/XG1C=/J/ ]@(\9:]NM HE/==R@5*3V--)<5ORN'"Q]Z#4MR
MA5U;^1BU=#$'KQG(^-C[^CQVX?O65."YZ:7'HP$8Q>/ZP;U_.1_ZMC_Y=ZJN
M,3F?!T3U3W*PYW XC9-)7#!NK6HZU,]1(ZW79%"(-S:2ZMSKJJ:O;6]SM$X^
M>6ZVI$56]6:XOLMDD?T)D]$DA3I>8_CP4GA?'& Z<(25B4&(*?#TO)[$G3K/
M?H:/K/+1MY&CED89I/+,@/H:D.JY&W-\9LTLZ3,+UD&\V>NRDO/$B"!M$30M
M-.<E4TIIP97!LL!.Z_(:SI/5JTO.D7I\,-J:\>-K8,>=X8O,C/LQ2>'IZ@,?
M+=[?MFS_8(OO??PD]K8.>2D+[KE$S!FPCHTB2(G2H^!D(%[@ (9#U ?NT'<"
M<$>+$I=4!\>Q$:IDUAL?* LX6C'7L&L[XOC!Q/%UZVSWZ% ;%0N1"40]9: L
M>H(,I1QQ9J0K"U,((YX]IYN72X#.B&,R2E#4DIQ72\H+?I9K ]=E-TM_>$/@
M$J4395& 94U*'BC5#&PSHW@PI"BHLW?I]>U(\OLD^1+LEZUS&!?;_?J)[/U]
MR+CSS+I(D@KPJE0%,@+L%^V9#XX43&.R'*\RU=S\J)8+3H23KBBY==9(:6@I
M>#RHQ:'4=^F,ZPAC1<*@^W\?%@5A7#."7,G!L.7<(&V$1HY1@559!J?Q<JQ:
M)(S+@+6HZL\5K*0!P\8U.G)6:I>8*%$5'2\H_7JRS&\#MUQ)D?DA=U*E;&?O
MU2JU=-(DDB'W-HUA?SZ/&?WA)T=_;5FY\Q6 "=0H57"-D2JCK'2%1Z:P&-F"
M<$^ 'KWBL2$NV9"2;"BVQ,%2F[_1WV:G)]-<(64FRU8G#PW0I IBK; E]QAT
M<&M+ VJY5T(K'[Z#6=>CDQ/WY>C7@YI%6F0R![&.2C*5Q,,H):3EL@@(M-X2
M<0KJML%>(0LBI< 6;-L89429VA!XB3>XAI)</2>"4 :KN?EWP<;]Y4+^>U>;
MYW*Q"W)U;9X'5&9GC5T8RXLP?+^HPD)XT&A89QE,CN?A)MEEUG;=I:.(%'ZC
M4SK58*/W_TUA$28ZFP?13P0?P&":3S8B$R4G9^W\BO$U;=_7YA(NNFFYF/(Q
MEHNA3ZU<S%O8A9CH &2T9>THIJX,CUZ/!GW;]^.U*0)SW@B[EV+WY,^3#P<[
M)#YW=_MO]OZ?O3Z8^.3]U[W^[L'NV=[7/^'W5\<7A=W[@T_G[T\^#'8__A>$
M'ERW[8[?4Q!DV__]N$MWONQ^W6*[)_#[/Z_"[D&L0'ATJ"4K-)$">:DEXE@[
MI*34J)""".U+S76X6&"E",P$HI15+/"2@+%M#?.\ &G)2Z_HQ2HPK0WHS7>@
MUVS!#4K"?'\$BR,V08#!J8AVN.0,!ZT,$9()84 '%ZIXL"5A7@^2KCGVOA?;
M5?=HHV-</)AXT3YOF)5%ZKUM'Z+4D'W%:<I61MDWZ80CGH.\BI4Z"$;_[[?.
M$&J;*:>PX1A)./"N.91(V4I@GZ44[VCB-UV!XLNCG%C?)+*W+U^L11(9+-"N
MKNQQ3]96Z;_6MD)-)( YT:S%ZN5T8 =P5?5/F\QQ/1@DCW4#67H.6:<U9&U>
MPJ@?*+]^U^/^>#]<D%WG^>^G+;\^'1)OF2 A(%HRL..YH4@JRU$HJ-=.:A5,
MN"B/'FZL0R*%2*/M,G</I/[%=\]-;U3*-L>V&Y_#[T]UE058Y-DJ575HJB;-
M>;@"21<+.XU[N731 .P,^-Z?MB(9KBQ9LI[2Z(^MK=?K :@QKZ,QS>;[U1]F
MQU3CRI_)_WXLMC"U.?D85)=&//R=LS1B>8B!AP_B%KR9)V*\1?^WF53)*EH3
MR2H\]N=-+D>MR20@KXW.BP,(H]$DUU!N4C%BMG-<QB03+.@^ P_ZU#*2V\PZ
MS4ZFE%B*K!8<L(SZ*%VSD=X]]_.,>_]*)3O&D[J-V3".)M8!B(DTR<5L;07J
MU?C?[=H>0Q_+4\5J5EE0!=VO(IG/6+^9WM(TC)E:U@2%U'=ZUV*:1NNK)W60
M9I2> (-J'GNC@[Y97&.J+Q7WI9E.+F*5D\X_^XMS2+DZ)_H\QCCF?'<_CU()
M_>B<3(IF:\0+\35U;,MR!30Y'!:2D))#;HX[WT$;/:DKOL G.9_>C?SX7JAN
MA7"8-4;Y\4UQ?GP\3Y[2":?AGH]-8;H9H!P#CXVJ.K/H>\]<#.*Z9 $M*JQ+
M?+5MH_7'ZH#OQGX_O(2]BXZR\5/4];;MH1%*%QK4/,REC-YXCA1E&"E).3$.
MON'J\>AZ[_(9TFS3'P?__U M+R)IC)M/L!O##&>?SHK<MH1TSJG\Y&.%L;S$
M.9)R/)Z>G-8:2<3Z)KHQR:@ZO%.?1'4R!U&.QTU0YZ"?TS4;=X:;U9K.Y\M)
M 8UOONJ>_):X#@TVW6RY4LVS]GB_^YA%5&PI$:T Q?RTI$-G5WNL S9-:DP6
MW39!=*Z&UBY7-EO@S5[;%SA?]T9V-I_ @,<^3 >P.I^;ZI^C22JP-HAU24$/
MREG (=7\]!7L=;PH;O)I^B:'%4WT\*@?NXOD!=]HO;+R1[K*I_OQNUZL@973
M?GLC,TA%KV#Z[3NRB)[M86OC<OCU23I4]<W 4D.2&/0)4UG8\.2Q6[A[3I/S
MO-^4FM,\ZSN9P8VS,R=_'(WBK.(1C(]50><3@ <E#?*S'DP3@:7SR:8JGCX_
MR2W[XB#C)3,-TWG8SU1K3G^I9_(8M)&=X2RX;78R:T:?_6(P?2S=VRZW%_7I
M&2DN1JG#/9_[#A'5>PUKZ$] #UBDW*&O:ZE%$H[W9<9))78;7;1NF'BQ &$=
M.1P%PM+"D)>*M_4G%_)^8N6_*M4/2,'V,R;*)7+K^+L(JK&L5*Z'F"@>9MV?
MI!QU?_'2Y1'PDVDU3%/S55S,5&@\:?+#<5,7-WMYQPV&UY;YQZD[:DJB 10F
MS(]V3RI/J\>CH39@.0SZG^+)($PQI[7/S@[K56W2VF^$G#]5R5OH9="Y]W8_
M_GV(N?%*2XH*6$7$&75(8Q)0*%TI#>.D*,WC4?E>SUU3P.@+Y/ (\/;FVE^C
M'B2(SGB1JR->;HB0Y'XL('$\&@S.T>AL&)6;5DN$7 ([N:AL#?&U^Z!6FRJ8
MHJX]4G.UTP_Z"4BC:G(Z&K8&?;D$\?VBQAMO??]S;&HV[C!C]^/+0VL<%:7&
MR)1!Q0H""AE%!=+<$.K+T@1\Z8CZX6+&5L,/<SIXB(E3LVE4LVE$>R-[+&?F
ME@.]-6E*MDYESSI*DPJ5LMYSLX7(LS$!ZRA5&][L_=&X^A>UNYGWKK8/8^_5
M6(X8+LV11>>U_C+.!]5)[QA/4VWRA#/SX:ZD$Z_-NO^NP6#S9M(H:#/3<:8&
MIA6.31HGT2";P6_4RK+E &C8\KI-*M!@ZQS'ND]"]N*VG-(+.F5=1ZC6[VKW
M<E[A]#O<X*T>3Q8K2\\5XX1YN4ATTCASDXJ9SFWJ"8YCO=79@-,,CVIG?';5
MPG[U7;9F9UL:#:JS6&LI&@$UR:%9X=16J%HOMH 85:#>CJ= BI$"]?!3-3V=
MV+JOB(]J]X7JV-GN&S?KD=+YS7D/Q!GHPU')/<W)N<F>R]?88V\_C>,4YBQP
M"J9!E0@SEERJDS6OF _L6BP6 *L#IFGHI>C(Y+)N[0!8-;#XXVQ9#@:-\R/$
MUB(MD7BBG9^Y '(% GCD./GN%WT ?L; ]1Y=3.Z\*#'7!XU7[HOP/;Y9M?C"
M#?OOKI3 T@SYU:C:K@?<X/'K"NS8Z<EX:^A2#DM+VUB?=)9[5S1F=1JBD4)V
M_SXD6O%2.X:,907BL7B(X@0C+CPO/?&.>_F].@TKICA)'VAI@V<&GJYL*7F)
MJ=*%X$QB^),)@U!&.L*X?\+ ^P<[;!\,6,(E<S(@1H- W,?X2ER62'CE"FY%
M&5@BC&^5*;VB@$=NR'-%G-TWRE!V60;?SS*@#S?+8&G ['<#8"\$S((!A0V3
MBA?*\4"DD8YK(4*IJ#*:V1\>M!U[:\6>!0 O.S,W_E;R/3=?96OWR4%,C'NS
MA]1XJF.T6[ 6Q SQ 6E2@-017&@NL"=$7=Q4CVG)RE(Z!]!3!*\5$ 6'SZBG
MLO#\\1C%#8D\1(NL&?O<_!WG@X$O,7HF'7E-*WNL4X^AV(QG]-G7P3$+ASM#
M/SMGC*>4M@DXJ8NZ^@NV2#YP@FGTCIH!I!HS\\,V/4EG5Y,ZWR;W]]H'LR>6
MBB&S_A4^#B>:XO'%5?*]36(&#Y@-+;>_[5<6M(=)=KS5T4!UH=YD,*1#N3H,
M* ^B*9<[MY[.>Z%?C:-1-(K'C#$S*,UBF66V6! 8!IK,>K"H^K&%6>5GYPHP
MQN01F UE<5EUZQ@T:F?Q_D%\9[HQN@2LKJKSW.,R:DJSTL3S[H?U*.ISCGL8
M0UV@N#V*VK2,!X;M#"O81CTX'_<O6:I (8/QJ+74YOQ4CS-IMI>[=7 Y:]KH
MXZ$PF*&3?&Y3W[+DG0^17[>N4,\6'4WSC#C8KGR\GMT+5VK\LRV.GUS,)+^)
M@+TZ51BF;J,E<#:J' #.15D,,AY8?#^\:484HV/'ZY,G?,\B>._@$]\].W0,
MC+JBU*A@L<N%*@MD)&&(ED:5M*0<]N?9\]'0+\L<;W/O@Z3Z=ZD&^I6<O-'K
M9]"; =$,O!8C21)\1=$6F]U&Y)HCW<9<$K6D4'_<\NO.XD(SS,WQ\L)KFQ>T
M'Y[P=51_E<-;4_VR^E&Q$6'S^NC3L>GLIT:O"QMXH;GM#-Y;J%TWJ1W:T4EV
M<;9;@FE[',7Q?$V;Z^HO-Y;(@(7 Q0S#C;=\=DU:SVEJP0Y+-AS%B 0#$CKT
MY]T/F]]AR6;1P/,2\'8TCI7<8Q?@&.6BO\#T7!VOO=$&^+I_;XHZZ(\;&W"S
M]]\TEH464S":NHESCG^-45)-", LX-?J\7$O#$9GXWK-YY'/]?QB9%:OJD.E
M<M1!+4]A\2K8GX2P:;?ZXT\HQ-#E='E#,],<8!=RQ^19M^KLP,Z3BS[DR?G<
MXQN?U!3/BX]81J 3GZ.\XWEF>T\O;/B%<XBZ(_+R?;[ +IF61B:[4EO79TVO
M%S6G7,\$GAWCRE)L2/JU2@[>Q=ZMX^547;<Y\+-0H(9B&E]NCLN(@BWE]%V1
M>-@T1,AU<)H.R/,EC,N5(]YRLX7&"QW']_!*E"X'RQ<YJ1'4WCJ)<J;C[\SI
MYJ"FF^VX%@]1)+1!T->%0>,10CWY%/Z69C_'U12D%VM#QG0;-$A1^1>C]J[B
MK0PX;V/:3BY6B>/;9O9(!F4[6_DD)?+[KWK@K.EVFS,3[R3E? *+%9]4U\$\
M;UK0@Q:4>ICFW\_;H57Y-"V&F7[IG\!2MG%G:4S?9]T?U&>?XQ&8>5$LW/"H
M9*UH8[E7ZKL.B>>_^U3P-<?PS@YK<XO">E>BR4-HDXT26ZM'L\3XR5D\I+I(
M<A?V?KP(P[51!%2XH-6D*Z.UNT!M<6]GY);]KDN*3\1&GNV"W*WJL6._; SM
MVAE+K;\K%:A:C;F@^^3CU;H4Z0KG"]J42G.JC0V6*Q. 1(44K."N9!A;=:%@
M_<6#AA5MC 81YX#XUVC\A&V,KT=X[^B0LP)X0AODK:.( S,@XXA"6HB2J^"Q
M5O39\^'HLHDQI_-[S57^3N>!+D!I[^#](=76.5Q0%##FB!OOD7)4(\VP+3CW
ME-M+%2P\P;2@)99&6^YEH2@L?VEBKT)5N. ?C^^V)J$8SQ2MO%MD.!.V2==)
M"+85I-C!*QN\LYY7IQ5 9TJ.C.';\_B->:!'HR^=^E1&*%I.DZIOILF_^:\Z
M5B,73JIF,?O1*;J>!2%F$UN'U.7-WHO9.H],*IH?EWLZ;G6O\_WD-&X:=H^/
M^Z?I(I.4V:J*NN9)X_A.20-'N5M=^[O&)KSZ[JP/-*L3/>@G67ON12%>P0-B
M!.JLJURM$M3]UN(5%SJ%PXMF9-:8:;.G9YKZ/.K;K/B>S-.&ZSO&HX%K!GW5
MI"X,>:(_^1B:E7S!K3SE^I$Y<[8]1K#?8<5A /W)P-?=Q9,CY.1TH.MDYXVZ
ME]ZLO?@52O2%F9["Q9?%X*, D9DC;-:TKV[@/>OHT$IE2O9ZF X"D)MWO]5!
MD_,2""-KIT#[*;HYT=-QG4J5DZR6$4^.YELDY$2 B0'2D]H;V&10S2@HQZL]
MDHUIY-:B@W(6<=CD$.65:--^]GF-ZZ[NR>54^U-FX7-QH:)!VZ]SD<;SG*.C
M*G:/C.*D+FYA_25N2V=#R<U4N]K2_E3>)!?9@N#86$]1,?<ZKH&LB(NWEJN4
M1<!:K17(U3^64&@_&L6I+K&N7')8FO,%ID@%+P9MY6<ZS&2<%.-H6(!1_]FG
M'B(S'IF[<'+!C-IQFSJ+PFLW>V\OK% "Q?E5T;O34KSJ%S4.U 4]+-[8KA]S
MW/>?V_Q>-T/)[\LYM OCJ3-H%YQFLTS-^6G$Q2VM4Y)[,Y?T3.9FCUH>QSPF
MH/(#_UDG;T=5=XJ)$K3QC#?/G44/1P&2:JG$^<4(WT;;&=42NQGXFQH]1F>U
MFV^^.I7/Y4Q2ZY.6\R%G^Z7/FW3 :R?K+;;0>2PR8R$ P^:^/'5]HE0UIRDF
MDLYG9AI;6]&<+_!<!XC*82T7C$Y'^6]!1)^F ZB%9-;^R3QW,N]#[0]H)$@D
MHS87MM^=3TB</DDA[,!N31OCZ&O+Z:$QE2KVDHH'!?!7HG8P3$:5WTA:0S.D
MZ--SWD>_6SR]B,<4L<$4:LG1Y4K-+%NAG:W;\CW'6O"3^:OB:59:X^@E^9QS
M[J.8S4I1(S-/^CG (0T_^ 5E^&)41'161[U5S_)>FWR$Q*:#=(#5WKUQSE1(
MIU4SK2J=6HT;U<B[C7I975)YAZ,ALG5-@^'11M:P,CNE/DSIHI@9$TV]2 SP
MVKJ)5@TH+87@<W_<:&+-B-MY$:U$CLBB%6C.\Q):=:Y_NNN*9(R<1)[ ID[U
M6("%R?EI?#8 YK?\4,IIYHRR!AO*-17::<&]-1Z7*F"YO./,15<C8*[3YPME
MS[_GG,J#/XAC?VJ>J:]'&,8B=K?MU[WHI3H[Y%IBK+1!%C,>(]H-4@4K$9%!
M6,P#H]X\>\[PQ0.)2(7?VEPJ'2:BU*(,,9E!:,N$Q(2795$XZ62WN3]X<_GN
MWX>.:2.%+9'3+D:EL]26A2/L!2V$9(HP_NQY<7ES8=7KD_Z4572:)44RVEM'
MXH]&/E]5(F(F:JNYD[)&_HT+?HU+%OJ%_,6$K;,,Y(6N(TF:MH^<<C>^5LIC
MJ]:8C0E8(,HO%(U;-M!9.\<3/VEJSJ3#S=BRXIN'C5WJP/=3!]@C2QWX;BK
MQ>K@5K-"&48U);R03(+$X$)I)ZU5VH8K#X._=\+Q@'%DYDO+^FK426.:Z(QG
M<U/GR)+&)Z[,'M#&,9-]G>F6;*2M;Y'G-SXJQ1&^&BF\)EZ(Y#R+R9=+ZH9-
M+D6*7*YJLP3O]01V;]CJM;H$J]=WIPZR==8Z7ONY&_1(5(;%4-"0++[C1<))
ML7GCI#HU/I?QR/:3GV-&CTL8J4:%:JFC.4<BC8^S(3G(-O!F;[LY!UQXX\:\
MUF7T..@J?94K'319^TWNR(T<-!M9R5@EG_5FW=%6RF==9ABDG+(]/WF1I]WE
MKAZ\)[L?C[[L'AV64E!'J$5<<(:XC3WZ"NY18945\'B#<_-Y<L?-&^\AL[FC
MA&M3POGNUJ%0!?:.@+TH+)"#P252P3C$P6 4LG2.6!8IX7(/M N4<,>IS#^X
M<9 ]]FXZ\/L!9$.K_4(U&L*/N01?S'_/X;WCG6'[FJ:2UU,.=MK=_G0HJ0^%
M+1@2VE,@'<:0 JL Q2)-EH(]H4NQ8O#2&DO_+=#23TZB\5V;Y:T*D4DZSU7Z
MF6A=)NFO*W6O+-L:;?]6J&GO%J7;=7Q:]F3_JXG]3VKR: I+Y<;__O7.5+>9
MY9Y+_\S\ ]'CC5)IIM.Q_[7YX;>8:3+0Y[_VAVDGTDV_+;XSVLR??>PCH ?U
M2]+[\M=S<WH39Y-Z4L$?U[RY_GHS??7+Q"WY3FX*P:[\&H3CU;?^F,=^^SM6
MRFZP#VNP_%J/_251;J9>8)#(D/_/,_9L[G!*C?=^Q3V26NXUSYM=JBY=2D^_
MQ(LO\^=%ALJ\=/^(B[.]%8'M$J!%"WP&2Q?G^@26Y>TRE+^T*+<EFOFE-48G
M6#]-,8-]UXO3_.UAK5L4?]>@F^]/]VFM&;X+7GN4*]-1TVVIZ3L@9;3]=)3J
MFJ-ZB-9Z4+N_->W8?G:M)KWGZVC8B]3RO4E>;]=Q[R$LPO_\H,FW)YVZ,JS5
MK%=PC'DB2<&"P(1I;CPVRCA,3>#8%UB4I/9I\"O*?B"V8KK6RR_120SKN)6+
M [D#_67F%F,/TZ%Q_/[DRV#_Y+^#O:]NL/?'[OF'?^#Z@[_//FQOB0__O!KL
M_O/JXX>370'/.M\_."+-/?"NZ0?ZKOCPSSNV1]_A]U__''S8=L=[V[]_VMT>
M#-[_\^X+O/?D_=?!,<Q-[&__-^SV\9>_#EY.=M_BLT/F5*$<<8AAH6/)+H]T
MD!9Q+C11@7 ?2P&R>("\U(GV8[@C?K4BEWQ+"'T/C"\*L@[?.GR;X1NCA0:$
M*PO+&"^$D4H*X1PMC::*.EVG'-?X=KGH+5OA!*"#OA\.?5]GT*>($:(,'%D2
M8K7"&&^F@D0<!)AD4AE=^F?/R4:)BP[\.O![FN"G0L&5XZXH")?$2U?HPE&!
MK3-:A.51SYUR]U,1CM0(]V7OXPXY5-C8@E*, BU K</PE_$>Z%KIPG"E6!',
ML^<%N>J\O,.X#N,>-\91:ZUQ0?$B8"Z4-:63UA&-A>'6"7NAIDRGX*TW_+$Y
M_.WB0QQ*HDI-4%3A$3>R0*J4#AGN#.&J@&T'):_8H/AA .#*?L>0_O>@_(XO
MVE&!5WJJZ6J37@K6#QJW[MSQ%M=]/\2B5S& Z*VO/L?Z&V]' ]=AT"H8=-[R
MKP4:@L."(*&C:1DP1=)SA4I?<EIB8T"Y?O:<\]N"SW(V_Z$ZUH577GD:].09
M]0X\2!VC_AA&G7N#"#"JEQ8C+85"G!J%-*$>?F4<:Q*"H>6SYY2ICE,?,:?>
MM;NCX]2[XM3&JW&^O_WNRR'3LA3.2R2Y+A 7!AC5EP05U'+.I""E%<^>RUL[
M;CMF75]FO0.[O6/6'\.L;(%9+3/,!AT0UQ:8U0:+E.<.,8D9PZYTFO+(K)?[
M$/X\;GT*\3VY!M9I-0K]R0V]''5 .X-5CEU%!SY[.CK_Z6V7YM&@])U[*1+5
MODY$V\'R"K"\]Z+EEE"\#([R@)1C@,N%8$A2+%!PJJ3:L )C!=9.<6MKYPYY
MXF&<&76(V"'B^@04=6!Y8["<NX9P60;KL406-@YQ8P72*CCD@^6R*&5IH_Y*
M-GAQN6%R!Y<=7'9PN58^N0X3;XR)BTXX#\!'"LF1-90@[F*[Y\)CI+0UT>3G
MA<7/G@LJ.E3L4+%#Q75S?G9*Y(\'S$5'J #=L= E0886. 8C1< TH%<*Q;"@
M-G"E 3 W&+OC=)N? IG)A?I+JG]Q_=*=/[9XSE\QJ,[_Y?78C[NV7WL'6X?>
M8**"YXB8 FP;SC0RJC2H)(P1PA4(^'"QF*8K=5EXL%YI*;D$^[5@OC2,&!-[
M)Y9XQ<HY-:VA1%+WWB%RQ0*%F7;6M07L"D4 9_V@^R$V<6K5T._%3MFY*4ZJ
M([_1T[U!G'8O]S'VIZGQ[H-<@[_R/'(5P<HWS9N75M>,M\4"R[';EA[FSL.#
MW& UM8!M6E+EM9FULLB_#OK:] >YFO^WW]-J')":LGYJGEC7K8]%ZONIN?*L
M\T[Z?K.W,)GTZM9+FT;(327&26NL=G1RXNM:8;G+[+Q#2*M"O[O<O/O"R&8=
M/>9KD&OPM]9D.LYM 7(7T+HK[6C6UAL><EHW$8E]SR<>YA$7-I%G'-K\\6?'
MOA[@%U_9?NY8FPK0-H_(DZZ[-9_W+(@GH. \I(;D9VVZX'%UY[2%IN67[\\C
MJU\9FQD,_5EL<38?97KB:9Y6?D(.WXYEJN!BF&M6ME*Y.=A-7[?-&Z>JK]/A
MI.X:?PJ:UJRL7*L?]>FH'_ERF"MB3R[-IC_.;5$J?Z0KUS2?.1FYV(UEH2_9
MQ8UJ)CZ-8^JG(EJV2H0!,P3]H!J=Q<>E'N7P_N:US2N^0R /$R3>Q)_1**!I
M&RMBK]P9%]9%S>#7-.%,>;/RI;!0&3U@06;/N&'1TIN4)]SL76,*R[ H $'%
M5U\Q*2!/F/?D/+>A__^FN7[T!I#X#6=WY>0V>UOS\K-M6$M#!ZHY;FU!',VW
M1G[CH2VO0=L:SD93@#\!5]TT9=XK9XZ3PQJG6IWO4FLD$WFE/\/'86QS,^L;
MG9O9Y)?_B)?.6U6/AKYW[G75C"-,)]/8&F?KBNU9["<0^]ND+6DV(0W[ H<\
M3"CX+Z!UJOH'(O,45FDX[W%W012FI8Y5"6-;;)C2)]^@HG9Q#G5'RNEDMHMQ
ME5*S'I]7K6X$5/FF$542'["MTU0K.5X>B[&W&?*:<-PBGK2G>MC(G=3\+#<'
M\G4)R,6]]5]J*3T^'E43E"1ZS6/'^G-JE10+2 /=Y?8Z\,YYWW.0:,&?Q>:@
M#W+S7\'X+Y+Q1KVD]19=J'>=FER-)Y5.\!N?F)M=+5.4YAU;<Q.ZC:9S6VZ(
MYN*VQD>E9N_-ZVY;@G.S%R>U")9YPY<(K*B>G,2.[E]CTZ>%:6VT9M0/?I$G
M=.P-!Z08X3NJ'O7@-^K^(/WQ0J%O/>>MI,_=ZVI<T;@T,B6PTJ3]IH5%6Y!)
M"\KS-_0G@.E\\\R(JOO>N0;1VYU6%M]SOCA6-_*Y0]ELT$O'?(%Z%X#@0;+D
MZY9P6ZJ#M1K)I=*V(96(O:"SS3NM;?;:3[S$%Y?E;&[>FQN*I1XRN5O;8M_"
M66>S1B8WFD7#)LVF;GQOS'E$5XYY,CJ+K2HSW=7;?QHY-@_B:I)-KQT F^?&
MC\"&UUJM=:69%9TX;WPL,0<6UI8#JPWF/Z^1W7M;]_]\F#Z>G6%O:WH$0ZC+
ME$?*>+7U]G< W7%L<;GU]EWZ!N'BIS?5O:)8]7PKHD7\8C1,3N:H@^T,00),
MYRTFYY6I4U_TWLO8I7ANS.R?P4=@I$S.?V8OD8VF/V\6?N/8>SHR79X"\&"5
M?VM\#6T72;RB5NGR!R>IN\NX1I[<XK2U0#[--K? ]":JBK,%V^R]K9NSQDZ'
M&XD06F-)3<065SXIM*TGQ&:X(-E&2>FKXJLJWZ!0JS]F\YBFKS8,+C=W]#K:
M%+G3)0ROZG_.PCSYU6 \+WH'H].^[4DBZ@:B];LRML[>ESI*MMYA0$^ :?5S
M;]SF=5W+L-NV#../K&78-5J /1"07SZ_[Y[*/)^Q8.,96,"'93*P]^XTN8=K
MD='3@_%HWL[:@EY1 >\>3?NY;]48+-5X"!F?$;NZ#T;PR=Q+V[^ W[,'S?I&
MSYX4&?MX=+;DOLK7/>E!MQI5H.PD(%SB7X:W;O<C\[G>R]=OL_H\>WX#.C-I
M&*V2W!8A8E)(1E(\ZDYND7&KG58B\YG?K4=$XQ')-DVVB&,#M9.Z*W7NIIA[
M$X 6UG[L9N^EKB)DNKGS^#0:](#R8'&9Z01T_!Y<"39"E3TU*XT*+QH-NM9V
M)K'KV*S/.;SV3PV45)WW2.U93&9L]A[[",23N5NZ:=Z<FB:GUF4P0I CL?7Y
M]#3>6,]E<PG(WF.;E&\T1\D'O]WQ[^[!NT,0I Z'%+CE=.R<8Y$TV"$M?>!.
M&6")\C$?Y\XL@9U:/UX&@GM@9[_WD\9:>*B&P:ZN $ROL N^ ?[_6LM.@8#=
MZ] BL)8??$VMJ3>QTUYJE_XF;N6;V.?^I/>O6M/F\M]KL(:-7W"F#DS\293K
M%9@I69;4C=]=?Z8Z^"^U!VW<,@<B]2YH$#.;JC84%TY$\X..O3M* G0>_Y!/
MHG62U<G[DAK,)[<*7&BF570Q9C,F'ZE%5:/V^$]F_2O'\U.VOT9#!Y)Q)ZH%
M1@\_]?9#2-Z>-^O+7G_M_+[_9@V(X]]I?P>QIVDV%ZL914?-;WQ!KXLNZ\^Z
M/TAG-A=.U+.SM3X.3[I*.N\& )P=6EF89^UW!IE@?-L_>PTBRA8B?'K</XTM
M3B9IET$='+54M0S#A&8-;78*,-/=ZD-<NLKIVV $ C<=*B2[O^U&SKQE@;ZS
MSV'N*$P^Z4D]N[3?^<'ZJ/+9TI[W]$[JV<EI]G=>>DA[?VI-/-:YJUVFZ=%Q
M9Z;#V=XL*J91]XY'5MG?F ,>QN-^]I'&-9@IR+E5L9\Y0&K-L][+.;_./?Z;
MO9W0:+Z+"S?SH4=LL;5K-V+0.#=""UE1CD8"+-"QCA04/3"Q.?+@PIL7CAN6
M#N-!:@U;L95[.G^&51@WRD)S$GD.@+=H,\4E7-K*K3>GW;R%F>A3)$NDH&:Q
M,\[6C5KG433)H55'K+G:_O/]-+ XD)JQ(\_#()H35%M[R-+.Q?.CDX5MNSK^
M(>Y<X\+II7;U$>4OGAW=Q,.4; PA"]"MN?2<46XXD11K'5B@TF*C"G7(V;/K
MT4FC:L?@_E^)7$HY^:-^/!>;_(KB13^<EI9+%+9Y/^)DV=LOK!3>%&D9?JP)
MNC.,&#BJSK=GKI U,3?Q[MS<C/=]W#OY</P^1L0?O/FX1]_!.U_BO3_>G^UN
M;['W7S^=[V]OB<OF9ASC+OUP\BK>0_;^V&4?#HX'NP=_XP\?M^!>]W'_8(?O
M;@_"WE=[6 AEA<4\5=1"7!06Z;(TR)8J%-99X]SE2&-AM=(%"30([B0Q$I=6
M<U70@DGKW$73=+;DE_GQ@NMAB?_L>^_ZCI^RU4.RN ?JFO>!G4VZ[A%\$('P
MJ5(:C..P*'B!N7.H4-@!I06)E,8E<C(()[7&A%R.4?\Y1GF]<_D(>!P%5GU$
MG)N;1G7H7\O;FMYO,U*E-DM<WJ07:4$W)55WWX2RW*3T9KTMO_V=8#^@<:K8
M5.3JKV_0,?,A9/@MSUA:;5)KV IN09V]VPZ##VLA+EJL3Z]!WAM]-C,(NR9Y
M78^!J]-UB::"!,:-TH$+71BCO!-:6N*=)X8>[ERO=L%,8P#2VVTH;UV2<F^J
M[.6DW(_PW<F[\P\?=]GN]AMX]]]D]Y\_^Q_^^7"RN_T)WK>+][9?P=CV/EY,
MR@5%D'XX^/-D]ZL]V_OCOQ_WMM]]>7_RY^##R?NS_0.8V]>_\>X_.V*7[H78
M&6!>]#<4(C MD>8A(*Z<0=+P C'8*4I48(12L%Q5UP"J ZZG"5S2!UK:X)GQ
MCBM;2EYB"F:RX$QB^). "Q/*2 =</QRXOK;:"FB,+6"6E=XB'CA&QG/ ,>9E
M43!AB$YM.V_=5Z!K:G)'//?/J/I4Y]!9/^[:FOP 5>G:!4UF8!0W96?X.F])
MAT:KH%&[B;"V E.0$,@19A#G7B$5&R@$0B@Q!>.B3$V6L.JZ)SQBSKVYKM!Q
M[KUR;JL'KM+2:*91H0E#W&.#C 8#2%D&GW+8P\BY?(.1=6JE\!1\2Z]BPN.Q
M=[VCV(_@1NK"DED_/M"Y3W6AV9/4(J(#G55 I]T3K5 2!\<]HJKDB!-"D,2B
M0,8:1X0W\!\&XV6CX/2.S)<U\JYTG/LSU(6.<V_!N7-UP6"OI&,6%'U-$)>V
M0)I+@Y@IJ/&EHU336,"P9'?53?4>U(7FC!P&Z[_-[/=UY6,;\$K*8)D3!-=9
M-\NDW HV6DT%_F913OQDZ_S>\>H\&CEYGQKNGE^;$K\/0CKNM=U@EG+%J3)(
M6TW!F"X#TF4LJ(HY%K!=V!7EL^<$;Q!VZT81=\LL/]F%U@%F!Y@/U+#H '-E
MP&SU7#8QY<'%=..R0-R8 AFO#1* HRJP0*3#"3!9<6M[8CT <[$F^L48]6^G
M?"P-,O\I64&+J8^I\,(H5C\8MXI?O=K>FJ75Y$((\9N7L1!N77@XID54/B?9
MQ.SD\R:0\$*"6YC&9+Q8!J?Z[%WO?U9  H5]P;ECQF'"@Z)&$V,X-MB48,9B
M\;W>,>)&1Q-5?^*W1V?#&3 4#Q,8;AR$OWNP)?8/WGW9/8!Q;%N^]_>A,UH*
MP8 =0P#=2)H22:$=DD0%HJRTGH45NZBY GLIG2.6&^&T*XD57F'CN>&,?:^O
M9+>U=[>U'A=><&3B_O* *3(%H'BP(&Q)J0F5%%!\$U^"\$L?] "M!C6(Q+3*
MM[DD:8\)$@,G8GV]7G^6-.&F59,O.CFN?$[A79I^>+&X\,%QKFTY3=7N%\I1
M-C5_8S765+D&MGE\ZTJ3=79D+ !35X59DC]XXWS!XC'F"_*GEB_XNJZN_7J@
MAY.MH7O9%-A>O_S!O7Z#.N^_ F*<P[._[!_\+7:_@N9X\JJ_^_&_)Z ]?OSP
M\>67O:\?^GO_)*UQ 76BIOGA8 ?O'KP4>]N?OH+FV'__S\[YWC_O07L$/#IX
MR?9.=LC[J#5N[X*VB%G)@@*CVL<HDP JH]98(FQ(Q']<.OO_L_?F/6TDW_KX
M6['XW?O3C$3QJ7V9N4)B0I*;46PF"4D$_Z!:P6 PU\L0>/7?4]TVMK%),!BP
MH4<: EZZJT_5>>HYI\[";B804N!\/FDJ/1CG(FE#P?:.8!;0$#%S4[5M_AFO
M<'X] 4.J.7=.X:]O/SE<;I6WP=#@I>6>&<NPHRPH(S@17O#G6X.O=^5]^'&
MC0$CDG'D>5"(8YX0$(^(0F*&2J4"5O3N59*6AL?_,[.<_SUR$><S7 B9N?&L
MK5!.(]G0^!'2!-4&UO?-6WSRG,8\V+M=MLII7/94OBJGL<II'$B@:"IUU&X5
MM74Z[7]+:V9A^0(OW2<_]_._&*\[!JKK!*-@F6(NK,H.7&H5E<Y'2K58P#'E
MK>RTZ%"Z-'[X>W+4@1_^PX\ZS;U%X=]=_Z,!8ZMOGXB=[2VVO[W%Z[LG%[G'
M:/WJ*YORPQ^_O=H[_792+Z[[EC;>?[C8V3WA]>UP4M\^A#'\=;SS_>U58S=,
MID$RBD5*(G>TCPGQX#W24D:4#%=<^10,\6N;>AVS!\?OSZL?JYH+6>'<2\4Y
MP#8FL!:!,\V)I\:F@%EP.H*UGJ);P.EBA7.+Q+G1>6,.SA".$<04Q8@3S9$S
M\(/Q:$B4E +8%7E*9-I7O:0X]QI2)S]:E\N\9Y=_V3,CPA@Z[?;IR&E1I5/>
M!E<>^^B!FQ$)B$5P<D;@!#@E#'4:QXJ6+1=<C<>3D4!5BMP 7!F*N"! RZ**
MB"JB!$O2T:C7-HE8Y_3!>=Y57N7RJK!56JLDA=;8<2*ML<0I1QAL95H0'BK&
ML60J/&(<BC*-@1>B: )!7(6$C",$B1B5$<Y+ZFBAPF*I5/@U.+K>]3N@<KD_
MS<3Q1Y5I>6M8I=44<QFX,X[#X]KH><)8)JHPXUI53&*I8&@\XY(%2@Q,'\)$
M,Y1/F9&AUB%LG+>*:Q:M+& (RRKE\B6K,.8IPH:4<M <3+LUU <.BHVE%"+Z
MBDDLF0J/F$00G@DL%")>"& 2CB"'14!)6&%-4E'PDDE0(Y9(A5^#?^)-NVA0
M5VI?6>+IL%/5>/KI69$E,4JG@P8Z$:-UP6O.N4_*8FLJ*K%4.-1X,T8EE$X*
M6R^1$QPLFJ "<HIII'0$#N@C=;EB#%DWZL%,HO))+*\&1T\#9CIIK T'OI##
M%3V1SCNCB""J8A)+IL%C65><>BV5!F. &L0C%<C9R)$E.A(%RIQ\S.57&%U4
MTE7EDKB;_FUUN[&7^ZT.6UWG)(3*(7$;!BGI.266TJ@U5U8;*V*DDL+OP7KK
M[UI4NP*:Q0'->%@)QL90DRRR@F/$3<Z'QS0BV"R43%S+*-/:II:+.FRM7 Y+
MJ*1:!<=-L!RX "?&:6U4=*"4'CONS4]<#I62/IZ2CM@ MH(P*CU*8(V!DC*,
MK'(2"4$BH3B"UO*U3:4KI\*3UW\LVI*VBDZTN17B=!1N98X,428)PK$'ZT,J
MQY6*-@J"F5#2F:!,O#,5&$B]"(+^G(>RD[YV8\'+_LJ]D^.6]_W3?M%\=.LT
MMP2^*M*]*OR9!W]&00X_ZE=OV0&GUN5T;D2HS1G$Q"/#)4.1<4L-8UY0MK9)
M=%4]^@6K,!<BJ!RB1(SD8(HZBT5TP8CHK=;8W,VC<!4[[6"[1Y5B/X]B7XT4
M^P,[,-%$H!0YL%PDQ",/N=(K1I(QYQP.44E=MOHF],\E4N[7X&PHI3O^<W8^
MZ'KM,#/LA[@A'E">:Z4A[0DJ]]UJ%L'O\V#>=CSOP!T*S(.O5A#X<&YS<1"C
MTDPRB:R1-K<72\@FH#E 5AG6A$0GY-HF)^N"OZH.8Q5V+$41NPH[E@X[1GX9
M&YEE7'@$1(DCSE1$VBJ7?R0O@1US30 [\+IABW+-5$V^'IX\W>W6[$@S0#-'
MJO'*O#>_O0BB5,'<XF%N/#+56Z.4C GY'$3"F7#(:&O@-TL#ERQ'%^1&ANM4
ML2F8^[UR_+P$[5]>JE-I_V-H_U@H"L,^".<0S36U>.YE6I"<X$F0DA+)15C;
MI&:=&[T<VE]YAL8]0V=Q*CSECB3S'@687U=)A44(:+FWB)?!#U,O=JIM8N';
MQ,YXS+&P5AJI$Y+<P39!$D562H4P,,087$B>\:)._"R2^"!;> %:N!H5;"H\
MKO#X13#V"H\?"X]'M)UZ&@4S'C&&*9CJ\$,KG:M3".N$YBDP"WA,UOG#&QTM
M#1Y/MNZX+MH^7A!ZCI*_LPO@/D<5X$>J*'T:?AS^\<4?Q=!OQ9TTKH>[68:O
MN* T.\ .4\&X1HD:C8#4Y!8XGB*GA<@!E\!OW<W:X%:2E !C?9"84X]M$#@0
M[P(/+A'!;Q:@'I=X+?XXS]T*BC8$T?JC86GGN?HF%)_+P)Y[)G3[I["B89V%
M6K-LCE!6;W:QU;ZH_58V5^C6;A:,_ED)]=D]$ ;J,%BSG);M(<_;W6;^S!^=
M"#C?_#<.BCH/MK*Q+PY4$(^^8AV@0[]W^U>FE7>J:NTS*2L1-T0V]O.H,ZJY
M>QB1ZT1[@FS>#_^PK0M[V5W[S^13PB/>D.J]!#()7YO_XSK_N3FQMU?(OT/%
M^_O6%;^>J)DW_J4Z/74Y<BTVC.3W*4=.^8;0M[]][PK?8@,+^0CER*5X[8/5
M&Y*J%1HLN]N [ECH_=:C$+.B5<-WBUVT7NZ>;Z]WSUQ1?1'%U%=5+%^ 4OQ:
M* ]=-&.^D;O&+RRYW.Y8A/_7C_NZ9(87H6MWD,Q*"N=!"VI1:VHE)??Z6D#,
MLAP?)Y;L9;N,7TW#96>HDCA8&BGAUCM# G<"6RNQ8M[Y7_7BG,<O/+XX7X@'
MMWY1OSID.]O?3O9VOS4;N_D^=0[79HW=[-7]=K+_'<9^W&A->7"OMJZ*+IS?
M/Q\UOG\@Q3-='<%S>%)X=;]_;NT??X;Q?ALO+?RC?E6_/ C,,5'4)B7!(&XC
M0P:L;Y2BMTXF(T3*7MQUAE]5<'J%;!6RC<H<<<=IKE FL.(B*,<L]]ZDE)P7
MU)0-I/$0V7"%;,^$;,.SJ<N=[3UVX$)D(GF+',UA988ZI'T*2%.'DTK*8UX@
M&Z>+JG;ZLI'MM8/;R\6W>QWP5?CVY/AV.:J_:#1.P5,4'' U3IQ"+CB*1-!4
M6YIH" GLUG4N%WST_E(BG2IX>SWPE@O6<YT",4QR# J2*]5'FU]4F'HZH&^D
MHF_/"V_X&MX<C\(K'1'S'(Q2D1BR463SE!MG5<(D4S>Z;NAT0L"2PMMDX-!4
MC,-\S;.7*G1H9HA)LUNSK5;;%_F/]K1]=M@M"UGFF),N:$5WO=:)W6@[_JB(
M* GQW]AJ#S(*BE"4V()[':[7#N-9[-A6^:H-I\VS9K?7*<(]KF_7+H-/^F>V
M'YKYEB#=D-\I?BMFLQA)MP?_%+UL\SAR;&$Q[.[&76)0"AT66B8>N(Z<@4G(
M"8"+M;G)J?;8&6D.!%W[Y706DGV&"50S)[!6_B<V:M,Y'P-M>ISHL"%H?CCK
MV;/#)JA&$;W9W6YV?:O=[7>6)3Z,U*\1],,5O$X;]//)_G;C:'_W\U$18'F\
M=[EWNB< !4_VKH[@^G^W;L:'[1T#:E[ML?WWGT_J]%VK\?Y=#K"\;!S_W=P_
M;L$]/Q_OO/]V7#\%-+S:NCS 0<L,3BAE*Y9;Z9&3&","6.A(DH8G>S,^C&$9
M6=)&"G@[!NZT]$)[*PEEBGI[,SYL)/K:UJ"ZW,^"LV8&T?SRGH\573A</Z,
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MYR(7105JG!OP$(:TYAIIKF+@03(=T]JF6%=B466)*TBM(+6"U&=,]JR(ZJ.
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M?K5WV=BML_W3#V+O^[>TLWUXX+4&)9$"!>LCXBY%9"SE2!DJG%!&>2+*#1<
M">R:O%V2"(J5"U_27.Q;29.B-;#;*@XJ!FIW,P!W(/O:P '3G<:\\25_ __*
M*?GE+9\J<'LG3:^DI0K+?OI%M'= .!;$<X,"F%^(DYPF38)'A% 5F6=&,KNJ
M4=G#Q3LH4=,M>0<LKVZSFX.UVZD(>BQ#K0&&R_<?)>+ZF6I&*K7!];UJ1@JV
M09E9>, U)1N"W[=ZX<_>4WSQT>$4;QBUT.CP.Q3'6JT(ZXGXX,765ULM08S'
MT=<>7A5L!5W8'^.A;<'3=>=P&PT>\]56<)_[^2O7S]U=/X/M_Y]..\5N%\9C
M6^]B[+[I=SJ 'V!8--IGOOQC:?Q ]Z2 @SKMAP(HG:B?OA7[VZV3.MRGD7U
M5UL_]KY_A7%]/JH7&;Q;4WZ@G>T3WC@^N=S;;9WL?/]T"<]$ZKLGK+[][FA_
M]^BX\?[M5<[@K6_?"!4WN?R-!/L#)I0@'BE&&D>'4C0^*BN<<V1M4ZT3.5UN
MY7[._:7I:_&+AKL5Z%6@]_1=*2K0>S30&U68DCJ C2P]HCI%Q(UT2!N"$6Q=
MFAIEN*$ >H2O:_K@0(JG0KW7<-[Y)?9ZK7@*:W\V3ZWBNYZ GA5A& .8&DW(
MFSP?;RI@FA^8Q@,M6"28*,Z0XY0ASE)"ECJ&L.#<2YD4BVIMDZ]SLZA3N24J
M 55I[Q/PC$I[%ZV](UIAL4[!*8584@%QBX%6,!V0)DP%PSFU7JYMFG6CEDE[
M7X-OZTW[]+19T.ENK=>N=6%]=VOV$%;[_3A$%:^Y4!?/ESP?HSFJ@.@>0#0*
M[H&_#Z\.I-+4PW:!F-<\'PQ2I!W 4@1ZD:S!VH7<TA1,'+9$49L+\MU42OST
M+HM*B1>AQ%<32NR5PUA*C10%HX!3Q5$.$D#.)A\9!_2E>FV3KA.^*.]LY8J8
MLS15K1-[_<Y9Y8MX]%RS-W#1?+OOS=[1FWX7GCUVX X@SF% T&4%.@]B#A<'
MP0B8*$I08E$A^ TCHZQ"5M@8?*) )@!PE%)+9,!4[H>EX0R5PCXM2[@X$)IJ
M(HQ$07,,"ALP<L1YA!4GUB5&C,WIYUHOD<*^!H_#,';1PUMY3+5>IPEJ4GD;
M'C4[="#U-P.A[Q8RKS!F?HR92#J7W@GL/4?*8I]/)7)#'DN1-\SY@%V(FF6,
M>7 YP<J1L+SZ^5!24.GG@O5SQ %<E((Y)9'RBB$>G41668(\)3$*201+N>*5
MJ'P$S\,!WO^S4TLQ5BZ"9W$15+;&0W"F.7ZL</+CP!(1 J \4D !$ ?# EEI
M.=)1DFBP\#3)M4V1X^>7QMZH' 1+Q@4J=7T\=;V:4-= N3;&>42TP[G#'%!W
M#20^<:,)USS$? HH%M9KKG(/S$<-.M'9WCV9P:LP.Q;I%OA<"KM"E/L1@(L#
M01QW"BS_9))"' O8][$P\)NQ,#4$:R[6-IE:5-!TY0A80HU<I".@TL@'[?&@
MD4X%1@CL[XI(T$,ID Z<H2!@A[=81T?IVJ9>*M?<:S#]=WI']RP%^2H,B"<(
M+2QF8+I@2&55S(\X.Z-ZUU?PN1\'B2=-!.9(" :H$U5N+<0\\H1'V!ZBYYSE
MV$+*S!+9%94;8,F80*6JCZ&J5V.J>G40&1-<*HD,)PX(0L3(A:"0E,1B:3U.
MT:UM*O[@(.#* 3"7FI72G?Y9E'2]9W+I[-**K[1FZR)%\V(0^^E2.BH<7Q3E
MNCA(T1AC>4!4>H-XXA$YR0'-"7/,J91W8:!;:AVK1>5R+$)M5J-^1P6:%6@N
M2PI-!9J+(K\70'PMTRI2E#3\ /*+D598(F*$Y31@:W.-#X;7N7SP6?42@.:]
MRUO?L6*SOJ[8O'3%0V=7.ZX-_E,;MU'M1RY;NQU=;_D*'>^\&>CQ<5$HGNV\
M_WR\LPWO9QW<W0<=/CK=RT7K=^ND\7[OHK[]0=RL4=NX.CK9V87OOZ_S^M5?
M60=_-$[?G>Z\WS]JO'_7JE]]Q?O'6Q?UXU:J[VZ!KN\=8,JDX]HCZ2PP%VH)
MTD Y$1;>@6YJ*PF_6>P8:Q\25EPYSKDCRDH>&&%*"NJ!]<2;=6T_ML\.:[NQ
M<UK+LK]'J>-?WW!R@$ERYB@UF%K,C>9&A41LI)Y92Q@.2U5JM[CB'TTP+YO^
M#OKSO_8R-<]*<7YLPXBV#CNQ*!8Q3T7=I:DEO'-6&Z]U"C]SZ> W[5,8RV6M
MJ$=:-E!IU^R-YZU=-'M'Z[G-"BRO=O95===K _%\B9U_FS[""Q\__K->^^W_
M__\TI:.=8YFF\I'']%/I%V(A?_Y>@UO;E(#CV%[,]9L'8GQCS_/3U.KVS!Z6
M0@=YUG[+<[3$(KU%,9Y3PNNUBZ.F/QH*-B=;P;I>#4'N=N#2)0-;!E'6VADS
M6I<U6D+&$DOQ#9 ,8)"U;5"KI1"=/0NU\T[[WV9>?>-(F[$4$+8;SYKM#OSC
M^QEW>WF7:>4U &LA8\0AZ-1AQ@A W3Z@ 4#%?\UALLF@O6-"6T$5Y]A;R5AD
MW.$HN2=<E"8;!CMNW&3[T'@WA\V6.<:'LRY0CZS[[ZR/6\58KTTV^<JH'IAO
M[" H%85)$@EK<FE%CY'33!>%D!1+GI $9I>8-KEJL!Q;>5J75\NNN= RJ-A&
M;1?D-*)GL&A!E;HE:(V(CEAB>=;SD)N]RZ6!K8W:AX((=GNU9K=V7G:PR1+M
M38@:(*)XQ=F6/?/P@7ZOVP/$RPC\?WW;@4O KM$[ZK3[AT?%)R>>=*/6: ,X
M-L]\\QPX#]PF TAW^CZV$VNA'TLP'0P& *;9FG'-E23E>07/9%(UP./V: /)
M L_R"*%HH 5""[%E+^&=T+$78[O'\J[U[>W:[L?G7./K@T6>?>NMZ'/+LM9@
M.YY8=:5AM)0R? -4H=FKP58[<)(N V;4FF>#+C0@0* I%@1\>MKLY=(PKM\#
MA<UK%$"C'/5EB=M#.G1D2WK4/B\H#5B?KMWIM"^&8% LFVLHF>C6,7FAT RU
MLW9OYM<!:S)BM2>_7\#*&#7+#T34G]VQL13:U3\O+]:-A371A3%W<TN>)LS&
MZL+.U%H:&DX9=&^PT[:#01=NHOPIV!\F_06]]F',7H&1,N7Z@L/N1#>E^P7&
M#(_R%[QQ5GAT,ZK_TXDI=O(5O_3:_J3V&X@X1,!%>"5/4XA=WVFZXHZP>P O
M-NO/K:.S9?OV__JPR)=%,6\Q)?KG>77/8U PF9P5EGA, W>&NTBQXL$0GHP)
M(E4&Q:/XCM]>-#X=>.LM99HC*B1!7#N.',P',L*[R+7U7)FU38)_9E.,;WI+
MO,.]:YX!H\P\<LP7LC3;7'& !9HS5T^UB1:9BMZA12:33] B<_;3_D9^K]UV
M7-3)>%SP_6+#'N/\>> .]ONSV.TN,07]/'@ &/)2K*CLFBP-J4GROUX+16$]
MV ,!JPO.0@K.0DRQ,0)H%D[-O#%F6RU_>(EU^J_=GQVB/*^ON#S3&*,II1Q;
M6<"=;B'AOUI@@>ZV.T"-W@W6_\>/;_+DV'#:/&O"?E7T/R[+*1=?R6 +D]+)
MO>F+%[/]UNW#%0877G^Y $)O!Q PX8LR$(6,ACTM 3R*=BZA9(\>&*'-?OOK
MC: WMA&LYZ^^7-FQVV4W#KT7[<Y)EHPO#XW6A[^4,@56G_U@A:C*T[H:K,%B
M,?IVY[S=R53PO ^_9>E/DO35-6>:0[]5\7CV_!RPJ? 7Y?-,, ]+LQ"DUAV#
MW3%/4Q%_!"L3%+B\1/R_?BY:UJY]_/#7SN?:;]V^.P8"55ROEEIMT&B0W:T,
M&HBNBYT;)-IH'8B*5@LO@;-I$R7E+-'$F#+!Q2*HHB#1Z%8V/99#.,F7AYZ[
MSS#Z=WE\_\1.[C,)"'1-H!%]=0S:TYU/!T;+E"S5R#L1$,=6(Q>H05@:BX-S
M6MN<K[,QW9;@OW^OG;?ZL#!JI08\YZ3/MI/^LMUF]\MY)]JP<_;-=IIYV>=%
M0%[UM(OZU@&QDAG&!5)&6<0CX<@D(Y!(#*N K=.1YK;P,]I1_'?M/&:?*TSI
M$C/:>K$FEX%*;=0^I %4-C/$VG]MLY57XH!099"] &,4]JI.YW($UP"XI2^_
M4*Y"U?+?P!)S7G1ON#_]TX%!U_*J+J_W+H9B1WM7..0^%UM:_NY\JLFL%,)&
ME90V7 >O-?=4,.E#,BD04JGF8ZCF":D?'O@8L,;,(TMRWK:1'+D4 _( BEX*
M3P+V:YMX%B*/-+/D.//-N4V12QX]7)]R@:E6BA*F?/)).F5Q->>/,N<,X#AJ
M;!0S%!G 7L0Y$; +\X2$8=@XP9G,?BPZ:\Y+7_\ )0!@(M#.PG%<G(R!%1SZ
MY>2'6%#@'*@V.$W,^62 =KW:Q_@O8,9A 2/-]O4AYN# \L]LT24PW-H7W?O[
M=[+U\$L3@^AG,S$*N):/O8O]9 B3XB)\0Q2RF(]1*<8XM9(80WF0UN%<Z %[
M'@UW1K)"A>DP-IG>S.:J5/@^*GR\Q1N?#J0,G' 7$0^)(TY-1#H&AS"1P02&
MJ8@\,ZJ?$ZIF^KEJCI_^#$X79YZ2_YZAH)6=CKTC>'V^510L$1I;CZV0\$Q!
M$PKD,,'^DPA.V-U]%17&6/$P\"S#1RF>Y'J]X%>W7-[FY:*\M0$GDRNQ*L2]
M3,C&I!$EV"4FL?%$9,2?/KGX49P=ES2P4TXOX/6U43[?5(M$87%J;PSL-UQ8
MBR,#BT\1$K36(E93_:"I_O!C9^L YI:Y%#P"^5+$DR'(@)&%)"8B4&8BR#Z;
MV#.F>AVFMMIQEWG'=0:F-GAGDTZPQ6+G<NTS9KC"20EBJAWW4?3JLG%X0+P)
M,D,H5;DAC346:1,)\L9ZR;3V2;F\XT[KU3P[[@/VT<6MC0I<9RT"WM@ZL+!U
M&N\Q$IJY;"T734X,DH'1&(RT--%;P'4U7?I;$\&.2^1EWX[)]EL3SO;7#%'U
MB_K%@0,I)N]8KL%' **40&"(<<2PLL'1( M?#IL)4:?7)GUQ9I-3(=H%5$T>
MZ RL ,"$,H IE--0&S,4W.7MAL)&;2M'-'?[Q1E:=AJ-SM;+\[5A4.#ZC8.A
M[*YL%F?M-T8T]SD ('4T)$866.2.!1.##\!)<> :6#*=F5$[6I931:-N/_W9
M[G=@O_\'-*\=7O/B_,2 EZ:@4B(V(1"^09P)BPRC&/F$)8F"P^8:US;UQG3A
MD/]>3>B<&=Q9+,6Q<_7B,!B4R>:X^PZ85<U.\V8@!*SH',M[5B3J%P$I+M.T
M]:RAIW"MXGIEY&_VFN4$_DF!S<ZW'XAC,&9.-Y3(G+[=+=#^CTYL%>$4?UXT
M0^]H6*QB[(L#H>/15ZR#(?9[MW]E<KK,Y&SY(I;UF2:+J!LB&_MYU!F.YAQX
M$'+ CD^033#8/VSKPEYVU_XS^93PB#>D>B^!3"[?S?]QG?]LSAKES SR7V:$
MW\@@IY%*85D"760<P$_;%+#UAHE(9,+IEQGDE3'X<&.P;G\T3\%*N-4\F'NS
MH]8ZJY3%5B2NG(#%(+ E5COJ6+3\%YM=913\?&?;PV 4 +GBVBN'G):PLYE<
M42(2BR+AA"D:39)J;9//\,7^F)U0L5Y+_4X1,%2<IY1<;,X3595KA,3 &2%<
M4><$QDZDB(,GW%R3'%7.N_@5]Z[F_<:\YZ@&Q2SV#$O$=,XPY=$A*UE 5%F3
M$C62:)_G?993-<]N+/:0Z_.O5C-=YVKD8WK8X$M"4,Z_B\"!6[[?*AA P0E&
M*7X%(9B+)E5PO0"X;IX5</VQ"=,4<@;DW0],YLPCCU1'8T5,#&,..FRD#=I%
M99T.6C-Y%UOZE_D?UV;VFP$E'3S@]?.]W@20XT-<STVIN1>4,41!YHAK:I"S
M7B"70J04Z):(,B> W)K_L5XD F4U:Z%>L3RG[8!:CK>!]7,*\W_46M%0T*V?
MFO7#7,%FCCK.:8KGK6;A$2B+,K1:/S&/0#*CP-'93H:5E-AL<[%(/^Z>@YZF
M[%;)8;$@M_-.'"1K#S>,L:S9?\$& YNP<YD/ZF!88#*V.V!&3D/3C&R ]3(X
M;!AD6V_68_A1QMJ.W11^/6T"\(V%]]KK$.8P\,KDWT??J4(YGGASVBD.:ET$
MU"^CU5.SD^/\SL[ J.]TB_4QB#D?J]GRR!E5SSI-!C;%99HF7F0X;(&.GD1T
M<=1NQ:%BK8\.V$=!F#G._?[3 Q;]TL^/Y$LX/W/:VTK@P"-(.P<X8 &6@2=*
M@J7M/+%27_,TA@8&V!QG'O]<H^D_L"6V>I>V.\@M:*?BO6;X9UC-8_#&*W8[
M7WVX B/-:BM\U!HQS'+&@4FY E!$-%(3'<8I!;ZV.2M,ZGH+&]9'&599*27]
ML!2H2AU?F3JV^MU!;>7A"5&EH5<?<C2R32ZHW"HL&N(13TDB;:1!F J=#"'2
M^UQ4'D_W\ON)CA9)"-<'A05QOFCW6Z%V9/^-P(KB,-4LU%*G?5I<9<1O"PH+
MFR^AI176'1VM3#&FRNORQ,1V*_4&UM^=&&T1O]B^28:[$7 B_)(-S^EU)=X+
M@1,A/C(>K-,V][T7C*5 DPCZVNO*RA"<:O=_/&SY^J/QZ<#$R& +,$A881'W
M-"(=F$5!!&)$U)([MK8Y%[*4DJZT_MFT_G%4EWFMHTDA16(XK K+DS.<82Z,
M5"KQ0?3<0'59I;J/J+IPC4\'@<MHN) H* :T@&B#M H"!1:%T@JFR %Q)Y7J
MKI#J]HZ:G85K;G04^+RPD@K)&;?YN-L*&HSRVM!8YH^PH>;^\JBSTMR':"YO
M'!X$L+G QL(H@9&%N%8*::ET;K@ MGC"R6*SMCDK"'&1FKM4COU9147A&5O]
M /<I@BF[X]&4'@8,-P;]R(?#:70<4 BHV:WU+L]CF70[+(I8:_NB?$M1!C:5
M16ZF+KQ>&ZN>,;I)+BY8*UJ[Y&HEK=9$3:GB*'KLR&7ZC.+47N;3:;"G8BMV
MRN/ISGCYGD')P4$]RK+&;"Z5VCS+'RY32J\/*L;.#+I%#<1"6-=G/S<#4&W-
M']FSPU@>))WU.NW6^J"437/8)6&B+M;Z=6F;\T[;QQBZI048FMWS=A?67+YH
MMQM[97F<YEFW*+WH;;>?];^\\T9MZ^P,_LXUW%R$I7>6;W9==C$U,P34+J/M
MU 99L-O1QPQ>-49N.0D;/^PO93!5WZN<"V>[901 H2O7Q46&VO/VA\\9!&]L
M]ZCV#HS6NQ]*K^?TA&+EP'#*6C5%1:OKYQJ[68CE#);1B*/QS A=ZAV!$7[4
M;H7N1FTE-7@@K6&L92Y"4IB>J*AGFL_]BP*=^9=KEP-\'G0MSUROF==)J5>S
M*W&6RVTUT6T'<*.9<P-R5'?,6N2+XI9EL=!!+=%1$2G?[O;&2DW97-RZ<WV*
M.;OJ8%GI%.37]F7T:^Q=9 ?.S0*G=RIH.JPU.]559K!^BTB:X16',;  P<U.
M[5_;ZH\J-8V7PRHAK'RVT3@'IS=3=RH>9QCA-?NQQ@HB#<9;%M"=-<C30=#@
M>;L7B\4VMG^.@\?X]:= ?*/V2$VH"D[UQ1_%T&_%=BK8U2#^_TV6UVX^/7[5
M/:F./QTD(H1.N9(H=6#K>&60B40CQAG#C!KL&+T9L"NB2A(3K8C#W";CM)':
MVZ!#XAH[=;,GU1;@T>GI&.<>K+Q,L(<G][?I:U'![!9%O^.RG>A?<I&+]EU7
M>8 -JB@OVRUWIW8?\"AT?__CYWVS?HZ/@Y=RCSMQ2YCYS+#I7TIU\W^*UG:C
M(/BBEUY1:/"\&_\8_O)GIA,M>_E'\ZS S.)+?TX.- _L1BN]8ISEVX.8<8TW
MJ&0Y;'S0AWIPXT%$^48147ZC+V#Y'N4;'-_^-MX@M[[WT\NR#4+%O2[[\_<4
MJ09+V-TN^XO&Y+=UHKW^*!%3GYW1/[94E:7JECH.(Q-=,1\JD;'^OK>UQ\Q/
MMEK2FNH3\]#'?EWBFVB548ENKI67S<!Y%'3NKMKS7&.U!'OW1@>%J(MFHT7G
MF5 T&_WU<JU$?4]1[Q0F6^EGZPW,]I40^,0-YM9$[V,<&^TJ=)J_Q2UQYT;:
M,QX9UU;AP?_K08]X]U[?S_%L<^3+N&1M/BZ,26#.$S,^.>$-]MQ'RP.;W28%
M_2*Y_RN\V09Y7,6P/5A1UZ<];#5]%T6/^YWC=R=[WS^(^O&WTYWO7W\TMC^?
MU-]_Y?7=MWAG^^N//0KC/6T<[>QNT>%WX%[]??I5UK_#W\<GEXWO>V(?/@_C
MO=C?/?Q1W_W$&[OOCO>WZY=[]*VH;^^G^B7^\7'W;:_^!5\<2*>P]+DRE>0F
M-^+6R'J-$65.,BT%=3GNB['I@@"#KND/6.CW;6Y_3\2\B>\5[+Q0V*')".V8
MMS8F3@W1U"7-.;'.4Y]KBU2P\SRP<W4-.QP'EK,FD8L\(!Y=0CIRC#S7/I&0
M:'(YW%2J"G8JV%D1V.&YO@./@5A!.1%6:Q*-X4I08P,VMS2%JV#GT6&'7,,.
M"UIY'BS"GLI<EE,BPSU&!AOB)>,ID)3;44^'Q3P?[#S49;,*"+)]RYG7K68]
MG>_Y9^+H2H/-_4VK.1I0EI,RZ/-5'!2_[[2[W0I_YL"?QILQ:TL#_W18>123
MY8AS2Y +UB%.E(O481Z96]NDZT2:AR+0;!1X5.)S5W_:JU?>^QLHE?(^M?*.
MV2R<<F\BV"S<@_(&:I%S,H+-8IF,/"4J"-@LZUCS2GE?KO+>G^97ROO4RCMB
M_I2$2+SQ2 :N$1=&(6-\1%2[I"+U(0F]MLG6J7BPIW.!REMP__\484NS"HBN
M5(SJ;1S_IW%MMMMM^V81F7D=_SP6W]8IVKB7UG&MWQUF!H/I57;W'D4"G\;>
M43M<5_HKNZSURG#A(H&X"!X=7.PZ'J\(PQ[&Q>6[G</%\AGI1-#L]4T&75S7
M:V>Q-XP2[9_9?FCF;^2$N?QVF"PC6W0L'E81:I_G<.\BWG98D2X';I=5FKO-
M'\-,Z++E\71EIXW:F+_@?J&$OQ;YA!#&VTT-8FVG,T?:4Y&)(^FU)D[.YY/=
M\/K=HQA[MU:QOA'3717B_:6N$OW""O'^LK#NC;A>1W%0C!(PK067CE@?=*[\
M1Y-(,@7YRT*\+P]VRR#B,@M@!N;FQM_YMK4\A%EP"^#8[$Q$.I=7'.4CE2A0
MA"F/U6'=J&W=0&7X;C=6L#P4X)0 VC,"9!X$J<.TJ<%#E;E3N-@RX=[%DCAK
M3VZ6XSD/M^)R[<.HL<7Z^"*#;XQWF)YH?S&V7E*\1^<!RQ.W"AA:3)(GEYQF
MPA#A#9>:.,8?U!#CZUD?)/K&GEL/S.+-]5#?Q5@UH&ZEQK$O"D($SKF1%C&O
M<ZUF,*=UI&!)1VZU4D:RW(5@5E;YJ(?/,'^B6&\Y,[)C+V 171PUR\RY3O3M
MP[-"WVQW"@M*NC=:;6?M7JVX0IG*>4<F\3C).D,K<)BOLU/DZU0I.KO^0!IB
MH@0K+IF@$%C?#-E(,9*.)683%SB(FRDWJ[)1[Q8I907X7F>531#FF2NRV#-F
MX_-@K[Y#AL]",WJ>-C-'F W#R7TR<QC;P%PN/'^$D0W&S&,DNZC[I=#\:K#\
M:9)=IC^Z-/''O\AU&>.B=P@S?K&"N)D[/U?FS\L(9Q[CM-<^CGE# NX<FO]"
M8W_N_OPOYL0@]WS!BO& ?>(N4$M=9L#"B 1BLN6)P537ESE/#,:MD#>VT[D$
M.6Z=OJ!PH<;QWNX'4M\.S0:M_ZA??6[N'?_=;+QOG.X?']+]XW"ZL_OULGY:
MOYPZ-*"-H_KQUXL&_<#VKMY>-=[_W:R?PECI_FDQ?KHG&KL?+O>N_D[U+V/'
M]8XQ2K3C2"IO<_4KBTS()WX!6Z,%TSSX'"ZTCA<6,31/YLXR1S%6,/?J8([R
M*!03C"0;P*97CEOBE<)@ZU/K*2D/1@EEI(*Y)8"Y46!#U"XEPAFB 6O$>4C(
M)&\0TU(I2P,->N5@KHJ:?#6Q&[\M&Q6;#MYHQ J>YH*GYGC0I#8B&J=0# ;@
MR6&.C(X2Z6!($LF8F$,WR+HF<@J=?J]"KEZ"VCX)M:C4=@%J.V(5-!$/JQ(C
M'+E"7 B#;-(&2<<E<3A'RZFLML8LB=J^"A?6W3+R[P0]=\U76VWHN3]C>)U9
M74^$-.,Y[%X$G0$%&68HXH0$9 4E@#F6>BLS#)FU3:JF<RKNCC/+ET=:Z>@"
MZ$&EHX^JHR,V((BUT5F-<)(.<>XBTI);)(P,24H5!<%KFPQ/)WP_BXZ^!O?!
MSTM6W;'BT>"LGH&<0[N?3_Z' W^U'N#%"VBYD7JYW"]Y5>>PF8SE%5S/ =<3
MB:HJ<4UC2(@$ D3*:(%T3 *99)FRCCG+^=HF5^L&3W=MO%^^S.+TY9G]-A5R
M5LBYBH=K%7+>'SG'LX1=E)%[1!@7B#.KD-/.H*!(=(9)&9TND%.:!Q<W6AKD
MG,Q3O,ZR&B\;_R2-#89=7=^64=Y5S/3QUP,3O))"2MC*.5A>7E $>[A"&N?.
MRPH;[>/-]">E54YH)Y$*Q95..A G8>F2X*T(U*QJC/6'&VD 96^149>0ZWCK
M]6%CJ*)9S^Q,HN:\F43=R52B]3MW8%CA^&RE-RB1]XG/YGC#B,7'9U.U 73V
M$>*S!5>/,]@[!Y//(*_#:03HC?-_\K7&?.\6N7WC.7VO.?#[RXW\QCO(8EF6
MW:W$9_F*H#]7$L)K%=&C+M$7<5;\I5?0ER'YJ1(=J@C@7[EW14@\<9=DT0O8
M:"F-\XE%8JFV,0T,.3YAR-W36W'#U,M.B[<_,F4O X*O"P:\$$]&:.V#W0>O
MD[WCOTX;QY]PX_VWHP;]=KI'WU[5=P]S^212/_UV?-.3 9]I-:X.P2[\UJR_
MWZ.-[4]X__M;MO]]_WAOMP[CS>63OH*-V;@9=\>"PLD@PP-&G)& 7, *$<6)
MIXDXYHH 'LRF,[67-"JX2GZHH.]QH _GJ@7,,".<X-)+(["6RE#E@R3,N)D^
MK KZE@KZADY<5M_=.J#8YF/)B%+T#'&7DR*XC(A3%B73@4@M<ZE6+.EJH]\3
M$^$5#)2X67_HMOH]KRSOXFF)X20$CD_)3KKN6%U$;5>P-P_LC0=2*NZ#=M$@
M13A!7&J!G,B]D$GB% <O(B5KF^;!@%?E6BROJBZ R%2J^EBJ.L903D!;(PE&
M)R0< ?N,1HDL ZXB30Q4$&,UIKF4XX.MLT=7U\H7]TL*XGTG#OG'+24"7UD2
MQ_+0CVR #2/$_^G$TV;_M *V.8!M(O)0D"0UEA@1[B3BG"IDO R(!X*]$U9R
MF;U.#RZQ7R5T+*^^/C('J?3UP?HZ(B)7>P<X<DM8]$@#XR@4%3E'/<HUEJ.A
MU& 9<_[5TJMLY0KYE1+?#*"JLD:JV.=5H&\/\:U7>\,\>\-X_31OI:5&6,2U
MTXA[PI'C0B!NH\!,PL^0+=1UPEY.*'251%(!Z;("Z3,?4E9 .A^0#DGVY<[N
MUM6!IY%K[0/"B9H<QR^05=(CY@DE/F^0WN<#2:H>7*1MR<%T 31],E?EA60O
M%.T,JLR%*G.ARERH,A>JS(4J<V$)IJ#*7*@R%YY<HF\F6H15B0M5].XO#&.3
MHR<B(3I$QUTRABDJ G::@<G,=+CS ?&,EG 33>!>2L3+_G$#WF_L?J+U[_NG
M>U>?\-[W#WSG_2>Z\_[=$7P>-[:/FGM7?S>G;& 8R0[8SHWMO1_[IW"=[=S1
M^1#&L,?WOK\%VSB/_^_C^NF-,L"2&D&]%\@%I1!G@>;@-(6BM(Z%B!D+>FU3
M/KA]<Y6+4*'9:J.9$]$2HS%W6G)-B+7,!:P-#UPQZ>*=C\\K-%LPFET?F^?"
M')BR1&/4R%D=$<=,(IV$1MH3;##S6*JPMDGH='GDE4*TZE"]RB]8&?[VBH*6
MGPCTQO,+.".6.">0!/J&>,0:&4DM2CA0K91G0H8<*+3\$<M5@L'SLY-*5Q>O
MJR."<O7AP+'(/,,1 :*"NAJ;D,W3@H6*.CKFA,U]H?CRYP-5+K,JP6"%^<?+
M#5A^&F";2#!@PM$$$X H4190C40$]A=%Q'(;B S*Y$KT#P>U*L%@>?7UD3E(
MI:\/UM<Q(G)X@#6G/&&+:"I<O\XBIPQ&7C,I!(G4YU92>E&NWQ?#0U;0%U(E
M&%1QL:M/WUYN\.L3;0#C6022*):LUHCA7'^'>(RTM1YL46(=MDD:GEL'J0?[
MR9<\[+7*(:BP\OFQ<N'4N<+*!V/E>*( .5 ^4N6M1L(E8,LZ)62D<<@Q8:A@
M4DKKUC:56)27?5GQ<N%I D_3TF*H%\.N%CNI;GO]3K/7C-V=--ZDI6IO<;QW
MX UA01.' LOL( :*+#<222^I9X)1K>FJMJOXI],\\\USVZJ=V\M!'L;99*.*
MG(713K4<0UIJ[S"0M&8[\<E2-$9B>MH<#6,V%%;WR='08H-*MO"T!T(W!+M;
M-L4=8\57@5CM1=O)$?8Y4F$[^GCJ8J?&R/H<\=ZK$:I]K9 33W;?\Z%Y]L4[
MSW^AQ\\AFP)T?HO#0K0%3'5O)&#,P*G?)Q&H"FNLPAIOL3R(I8(DQIVQB0LK
MG3,Q"*L]B2$21^_6//0J=MK!=H]^UOUN1+@^Q^'.NY.NE?]S/+5-6,Z='&V0
M+96,?R_#9CFML\95G>SMGK#]XEZ?+AI7GT1C^^^3G>W/)PWZ]<?>+M@=W]_R
MFS;+WI5G]:MO1SN[X20_5V-[BS6V3W#]]!.'L;/]W7=']=,Z?/\HU<?].PPG
MZ[PTR'D@;SPY,%4$\<A&8XC2-,*4KH%MHBFA?ZY*+.1K\-6#NM$J)G'IX>K#
M60,&M7L16__&>K$95U@U#U:-)Z$HY[7/5<Y\H@%Q$332T3I$>"364V^IL0O#
MJ@6&1;V&$"90)U:%**T '&6ZM'O1KE!H'A0:CZ,.T4B.N40T>)U3X2QR3!N
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MBC6!9BV.PJ+_&>T8UO0!]8T?!IJ^'<M_K]<$HJ]N47S*ECPUWDJA%1*YMC9
M,2P*8!W(.QX2,33:Y-8VIZOSU,YC)Y\09%P\;P/EG0+1:QI<&)2P9#Y^^&OG
M<^V\U>\NV0+YRW:;W2_%,=C.V3?;:6:3,:\6\JJ7!V\<'N#D;$S!(J]C0MP8
M@C0G! 4P>+/%:Z)G:YO3-M9_KRSI^+L/F_DUY;"PN#O#2N2]*7]+M, $!N]T
M8:'<]&%?6WA?RM/;O^"-LR(B(CLE_ND,&=N77MN?7'M"2K\8;-YC7IW_M9=
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MZQ@VLD23/'BE"+'!)1XC*RL 2Y^<Q"IQ3M<:$037$2SZ<# "M:L=AT#T1=&
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M:1'".4^-1$DFAGC2&CF9/+*6*TMI,M[2?'23$-74['(W^Y?C^SH#HFK0-]-
M\)KF>W6:Q&*X-:YQP([[B%WRP]:P=A]8FRXS$WRRI<]5T)00#TPC(V1._L+)
M,J^C=K1.E%@='G_Y1(F:Q^?#X^>^"F>44SR'670 'H<]S0=\"#+P&2&4&\U2
MG2JQ.CS^\JD2-8_/A\>G3J]09U@T!B7.* *35"/MA$""1":U<B))7"=+K Z/
MOWRR1,WC\^'Q*1<$A]T3GJ!(.08YKFCN]N*0HC2YR)0,+M;I$B]9XO:6SL0/
M/!PS[@5\H?!P??)N+HNSV*!_X[&\B6MWOFX:.G4Z;Q;HK^GJ7@/Z/0!]:[H
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MLI#("U-L]S="Z.3!V>XGD&,?>^.\V[-X\<?>.U#4BF(K?8X9LF.8G'5<8>Z
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M(?OB#J<7ZMR+.O>BSKVH<R_JW(ME6[LZ]V(S^K)<PB3] M?I%P_UKL#\LA5
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MEKUWE[USD;GX9?3QL](+KZG4W[.QXW0ITRB%2L(*Y&7@B">0PEI'DXO!$Z&
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M7ENDJ7>(&Q:193X">VIO<*!!F'SV=9%:3JV(OZE].9KSYBF**2S$,^:DT57
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M]2"Z')X4V&Y>+4:_P<&3$H\7T#U7B3Z<F*-<)&D*:,?!7U0@7:- $#,>I%S
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M1+H!)WJ;*;^S;(%A=-U!,M9](1/^RL@N_( L4^*4UWF1A'/@5HS$5B'-D[Q
MZS)KO@=R><-S0#93:#P:Q?D4FCC1LBR1TC8JZ5( ^3)$"(LOEY2V&096Z,0V
M]W7?LH+0]X+8C%AD^JZGVZZ'2AO,25UWU.J/FXYH;_G;Z'Z?+*8!+][&#2$0
M'0@R:+3Y/<]COWMM_N4OX_CL,_.YQ8,X4KD;F*#!8U\-/-M60["M L_1##<
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M CW\:URE-=[Q.:]B]O!W @M_1*>(39670$'L$J $&YL4H*CS&4:$CL<TK1T
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M?BF"H=Q!NX*<F8*.#%E+A^)SKP\/6K]$G[4"2%<LDHM,_E[97.9I\+2:LCT
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MZH_ER^\E2'[XZX>[V'1ZV(@R'#D@B!]R\;_#7?G33\;Q]]!X^^=GA_O<-K5
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ML'03>!SHPO&TV'5-QPC#(<"P5TQ>!QA.OA]HGYW0 SPZMLK\ (QU%H8J"X)
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MWPB8'@26%FB!ZT6FY.\A(+$O_*W7_&U9KNZ"SZ%ZFN>HEJV'*F,Q5YU(\WB
MHY<U]\D+W1DY_J# 'S"#6Z$?F'[DAJ;#K=") >\L=O7 <K@7,L<>X@I[Q>!F
MS>#@75FN2[<V(E#@FFVI?FP[JAWK4>3:CFVZ6$AEC3RO3PQ^UT46U,'S/GBT
MTTOE5C?@8!/1:W>PIE\S!H-4<[RF9RB.T<(%GKQXJC];ZB1\@R#NPQ:I+/9B
M/8XBPV:V!8P6.*[I@-GLV\S3@WB;OBF#W+RORR3PEL^1$_@6( ML(SM4+==B
M*HNXK4:.YKB6%CN.$SUY8>JWE:39TU3,P^9B(V*AXX-[&VF6%6I.$(#&!"H(
M0I^'&C>&R,9>,?CW-H/'AAUYCN6JFA]YJA5'NAH$P. ^A[^=V'1-BX%M-'*U
M'ZXQ'UB\ORS. M>/O<"+8].Q0$E[W+<M7],CG[G T=M46PQ\?%^W18B/03Z#
MCQ.H3NPRK,$$/N8,M#7XKR$+0IN%WI,7CGY;=58#%_>0BRW'<W%@G0&<:=E6
MS'S?Y0SL;"\"7K:&",9^,;C987 >Q0'WD;>#6+7\P%:]P.<J]J=@AN^$>J!A
M%L+0^L3BCZ'Z@2Z*[!H@DD4G<C:)">"-\@5..JGVNW7;[H?6+.CV ?1@Y'O@
M&ZZC1<S@AFZQ,/#UR ILC3%'<_&6X%!"LD?R_4.KA,2,66S:GJ$:NAFJEJX%
M*C,U1S6"R UTWV .#AMSO)'NV+<4H;X]_KKG!-8@:0=)>_O7DJS ,JR <ZPQ
MMH$)36:%H0]F$;A2AC\4\^R7I&V*>3Q?#V(LT3-CUP))RR.5<=-3-=^PC=B)
MF!9Q:O;M6#_<A'*0M(.D'23M=>TS;S(E=9"T?96T35F5R6PGB@Q-M<(X4"WF
M,#5PX"_'B1V/,<T)3.O)"]T H]8T!E$[B-I!U/[3W=4-S;*\.-)]T[$TS_!<
MS;0XPP]=S0B-(3R\5Z*V*7"+@30\Q]=4+]8\U;(#$+4FMU5=#W#RA^,'<8S7
M:>V1Z=U6/\#[%[446_Z%1CV_V'W^]&VSJ[/5W.VG^C/EO_Z/9QC:<ZIZH[_U
MYTK!9P4O>38OE9"5$]0AJ;A45RHY3MSFRGL^94D&0%,JABK'ZSY46,%Q1'?)
MB?O%9\"WRL4D"2?*C!?$Q%G(E3P L#+QE@D[YPHXO  1^*2,$QXIC$9_?^"S
M.9\&O,"IL8JAZ?Y("1;SUIJXO;!(Y@ 2!D?YSR(IX-?X?2'$ /QOF)]E5&0'
M;XJ4+)^+ETWY7&%9I%SDB[3ZF#Y<9/,DI947Z1PDS)RW@(+;0CB-E=?P$I:F
MRHRH.:1AX;-%,8/CER/Z^<M\"GB^Q&'GN#P],<_Q1WF(J\(S):\V6N)741+'
MO !DU%//D0-FY7BIW$_PT<D"Y%D27C?Z_9^EOD99T(J_)G/@F+!#D.Y:@CQ,
M2G9V5G!!!@A7*;EQ!'PEK;<?\G[W2I!.<9P<\^@;4%:I;-2'45+.BP0(%SX-
M)RS+>+KLBC##UF/3"GP66S9S@L#GD<V\4.<1UP/C\]$Z#^3HY'5'+\(90M2-
M%R#_@*,KQ3B-OIU=IQ6!E(#-WL:'K:V^%%LM:^VH[:=V3/F_WE_^_3&:!8;E
MG!RFDT_&7Y>@'^VWIR=?3]Z\_GKR_<Q\^_'W+Y^^__OKV],C\V_8-^PJ/OY^
MIL%>[./#\ *TX+>W?W[V--<T CU66:1CTSS'5@.#N2JS?=VQ?==D>"-K?I&O
MZ#K@:$!;<:FTJ4&1Y%#^JJ!\CD!Z <^#( @E7DKEZ82S=#X)4;:"4(C!9H$?
M OY1>/T",BAF89*"?./E,^6IE/#_2$GS#W Z':NBM?(?WMV5_"K5WK,1R?ZG
MQC-0.BD*WPD(VK-)@YT<8=]3<#9;[ ,HEY03T#W*MB1;",%.(H-[9N183A![
MNF/%;A2XW(AC;-X6 DOYP9->"O??>)I?H/IF2KF8$O>"FLK 1A!$ XJ*,[!"
M*FY5YI<SKCQ-T&S*%_#FJ'SVZ_8J;'4&-IR;K,S:)A:6+9HC;%;R7ZL_G@/9
MSE)V^6N2T2GH1\^[+UASHX#>)[Y^?I%$\\FOGCTV3!.=.UDZ(5\LOM7'Y/<M
M&>KB.\,:&YZ]\6MMK&_\[JIE=6?LZYN_OFK9J[]S;'?8['YMUMIJV6L*?ZZM
MY?-7'MV/$?6GDX)SY1B>FY3*JRP"/^CW1<;1==IB:ON#!<N'Y-L60/E1HFD%
M7'<(/O0<=.AS;$$ZMS8L_D%!3KL-IGNHP!G(ZG;(ZC$4N6[R'G<,%S_V?-1C
M2C=I)O-CAWFN'C,KYI$?A\SSN6-HMALRUQFJ56\CW03/OGD__63\.SE^ ___
M_<_OG[[#_CZ^LD^^?+K\^\TG\^WIF?'WQS^UY733\?=CZ^\W?W_Y^^/1!?S_
M]Y/#DR\G;X[T3Z=?C9,OOW_]^TMHPSE2V$=\G-35JI=O3_\R/NL\C WFN*KA
M6:9J,5]7/1_O&SFN;5G<,9W8>/+"<4::\\/W$79EH?W(W0^B\/&(0LO6;"O@
M$3<LW3(<W7-]W0Y=BQD><[2A-]R>B<+O+5%H?>8!L^/(=-7 CG75LFSL'P7_
MY1E6Y)F WBB(G[RPC9%KWW+Q_B *^R41!E&X13,)UX\8XY;IAK%E,=UGOA5$
MAFN&>J2[FCG4>^Z5*-0;4?CIXK//+=NQ-%=U I.KEN99( 5]K@*.#<=P8\WS
M-:SY-$>.[C]067BCB,D@* =!N3P )8C]V(NMV @"*S;] &_QZU'@QX&A,8,-
MU9I[)2C-EJ"\_ PZ, HL,U0-%V>[^CQ6?<?UU-"._,@ _/(8!:5NC!Q[;_SG
MQS 5<EW9Q]"(9.6B>FP9/@-/*+;A+XUYEL=\'EFN:P<F& E#Z&^/9-?E4NA/
MT]PXQ,$L3A0$JL4CD%V6K:MQ$&&/.%,/8O/)"V,$^.U1)Y*AV=!MQ[0"(_0<
MS7%P++45Q\RV/=!=/H:Y/&9X6\2T!D:^8T;N!JX<CSN18V#;/XSA1X&N,BTR
M5-^S'#NR?)W*:#W_AV_G#6S<7S;6M- U-1MO"KF6:<:>KL6>YYAN9+IF$,9#
M/&:O.+P;C[%M4]-MAF-7=4O%NWZJ[P:&&B"* VX#CN,G+ZR1/33P?<@\;H6&
M9G'#=4U#MRPC".+ <6S0U 8S]4@WAU#"7O%X-Y1@.3B@A/FJ']E,M6R-J<PV
M-#7R0UWCFN&[FH[FN/OCM^R'QH#WW!CP1V:^]@X\MWNG?UO0/!BA/C0#?#A"
MO35V0<18;*:%MATZJF/$AFH%9J1Z!M=4D[L^6'&.I[G>738$[,GT['^R:\H@
M6P?9.K3_>Y"RM1OV\H'B?<,(5>YXGFHYNJ[ZML]4C3.?>:X5:II_ERT !]DZ
MR-9')%N'AG\/2K9V XY@FH*!&I@@3!U3M>+85'W7#50OTH(PBG7+]IT[;?K7
M+^%Z;=.L0?H.TG?H 3A(WVVE;S<4[&D!!WW*5-L)+!50JJF^$WMJ9/F:9FN!
M2=,:[[ /X#\L?==T /QEJ?'-O?8$W++!S6FK2UV4B"YXU(ZOA",G,1P_HVY[
M\)M,R6>\D"W[L/4=/).= ;0!;KS(6-ITP8F![61_/EW[&1^>PA+8.J?N=7?!
MX0/ 3W+.(R5:%-A'$%OFS:F)!?RB3+[!KZAM Z_;-@@Z$;T #1T?0TFQICG>
M*AZ(I6W/B:W(\G!2%?C9.H@DQF(S-KQ0"WS'_^P93ZYMU$.@;5'+%SAV$E_^
MXQA<WPQ*M\:*LJX+U,8<REWM[+\[30IOP1+OBO@/BZ#D_UGP;/[J'+M7GL+B
MOZ5Y^/5^Q;=U7(GOZ5_&B?%*^_0]M#Z=OKH\/GV/HG-R\O%]^ND+"./3R>3D
MRZO+D].OWY:;U/U]^LG\=/K^R\GWR>3X].C;R9M_?SUY\TK_&T6Z<3)Y^^:5
M 9_K;T]?Q\=?SKY]CGP6A;9IJ+K.=-6R>:@&%C=4S[6XQG77=FVICH$K>'2
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MF&3G8*,(=R=!3[_DK @GRG^QZ>QYE:O%K_=1BJR:^(+D*KM]75Z5<J_D%X5
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M+0/A4@VLC&A4>7H,AB=DTHOP0$(^\JC.L05EE9@1M"L?EE6U-6#*B@3.6B3
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M!8W6HM0S,] >()'AX<ZO+M$LDA91239PI8@I;56;BTVZL#(T!"(INL'1V,P
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M:N#,BZ2J1ZG-AXN\^$K!+7)Q1*0P3E*I;1%7O_UQ4 I"7JN0Q98:JQI#A:Q
MK&!N@L^0+="[R$!U<[(1$@SF)%,9I)*A?7R3M.V4HY/#E4V+N&3E9S1T\S"U
MRW*;RJ.F3>5!MTWE_E)UYXQ5V+,)#_RDM9Q^44F#:;2ZQ.+J@K5MRMKT-8[L
M4C5.!PU@V + <G1[1 04Q O67XC&H:U0.9:#)$4W.A[G2+K+=1U[(IUV#M?)
M3E>OJF89)ZUF&;T^Z7;G:C<!D24.K5S"EI&PCFUAWS2.E8!J+TC4+X5V1*XT
M7\S!0,\HX3$#8L3X4*H$+,70QT@8[Y&0R'BP OXI'#RV)($B#N\I&LL?UA-J
MB&(X17*&949*4I8+W%0I;(9<5"J=\F*J_)$S$0<[/%1._^B<7H2=1!A'F>/#
M*3S\,'E#=)%Y8(RQVAJ'N"+C9[ YTEH8365@*%;N_]6L@63R ^*QY\I=]B4X
M9=^P2$SV)?AMJ2_!'L6E3FL/ VUT;+> 8J3)"%110-*-3_&6[L^$8<L>^S\+
M5W5+D5G1!06D9N*%Z:60A.$$+"1!:&OVT@WS3_.HCG"6E<"DAQ=5;5O(BN(2
M[X4@R2)!Y^",,?+5\#(J6KKPGY:M0"<]>/_J@W( AKH(4XEO16TG Q\OHJPO
MO8AC@%S6T[<*!4CT4H%<U;I"-JRH.8=-:T-\V[RTT!4 ?,) EI. +CCF">9\
M6A7,5$NM@F]+C;:&6Y/H_SU);,^)K<CRN&4:5F#IGJ$Q%INQX85:X#O^9UUS
MGFQ7CW(/-.^N#^1A\!+=DX.05!T"[YW,6SP @7Y$OC@H:(I-K(GU405DG*=@
M9> %B H$TL1 )I(U#JFX(#&;-Q7.?V446?R B]6U_P7_SP)L9F4AHA?L*Z]3
M#1B(GA(7$W?,9K#FET5T)L(&9'8+"@9R+EN[K8H/9,!:.)OHU I.QN" <EPG
M=>")LT7*"BI1.4_X14EV2?MP$K^TWOH\'S(6B(<%O&VL'"CE8CK%^AJLFFV*
M8-:N2<>H@$ A6%$>VSU\<^RDC2'AM*^)R(I*00SW"/#CB<@_>@U;5G1-_9^Q
M$,"'C2BI7)00@PK5U8$$X_D8AJ'0?$N4X-X*"L&0_*VEZ2:X@;.TF,Z$X&V5
M%$G X6T8_@W)!<5K_2%NG0+[1K7\S0+4&/4 BH*O\0Q750,.I2]4^F)M+GW9
M1;S[3_:^8*9?ZN<DS]0W!P?OZ':'(/-CSDCN[*,%V8H:5_X@G4X*;5(V4HS5
M6J$&P91C,6+9JNQ;=\/L%2LR2B7_QF,LAZA\^1':X?C (<?H<]+4:W3B4T_O
M.9VXG@Q>_79T>GC0@[SALY&LP)6 %QNCXI2 IPD_EY6DHK:2ER#46"L=#*IN
M*LFWPC/=70,$H+[$#$!*(GQ)W9*E4"MPD3XYIS)75%=GK"!RH/ "+^AG6<C)
M&&[>*).QI,TP(5XN F"%^4*:O9+$FD='=3'/%',8&(MN+G.!11@N, PC"A(J
MTIRR2UH] (L;H^$BL)VO747DT2D\DE%ZO%Z24AX">&!. #)94;UA7#M9+7@L
MJ!2"SMIBEO:AX3])1+8$6/4)@*T"5Q6);QE3#0!%$%::"6"[JI7%@!ND2E7X
MC.I4D9,JNTH)6)E(VPG@"FY-. &11,D'=@8<7<YE4 @OR#4 V*EBOQ=>_WI>
M715*^RBI14(6&;-]NQ*P.;_@O+K942Y=*)E/<LI^RI_55PW)'D3=3XQP6L"^
M9.8P%8%!^.=".ND7TNJL[FTV%^5;55_RHC!='V[(#3^2XIO!P2?);,:CJN!!
M/"8]$W*NJ]LI[S'BB;L0EF=/*TH^M/R*-;[HJ ?*H0I=W&9124N\=VEGO$;[
M-SI%"AB*;F#:IBS%2V2JLR(IZ:@D\FH"/V?I0L1^\"E!\AV-LN:=>#): -8F
MT=MP2XK] M;DY:O7S^O3B)V@EXTM$JC8:P&@*RBF+Z)6!2>U)Y=.BB8R5BW;
M1,:66$947'%@SV@O"^(.Z"! ,6E26Q-+H : K<%-TO6*1?0/M0X8*_F%\I0^
M \<4@%P^^_5F\1Q=W^#(B3?5[F(!Z,2N,RF;E?S7ZH_GU9"<)*-STX^>=U^(
MSM!2YQEZG_A:^DF^-[9-#UTEV250OEAZ46/RHI;:X8CO3'?L&YN_UL;ZQN^N
M6E8WQ[;GW6C9J[^SK9O]<MCL?6W6-[===DU_JYY,INI%(\WKY:6VIBQP&0[^
M-H<28JQ7QSJ=%)PKQR(O\:J3E]AXUE4$;FR'MJ]@^9!\NS%0!N:Z;>9J->83
M*I]LA!G8*6C^*M7^]HO$,.MW6R?>R'\/%7+:;0BGAPJ<@:S^2;+JB7CO]Y"1
M+4%>]S_<M?7\UF1WS^U]MX3#]OU]=S[_/35<W?+@CC?2'?MF\SMV$3WW.3MB
MH.7'0<NV.7*L&\ZB&6AYH.4^'5PW0#";QD#, S$_ &+6[9'IF7M%S+WU,OHT
M VE+_+\2!:YX ?:J;-Y#F4B\)52>FOHP^+;'Z-%'KN8,".HO@AQ]KV=R/7CT
MC RM3PCJK4;?P[CAP<J,@AN:=;(:Q 1,1_D":TMP\YN-OD=D]O\8:/HM'!QW
MY-D_YMW^$'CVP_$=F.-1,H>MCWQ+'YAC8(Z!.=8$1MV1;0S<,7#'P!UKN$/S
M1[KW8 RK.W79MIPTVO>K6N+VXKH;C?MX2T*>AFXYS47;CGE>7Z=EU97 I9[-
M]0R?IN])^PH@]HF<*SS%-H#4G6#I.DO3)8JZ#3(:A2DZ!$7)7/1'D!M;>U$&
M>ZS(>9#(%\K3Y!DV$ZQOZ([@$_AHN4M54O?)*^D)>"19U[1+7.)\FIP_:[=:
MF57=>,9*7R\=;C=9\QJ49]B]A1H^ # 0HRG=GL.F%S3VKR%_O.X4%#D#L:4$
MBQ+>6):M_AE5S[M67VK\JTBH(1E=7ZJODHJ+=@%VUY ]J:N;W"!&5+JR)[O1
MX'TF^DM<B,7+LWAQMI 724=X$TK%9I?4X15_7?"JW3U=314'>*Y,<6)==_J,
MN(JXKCL\$O !WD]31)/F.<=+XJTNV'+41'TU#>\1XPU#'$A3#Y,L)ZS@:L#$
MW;8IOD;2JS@,W3SB48YL0QLJ^7R>BFM(]-M2+LLS%*6E[(<B;@W'E^+V5WI)
M]][PYE=9=?6HL4,H"?-%&HFKQ!=)B?>: (SE5]'-@ZXF$X1[>[=V)S*_<P&R
M46[ 5_#-4]FRJ7Q63S>BKK61F-:397*H&O73WXGD<'W842-KM[OBEV<U2*3@
M.\>#;:+5_:2*5B<?8DEQO1/6EU0B9^>M4>K55UT1V;IS"K:.:-E) Z&^S9OY
MS%U5*2;-L2!)D_GE\[H+L;PV*C^7S?O1E&O=)@4BP_[*)0I$NA_8J%W9!&.\
MM-NDU1H ;ZM67P.ZZ%XC,'KW+N18^2":!N"PO0T@6%ET^;G-JP^M=*YNI6,_
MP"E2_9( 5UX')GT /+;9ML?.8IP5Y7 C>+@1/&RVUS>"'\^UP7V]?#K<R?V!
M.[F/A[P?ZB6\X?KB<"MV(*L>04[;1< ^B/JR$^GT#-=2'^>-$2R^=OWMBT>'
MBT\#&?>1C+V1Y>QPAV @XX&,^TC&NC;2G1UJ^0<Z'NBXEW1LC@S/[1\=[_4E
M4&_WYK^UC2\R  _EXN=-(?'4&-_Y1<->'/SG;4("C^5>W8VI1[?'WD ^ _G<
MD'S<\0Z.]D ] _5TA8\^M@?R>1Q!V6H.BZ@]H>$#O]Z(B:[QQX8U^K'&7O09
M6).DO25WBL22*TK4^LR7G>%?LL[WH;A4V]Y[&IF:L^.MIZ$CR)TCR3)VO9HV
M(.FNT\TCR]FUA^: I#M'DF]X]X>D6S)V]T6_'FR\9D/W-.8K50I;4=\:F.P+
M]>DW;!C=HY3/0T>1>\,."0.*[@I%EFT-*.HWBFSKAIT4>I03W!<E>[3NIOOC
M\V)WEMN#[7WGMK?M[BJY!R3=.9(\:T!2SY%DC7SG'L7=-0KVKGH//;PG'UEX
MX&A-+XVZC<:S'PK([Z_I_'2'I/#@U]QY=&#P//N-(?N&PU(&#-V9@-/UD>'N
M7DO<H]! K[7J4LO"&UC$/U:UWS^*TT>Z=L.D3V\N8MRBP_/0T/O4&NFNL7,I
MW8#:O4"M:>T^ZVE [1Z@5G=&NME#W [1C7Y'-_;KKE:GT>*/A#):=+_48+QO
M N"FH-+'NQ8B[@R:AU$R?P]^YL.GOJ?N+G?!!LH;*._6*,\<6P/E#91W#Y2G
M6V-M(+W;OJ&VAT'#@Z;M^;K+:O_HA<]AC?ZL\<@RT$]_^Z=F-CRVK+4QTIP=
M8K!#UNVN<R#ZR+)NZ%\/6+JS[/5(-X?B]IXCR7!'FKEK/K%_2>Q]T=&OZI%'
M5XX[>F05[T\-Y\Z;SPP5NKNTX;6<'6I<!@3=>9FE<>?==P;T[(">D7F#Y/"0
M_^WQDX\LMO!APYS%1Q89L$::HPTN3=^19 U^9]^1Y(Y,;4!2[Y'D>O=X!>%Q
MY*HZ SS_L0+"A]:3?N?S]YO3C)%GWK#?UK[4!]_X'(^:CO>)B'5M9%@WO,J]
M'0#VE80?.Q7O&2&[(]O=U<U[+-)X(.6](F7=')GVKHWZ[HJ6'^4EBB6+?[A-
ML4U(9WS#%FR/K;RS5Y7%#X+T=']\PR::6P)F(+RAI'U3!=78'\3>0'WW)?F&
M.XRW<ZFB?]GK?7ERKS, M^0@C)2?L5[P_[?WY<UM*U>^7P7EW,RS7U$T%ZUV
MDBI9MG.5L2T]V??=F;^FFD231 P"#!9)S*>?L_4"$)0H7<DB9:9F$ID$&[V<
M/OOY'?LI-LS\JF)]/[SY-<RB^7%&P<,DUJS%XK=MZQY&MW^:)B=KL?HM"3V)
MBKZEH"T%59A0;RO'*HKTZT*!N0#_&T:7?_L+_%<0A7]]$>T=[H]VP]U#O=OO
M[0YVNX>]CE*C_JAW..P,CO:/_J?;[;WP?R5+8__J#B^;W>;>%J%2%8WFC^Z=
M/ZBOOD<]^Z)\6.:Y=!0Z4?DD^!BG5TZU6[/%+#W<YN6=S72F"B#1X'A81)=1
M$>E5EW;T-,>T0*0]TZ-^B(=3YEQ-F_+"TB0/PC+#!183'>31=3"%P29YH),0
MGOQ'F6B^VOU.*^AU>MT@U,-,4QJMFLVR]#J:JD+'\^"7;J?=#V#N,1)#D=:_
MWFMWS;<MRL!56-@+S_W2W6OOVA^.TFS%J73:P3=XT,R':H3M$J]4'LPR>'D&
MFQED.E8%O\T\CL7%\']>S7 KR%S!,!40FY\)]'7>"F#2P(G*6&4P:C%)Z;52
MHTQ5R3#$#.NCX$VX"G]$N!]IF>&L8(FP_5$:!J,H4<DP4C$, RN?NN)E_'4$
M"Y\FT0AXG^G9A0_I#/Z"#W66TZ-AE,$K4_@7/("_.\'=3>:\/_>;PC!-AG$9
M,K%,HW"'-_P,AH=?ICG<A$L=:"H&HSIM?GBN5;:3 K_>P;_P<[?9.9I\P64:
MEU--\ZX]7#D9.LFHUDN%%I2[UU[!M[@5.5#W8"X;#N/!F\Q2X=$T@T?A/*81
MG;26+;J$176/@G.%FQP-6\'5)!I.X,5$/VK94F@E&F@U&;>"L4[@&L6T&A5.
MHR3*"[Q6N#6F_8O"><8Q_N]-NP/KA,]@ G2BL(HXG=&9&>*#)5RIC E#A9=P
M9O9,\:-1A%,RRW[WZ3AO/Q,>+(7]]^7!\@FZ\O;7ER4CVXOL0I5=Z%VY,_*]
M7WKMO66LMKU_7TX;Y>X.X%N$O94QD: *?NFTC^S8-UR>H9KAT3-=AU%19LA8
M+1>%6493[#^@B9!AF\L1; ?O OP%9$[[(K?AY.^?SVF)<80WHAW\]PUWC+9[
MIB+>[AGP F3T,_CMT'"]?)&M +<$_CB#*<_4G/!7L-!5PR4/ V3*,,LD+;3Y
M%%6_YW+U/K)L>-Y7#PAC9-?IWSRKZ !I'_B:S2_]=L_^^XX7M'(=^]Z5N=,X
MHOM("39>QS #@DR07N&2NU'A:CKZS;2E8"'<&<C+*"WA.NEL&L0IG(4:9YHE
MRUUG]"5MNBNP6!A)FS=^PQ=]@A>19 PU;#T,-P!Q=]4*RJ2(0 ^!7X$: F\O
MYG@Z,/H>B<4K'4P4, :X;O! B%I$X_6\VY'4U$C<S%&9D:+C-O5&?8#Y2I8.
MM0[AQUDZI7?K:YT-HQQY"5!X.OP.6C<KFHZYK#"NX5<\!)QA"6H"L33BX.J:
M-,])&J,IO9SSR W8[7&M'NMP*9C8J.3",M]>16$Q$:/6_Z%<Z([[B1KDH,45
MRW]RHR4TU*C6/='5[^]7-\C_[[L8ZGO64)]D9@TS-=8[ SB][SMJ!$M\H^(K
M-<]?O*[N#6Q,[2SNM8U5%OJWOPPR>$_#VM9'^-PH:D[@B0P%/5SDLT$L-ME&
M&ML?5U:LNBU\$!@DJ1Q)"C\9L[T'[)>9>VY,R:&W0:G;(,-NT!0-HWP8IR+3
M: 8"F/4??SKL]9Q[[D<K%\W;]%DE<&&08^/TN@=O\\#S)B&_/TY4/,\CLFL_
M6C,5*(71\0S(%ZB@L@UGUJOQR$N]<6&TV]VWY&8!B8?",0":F ;=SLY_-C#H
M57G.X:8Y!S]%_RJC$*4XGM2)*/YP8K MPV>A29[!^0[*'#[/4?^'Y8(U8TT<
ME,]( :GU(CKULB5.$_R4S0Z5YRD0>&%<272!5:Q9ATO#$MU*DRPMQQ-Q^="V
M1HG\@_TKR#42'><MPS3H=S#$4@>#/R=G2?&D6O1TK,?BY(#Q\+J1+:;%J*KA
M\J7).,7OXZ@"QI>20@5J'0C&E5T3:\76CXD/-?%PTDO!3#C<:W=\S9OT-]HV
M_ .IXQ+."#34=O [&L^S-&.O)!(+V;]X'#FHAO2J7[J[!Y[A05[!RJ-P4@-C
M#^/S>QW/O%=%\US)RP7O1GH@_=P.1ZP3!^J! :&6K/8N1[>NMQ8V'ZT267<\
M1\N!G&=X5SW1*E(T0:\H[#I\S<J\N?%TC&"Z1'";X$G8<1P!9'>$!@D>+1T\
MB:8;>$"._D+TH: UDZ)3 L5<HL>JXF2U=@7[9DW,!3_Y^/[8RE"-7ESQ#:)"
MD&FZ@SP*CO=9S8-^U] #4I6^CMCOM)1@X6K',0R-SHV@9'>JUH7/W0BM-K8<
M/V%;2%2A;L]H0J,T!E//F&=1GI?$;6@A(.G_7ZG@3J!W_8*NQW,A-TL3O+4B
M*HPWR48GR)-K=R@J]#0GKHJJ1*+)5C1G'N)@"\[?QDU\<_]-E CM#B:=O>DW
M;RM_A,&*I'BSTSVD8/B3*5[[CZWFWC"%ZG9U=]M[N!?LUQ5OB!6%OO_3T /1
M@#CWZ6Z=?GG/OT&'?@L#+WDTB.>>[E ;)F8> \/ %XJLCF4NU"U1/"51Q.HJ
M+]'3A9YHR_1!]!>QL 7DG2RMKUA>H=N+&#">+FPR1E9!?(/%!Z0!#[L?(.F@
MFD9/X/= #>R<HIB8_+8=G(*:(%#C((L*8,=!":27%0J#HR-\\55:QNB?"W"&
M,#?VT-<"DRSA2O1>Y65&U$LMA$,,49+OJH19B?+W%@EZ2WQ/RY&JYV=]OJCS
M7*;Q)2D#0@<2<I[JZ4!SC%D",V*]!X56TV<BI\F]K-#M\&^,[J V1QKVG!ES
MF*&=IV!':.6P=8PF-HT\]NYNLZ^?+VI"L&SDW,B3C69W!YGNVX_T> D*6C2=
M*;;V/GA:X'NG!8;L8,&<!I6!WIJU@V-T5;+AIUEVX.N4N%Z,P6 C_ I#[!%L
M.+RDG(4V/V)8B-),IB;AP;:D,C0W6J;)HKAR6C,S'6 6 ^9LJ$0CUT%UDS1,
M%5?=71QYG ?4JSPLGTVHS<9%GL%%.DO(< Q,:(A.G+S^Y)K$JT1+#8YMK F5
M7" 3N!ICUH^ 3'Y5\Q'PGZ\ZNXR&2#>?/IVW@I=/[,QL/CZ>ZQIX'5\%&,,;
M(?<09B+;:-QOSNV*^QF\1.:QQEM:(Y1UV&'#$V6"HY+4[,W8R&^@G>5JZ"-?
M/BFQIL@J0*CUF%.L\2Z>@!Z-XO$]7*NUV#K2-5C+#M$G0]Y7!29$@ME]N1Z6
M9%#:P'Z4$&L8PU6B-#A@MB7GC_VRY]R6ZWL "Q+R*7>?DP;LE#A?0>=,ST[T
M[:WQ?GXV*1;K0M%HCTK")^J$:DXJ8<I.6+?5_[*:L(F&X/>5U2S+15D8RR2G
MT%V2%W(2RN*8ST Q0YIM%*N@9N=I S=Q_@'8QE#':@[?AIFZ\OC*^E+X^_?!
MMT_K0-DFDH"F-&=+#J5O51@,R@)(#O<T,<ZYN>'5S*'1[T,./73A!+_T;'(G
MQ1_"**0GZ%3*F9 X+5T2O=%A4Z"].8O84;^1X;=OE! O_"$C <:9F^(1P^C)
M(,TR<IVC'RO46>VV U?1_\+\"7C\T^F[LXO@95X._BGY^BH8Q6E*_O5N>^_/
MKX)97&)XC/<$/]YO'^S]&?/FX65).05^-9)QR'&F+E44XW0X]DJ7@PS9H<JR
MN9N\*NA[N'NPBMQF<)]GL%W!!7S&O_^H0THN_PA+R>ESGE&G[4^";>L>?-;B
MK_&GM2EO['F;=212#N&?/AXF3#/"XT?G"CHF,-8-]/T6O00<1LGO$OO8NA;_
MN&NQ=D?0BTR7D +7F'C["2LTP )%BH[2X*67!2I<LE%"O<(#YRN#UQJ^ZK4[
MUZWMZ?[@T[W3X<*1Q>@QM>=%TJYRBG!S+4_NXHG")]M#_<&'VKGWH>*1;:1X
M.6Y.C[EQY9@:WF_O7[>#X\*F+K  7I8NTZJI(*@*1.A&3VKB#'Y]V.[?(*JW
M^=N4OWVP/'][8S.QU^IBG&(B4H 1'-),03:K,BZJU1IS7TX[XK;"&ICX<%AF
M%/CQ+<@^<AI1ZC#(A J\2WRI7@@VPREP7)\,_I:\6W 18_A-0A<@GMN0P53-
M03D4O7Z((22CD+<DU0(]>9S'1$4Q'&8JB[Q0')*SSH.6;V;,; 4-_CF-C/JM
MAL.LY-B&^"^F4QU&5/F\D=RQZMS"U',58:ZY3<(>IG FBK.7S'YZI<<MU-D5
MI8LBYBY%"0>*XHF8.@:#46BYDNYT;TW]H+>"V$?=8"OV24OJL=C_K*ZC*<C[
MI>(.+AQH"-<5-YLXWP*)7/N^3I!UIFZ*+#&^V+NH]5&1 W%B&P>/HY$-=>/%
MS%N5)*@!)LK%6&E?<)FE\OQ^1$EWN5=;<GD <HD2(A>7U+_<=&L0":\XH[GC
M"I-1-. 9Q#L%S7V1N0"ST(081QD3P$J#Y3G8'O.Y:S+VYC-HQ)R(1E06C0D4
M7!9I197<,J_R$D$8@ -G<S2_8"[ H--L7I'Q4=U5[@EWS@DSKC,6HZI!./JB
M4^5-B:ON-ZVMS^;)#, S,L,'&O.:)/<H0S]EDD2$IH%T(L@B7A#T<>7UDY[2
MT4&GMTZGM$O2")'VO^N=JTG*JBCKG]9[XGS*Z,.^]^ET.X=K?SS[NVMX/'M_
M=ES-1!X'*J9L6&1S4=BZ8^;K]EP>XERZG=X-)T,Q$VNW<?XAB3=*!1UHG5CK
MSJ9I.D%'L@P]ETOJ6WQ^>6^%=2O5[B75.+%U97%&KNFT+@ESC264MXK"X"82
MX\N_/?ZG.O[5SK#Y_(M)E*UP_-WM\:_M\:]XA)T'/<*U,A2;<GTDH3^W91ZV
MWM2Y]LCOFON.UR&L!>8$>XA^' ^.RY0I%/.91$1L*@JY@C,M59[.H9M7W,M>
M(H9["3IY \* 15=RS45+7B,OS^,DTV%4!!_=I- -/- HOW6,-:KH21+O$P)R
M9+D4S59*.#"Q*4KP8<[QL^:Q9ZPRJA'MHW5:B<%L?=7*H#-QC7R1I;&!.8M,
MDCL54@W@55A-W+)'4842PK8"J4 :2G$XU_WGE. Y5#D8 ,6<W[R1-/I.P\P2
MW!4+?#"*\B$LF0I>Q=?X7@^I!,DK7I;".-]QR(?$A+= + ."\Q*ZG.D,0UGH
M[\2"F>LA!C4M@NWJB0DMC)@266.& B%"PHFVW%J\%X6:R8O=X6XN#3[88@(:
M*:(Z/1L@QZ\P$(S_#A%<"-(9_4+GF1YI0O[[BOA6Z[K4V^M=7!([T26&AS%;
MK]NI>"&QI&R5?2"HV>!2Q:5&^+E.ITL1^GR"]+Z^&9=V:4N.]4F3,"E)L%H;
M\^'WX%<-W',RQ'T]5UF1&%1=6_Y(Z7=<[DBASUOJ:1"/Y3(*@2=C0')M3^I7
MX"Q/FO6=R;D@Z$P<,S;%^N]8M@[(4J^"69EA]HGDK7[%6@]6><X%'+!66@=:
M40Q*".62!KW@5P8+=-':3^WS=FO%V]$2))I[WI!6P.%@ES%CZP37FK'=L,7K
M0!(M3H+U"WP,4"0:-*Q\^])H;;6*6\V994*&H3(5AIS_#*;#M.3$J(#XL<8*
M#YOC9A/CO9@V"'#WI/CW1/6L5?4(; X\A/GA^[>_SL6_V\%[^5J04?4P)CA8
M20K/T;?OP?:(RC!($>P8[26#]>X-1 JH&:A%P]).& 11&1JG!"-H!9JJ">-;
M)=1.FFL.3"!Q*.M"3ZC1T45EC55>!%4_J)<G$*IY=9,;WD[X$W&D2T(X8P@F
MY68BTR=MJI+0P_Y8?HUY.+UB]9\4I ES:K=%QI#/_17)MB $KN):>SL:)2#A
M?:+I^@=*B/D69X,JT7&_/5-C(RVP#[A.5B[A+)9=,!]S &/,QC%.YGY"-!=Z
M1)FCW6L57*K[1EI&8SO%%>*5E6@U9@"8 V&07..,8:E+S\EP!'SE6%J_?;A'
M5\V,BZL@/)3>WE'[8+?R>>Y.]=;5.OJ];:WL*'B875,E^CZHW4T\-QN8\^XM
MW[G;G5T6:2ND A-;ZD7WG%'%O,$G"+.0J9 94Z^#SK$LF*:9C=POG,7+Z!5M
M+HCQM"0/2+]#"6 @.8DOXGATRXAMPN)?1A$5 )/M;+("W+C;5-A;4F$/MZFP
MC[O#IX2 1![&<>H<>DRE[- S6"44+?2X%R>6&@4L1[ 25,_BV-P?^/]DQ_=0
M"7^ZB2'A]9+&*%YY8"4!@ 'X&-5G1C_7E*/NN5<I@DD^U2J/M?]<^OX&M$^Z
MNPN.3JJ,@ZT)4RI-M$#H]+2W+S2-ULKO7[;3+[NOC _0)?6:=R"3K&Q]E/W8
MS<>WO^R],KQ<IG#[&RMRXP:9T20;J'D1]:B0UP&_1ZV&4W(1EXMG28HI$?A&
MJBV_>PT!K"9-K3W0$("#IP-S.R4]"%9QP 5YA&=GQ&9%;[<Z)%?OXMOYC4NR
M$QG>N]8/:]?UP]K4O?]#T*>/!SJ*8Z%/@CM<Q(B''#8VUZDT9R)RF0";T(2Z
MSC=-7!QD]^=E1CT,+5*L758F&.1L%*"MHC)D=X@L(*RAH=]4 S8J[M9Q.89S
M%0*Z&^;NV@< 2.6^<!TL[K*N=<54>.^:C6#(1B]"_@<5I&@GFD(X^H-69W??
M"(.<XJ0AP60-P."=SN)TKKD%0 ZDEH_F]7X?%6PT"KD:,F?([P)T<[R-)!=,
M_S:JW"NHE5KA\( 8F,W "=0DJ!-7"R:<H>/;5L]6$M@K; B%'@#-J"PHTNLH
M@WP:Y)HD)A!J1#GE!>($<F.@H6Z#Z1TI7"D:%,CD.[;W,4T"J*Y@C-P:0[@^
M[F[+ V,=IMDL):N_(A\9X1DO=)3 :&0YY65.<X%5HY\&EALEI7.VY;YA]EPN
M[@FM<@S:S/-H /45"/5+6A#O%:]$F2A0M4API9A4D_-?KGS)E2?8?HJ$$(YN
M\>"T%9S"9T$W0(4J:I+H*W9YZ'4WK<O#V6BT\TX29;Y.4$ ?9QD:!+1%FZC:
M?*O5DB18"S7:,=E .2U2>8N\"UK^JG2PNVET<*'1'1(<#X?(UI')GV? F$MI
M5'E_OO'$;7P8.9_EZ9 ;9M@5SBHK!.%@&$O/*'[WXRM2<0E?_V%^<K!I=$2,
MM-]&Q%N$G.:@"HIJ^" V_W[/K8X(<TT-T.'XF07_192OFD2R5CSGG8G$H#"*
M%3:+&QEE!HR)[XCK)UUWHP34NE(0S3PGQK*.'V(D>[E'QNF;<;N[!$MRX4LD
M0O^5^GI&6QQ8SWTCW1IG:LL:0J@FN@;3QG$RPMHN8976YWM_RNYW-I*R=]O!
M"7O)V,@\QV2_$ EY797%&]?T 7.4;'MJ=RW_X"+7ZFYZ"0RF=#TGI$T&)7!K
M'OIKGMDUUW,)+TKLU-3MJYWNWDO-2)[=O5#^Y3):O:2##]?B9#UF4=0]ZN^2
M^T)-]0+\K/^PRP\(-7:7XS"I3OA>(Q_PVW[72K!=0SDP1TOI4SWCAMJ"U#V*
M8O)PYN5@&A7>Y"LSCJ@[;IJ%&*"FC4$0<C2FIMBB_=^::Z-<3R1I>E*PQ:@E
M])K;2E>;D_GUP\G_@<%I1\GQ VLQ*2HX14[,])8851UXW-5J.BT3!,/GE3ML
M>]\'BQSPY,,9]S+[>$9(!@J+?=@"AEEB!@%,+R>NATD86<CN(=E41RD;Z?$[
M1E@0_[8[[0C;I&+ZK"GQ)5)C^]K( >,[6.&ZH$R"GU'C@= CJ;R<(1:X[0_H
M,FS!!F/'H_>BE4Z12LJ5U\B:LMC=,EOU'TCW)1LZ775)6AIXN#Y,BPE07;AS
MU'^>0DR2764E\Y56WW&3-=U#*EE+J%B>WAA@"UE/*/--HB[UQ'SR818-^-J0
M&#HZ;AEVL813FS:&LIV4H+6D@^$V+NO'98^>85QVO92.$VF-BL1L[L&)?P]<
MM] +<P\VD>/^1JRO(DDKND-8T1W"5RV_+4M4;2LE/$VW;F&;KOI)7YO4C70T
MBH:4S19ZWSMF(]^W3!#%',[*3$IX*5<*A::!-^7I2"6(R5BC!PU/!(&KB)^B
M_H!!7G(BJSS%F-$\B*/O*).+=/$'+6E7M.+\2$RXYBG".!LZV#*YH1VW0)AG
M2PC3:Q=K.?.+)3SY184;VZ:R7'& I8"L&Y4)^KA#;B;:)$! %8/19BD;CGZ'
M89BH"Y!16Y@TD8JFA=VJ0H*)0E9?]PY^,.;JJX\9J*M7:?8]>-GK=/NO3)6$
M (J=""@RIV7-T-HD.CC+QBJ)_NT:S%#)#!QT""R3?\5-@TD)?G%R]O4L&)E7
MO7@EDK9>/]2IA$-4OM@^68[Y0O82WW >*]8]OA:J**V,9!U%GI=3?+/,!/(.
M'-]2/\JBTA':NTUWHEASAT@32A%4C9U73=>)W -/<*<VTN ]3?!\,)<]FD:%
ML$X^R0]U7;A^%S;2^OW6I.533'">(Z4W<8:E5!GE?BI29/8RMGN9UQM;V>0A
M>,\_RW#,LBT1&X,4W A[5U%#+OR7C<M+VRG1Y66X)0JZL1C1N^:U_-(X,2P&
M#:84ZZ-FRM(K2Q,@U1"M6A@<2U?NNRE#Q,%-L \M9V6Z^P;2FKO^L3:,NKQI
ML,>V.SK;:#OA;"1A NSVJ2YJS?U@Y']RWI8]OJHM5SUA6+K$9(WAC6Q@(8DL
M_\[3L)O*%;?4FPO6&6)V%.6..ZO&L3,_1)MF+A$UU%A7P5EVMANUTUG2.!I2
MQ7'FVU?X8G)P1A3&I;@M'H!4JI@H+;*M-(F*-),:Y3$FN3;R+?)4)AH]%0*4
M10D\H/Z8Y/#4:_[=HDR@*T2M2^C$<N=@81?$% ]7W/OFG/(2%:=(<R&/.7W3
M?<&9BG>X7PD;DEB=73G !_$X-!D.CS+2UI+$6>YVEEN2=W&4]U]LO/UY<S;!
M#SJE9H7@_/CB6W!Z2MI?%]2ZLV^_?K@(3K]\/+OX?/SM].S+(R1,++L^JU+$
M_D:&3KKMX),> [\[9X $;/2QYCKD[0D&A.50D%J41V!F4&HJUW!E9(.!9$C*
MJ<Y2D O#6$53UEUL V',-136CP)RH5L]/F/$5"7YD;/21[;#)S9^U>85W+5W
M@,%%ZF4J=6&<Q&5["Z=E,911.)^,IR1"$+$W<O%CFA(WQ C!S"BT>'QH:,]%
MSV'T6XHJ1Z-'.Q^FDQ#C%32?-V3=X5- +FIMYA),,CWZZXL_W7[?#T  8%8"
M1X:[O:KG%UN#DXE2;6-;R?EJ_>6U^MLM)_(CRES_6%:%;6+KTK9X2YB[\-\2
M ^!_+';=E<M"@YFD09.E@7X,F_;_!P+;1YO)G8_;E'V!"#Q8H;JJ>;^2L3M0
MP^]C2K_>D46-Z#]O?UCP*R>&;!@J3 5NA_::(=.GN/P1+[\.2>Q"M2/*'E_\
M!2?%AA1:N@*F#^-6OHZ<0<?W(,W]$&W%!^4?A.=OJB8K'C=[$Q\T./G$!W<3
M+_]=VR.I -%7=KV)Z3TY,2X'=UWC).(S9V2+S-?7,#$;S?4SALH"D[#I6'YK
M?VUS)I(M[H+C0>L\3X?LX29KN3ITKDQ"@!OV!H?C?>W4M=$H?V<D+,(%H9;R
M@L3OMGAA3REZP37WXS@=8!C'\[.CB LC=$\0/!LE8:"$+6WZ/O=S!V.\'>#1
M>EXSXRBS6B>"A*0@(<>)Y)?EE(8A;F84FU,JTV//?@ZW4@X9$TS44!OO-\W;
M'6BE?J=,HG^5.,=<%!@[>\&GFYKU5BG%IX\+>JGU2KH(UL*S%1"]>N/R&>A:
MHC6'6,RLJ6J#:J%AB@GU,C=(S7:6%$#1J 4/S20)%@=U,_0[@1H]MUAXS5<
M-^^C[/-)FF7EK !3"55^A#[ Z"$9#BD& %"M!_L_&NALCK:$YVQKU2:5#E"!
MES)$/2NH'@O>,AV@B2& [Q'-VKC%8,)( 7EEJ$$9Q:&AGJFC/L:TD"N+Z]<&
MIL^X>T#_,ON%YRMY&EFX@R(983NPSF50LMBUCER0O)PL96A/< CGV$J3(ZJH
MO4G>4%SB7@LA',/IMH088\X^S2?1S,#I^TN$3<G2/*]1R@!SG;(JA9+[TA35
MB'N3@FO6&<T#4AE8C9W!&XELJJ#[P'WX"O+-D/PG6NL8780)3ACK4]'+27YR
M#$[*Y35_,MQB;LIDF+K%P/2<\1PWQDQ;YZQO2:87C74< FO DV#^<5$;CN8
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MS)O#F'/SN$/UO?F:REVT(JCZ6M/;U8/1;1AGD^-$G+Y5D7IRET3F")V1-ME
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M3SL55^9=KT:-59F X5D[>QQY.L,6C'5L#\1*!,XD9^/_Z#D+F3,?0$4*X"J
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M*_<9>Q_EPSC%+G'/X?)\X9Y @D!R?P:YU]W(L]UK!V=TI4Y=C>!MI[I.9TA
MB<@ 'QE#B$9L0D=KGM%YEE[/@V-JXM->NT;J-,6SA-)P>@>^A""M!34+Q*JR
M?:X0_! A6PD%1!#:ZH6B[^:QNLI]C![J@D'[P,V,+/XJM92D%G0:B(>Z/^;^
M>VL5HO@V?S_Y5:]@M"JZ$..(>. A.;>N+B9F%#='HW=QF\CT*@F2= HO%)S7
M,$(L$8+^:5PL+\O!3BKL[>)FX:$2T;"FMSS-(559V$P2/^KDC_WM)H1<H,,9
MM:6>X>;T.K7S("%;^XW_3_H]@IT$!%G:>6S(TJ67<1&J$-?[P5"91]U/N?^T
M2=VWKQQZT51%"38A1H2:E!K"8RL+1OF:DRY_E<!)3"(Z)?A1K%5>!/T_&X4L
MRO.2^PU5=#.K\/F-VPD-Q0S!V%+<VD[*K.>@2'JP<3-0TJ)"=#%#SO0F<XF8
M:I2'C.=U2O(8@+MC*UXKG&E$*$ )=K)'7"PQ;"KT*0PG=$TPFT[<( 4N3.=E
M_LH95W4>(OM;X3_'AA?FW'AZJJZC:3F]==5V>N98[![[0-1F5V&/<.WU/;FR
MR$?Z&I$G:$ #APRO?AF]HM;G+WNO\)J^C.#?(.[-0@QG8XPT1&_2!F4_1GH(
M%;4L9$ZMS'DSX)U,EI&RD2!>DOQ"I1LYJ B&1*,]4"![CDV#[%?MX(." 1O/
M)=?Z.]G%;NVJ<0=7)9O&;352R;3[]C$1JB+-H^.ETJ<MD N9YK85>3F=(NIP
M$[G0#Q"RR*'VR=DBV$^&*O4 P:O 9"($89G-J(RQ[^RU-;I$>LG19/ $=1T&
M]O'A>A(-(N '[1[_.B+' XB^!T3"6%4/WKU=#[XS,,T3H1(!@Q_NP#RQ"<0;
M.>*W:PQ5M/<LNF3=?=?7P([:;YM;>$^C>&_9DGXPT,A1^W"O?Q^@$?CAX?)O
M[PM;T6MW=Q\>O>1PK[UW</B0L!7K5C:^0*J(YD"3"_4P952X-U1>SY -0KQT
M/[^0S/YAY?6F[<)F;-1[G0^S:%;QD]PKG6,PTKLWIW,T$]#3)73TV\OS5N^P
MTGN%G6[?K>7)+VL&549[>:$)?SD,CG'"@C1WF@#%S83H\(//T6<=7@=_9_L:
MOFZ#E1VF,_SA9Y6!'KAKO#<,2XK@C_S%'G\1O+S%TAV-'FV5-UVCOZA&<:^9
M#;U]\@D&8 J/0-LLBEG^YO7KJZNK-LRS/4XO7Q_#]L(^YZ]U.%;9:VPZ];K;
M/]CO]X]>PWSESUX7)]_MOM;7_6XFIZWDL-,1=BMK3PK@;Y$]='8250P!I]EW
MC5UP01"%F4H*:P!]Q.97W<[.?XI)P!1P:%+-U=^>R-M!E/ZJ!3,?:W(RDX?,
MI_ACWZUX^YWPR9SC6ULJ7P,J/]Q[K? 8.GN]@\.=[TCQV U0Y3DPV >C<B+D
M[8;*AIX(PO!V5_Q=N2"O!WJPB"<>[FRWQ]\>(R"VN^+O"I=H=;:;XF_*FB@/
MY+7?:@S/F0"!^GKD<E>Q1'CNI#+\I-=VV:[UMOM1V8\;%$JC0BTH#49,BF!8
M$U98B^4\5A'1^GF=>O?R.CU@LO.S\3I)"'&99RGG-!]))#!."_P<!2_C.AYM
MY><3<;[N4;_;V^MUN[W^_N'1Z["[>]3I]T-4WA[4D\15$, %^0]FA< <F0!Z
MW35AAPMN):L8?DG;0?>6/#7?7>J2X+94_;3RO%^1YUU*[. <D,&B'^EG4G1N
MWYAPNQW^=@C_VVZ*ORD5:;#=F@I?\63C=F?\G;&:PG9;*MN">M-V2_PM$1UK
MNRG^IOQ<<:O;]^,&I\O':+M5_E;%>JO4594ZWX/_Y ;H@_CC-B\+K-MI=__T
M,^6!;6W^FZZ]ONYVND.5Q7F:J"P=C>!K70#%\I7]0! &Y)8YP^^"3_1E,-#%
M%?:%]NLNT.EXKO';S^W@A(=<[I4$R5$I<6_[#.'G<I'#E>S=[TINJ)-\>R5O
MNY(]K&Y*1Z;<*\N5NE)R)TGA2D?!>U/E>N%@0@BP(?@M 6OX&'X0!L?C3%,M
M7/#RVWRF@]-@)SB%K[%+^=_1!FH%'[%2Z7@*-%&\>K!;N)&"L;\5C-M;Z-W"
M_J/=PH9K>)ZEP05HV ]^%3=2(.YN!>+V*GI7<??QKB+>Q6,N4:>K^#,+P7ZW
MW0VV4G![]>S5H_GTN]T=<N[L]SOB!\0C&,$AF%JGDTFD1\&':STL*2Y_1N $
MV5.[>; ;<5XJSC?]BCD#,-U^IV>J\K^J;* 2G>^<7<<::_ZI7K_7Z?1^UGRM
M;KMW3PZP%;[/F0/T5N, 'Z-$)9C&N>4 FZH#]+8ZP)8#+'* WK/2 8XZ^UL=
M8#D'V.H 6PZPR &>E0[PXSC YND W4ZW??KEZUJK 4N 9YYNT_[KW<6GX#1!
M^,:A#MZGPQ+]3'\,9F;SA >2SM>37]=:?JPGZ7Q3UVF23N>@014ZR9%'?1U.
M]%0]$"UM)ALZ.?ZT94,/04LGTC8 __X4)=\'*O^YN=3[#Q^W7.HA*.L]HGU'
MCT%8F\FR/AV_V[*LAR"L3VJ@XRVS0IHZO_BP958/05/GF<[A?%>6@ZNWM/KA
M:*_]PW9W[^!>:*^'[:/.:G"O<K_, [+'?5YN,_E4FHOU'J=]V/IA[^YUN^V]
M#N]+\W$T];\4G-P] FF^ 0SWGE_N'G97'[GYJ+N[-YSUQK2S_;]W ,3=!/9V
MFH3H=X,!50"#J3$GM6#_"?0A8O, [*X"3$\5:38/@,03_%!EF4KXX28Q^BS/
M?A6YN4EG_Y$P';#O&D(G_!&1=6\<_P<8:=6.! >K=218WMWJ!Z'Z-\/+?SW]
M^Y?C;[]=?/AZ[VYK3]2/8%D#\'//E[ZLX8IKT B:UW""',=XU;M'_=V6_-
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M-]Q?WM[P]2 -Y_ _DV(:_^U_ 5!+ P04    " #&B0-3#FCK>_P0  !9KP
M$0   &UD>&<M,C R,3 V,S N>'-D[5UM=Z,XLOX^OX+K+[OWG'4';/+69])[
M',?>SKWI)!N[I^=^VB.#L'4;(X\DTO'^^BT)\!M&",?989;,Z3/!H*I2U5.4
MJH0$/__U91Y:SYAQ0J.KEO/!;EDX\JA/HNE5Z^MXV+YH_?733S_]_%_M]J_7
M3W?6#?7B.8Z$U6<8">Q;/XB86=]\S+]; :-SZQMEW\DS:K<_*:(^72P9F<Z$
MU;$[SNY5]K'3=2]\^]QO.P$^;[O!Q6E[8E^@MG_NG;L3W.E, OLOTX_!!+NN
MWPG:V/-QV_4NN^V+<]]MV^<>LCU_,K&[EXKI"__(O1F>(PL4B_C'%W[5F@FQ
M^'AR\N/'CP\_NA\HFYYT;-LY^?7+W4@U;:5M0Q)]WVK],F%AUKY[(B]/$,=9
M\[G_,ETUGY,Y]E\^>'1^(A6US[IVUDYR(1J^).("1=Z*KR]86RP7F.^G@<LG
M\K*48[=MI]UQ6A82@I%)+/"0LOD-#E <BJM6'/T6HY $!/L :X@E<%L--BX+
MQ*98W*,YY@OD8:UBGWZR+&EI,E]0)JPH1Q0@/E&=Y4PH,MG/+O0SP>:.>D@H
MAY/M.1 H[7)4)S@47/YJKWE\>.%^Z\2\!S%O3Q%:'-"+3<JD)^F9ZKW9<#WG
M\O+RY$7ZTOY^['41U;XM#]M.IYK8(E\SEPV_VAG=,?JPOH^J]2&C>V4?]MX_
M11Y11JE^<\-N*$8<>Q^F]/G$QT1Y5HDW[C:7!\K_MF6B**)"T<LSZ;G%@D0!
M34[ *6F_CYD1GW"0A:=<V-OCJ>K/1\0\1L,2MSY9,+K 3!#,-T.F8C!C.+AJ
MR<#9SH+)/T(T^0 ]R9KD!&Q[@KQ\ B0XO%MKDM%*,*Y:'  (<6*;.BN^8+BJ
MXD#"(88KH/_P^GLHK*H_D'AQ^)^AOH^#JNH#"8G( =I+ZC%<MXA_U>I3R/=:
MECSW]>EVWT"OA"7-,CX9IW47/MF01,$_J[U."MN6HOKY9+?M#I>88_\A^J2.
M=WTZ)4Z;: AWG,&8;MN*>\G2DYG9=,9\N+\9W(\&-W P>KB[O>F-!S?7O;O>
M?7\P^CP8C$<&EB[GH8'!43!TP/8C,"+.<,AX6IM,K92KE;!]QVG#QH^(@7HS
M+ AT^!B@;3/4(RCO\4,0M/Z\)>6_FX[H: S__S*X'X\>A@^/@Z?>^!:N'HAF
M 3,]DEW;=LV07+.W'H;66L [AFNSC\8/_?_]_'!W,W@:W0R&M_W;\1' W,=5
MCZIKVZ>'H+HIZ4]6*NL=X#44_=[H\_#NX=LQ[M$U+SV8I[9]=@B8DK^E!#0(
MP7LD8H9I<!US$F'.RW'*46C0@%S8<9(<DG OI!PHX4?"PJ*!E3%IL,5OL$ D
M/,#P&:'._JX-_PSL;_TYY=:D%&-$IA$)(+&*1,_S:!P)$DT?:4@\*/+*\="3
MZ^^*KJ-2^BU4-OA9:X96QO$=F,0.1P+("*B.[7;RMT\)4)"TIT?O-U-J".W%
M,9J$KX;31((.Z:Y]VJV.=*DG))+?_2 UR#UB#/KWC(T'O6KL]$/AF5LYZ*K!
M,A7R/D;NVK_'.>0.,L>FP1-^QE&,X\C'K#?JG]EGQ\'83(8>^'-73;]4!'XM
M669*J6Q+";= N@7B&^D2M]&S1(,MRY%=-]6G0Q=.'J 5;1--:SHF[A+HA[C+
M;CX KC@T<;!:*6\<JW(4VLCCV*Z:+BRR> .CQV/R&&V)(G_P6TP6,KZ6FWTO
ME3:FP']YTV=L+.!CK1@UW/JFL49#JPT[#D2>7'3?CT038] ^LX[B^1RQ)0WV
M732.50=SUL>TKJLFRTW@A#0KD2<SJ"+(WX-@:GS0R2.J9X.7!8ZX>954D9\>
M7]=5\^=F^&Y*L5(QC83T%GH>30E$+UDW"*-48H="/YZ=.OG;;LW"2G@TV.#F
M*?->.OT0=M;=E\?M&+^)H]>N-7N>(,]$+-.X7R&O-N*CCUQ0YY^7HP25?<I\
M-3J]!RRP^)PR0?YYT/A3@9<>P0O7OC!"<$/ ^["S8?D!%V0N=VX,8_F,;P\0
M 66[1 ?C_"II>D^X=.U+$T]8=<%*^K#?-: ;^^)U QVFYWDLQGYJ& /,=PFT
M64K'=O+)8\HA Z-)2<J.\4QSE/UDVA2EXW3S^>&NY9N8H>S8TCC6%=!IHU9'
M3OF5@]# L'-'H^D8R[UI$X/IOJW6^H#3=?(YGR2W)+TE&334RJ:Q9@^-/M"X
MW7R(W[9X$\/,EAGA[QU%D7&LT1'K \ZIZ^16+>R T4Z.)<_&AYZU<2?BEO-8
M;GKL4UXA!:[$38_=F>OD'L=IL%,G,C&6DO..9XK -0JE55X'XRX3/7KGKI-[
MJJ%!+V/^#EEJ;2C',"@EJLXU5."E!_#"=7)S>AH ,QF-GF[89_PO<C4Q$>9S
M?29,]-!=NDZNUM% ES%O/&2/:.G-L/?]D5&!/2D CJ8,'9ZM&''4@MFU7:<L
MGVQ;F1QK+<A*)34WL[G'XHYR_HA9G\[G-!K-$,,&&PGVDFG+K*[CY"=F@8\E
M&5G R4I868I7TR$P+;UTQ-H:K-OIYJO>0CB:6([M->TUXL3;>\5\$\YA?/41
ML.LZ%=!L6TJ>#N_W6)B:GX2QP/X;0&["60^ZZSKF$54U5!+?8=^"7:Y%$08K
MD=-V^D'NU,D_<TH(&V?1Y/^F ]D>&OWX==;-IQ,)>?:G@6-6HGGU/3(%=/KP
M<^XZ!;[>^#TOB1GZ,Q1-,2?1"#."^?4CPP%F#/LC0;WO%<$Q8Z9'[,+MY)XM
MK1!+!5@$!@,EPKJV5D(L):7!6#YA+ACQ1&KOW@_$?/.Y0@,>>N0NW4YNDGZ%
MW)IO"E/"N<%H*3/<1A[H 2'H,4115:PT'+1(N;;;R4W)KY!*X%FQM13?1N($
M-J!S4/O%;,'ENK$V_W+EGHW\FA]);2GR9EJXPNJL'(W>VSMN9\^VN[6]&^G;
MHWBQ2-ZEB\*U96C01WPV#.D/%/GW-)*_Y$8N+G>-PJDAB5#DP7&ZMM3L!05'
M$Z6_K[I._B'QINS-*S2PI$!+RE>K_:$';75FU0=U>M4+:]V-=R^I#IWQVP^.
M+%!;G[EN-U\)OX7'-+',.QJ2YAOLCRU1/ZR<PL#R[W&>!@Y/?1H)ACP1HU!.
M_A$A;<K!1/("V ='9B_',>2C'UC.G/P*E@W&U@9GA>(6[W?0=HQ=?>;G0+[Z
MV_?<[>0>KAN#VOC)H_0](>7890WU=]B%DU]EE%(VSZBFN=)V<WVF<]G-UYS9
MNUX:F)RDJJ^VB:>_)\M'1OW8$[*A<7BJPDP;DTYMMY-;(Y*AM+7)/#LY65JI
M$$OIUN!0E#=_/^8"BGQV'##W<=.CZ;B=W//N,C0S*<V%<Q1/./XM!@4&\@4R
M1GG_#H5VK#GM./D%D6L65L+C/]/@/Y]L?U$E^;WUU17YS97T(TL*#OFYAW^H
ME=\1%TQ](.&1X05:JB,<H5 LD5P9X*EWEZEKQ']D!/*D!0K3"RT+3;A*K:Y:
M 0KE-R7DEV6N6D?@')$PE /850NXR(]5R"]5?5Q@1J@_5I^3\&.F]&M9'' 6
M1,3RU]\8C1=7K:0Y$7C>LI*O3ZP^72692!FW<%%R6G^I)F>A,9;?RX'[.9E&
MOXT\AA&'?!$DXQNHY'P,I296;Z0M-$8U)N5Z)]\[$MFE2;(V^ZH%;'TB#*V1
MG)G3"$(16U8W!>3-Z9?9 #H/ VSI^CTS(Q22ORWL2HB!LI_1$FY%N32S-V48
M)V\D"=$2^S<,_5@M^\7SB?Q:R5KEI,^)QM5XO*'>/ITC$AEHG4Q3X#OPSG2W
MLU[#XO9UT":=@IDJ,?(Y9?I&=:CZG@ '(3\L5^"L)J155-RY47T\>;O[] &Z
M@&1)JV!YDI\WI$&< K2YO;Q0^PH<ZFJ$(2+L%Q3&^"%(YP8AX' (M"R%U,-0
MXOM#RAX6\L3@!88$PHO#U^$,7V&BMPWH/?CI8S\+1*L@I;_GRZCJ<.=O9Q]?
M(YE"]=$">6K@R>9_AABGR0::%@-_$*]:Y"YW> KI%*,>QO*+J26QO*AU'? <
MRWPI9LG""#6$\Y[__U!2S74Y: G5T15+SG EJ+*3;KD2-_3&7:*Z1F/Y)5L_
M#B%V;KYP34U/C?&+N X!H$*5S8C?T$U%)J6"IC3([:JMJ*X!AYKH7)C9CV=P
M)\QHZ(\9DC'E!BV+/;LBES>Z>TDD\!2SRK=OI0HWC'GZ5HUL5^8;EM,:8349
MI;(<\R'XFN68D7]'T(2$:G%\@4W*"6N;>97[^CJ9H($:OU25/&9D"MY)HQLH
M06BPIGO%75594BV\9ATE=S9/5XZR)?0UB;&C9--H]]319W'Y=G7(W]*TD@>,
MSK,1C08[OEF(E2%U79,?%9B>L" ,)SD;+ZNPB@GJ &8ZFHRP$.&J@[P?,Z8;
MP4JHZCKIV>\]#48]KP2QW59U@&FUY C2IH@C%1:,IO,*2.J@TY@*%,I-BQA&
M(QBQGJ2\XK%O?^LWRAP7L='$<L]_EG[K?Z-QY/>A5/PZE^F*)Y? ,/\&>O&,
M_9+X4(5%'6#3OF5!KZL1:1UTO(?^\6064'9E2-D(R9HU>_5X;^N#$04>6XU)
M;=/;QZ0XX0%EO<5">J;DKP+^(Z23&@,84-96Z_6^JB^$KYX8E(3<$J(Z>':V
M= &<3RV#)9BI9R!R<)B118F"IM1UT#3-4?HAB60TA1H(?-,PL2D@JFU>LUKU
MN)2[\>]CB<)# .6#?-40P;P?(JY>8PXX%>I>D<OO/F<#M>X"RU6@V4-W2 DP
M"J  _'N,&/P)E]F5-!+!$2A(H_^)(]RU.W:GI/XZIH0ZW!([599T=BRP/XG%
MUXAA#_(-[&<*&<_ME7&I:R4W" *9@SSC9)?9&+U(=&&\II UA\F\M%Q^))63
M[(H-<@"GNAJE<(:I)#DO(:L0.(^?I!?$-<C'8"3[C%$H9A[DW9"629]EE0.D
MAM'O'B.WIYIO<(#B4&239-)+#2>I]U+68NXP0R%=85N,7K[AVWBE.3CKYY>0
M567A @L*56X22:27]9X14;T4-'VMCTPRY5ROSE6/P?H/$J,VQV:#%0"&U+7P
M;4!E$2>K/A\"]:(M2+QS;WM2#\-[J;:%F?LAK-[JH;I@$$:-RO#(0WRVN><O
M>8G(:FY+%9.:"MR0OK9E:%]Q'R*91T@%2LJS@M9UR#US\UQC*)%C#%[X(&:8
M59PDVT]<"SV3"O()3R"B: +T3K.ZEI8[X3)9>".?VV _7LC)G*H/+74<WF9
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MEU,FX%%:4@A\RIS'APY#X<RBH):V"8]NQC0F/[D6&RI)H(6>>[G"@4K<*@9
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M(DB"*,I"70$$G)*4J/9 9<I:M$YXKT56L_8W*L-S#H:@Z1:EMIF2$!@C6<D
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M"QK#_SJ[< ?0YTW!H;2Y@XF=STW004513:_@U70^'U$AP6<)Q >1B332E/(
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M3"[FKV[J/AU+D@>CRYS+4K&+;D3@$4A,3.L R:I<IQ^M";K.L>GEY?2/4LF
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M(PM_GRSGD)[Z3SZBK7TZO;H:K^XH?@%P.P ''75QN(/S&("#3<0J2 2"YC0
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M\'$3I:H^*GBEM[&\R07F]:G;VQE<C9=7(\4L[IU,(K925$ZM)H'K3 SWF0=
MPUWI=L4'H9T'4_K50(5X=AO@^AB_[,=O9N,/X\GJ!\4&EM/\$J]+W,2)#HFB
M&32T.%R\N/!*6W QF&'8<A_*\R1.;WJI<+SZ/=:;6X9612"E/AW]<*H)11#E
M8B'$ELM7.:!-!$8AUSE2OP_5.7*D@]Q[O!#CGBUR!-9%"N7^,,M6M:^.> A
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M;/3ITJA&@6S]U:Y'+XPDL&"S#01DZ8#G&KTFEBV)'C(7AM)J#L502WQ$K\H
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M\?_^]/$K^R8>"<R614F63 ]09/]45+_\N&*DK#"_*!<X>X7^+]A>!O6OH!_
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M_[VN"QEYD8A\I%"D0NV'<>A!P@F#21(P[+.4>'%L\VU?)\[4N*#11N<K5OJ
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MF4B:)#PT.L_O&&-J9%N+"1HY9T!+JG $6E8SEN@"M)M>'<$T,*?V0LCXFS?
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MS<A3HZ^J@.-VAP?D*@<%J5W#3XW\=1G?5@.+."RK*>GFL4&!'IC(*K%W-GU
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M350_= 8:W=./+@ZZD]Z1_'.N8^T$KPYSVJ9:<Q8*)L((P9B%&**$*^,FT#Y
M9=H$U&.!+ZV8PW#<J9'(IMDTT^=A>5GU43IH/ V>2 Z>JZ-?%XWS3&?(HX%(
M C_1-: 81'$<P!3C&'HRYH&@TF/"LE7D ',T3O/("<^2V2HQ /(#+QC'_:B5
MT(J)0"UV$PJQZ8_H;BFQA,KIJF(Z]J@+C"4@AVN-[>W7%[Z;^S%)THAPF! /
M092&,50K"H8T#1A%?D2(Y]N4;]I]N-4",D+=)BT;J PKWE6&Z#)H9D32%XI1
MS<MA2L4-\L7O#?!JA=S.?;LGK^GAVMKF8KU\5'9_G;/\6;Y?Y8\B_S=!%N4W
MICC@+E\]9^J1Q9RQD(4Z/X)594MB+"$-U0Y3$!+0F$4!]XW2J7J-/C4;<9OB
M_6TCK+(^&FDM_$/6TV#@31L2W(%)8T=TH&7?)--_EJ"6'VP5 '=C &[AL!L2
M^)$<>JXGP,[YUQ? 3N>@]4/'<Q[VU7?/N=C[(?W,ND^BO"7%M^9Q_,W+SX5N
M//NABAW5+@N=EU$5"]V$KPLI9>3Q"!*$4[UMQ1#KG-P@Y$$2$1$C;!17U%^$
MJ:T?6OQ__*,?>W^1B]5O!=#O!<A:^0'9*/!/=N9CC\DQ,S*'A7S@544)#[3T
M+5]QG0CP@]9 8?XGL%$";+48)**_/XA.#=P>8HQJ!O>'Z=!8ON))/>N7K%;\
MMVRQ^/#X1+)<K]>:DN>4Q"+UO!2&B!*(?$X@E6D,64B)^CV2H:!6M4M.#C,U
MDFNEK)*':S$M:Y6<1M.,L:[':&!6:@6<@:V(E<WEL#I))P9N*Y.<'FK<JB2=
MZAY5).F^^HK&*INV=G5I@[E'69JR.("41QBB@%)(2$RAVDXGC&).,0VMFZP<
M##*UCW_;<V3;%;*6M$?WE4- NQG %4P#?_\]$.K7HN4,!->U:SE\Z/BM6\ZH
M=;*-R[EK^];U;9+.=8KY8E6L\VVJ;D2CA,F40X_JADHH8)!X7@)9Y D6A$$D
M R,WF<%84_OD=RHH;(4U,:2M03:S !Q!-S -]$:M1PW@BW@XK@1\?KR1ZP%?
M5/RX*O#E6_KD7FU3OLI56ZY"E"NU4:E'U";(S3/)U!WZ][>KQ\?5\JL^S-8I
M8=H?27TF?<HPY!3I)"T:PI1& >0I\Z(DDE3&TN0DS9$\4SM\JYNFD*U>-OE)
MU\].&%!/BA1!GD1JIR?53\13LQ-*S_=T U@1&I5B?HW9&<,JS/1&?,D+H(R=
M30C'[4X(Q]TFA*/28]S9,SA<&7=.!EY[=I0!Y6I3\DCH_]!.LV9M^D'K]">P
MT4K_N=8+["HV[ES9I R..F=CY1:.,W>6N8C.D.Y.6KQ^F!&S&YUALI\&Z>ZQ
M_79![[-E5HJ/V;-VJ9;JU=3\7:7<[-041FF2D%A;*R1$NC5!##$*/(A2$6'&
M(QE28;,=,AET:HM>+3.LA 9;J4$M]A6UG(UFP&ROY!K7@1<N%Y!:[Y]L,'*Z
MD3(:>-0=E0T4AULKJWM[AAYFA&:+^F!GR7<YKXYXG'/J8QEZ"8PIIXJ6O!#B
M4&K?+$\\@@GC*;$*1[PPX#1W28NMU+.N..H9(,OFQT:K?_QC&OC)7P 7,F.9
M;8SCI=DQHRR7F ],5SNB5E#6 CJ,B32$PFV<Y*5!QXV=-(3@*)[2]+Y^3%3U
MS- -&M>"[PS5E+Z>HS 0G(@(,AQ(B#PB(25"_13%(DZ]A(9VO>"ZAYN:851)
M:\<=%_ T8PYW* W,&W6CH492\'&7KAMAW7&(&2A.&>3"D*/RAYGZA^QA>%?/
M\HCU<^_RE11%D:V69*'[4C8/5VSU2:G6O/@1]K0IP]7N*E'[+,P9Q)+Z4":<
M(183B3S/JA^N^=A38Y6/XD'9-KJ(EV7K-AN\S8AF(!2']@HV?+,K=M7HUF$9
M0GM@W)8=M!A_W#*#]L <E17L\8A^!*4CC_6)F*Y8>+M6^X-'D;<LV';WF!.$
M?$8" 6-.=*=NA"%AJ0]9A"D*(Y$DPJA4ELV@4Z.D]HOZZ]UGW9;;DI>,8#8C
M)-?@#<Q$K;A5I5K0"CS;6$(O ]A!-A YY22C@4<E(QLH#EG(ZEX[^BGR<EZE
MJVKG]U<FEB3/5C??LV*>>"SV(IE"C$FDK" =<J=L'\@2%(8A%@1+H]/7LR-,
MC5A:V<"O6CI#]_%Y_+I)Q DJ S.&*2#&M'!1Z2X.4#?O?/_JOPZ__?-/'^5#
MOZA<^U5?OG"@1MG%N>ZD3<WZ=]]%SK)"%!^6=T+)=%B[OOW[79XQ,4^]A'D4
M!]"G2/$##T-(B)? A%/JQY1PBJULD7'%GQKYM,)Q)]4U1GX5S.REZ4[PT#QJ
MT$ZE,.VGL@$!J/>DAN%$9Y7V*E!A,6*7[$'F<-PNV6Y5F%:7[$&FQ[I+]C!2
M]$S!7>D CR=1BIN'7-3B->4EXR2FG"@+6 CU&J$X]B -N =%B-) ^&D<$ZL5
M[OQ04UN-E*2P$160C:R6Z;/G@35;+]S -3"W;X4$6RD=5J4W!\-M6NOYX<9-
M7[VH]E&:ZN4[^C98XE76"UG<D8Q_6-Z2IZPDZC66H1<2+X04B1 B7T80\Q1#
MCP4I2RE*";&*RCHSSM0H8BLF>%)R0F6-L%I2V_9'IV$U/!2X'JRA#P"V.&D1
MM=5V>P&G'HV(.E%PW&3H]%@C-Q#J5/BX.5#WY3WWV^NGIT5%,&2A,^/?+U:_
MO:M_L:T((6GB!8Q41<X394,@?:JH4*5>&"72CV/,D-4NV6#0J5'%KLQU[0@M
M-6C%[IW59C0!AGM3Q[ .O:.\'E'[K9\%1&XW;"8#C[O-LH#B:'-D<^\P$9N;
M;R/!DE(_BJ"?Z"+%DA)(XSB$4>"+*/%($-AM<$P'GAI!??QP\^;#QP_W']Y]
MG8';SY_^X]V7^P]O/KX#=U_>O7_WY<N[M^#K_>?;_S,#-Y^:'__M\\>W[[Y\
M;6,WW[Y[_^'VP[W;V$U+#AL"_8%Y['0LYR#T98O.J.&=KT-CMI#8AGNZ2/*]
MRU=,"%YHZ3\4Q9HHS5;RH.CN/(V"**"A!P/L$8C2!$$BL >CA(0,"<P1,J^G
M:33DU"BL%;JI?M:(K8MJEIM*TZ([4KHO^-WL- RD _/2/IH?=M \K-OM'$V+
M5$SGJ(Z4;>D 7;M,2BN@.I,ES9XT7CZDE69[*8]V=_:N[5)U9&X[,W]8WC"F
MFW 4=^1%9U+.TT1@7T@*!0]B1=P^@CAFRB!-@UB&'O$9L8K9OSCBU'B[%0\\
MU?)9UW6Y +"9Z>@4MH&YN945_-!*^R?M5-L >7<!R#ZE7LS <5WPY<*H8Y=]
M,0/A1/$7PQM[>N'8-\'7"_%9OB/Y,EL^%&W+A;?98EWJ0I5UMO;M@A3%O?A>
MOE%Z_7T>XM"+*(XA\XFOPU<8)%$:0R\5W N1GXK0JD%/3SFFQD>M&GHU;A79
MMB&9@4892T==SSDR]-T-C_S0[CPST&<Z1J2I-U'I,M.%*1;KJD7;_6^K^I?@
M)U%^6W'PZWU5HD+K"RJ%7?H"KX/<K7NPIRSC>@RO ^S(B7CEX_I1[>%8VP^5
MZ+8S4>+!-!+*C,,T460J(RA)C"AE,44DL>NE=78LF\]VG.Y9ND",K@]2?;%M
M.9C.IDV6Z)K1H!/$!B:Z8W)3-#4$05T$PRD%G1]M5)*YJ/0AC5R^H6>B=MM4
M^MUW'?ZUV[V 1FI#C07$/,80A22 5"88>IQ3GW,9^[%5]X*S(TW-KMHV11>-
MI);=",YC:D8/3I :F!ZV(+5"#G(4<!$*MXG99T<;-R?[DM)'Z=@7;W!>ZNKF
M<967V7]7[L=FU/\4)'^O7K Y9P)C/TA@Z'FZ%G"20AHD$L92\M@301HE5IZB
M?F),C5;4.Q<YJW/5!;\9R0P/ZL ,U%D+:U;1$JOB['>TF0&M"-":C%(?RP#)
ML2IF=8DRE1I:!G!95-4R>5I/1Y8^/]6>>,'?KG/%NW7H>]5%M/K;07 \GQ/$
M0B_R/$@X0Q!%?@HQ0ABFF%&NR))&=LYS:PFFQH:;K)>5;)H6KVJ)+=U5UC-A
MZ*@:$M^A7505G+7PH)9^DWU4*3"K2Z"VB4J;#*3SKD)[KU-?_-SZFZRE&-?3
MU!>D(Q]3[P?99Z#_I CW<?W8I(<PX458< )1G#"("*$P%=B'<8"X$+'/(FS4
MXN7HR5/CJT8X\TSS?9RZ6><J[0=FDT8NAWDR9[6].J5\_ZFCI9*?5&8WA?ST
M!3T]NWF^RF]7>:ZL6_U-WRSYG?K8\_J3WZF._$44;>;ZFY>=_V@N7')E'ZV7
M954 (9 Q$2F/8$1\G1C#$Z@LDA1Z2<Q\)HB@=KZ>(82<&B-4.H*MDC-PK\:P
MJD@QZ)P:NJ)?>::&]F+WFB1['_: *+IU?P\AZ+B>\P&A/G*Z#SE63W]]_D"6
MS:;V5HFT6F2\SMG6LHFB#0G\+-7.F"Q91A:; B;%MJG/]L2*1<IJ8XF BOXC
MB'2[8K4S372*)$UUY(6?VKGY'0LX-=K_1$K=J$IM6]^LBVPI.OI6CC.!AF<*
MKS@M0Q]%[*@V WO*59D*N^KI>=LH"+8:[O4@&^28<Z@)<'L XEK(<<]-!H+X
MZ+AEJ'&N;,LHU#K$1/9<19.RP/<10CX,F)\H7@\PQ%$L81K[7H*Q1!);5<8]
M.<K4R+EI_E.2[R#?"-FS_^(>FF8D>S5& S/EMN>B*,!6P@&J278B,4RWQ;V1
M7J?/XBEESW98/'EQ/P9H$P3>[R0(?)8_"9ZM'^]%_OAI58IBSB3E 0XB*,)(
M0(0EA6G".(P)DQQ'."9!:L,(1J-.C2'V$UK4B(]@L2*VQPYF@)N1AG,8!R:1
M\RE!M<RP K62VAV?6('DE%_,1AZ5;ZS ..0?NYO[\=%?\U51Z$+<63F7J1?&
ML0B@1T-=FS:(84J]$(8R3A(D/66G4)N60SO/MN*6$;H+5:*!ITHV.S[9!8PH
M2)#D%(8>1Q"I[3<DG'J0>9[PN<\2CT@;FNX+V AD7 -V=R5@9C3;$X:!R=0(
M 6NV/*&K4T[<??ZHS'="L4-^.W5)/Q9[0Q::'+]^$Z+\J#%76[JWJT>2+>>8
M"V5)80EQJ@N)A8)#'$8A],*0R8 3]05;5>,X/]34/ME&4E")"EI9P:^UM);G
M'AT(FWW4;G ;^!OO"YGU9W\9#:<LT#'<J*1P6>U#CC"XXQI7C,XPT>:5[@60
M+=?9\J$)T%TMBS="KG*QLPG\*5NN\JQ\^;!4GZ\H=*.2_:?4Z=UUIMB'Y;-H
MCASFC")&PE3 5$@&$?-#2/Q$310B"?&"R$]T46]SPVI$V:=FN%4I0;32#F1;
M%Y*RY)XSW4FFCP=IG)? QB\UN:D=Q]O5= *O=JM;U<%6]W;FFXI&34[FCDXS
ML.LXFX&J;NFR5#HL])-:B%Q[ST:=KP%\<N/(_PJ>OE$GYK3_<%P1>D9)B^K[
M^*M8*LD6^A"</V;+3&>FE-FS:$*RYQ3'OHC]%'(1QA"AZ@!:^,JTYI[TPU#R
MU"B$T&[8J=G5C=0S\%#+79U<DCW)+2.CS= W6T#<8SHP]V_@_.L.G/M"MXEK
M#H.>K5!R&^EL-O2XX<U6<!S%--O=W:->W4$!I=NJ$;@V]^[5U!2Z/-Y]3G3!
MAK?DI9C[G F?! 02J5L6TUA [ <4,D235(:Q9+YYW3JKH:=&59_6.HRUJE=7
M"PFXDK+J5:<KBZL52+!U]86IWV^N>:I"H=2?JZ3[.N7C<5V40'S7_FAU7?;P
MH![+-E@H^[NK(<JU$]K-?,-.T\#L=UB;K8J*:42?@8WPH)$>:/$'P]FB2MY@
M>(]4+<\I[G9U\WI!UUD_S^Z)X]71ZZ7I7CV]?D_H9P2_%5+DN>!U))"XU>V9
M/XERCA*"HD!R*-6K!%&$*$PQQ>HG1L/0"T0HY7PI'D@IN)G=>V8DH\\$UY_)
M[GC#?26MH$#6T5'J0^C1M?H<L&8&[35@C</A;P4MMZ?KE8 SH$1T9ZY>P,"I
M?7INK%$-T@L*'UJ@ER[OZR+F0IY/6G[S\A/YVRJOBD'5O5VQ%W".*?32T(>(
MQ0Q2B7S(PABS0+&%GQKU=NTY_M2,SZWX<'$R\[_HE8%C.RNF?M?!L![<=WHM
MS#V<GKW <NRXM)-A9.=C+X".'8C]'M,W-+%AT2H/N2I=5=RLRV^K//MO71=!
M1(P)+X&A2"A41I&$A"J#*)41(R)F,0VLHI2[AYL:F6VDK??#L[J!; '(1N*J
MQ6S]6\N^LA> -R,P=W .S%=;)+_62-:R@JVP+F,134!Q'(38.>3(T8<FZA^'
M'1K=94<R7&3S9JOV]>61KA;S1 9>X@<$TDC] U$20ARED?J'1$'D!6DLC7IX
M'3UY:M31NA!JZ<RHX1BN;A:X"H2A75QF^AM_W&=U/?$=%X+]^6'U_*.ZI_Z$
MU0_5EUM]L\=/&N7S/*M ^R6>OZ"'[_P]R?*JO,AG^6FUU,VQ=")4QILSR#JS
M06V=5GE=>J2M/#+'/@H$]2ADS$-ZP?=@&B(/(AY'(55?+O5C8S=Z7RFF]C%K
M/<"S5D1[U9>ZHZ]N%,=VE6D2FK3;9)4WQ9* :!2R<-[VGCD#?_D8\S$PK^Q,
MQ6>I(SU@U;-O3P_0*@*4)DT5I4T1I3&FPL*E/L:4C.1='VYJ[%SMUT+:Z77O
M_?#Q'/#7ZK_GB[_Z83T6KQO&\K7@7P0E.DV+$QE'V,,PCI6YJ*,G(>5> (G$
M0G"&PS@T7Y+VGSVUA::13JTEE7@67'6 F<%BT!^)@2F^!>'+M2!8T'!_,$8B
M5U-0[*CRM-J=!'APRWBT=EK6/;(Z<\G5K5^;].MMLU<FN/12'^+$\Y61G'"8
M!G&@S>4($XPDC3V['@WG![-Y%\=ITM ("!9;F2T+L'= :^;W<@/7P#RV(^0F
M@W_H?JQGT!BJ ^OA<*_5<_6,VAU=5L_=T9,K5LL'G9RK#X5_T@6(JC&^B"?R
M4D7J?I9W>;9DV1-9?%AN"H$KEDA]GW(8>[XN.HPYI('@,(D\3&.?,S^F5CVC
M^T@Q-1/(O@Q[/_ -B69H2(?F("4_U H K<$,-#J\#%)H_2JPW%)4+TG&9:]K
MP#HBMJL>UH_S]%[P_6+UV]?UT].BJIU$%MOB23NMYYBO[I=1#&,>*)KS4F4M
M^2B"<1(IFDN#%,56[0%-!YX:L^W*NUO/;"5!Y2C1.E5Q\!O729WKH=WH^M?O
M-^%8-ZS,GJLIMF-*XRDS(\<A)F)@/MP /0-GIJ,8J+Z<+5A.^=!X\%$IT!:2
M0]:SOM^^FOI.K= JKHA@3R28>3"1,5=<AA"DH0@@)81QE J/)D:%!4X\>VIT
M]474R;6:GZJJJDV3 JOXK5,8=I/+E<@,S!]]0;$JOGY&_:O+KQ\^=[0"[&<4
MVBW!?NZ2OE'=M#Q5BS7@ >%$II#AB$"$XQ#B1.VX@B#U:<RX((S9F")GQIG:
MIZS-0[#9!=C&<9^&TLQ$< #0P%]T%<<]>'79"S@XCN4^/=;(L=R="A_'<G=?
M[J#N8IMO_47(]9(7\R!-O"").)1<P8B$QR$.N(2QEWJ<^9ZDV"@4R62PJ1'"
M>\&KK-NZ$*L6\8KZBH? FC&#*[@&IH>#:HJ;.A.@$76@$HIG !FN<N+A@*]7
M,/&,ZIUU$L_=T[,P@HY^?$,*P6]7CSJ-N2X>G>?JQ6AZ"&PON:M=+#>_D9SO
MMW'2A6-_$=G#MU+PFV?UO3V(]G3\3F?.SEE$2<H2":.J2AD*)"1$8AC&H<0^
M4UN)U,K_.Y+<4R.S';&K<&R^6BQ(7NB,YCHTVS(R>ZSI-^/)"4[JP)1;J:-V
MU$H?L*LSV%$:T!>P>UVC.*@TG[6=\V9@1_L9:/4'#0";P"-PUYG);E]H8MPY
M<UNI8B39QRUU,>Z$'-7*&'GXOIF/SVK<5?YR:KOGA9&7A#Z&E =<=YOWU%I%
M(HADP*.0AG'B!W8A#UW#32_H82.M;=YB!Z9F"X KG 9F[8V8PV^F31!QG';8
M,>#(.8:753].*#2XIV?<@R@*(3X*Q5O%W6J1L9<=7UL24TI" ;G'U/X:*^Y(
M>>)!1 +*/!DADEC5R>X8:VH6:2VD911#!Y2&L0IN !HZ(J&2<@9J.<&OM:1@
M$*(P0,1MV$''>.,&%UQ6_"B$P."6WEXXM14K7^[4>Z!K&^JJ+D^5B;-L:S=4
MPW[1ELUG^7-19SK?,+9^7"]TP9.WXBD7+&M[..TVCI_S.%*62<(ACG6A%J0#
MPQ-,89P$@;)81"A]KRW4<F_ES1M.:*//<;_FR_THM%44@&PU 'Q'!6L'X8!S
M;NQA?.4I',U%6>DY Y6FLRI89*/L3NB(J$D75 K#E81*Y;I:Q SL: UVU:X+
M,^XH[M3A.?S\N/:8#BCQV"[7X<$_X;,=8=!^JY0:1+> S98/U>J7B6(3DQYR
MPE/,4AA1&D/$&(:$AQ1R9<(*Z8?8][&-)7M^J*D9LEM)02NJ202[+<!F?.X&
MMH')N"=BUN1Y&0RGS-<QW*BT=5GM0\XQN..*4R)ZV:E'SSCU/J_+HE2KJY+L
MP*GW1>A6%^KWNGJXEG1-%CIZ(YB'GHR],(EAC%D(49P0F*9>#%D0^F'* TJ1
M_8G1N#I,C>)V5*A.CUX$R6UK^;S&JV!Q>C3="?X=G23M(''B)&F#!MB!HPJY
M<GRJ]#ISZ?Z$:60]QC]M>IV).GGR]$JB],C\KTN7ZVR5%5^SLIB'D8[41 $,
MA!00"20A)B&#:>*S()$)17%@G/M_^/2I+45-X?;/.K2XEM B]_T(NNX%XFI
M!J9NMUA85 *X!I.1:@%88&-7#N"<[IT% 8YN&J\DP#EY]XH"G+WH^I84NMZ
MT'.]DA^6ZD=2*#[,22G>9L\9%TO^7NAD/#$76"18L@0*D7H0(::K:B4A%.IW
ME% OY,S(;K]&B*FQW49NG4N1;22'6G3 &]F!K(7OW_W >(X09IR'40R3B$B(
M F6[8!QRZ <\#K"@DB3(+,)AK%D:)_+AK5"& M_,2 '4C'T5N79LO&GZ)Y15
MW>&#&I\C3)G!$C?"- R\$AXWK=C[<CX<?#FM(N#]:%]._PXB0TS'J_42<3,M
M5[45L<73IL&(\;-?K=6(K?9=34>LG]73B<B^";Y>B,_RW;)4P_ZBGOUA*5?Y
M8U->[5DLUZ+J ?A=+<I+LKA=%^7J4:W/;UY:B^9FR14A/V=L-X4[3M7_1"B$
M"4LX1 F/U<[)5YMQ(=1*ER!$I56JVV"23LTN^;I^?-2?M?J(/XD2?"4+M=+1
MEXVM79V(MKJ!>S6^I;-PL"DW= E.82('7C,;)>JDG5:-S:0=3V>K"_CUODHC
M&"0::7#@W7KI!I-V7%_<T* ?>=P&'["/7TV!18IOV[HA.M_RP[(H\\I4NE'_
MX/J']T+,TT#M@B1*8,H\"I'NH8BI)V"2R$#&:<C#Q.BTVW;@J:T#&]G4'E3H
M3<^;^SJ'^N.*&$9#66-OXK,;!M&AW7EMS>RMW#-0M]#:B*XLZ WD2OJ!(+9Q
M!0X#]5A>0H>06[H1[7'K]C!:/&]$YZ.]EOM^R1[W]ZS45?5TK9PR52GG>1H)
MQ?&)#R,:2NV.#""EOH!IHG8'/HNC-#4Z53DWP-2H_':GJ>U?P/_R_NQY/G@B
M3;7ROP _36:1Y\T\SSMN\:/^[ >SQ MG.(A!5A2Z#*\V&GW?GZ6I/\-A"E8[
M402D!/^^7HI__*,?>W\)O1G0;W1SQYD'>>HAWBQ X>&#W@HFM/NZ>9A?/<RS
MK/IU./UF^X1K)G7@U:29SZ:54"7=K.K%Z+*-T#G]W1;F.AQDW )<9U0\*K1U
M[KJ1\^MKU\R6(XO/Y3>1WW\CR^:X^M.JJI@G^,%A]5_5H\NWI!2;<O;S,!$L
M8B&&/DDBB-17!:F'?>A+(E,O2K%'XWG=%/MK2?+2T$LR =5L/M1#!8?[9G]N
MQ)^!-^(A6U:Q,F_(H@I+?]6L?9<O52HCZ7N1A"GGJ5I8*8$I8CX, L0XQY$0
M7M"\5.^6AGV#IZ"8_2O5JC?&"_6N7B[_Q[U-AOZ\"8@Z(=O 0<Q?#<S.-JD
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M8>4O6?FM[9CR[CM;K+6EI$\-U/_Q>_)]'H>IGZJ] B1A$.JV)CXDND@LXBS
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MQ4-$ +8U2N*>[P\7.Q$!A:.(BAC?ZW@H?G#X4N0"0L4T,-(T1U[4H +D%+F
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MQ45;.UU9'']IL#N+BP8<7EI<?J#K.OS#?FA9/E^H;I-G".<8%L#ZUA3@(A-
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M0X2.C;Z.&MCLM$ZV:L=H"G1] #SW,)%A[7LS<S^B]S0$N@E17_V K@M^J79
M-Z%HZ09T^]T7JLOT^Z^G65F]Y%F7*5>4"Y&"S!V:8I5+P"DC(,T,S7,M5,[0
MH'69 @T8&V'^_;@JDW;6C*4F4^AO(]+=Z0N.^ @N4+UK,AW \,]9DZGC.(ZK
M)E.H$>.Z4.UIB*+79.JJ1[=%]??'I_GR6>LONOQAOW99^P_+IJ)>I>>J"JL[
M_/O7R]7ZPW+]'WK]6<OEM\7LOYN.I8U)4P.QUIG 0*4$ 2P, TRD!N0:YC3G
MA*(\Z,QC$*W'MGS6T8R;1;G3-I&'Q*I#"B(,._Y^J^7H1G7 )7*W\NV)8I+L
M;#U>$">),]+^[3IYUNMD;^<D>7ATN:OQ%KY!AR3J:C>,YH,N<8,.QNFZ-JSP
M\':QG\JEVLCUQ[)1L,IZP4I3E>,,I 6% ".6 ::, "RG3&>(\8QYQ0I=$S"V
M):+1,>$+E31J!F4B706RG<!CP-,SUW9 )JA9;)OY=_>+O?CQP5K&MIEVV#6V
M];G./0">=+E^_F3'<OVPJ"(/G]S:^-5^K^EEG!62Y1)EP*0TM[YEEMKIG14@
M51E*<YYG&LG +@"W9(YPVE<J3Y)*Z>I'OE-[DCC% ]M&APR GW,7&=:>Z:)J
MJU37 ?UZ5 4T8H_I#LC$[@=P4^[0'0%\@;C0$\#[U:YA-ZX$8/FTK/?FU7GW
M:^=LE\^OETI/)>(YD@0"KI"P-,2L9V]( 4RAC> 8:T6\^B]YRAL;!34A*4<Z
M3^K.S8FK<%1KGCC50Z-VVG'W#>2)AN8PL3UW =DAZ,<+GCOB@-J_/W!HD)>Q
MY]%"?J]UI9<OCWP^?[59S19ZM9IF*>09+ C(N6NHF6$.&((,L+00J8"Y3M,B
MC$Z.OC]2^JAT3+9*AA+%,8*^Q- 9EV&(P!.2#E/^HN%W3/'C[PT\I2\:<SZ%
M+S_6=7.BC2[+Y@3C$R_MSL>1@OJ[ZS6XS>R?I@*G%*<,Z((1EW]3M<;5(,,I
M5JFF- OM4N8C=FP3?*=UW9ILDCSQLF[*&.7^UW,L?+<JL1'N_7!C"^Z7&ERK
MLW,6:JV32FUW:5K?M<;<N80 %7GSXB5ZX/U+"!SG6YB@MSL6 U'_N5FMJVO(
MM\OR][)<EJ^75JAT+DVSGS=8I#D5"J32!2AKI0 3F #.B&0\Q[1(@[*0/&2.
MC:TJ)9.]EG>=H?A@[D=,D9'LVX'I"&)X_1%_6.)6)?&0.VRM$G\@SBJ8!+S:
M,=+@N"1F\\-/4ZI3Q27@B%&[SR$IX$2D0)&"$)U;MN%Y4&3 )2FCHY>3TJT=
MB>4RHIYW[??BU#=Y!$,4?K?=!D'<N^B+DH:].VXS]NRNM_7ACI['X[)<S_Z[
MJ7_FLAG>S%95I6WK^#S.-H]39J"6-#. RM05=A ""+M= BE/,\(+"C$-VBC=
ME#@V6GB0LM15*,_26&QGWV8+;H%<K:SWKAK5 UV/FZ![.AXQH>R9.0YUK9O&
MB'6R53?YK5$X8LJ3-SAQG8^;4H=U/7Q!.',\O%_LFIE9[ZKJK 3M(E!6?Y3+
MU6J:(Z5IFBI02)6[JK<24)X:8)#.!68F-49.?^A2+/U3,:_("ID>AQ+[FR5;
M51-39VLLOB72J1N:<'D-7#]>B0)8SWQ2IU-:$J[:=50J3I)*R9A9DS=PB)PD
M>4W:P#F1-XP^3X&\]<*=&8_O9PO]SO[K:EH@2DVN"5 I12[U!P*6<PU(!DT&
MN:4.R3OE-^Y$C,WYV.?>_>5T3"HENV8N[H'TXX'[X.F9  *1Z9Z!>&9\/_F&
M>S$ODUUX9N;57,+S)R.'D=E_;\CDO<N<_NS2+#Z:/U=U:]@'UZK).N6;Q\W<
M'<0>=ARS;QYZ+E-,$>)*9D!GKD]C)MTVADM0,&-TSE7."(P2A19-Y;$1T-;B
M*GI-[Z/7@AN,#3#:#!8<&Z8 QX4&.'4U" LN )2Y2)&!1&L64E-O9*,]0*6^
M?Z;1]KTU'-,8]G[C>!1Q.CD..:W^J[$YJ8Q.*JO!T@!K=QU)N6N%M[?]N#VI
M^\BA^0-$7$8?JF$"-N.I/8YXS^C#X!TN&E]RA\;0#^J'TT#]8[E9J->\U%^K
M,T KH2JT^S==53##2E!.#0<F9=BN09("@8T!RE!!%<92(J_J!/XBQ^8QU#K^
M6Z5A0.=B/WC;2;\?T/H^&6WT32J%$Z?Q)*EU3JS2377ROVJ]0WI!^R$:T PZ
M.K(#=8/V0CA2:^@@C%I[0_M]:;CFT$&6'76'#GNS"S5+66ZT>FW_?B;Y_&LY
MX_-=>QA%L$Z5A$#2- =890K0++7<; 3/#32$:J\&KC<EC8V(&UT3V2B;K"MM
M0QBD#5<?*HZ$5M\,W "UU3.I%;W=DR?TEQA M9&0&XIANR(82*X>J+1S:ML'
M!J12#SN.&=3GA:['[$OY7^XBQ3K.FW*V^%87-ZG"&E>?]<J2AEPWX8]5_OBN
MC<24%L3^,K@!%$,(L*29958H <,\(Z+(44J#NMQV5V5LU+M7M@ZL3J1; .=:
M_9N)T(RH^XCYGOL/,0Z]WP\XW&LKDMJ,786JVI))<C!,]>--08^=/3&O$^[%
M-/*U0V=U!KZ>N!>V\VN,N[\8IU/X_C9.YPS!G*< IJYWCJ044,(A4%I RBRW
M<A(4VGU5TMAH\D([;)^[O$!X/8,>8H#6=]!#-[SN[B%^AD6O?<3?O\Q-Z$VC
M;_43/W]AX%:33;F>CYOU:LT7RG);6XFZS\OYW'HC[L5IRGF6"I8!R%4*<,:9
MZVZ#@))*I/;_*6)A@16#FS V:MNJ#4*K8([E)^'I*HYZH/MV,>_O1KFKI7H
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M@6]W=GDJS^D?L_7WUYO5>OFHRZJGT@>];DK^3"G/*:38>CZPX*[E$0$"9AF
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M^WI:^67U^6ZCN?JP^@??E$Z4J^*0+121,DL-!%1E=D>FJ 0\QRG(<P%10:%
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MA^HT2KK'6(/WP3P(<_7;VRJU AI8%&D!A'1A5!!A('!!@$JARA4GE*F@,*I
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M;%7<U_MK<C<#\S4]D0[FTY[X34VJ.RP?Y6D.BF TO_9$\KE(-@S1/E3; 5
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M%^A3DYXNQ9/?1T2@U\4L/F[64NNZX4U[#E5P"M.,"U (A.R&POY-*(D ,YG
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M<)@4R,RB=9&%I._=WC^\C#G@O3VXC4>AKS6O.SB _S*?YS^FIZ<3F\E$0"4
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M#4YF+;CSLO VV:B[T3>V.SH,&K;F0PPBFNX ]\#(1"TC&JM \US[4B0/CK,
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M9I&C"!C:I+<=0.RX0?4A4/0PN;ZMQ#HX#9_-EZNWI?:)7U]_X>+K-.'R QT
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MAL;%PR9<!W.]@U/SFOK+ 7WSLR_S68W\GGR;+B?1D1%03 &K;:RU>4A*WEC
M%"USQ)QH&T/H,;(Z0=0!\MX$G:.9WP&2[JWA^?PL3&<3LA(R69$)>$)/1[=W
M$+-'L)[3]V-..K>)>CU*3B?(.5[<]]W(HWG? 8!N1>-^QVH13D+*/DO:5EI+
M\D!\1@CH"PC'(ME^#KUM$X!X0,JXP!E O)LK[P_@=0=@V3 V[7(Q419#RU#
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M$;A/5*(UE- ZT)7D;EVURD[_.)\N\/= S)[AXOO)+-]<F.OB54DNTS*,H1-
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M/K&B_FGTTCZXV5DO'2:9T1WOZ\R-YT@$I&FX+B>Y-;[$D=\H'%F/,J>:)&;
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M.0(53(&@:$<E&8,--BD;VU1)[T?GSY3J,LSMU^#2Z^"0_L&:'L3''6JGI0G
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M*)[:E-IM(&C<F/( 6+BO(X9@?'^W6+=WY>'WZ(\\94!MT? &?0-.C(XB(SI
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M,IUO^O,D.!,#>)D9+TSQ8/<KRFY!W;2[AWJ"ZS@"[ O!OR^NUIA?AB\AU<6
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M<UG>W)84*,'JTE -Z U69M6NOGH]<^V*$*QDVR9@.F;DR$GWHHWGZA[&]>[
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M(B=F.1>SKMG@O-M&=%X)KG'%.7"G\ #>=F=H[MZU/$<TZ"*0*M5R6)8A2!'
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M*#YWAI.M&I'>:.,"0O)UW*'4Y(8EH0CX)6M75(JI3:7*][1,:VB.D^T30#F
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MF44?N%!%@HFI;GHF0^Y-<9#I\$IG^F/5:';R. ?8#[5GDA684KC#,>VO,;W
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M6,_3]8@8S<EVH$Y@A'$4-6<)3BOB2Y8\VQQXP,X6:?WH2!VXDAUCN=U#Y!'
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M^D74S\N:K9J5)(*.QH&L^2FE<DVEZ3IZ7$3AM<A"MWE(?I*L+E$U7/C[@>H
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MN@R,?N),@N>%2Z:-)VO;I@)E#^J.O9=O/O=A.:WO\IU),$\ XR RW3**67)
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M'U!+ 0(4 Q0    ( ,:) U-(?Z0VN1<   B"   =              "  0
M  !E>#$P,6-A<FQS;VYA<F]F9F5R;&5T=&5R+FAT;5!+ 0(4 Q0    ( ,:)
M U,R?1!02!(  *5C   >              "  ?07  !E>#$P,F9O<FUO9F1I
M<F5C=&]R<G-A87=A<BYH=&U02P$"% ,4    " #&B0-3\QFN7.<1  !A9
M'@              @ %X*@  97@Q,#-F;W)M;V9D:7)E8W1O<G)S86%W87(N
M:'1M4$L! A0#%     @ QHD#4WK\SA#Z$0  *&0  !X              ( !
MFSP  &5X,3 T9F]R;6]F9&ER96-T;W)R<V%A=V%R+FAT;5!+ 0(4 Q0    (
M ,:) U-,DW-C+ @  % E   7              "  =%.  !E>&AI8FET,S$Q
M+3(P,C$P-C,P+FAT;5!+ 0(4 Q0    ( ,:) U,**RMV+P@  - D   7
M          "  3)7  !E>&AI8FET,S$R+3(P,C$P-C,P+FAT;5!+ 0(4 Q0
M   ( ,:) U.,6+2*!P4  #05   7              "  99?  !E>&AI8FET
M,S(Q+3(P,C$P-C,P+FAT;5!+ 0(4 Q0    ( ,:) U/4Z,N#"@4  +H5   7
M              "  =)D  !E>&AI8FET,S(R+3(P,C$P-C,P+FAT;5!+ 0(4
M Q0    ( ,:) U- 8U?)?S(" /MV&  1              "  1%J  !M9'AG
M+3(P,C$P-C,P+FAT;5!+ 0(4 Q0    ( ,:) U,.:.M[_!   %FO   1
M          "  ;^< @!M9'AG+3(P,C$P-C,P+GAS9%!+ 0(4 Q0    ( ,:)
M U-QCW%:UQX  "0I 0 5              "  >JM @!M9'AG+3(P,C$P-C,P
M7V-A;"YX;6Q02P$"% ,4    " #&B0-3W9!]H81)  "C)0, %0
M    @ 'TS ( ;61X9RTR,#(Q,#8S,%]D968N>&UL4$L! A0#%     @ QHD#
M4U*4TE((W0  $#@) !4              ( !JQ8# &UD>&<M,C R,3 V,S!?
M;&%B+GAM;%!+ 0(4 Q0    ( ,:) U.:R?.N:(<  &(C!@ 5
M  "  >;S P!M9'AG+3(P,C$P-C,P7W!R92YX;6Q02P4&      X #@#- P
&@7L$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
